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XPart 1
P R E F A C E
PREFACE
The estimation of the viscosity of blood plasma has attained 
an accepted place among the accredited tests of clinical pathology. 
The original suggestion that the plasma viscosity measurement 
might be valuable to the clinician was made by Miller and
Whittington (269) in 1942. No-one except myself followed up this
suggestion.
I worked at first in conjunction with Whittington and 
Houston (successor to Miller) and later with other clinical 
colleagues. All the interest in the test shown by other workers 
dates from the later papers of Houston, Hkrkness and Whittington 
(1945) (119) and Harkness, Houston and Whittington (1946) ( 99 ) 
and even that of Cowan and Harkness (1947) ( 54 ). Thus while I 
have no claim to the original idea of the estimation, I may claim 
that but for my intervention it might have sunk into oblivion and 
I do claim that I was responsible for the major part of the later 
development which led to its present status as a valuable test.
This thesis is based on that portion of the combined
researches for which I was alone responsible. It is based on
eight years work.
3The main thesis consists of three parts. The first part 
deals with the investigations into the fundamental technical 
aspects of the estimation of the plasma viscosity; the second 
part is concerned with the plasma viscosity in normal persons 
and the changes in response to physiological stimuli; and the 
final part describes the changes in the plasma viscosity in 
disease.
An Appendix contains the details of the technical methods, 
the tabulated results, and some selected case histories. Reprints 
of the published papers are included in a pocket of the back 
cover.
4Part 2
I N T R O D U C T I O N
5Part 2 
INTHODUCTION.
§ 1.
Life on this planet probably began, in water, when a 
fundamental change occurred in a small mass of protoplasms and it 
became a single cell. Evolutionary development led to organisms 
of larger and more complicated single cells and later to organisms 
of more than one cell. These early forms of life, if they were to 
survive, had to be capable of dealing with all the changes 
occurring in their aqueous surroundings, eg. , changes in reaction, 
temperature, chemical constitution, etc.. As the organisms 
increased in size only the outer cells were coming into contact 
with the water, while the inner cells were protected and thereby 
given scope to develop special functions, such as the contraction 
power in muscle cells and stimulus conduction in nerve cells.
All metabolic processes take place as reactions between 
substances in aqueous solution and an internal system for the 
transport of metabolites in solution was also developed. To 
Claude Bernard ( 18 , 19 ) is the credit of first proposing the 
hypothesis that the larger products of evolution, a group 
which includes Man, live in an outer variable medium of water 
or air with which only the outer cell layers (plus the lining 
of the alimentary and respiratory systems) are in contact,
while the inner cells live in contact with an internal aqueous 
system (his ’milieu interieure”) of almost constant 
characteristics. Although the internal medium maintains a 
constancy of its composition and its properties, recent work 
has demonstrated that this constancy does not arise from a 
static arrangement but rather from a dynamic equilibrium in 
which a balance is maintained in spite of large reactions.
The fluid within the human body has been divided into 
(G-amble (86)), (l) the intracellular fluid forming part of the 
protoplasm of the cells, and (2) the extracellular fluid 
consisting of (a) the interstitial fluid - the fluid lying 
between the cells and within the lymphatics, and of (b) the 
intravascular fluid - the fluid contained within the cardio­
vascular system of heart, arteries, veins and capillaries.
It is again stressed that these fluids are in equilibrium and 
any alteration in one part of the system will produce an effort 
to 're-establish the equilibrium by changes either in this 
primarily affected part or in the other parts. Alterations in 
the fluid of the cells will affect the fluid of the blood.
The blood in its course through the veins comes close 
to the skin at several parts of the body, especially in the 
antecubital fossae, and is there readily available for removal. 
Records show that from earliest historical times blood has 
been removed from these veins either to be studied as an aid to
diagnosis or as part of therapy. Prom the appearances of 
blood shed from these veins and allowed to clot in a shallow 
receiver, the Greek medical school of Cos (B.C.400) developed 
the ’Humoral Pathology' which affected the principles of 
medicine up to the nineteenth century. Venous blood, allowed 
to stand and clot, shows four layers:- an upper liquid layer 
of serum (= yellow bile of Greeks), a layer above the cells, 
known later as the ’buffy coat’, formed by the contracted clot 
of fibrin (= phlegm ), the upper layer of the erythrocytes 
which have more oxygen and thus a redder hue of oxyhaemoglobin 
(= blood), and the lower layer of de-oxygenated erythrocytes 
with reduced haemoglobin (= black bile of Greeks). The four 
humours corresponded with the Greek philosophy of classification 
into fours - eg. the four elements of air, water, fire and earth 
and the four qualities of dryness, moistness, warmth and coldness. 
The proportions of the four layers in the clotted blood varied 
from person to person, and in the individual in the course of 
an illness. According to the relative proportions of the layers 
the Greeks classified their patients (eg. an excess of phlegm = 
phlegmatic) and their treatment was directed to restore the 
balance of the layers of the blood. Later, the bleeding of 
patients as a form of therapy had as one of its objects the 
removal in the shed blood of the excessively large layer and 
thus a restoration towards normal proportions.
In the eighteenth and nineteenth centuries several 
attempts were made to correlate the blood appearances with the 
clinical condition and the chemical constitution of the blood, 
but there was little success in either field. The examination 
of the shed blood was one of the things which was neglected when 
the work of Virchov focussed all attention to the cellular 
structures of the body and their changes in disease.
In 1918, Fahraeus (73) re-introduced a modification 
of this historical examination of large volumes of shed blood.
He used a solution of sodium citrate to prevent the blood from 
clotting and studied the rate at which the erythrocytes 
settled out in a long narrow column of this blood held in a 
vertical glass tube. He found that the rate of fall was faster 
than normal during the later months of pregnancy and proposed 
the use of this measurement as a diagnostic test for this 
condition. In a later publication (74) he studied the rate of 
fall in other disease conditions and he attempted to correlate 
the rate of fall with changes in the chemical composition of 
the plasma. This test was first known as the Blood Sediment­
ation Rate (contracted to BSR) but when it was later realised 
that it was only the erythrocytes which settled, the test was 
renamed as the Erythrocyte Sedimentation Rate ( or ESR.). 
(Fahraeus ( 74) gives an excellent bibliography of the work by 
earlier writers who studied the rate of erythrocyte settling,
including that of John Hunter.)
Since the original paper by Fahraeus, over 3,000 
articles in the English language alone have been published on 
this ESR test. Nevertheless, the knowledge of the chemicals 
which control the rate of fall has shown but little advance on 
his original work and must be regarded as unsatisfactory. The 
variation in the chemical constituents of the plasma and the 
ESR have formed the basis of numerous papers. It has been 
shown by several authors (Fahraeus (74-, 75), Tiffeneau and 
Gysin (24l), Frazer and Rennie (84), and others) that there 
is some relationship between the changes in the plasma proteins 
and the changes in the ESR, while some other workers (eg. 
Bendien and Snapper (15)) go so far as to give a formula by 
which the ESR can be calculated from the protein fractions. 
Unfortunately, while this correlation formula may yield 
calculated values with excellent agreement with experimental 
results, the discrepancies can be frequent and large. No-one 
has yet demonstrated beyond question that the ESR changes are 
caused by changes in the proteins themselves and not by some 
other factor or factors changing much in the same phase as the 
proteins. Gordon and Wardley's (68) recent experiments with 
artificial plasma built up from purified protein fractions 
were unable to settle this problem.
I have had a special interest in the ESR test from the 
occasions when it was used to investigate an illness I had 
while a medical student. In 1941-42 I spent a year in a study 
of the haematological changes which follow the exhibition of 
sulphonamide drugs - I was investigating the claim by 
Browning (34) that rheumatic subjects are more likely to react 
severely to sulphonamides than patients ill from other diseases. 
Among my battery of tests I had included the Westergren ESR 
and I found that in serial testing the ESR might increase when 
the drug was given to a normal control subject. (See Fig. l) 
This research programme had to be left incomplete because of 
war-time staffing difficulties. I transferred my research 
plan to an investigation of the relationship between the ESR 
changes and the alterations in the chemical composition of 
the plasma as induced by the sulphonamides. I hoped that by 
replacing the study of random pathological conditions by a 
controlled physiological experiment I might gain a success in 
a field of research in which so many previous workers had 
failed.
§ 2.
Following Fahraeus* original publication, several 
different methods were suggested of expressing the rate at 
which the erythrocytes settled in the column of blood but
11
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there were only three basic forms, ie. (a) fall (in millimetres) 
in a fixed period of time (usually 1 hour); (b) time (in minutes) 
taken to fall a fixed distance (18 mm. ); and (c) the rate of fall 
at that period when the velocity was maximal, the rate being 
expressed as a distance relative to time, such as mm./hour.
In 1940, Day ( 61) introduced another modification in the manner 
of expressing this rate of fall - his "Sedimentin Index". He 
measured the fall of the erythrocytes at frequent time intervals 
and plotted these figures on squared paper, time along one axis 
and distance of fall along the other; the points were joined to 
form a curve; a straight line was drawn along that part of the 
curve where the velocity of fall was maximal and from the slope of 
this straight line the distance (in millimetres) fallen in 100 
minutes was estimated. The logarithm of this figure was his 
sedimentin index - it displaces the conventional units of time 
and distance. Day studied tuberculous patients. The novel 
mathematical treatment of the results rather over-awed Dr. A. K. 
Miller, medical superintendent of the Cross ley Sanatorium, Frodsham, 
Cheshire, and he passed the-.^odmal on to Mr. R. B. Whittington, MCc. 
lecturer in hydrodynamics in the Engineering Department of 
Manchester University. Mir. Whittington had a special interest in 
hydrodynamics and a personal interest in the ESR test. He decided 
to carry out some investigations of the haemo-mechanies involved 
in the sedimentation of
15
erythrocytes in plasma using "blood samples supplied by Dr.
Miller from his sanatorium patients. The results were 
published in 1942 as four papers (249,250,251,252).
As the erythrocytes settle downwards they have to 
displace plasma and furthermore, plasma has to flow upwards 
into the space vacated by the cells. One of the factors which 
has to be considered in this process is the viscosity of the 
plasma as a highly-viscous plasma would resist both the 
displacement by the cells and the flow to the upper part of the 
tube more than a less viscous plasma. A plasma of low viscosity 
has been included among the factors producing rapid ESR values 
by the writers on the ESR test who dealt with this aspect only 
from a theoretical aspect. However, in his actual experiments, 
Whittington found an apparent anomaly in that the rapid ESR 
bloods frequently had a ~ plasma of high viscosity. The 
correlation between the ESR values and those of the plasma 
viscosity was not linear. The 20. estimations of both values 
were reported by Whittington (249) and Whittington and Miller 
(252) and on a scatter diagram these 20 points were joined by 
three curved lines. (This 3-curve diagram was to affect all 
future work on the plasma viscosity estimations, in a manner 
not-foreseen at the time of the original publication. ) (Fig. 2) 
They next considered if there was any relationship between
14
Fig. 2
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This figure has been traced from Whittington’s (249) paper.
The citrate plasma viscosity has been multiplied by a hundred 
and expressed as "stokes'1.
”N" was the "agglutination number" and represented the ^ize of 
the aggregates of the erythrocytes at the end of the first 
period of the sedimentation curve.
The sedimentation velocity is related to it very closely.
"N" can be calculated from viscosity measurements, but as 
with other non-Newtonian fluids, the value of "N" depends upon 
the characters of the particular viscometer in which it is 
measured. Whittington obtained a correlation between "N" and 
the sedimentation velocity (V^) according to the equation -
N7*7 = 0.759 Vt
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the plasma viscosity value and the clinical condition of the 
patient from which the blood was drawn. They found that the 
plasma viscosity was generally increased in tuberculosis and 
that there was a correlation between the degree of this increase 
and the severity of the clinical condition as assessed by the 
Ministry of Health scheme (166). The results of 63 tests were 
published in the Lancet (267) with the recommendation that the 
estimation of the plasma viscosity could aid the clinician in 
the management of his tuberculous patients.
At the end of 1942 Dr. Miller left the Crossley 
Sanatorium. Mr. Whittington knew nothing of the proposed 
successor and of any further work on the plasma viscosity in 
the Crossley Sanatorium or elsewhere.
§ 3.
During 194-1 and 1942 there were several articles on 
the ESR test in the British Medical Journal which resulted in 
a lengthy correspondence. The final letter, by Hilliard (113), 
quoted Whittington's papers and I worked back through the 
whole series. I was specially interested by the relationship 
between the ESR and plasma viscosity results, and by one 
sentence (251) - "In the case of viscosity, for example, 
though as far as we are aware this has not yet been studied, 
it is inconceivable that the plasma protein fractions should
all exert the same relative influence on the plasma viscosity 
as on the agglutination". ("Agglutination" is the clumping of 
the erythrocytes into aggregates which sediment together, and 
the ESR has been shown to be dependent largely on the size of 
these aggregates and thus oh the agglutination. )
I then had the idea of including the estimation of the 
plasma viscosity into my scheme for the investigation of the 
ESR test. Whittington’s original 20 duplicate estimations of 
plasma viscosity and ESR indicated that if there was a 
relationship between the two values it could not be a simple 
one. Yet I considered the possibility of correlating the 
changes in the ESR with those of the plasma viscosity, the 
plasma viscosity changes with those in the constituents of the 
plasma, and thence indirectly correlating the ESR changes with 
the constituents of the plasma.
Therefore I travelled from Montrose to Manchester to 
discuss Dry problems with Mr. Whittington and found him, as 
described in the previous section, with his colleague,
Dr. Miller, due to leave the Crossley Sanatorium.
§ 4.
Whittington and I found that our problems and fields 
of investigation overlapped and we decided that by combining 
our forces into a common plan we could better tackle these
17
problems than "by continuing in our individual researches.
We decided that Whittington should continue with his academic 
research on the viscosity of pure liquids and with such plasma 
as he might receive from the Crossley Sanatorium, while I 
attempted to find some correlation between the clinical 
severity of a variety of diseases, the chemical composition of 
the plasma (especially the protein fractions), the ESR, and 
the plasma viscosity, I-was to idd other physical properties 
of plasma, such as osmotic pressure, specific gravity, and 
surface tension, when I could obtain the appropriate apparatus. 
This partnership has continued since (unbroken even by the 
departure of Whittington to America in 1948) and a series of 
papers has been published on our results under our joint 
authorship (99,100,101,102,118,119,120).
§ 5.
Other Collaborators.
Dr. John Houston succeeded Dr. Miller at the Crossley.
He became interested in the researches and assisted both by 
giving Whittington his laboratoiy facilities and by dealing with 
the clinical aspect in the choice of patients and the assessment 
of their clinical condition.
Dr. Ian C. Cowan, director of the department of physical 
medicine at Sunderland Royal Infirmary, assisted us in the study
18
of rheumatic diseases by selecting patients for study and "by 
assessing the severity of their conditions. We -were also 
helped "by Dr Nicol and Mr Waugh, the other members of the team 
of doctors which controlled the Rheumatism Clinic. (See 
Nicol, Waugh, Cowan and Harkness (182)). Dr Cowan has obtained 
his M.D. degree at Aberdeen University in 1950 for a thesis based 
on his share of this work.
Dr. A. B. White helped at Portsmouth by selection of 
patients fulfilling the requirements for a special study. He 
was responsible for the final assessment of their clinical 
condition.
In addition, many other doctors assisted me in a less 
direct manner by sending me patients with diseases in which I 
might find my investigations of special interest and by making 
available the clinical information concerning them.
§ 6.
As many of the results have already appeared in papers 
of joint authorship, it is essential that the share of each 
author should be clearly defined.
The Crossley laboratory consists of a small room with 
the equipment necessary for urine and sputum testing, plus the 
apparatus for estimating the plasma viscosity, ESR, and haematocrit 
values. Whittington visited once per week or month; the other
19
technical assistance was supplied by convalescent patients.
Dr s. Houston, Cowan, and White did no laboratory work. Their 
share consisted in the choice and examination of patients.
The papers were written mostly by myself, modified by 
Whittington, and approved of by these clinicians.
Whittington (a) supervised the estimation of, and estimated 
the plasma viscosities of Houston's patients, (b) carried out 
experiments on the viscosity of pure liquids, (c) calibrated 
and correlated the early viscometers, (d) analysed the results 
produced in all the laboratories, and (e) produced the 
mathematical analysis of the protein fractions in our 
paper (100).
I, myself, (l) assessed the clinical condition of my 
Montrose patients, (2) assisted in the assessment of the 
Sunderland and Portsmouth patients, (3) estimated the viscosity 
of the plasma and serum of all these patients (3,000 + tests),
(4) estimated the protein fractions and the non-protein- 
nitrogen content of these plasmata and sera,(5) prepared pure 
fractions of albumin and globulin, (6) estimated the viscosity 
and specific gravity of protein solutions, (7) estimated the 
specific gravity of plasma and serum, (8) measured the J1SR, • 
(9) conducted further experiments with sulphonamides, (10) 
calibrated and correlated the later viscometers, (ll) also
20
analyzed the results produced by my laboratory, and (12) carried 
out the series of experiments on anticoagulants, ultrafiltrates, 
temperature effects, etc. (to be described in detail later) which 
were necessary before the technical aspect of the plasma viscosity 
test could be regarded as satisfactory.
There are many problems arising in the course of these 
researches which await solution, yet I believe that a stage has now 
been reached at which, from my own results alone, I can give a 
general picture of the present knowledge on the subject of the 
estimation of the plasma viscosity. Prom these results this 
thesis is derived.
§ V.
i
The plasma viscosity had been measured by several 
earlier workers in a rather haphazard manner but it is to 
Whittington and Miller that the credit should go for the original 
use of this measurement as a clinical pathology test as a guide 
to the severity of the clinical condition in pulmonary 
tuberculosis. Nevertheless, almost identical work was being 
done in China by T'ang and Wang (240) at the same time as the 
English workers were carrying out their experiments; this 
Chinese paper only came to the notice of British readers in 1946.
I was the only person to give further attention to the 
paper of Miller and Whittington (267) and to carry out further tests
with their technique.
The plasma viscosity test is now used in many parts of 
the world by workers who date their interest to the papers of 
Houston, Whittington and Harkness (99,119) or even to the later 
paper by Cowan and Harkness (54).
Thus, while I have no claim to the original idea of this 
test, I may claim that my work has been largely responsible in 
advancing the test to its present state of an accepted and 
valued laboratory procedure.
$ $ $ $ $ $ $ $ $ $ $
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Part 3
P E F I N  IT I O N S
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Part 5
DEFINITIONS.
In deciding -which terms and tests have to he defined for the 
reader of this thesis I have to assume that he has a knowledge 
of the interpretation of the values obtained in the ordinary 
tests of clinical pathology, even if the technical details are 
not so well known* I will also assume that he knows nothing 
whatsoever concerning the estimation of the viscosity of plasma.
(A) Viscosity and Plasma Viscosity.
Physicists are still uncertain concerning that physical 
property of liquids called "viscosity”. The viscosity of gases 
is understood much better; certain equations and formulae have 
been derived by which this viscosity can be estimated. The 
earlier workers on the viscosity of liquids applied these same 
formulae, with modifications, to the liquids in the belief that 
the viscosity of a liquid was analogous to the viscosity of a 
gas. Unfortunately, it has been shown that such an assumption 
was not valid. In the past few years, many workers (including 
Whittington) have begun their investigations anew on this 
property of liquids.
A practical example will help in giving an idea of what is 
meant by the term '’viscosity”. Consider three 40-gallon casks 
containing water, treacle, and pitch and in each we make an
air-inlet in the lid and remove a 3” bung in the side near the 
bottom. The water would gush forth, the treacle would ooze out, 
and the pitch would take days to months to empty out. Each 
liquid resisted the force of gravity in its attempt to force it 
through,the hole and it is to this property of 'resistance to 
change in shape* that the term viscosity is applied.
The British Standard Specification 188:1937 (''Determination 
of Viscosity of Liquids in Absolute (C. G> S. ) Unitsf,) contains the 
following definitions. - "The viscosity of a fluid is that 
property to which is due the internal resistance offered to the 
motion of any portion of that fluid with a velocity different 
from that of a contiguous portion". It determines the resistance 
to shear (shear = forces in slow stirring, flow through a 
capillary, and the like). For quantitative expression of 
viscosity a distinction is made between the dynamic viscosity 
(also referred to as "absolute" viscosity)(symbol = /j) and the 
kinematic viscosity (symbol =^ *). "The dynamic viscosity of a 
fluid is the tangential force on unit area of either of two 
parallel planes at unit distance apart when the space between 
the planes is filled with the fluid in question and one of the 
planes moves with unit velocity in its own plane relatively to 
the other". "The kinematic viscosity of a fluid is equal to 
the quotient of the dynamic viscosity by the density of the
fluid, t h u s ~r where 9  ^is the density of the fluid". 
The C.G-.S. unit of dynamic viscosity is the "poise", that of 
kinematic viscosity is the "stoke". The centistoke (=1/100 
of stoke) is a unit of more convenient dimensions for plasma 
studies as the kinematic viscosity of water at 20°0. is 1*008 
centistoke. (Usual contraction for centistoke = cs. )(31 ).
There is a further complication to this subject.
Fluids can be divided into "Newtonian" and "non-Newtonian".
With Newtonian fluids ( a group which includes such liquids as 
water, benzene, aqueous solutions of electrolytes) the viscosity 
can be measured under a variety of conditions but identical 
values are obtained. In contrast, the viscosity of a non- 
Newtonian fluid is dependent upon the conditions under which it 
is estimated and the viscosity is a function of each instrument. 
Using 'x' viscometers, calibrated with Newtonian fluids, a single
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non-Newtonian fluid might yield x viscosity results, all 
differing slightly from each other. It is obvious that the tern 
'viscosity* cannot properly be applied to non-Newtonian fluids 
as the corresponding property cannot come within the limits of 
the first definition above - but the term of 'viscosity* is 
retained for lack of a better term.
Among the non-Newtonian fluids is the group of 
"colloidal solutions" of which plasma and serum are members.
Thus when I write of ’plasma viscosity' it will he realised that 
I mean - "that property which in Newtonian fluids is known as 
'viscosity' " and that the physical property must he interpreted 
only according to the known conditions under which it is 
estimated.
(B) Plasma and Serum Protein Fractions.
The plasma of human hlood normally contains 6-8 g. protein per 
100 ml. of protein. This protein is not uniform hut can he 
divided into a number of fractions: the number of the fractions
and the nature of the fractions depend upon the technique used 
in the separation. The fractions separate according to their 
physico-chemical properties and not according to their original 
function within the body.
Plasma protein can he subdivided into two major fractions 
called Albumin and Globulin; that portion of the Globulin which 
has the power to form the fibrin clot is called Fibrinogen, and 
it has become customary to speak of three fractions, viz.
Albumin, G-lobulin (meaning total globulin minus fibrinogen),
‘ and Fibrinogen. Thereby we have the same Albumin and Globulin 
values for plasma and serum, as the latter is only the plasma 
from which the fibrin has been removed. This convention is 
, used throughout this thesis.
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The "best method available to our laboratory for the 
protein fractionation was the classical salting-out technique 
of Howe in which the total globulin was precipitated from serum 
by a 1*5 molar solution of sodium sulphate. The albumin of the 
filtrate was measured, the globulin was obtained as the difference 
from the total serum protein, and fibrinogen was measured as the 
fibrin clot obtainable from plasma.
The fractions of albumin and globulin prepared for the 
study of protein solutions depended on similar methods so that 
the results from solution experiments should be applicable to 
the plasma and serum. The fibrinogen was obtained from the 
Medical Research Council, without knowledge of its method of 
preparation.
(C) ESR or Erythrocyte Sedimentation Rate.
The erythrocyte is so minute (diameter = 7ji) that the 
surface area is very large relative to its volume and mass. In 
a column of blood there are groups of forces acting in opposition. 
The difference in the specific gravities of the cells (= 1*097 
approx.) and the plasma (= 1*027 approx.) tends to make the 
cells fall towards the bottom of the tube: the friction between 
the cell surface and plasma, the mutual repulsion of the cells 
because of their electrical potential, etc. hinder this fall.
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The resultant force is so small that the cells would take many 
hours to sediment, if the cells were to remain as separate units# 
However, in all bloods there is another force of variable 
magnitude which aggregates the cells into clumps in which the 
surface area (increasing as the square of the radius) is now 
less in relation to the mass (increasing as the cube of the 
radius). These larger masses are subject to relatively less 
resistance in their fall than the single cells: they fall 
rapidly. There is a sharp upper border where the upper margin 
of the column of sedimenting cells meets the clear supernatant 
plasma.
The ESR test measures the rate at which this upper boarder 
to the erythrocyte column falls and is usually expressed as the 
depth of plasma obtained in defined time periods. If the depth 
of the plasma is noted at intervals of a few minutes in a tall 
column of blood and if these results are plotted on squared 
paper, graphs such as shown in Pig. 3 are obtained. The sigmoid 
curves can be divided into three parts as indicated in line II - 
first part, OX, "period of aggregation", during which the cells 
first fall slowly as discrete units and later a little faster 
as the aggregates are formed: second part, XI, "period of 
maximum velocity", during which the aggregates increase no more 
in size but fall at a uniform speed which is also the maximum
Fig. 3 The different types of sedimentation curve.
The curves are prepared hy joining the frequent 
plots corresponding to the distance fallen (in mm. ) on 
the vertical scale against the time (in minutes) on the 
horizontal scale.
The part - XI - is the period of constant and maximum 
sedimentation velocity.
velocity attained: third part, YZ, ’’period of clumping", in 
which the rate slows as the falling cells are hindered by those 
already filling the bottom of the tube. Fig. 3 also illustrates 
how a reading taken at the end of one hour contains a markedly- 
variable proportion of these three periods, and how it is 
possible (cf. Ill and IV) to obtain a higher 1-hour reading in 
a blood which has a lower maximum velocity.
The Wintrobe ESR, as used in this thesis, measures the 
depth of plasma, after 1 hour at room temperature, in a column of 
blood 100mm. x 3mm., using Heller and Paul’s (106) ammonium and 
potassium oxalate mixture as anticoagulant. A correction for 
variation in the number of erybhrocytes, as measured by the 
haematocrit, was made by the nomogram of Wintrobe and Landsberg.
( 258).
The Corrected Citrate Maximum Velocity was measured at 
20°C. in a column ( 200 x 2*5 ram. ) of blood having a haematocrit 
value of 56°/of prepared from blood which originally had 20^ > of 
3*8% sodium citrate solution as anticoagulant, by determining 
the maximum velocity from frequent readings and a graph such as 
in Fig. 3.
(D) Note on Significance of Results.
It is essential that the reader is warned that in this 
thesis there is a correlation of the results of many tests.
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The text should leave the reader in no doubt as to what is 
"being compared - whether it is the numerical values of the 
tests or the interpretations of these results as usually 
applied by physicians or clinical pathologists.
,32
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Part 4 
METHODS
This section supplies the details of the estimation of the 
plasma viscosity only. The other techniques are described in the 
appendix.
The Estimation of the Viscosity of Plasma and other liquids.
Apparatus:- Yfater-bath at 20*0°C Reagents:- Distilled water 
Whittington viscometer Absolute alcohol
Stop-watch Dried ether
Water suction-pump, 3> aqu. NaOH soln.
Water-bath - These baths cost £30-£200 to purchase. A satisfactory
model was made from a glass accumulator tank, 10"xl2r,xl4!' deep,
holding 30 pints to its working level. The temperature could be
controlled manually to within 0*03°C. as measured on a N. P. L.
thermometer graduated in 0*1 degrees; the heating was by a
small immersion heater and cooling was by ice cubes or cold water
added. A light source behind the bath tended to neutralise the
heat loss from the tank and allowed a more accurate reading of
fluid levels in the viscometer: see Pig. 4.
Y/hittington Viscometer - see Pig. 5. Whittington designed
this modification of the classical Ostwald viscometer which
required about 10 ml. fluid so that his instrument requires only
0*7 - 1*0 ml. The viscometer is of very simple construction.
Two Westergren ESR. tubes (300 mm. long and 2*5 mm. bore, with
200 mm. graduations at one end) were joined to the ends of a
U-shaped capillary of 200 mm. length and 0*35 mm. diameter, and
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Fig. 4 The arrangement of the apparatus for the viscosity 
estimation.
The viscometer is adjusted until the limbs are 
vertical, as compared with the plumb-line.
The ESR. tube is also made vertical by comparison 
with the plumb-line.
The water is heated by the immersion heater and mixed 
by the electric stirrer.
A small electric bulb is placed behind the bath to 
illuminate the graduations of the glass-ware. It is not 
shown in this sketch.
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the upper end of the right-hand tube was bent over. The later 
viscometers have been more elegant examples of the glass- 
blowers art where great skill is required in making a smooth 
funnel-shaped union between the wide and capillary tubes which 
is essential if turbulence of flow is to be avoided. Turbulence 
greatly detracts from the accuracy possible in viscometry.
The viscometer was mounted in the water-bath (see Fig. 4-) 
as follows. A shallow slot was cut in the top of a paraffin 
wax pillar to steady the capillary loop. The split-and-wired 
cork which held the upper tubes was fixed in a special clamp 
which allowed movement in two planes so that the limbs could 
be adjusted into the vertical by comparison with the plumb-line. 
The ■whole of the inside of the viscometer was visible so that 
any dirt or clot in the capillary was immediately visible. 
Technique for use of Whittington Viscometer.—  The method for 
using this type of instrument will be given in general terms and 
the appropriate figures for the V5 instrument are given in 
brackets. Let us suppose that the plasma has been prepared 
as described in the appendix.
Ascertain that the viscometer is clean and dry, that the 
limbs are vertical, and that the temperature is exactly 20*0°C. 
Apply oral suction, via a long rubber tube, to the top of the 
straight limb (F), apply 1 ml. of plasma in a small basin below
the curved linib (E), and bring the fluid level round to 'd '
(132) which experience shows as the most suitable for each 
instrument. The basin is rapidly removed and suction is 
continued until the level in the left limb is 3 mm. above the 
upper "fall”level (123). Allow to drain for 3 minutes. The 
fluid levels are made equal in both limbs by suction at *E’, 
and the levels noted to the nearest l/lO th mm. Change now to 
suction from a water vacuum pump. Apply suction again at 'F1 to 
bring the level above the upper fall level by 2mm. (122). Note 
the time taken for the level to fall from the upper (120) to the 
lower (100) fall level. Repeat the levelling of the fluid on 
both sides, and again note the time taken for level to fall. 
Calculation of the Viscosity from experimental results:-
(l) The viscometer calibration is made with the fluid—level in 
the limbs which we call the *'ideal” rest levels but it is obvious 
that such levels will not be attained on each filling. Also, 
the levels alter during an experiment because of a continual 
slow drainage of fluid from the upper part of the right linib 
which was wet in the process of filling. A correction for the 
variation of the experimental rest levels from the ideal is 
made in equation (l)
T ‘ = T°( 1 - Ak ) ..................(l)
where k = a constant (0*0116); T° = experimental time of fall;
T' = time which would have been obtained if the rest levels had 
been ideal; and A = (sum of experimental rest levels - sum of 
ideal rest levels (129*7) );
(2) The kinematic viscosity in centistokes is found by equation
-fr- = A T 1 + B/P1 + 0  (2)
where A, B, and C are constants.
For Newtonian fluids, the factors for viscometer V5 are 
A = + 0*01055, B fc + 7*369, C = 0 
For Plasma, for reasons to be given later, the factors are 
A = + 0*01254, B = + 8*519, C = - 0*201 
These complicated equations can be readily solved by the use of 
a nomogram. Fig. 6 is a copy of that prepared for the V5 
instrument except that the laboratory drawing is much larger.
The viscosity value to be reported is the average of the 
duplicate experimental results.
Cleaning the viscometer. - The plasma is recovered by applying 
pressure at 'F1. The viscometer is washed and dried by suction 
at 'F1 to draw through in succession - water, alcohol, ether, air. 
Time taken for the complete test, from drying to drying, is 
about 15 minutes. Other small laboratory duties can also be 
undertaken in this period when the fluid is draining or falling.
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To maintain the viscometer free from protein deposit the 
instrument should he cleaned regularly with dilute caustic soda 
solution ( 3-10%). I usually begin the week with this treatment. 
A thorough washing with water is necessary to remove the last 
.trace of alkali.
It is recommended that a similar washing with alkali should 
follow any plasma known to have a high globulin content, or the 
preliminary cleansing of the protein can be made with normal 
saline which will not precipitate the globulin as would distilled 
water.
$ $ $ $ $ S&S je $ *
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Part 5.
MATERIAL.
(A) Royal Asylum of Montrose. (1943 - 1946)
421 tests were made on the physically ill patients 
among the total population of 700, and on a few sick members of 
the staff. I was the medical officer in charge of the male 
patients and staff.
These tests included many on tuberculosis which was rife 
among the patients and on pyogenic infections. A series of 
general paralysis of the insane cases was also studied.
(B) Sunderland (1946 - 1948)
The laboratory at Sunderland Royal Infirmary carried 
out the pathological investigations for all the hospitals in the 
region from the Tyne to Tees.
The close liaison with the Rheumatism Clinic produced 
1067 tests in the rheumatic diseases. Another 424 tests were made 
on the patients in the general medical and surgical wards, 
especially on the malignant diseases.
(C) Portsmouth. (1948 - 1952)
The Central Laboratory supplies the pathology service 
for the Portsmouth Area and the Isle of Wight.
The 1218 tests, at the time of typing, include most 
of the normal control series, the subjects of physiological 
stimuli, many tests on children, a further series of G-. P. I. 
patients, the series of sarcoidosis subjects, the series of 
tests during pregnancy, and a special study of some aspects of 
tuberculosis.
Many of the tests reported in the Pre-clinical Part
(Part 6) which deals with the technical aspects of the estimation
*
of the plasma viscosity were made at Portsmouth and involved 
an additional measurement of several hundred viscosities.
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Part 6
P R E  C L I N  I C A L
S T U D I E S
Part 6..
Studies on the non-clinical aspects of the estimation of the 
viscosity of plasma and serum.
This part of the thesis is concerned with the study of 
that physical property of plasma and serum which in Newtonian 
fluids has been defined as "viscosity". It is the preliminary 
to the following part- in which the variations in the plasma 
viscosity under physiological conditions are described, and to 
the later part in which the changes in the plasma viscosity as 
a result of disease conditions are considered.
We are here chiefly concerned with two problems - the 
errors possible, from a variety of causes, in the estimation of 
the plasma viscosity; and the relation of the plasma and serum 
viscosities to the chemical composition of their respective 
fluids. Other relevant but lesser problems are also discussed.
(A) The potential errors of my technique.
§ 1. General consideration of the technique.
If the Whittington viscometer has been filled to the proper 
rest levels with a representative sample of a plasma, the error 
arising in the actual estimation should be of the order of 0*01 cs. 
or less (= less than 0*5% of total viscosity value). There are 
five possible sources of error - (l) time of fall, (2) rest levels,
(3) temperature of water-bath, (4) dirt in viscometer, and (5) 
alteration in the characteristics of the viscometer. Let us 
consider these in turn.
(l) Error in timing the fall.
There is a period of time between the eye detecting 
the arrival of the meniscus to the graduation marks and the 
movement of the finger to stop the watch and this ’’reaction time” 
may vary slightly (eg. by 1/lOth second). The process to be 
timed at the beginning and end of the fall period is exactly the 
same and the reaction time should be the same for each process. 
They thus tend to cancel each other out. Examples of serial tests 
when the rest levels had become constant, are 164*1, 163*6, 164*0, 
164*0, 164*2 seconds, and 159*4, 159*4, 159*6, 159*6, 159*6 secs.
Larger errors could be introduced by parallax by making 
the eye too high or too low in relation to the graduations. This 
source of error was almost excluded by drawing lines on the back 
of the water-bath at the same height as these graduations; the 
eye was adjusted to bring the graduation and its corresponding 
back level into line.
The error due to timing should not exceed 0*5 seconds 
and is usually of the order of 0*2 or 0*3 seconds in a total of 
150 seconds (= 0*2%).
(2) Error due to variation in the rest levels.
An error of 0*1 ram. in reading a rest level introduces an 
error of 0*002 cs.; however, the meniscus level should he read 
with an accuracy which does not include so large an error as 
even 0*1 ram. The secret of an accurate reading lies in obtaining 
a satisfactory system of illumination.
During the filling of the viscometer a thin film of plasma 
remains on the wall of the right limb. The plasma drains down 
slowly to increase the volume of fluid under test; drainage is 
greatest in the first three minutes and negligible after twenty 
minutes. Similarly, a little plasma remains on the wall of the 
left limb when the fluid levels are made equal after each fall.
Prom the third to fifteenth minute, a time sufficient for three 
falls to be timed, the sum of the rest levels is greater by 0*5 
to 0*8 ram. after the fall than before it. The mean of the rest 
levels of before and after the fall might be used in the calculations 
with more accuracy than the single preceding values; the maximum 
error, corresponding to the 0*8 mm. difference, would be only 
0*008 cs. We believe that by the calibration of the viscometers 
using the preceding rest levels only the possible error has been 
reduced to so small a figure as to be negligible.
Errors due to inefficient filling of the viscometer can be 
minimised by requiring that the sum of the rest levels must
not differ from the sum of the ideal rest levels hy more than 
4 mm. If too much fluid has been introduced, the difference 
between the levels in the limbs during the fall will be less than 
usual and the hydrostatic pressure forcing the fluid through the 
capillary will be correspondingly reduced, hence making the time 
of fall too long. The opposite results from insufficient fluid. 
The correction equation can be calculated from the dimensions of 
the viscometer: this formula was found to give excellent
agreement with our experimental results in which we derived a 
correction equation by timing a single fluid with a wide variety 
of rest levels. Furthermore, our experimental results showed 
that the correction equations could be applied for errors in 
filling which resulted in thei sum. of. the rest levels being 
.deficient or excessive by 10 ram. The correction equation thus 
appears to give adequate and accurate allowance for the minor 
variations in the fluid volume contained in the viscometer.
Air bubbles cannot be permitted in bither limb. The 
rest levels, the time of fall, and the hydrostatic head of 
pressure are all affected to an amount for which no accurate 
correction can be made.
(3) Errors due to variation in the temperature of the water-bath.
Experiments to be reported later will indicate that a change
in the temperature of the water-bath by 1°C alters the time of 
fall by an amount equivalent to 0*05 cs.. at 20°C. As the 
temperature can be maintained to within 0*03°C, the error from 
this source should not exceed 0*002 cs..
(4) Errors due to dirty tubes.
Mechanical blocking of the capillary is the potential 
source of large errors (eg. 25% or more). The dirt can consist 
of specks of fibrin, cotton fibre, etc which act as plugs in the 
capillary or of a general deposit of precipitated protein on all 
the glass wall.
Experience and vigilance are the best means of detecting a 
capillary blockage. One inspects the plasma as it fills the 
Pasteur pipette and as it flows in the viscometer. The 
resistance to oral suction alters with blockage; the rate of flow 
varies when the suction pump is applied at alternate ends of the 
viscometer. With a blockage, duplicate faiietimes:aiever agree 
well enough to yield viscosities within the necessary 0*01 cs. 
This is one of the reasons for running the test with duplicate 
readings.
A general deposit of protein, resulting from a precipitate 
of globulin by distilled water, can be removed by a 3% NaOH 
solution, applied for 10-15 minutes. A viscometer may require 
this treatment twice in one day if many nephritic bloods are
being examined. On one occasion, in a study of the rheumatic 
diseases, I tested over 200 plasmata without requiring to 
clean the instrument in a period of 6 weeks - this was also a 
special study on the question of cleanliness of viscometers 
and a frequent check was made with distilled water viscosity 
estimations within this 6-week period. Such delay in cleaning 
must not be regarded as a routine procedure.
(5) Errors from an alteration in the characteristics of the 
viscometer.
The results obtained from a viscometer would vary according 
to any change induced into the bore size of the capillary tube. 
Such a change could result from large variations in temperature 
(glass does not fully regain its original dimensions for periods 
measured in units of months) and by the solvent action of 
distilled water and the caustic soda cleaning solution.
My results with distilled water viscosity measurement in 
viscometer V5 indicate that no change has occurred within the 
period of 1944 to 1951. In this time over 2,000 measurements 
of viscosity has been made in this instrument.
§ 2. The use of nomograms.
A nomogram has been used throughout these studies 
wherever a result has been derived from experimental values by
a complicated formula. A nomogram reduces the time for the 
solution of the equations to a few seconds and it excludes the 
errors included by faulty arithmetic. If carefully drawn, the 
results produced with the assistance of the nomograms for the 
viscometers should be within 0*001 cs. of those produced by the 
detailed solution of the calibration equations by ordinary 
arithmetic.
Discussion.
To be considered as a suitable test for clinical 
pathology the technique for the estimation of the plasma viscosity 
must measure this value on a volume of plasma removable without 
distress to the patient, with a sufficiently high degree of 
accuracy at a cost in equipment and technician's time comparable 
with the value of the information obtained for the clinician 
from the experimental results.
The volume of plasma (2-3 ml.) which was available to 
Whittington from ESR blood samples was an important factor in 
the original design of his viscometer with a capacity of 
0*7 - 1*0 ml. Reflection on the daily blood regeneration, the 
negligible effect of menstrual loss on blood values, and the 
recovery from the donation of a pint of blood will indicate that 
a patient could usually spare 50 ml. of blood without incurring 
any ill effect. The removal of such a volume, however, would lead
to considerable mental distress for several reasons. In 
addition to the pain arising from the large needle required, 
the ordinary patient has only the vaguest ideas of the total 
blood in the body and such an amount would be vastly greater than 
what is accepted as the 'usual1 volume of blood required for 
testing, (in Portsmouth and Sunderland, the 'usual' volume is 
5 ml. This probably arises from the routine procedure of these 
haematological departments where 5 ml. has been removed for the 
ESR and blood counts which form the majority of the tests 
requested by the clinicians.) Large blood volumes are unsuitable 
for serial tests as the psychological stimulus of their removal 
might possibly introduce significant changes in the very value 
which is to be studied. Macfarlane and Biggs (172) and Latner 
(137) have shown that fear can alter the chemical composition 
of the blood; similarly, Houston (120) had a patient whose 
temperature, ESR, and plasma viscosity increased on the mere 
proposal of a minor operation.
It follows therefore, that the technique chosen as 
suitable for the measurement of the plasma viscosity should need 
only the plasma obtainable from approximately 5 ml. of blood.
The Whittington viscometer can use the plasma derived from the 
re™fl-inaer from 5 ml. of blood after the other haematological 
investigations of ESR and blood counts have been made.
The criterion for the suitable degree of accuracy required 
in the estimation of the plasma viscosity as a clinical test is 
the smallest difference between two results which is considered to 
be of clinical significance. Prom my experience, the minimal 
difference of significance is about 0*015 cs.. Even if all the 
theoretically-possible errors occurred in the estimation in a 
clean Whittington viscometer these do not amount to more than 
0*014 cs. - later-reported experiments will show that errors of 
such a magnitude (as measured by difference between duplicates) 
do not occur in practice. Thus the Whittington viscometer 
has a satisfactory degree of accuracy.
The economic aspects of the estimation of the plasma 
viscosity as a clinical test require that - the initial cost of 
equipment should be low (certainly under £50), no special 
services need be supplied, the bench space occupied should not 
be excessive, the reagents should be inexpensive, the technician 
must not be highly trained, the viscometer should be robust to 
withstand handling by such junior technicians, and the time taken 
for each test should be sufficiently low so that many tests can 
be performed daily if required. All these requirements are met 
by my technique. If three viscometers are used in the water-bath 
and the time wasted while waiting for the levels to fall and for
the plasma to drain down after filling thereby employed 
usefully, a student technician should cope with 20 - 30 tests 
in an afternoon.
Three basic principles govern the design of most viscometers 
in general use:- (a) measurement of the force between two 
concentric cylinders rotating on each other with the fluid in the 
space between; (b) measurement of the time taken for a more dense 
sphere to fall through a column of the fluid; and (c) measurement 
of the rate of flow of fluid through a capillary tube.
Type (a) - Rotating Cylinders.
du IsToiiy (l84-) has designed an elegant model which requires 
only 1 ml. of fluid. It is a delicate instrument, including a 
galvanometer-wire suspension of the inner cylinder. The surface 
tension effects are excluded by adding a drop of oil to the 
plasma surface, which must make the later cleaning more difficult. 
The cost of over £200 is prohibitive for most laboratories. This 
viscometer, however, is a useful research tool for the examination 
of the continuous changes in the viscosity of a fluid and it does 
not subject the fluid to the mechanical stresses of flow through 
a capillary which might be sufficient to break down fragile 
complex (and highly-viscous) structures.
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Type (b) - Falling or Rolling Ball.
A tube, graduated at two levels, is included within a 
water-jacket. The tube is filled with the fluid and a sphere of 
selected density, the time taken for the ball to pass between the 
marks is noted with the tube inclined at a standard angle, and 
the viscosity is calculated from this time.
Standard commercial models have a capacity of 50 ml; 
smaller models (234) down to 1 or 2 ml. capacity have to be made 
specially and are thus expensive. They are not more accurate 
than the capillary type as they are liable to the same errors of 
timing, etc.; the temperature control of the small volume in 
the water-jacket is not exact unless a thermostatic control is 
incorporated. There may be a benefit in the absence of a 
capillary with its risk of blockage.
This particular type of viscometer may have a potential 
value in the fact that the viscosity is calculated from the 
experimental results according to Stoke’s Law, in contrast to 
the capillary type which applies Poiseuille's Law.
Type (c) - Capillary Flow.
There are numerous viscometers which depend upon the flow 
of fluid through a capillary tube. The viscometers used to study 
the viscosity of plasma and serum can be placed in three groups.
i
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A very simple instrument can "be made from a pipette with 
two graduations plus a constriction to the outlet; the capacity 
can he very small hut most designs use 0*5 to 2 ml.. T'ang and 
Wang (240) used the instrument originally described hy Sato (125); 
Woodraansey and Wilson (259) and Steele (232) of Harrogate designed 
their own instrument hut it is almost identical with Sato's;
Mann, of the Mayo Clinic, (158) advocates a hypodermic needle as 
a replaceable constriction. Temperature regulation is difficult 
because the outflow at the lower end makes complete immersion 
impossible. All such instruments are inaccurate in that the 
'viscosity' value is really a combination a fraction reflecting 
the true viscosity of the fluid together with a fraction depending 
on such non-viscosity factors as turbulence of fluid-flow and 
surface tension effects (in the Ostwald, Whittington and similar 
viscometers the surface tension effect is the same in both limbs 
and therefore self-cancelling). Steiner (personal communication) 
has informed me that in some viscometers the true viscosity 
fraction is responsible for only 10% of the apparent viscosity 
differences between two fluids. It is a pity that the apparent 
simplicity of this technique has encouraged so much work to be 
done with these instruments by medical technologists who have 
not had the advice on this problem by specialists in the physics 
of viscometry.
Moreover, -with capillary-flow viscometers the 'viscosity* of 
colloidal solutions depends upon the 'shear* which in turn depends 
on the pressure exerted to force the liquid through and on the 
dimensions of the capillary tubing. That Mann should have 
recommended an instrument designed with a variable shear from 
needle to needle, without an appreciation of the effect upon his 
viscosity results, is particularly to be regretted.
The Hess viscometer (= Hellige in America) has been 
used by Benson in his recent study (16). It has been the 
instrument chosen by many investigators since 1907; many large 
series of figures have been published especially in G-ermany. Yet 
it is now realised that the significance to be given to these 
results is low because of faults inherent in the instrument 
itself (in spite of the extravagant claims of accuracy made by 
its manufacturers). The chief attraction to its use has been its 
need of one drop only of plasma or serum. Some of the points open 
to criticism are now mentioned. Only recently has a water-bath 
been used to maintain a constancy of temperature - previously a 
tiny thermometer (? accuracy) was attached and a correction was 
made from this air temperature, with no guarantee that the plasma 
and water were of equal temperature: the viscometer itself is
i
small and graduated only to 0*1 cp. divisions, the second place 
of decimals being obtained by interpolation, and some authors
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did not even attempt this: the tubes are graduated with water - 
a Newtonian fluid: the force producing fluid flow is either
oral suction or rubber-ball suction and is thus variable, 
producing a variable shear with its associated inaccuracies.
The third group of capillary viscometers consists of 
the classical Ostwald viscometer and its modifications. The 
smallest B.S.S. Ostwald requires approximately 10 ml. of fluid.
It requires a minimum of 10 minutes for the fluid contents to 
adjust itself to the temperature of the water-bath; the volume 
of the fluid has to be carefully adjusted to a standard mark at 
each test. The accuracy attainable is high (error about 0 • 2fS) 
but not significantly better than with the Whittington type. 
Stewart Lawrence (138) designed a small Ostwald viscometer, with 
a capacity of 2*5 ml. only. He fills it from an accurate pipette 
and so obviates the later adjustment after filling. It has a 
wider-bored capillary than the Whittington and is thus less liable 
to blocking, but it does not offer any other advantages in use.
The Whittington viscometer is also a modified Ostwald. It has 
been accepted for use in laboratories in all parts of the world 
because of its simplicity, cheapness, and high possible accuracy. 
In addition, these viscometers are now sent to me by the glass- 
blowers so that I can calibrate them with plasma and correlate
them to the V5 viscometer scale, thus correcting for any 
variation in the shear. Thus all reported values from a 
laboratoiy using a Whittington viscometer can he understood 
by everyone who also uses this scale of values. Published 
results from any other source can be appreciated only when some 
key to this scale of viscosity values can be obtained from some 
characteristic feature common to all workers, eg. if Woodmansey 
gives 1*80 as the highest normal value we can surmise that this 
is equivalent to the upper limit of normal on the V5 scale also 
(1*915) rather than that his highest normal value is really 
0*035 cs. below ours. Similarly, the average serum viscosity of 
the last month of pregnancy of continental workers is 2*4 
(quoted by Schwalm (224)) as conpared to my 1*655, and this 
remarkable difference should be regarded only as a technical 
difference rather than as a clinical difference. Further 
examples of comparison of viscosity values estimated by 
different instruments are given later for citrate plasma, 
oxalate plasma (Wintrobe), and serum.
For the past year I have attempted to design an 
automatic viscometer in which the fluid is poured into one 
orifice and the result presents on a dial. My plans are 
practical but not yet economically possible. Until this type of 
instrument has been perfected in a cheaper model the Whittington
viscometer can "be recommended as an accurate instrument and as 
the type filling the requirements of the instrument for the 
measurement of the plasma viscosity as a test in clinical 
pathology.
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(b ) The errors in the estimation of the plasma viscosity due to
differences between samples.
In the next four paragraphs the results of duplicate 
experiments will be reported. These tests have two important 
aspects - they indicate just how small the error in the estimation 
of the plasma viscosity by my technique can be, and they indicate 
that the reported value does bear a close relation to the viscosity 
of venous plasma in the subject tested.
§ 3. The error of routine plasma viscosity measurement.
The description of the technique states that the reported 
value is the mean of two values which agree to within 0 *01 cs.. 
Such large differences are seldom included within our results.
Ten consecutive plasma viscosity tests were chosen at random from 
amongst the clinical cases where special care for minute accuracy 
was not taken. The ten pairs of viscosity values are:- 
2 *550,2 *548; 1*836,1*842; 1*903,1*897; 1*848,1*851; 1*920,1*920; 
1*874,1*880; 2*040,2*043; 1*828,1*832; 1*925,1*923; 2*021,2*022. 
The largest variation from the mean was only 0*003 cs. Other 
series might have "been selected in which the variations from the 
mean were larger or even smaller; I believe that the above is a 
representative sample of the accuracy in ray routine working.
§ 4. The sampling error of a single plasma specimen.
Ten ml. of venous blood were collected into mixed-oxalate 
anticoagulant and centrifuged; 4 ml. of plasma were pipetted 
into another tube; the viscosity was estimated on two samples 
drawn from this plasma specimen.
The results of 25 tests are given in Table A in the Appendix.
The differences had a range of 0*000 to 0*006 cs., with a 
mean difference of 0*0027 cs., and a standard deviation of 
0*0020 cs. There was no consistent change in the direction of 
the difference between the first and second sairple, ie. increase 
or decrease.
§ 5. The sampling error of a single blood specimen.
Dr. J. Stewart Lawrence, in a personal communication, has 
found large differences in the plasma viscosities from different 
blood samples from the single syringeful of blood. My own 
preliminary results did not confirm this and therefore a more 
comprehensive investigation was made. The results of 45 tests 
are given in Table B of the Appendix.
A 20 ml. syringe was filled with venous blood, without 
the assistance of a tourniquet. Two specimens (5ml. each) were 
collected into mixed oxalate and the viscosity of their plasmata 
estimated. The sampling from the syringe was varied as much as 
possible - the blood was sometimes mixed within the syringe before 
sampling and sometimes not; the sanples to be compared might be 
the first and last 5 ml. volume of blood, or second and third.
As might have been expected, the difference between 
the duplicates was greater than in the previous section, but the 
mean difference was still only 0*0066 cs. , with a standard 
deviation of 0*0048 cs. There were now seven tests with a 
difference greater than 0*01 cs.
§ 6. The sampling error of a single sub.ject.
For these experiments, subjects were chosen with large
veins of the arm so that a sample was taken from each arm 
without venous stasis and with a minimal time interval "between 
samples.
The results, presented in Table C of the Appendix, 
indicate that the difference of the plasma viscosities of the 
two arms was similar to the difference found between two samples 
of blood from a single blood specimen. The mean difference was 
0*0054 cs., with a standard deviation of 0*0035 cs..
Discussion on §5 - §6.
From the results presented in these four sections it may­
be claimed that my technique can present an accurate and 
reproducible measurement of the plasma viscosity of venous blood. 
The mean error is only 0*006 cs.
A measurement of a plasma viscosity is representative of 
the viscosity of all the plasma, one part of a blood specimen is 
representative of the whole specimen, and the blood from one arm 
is representative of the venous blood of both arms. The next 
stage in this investigation will be the comparison of the plasma 
viscosity of the venous blood of the arm with that of blood 
derived from the veins of the head and legs, from the veins of 
the internal organs of the body, and from the arterial systems.
A technique with a high possible accuracy is valuable in 
a clinical investigation as it allows a sharper distinction to 
be made concerning the changes in the serial results of an 
individual patient which may be of clinical significance. Thus 
I believe that in some instances a change of as little as 
0*015 cs. has been important, and while such a difference could 
arise from experimental errors, such errors occur so infrequently 
that they can be dismissed as an unlikely cause. This accuracy 
should be contrasted with that claimed by Dawson and Salt (59) 
who, using a Woodmansey and YYilson viscometer, obtained an error 
of * 0*08 cp. : .similarly, Mann could never be certain that his 
results did not contain an error of 5% .
Later in this thesis there will appear complex graphs of 
the relationship of the plasma viscosity to the sedimentation 
rate, and of the serum viscosity to the serum and plasma protein 
fractions. These graphs could not have been drawn if the error 
of the estimations had not been so small; with larger errors 
the results which now fall on a definite single line would have 
appeared with a degree of scatter which could have obliterated 
the linear relationships.
Tables B and 0 show the accuracy with which the 
packed-cell-volume, the Wintrobe ESR, and the total plasma
protein by a specific gravity technique can be estimated in 
duplicate tests. It will be shown later that for the total 
protein, the error is much greater than appears here.
$ * * $ if #
(C) The errors possible in the estimation of the Plasma Viscosity 
which do not arise in the viscometer.
The results presented in the previous sections were derived 
by a technique in which I had the full responsibility from the 
obtaining of the blood specimen by venipuncture until the final 
cleaning of the viscometer. It was essential, however, to 
investigate what errors might be introduced unwittingly by a 
less meticulous worker and what precautions should be taken to 
prevent their occurrence.
The experiments will be described according to the 
chronological order of the procedure of the plasma viscosity 
estimation.
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§ 7. Errors arising from the technique of venipuncture.
A later section will indicate that the plasma viscosity 
value depends upon the plasma proteins. It follows, therefore, 
that the plasma viscosity value can "be altered by any manoeuvre 
at the time of blood sampling which will alter the plasma 
protein-content. The only likely cause of error is the production 
of venous stasis in order to facilitate venipuncture and in order 
to allow dammed blood to be aspirated. In the literature there 
are several references ( 20,192,157,210 ) to the increase in the 
plasma proteins as a result of stasis, Peters claiming a 38*5^ 0 
increase in one instance after 5 minutes.
I attempted one test only to confirm these reports, as it 
caused much distress to the subject. A light tourniquet was 
applied for.5 minutes, by clock timing; two venipunctures were 
performed. The results are:-
Normal 
, Subject.
(P. S.) -1
Plasma
Viscosity.
Total
Prot.
!
j POV.
Wintrobe
ESR. Haemoglobin.
\ cs. g./ ! % mm/ 1 hr %
Before stasis 
After stasis
1*803
1*937
7*09
7*70
1 4-3*6 
| 45*2
1*75
2*25
105
108
The error introduced into the plasma viscosity was very large 
and emphasized the need for the prohibition of long venous stasis 
for blood sampling for this test.
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On the other hand, I found that with a brief constriction 
in order that a vein became engorged sufficiently to be visible 
or palpable, and with the pressure released immediately the needle 
entered the vein, no significant error was introduced. This 
claim is difficult to prove by figures, but attention is drawn to 
the serial tests on the same subject as above, normal male P.S., 
where there must have been a variation in t then amount of stasis 
incurred each day yet the plasma viscosity produced consistent 
values, and to the results in §6 above where the difference in 
the stasis of the two arms is not reflected in a significant 
difference in the viscosity results. (See Pig. 53, page 199)
Furthermore, with a syringe lubricated with paraffin there 
is no necessity to hurry the removal of the blood. The blood 
originally in the vein above the needle can be milked towards the 
heart. Similarly, if the vein tends to collapse on suction with 
the syringe a gentle pressure on this single vein will produce 
sufficient damming of flow to allow the blood to be removed as 
fast as it flows into the vein. The blood sample of 5 ml. 
should be obtained in under one minute.
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§ 8. The errors possible from variation in the proportion of 
anticoagulant in the blood.
If air bubbles had entered a syringe and if the blood 
receiving vessel was ungraduated, it was often impossible to be 
certain that exactly 5 ml. of blood had been added to the 
mixed oxalate crystals prepared for that volume. Experiments 
were carried out in which 5 ml. samples of blood from one 
syringe (cf. §5 for report on the uniformity of the contents of 
a syringe) were added to amounts of this anticoagulant to yield 
concentrations equal to x0*5, x2, x3, and x5 of the normal.
See Table D of Appendix for the experimental figures.
These results indicated that an excess of blood to the 
anticoagulant introduced less error than a deficiency. An 
excess of 1 ml. over the expected 5 ml. caused an error of only 
0*005 cs., while a deficiency of 0*5 ml. might produce an error 
of 0*01 cs., but usually nearer 0*006 cs.. I have found that 
by practice with syringes and 7 ml. bijou bottles I could keep 
my error to ±  0*25 ml. , which should have introduced no 
significant error into my results.
The errors from less experienced workers can be eliminated 
by two simple devices - the receiving tube can be graduated or 
the receiving vessel should have a capacity so that it must be
filled completely with blood except for the air bubble needed to 
mix the blood.
§ 9. Effect of variation in the time taken to separate the 
plasma from the erythrocytes.
Any text-book of biochemistry, when dealing with such 
estimations as the alkali reserve, inorganic phosphate, and 
chloride of plasma, emphasizes the changes which might occur 
between the plasma and cells, and between the plasma and atmosphere. 
It was necessary to determine whether the plasma proteins might 
be affected similarly.
A 15 ml. blood specimen was collected and divided into 
three samples. The first and second were centrifuged at once; 
the viscosity of the plasma of the first was estimated as soon 
as possible; the second tube was stoppered and the viscosity of 
its plasma was measured after 24 hours; the third specimen was 
placed in a bijou bottle, and mixed several times during the day 
by gentle rotation, centrifuged after 24 hours, and the viscosity 
of the plasma measured within a few minutes of that of the second 
sample.
The results are given in Table E of the Appendix.
These experiments indicated that a significant change can
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be introduced in the plasma viscosity by the prolonged contact 
of the plasma and cells outside the body. The change was 
consistently towards an increase in the viscosity but the degree 
of change was not sufficiently constant to allow of its 
correction by an empirical correction formula. The error'could 
increase a high normal value to an abnormal value.
The errors from this source can be eliminated by 
centrifuging the blood without delay and by removing the plasma 
from the cells into another container.
§ 10. Errors which may arise during the centrifugal separation 
of the plasma from the erythrocytes.
The centrifuge has become such an accepted article of 
laboratory equipment that one has tended to use it with scant 
consideration of all its potential actions on the contents of the 
centrifuge tubes. A very early experiment focussed my attention 
on these actions as a possible cause of error in the plasma 
viscosity estimation - in an early test with a plasma in which 
the pipetting disturbed the cells, I believed that I had not 
drawn any cell into my pipette but I recentrifuged and repeated 
the investigation: the second value was greater than the first 
by an amount outwith the range of experimental error. At that 
time I was following the usual laboratory procedure of using the
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centrifuge tubes unstbppered and I soon suspected that therein 
lay the cause of the increased viscosity, by evaporation.
Several sets of experiments were performed in relation to this 
problem. In all tests a MSE major centrifuge was used, with its 
16-bucket head, running at 2,300 r.p.m. for 15 minutes by the 
timing device incorporated in the machine. The temperature was 
measured at the intervals by placing one thermometer in contact 
with the metal head and another into the water contained in one 
centrifuge tube.
Experiments (i) - see Table P in the Appendix, (page aol)
On two occasions, four 10-ml. graduated Pyrex centrifuge 
tubes were centrifuged unstoppered, containing distilled water, 
for four 15-minute periods, the centrifuge being stopped for a 
time sufficient only for the appropriate readings.
The loss of water after 15 minutes was about 1^>, but after 
60 minutes the loss could be 8*5/6. The amount of the loss 
increased as the temperature increased. Such a large change in 
volume could not be explained by differences in the specific 
expansions of water and glass but could be explained by an 
evaporation of the water.
Experiments (ii) - see Table H in the Appendix, (page a33) 
These tests were repeated with open and capped Wintrobe 
Haematocrit tubes, containing blood.
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The loss of fluid, although detectable, was less than with 
water in tubes. The difference in the losses can be explained 
by the difference in the surface areas from which the fluid 
could evaporate. Kagan(l29) has similarly found the loss in
t
proportion to the area of the surface of the fluid.
The results stress the need for the routine use of capped 
haematocrit tubes. The cells were packed into a smaller volume 
for the whole 60 minutes, and even this value could not be taken 
as the minimal constant volume. An apparent constancy was noted 
in the open tubes in the 30 and 45 minute readings as the decrease 
in the total volume as a result of evaporation from the plasma 
surface was almost proportional to the decrease in the cell 
volume as a result of increased packing; in the 60 minute 
values, however, the evaporation loss exceeded the packing to 
give the anomalous result of an increase in the haematocrit 
value expressed as a percentage. Because of the large radius of 
its head the MSE major centrifuge exerts a much greater 
centrifugal force than the ordinary small laboratory centrifuge 
which may rotate at 3 - 4,000 r.p.m..
Prom these studies it may be concluded that the haematocrit 
value as ordinarily measured after centrifuging in a small 
centrifuge for 30 minutes, with the tube uncapped, is neither 
accurate nor. minimal.
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Experiments (iii) - see Table G in the Appendix, (page a31j 
10 ml. samples of blood were centrifuged in uncapped graduated 
tubes for four 15 minute periods, removing about 1 ml. for tests 
at each interval. There was a small increase in the plasma 
viscosity after 15 minutes, but by the end of 60 minutes this 
increase might equal 10% of the original value.
In contrast, the plasma viscosity was lower after 60 minutes 
centrifuging in a capped tube than after 15 minutes in an open 
tube.
Experiments (iv) - see Table I in the Appendix, (page a37)
Two 5 ml. samples of a blood specimen were centrifuged at 
the same time, one capped and one open, for 15 minutes.
There was a slight loss of fluid by evaporation from the 
open tube which was sufficient to introduce a significant increase 
in the plasma viscosity (mean increase = 0*0171, standard 
deviation = 0*0043)*.
The results of experiments (iii) and (iv) indicate that a 
significant increase in the plasma viscosity value can arise from 
the use of uncapped centrifuge tubes in the 15 minutes which is 
the minimum time rquired to ensure a clear plasma from all blood 
samples. The simple procedure of placing a rubber bung into 
each tube before centrifuging eliminates this possible error.
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Experiments (v) - see Table J in the Appendix, (page a38) 
These experiments were performed in order to determine (a) 
if centrifuging could he replaced by allowing the cells to 
sediment to leave a clear supernatant plasma, and (b) if
centrifuging causes any alteration in the plasma.
Two 5 ml. samples of a blood specimen were obtained: one 
sample was centrifuged (uncapped) at once, the plasma was separated 
and its viscosity measured; the other was placed in a closed 
centrifuge tube and allowed to stand on the bench until 1 ml.
of clear plasma was available and then its plasma viscosity was
also measured.
In comparing the values of the parallel series of results 
it is necessary to take into consideration the increase of about 
0*02 cs. which was incurred by centrifuging in an uncapped tube 
and the increase in the viscosity which may occur on prolonged 
contact of the plasma with the cells. Nevertheless, the 
differences between the results are noteworthy on account of 
their direction as well as their size. A plasma from the 
sedimented blood sample could easily have a higher viscosity than 
that of the centrifuged sample on account of some retained 
erythrocytes ( a point which was unfortunately not checked at 
the time of the experiments) but a change in the plasma protein
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must also "be considered, as it only t>y such a protein change 
that a lowervalue in the sedimented plasma could he explained. 
The largest differences in the viscosity values exceed the 
usual range of experimental error. It is known that the 
j3-globulin fraction can he broken down into its protein and 
non-protein components hy mechanical stresses and it is 
possible that centrifuging exerts sufficient stress to cause a 
change of some similar kind to occur; the further investigation 
of the plasma proteins will form a future research now that 
the filter-paper technique ( 55, 65, 82) has brought the 
refinements of electrophoretic fractionation within the 
capacity of any laboratory.
Discussion:- These five sets of experiments have all 
emphasized^ the need for the capping of centrifuge tubes when 
estimating the plasma viscosity, thereby eliminating an error 
of appreciable size. The last set has shown that even the 
minimum period of centrifuging may introduce a slight change in 
the viscosity value, probably due to protein changes.
These tests have shown that the ordinary method of 
estimating the haematocrit value may not be the most accurate 
available. Uncapped centrifuge tubes should be prohibited 
from even "routine” laboratory procedures.
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§ 11. Changes in the plasma viscosity with passage of time.
It is known that the ESR test (from which the plasma 
viscosity estimation stemmed) becomes invalid if there is a delay 
of more than four hours between the venipuncture and the setting 
up of the tubes; the osmotic pressure of plasma, another physical 
property, may alter within thirty minutes; du Nouy claimed that 
the serum viscosity did not become constant within the first two 
hours; hence it was essential that I should study the changes 
which might occur in the plasma viscosity with the passage of time.
The experiments can be divided into (a) short-term tests 
which extended from 30 minutes to approximately 24 hours, and 
(b) long-term tests extending up to 8 days. For the short-term 
tests, 10 to 20 ml. of blood were centrifuged, the plasma was 
separated into a stoppered tube, and 1 ml. samples were removed 
at intervals from this bulk specimen. For the long-term tests,
20 ml. of blood were centrifuged, the plasma was separated,
1*2 ml. samples were pipetted into clean but non-sterile tubes 
(L5" x 0*25”) which were allowed to stand stoppered on the 
bench without special precautions except to avoid heating, and 
a tube was selected at random each day for testing.
(a) Short-term tests. - see Table K in the Appendix, (p. a40) 
The results presented in this table indicate that no 
appreciable change occurred in the plasma viscosity values in the
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first 24 hours. Tests performed specifically to obtain the 
earliest possible viscosity (about 30 minutes from venipuncture) 
showed that such a value was identical with values obtained 
later. The results of §4 (fc tests on duplicate samples of a 
single plasma specimen) can also be regarded as further evidence 
that small differences of time do not introduce a variation into 
the plasma viscosity values.
(b) Long-term tests. - see Table L in the Appendix, (p. a4l) 
These results indicate that valid viscosity measurements 
can be made on plasma specimens up to 5 days old; thereafter, 
a significant change can occur in some specimens, but not in all. 
In several tubes a fine flocculation became evident: on shaking 
the tube the flocculation became resuspended but it did not 
disappear, yet the viscosity was identical with that of preceding 
and succeeding clear plasmata.
Discussion
The constancy of the plasma viscosity ‘over a period of time 
should not be taken to mean that no change is taking place in the 
chemical constituents of the plasma, but rather that any changes 
are of such a nature that the viscosity is not affected 
appreciably.
The viscosity of the plasma depends upon the protein and its 
subfractions. It has been shown that solutions of albumin (35)
78
and of globulin (36 ) maintain their physical characteristics 
unchanged for long periods; serum and plasma can withstand 
lyophilisation without alteration in their viscosities ( 2 );  
and plasma and s^rum can be stored in a frozen state for months 
or years and still yield identical patterns on electrophoretic 
examination. A constant plasma viscosity on simple storage on 
the bench is thus not unexpected if the plasma can withstand 
these larger traumata.
The papers suggesting marked changes in the plasma were based 
on incomplete investigations. The ESR changes after 4 hours 
have been shown, by interchange experiments with fresh and old 
plasma plus fresh and old cells, to be due entirely to alterations 
in the cells, the power of the plasma to produce agglutination 
remaining unchanged for several days, du Nouy, with his 
rotating-cylinder viscometer, found that the viscosity of serum 
first increased and then fell gradually until a constant value 
was attained after 2 hours. Sato (218) verified this finding 
with a Hess capillary-type viscometer but he also showed that if 
a second sample of the serum was introduced into the viscometer 
without it being cleaned, the rise and fall in the viscosity were 
not seen - thus the changes in the serum viscosity are due to 
errors entirely produced by the viscometers. The changes in 
the osmotic pressure after 30 minutes if the measurement is made
by a ’dynamic1 technique which requires a few minutes only 
rather than the usual ’static' equilibrium method which takes 
24 hours or longer appeared in a paper which has not been 
verified by any other worker (all my notes and its reference were 
lost in the mail and I have never traced the paper again).
A test in clinical pathology which is based on a plasma 
property which is constant over a long period of time has marked 
practical advantages - especially if one makes a comparison with 
the ESR test with its 4-hour restriction. In the laboratory, 
provided that simple precautions are taken to prevent evaporation, 
the viscosity of a plasma can be measured at the convenience of 
the technician; an individual estimation can be interrupted and 
resumed again after several hours, without introducing an error.
A large number of tests can be accepted at one time but the 
actual measurement can be spread over several days. There 
would be no ill-feeling if a specimen arrived about 20 minutes 
before the laboratory was due to close. Similarly, to the 
clinician, the advantages are numerous. This test is useful in 
just those conditions which can be treated in large-attendance 
out-patient sessions; the number of tests acceptable by the 
laboratory will be the capacity of the laboratory in the next 
few days and not in the next few hours. This test can also be 
useful at an evening clinic; the plasma can be separated by the
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sedirnenting of the cells or by a few minutes centrifuging, 
to "be followed "by thorough centrifuging in the laboratory in 
the morning, and thus the need for the patient to attend again 
during the day at the laboratory can be eliminated. Also, as 
no two laboratories are separated by more then 5 days by air, 
the results produced in these laboratories can be compared 
directly by the examination of multiple samples of plasma 
specimens - sealed ampoules would prevent evaporation in transit 
and would withstand changes in atmospheric pressure.
§ 12. The stability of the viscosity of the plasma in face of 
rough treatment of the blood and plasma.
Section 11 indicated that separated plasma retains its 
viscosity unchanged if allowed to stand undisturbed; § 9 
indicated that contact of plasma with erythrocytes for hours 
and days caused a small but appreciable change in the plasma 
viscosity. The next subject of study was the effect of rough 
treatment of the blood and plasma on the viscosity results, 
especially to determine if the plasma viscosity was sufficiently 
stable to allow of postal transit of specimens.
Two sets of experiments were made:- (i) 15 ml. of
blood were collected into mixed oxalate and heparin anticoag­
ulants, centrifuged, and the plasma separated. 2 ml. were taken
81
as the control sample: 5 ml. were put into a 7 ml. "bottle and
shaken thoroughly for 4 hours in a Griffin and Tatlock Microid 
Flask Shaker. see Table M in the Appendix for results. (a42j
With the eight tests with mixed oxalate plasma the 
difference between the viscosities of the shaken plasmata and 
the controls ranged from + 0*009 to - 0*006 cs. , ie. within the 
experimental error; with the four heparin tests, the difference 
was of a similar magnitude.
This mechanical shaking far exceeds in degree:of'violence 
ill-treatment any postal specimen might suffer, but the period 
of violence is much shorter. Within the limits of this testing 
technique, the plasma viscosity value has been shown to be stable.
(ii) 20 to 25 ml. of blood were collected into mixed oxalate 
anticoagulant. Two 5 ml. samples of blood were placed in bijou 
bottles: one was left untouched on the bench; one was posted from 
Portsmouth to Glasgow and back to Portsmouth (about 1,000 miles 
in 3 to 7 days); the two bloods were centrifuged and the viscosity 
of their plasmata measured. 10 ml. of blood wereccentrifuged 
and the plasma separated: the viscosity of one part was measured 
at once as the control value; 4 ml. was sent on the postal journey 
and its viscosity measured on its return. 5 ml. of blood was 
allowed to stand on the bench for 4 hours; the supernatant plasma 
was pipetted off and sent on the postal journey, it was
centrifuged on its return, and the viscosity of this plasma was 
measured. The results are in Table N in the Appendix. (a43) 
The results indicate that in the eight tests of normal 
postal service the difference between the viscosities of postal 
and control plasmata did not exceed the experimental error; 
in the last four tests where snow-storms caused a delay and 
increased the time interval to 7 days, the maximum difference 
was only 0*036 cs. , which compares well with the differences 
obtained with plasma samples allowed to stand undisturbed on the 
bench ( see § 11 ). The supernatant plasma showed excellent 
correlation with the control value. Similarly, the plasma from 
the transported whole-blood sample did not differ from the plasma 
of the blood remaining in the laboratory, but both of these 
showed an increased plasma viscosity when compared with the 
control plasma. (As shown later in the clinical part, the error 
involved would have been of small significance in the clinical 
interpretation of the viscosity result. ) The seven-day delay 
introduced gross changes because of bacterial growth in these 
non-sterile containers.
Discussion:- The mechanical shaking, and the delay and 
shaking of the postal journey, produced such negligible effects 
on the viscosity of the samples that a postal service for plasma 
specimens is possible. A properly-centrifuged plasma sample
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can be sent by one laboratory to another; the clinician in his 
consulting room probably does not possess a centrifuge but he 
can allow the blood to stand on his desk for a few hours until 
the cells settle enough for him to pipette off a plasma sample 
which can be centrifuged on its arrival in the laboratory - his 
error will be within the experimental error of the technique.
The postal transmission of the whole-blood specimen cannot be 
recommended if the plasma can be obtained, but the error with this 
whole-blood is still sufficiently small for the clinician to 
apply the plasma viscosity results to his patients, except that 
greater care will be necessary at that part of the viscosity 
range where normal and abnormal results meet. Although the 
ordinary postal specimen would be received in 2 days at the most, 
the earlier experiments on delayed separation of cells and plasma 
have shown that a small error is unavoidable with whole-blood 
specimens.
§ 13- The effect of temperature changes on the plasma viscosity.
Plasma exists in nature as a fluid circulating in the 
body at 37°0. , and the first choice of temperature at which the 
plasma viscosity should be measured would be this 37°C.. Any 
other temperature of measurement entails the possibility that
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the values so obtained bear only an inconstant relationship 
to the original viscosities. The use of 37°C. immediately 
raises a practical problem. A water-bath accurate to 0*03°C. 
or better at 20*0°C. is easily constructed by apparatus 
available to any laboratory at a cost measured in shillings; to 
obtain the same constancy of temperature at 37°C. requires much 
more elaborate equipment costing many pounds. (The commercial 
water-baths recommended for viscometry, accurate to 0*01°C., 
cost £200 approximately. ) Furthermore, even if 37°C. was the 
temperature chosen for the measurement of the viscosity of the 
plasma it would still have to be shown experimentally that the 
cooling to room temperature after venipuncture and centrifuging 
did not introduce irreversible changes into the plasma, a 
definite possibility if one believes, as I do, that there is a 
protein equilibrium system in the plasma and such systems might 
be affected by temperature changes^ if the experimental proof 
was not forthcoming, the only possibility remaining would be 
that all laboratory procedures were carried out in a 
thermostatically-controlled room at 3’/'°C..
My experiments were of three types.
(i) For this test all the syringes, glass-ware, etc. 
were wanned to 37°0. in an incubator; a centrifuge was arranged 
in another incubator. 10 ml. of blood were collected with the
85
warm syringe. 5 ml. were collected into mixed-oxalate in a 
warm tube and centrifuged in the incubator: the plasma was
separated and introduced into a viscometer already at 57°G: the 
'time of fall* was measured at various temperatures down to 15°C. 
The other 5 ml. of blood were collected into mixed-oxalate at 
room temperature, centrifuged as usual, and the plasma was put 
into a viscometer at 15°C; the ‘time of fall1 was measured at 
various temperatures up to 37°C. The ‘times of fall’ were 
plotted against the temperatures to produce Pig. 7 ; within 
the limits of the accuracy of the technique, the two graphs 
were identical. Only one test of this type was made because 
of the possible damage to centrifuges by high-temperature use 
and Mr. Steiner, in a personal communication, had informed me 
that he had obtained identical results when trying out this 
method of comparison.
(Note:- In all tests on temperature effects, the corrected 
‘time of fall’ (=T‘) has been considered rather than the 
’viscosity’ calculated from it -- for reasons given later in
the discussion. )
• (ii) Serial tests were made at a variety of temperatures 
from 15°C. up to 40°C. on mixed-oxalate plasma, heparin plasma, 
citrate plasma, and serum. Representative graphs of these results 
are given in Figs. 8,9 and 10 , in which the ‘time of fall’
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Fig. 7 The fall in viscosity of plasma with rise in 
temperature.
In this experiment, one sample of plasma was prepared at 
room temperature and its viscosity measured from 15°0. up 
to 37*5°C, while another sample of the same blood was 
manipulated throughout at body temperature to yield a 
plasma whose viscosity was measured from 37*5°C. down 
to 15°C.
The results for the two plasmata agreed to within the 
experimental error of the technique.
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P + A Oxalate Plasma * 
Heparin Plasma +
Serum ©
Pig. 8 The irregular relationship 
sometimes observed between 
the viscosity of plasma and 
serum and the temperature .
The three fluids were derived from a single blood specimen
3020 25
Temperature (°G. )
Ti
me
 
of 
Fa
ll
" 
(s
ec
on
ds
)
89
Disease.
a. P. I.
Multiple myeloma © 
Pulmonary tuberculosis +
Temperature (°C. )
5020 35
Fig. 10 This graph contains the results from three patients.
The '*kink" in the temperature/viscosity curve is 
observed in the two patients with pulmonary 
tuberculosis and general paralysis of the insane, 
yet it is absent from that of a patient with 
multiple myeloma.
Case - L.B. (Still’s Disease) 
Plasma Viscosity (20°C.) =3.141 cs.
-130
-120
-110
-100
3520 3025
Temperature of Plasma (°C).
Pig. 9 This graph is included to show that the ’kink" in
the viscosity/temperature relationship does not 
depend upon the degree of the increase of the plasma 
viscosity above normal.
This patient (L.B.) had a plasma viscosity of 3.141 cs
(very high indeed.)
(= viscosity) has been plotted against the corresponding 
temperatures.
The three types of plasma and the serum all yield graphs 
of two distinct forms. In one form, the curve is perfectly 
smooth and regular, as in (i) above: in the other, there appears
a ’kink' about 32°C. where there is a decrease in the viscosity 
plus a return to the original line of the curve when there is a 
sudden increase again in the viscosity with a further small 
increase in temperature. Fig. 8 includes the curves of the 
serum and plasma of a single blood specimen and the kinks are 
almost identical. The kink;, was- only found in the plasma and 
serum from subjects suffering from disease; its presence could 
not be foretold; its presence did not bear a close relationship 
to the plasma viscosity value; the few tests so far performed have 
not shown it to be related to any special type of illness.
(iii) The viscosities at 18, 20, 22, 25, and 37*5°C. were 
measured in a larger series of mixed-oxalate plasmata to determine 
if a consistent relationship was maintained between the viscosity 
and temperature variation, and if consistent, to derive formulae 
by which the results at different temperatures can be correlated. 
Two series of results at least have been published with 25°C. as 
the standard temperature (138, 240).
The results are given in Table 0 of the appendix.
I he 1 time of* fall for distilled water in my viscometer 
showed a decrease of 31*5% on increasing the temperature from 20°C 
to 37*5°C: the International Tables give figures which correspond
to a change of 31*7^ » .
Under the same conditions, the ’time of fall1 for plasma 
decreased by a mean of 32*4 :/o (standard deviation =0*81)
The change for serum was of a similar magnitude (=31*6 %)
The 'time of fall' for plasma:was -about 11 *7% less when 
measured at 25°C as compared to 20°C.
Discussion:- The results presented in this section have been 
restricted in number. It was realized that the cooling of the 
plasma to room temperature under the usual method of preparing 
this from the blood specimen might have caused the removal of 
plasma constituents insoluble at room temperature; hence it was 
essential that the tests here reported should be repeated with 
plasma prepared at 37°0 and tested at decreasing temperatures as 
in section (i). (These investigations will be undertaken soon. )
The results of all three types of tests have shown that the 
viscosity of the plasma as measured at 20°C. bears a consistent 
relationship to the viscosity at 37°0. and at intermediate 
temperatures. There was a variation about the mean percentage 
of decrease in the viscosity on increasing the temperature by 
17*5°C. but this might be due to change in the plasma such as
escape of dissolved gas, etc.. The consistency of my results 
for change of temperature of this order compares well with the 
seven tests reported by Jochims (127) who increased his 
temperature from 19*5 to 40°C with a decrease in viscosity of 
35*1 to 37*7fo, as measured by an Ostwald viscometer: Schwalm (224) 
reported 11 tests, using a falling-ball viscometer, in which the 
increase in temperature from 20 to 40°C produced a decrease in 
the plasma viscosity of 20*3 to 38*9% - yet he was critical of 
the accuracy obtainable with capillary-type instruments • My 
value of 11*7% decrease in viscosity on raising the temperature 
from 20 to 25°C is almost identical with the 11 *2% suggested by 
J. Stewart Lawrence (139).
Corrections for temperature change cannot be so accurate 
for plasma and other non-Newtonian fluids as for the Newtonian 
fluids such as water. When the viscosity of a non-Newtonian 
liquid is measured in two viscometers, the 'apparent viscosity' 
will be lower in the instrument with the higher rate of shear; 
other things being equal, the faster the flow through the 
capillary the higher is the rate of shear. It follows, therefore, 
that as the temperature is increased with a resulting increased 
velocity, the rate of shear also increases. The greater decrease 
in the ’time of flow' and thus of the viscosity for plasma (32*4 %) 
as compared with water (31*5%) can be explained by the non-
-Newtonian character of plasma; conversely, the existence of this 
very difference is additional evidence of the non—Newtonian 
nature of plasma.
The formula by which the viscosity (-ja) is derived from 
the time of fall (t ) contains the two constants A and B.
Further experiments are necessary to determine whether these two 
factors are equally affected by temperature changes; until then 
the figures given for A and B can be applied only at the 
temperature at which they were actually estimated.
W '20 = A20T' + B20/C' + C20
The existence of a kink in the 'time of fall’/temperature 
curve is interesting. Speculation as to its cause leads to three 
theories.
The kink might arise from a cause inherent in the conditions 
of the experiments. This explanation is unsatisfactory in that 
the kink- was not found consistently and it occurred only with 
plasma from abnormal subjects. Furthermore, Whittington was able 
to obtain identical kinks with some of his citrate plasmata from
tuberculous patients, although it must be remembered that he was
using the same type of apparatus.
The kink might arise from a temporary alteration in the 
protein equilibrium system between the plasma protein fractions 
and the complex molecule formed by a combination of the fractions.
I cannot devise an experiment, at present, by which this theory 
could be put to a practical test.
The kink might arise from a change in a single protein 
fraction. A protein of the "cryoglobulin" family could produce 
the effects seen in the experiments reported here but the 
protein would have to be one of very special characters, such as 
have not been noted previously. The best known protein of this 
type is the Bence-Jones protein of the urine which precipitates 
at the correct pH and salt concentration on raising the 
temperature to 50-55°C and which redissolves on heating further 
to a temperature just below that of boiling water. (Incidently, 
the Bence-Jones protein is now regarded as a family of proteins 
of different composition, but all having in common this special 
reaction; similarly, it has been shown that the critical temper­
atures for a single Bence-Jones protein can vary with changes in 
the pH and electrolyte content of the urine. ) Bence-Jones 
protein has not been identified ■with certainty in the blood but 
other cryoglobulins have been detected. Very rarely, as in the 
case studied by Wintrobe and Buell (257), the cryoglobulin can 
be present in tremendous amounts (eg.- 7*25g.%), but the two 
classifications for the presence of these proteins consider 
concentrations measured more in terms of milligrams per 100 ml. 
Wertheimer and Stein (248) defined their Cold Fraction as that
"protein portion of serum which precipitates when the serum stands 
for twenty four hours at from 7 to 11°C. " (Later extended to 72 
hours), while.Lemer, Bamum and Watson (144) examined their 
sera daily for 6 days while stored in a refrigerator at 5°C.
Lemer et al. were able to detect the cryoglobulins in 31 out of 
a total of 121 tests performed on a wide variety of disease 
conditions. Flembert and Lehmann ( 81) detected a globulin which 
precipitated at 33°C; Hill, Dunlop and Mulligan (ill) found a 
protein in the plasma of their case of multiple myeloma which 
precipitated at 32°C and redissolved at 38°C. .Jochimsi (127),
Hill et al. (Ill), and Hansen and Faber (95) used viscornetry in 
the study of these abnormal proteins. In the light of the 
properties of the proteins already described, it seems possible 
that a protein can be present in the plasma and serum with the 
kinks, with the appropriate behaviour towards alteration in the 
temperature of the fluid. This particular protein may have 
escaped previous notice for two reasons ~ the physiologists who 
would be studying the effect of temperature change on the plasma 
viscosity would probably use blood from normal volunteers (in 
which the kink is absent) as was done by Steiner and by myself in
(i) above, and the technique of other workers may not have been 
so scrupulously accurate as myself (and Whittington). It will be 
interesting to note if the kink can be obtained on cooling the
plasmata which have been prepared at 37°C. The existence of a 
precipitated protein at 34°C, for example, should be detected by 
other types of examination such as photometry or centrifugation 
and thus it should be possible to subject this hypothesis of a 
cryoglobulin to further experimental testing independent of 
viscoraetry.
§ 14. The Effect of Different Anticoagulants on the Plasma Viscosity.
Whittington, in his original work, set out to study the 
results produced by Day (60) and followed the latter in using a 
sodium citrate solution as his blood anticoagulant. My later 
approach to the plasma viscosity estimation was more critical; 
besides a study of the plasma viscosity and ESR. as physical 
measurements, I wished to determine which anticoagulant was the 
most suitable for the further development of the plasma viscosity 
as a test in clinical pathology.
There were four anticoagulants in common use in the medical 
laboratories - sodium citrate solution, potassium oxalate alone, 
potassium and ammonium oxalates mixture, and heparin - and a 
series of tests were carried out in which specimens of blood were 
divided among these anticoagulants and parallel measurements made 
on their plasmata: to complete the study, measurements were also
made on the serum.
The results are given in Table P of the appendix, (page a5l) 
Potassium oxalate alone, in the concentration usually employed 
(= 2mg./ml. ), produced a diminution in the size of the erythrocytes 
by a passage of fluid from these cells into the plasma, as 
indicated by a lower haematocrit value as compared with the other 
anticoagulants which are claimed to leave the cell-size unaffected. 
The fluid from the cell appeared to have a low protein content 
as the specific gravity and the plasma viscosity of the resultant 
plasma were lower than in undiluted plasma. The decrease in the 
POV. was not constant either as a percentage of the total blood 
volume or of the haematocrit value in heparin blood. Similarly, 
there was no constant relationship between the decreased plasma 
viscosity of potassium oxalate plasma and the plasma viscosity 
of either heparin or mixed-oxalate bloods. Hence, as the 
potassium oxalate alone had no advantages to offer in other 
directions over heparin or mixed oxalate, its further use for the 
preparation of plasma for viscosity estimation was soon 
abandoned. (See fig. 11 and 12)
The 3*8% aqueous sodium citrate solution also fell short of 
the requirements of the ideal anticoagulant. We have no proof 
that the citrate remains in the plasma and has a diluting effect 
only; the chemical methods for the estimation of the citrate are 
too inaccurate (error at least 2%, probably nearer 5%) .
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Pig. 11 The correlation between the viscosities of citrate plasma 
(corrected) and potassium oxalate plasma; duplicate 
samples were taken from the same specimens of blood.
Potassium and Ammonium Oxalate Plasma 
Viscosity (cs.)
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2*0
1*9
- ■  1*8
2*62*42*22*01-6 1*8
Potassium Oxalate Plasma Viscosity (cs. )
The correlation between the viscosities of* potassium 
oxalate plasma and of potassium and ammonium oxalate 
plasma; duplicate samples were taken from the same 
specimens of blood.
Pig.
The sodium citrate solution has the following disadvantages 
which have- led to its adandonment also except in a few laboratories 
which have always used it, following Whittington’s original 
publications. (i) The mixture of blood and citrate must be made 
with accurately-measured volumes, usually 8ml. and 2 ml. This 
citrate-blood mixture can be used only for the viscosity and ESR 
estimations. (ii) To obtain this accurate mixture calibrated 
glass-ware must be used which is fragile and costly. Such glass­
ware is not suitable for use in busy outpatient departments, etc.
(iii) Each viscosity estimation requires an accurate haematocrit 
measurement also (preferably in duplicate) and when large numbers 
are being tested the strain on the centrifuges is considerable 
and the prolonged use of these centrifuges may interfere with the 
routine tests of the laboratory. (iv) An empirical correction 
has to be made to the experimental viscosity result to allow for 
variations in the proportions of cells and plasma in the blood 
samples. The corrected result is what we suppose would be the 
value if the blood had originally had the ’normal' composition of 
45/6 cells and 55% plasma. This formula includes the possible 
error arising from the passage of citrate into the cells and the 
actual error which arises from the fact that the haematocrit 
reading includes an extra 5% because of the plasma retained in 
the interspaces between the individual packed erythrocytes.
101
(•// klifmmiu *rts0$j/j4g \
MotlQGAAN
C u r a t e -Pl a s m a  V / i c o s m t i
(lb r/o J /a a  o f  Cbacmfrolinn <v/Zfr Mo«mofocril Hi)
Afaw/wian «n Misym&r V.i
? inn—
1900
11QQ.
. Tton
Pig. 13 The nomogram by which the experimental citrate 
plasma viscosity is corrected to the viscosity 
expected if the cells had originally amounted to 
36% of the total volume (=45% in undiluted "blood)
In this calculation no allowance has been made for the 
plasma (about 5%) which remains in the interstices of the 
packed erythrocytes.
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Pig. 13 presents the nomogram by which the correction for 
the variation in the haematocrit from the ideal (36'^ ) value could 
be made to the experimental citrate-plasma result. (The 
correction formula is included within the figure. )
An attempt was made to test the validity of applying such a 
correction formula by preparing a second blood sample in which 
the citrate content had ‘been calculated to yield a perfect 20:44 
citrate:plasma mixture. (The nomograms and the various formulae 
are given in Fig. 14 ) It was also possible to prepare a 
similar perfect citrate:plasma mixture from the ordinary citrate- 
plasma by the further addition of citrate solution, but the 
viscosity of this preparation was not studied.
My investigations amount to three tests only (see page 105). 
While the plasma viscosities in two tests agree to within the 
experimental error of the technique, there is a marked discrepancy 
in the third. Further research is essential on this point; the 
subjects should have both a severe anaemia and a high plasma 
viscosity.
The ESR results are also of interest. Two bloods were 
prepared to contain citrate:plasma:cells as 20:44:36 by different 
manipulations, yet in only 1 of the three sets of pairs was the 
agreement really close (see lines K and L ).
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Pig. 14
Let $ — the haematocrit reading of a hlood prepared by mixing 
4 volumes of blood with 1 volume of 3*8% aqueous 
solution of sodium citrate.
(1) To obtain a blood in which the cells will amount to 36%
(equivalent to 45/o in undiluted blood) remove or add to
the blood a volume Of citrate plasma equal to
100( 1 - ;>o of total blood volume.
a OQ
(2) To prepare another blood sample, with a total volume of 
10 ml. in which the perfect ratios of citrate :RBC. : plasma 
are 20:36:44, begin by placing this volume of citrate 
solution into a 10 ml. volumetric flask and filling to mark 
with blood.
800 - IQd 
256
(3) To obtain a citrate:plasma mixture identical with (2) but 
using the ordinary plasma, line "A" gives the percentage 
by which the ordinary mixture is deficient in citrate 
which can thus be added to the separated plasma -
100 x (lI J T T j  ) /°
(4) Line UB" presents the amount by which the plasma in the 
ordinary citrate :plasrna mixture is in excess -
500 / 56 - j s
11  ^100 - > /°
(5) To prepare a perfect 20:36:44 mixture from the ordinary
mixture, calculate how much citrate plasma must be removed 
according to the formula in (l) above; then calculate how 
much more has to be removed by the following formula and 
remove lit j and add this same volume of citrate solution.
.2Q f0 of the volume calculated by formula (l)
(80 - p)
This formula is represented in line •f,Ctl.
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Experiments to prove the formula for the correction of the 
ordinary citrate plasma viscosity value to what it would have 
been if the ezythrocytes had "been exactly 45^ b of the hlood 
volume.
Prom a preliminary estimation of the packed-cell-volume (line k) 
in a second specimen a plasma was prepared in which the citrate 
to plasma ratio was the ideal 20:4-4-.
Later tests also prepared an ideal plasma from the ordinary 
plasma mixture."
Number of test. 1 2 3
A PCV. of preliminary "blood test, with 
citrate to "blood as 2ml. to 8 ml. 11‘7 23*0 23*5
B PCV. of second "blood test, similarly 
made with citrate;"blood as 2:8 11 *7 23*8 24*0
C Volume of citrate required to yield a 
citrate:plasma mixture of 20:44. This 
is calculated from the PCV. of line A. 
Total volume of mixture equals 10 ml.
2*79 2*45 2*43
D PCV. of "blood prepared with citrate 
of line C. 10-6 21*6 23*0
E The PCV. value as calculated from the 
results of lines C and B. 10*44 22*1 22*3
P Experimental plasma viscosity values of 
blood of line B. 1*397 1*625 1 *805
G- Viscosity of line P, corrected by the 
formula. 1*398 1*588 1*745
H Viscosity of citrate-plasma of blood 
of line C. This value should be the 
same as in line G-.
1*392 1*583 1*715
I Maximum sedimentation velocity in 
blood of line B. (cm/sec x 10~4) 13*0 12*22 -
J Max. sed. vel. in this blood after 
the PCV. had been adjusted to 36fo 0*60 4*03 9*83
K Max. sed. vel. in this blood after 
the plasma had been adjusted to a 
citrate:plasma ratio of 20:44 and 
the PCV. to 36 %
0*47 4*44 6*94
L Max. sed. vel. in blood of line C, 
with PCV. adjusted to 56%. This 
final blood was expected to be of 
identical composition as line K.
0*47 3*12 7*50
The citrate anticoagulant has one advantage in that it 
allows of the estimation of the corrected maximum sedimentation 
velocity as well as the plasma viscosity, and the relation of 
these two values has an additive value to each other in the 
clinical interpretation of the results (see also § 21 later;.
The mixture of potassium and ammonium oxalates was first 
recommended by Heller and Paul (106) because the constricting 
action of the potassium oxalate on the erythrocytes was balanced 
by the expanding action of the ammonium oxalate. Heparin also 
does not affect the cell size. It is probable that the plasma 
from either of these anticoagulants would be equally suitable 
for the viscosity estimation; the differences between the result 
of the duplicate tests in Table P are usually small, ivlixed- 
oxalate plasma, however, has a wider potential use than heparin 
plasma both in biochemistry and haematology, and the mixed- 
oxalate plasma has been chosen as the most suitable plasma for 
our purposes. Other workers have come to a similar conclusion 
independently.
The results of Table P have been shown in Pig. 11 and 12, 
and are shown further in Pig. 15, 16, 17, and 18.
The correlation between the viscosities of plasmata 
containing different anticoagulants is not linear. Also, the
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consideration of the serial results of a single subject shows 
that the correlation can change over a period of time (cf. Pig. 55 
This inconstant relationship has raised difficulties in the 
definition of the ranges of normal values because if these ranges 
had been derived by a series of studies with single types of 
plasmata it is possible that a later duplicate estimation might 
produce a value within one normal range and outwith the other 
range. Such a dilemma faced me in the interpretation of the 
results of normal male subject , No 47, when on 29:10:4-7 and 
2:1:48 the mixed-oxalate viscosity was abnormal while the citrate- 
plasma viscosity was a low normal; a little over a year later 
the same citrate-plasma viscosity figures were associated with 
low normal mixed-oxalate plasma viscosity figures. This 
discrepancy serves as an indication that the anticoagulants 
are not relatively inert substances apart from their action in 
preventing fibrin formation*.
Because of the variation in the fibrinogen content it was 
not to be expected that the plasma viscosity/serum viscosity 
correlation of Pig. 17 and 18 would be linear.
(D) The Correlation of the Viscosity of Plasma and Serum with 
the Chemical Constituents of these Fluids.
The mean viscosity of normal plasmata is about 1*850 cs. as 
compared with the 1*008 cs. of distilled water. In the following 
sections the attempt is made to discover if this difference in 
viscosities can be ascribed to any particular component or 
components of the plasma.
In a table of the concentrations of the various constituents 
of serum and plasma attention is drawn at once both to the high 
absolute concentration of the proteins and to their great 
concentration relative to any of the other plasma components. 
Also, from a knowledge of viscosity in general, it is known that 
the viscosity of a solution of a substance with large molecules 
(such as protein) is greater than a solution of equal 
concentration of a substance of small molecules (such as urea 
and glucose). It thus seemed probable that the proteins were the 
constituents having the greatest, if not the complete, effect in 
increasing the viscosity of the plasma over that of water.
The problem was tackled by three experimental approaches.
The viscosity was measured of the plasma after the proteins had 
been removed, the viscosity was measured of the solutions of the 
purified protein fractions, and the viscosity of the plasma and 
serum was compared with the concentration of the total protein
and the protein fractions.
§ 15. The viscosity of the ultrafiltrate of plasma and serum.
By the technique described in the appendix, the viscosity 
to
of the ultrafiltrates of #  sera was studied. The values fell 
within a narrow range (1*021 - 1*035) with a mean of 1*029. 
Included in this series was a case of chronic nephritis who had 
a non-protein-nitrogen level increased to 125*3 mg/100 ml. yet his 
ultrafiltrate viscosity was only 1*026. Thus a three- or four­
fold increase in the nitrogen-containing non-protein components 
has introduced no significant increase into the ultrafiltrate 
viscosity, confirming the hypothesis that the proteins are 
chiefly responsible for the plasma viscosity values. (Table Q)
My viscosity value for ultrafiltrates compares well with 
the 1*02 cs. already published ( 147,179,193).
It also compares with the 1*021 cs. result of my estimation 
of the viscosity of isotonic saline (0*9/'b).
(Note: The original crude apparatus yielded excellent
ultrafiltates but required almost 100 ml. of blood; hence the 
scanty results presented in Table Q of the appendix. Recently 
a simple apparatus was described ( 69) in which the pressures 
available by high-speed centrifuging are employed to force the 
ultrafiltrate from less than 10 ml. of serum through G-radocol
membranes. ITurther experiments will be made with this apparatus 
"both on serum and plasma from patients with diseases known to 
have gross abnormalities in the composition of these fluids. 
These results and their discussion will be inserted here later. ) 
(* not delivered in time for results to be obtained)
§ 16. The viscosity of solutions of the purified protein 
fractions - albumin, globulin, and fibrinogen.
(The results reported in this section have formed the basis for 
a publication - "On the viscosity of solutions of human albumin 
and globulin" by Harkness and Whittington, Biochimica et 
Biophysica Acta, 1947, 1, 487-496. )
Introduction. The viscosity of a liquid was defined as that
property which is responsible for the internal resistance offered 
to the relative motion of different parts of the liquid. Since 
the work done in overcoming frictional resistance is transformed 
into heat, a connection must exist between the viscosity 
coefficient and the kinetic energy transformed into heat. Thus, 
there is the alternative definition of the viscosity coefficient
q = (j. (fj)2 (ergs per sec. per cm.2 )
where q = the kinetic energy transformed into heat in unit time 
for unit volume. The view of the viscosity coefficient as a
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measure of the energy dissipated (eg. in forcing liquid through
a capillary) is sometimes more fruitful than the commoner one in
forming a physical picture of the processes affecting viscosity
such as the increased viscosity on introducing colloidal
molecules into a pure liquid ( 5 ).
In a dilute suspension of large rigid spheres, in which each
sphere may "be considered surrounded completely hy a large volume
of unaltered solvent, Einstein (68 ) in 1906 calculated the
formula of / , _ _ ,
IWo = = 1 + 2*5 P
where ja = absolute viscosity of the solution,
i-i0 = absolute viscosity of the pure solvent, 
fi/fio = = relative viscosity,
/ = volume fraction of the disperse phase
(volume of particles / total volume).
The viscosity is not increased directly by the suspended particles
but arises indirectly as a result of disturbance of the solvent
flow. The relative viscosity at low concentrations is independent
of the nature of the disperse phase said of the particle size.
t
The introduction of spherical colloidal particles into a 
pure solvent leads to increased viscosity mainly as a result of 
the extra dissipation of energy involved by flow distortion 
around each particle. With asymmetrical particles (eg. plasma 
proteins) additional causes are also involved —  thus the 
rotation of the . asymetrical particles, enforced by the velocity
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gradient, results in extra energy dissipation, a mechanism which 
is clearly much less important the more nearly spherical are the 
suspended particles; the deformation of the particles in the 
velocity gradient and the much greater interactions occurring in 
the suspension of asymmetrical particles provide further 
possible mechanisms.
Many colloidal materials are strongly solvated in solution. 
Solvation involves the strong binding of solvent molecules, 
usually in a layer not more than a molecule thick, the 
(particle + solvent layer) acting as the kinetic unit in solution 
- so producing an effective increase in the volume concentration 
of the solute. The degree of solvation of the plasma proteins 
is still under discussion.
Methods. From blood drawn from normal human subjects, specimens 
of the sodium salts of albumin and globulin were prepared, as 
described in detail in the appendix. Care was taken in their 
repurification but it cannot be guaranteed that there was not a 
small amount of the other protein contaminating the final products. 
Albumin was dissolved in distilled water to a concentration of 
about 15% and its viscosity was measured at this and decreasing 
concentrations. Similarly, the viscosity was measured on 
globulin dissolved in normal saline. A specimen of fibrinogen 
was obtained from the Medical Research Council and studied in
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in aqueous solution. The concentrations were measured by 
analysis of the nitrogen content by micro-Kjeldahl techniques.
The viscosity results are reported both with the Newtonian- 
fluid calibration and in terms of the arbitrary V5 scale.
Results. The results are given in Table R of the Appendix.
Prom these, Pig. 19 was constructed; similarly Pig. 20. 
Discussion. The viscosity of the protein solutions did not 
increase equally with each increment of protein concentration, 
the addition of further protein having an increasingly greater 
effect. The plotting of against c (g./lOOml.) yielded the
three curves of Pig. 19 , where the viscosities of 17° solutions 
were 1*400 cs. for fibrinogen, 1*150 cs. for globulin, and 
1*065 cs. for albumin; while similarly a viscosity of 1*600 cs. 
corresponded to 1*3 g./100ml. of fibrinogen, 4*0 g./lOOml. of 
globulin, and 8*0 g./lOOml. of albumin.
Cohn ( 44 ) has given the dimensions of the protein molecules 
as (ie. length of ellipsoid x equatorial diameter of ellipsoid)
900 x 35 °A for fibrinogen, 320 x 36°A for globulin, and 
150 x 38 °A for albumin. If one could imagine the extra energy 
expended to rotate the long fibrinogen molecule as compared to 
that of albumin, one can readily understand how this difference 
in viscosity arises. Similarly, one can visualise the long 
fibrinogen molecules interfering with each other.
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Pig. 19 The Viscosity of solutions of the purified plasma 
protein fractions at different concentrations.
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Fibrinogen 
Ooncentrat ion.
g./lOO ml,
1*4
0*4--
V5 calibration scale
Vg calibration with distilled 
water.
1-4 1*6 1*8 
Viscosity of the Fibrinogen Solution (cs. )
1*2
Fig. 20 The viscosity of a solution of Fibrinogen in water.
The fibrinogen was supplied by the Medical Research 
Council.
Taking the albumin viscosity effect as unity, the effective 
action of globulin was roughly 2• times, and that of 
fibrinogen was roughly 6* times. These figures should be 
remembered when we proceed to the discussion of the relative 
effects of the protein fractions on the plasma viscosity itself.
If log (j. were plotted (rather than y/') against the 
protein concentration, the graphs of Fig. 21 could be drawn. It 
appears that each viscosity/concentration curve is now formed 
really from two straight-line relationships, and furthermore that 
the • change from one slope to the other occurs at the same viscosity 
value ( p = 1*4) for all three.. This finding suggests that the 
explanation of the phenomenon lies in the characteristics of the 
viscometer rather than in the protein solutions: to the critical
viscosity value at which the lines change direction we have 
applied the term - "shear point". It should be noticed also that 
the viscosities of the protein solutions at the concentrations 
encountered in the serum and plasma lie to the left of the "shear 
point" of these figures, yet the viscosities of the natural 
fluids lie to the right of this point; this makes it difficult 
to apply the findings for solutions to the plasma itself.
The viscosity of the albumin and globulin solutions has 
been studied many times previously ( 5 ,40 ,41 ,105 ,109, 179 ).
All agree concerning the shape of the y / o  line of correlation
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Fig. 4. Variation of log^o with concentration: 
X  sodium albuminate (V6)
O ,, globulinate (V6)
4- ,, chloride (0.895 %)
□ water
Fig. 21 On plotting log |i of the solutions of albumin and
globulin against the protein concentration, the 
line for each was formed by two parts. The angle 
of both lines corresponded to the same viscosity 
value (p = 1*4).
but none would coincide exactly if the curves were superimposed. 
The responsibility for these differences can be divided between 
variation in the proteins as the techniques for their preparation 
differed from worker to worker and discrepancies arising from the 
characteristics of the viscometers. As an example of the latter 
cause, Fig. 22 presents the values for Fig. 22
the fibrinogen solution as measured by 
Lawrence (X ) and myself (0 ) on 
fibrinogen obtained from the same 
source. Lawrence suggested that the 
viscometers could be calibrated and
0
*
f 1 X
X
0
" °*5 X o 
X O °
©G
0*1 0*2 0*3 cs.
correlated with a commercially-supplied
Viscosity of Fibrinogen 
albumin solution, but in view of the Solution minus 1 cs.
differences possible in the batches of protein, I do not consider
that this would be the best method available - the method to be
described in the following section is superior as it is independent
of the protein characteristics.
It is well known that in certain homologous series of 
compounds (occurring in nature as liquids) the relation between 
the viscosity at a given temperature and the molecular weight is 
fairly uniform - for instance, in the aliphatic hydrocarbons, if 
log p 0 be plotted against the molecular weights, the compounds
CiS-J
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lie close to a straight line, from pentane to octane. In an 
original hypothesis Whittington and I attempted to apply this 
finding for pure liquids to substances in solution (for details 
consult the reprint of our paper).
We proposed that instead of treating a solution as 
consisting of solute and solvent we would treat it as if it were 
a single substance with an "effective molecular weight" made up 
from the components. If the weight; of the molecule of solvent 
= M and that of solute = Mq , and if the concentration of the
solute (g./lOO g. ) be S , then the relative gram moles of 
solute and solvent, per 100 g. of solution, are
Taking moments, therefore, we defined the "effective molecular 
weight" of the solution (M1) as
Evidently, as Mq— > oo * ss in the case of proteins, then
S/Mq and (100 - S)/ M respectively.
100
S + 100 -  s
M
10GM
100 - S
For aqueous solutions 1800
100 - S
and for saline solutions
M 100 - S
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On testing this hypothesis with the results for sucrose 
solutions published by Bingham and Jackson ( 21), an excellent 
straight-line relationship was obtained between M' and logp9no ,
<U\J
i * / 1800 N .
where M = ( q^q _ g )( 1 + aS) where a = - 0*00143.
(The (l + aS) factor was introduced to compensate for the
omission of the S/Mg which was not negligible.) (cf. Table -R(b))
Applying the same formula to protein solutions, both the
albumin and globulin solution values lie on the sucrose line
(until p = 1*4) if a = + 0*025 for globulin and a = + 0*008
for albumin. After p exceeds 1*4, (= approximate "shear point")
the protein line diverges from the sucrose line, but still lies
as a single line. When the fibrinogen solution was studied the
falling-drop apparatus was not available, the specific gravity
was not measured, and p. could not be calculated from is- 4
but from the small concentrations used the specific gravity
could not have increased by more than 1*5% The results
available indicate that the fibrinogen solution behaves exactly
as the other proteins, that the fibrinogen line coincides with
the other proteins' line, and that a = + 0*093 approximately.
Further, on plotting the a values against the (Fig. 23;
corresponding M values, a straight line is obtained if 
S
Mg for salt = 58*5, for albumin = 69,000, for globulin = 159,400
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Ms
1000
100
100
70
24 20
1000 a
Fig. 3. Variation of a  with Ms at 20° C. 
Aqueous solutions of:
+ sodium chloride 
x ,, albuminate 
O ,, globulinate 
/ \  sucrose
Fig. 25 See text for an explanation of this figure.
The relation between the Molecular Weight 
of the proteins and the factor "a" 
whose derivation is given in the text.
The basic hypothesis is to treat an 
aqueous solution as if it was a homogeneous 
single substance.
%
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and for fibrinogen — 520,000. These figures are very close bo 
those generally accepted for the molecular weights for these 
protein fractions. This technique, with further values derived 
from proteins of accepted molecular dimensions, offers another 
method of measuring the molecular weights of new substances 
somewhat analogous to the intrinsic viscosity techniques (125) 
used at present to study the large polysaccharide molecules.
It can be demonstrated also that the effect of temperature on 
viscosity is capable of expression as alterations in "a’*.
The reference to the "effective molecular weight" of 
solutions has been included here as the idea was original; from 
the promising results which I have obtained with protein solutions 
Y/hittington has proceeded with further fruitful researches with 
other substances (unpublished results).
Yet another method for correlating and calibrating (Fig. 24) 
viscometers also becomes available. The sucrose line is a 
universal standard and readily reproducible. It should be 
possible to use an albumin solution (purity is not critical) 
to derive calibration formulae for any viscometer by which the 
log (i values can be adjusted to allow the protein linejji to coincide 
with the sucrose line. Such a scheme would eliminate the effect of 
the variation in the shear of individual viscometers. It would
127
. . ' J y '
1
o A * '
Approx 
"shear /:
Imate
0 0.1 0.2 0.3 0.4 log p 20
Fig. 2. Variation of log fi with “effective” molecular weight.
, ioo M
=  7oo-S wilere M =  mol-wt of solvent; S =
g/ioog concentration of solute
A  Sucrose 20% ( B i n g h a m  and J a c k s o n )  a  =  —  0.00143 
+ Sodium chloride 0.895 % a =  —  0.00406
□ Water H
x Sodium albuminate V6 )
*  „ „ V 5 (calculated) \ a =  +  °-°°8
O ,, globulinate V6 i
•  „ V 5 (calculated) \ a =  +  ° '°25
Fig. 24 This figure shows how the viscosity of a protein 
solution can he made to coincide with the 
"sucrose line".
This figure contains the foundations of 
(a) a method hy which the molecular weight of a
solute may he calculated if the characteristics 
of the viscometer have heen studied with 
solutions of suhstsinces of known molecular 
weight, and
(h) correlating viscometers hy a protein solution 
to supply results corresponding to this 
sucrose line which is internationally 
reproducihle.
128
have "been more satisfactory, in the light of our subsequent 
experience, if all our family of viscometers had "been correlated 
to this sucrose line rather than to the arbitrarily-chosen 
V5 instrument - a consideration of Fig. 24 mil show how 
simple such a procedure would "be.
§17. The Serum Viscosity / Serum Proteins Relationship.
The first 212 tests in which I made the estimation of both 
the serum viscosity and the serum proteins will he considered 
only as these results have been analyzed previously as the basis 
of two papers by Whittington and myself ( 97,100) and further 
later results have added no more information to that obtainable 
from the originals.
Methods. The viscosity of the serum was measured at 20°C. and the 
values recorded in the V5 scale.
The albumin and the total globulin were estimated by a 
micro-Kjeldahl technique, plus fractionation by the classical 
sodium sulphate salting-out method of Howe (121J.
Results. The results are presented in Table S * of the Appendix.
The protein concentrations were plotted against the serum 
viscosity to yield Fig. 25 . The distribution presents a wide
scatter but there is a back—ground regular trend of pattern which
( * the results have not been collected into a single table, 
but can be extracted from the various other tables of 
parts 7 and 8. )
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prevents one from applying the adjective "random scatter" to 
the diagram.
Now, if from the total tests I removed those values from. 
cases of liver and kidney disease, together with those from the 
cases of general disease approaching death (a condition later 
defined as "terminal decay") the distribution shown, in Fig.26. 
remains. The points can he joined hy hroad lines, as shown.
It appears that as the serum viscosity increases the albumin 
values can he found arranged along periodic curves; the globulin 
is arranged along similar curves with the same phase hut in the 
opposite direction. At the nodes where the periodic curves 
approach or even cross, the A/G- (albumin/globulin) ratio may be 
unity or less; the A/G- ratio will be highest at the intermediate
stage when the curves are farthest apart.
Fig. 26 also includes a graph of the fibrinogen values as
it is permissible to consider fibrinogen only as a globulin which
has the special property of forming a clot under appropriate 
conditions. The fibrinogen curve moves in the same phase and 
direction as the total globulin curve.
The total protein values (not graphed) increase as the 
viscosity increases, without a periodic—curve distribution as 
obtained for the components.
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Discussion. As can be confirmed by a study of a few results in 
*
Table S it has not "been possible to get an agreement between the 
viscosity of the serum and the sum of the viscosity of its 
ultrafiltrate plus the increments of (viscosity of pure protein 
solutions of the same concentration as occurs in serum minus the 
viscosity of the solvent). The kinematic viscosities (y) and 
the absolute viscosities (|u) were studied according to the 
Newtonian fluid calibration, the V5 scale, and after calculation 
to the sucrose line, yet the viscosity of the serum always 
exceeded the sum of the viscosities of its components. (The 
sucrose line technique was specially useful as with it the 
divergence at the "shear point" can be eliminated; the results of 
pure solutions lie to the left of this point while the serum 
results lie to its right.) This discrepancy led us to postulate 
the existence in serum of a conibined-protein formed from albumin 
and globulin - this large molecule would have an effective action 
in increasing the viscosity by an amount greater than the sum of 
its constituents acting as discrete molecules.
Prom this hypothesis 'Whittington analyzed my results 
working from an equation by which a mass-action equilibrium 
was proposed between free albumin and free globulin and a 
complex of albumin-globulin. He derived the figures -
A0*59 xG°*41 = K(A + G-) (K = 0*51 approx. )
( * see footnote on page 128)
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Support for the method, of analysis and. for our hypothesis came 
in a personal communication from Dr. J.D. Hamilton of Canada, who 
had employed a different approach to end with a similar "belief 
in a protein complex and an equation as under - (94)
A° 5xC° 5 = 0*63(A + Gr)
The agreement "between these two equations is noteworthy.
(A reprint of our publication is included in the folder of the 
appendix. )
Unfortunately I did not study solutions of mixtures of the 
pure proteins. The regular relationships obtained by such workers 
as Rohrer (.212 ) and Nugent and Towle (187) for solutions of the 
single proteins and their mixtures are rather against the 
existence of a combined-protein under these experimental 
conditions. This may be due to small but vital changes induced 
in the proteins in the maltreatment of their separation and 
purification.
A series of papers by the Heyder-Rohrer-Naegeli school in 
Berlin introduced a novel method for the fractionation of the 
serum proteins by a combination of viscosity and refractive index 
measurements. A series of viscosity measurements was made on 
various mixtures at various concentrations of albumin and 
globulin solutions, prepared from a single blood specimen. An 
elaborate chart was constructed from which, if one knew the
viscosity and the total protein content, the ratio of albumin 
to globulin (A/G-) could be readily estimated. They proposed that 
the total protein content of the serum could be estimated from 
its refractive index, and the A/G- ratio could then be calculated 
if the viscosity was known. This elegant plan did not take into 
consideration the differences in the viscosities which might be 
due to instrumental characteristics or the qualitative differences 
which may be found in the proteins in certain diseases, as no 
mention is made of studies with pure proteins derived from ill 
subjects: furthermore, the possibility of a protein-complex was 
not allowed for. This scheme of fractionation was used widely on 
the continent for 2 or 3 years (cf. Bircher (22,23,25)) until a 
more critical approach led to its complete discard; some papers 
included such impossible results as 100L/o albumin or even 0/'o 
albumin( 122).
In the T>revious section we saw that the viscosity effect 
of globulin in solution was approximately twice that of albumin. 
Consideration of the results in Fig. 26 might indicate that a 
generalisation concerning the effect of these proteins in the 
serum would make their ratio nearer 3:2. This again could be 
explained by the presence of a protein-complex.
The periodic wave relationship between the serum viscosity
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and the protein fractions is quite novel. One immediately asks 
how it had been missed by previous workers in this field and 
several answers can be proposed - (a) such a periodic wave 
relationship would appear so unusual that some might attribute 
it to chance only, (b) the worker might have omitted to include 
it in his results as he could offer no explanation for its 
occurrence, (c) a large series of results is essential so that all 
the 'critical' values-may be encountered, and (d) a high degree 
of accuracy in the technique of viscometry is required as it is 
obvious from Fig. 26 that minute errors at critical points would 
disturb the pattern greatly. I had had the experience of a 
similar periodic relationship between the plasma viscosity and 
the BSR, so that I was willing to accept my findings without 
qualms. Nevertheless, a search was made in the literature for 
similar investigations but that of Petschacher (193) was the only 
one in which the protein fractionation was by the same technique 
and the viscometry was similar (Ostwald at 25°C. ). His 57 values 
were reported in the form of a table only. I plotted Fig. 27 to 
correspond to my own, and the similarity is indeed striking. 
Further, if a letter (a, b, etc.) is applied to each characteristic 
point in turn in both figures (ie. each peak and trough) and if the 
viscosities of these letters are plotted against each other, & 
regular sigmoid curve of correlation is obtained ~ x1 ig* 28.
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2.1
2.O..
1.8--
2.22.0 2.11.6 1.8 1.9
Petschacher's Calibration Scale (25°C. )
Pig. 28 The line obtained by plotting the characteristic points 
(ie. viscosity corresponding to a wave peak or trough) 
in the serum viscosity/protein fraction concentration, 
of iry wave in Pig. 26 against the corresponding value 
of Petschaher's wave of Pig. 27.
Proceeding one stage further, if the correlation graph is used 
to convert Petschacher's viscosity results to ray V5 scale, and if 
the serum albumin and globulin of the periodic lines corresponding 
to these V5 viscosities in Pig. 26 are read off, these protein 
values differ by less than 0*2 g. from Petschacher's originals.
I also considered that it was possible that similar 
periodic relationships could be discovered where the albumin and 
globulin fractions had different physical properties. Therefore 
I plotted the osmotic pressure of serum against the concentration 
of its proteins, as reported by Wells (246). (The fractionation 
technique was similar to my method. ) As the albumin exerts a 
greater osmotic pressure than the globulin, the relationship is 
reversed as compared to the viscosity effect. Making this 
adjustment, Pig. 29 makes one consider seriously that this 
periodic relationship would be again encountered if some of the 
irregular diseases were removed.
In spite of pondering on this subject for years I have 
still no explanation to offer for the occurrence of the periodic 
curve in the serum viscosity / protein relationship.
Two other problems arise.
Later, in the clinical part of this thesis, it will be 
shown that in normal subjects the plasma viscosity values fall 
within a narrow defined range, that in illness in which there is
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a generalised or systemic reaction the plasma viscosity rises, 
that the increase is proportional to and indicative of the degree 
of this systemic reaction, and that with recovery the plasma 
viscosity falls again to the normal range. In the rheumatic 
diseases where changes in the fibrinogen are moderate, Salt (217) 
and Coke (4-9) (also in personal communications) find that the 
serum viscosity changes much as does the plasma-viscosity; my 
own results showed a wider variation as they included more cases 
of acute disease with high fibrinogen levels. The periodic curve 
was obtained by joining many results from individual patients.
We are now faced with the problem of the behaviour of serial 
results of the individual patient in the course of an illness - 
as the viscosity increases and decreases, are the curves 
followed through each peak., and trough ? There is no answer yet 
because of the intensive tests necessary being beyond my capacity 
as long as my researches are being carried out as an addition to 
routine duties and not on a full-time basis. I found that it was 
possible for the results in one subject to move more than the 
distance between two critical points of the periodic curve within 
24 hours. Hence it will be necessary that serial tests be made 
at intervals of a few hours only, which requires a staff of 
several technicians. In contrast, some cases of chronic disease
may have results showing no change over a period of weeks or 
even months. There is less difficulty in believing that such 
rapid and involved protein movements occur if one considers the 
work of Schoenheimer and other workers who showed that 50;b  of the 
protein of the liver is changed every three days, the results of 
Chick who found that euglobulin could change its characters in 
vitro to that of pseudoglobulin, and those reports where it was 
shown that a subject can be maintained in a positive nitrogen 
balance by the intravenous injection of plasma, alone.
van Slyke is credited with the introduction of the estimation 
of the albumin/globulin ratio to clinical medicine, and it is 
claimed that as the severity of a disease process increases so 
does the A/G- decrease and that an A/G ratio of 1 or less has a 
serious clinical significance. Now, on consideration of my curves 
again it is noted that the A/G ratio would be 1 or less at the 
several points where the albumin and globulin approach each other. 
This low A/G value can correspond to a serum viscosity just above 
or far above the normal range. Thus the A/G ratio and the serum 
viscosity are both claimed as guides to the same clinical states 
yet a comparison of them simply as physical values shows that 
the two tests must differ - which is the more reliable? My own 
opinion is that the viscosity is to be preferred. Prom ny 
experience in chemical pathology X have come to discard the use
142
of ohe A/fcr raoiO completely and rely upon the absolute values 
of the albumin and globulin. Salt (217) also favours the 
measurement of both the viscosity of the serum and the protein 
fractions, without the calculation of their ratio.
§ 18. The plasma viscosity / plasma protein relationships.
The viscosity of the mixed-oxalate plasma and the plasma
protein fractions were studied in the same series of subjects as
reported in §17 for the serum functions.
The fibrinogen was measured as the fibrin clot obtained
by recalcifying plasma, the albumin and globulin were measured
in the serum, and by allowing 0*75 as the specific volume of
fibrinogen these two serum proteins were recalculated as plasma
constituents by multiplying by (100 - 0*75x3?) / 100.
%
Results. See Table S of the appendix.
The plasma viscosity was plotted against the protein 
concentrations to yield Pig. 30 . The absence of the periodic 
curves is noteworthy.
The fibrinogen values were plotted against the differences 
in viscosity between plasma and serum, and Pig. 31 was obtained.
Also in this figure are the results of the solution of fibrinogen,
with the original viscosity values converted to the V5 scale.
* see footnote on page 128.
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Pig * 31 The relationship between the plasma fibrinogen and
the difference between the plasma viscosity and 
serum viscosity is only approximately linear, and 
this line is markedly different from the viscosity line of a 
fibrinogen solution.
Discussion. xhe absence of a periodic relationship bety/een
the viscosity of plasma and its protein constituents is due to 
the difference in the speed at which the protein fractions vary. 
The fibrinogen has a very rapid rate of change, about 100% in 
24 hours being seen in cases of acute inflammation. A change of 
similar dimensions would not be found in the albuMn or globulin 
in le'ss than a week, such a slower rate lending itself to the 
maintenance of the periodic relationship.
An increment in the fibrinogen concentration has a greater 
effect in increasing the viscosity of plasma than in increasing 
the viscosity of a pure fibrinogen solution; we have already 
encountered this phenomenon for albumin and globulin. The same 
explanation is offered, ie. there exists in the plasma a protein- 
complex formed from albumin, globulin, and fibrinogen whose 
effect on viscosity is greater than the sum of its constituents 
acting singly. This discrepancy between the fibrinogen effect in 
plasma and solution has been verified by Lawrence (131;.
Furthermore, the increment by the fibrinogen in plasma is 
not constant if one compares the fibrinogen values with the 
difference of the plasma and serum viscosities, as in Fig.51 .
If one used the mean line of the plotted values together with 
this viscosity difference as a means of estimating the fibrinogen 
concentration, an error of 25>o could be frequently met at low
±4bb
fibrinogen levels. This error might; arise if there was a variation 
in the size of the protein-complex or in the proportion of the 
fibrinogen in the complex. (The idea of a protein-complex in the 
plasma has been made by several other authors (eg.(171,231 ))).
Lawrence (131) has suggested that information regarding 
the chemical composition of the plasma can be obtained by his 
scheme for the fractionation of the proteins by serial viscosity 
measurements after successive protein removals. This scheme can 
be criticised on the grounds that it is inaccurate (eg. he uses 
the plasma-serum viscosity difference to estimate protein) and 
that information which bears a closer relation to the protein 
composition can be obtained more readily, eg. by filter-paper 
electrophoresis ( 55, 65, 82).-
One further point has to be made from the results. There 
was no instance in which the plasma viscosity was increased 
beyond its upper level of the normal range (= 1*915 cs. ) by a 
high dlbumin level: an abnormally high plasma viscosity is due to 
an increase in the .globulin and/or fibrinogen.
§ 19* The plasma protein equilibrium factor.
•Ye had to postulate the existence of a protein complex
in the plasma to explain the failure to correlate the viscosity
with the protein fractions. Whittington continued with his
mathematical analysis of my results, beginning from a mass-action
equation Ao nl - a J3  v _ \ ct + (3Af + cf + p£ + Pb)
He also prepared Fig. 32 which I later redrew to the form shown
here, by which it is possible to read off the value of K if the
values of albumin, globulin and fibrinogen are known. This chart
includes the A/G- ratio as one ordinate, and the A/P ratio as the
other. (lOO)
I found that this K value had a closer relation to the 
clinical condition of the patient than the simple A/G- ratio from 
which it is partly derived; it could also possess greater 
clinical significance than the ESR or the plasma viscosity 
estimations, on occasions. It is an ingenious method for the 
expression of the inter-relationships of the three protein 
fractions as a single numerical value. (97)
(Reference is made here to this factor as its existence was 
derived from the results prepared in my viscosity studies.
Reprints of the papers in which appear Whittington s analysis and 
my clinical application of the factor are included in the appendix.
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Fig. 32 Taken from my paper ( 97 )
The nomogram by which the plasma-protein- 
e quilibrium-factor (k ) may be calculated 
from the A/G and A/F ratios.
The consideration of the A/F ratio has led to 
an improvement over the single A/G ratio.
§ The relation of the specific gravity of plasma and serum
to the -protein content.
Some of the data given here have been used as the basis of a 
publication by "Whittington and myself - a reprint is contained in 
the appendix.
The Heyder-Rohrer-Naegeli scheme for the fractionation of 
the serum protein from the measurement of the viscosity and the 
refractive index, referred to in §17, failed in its practical 
application because (in rny opinion) they attempted to apply their 
results from pure protein solutions to the serum without making 
any allowance for a possible combined-protein complex of higher 
effective molecular sizet and specific viscosity than its 
components. I decided that if I had a simple method for the 
estimation of the total protein I might reinvestigate this 
problem from measurements of the serum viscosity.
It was essential that the method for the measurement of the 
total protein be simple and accurate, otherwise the routine 
chemical methods of fractionation and estimation would be less 
time-consuming. In the early 194-Os the specific gravity methods 
were being advocated widely, several techniques had been devised, 
and the possible accuracy claimed was high. All these methods 
assume that the non-protein constituents affect the specific 
gravity to a constant amount and that the protein fractions
S-ll affect tne specific gravity equally (186). The specific 
gravity and the total protein were correlated by formulaej 
unfortunately there seemed to be a different formula in each 
paper. . Nevertheless, X decided to give this method a trial. 
Methods. The specific gravity was measured by the falling-drop 
methods of Barbour and Hamilton (12) and Phillips et al. (1S4-).
The total protein was measured accurately by a micro-Kjeldahl.. 
technique. The details of these methods are given in the appendix.
Results. For serum I obtained the best correlation between ny
\
specific gravity results (Barbour and Hamilton method) by the 
formula originally derived by Y/eech et al. (245) from dog 
experiments: for plasma, as I was using Phillips copper sulphate 
method, I used the formula recommended by him.
I express my results in Fig. 33 where there are three 
frequency curves for the differences of the protein as estimated 
by a specific gravity method from the protein as estimated by the 
micro-Kjeldahl method^ one curve refers to my serum results, one 
to my plasma results, and one to the results of Adams and Ballou 
for serum tested by Phillips technique( 4 ).
Discussion. There can be a discrepancy of 1*5 g./lQOml. between 
the protein as estimated by these methods.
Both methods used Yri.ll yield specific gravity results which 
in duplicate tests agree to 0-0001 . The copper sulphate method
1*0 0*6 0 0-6 1*0 minus plus
g./100 ml.
Fig. 53 The relation of the Total Protein of Plasma and Serum 
calculated from the specific gravity to the value 
obtained by a micro-Kjeldahl technique.
The black area represents my results for Serum, -with Barbour 
and Hamilton's Falling Drop specific gravity technique
Serum Protein = 347*9(Sp. gr. - 1*00726) g./lOO ml.
The red area represents ray results for Wintrobe's Oxalate Plasma, 
and Phillips Copper Sulphate specific gravity technique.
Plasma protein = 360(Sp. grav. - 1*0080) g./l00 ml.
The green area represents the results of Adams and Ballou ( 4 ) 
for Serum, using Phillips method.
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is simpler "but Barbour -and Hamilton's method has the advantage 
that it can "be used for non-protein-containing fluids or for 
fluids of such low protein content that the pellicle necessary 
for the copper sulphate method will not form.
The discrepancy cannot be ascribed to the non-protein 
content of the serum or plasma, as perfect agreement can be found 
with non-protein-nitrogen values of over 100 mg./lQO ml. , while 
the largest errors occurred with N. P.N. values within normal 
limits.
The results of Mams were included to indicate that my 
errors were of the same order as found by other workers. Papers 
still appear in which the method of specific gravity is praised, 
but more are critical ( 8,113,151,152,263,264,245)
An indirect criticism of the method can be detected in the 
gradual disappearance of the copper sulphate bottles from many 
laboratories of repute. Their departure will certainly be 
hastened by the simple but elegant protein fractionation by 
electrophoresis on filter-paper ( 55 , 65 , 82 ).
Because of these potential errors in the technique for the 
estimation of the total protein I did not pursue ny proposed 
investigations for serum and plasma protein fractionation by a 
viscosity method.
#  sic $  3js Jt< !j£ if. -Jf. S}S-
(E) The relation between the plasma viscosity and the erythrocyte
sedimentation rate.
Later, in the part devoted to the clinical aspect of the plasma 
viscosity estimation, it will be shown that the viscosity is 
increased in the presence of disease and can be used as a guide 
to the severity of the reaction to this pathological process: in 
that part there will be a comparison of the values of the plasma 
viscosity and the ESR tests to the clinician. We will confine 
our attention here to the comparison of two physical measurements. 
Methods. The appendix includes the details of these estimations. 
From citrate blood, the corrected plasma viscosity and the 
maximum corrected erythrocyte sedimentation velocity were measured. 
From mixed-oxalate blood, the plasma viscosity and the 1-hour ESR, 
corrected for variation in the haematocrit according to the chart 
of Wintrobe and Landsberg (258), were measured.
Results. The results have not been collected into a single table 
but may be noted scattered throughout various other tables. The 
relevant information can be depicted in Fig. 34, 35, 36, 37, and 
38, .and also in Fig. 80 and 89 of the clinical part.
Discussion. The discussion can be divided for convenience 
according to the ESR techniques.
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§ 21. Corrected maximum erythrocyte sedimentation velocity.
Whittington’s original 2.0 tests in duplicate of the ESR 
and plasma viscosity had indicated that a straight-line 
correlation was unlikely - he joined his points "by three dis­
continuous curves. Later, when I came to plot my ESR/viscosity 
relationships I found that they could he joined hy a continuous 
periodic curve, as in Pig.35 . Whittington was able to confirm 
my curve from further results of his own and his curve was 
identical in shape. Moreover, if each peak and trough was given 
a letter and our viscosity values corresponding to these points 
plotted against each other, a regular curve of correlation was 
obtained: we used this discovery as the basis of our attempts to
correlate the results for non-Newtonian liquids (such as plasma) 
when measured in viscometers calibrated with Newtonian liquids( Pig. 39)
There is independent support for the existence of this 
curve in the results of G-ibson (87 ) who studied mixed-oxalate 
plasma viscosity and a maximum sedimentation velocity in oxalate 
blood. He did not discover a curve but he did find that there 
were peaks in his ESR/viscosity distribution chart. Unfortunately 
he was using an instrument which was nor correlated to the V5 
scale; nevertheless, on plotting the plasma viscosity values 
corresponding to his peaks (oxalate blood) against my values 
(citrate blood) I obtained a series of points which could be
\ 160
cs.
Viscometer
2*0 - -
1*9 --
1*8 --
1*7 --
1*6 - -
1*5 --
1*81*7 1*9 cs.1-61*5
Viscometer V2
Fig. 39 The correlation of Viscometers by the comparison 
of the characteristic points on the plasma 
viscosity/ESR. (maximum velocity) periodic curve. 
Viscometer V^ was used at Montrose; Vg was used 
in Cheshire.
® = experimental values.
x = values calculated from logarithmic smooth curve.
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joined by the smooth curve of Fig.40 . This curve allows me to 
make an approximate correlation between his results and my own.
The periodic curve was made by drawing a line through a 
large number of separate points representing individual tests.
The behaviour of serial results of patients in disease with 
reference to this curve has not been tested as I found that the 
speed of this movement would entail that these serial tests be 
carried out at intervals of a few hours. I have never had a team 
of investigators available such as this problem required for its 
solution. If in two successive tests, point A is 
succeeded by point B, we must admit that we do not 
know if the curve has been followed to the peak and 
down again, or if there has been such a rapid jump 
across the gap that random testing fails to detect an intermediate 
value, (cf. F.M. where the citrate viscosity fell from 1*811 cs. 
to 1*725 cs. in 6 hours) (see Table XV).
From the shape of this periodic curve it is obvious that it 
is impossible for both the ESR and the plasma viscosity to be 
exact guides to the same thing - (in this instance, to the 
severity of the reaction to pathological processes). While the 
general trend is for the ESR and plasma viscosity to increase and 
decrease together, it was quite possible for a high value in one
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1. 6 - -
2.2 2.32.11.8 2.01.9
Viscosity of P+A. Oxalate Plasm (Gibson)
Pig. 40 The relation of characteristic points (peaks) on the V5 
periodic wave of Corrected Citrate Plasma Viscosity and 
the Maximum Corrected Citrate Sedimentation Velocity 
(as shown in Pig. 35) and the viscosity at the peaks in 
the potassium and ammonium oxalate plasm viscosity and a 
maYirmim Sedimentation velocity as derived by Gibson ( 87 ).
It is necessary to use a maximum sedimentation 
velocity technique to obtain the regular peak arrangement.
to be associated with a low value in the other.
No explanation can yet be given for this periodic wave 
formation with its complicated inter-relationships. These waves 
seem to be inherent in the measurements of physical properties of 
plasma and serum, as we have already noted in the discussion on 
the serum viscosity/serum protein section (§ 17).
There are many instances in which the ESR/viscosity point 
does not lie on this periodic curve, but the explanation of this 
will be delayed to the clinical part where it is discussed under 
the title of "terminal decay".
Also, in our treatment of our viscosity values from the 
clinical aspect we wished to have some large subdivisions of the 
total range; we divided the range into "zones", a zone being the 
distance between the principal peaks of this curve, and we 
designated each zone by a number as in Table T .
The periodic curve proved to be a sensitive guide to 
small errors in the ESR estimation technique. For instance, when 
a series of results would not conform to the curve. I traced the 
discrepancy back to an accelerating effect from a faulty stirrer 
which made the whole bench vibrate gently. One interesting case 
showed a slow ESR which had an apparently low maximum velocity 
where a fast rate was expected from the viscosity result; the 
test was continued until in the seventh hour the erythrocytes
fell faster and soon attained the calculated maximum velocity; 
the "period of aggregation" had lasted 6 hours and the constant 
rate of fall in that period might well have been mistaken for the 
true maximum velocity.
§ 22. The Wintrobe 1-hour ESR.
The peaks, troughs, and curves of the other ESR method 
are no longer detectable with the one-hour method in which the 
reading includes a variable proportion of the "period of aggregation" 
and the "period of maximum velocity".
Steel (232) and Arnold and Salt ( 7 ) have claimed that 
the relationship between the plasma viscosity and the ESR is so 
close that they have presented equations, prepared statistically 
from calculated regression lines, by which one value may be 
estimated if the other is known. This good correlation arises 
from their unfortunate restriction of their choice of cases to 
a single disease group. They studied cases attending their 
rheumatic clinics: from a knowledge of how such diseases affect
the population, one can say that the majority of their groups 
would consist of female patients suffering from chronic rheumatoid 
arthritis or that they selected their subjects and they had not 
a random sampling. Now, if you look at my figures correlating the 
ESR and plasma viscosity in rheumatoid arthritis and tuberculosis,
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you may note that (a) the line passing through the origin and 
the average of the distribution (ie. the line of regression) 
differs; it may differ in the same clinical condition between the 
sexes, and (b) if a line is drawn for the chronic conditions this 
line cannot be continued further for the higher viscosity values 
in the more severe clinical condition as there is not the 
corresponding increase in the BSR values. The chronic rheumatic 
diseases are usually associated with an increased globulin, 
slightly increased fibrinogen and a slightly decreased albumin; 
when one also considers those cases of acute inflammation in 
which the principal protein change is a high fibrinogen, and 
those cases of advanced tuberculosis and cancer where the protein 
characteristically has a low albumin level, the scatter around a 
single line of correlation becomes extremely wide. I would also 
cite my series of selected cases of tuberculosis in which there 
were more than 75% raised viscosity results as compared with only 
25% raised ESR values.
My opinion concerning the BSR/plasma viscosity correlation 
can be stated as follows - generally, an increased ESR is 
associated with an increased plasma viscosity (and vice versa) 
but the amount of this increase in one bears only a low 
correlation with the increase in the other while discrepancies 
are frequent and sometimes large.
»,• »y» ijl ^
(F) The non-Newtonian character of plasma: 
the V5 scale of viscosity.
i
In this section are gathered several topics to which 
reference has been made in various earlier sections.
The importance of the non-Newtonian character of plasma 
lies in the difficulties which it causes in the correlation of the 
plasma viscosity results. As long as the plasma viscosity results 
were to be restricted for the use of the clinicians attached to a 
single laboratory it does not matter very much what type of 
viscometer is used provided that it is capable of a sufficiently 
high degree of accuracy. However, if the plasma viscosity 
results are to be included in publications or if the results are 
to be included in patients* notes being sent beyond the parochial 
limits of the original laboratory, it is essential that the 
viscosity values conform to a standard to which all workers can 
correlate their results. (52,269).
Whittington and I had this problem always before us and we • 
devised three methods by which viscometers can be correlated.
(i) The earliest attempts depended upon the periodic curves 
obtained from the plotting of the serum proteins against the 
serum viscosity and from plotting the maximum sedimentation 
velocity against the plasma viscosity. Fig. 28 shows how it
was possible to convert the Petschaeher values, measured at 
25°C. to the VS scale at 20°C. This technique of correlation 
need not be considered further as the labour involved in 
making the numerous estimations necessary for a detailed periodic 
curve precludes its general acceptance, especially as the next 
two methods are much simpler. (See also Pig. 39 and 40)
(ii) It is possible to calibrate a viscometer with colloidal 
solutions whose viscosity has been measured in an arbitrarily- 
chosen standard instrument. Whittington calibrated about four 
viscometers with citrate plasma against the V5 instrument, and 
since his departure to the USA, I have calibrated a further 
thirty to the same scale with mixed-oxalate plasma. It is also 
possible to use one of these new instruments to "breed” more 
viscometers all on this scale. It is relatively easy to prepare 
calibration formulae by which the plasma viscosity results on any 
two viscometers differ by values within the experimental errors 
of the technique.
I offer this service of calibration to the V5 scale gratis 
to anyone interested in the plasma viscosity test to prevent the 
chaos which has arisen in connection with the ESR test from the 
multiplicity of suggested methods. Thus there are now viscometers 
calibrated by me in use in Australia, America, Europe and 
Great Britain.
(iii) In my opinion, however, the method of correlation will 
depend upon the discoveries regarding the relation of the 
viscosity of protein solutions to the viscosity of sucrose, as 1 
have described in § 16. The sucrose standards can be prepared 
so that one can use the figures of Bingham and Jackson; the 
viscosity and specific gravity measiirements, plus the protein 
concentration estimation, could be completed in one or two days, 
using a commercial albumin product as their protein standard.
All viscometers already calibrated to the V5 scale can be 
adjusted to this sucrose line by the use of Pig. 24 as a 
nomogram.
The V5 scale, to which I have made so many references, is 
only the scale obtained originally on the fifth viscometer in a 
series prepared with the capillary tube bent into two vertical 
limbs (hence the 'V') as compared to Whittington's first design 
in which the capillary was a single horizontal tube ( = fH* type). 
This instrument happened to be the one in which I had made the 
greatest number of studies and Whittington converted his results 
accordingly. This V5 instrument is now preserved as a reference 
instrument only and is used, when more viscometers arrive for 
calibration.
I requested the British Standards Institution to prepare a 
specification for the plasma viscosity estimation but the
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Institution could not accept this responsibility.
The use of a V5 scale as a standard can be regarded a3.so 
as the standardisation of the "rate of shear” at which the 
’viscosity” was being measured. Another possible field of 
investigation is the study of the plasma viscosity at different 
rates of shear. It is quite possible that two plasmataof 
identical (V5) high viscosity values, one due to high fibrinogen 
and the other to high globulin, might differ when measured at 
other rates of shear.
The Whittington viscometer is an instrument suited for such 
a study as different rates of shear can be obtained by varying 
the standard conditions of the estimation - it may be filled to 
the 100,100 levels in the limbs, and the time of fall noted from 
200 to 180 mm, and then with half of the contents removed until 
the 50,50 levels are reached, the time of fall from 100 to 80 mm. 
can be recorded. However, more elaborate procedures with 
multiple viscometers and multiple pressures may be necessary to 
detect small differences in the plasma characteristics.
Dr. Scott Blair, in personal correspondence, has supported 
this plan of investigation as being a possible source of further 
useful information regarding the physical properties and 
characteristics of the protein constituents of plasma. (27)
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Pig. 41 This figure shows the close relationship between the
viscosities of plasmata as estimated on the special VE 
calibration and in a 10 ml. B03,S. Ostwald Viscometer 
which had been calibrated with distilled water only.
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(Gr) The relation of the ESR to the constituents of the plasma.
All this research began in the desire to determine which
constituent of the plasma was responsible for the changes in the
ESR. The scheme proposed for the investigation of this problem
indirectly, via the plasma viscosity, had been discarded in favour
of an intensive study of the plasma viscosity itself; however,
from the results which have become available it may be deduced
that the proposed scheme had but little chance of success. I
/
interpret my results as indicating that there is no close relation- 
ship between the ESR changes and any single plasma constituent 
capable of detection by the present techniques of investigation. 
Method. The maximum corrected citrate sedimentation velocity and 
the proteins fractionated according to the method of Howe were 
estimated as described in the appendix.
Results. The detailed results are not collected into a single 
table but are scattered throughout the tables of the appendix.
No hint of a close correlation was ever noted between the ESR 
and any of the small-molecular constituents of the plasma, such 
as urea, glucose, cholesterol, etc..
The relationship of the ESR to the protein fractions is 
indicated in Pig. 4-3 , 44, 45 , 46 , 47 , 48, and 49.
Discussion. Even where an attempt has been made to reduce the 
comparison to between the ESR and a single fraction by considering
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There appears to be no regular relationship between 
the ESR. and the Plasma Albumin Concentration.
This diagram contains all the Albumin results.
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Fig.47
The relation of the ESR. and the Plasma Globulin, in 
those cases where the fibrinogen was less than 0*4 g./lOOml.
There is a tendency for the ESR. to be high where 
the globulin concentration is high, but there are many 
exceptions to this general statement - a high ESR. may 
be found in association with a low globulin, and a low 
ESR. with a high globulin.
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Fig. 49 The correlation of the Plasma Fibrinogen with
(the total ESP. minus the ESR. attributable to the 
globulin as estimated from the line of Fig. 47 )
Even after this attempt to eliminate the globulin action 
there is no close relation between the level of the ESR. and 
the level of the fibrinogen.
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only those cases in which the other two fractions were normal, 
the relation cannot he regarded as close or approximating to a 
straight line. There is the definite tendency for a high ESR to 
he associated with an increased globulin and/or fibrinogen, hut 
the relationship is not siifficiently close for one to say that 
it is "cause and effect".
The hypothesis that the proteins are chiefly responsible for 
the ESR changes fails to explain two phenomena. (i) It fails to 
discriminate between the effect of the protein concentrations in 
a normal person and the same concentrations in the early stages 
of disease. A normal subject may have a protein pattern of - 
Albumin = 4*8 g./100 ml, globulin = 2*6, and fibrinogen = 0*38 , 
and have a correspondingly normal low ESR: another normal
subject has a pattern of A = 4*8, G- = 2*2, and F = 0*25, with an 
identical ESR value, yet, when in response to an infection, his 
ESR and proteins change, the protein pattern may have the results 
of the first case but now associated with an increased ESR. This 
problem can be tackled better by a comparison of the increase in 
the ESR with the change in the plasma proteins from their basal 
normal values. The present method of making the first measurement 
when disease is already present is unsatisfactory. If the 
volunteers could be obtained there are several stimuli (such as 
protein-shock, TAB injections, oral sulphonamide administration;
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which will produce the necessary changes in the blood. (ii) As 
death approaches in such cachectic diseases as tuberculosis and 
cancer, there is a progressive decrease in the plasma proteins, 
especially the albumin fraction. There may be an associated 
decrease in the ESR from its highest values but this decrease is 
less than expected from the final protein pattern. The extreme 
example of this in my series occurred in a senile patient -with 
gangrene of toes, who, 9 days before death, had a protein 
pattern of A = 3*55, G- = 2*54, E = 1*02 , and a maximum velocity 
of 540 ram. / hour (the correction of the PGV. excluded anaemia 
effects).
My investigation followed the plan used repeatedly in 
the past by other workers and my results were similar to those 
previously produced. They are equally sterile of any definite 
interpretation except that this approach to the problem is 
unlikely to yield a satisfactory solution.
It is my impression, and I speak from personal experience, 
that the ESR is a test which has attracted the investigations of 
the young doctor whose enthusiasm is greater than his powers for 
constructive criticism. His clinical experience with the test 
has been confined to a number of diseases for which the test is an 
"accepted1 procedure and he has not encountered the apparently
anomalous results which occur in the advanced stages of disease 
where the outcome is so obvious that further testing has been 
discontinued as serving no useful purpose to the clinician. He 
tackles the problem by a direct attack in a search for a plasma 
constituent which changes in parallel with the ESR, with the 
intention of ascribing the change in the ESR to this constituent. 
Nowhere has it been stressed sufficiently that the protein changes 
and the ESR changes may show a degree of correlation because theyft
are responses to a single cause or stimulus.
I believe that the technique with the greatest chance of 
a successful solution of this problem is a fresh atteirpt to 
isolate and identify the "sedimentin" (so-called in analogy to 
precipitin and agglutinin) postulated by Day (60) as being 
responsible for the aggregation of the erythrocytes which is the 
fundamental process in the ESR. Day did not attempt to define 
the nature of his sedimentin. It might well be protein in 
character, forming but a small part of the large fractions into 
which the standard methods divide the plasma protein, just as the 
various antibodies whose specificity can be identified by 
agglutination tests form part of the gamma globulin. If as part 
of the reaction to an infection or similar stimulus there should 
be a change in the protein fractions in general and also in the
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sedimentin part, it follows both that there would be an apparent 
close relation between the large fractions and the ESR and that 
discrepancies in this relation will depend on the differences in 
the primary responses by the proteins and sedimentin.
•The nearest attempt to such an investigation were the 
experiments by Gordon and Y/ardley ( 88 ) who prepared artificial 
plasmata from the pure protein fractions as separated by electro­
phoresis.;- Perhaps a greater success might be attained if less 
attention were paid to the plasma proteins and even to plasma 
itself as a source of sedimentin. Pleural exudate has a low 
protein content but is particularly rich in sedimentin; it can be 
richer in sedimentin than its corresponding plasma as its 
addition to the blood causes an increase in the ESR greater than 
can be explained by its dilution effect. With the delicate 
chemical fractionating techniques for protein as developed by 
Cohn, plus the physical techniques of electrophoresis, 
chromatography, and ultracentrifugation now available,it should 
be possible to determine the nature of sedimentin more finely 
than hitherto, always provided it is of protein nature.
Gray and Mitchell (89 ) studied the effect of protein 
fractions by adding them to whole blood and then noting the change 
in the ESR. from the original.
& >[< i$t -j/-. $ #
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Discussion to Part 6.
Short discussions have been included at the end of each 
section and there only remains the necessity of a brief general 
survey.
The results of this part have shown that it is possible 
to estimate with accuracy a physical property which is truly 
representative of the viscosity of the venous-blood plasma.
No error has been introduced by the measurement at 20°C. 
rather than at body temperature. The plasma can withstand 
any physical violence or delay that it is likely to encounter 
in a routine laboratory. The only real sources of error are 
venous stasis, delayed separation of the plasma from the cells, 
and concentration of the plasma in un-capped centrifuge tubes; 
now that these are recognized the obvious steps can be taken 
to prevent their occurence.
The ultra-filtrate experiments placed the responsibility 
for the variations in the plasma viscosity on the proteins 
alone. The results of the study of the solutions of the 
separated protein fractions do not coincide with those of the 
tests where the plasma and serum viscosities and the protein 
fractions were estimated. This discrepancy suggests that the 
plasma and serum proteins do not exist in nature as simple 
solutions of the discrete fractions. This suggestion is in
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accord with the recent trend in biochemistry to treat the plasma 
proteins as a single entity which is capable of subdivision by 
application of electrical and chemical stimuli, etc.
Our results have yielded two other tests whose potential 
use has not yet been fully studied. The tests are the treatment 
of solutions to yield the molecular weight of the solute, and the 
plasma protein equilibrium factor.
There is a suggestion that the correlation of a physical 
property of plasma and serum with the protein fractions (and the 
ESR. ) may have the shape of a periodic wave; such waves have 
been noted with the plasma viscosity, serum viscosity, and 
perhaps the serum osmotic pressure. No explanation for this 
phenomenon may be risked at this stage of our experience;
The ESR. results presented a low correlation with any of 
the protein fractions so that it was inpossible to ascribe the 
ESR. changes to these protein changes.
End of Part 6.
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Part 7.
A study of the plasma viscosity in normal subjects and of the 
effect of physiological stimuli.
This part of the thesis will he concerned with the range of 
values of the plasma viscosity which can he encountered in normal 
subjects and the range of variation in these values which can he 
induced hy physiological stimuli. This study is a necessary 
preliminary to the consideration of the changes found in the 
pathological conditions of part 8.
§ 1. The plasma viscosity in normal subjects.
Material. Approximately equal numbers of both sexes of healthy 
young adults were studied. These were obtained from three main 
sources - (i) volunteers from all branches of the staff of the 
Portsmouth laboratory service who had recently passed their 
medical examination (including X-ray of chest) for superannuation,
(ii) emigrants who also had been medically examined and who 
attended the laboratory for their Wassermann examination, and
(iii) a few patients who were referred to me by a cooperating 
clinician when his most thorough examination had failed to detect 
any organic disease.
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The subjects walked into the laboratory and had their blood 
sample removed within a few minutes, while seated at a bench: no
precautions were taken to standardise the time of day* amount of 
previous exercise, or relation of sampling to meals.
Results. See Table XJ in the appendix.
The results are presented graphically in Fig. 50.
In 95 tests on 53 males, the mixed-oxalate plasma viscosity 
values ranged from 1*663 to 1*910 cs. , with a mean of 1*8148 
and a standard deviation of 0*054. Fig. 50 shows that the 
distribution curve approximates to a ’’normal” curve.
In 63 tests on 51 females, the plasma viscosity values 
ranged from 1*665 to 1*910 cs. , with a mean of 1*8024- and a 
standard deviation of 0*062. In Fig. 50 , however, the
distribution does not comply with the requirements of a ”normal” 
curve; there are two peaks, one on either side of the mean. Thus 
although the range of values and the mean values are almost 
identical in the two sexes, the standard deviation is greater in 
the females because of the difference in distribution of the 
values towards the ends.
The third graph of Fig. 50 presents the frequency of 
distribution curve when the 104- subjects are treated as members 
of a single family; the mean is 1*810, with a standard deviation 
of 0*057 .
MALES
BOTH Mean
Mean
. 50 The incidence of the Plasma Viscosity results in 
Normal Adults of both sexes.
(54^ male subjects; 51 female subjects)
- Limit
of
normal.
Mean = 1.8148 
S.D. = 0.054
= 1.8024 
= 0.062
= 1.810 
= 0.057
Table - 11(10 190
NORMAL VALUES.
Sex
No.
of
Tests
Range of 
Values.
Mean
Value.
Standard
Deviation.
PLASMA VISCOSITY.
M
F
M+F
ESR.
M 
P
PACKED-CELL-VOLUME
PLASMA TOTAL PROTEIN.
9$
cs.
1*663 - 1*910
cs.
1*8148
63 1*665 - 1*910 1*8024
158 1*663 - 1*910 1*8100
50
men/ 1 hr 
0 - 8
mm/ 1 hr. 
2*24
43 0 - 2 5 7*84
% *M 89 ■ 40*0 - 52*9 45*7
P 59 31*0 - 46*0 41*6
g*‘%
M 88 5*39 - 7*96 7*23
P 58 6*16 - 7*85 7*06
M+P 146 5*39 - 7*96 7*13
0*054
0*062
0*057
)“corrected values"
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Discussion. It has "been a constant misfortune to our team of 
investigators that none of us had access to normal subjects (such 
as medical students) who would act as controls and volunteers for 
experiments with physiological stimuli. We attempted to overcome 
this deficiency by studying the 'apparently normal1, ie. members 
of the nursing staff v/ho were symptom-free and asylum inmates 
who showed no abnormality to my physical examination ( X~ray 
facilities were not available). This plan was discredited when 
two of my normal patients showed frank;evidence of pulmonary 
tuberculosis within months of testing and who must have been in 
the early stages of the disease at that particular time. Hence 
our original series of normals has been discarded in favour of 
one where an experienced clinician, with full ancillary diagnostic 
services, has failed to discover evidence of disease in people 
the majority of whom were also apparently healthy. The stricter 
choice of subject has caused a reduction in the published 
upper limit of the normal range of 1*950 cs. to our present 
level of 1*915 cs.
The range of values (1*665 - 1*910) was obtained from a 
series of normal young adults. I have no comparable figures for 
the normals at the extremes of youth and old age, but I believe 
that the same range is applicable to all ages, for the following
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reasons. From the clinician's aspect, it was found that 1*915 cs 
served as a dividing line ‘between normal and abnormal just as 
effectively in the extremes of age as in the young adults from 
whom it was derived. Also, in the many young and old whom I 
followed through their illness with serial tests, a satisfactory 
convalescence resulted in plasma viscosity values within this 
normal range.
No explanation can be offered for the two peaks in the 
frequency distribution of the results of female subjects; it 
might be hazardous to try to explain something which may be due 
only to chance sampling. From the statistical aspect and from 
the practical clinical aspect, one can treat the results of the 
two sex groups as if they were members of a single family of 
results.
A single range of values thus includes the normal plasma 
viscosities of all ages and both sexes. Compare this with the 
results of the ESR test where the ranges are different for the 
two sexes, where some workers apply the adult ranges to children 
while others apply the female range to children but do not show 
a uniformity of opinion as to the age at which the male child 
should be transferred to his adult range.
Apart from a small percentage of the total normal range 
at its upper limits (1*900 - 1*910), all values within the range
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have the identical clinical interpretation as there is no result 
which can he regarded as "more normal” than another; 1*875 cs. 
is equivalent to 1*775 cs.. In contrast, the lower values within 
the normal range of the ESR test are preferred to the higher values 
and in a female subject an ESR of 18 is not equivalent to 8 or 
even 3 mm./lst hour. Wintrobe technique.
Referring again to Fig. 50 , it is seen that the upper
limit to the normal values has been sharply defined. The highest 
recorded value in my series was 1*910 cs. , but I made an arbitrary 
extension to 1*915 cs. for my practical test. No value over 
1*915 was ever seen without some present or later evidence that 
an active disease process was present or a physiological stimulus 
of such severity that it could not be encountered in the patients 
who would arrive at a laboratory for investigation. On the other 
hand, plasma viscosity values below 1*915 cs. could be seen in 
the presence of obvious active disease and therefore a viscosity 
within the normal range is no guarantee of the absence of disease; 
it will arise in part 8 that the frequency of this anomalous 
association of disease and normal viscosity will be discussed 
several times. Furthermore, while the value from perfectly normal 
subjects, (ie. normal to all our criteria) can be as high as 1*910 
cs. I prefer to regard the values in the 1*900 - 1*915 cs. range 
with suspicion, and I make another test after 2 or 3 weeks when
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a result more characteristic of normality or abnormality should 
be found.
My extension of the upper limit of normal values for the
plasma viscosities beyond the highest I had seen in my series is
in sharp contrast to the manipulations of the ESR test. With it,
the practice appears to be that a series of ESR tests is made on
normal subjects and then an arbitrary choice is made for the upper
limit of normal somewhere within the range of experimental
results; the remaining higher values are merely disregarded.. A
typical example of such treatment is that of Wintrobe who, after 
*
verifying by physical examination the normality of his apparently- 
healthy students, discarded the upper 6% of the results in both 
sexes. Among his female subjects his highest value came into the 
27-29 mm./hr. group; he introduced some statistical analysis, 
without taking into consideration that his results did not have a 
,,normal, frequency distribution, found that his (mean + 2xstandard 
deviation) = 20*8 which he approximated to 20 instead of 21, and 
thus derived what is accepted universally as the upper limit of 
the normal range for the ESR test in female patients .* Gibson 
(87 ) did exactly the same, choosing a lower value than his 
experimental maximum. He next proceeded to make a comparison of 
the sensitivity of the ESR and the plasma viscosity tests using 
his arbitrary choice as a guide to abnormality, thus favouring
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137 normal MALES
Mean = 3*7 ± 0.16 
S.D. = 2.8 ± 0.12 
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100 normal FEMALES
9.6 ± 0.37
3 .6 + 0.26
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=  0 - 20.8
V
Fig. 51 The incidence of Wintrobe ESR. results in Normal Adults of 
Both Sexes.
(Published originally by Wintrobe & Landsberg,
J. Amer.Med. Sci. , 1935, 189, P102 )
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the ESR test unduly.
The maximum ESR value is about 55 mm/lst hour. Accepting 
Wintrobe’s highest normal value in females of 20 mm. , the ratio 
of the normal to abnormal ranges is only 1:1*75. The 
corresponding ratio for the plasma viscosity test is 1: 18 .
The normal values for the plasma viscosity test have been 
published by several other workers ( 16,130,87 ,232 ,259 ) but 
no direct comparison is possible because of the non-Newtonian 
character of plasma to which so many references were made in 
part 6. Benson has produced a very large series of results; it 
is especially regrettable that he used the relatively inaccurate 
Hess-Hellige viscometer but something of worth may be salvaged 
when he has correlated his instrument with the Whittington type 
viscometer which I have calibrated to the Y5 scale for him.
A few normal citrate-plasma viscosity values are also 
given in Table T. There are insufficient tests to produce a 
valid range; several tests had to be later discarded because of 
unsatisfactory clinical standards. Since the citrate solution 
has fallen into disuse, no attempt was made to obtain further 
normal value s with'. it.
Conclusion. Of the total range of plasma viscosity values, the 
normal results form a narrow and well-defined zone. The normal 
range (1*665 - 1*915) is applicable to both sexes and all ages.
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The Effect of Physiological Stimuli on the Plasma Viscosity.
The results in the following sections are sometimes rather 
meagre in numbers and this deficiency can he attributed to our 
lack of volunteers; no-one enjoys being the subject of repeated 
venipuncture so that few volunteers could be expected to take 
part in more than one study. However, I believe that there are 
sufficient tests to allow valid conclusions to be drawn.
§ 2. Variations in the plasma viscosity from day to day.
Method. Daily tests for 4 to 6 days v/e re made on seven young 
adults - 5 male pathologists, 1 female technician, and 1 female 
cleaner. The blood samples were removed at the same hour each 
morning. No restriction whatsoever was made in their general 
mode of living and no special constancy of diet, amount of work 
and leisure was required in the mornings prior to the test.
Results. These are given in Table U of the appendix.
Representative results are presented graphically in Fig. 53 and 52. 
Discussion. Of the four estimations - plasma viscosity, ESR, 
haematocrit, and total protein - the plasma viscosity shows the 
greatest constancy. The variation about the mean value was less 
than 1% .
There is no constant correlation between the changes in the
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% of 
mean
Plasma Viscosity104
1*781 1*7711*769
100
1*748
96
Corrected 'Wintrobe ESR.
110
9*5
100
90
8*25
Plasma total protein 
7*157*13103-
7*02
100
97- 6*916*88
Packed-c ell-vo lurne104- 43*7
43-0
100
42*7 42*242*096-
0 1 Days 2 3 4
Pig, 52 The daily variations in the results of a normal
adult female.
The values are expressed as percentages of the means.
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mean 1*857
" 105 PLASMA. VISCOSITY
1*759 1*755
■* ■ ■ i
1*7541*753 1*754
1-749
- 97
Corrected Wintrobe ESR,
1*25
- 80
7*38
Plasma Total Protein,
6*95- 103
6*77
6*77 6*776-736*70- 97
46*7
Packed-cell-volume102
44*644-444*3- 98 44-2 44*2
0 1 2 3 Days. 4 5 6
Pig. 53 The daily variation in a normal adult male.
The rise at the 6th test m s  due to post-alcoholic 
dehydration.
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plasma viscosity and the changes in the other three measurements. 
The plasma viscosity could increase while the total plasma protein 
decreased, which would require that a change occurred in the 
protein fractions whereby there was an increase in the proportion 
of the larger molecules of globulin and/or fibrinogen. Similarly, 
a protein increase could occur while the haematocrit value also 
decreased, an indication that the change depends upon a more 
involved mechanism than the simple passage of protein-free fluid 
from the plasma.
The plasma viscosity is the most constant of these four 
measurements but the variations seen in the three others are 
small in comparison with the findings of other workers.
A daily study was made on another member of our staff who 
was able to perform her duties in relation to the syringe-preparing 
department in a satisfactory manner although she suffered from 
rheumatoid arthritis, asthma and chronic bronchitis, and diabetes 
mellitus which was treated vaguely with insulin and no dietary 
restrictions. These results are shown in Fig.54 . The variations 
in all estimations are considerably greater than in the healthy 
subjects; this may be ascribed in part at least to the variable 
insulin effect on a variable carbohydrate intake.
$ # # # # V # sji $
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2 -06.7105 PLASMA. VTSGOSITP
1*97-
1*961
100
1*9271*911 1*902
95
120 33
110 30Corrected Wintrobe ESR
28 ‘5
100
90
23*580
7*52
105 Plasma Total Protein 
7*207*16
100
7*137*06
95
6*77
Packed-cell-volume
40*1
104
40*2 40*0
100
39*4
96 --
0 1 2 3
Pig. 54 The daily changes in a working woman who suffered from 
chronic bronchitis, rheumatoid arthritis, and diabetes 
mellitus.
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§ 3. Variation in the Plasma Viscosity within the Day.
One test alone was performed directly on this problem ~ 
a typist had a test just after cycling to work, another 
immediately before she left for lunch, and a third in the middle 
of the afternoon. The morning and afternoon viscosities were 
within the experimental error of the noon viscosity.
PGV. Plasma
Vise.
ESR. Total
Protein.
% cs. mm/hr. g. /lOOml.
9.15 am. 46* 1*763 1* 7*31
noon 44 ‘5 1*763 1*3 7*20
3. 20 pm. 42* 1-753 1*5 7*63
Note again how the total protein changes in a direction opposite 
to the plasma viscosity and the haematocrit.
Indirect evidence of the constancy of the plasma viscosity 
within the day was found in the serial tests on the nonnal males. 
J.H. and P. S. of Table U ; the majority of the tests were made 
about 10.30 am. but occasional tests were made in the afternoon., 
yet in the serial tests it is impossible to pick out those which 
were made later. Similarly, intentional variation in the hour of 
testing was made in the serial studies of chronic illnesses such 
as tuberculosis and rheumatism; the results show a. general trend 
of increase or decrease and the results of a particular hour of 
the day could not be associated with a tendency to be above or 
below the oeneral level.
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§ -• Variation in the Plasma Viscosity with the Seasons.
Fig. 55 presents the serial tests made on the writer over 
a period of 8 years. The graph is divided into three parts 
according to where he was living - the first part relates to 
Montrose. Scotland, the second to Sunderland, N.E, England, and 
the third to Portsmouth, S. England. (The picture is rather 
complicated hy the period in a sanatorium which may cause the 
later Montrose results to he regarded as convalescent instead of 
normal. ) The cold, damp, foggy winters of N.E. England were 
accompanied hy catarrh of the respiratory tract and this is 
reflected in the graph hy the winter increases in the viscosity, 
in the milder south the catarrh was absent and there was no longer 
the winter viscosity increase. This single test suggests that 
there is no seasonal variation in the plasma viscosity due to the 
seasons themselves hut that if infections or other conditions 
which may cause a systemic reaction become associated with a 
season their secondary viscosity increase (see next part) may he 
mistakenly associated with the season.
In Table U of the appendix, other normal subjects have 
been studied at intervals and again there is no great difference 
between the results at different seasons. The same might be said 
of a very few chronic cases where there was no clinical change 
over a period, of several months.
Plasma Viscosity (cs.)
© = Corrected Wintrobe ESR. (mm./lst hour)
£3= Maximum Sedimentation Velocity (cm./sec. x 10~^)
00 VO
vo
.5
§ 5. Menstruation.
Our evidence, available to date, suggests that 
menstruation does not produce a constant significant change in 
the plasma viscosity values.
Lack of volunteers again prevented the problem being 
tackled directly.
In one patient, convalescing from pulmonary tuberculosis, 
there was no significant difference in the plasma viscosity values 
measured at a week’s interval -
Date PCV. PLASMAvise.
Wintrobe
ESR.
Ord.fCor.
Total
Plasma
Protein
Remarks j
% cs. im/\ hr. g. %
itI
28:5 38* 1*865 11 6 6*95 1
4:6 38* 1*853 17 12 7*38
___1
Similarly, no anomalous change in the trend of a plasma viscosity 
series could ever be traced to menstrual interference, although 
this factor must have been acting in many of my serial investigations.
My colleagues, Whittington and Houston, also believe that 
the plasma viscosity test is not upset by menstruation. In our 
paper (120) Houston reported the serial tests at 3 to 4 day 
intervals on a female tuberculous patient in whom the 13 menstrual 
.periods did not produce a greater variation in the plasma 
viscosity values than was noted in the inter-menstrual phase.
Benson ( 16) has reported that he could not detect an effect due to
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menstruation, "but the low accuracy of his technique must be 
remembered. Allbutt ( 6) found no change in the viscosity of 
whole blood during the menstrual phase.
I consider that the pre-menstrual disturbance of the 
water-balance of the body has a greater potential action in 
causing a variation in the plasma viscosity level than the actual 
menstrual phase itselfj support is given to this belief by the 
report by Allbutt that the whole-blood viscosity is raised in 
the premenstrual phase. Similarly, I consider that it might be 
possible to detect in a subject under basal conditions of rest in 
bed or of a regular mode of living, the lesser water disturbance 
at the time of ovulation. These aspects will require further 
study in the event of the test being adopted by the gynaecologists.
§ 6 PREGNANCY.
Pregnancy was the condition in which the ESR was first 
measured by Fahraeus ( 75 ) and in which his preliminary tests 
found the ESR to be increased. Later it was shown that the ESR 
was raised in a variety of diseases.
Because the test was applied almost exclusively to the study 
of disease no thorough repetition of Fahraeus* original study was 
made to place the effect of pregnancy on the ESR on a satisfactory 
basis. It is stated in the text-books that the ESR is raised in 
pregnancy but no guide is given as to the amount of this increase 
or its differences at the various periods of gestation. The 
clinician has been allowed to take the attitude that -"the ESR. is 
increased in pregnancy" - and to abandon the test for its ordinary 
uses for the whole- duration of pregnancy. The authority to which 
most writers refer is a paper by Obermer (189 ) who used a method 
of his own devising which makes it impossible to transfer his 
findings to any other standard ESR technique; also, his 88 tests 
form an inadequate number. Similarly, Walton (244) reported on 
30 tests.
My opportunity of studying the plasma viscosity changes 
during pregnancy did not arise until 1951 when I had to remove 
the blood for routine ante-natal Wassermann tests. I had no proof 
of the normality of these pregnancies beyond the patient's
appearance, her lack of symptoms, and the absence of any indication 
by her clinician to the patient that any complication might be 
present. In any case, this was to be a pilot investigation to 
discover if there were any potential uses of the plasma viscosity 
in this condition: the results are sufficiently numerous to 
allow of critical consideration, (i am now engaged in a repetition 
of this investigation in co-operation with an obstetrician and 
another clinical pathologist as part of a research into the 
haematological changes of normal and abnormal pregnancies.)
Results. The details are included in Table V of the Appendix.
The means of the gestation periods (of 4 weeks) have been 
plotted in Fig. 56 to 59 , for plasma viscosity, ESR, haematocrit,
and plasma protein fractions.
Discussion. (a) Plasma Viscosity.
Fig. 56 and fig. 57 indicate that for the first 31 weeks of 
apparently-normal pregnancy the majority of the plasma viscosity 
values isc still still within the limits of normality for non­
pregnant women. In my opinion, the instances of individual 
results above the normal level are remarkably few when one takes 
into consideration the high incidence of minor complications of 
pregnancy (eg., pyelitis, cystitis) which may cause no complaint 
and the large changes going on within the body in the uterus, 
placenta, and breasts.
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After the 32nd week, not quite half of the results are above 
the usual upper normal limit; after the 36th week only 3 out of 
13 tests fall within the normal limits.
However, the extent by which the values are abnormally-high 
is small, seven cases only exceeding 2*000 cs.
The clinical application of these results is as follows.
Until the 31st week, a pregnant woman has a plasma viscosity 
which is usually within the same limits as her non-pregnant normal 
sister; values above 2*000 cs. should be interpreted as abnormal 
and an explanation for the increase should be saught for in a 
complication of pregnancy or in an additional disease process; 
values between 1*915 and 2*00 cs. must be accepted as normal at 
present, but viewed with suspicion, until our later studies which 
include,- co-operative evaluation of the clinical condition have 
verified the need to extend the normal range or have attributed 
the small increases to minor complications. After the 32nd week
the upper limit is necessarily placed at 2*000 cs, and a still
higher level is required for the last four weeks. With these 
slight reservations, the plasma viscosity test can be used by 
the clinician up to the 32nd week of gestation at least, just as 
he is accustomed to use the test in non-pregnant women and in men. 
The plasma viscosity serial tests will be reliable indications of 
reactivation of tuberculous or rheumatic disease; they will also
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reflect the presence of a more acute infection. For example, 
in a patient who was 6-months pregnant, with a pyrexia of unknown 
origin, the diagnosis of a reactivation of a previous rheumatic 
fever was strongly supported by the plasma viscosity of 2*066 cs.; 
such a high value was only equalled twice and surpassed once in my 
series.
The literature contains references to small numbers of 
plasma viscosity estimations during pregnancy, but only Hamilton 
( 93 ) has included enough cases to make a comparison possible.
Runge (215 ,216 ) noted the average plasma viscosity of the mother 
was 2 *4 which was 25% more than the viscosity of her child; the 
total protein was only 13% more, and he traced the apparent 
discrepancy to the lower fibrinogen concentration in the child.
Schwalm (224) found that the plasma viscosity remained practic­
ally unchanged during normal pregnancy but his series consisted only 
of 24 tests in the last month; the serum viscosity was lower at 
the end of pregnancy, due to the increase in fibrinogen levels.
The accuracy of his technique, using a falling-ball apparatus is 
open to criticism.
Benson ( 16 ) originally claimed that the plasma viscosity 
remained unchanged during pregnancy (number of tests unknown) but 
in a private communication ( 17) he has informed me that by using
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the Whittington viscometer which I had calibrated for him, he had 
been able to verify my claim that the viscosity increased slightly 
in the last two months of pregnancy.
Hamilton (93) collected a series of 362 normal pregnancies, 
with at least 10 tests per week commencing at the 8th week. She 
used an Ostwald viscometer, at 20°C. The mean of her normal 
controls was only 1*74 cs. She was one of the few medical 
writers who realised the importance of the non-Newtonian nature 
of the liquids with which she was dealing - "It must be clearly 
understood that the viscosity of blood varies with the conditions 
under which it is measured and compatible results can be obtained 
only when a single viscosimeter is used and when standard 
conditions (temperature, pressure (if any) and completeness of 
mixing) are maintained. Results using a different make of 
viscosimeter even under similar conditions may not be identical 
but relative trends will be shown to the same extent”. She found 
that the plasma viscosity in the 6-9 week group was lower than 
the control mean, and thereafter the variation was slight; the 
variation from the normal was stated as - "The fall is not 
significant statistically”. I have copied her mean results in 
Pig. 60 for comparison with mine; the shape of the curves is much 
the same for both series as Hamilton’s results also show a 
tendency to increase as pregnancy lengthens. A possible
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and probable explanation lies in her choice of her 23 controls.
•’Twenty-three normal,healthy young women in the child-bearing age,
comprising a group of nurses, technicians and patients about to
undergo minor gynaecological operations. *• There is no guarantee
*
that the nurses or technicians were truly free from minor disease; 
we have reported (120) how the fear of a minor operation was able 
to produce a significant rise in the plasma viscosity and this 
factor would be acting in the gynaecological subjects who might 
have been suffering from diseases which would have raised the 
plasma viscosity initially. (Although the paper was published in 
1950 the author was apparently unaware of the use of the plasma 
viscosity as a test in clinical pathology as no reference is made 
to any such paper) Thus I believe that the control value is 
unduly high. By taking the mean of the 6th week group as the 
control value (=100%) it can be seen that our two curves would 
be almost superimposed and certainly not significantly different. 
Her results may also be interpreted as indicating that there is 
no alteration of significance in the first 29 weeks of pregnancy 
but thereafter there is a slight increase.
(b) Haematocrit.
During pregnancy there is an increase in the total blood volume. 
The change in a blood constituent is the resultant of the diluting
fluid being introduced and the increased formation of the substance 
which tends to maintain the original concentration. The decrease 
in the haematocrit values is an indication that the formation of 
new erythrocytes has not kept pace with the dilution, while, in
actual fact, the total circulating erythrocytes has actually
*
increased.
The fall in my series occurs earlier and to a more severe 
degree than that of Hamilton; her results are included in Pig. 60. 
She treated her patients with prophylactic doses of iron and in 
this may lie the explanation of our difference.
(c) Plasma proteins.
The changes in the total plasma protein are similar to those 
of the erythrocytes; nevertheless, as the fractions do not show 
the same percentage changes, positive variation action must be 
taking place in addition to the dilution.
The globulin changes are least; an increase is later followed 
by return to the normal level.
The albumin showed an almost consistent fall.
The fibrinogen increased steadily throughout pregnancy.
My figures of the 16th week period are instructive. The mean 
globulin is almost normal (102%): the mean plasma viscosity is 
also almost normal (100.1%). Therefore, the effect on the plasma
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viscosity of the 7*7% increase in fibrinogen (=0*03 g./100 ml.) 
was equivalent to the effect of the 11*1$ decrease in albumin 
(=0*68 g./lOO ml.). These figures illustrate, even if somewhat 
crudely, the effect of the difference in the molecular sizes of 
the proteins.
Now, although the fibrinogen is increasing steadily it does 
not attain a level accepted as abnormal until the 20th week; the 
globulin level at the 12th and 16th weeks is almost normal on 
both occasions; yet, the associated ESR values are also increased. 
This finding is another slight support to my contention that the 
action of newly-added fibrinogen differs from the normal plasma 
content in its effect on the ESR - a subject whose normal plasma 
fibrinogen level is 0*37 g./lOO ml. will have a lower ESR than a 
subject whose level of 0*37 consists of Q*05g. added to his 
normal level Of 0*32 g./lOO ml. It would appear that the effect 
of the protein on the ESR involves something more than a simple 
concentration action.
(d) Erythrocyte Sedimentation Rate.
There is a steady increase in the mean ESR values 
throughout pregnancy, with a specially-sharp rise between the 16th 
and 20th weeks. The uncorrected and corrected results had risen 
by 457/o and 345% respectively above a level of 9 mm. / 1st hour.
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"by the end of pregnancy, yet the mean of the corrected ESR. 
results was still only 13*9 mm./lst hour after 19 weeks. Only 
one result below 10 mm. was found after the 20th week. The 
incidence of values over 20 mm. before the 20th week is 
sufficiently low to allow the ESR. test to be used as usual up 
to that date. Thereafter, the upper limit of normality has to 
be raised to 40 mm. /lst hour: there is a small region between
this and the maximum of 55 rum. in which the result would be 
significant of super-added active disease. The curtailing action 
of pregnancy on the usefulness of the test is very much greater 
with the ESR than with the plasma viscosity.
The increase in the ESR. is not caused entirely by the 
decrease in the haematocrit as the application of the correction 
chart is able to retain the normal level in the first mean value 
only. The explanation is to be found in the alteration in the 
protein fractions, especially the fibrinogen, although the effect 
may be ultimately due to some substance changing in the same phase 
as these proteins and associated with them.
if  if  if  if  if  if  if
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§ 7 Dehydration.
Three instances of post-alcoholic dehydration were 
encountered hy chance among the physiological controls. Two 
tests were made on the Monday after non-excessive alcohol on the 
Sunday (male,K.H. ; female, F.K. ): one (male, P.S.) attended his
annual re-union with his old students in the middle of his control 
period. This state of dehydration was associated with an increase 
in the plasma viscosity which had disappeared completely within 
a further 24-hours.
It is unfortunate that all these subjects had initial low 
plasma viscosities as we cannot tell if a normal viscosity can be 
raised to an abnormal level by this stimulus - a high plasma 
protein content might react less violently than a lower protein 
because the osmotic pressure action of the protein might then be 
effectively different.
Strauss (257) has reported on the cause of the dehydration 
which followed whiskey ingestion; he attributed it to a diuresis.
§ 8 Fluid Intake in Excess
This section on excess fluid intake should he contrasted 
with § 11 in which are described the changes resulting from three 
laboratory tests of functional capacity in the body.
I have no personal tests to report but wish to include the 
information available in the literature for the sake of complete­
ness. There are no published results for the plasma viscosity 
itself but two papers note the changes in the protein on which 
the viscosity is ultimately dependent.
Kagan (129) found an average fall in 3 cases of 0*15 g. % 
after 600-750 ml. of water: and an average fall in 3 cases of
0*5 g. % in 1 hour after drinking 1,500 ml. of water, with a 
return to normal after a further hour.
Renboum (207) could produce no significant variation in 
the plasma proteins or haematocrit values following the tremendous 
stimuli of 1 litre of water hourly from 9 am. to 6 pm. , of of
5 litres of water, with 0*5 ml. of pituitrin at 10 am. and 2 pm.
Kagan found a greater effect with normal saline where in 3 
cases the average fall in serum protein was 0*9 g. % two hours 
after ingesting 1,500 ml. ; another two hours later the serum
protein was still 0*1 g.% below the original level.
These results would indicate that the ingestion of large
223
volumes of water or more-especially of water plus salt is a 
potential cause of a diminution of the plasma proteins and of 
the plasma viscosity. The small degree of change produced in 
the reported experiments would indicate that the viscosity 
changes would probably be insignificant.
Sato (220) has studied the effects of water and saline 
ingestion on serum viscosity, and these results are directly 
transferable to plasma viscosity terms. In 4 tests with water, 
a fall of 0*05 cs. was noted in 3 and of 0*07-0*08 cs. in 1; the 
minimum value was found in 10 - 30 minutes, but it required two 
or three hours for the original value to be regained: the volume
ingested in each test was 1 litre. With the same volume of 
normal saline, the minimum was not attained for 2 or 3 hours 
and the recovery was not complete until the 5th hour or later ~
1 *579-*l*521->1 *579 (4 hours) ; 1*621-H *550->1*592 (after 5 hours) 
These results would indicate that the ingestion of 3 pints of 
saline about 2 or 3 hours before the venipuncture for plasma 
viscosity measurement might reduce a low-abnormal value to within 
the normal range; I cannot imagine a situation in which such an 
action is likely to occur in the ordinary use of this estimation.
:/>: ij: if  if  if  if  if
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§ 9 Exercise.
Again I have no tests of my own to report and must refer 
to the publications of others.
Reriboum (207) found variations in the plasma proteins of 
borderline significance in troops who had marched 10 miles in 
3 hours with full equipment in Northern India.
In contrast to this prolonged exercise, Sato (220) studied 
the effect of 1 minute of exercise on the serum viscosity. In 
his five reported cases the increase was small, amounting only 
to 0*64%, 0*85%, 0*86^ b, l*36?o, and 5*53fo .
Sat$ quotes Mag aria (155) as finding an increase in the 
serum viscosity of the order of 1% on exercising to exhaustion, 
and Mabuti and Miwa (153) as finding no alteration in the serum 
viscosity of rabbits after exercising (but they used the Hess 
viscometer which is accurate to the first decimal place only).
These results are reassuring. They would eliminate the 
exercise of the journey to the laboratory as a possible cause 
of a slightly-increased plasma viscosity value and they allow 
more significance to be attached to small variations during serial 
testing.
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§ 10 Posture.
Publications by other workers are again required for 
results concerning this physiological stimulus.
The adoption of a horizontal posture leads to a rapid 
fall in the plasma proteins which is maximal in 5-6 hours.
Reribourn (207) found a mean fall of 0*35 g. % in 30 minutes and a 
mean fall of 0*65 g . f o  after 48 hours in bed. Widdowson and 
McCance (254) had an average fall of 0*48 g . f o  after 2 hours in bed 
in 8 normal controls, and of 0*36 g . f o  after 3 days in bed.
Perara and Berliner (191) measured the plasma proteins at 2-hourly 
intervals to find the maximal fall in 5-6 hours when the average 
fall amounted to 0*8 g . f b  which was equal to 10-15/'b of the total. 
This fall is important as it might reduce a low-normal ambulant 
level into a hypo-proteinaemic level when in bed. They also noted 
by tilting experiments that an increase of 0*48 g . f o  in the plasma 
protein after 5 minutes walking following 45 minutes resting was 
largely due to the change in posture. The return to the ambulant 
posture was associated with an increased plasma protein. They 
wrote - ‘'The effect of the horizontal position upon the resting 
individual is comparable to the administration of a slow but 
sustained infusion".
Such large protein changes cannot but have an effect on
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the plasma viscosity. They must he taken into account in the 
study of the patients. Two periods in an illness are especially 
liable to include this postural effect. At the beginning of an 
illness, the retiral to bed will in itself produce a fall in the 
plasma proteins which will be occasionally just sufficient to 
withdraw a slightly-raised plasma viscosity back within the normal 
range. Then, when a patient gets up in the convalescent stage, 
the postural effect may be sufficient to cause an apparent increase 
in the plasma viscosity which would be interpreted by the unwary 
as a sign of a complication, recurrence, or that the patient had 
not yet reached a stage at which he might be allowed up; this 
effect is most important in dealing with cases of pulmonary 
tuberculosis where the patient passes from the ambulant to the 
bed state several times daily and where the constancy of time 
of venipuncture is no criterion that the postural effect mil be 
correspondingly constant. Similarly, if the serial tests in a 
disease like rheumatic fever have been carried out until a 
satisfactory low value has been reached with the recumbent patient, 
an apparently higher value is quite to be expected when he 
reappears as an out-patient clinic.
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§ 11. Tests of Function, made in a Biochemistry Department.
The opportunity was taken to study the effect of the 
physiological stimuli afforded hy the "biochemical investigation 
of the gastric, renal, and carbohydrate metabolic functions.
The results presented here are the preliminary tests; they have 
shown that the future studies must include that of the plasma 
ultra-filtrates and the proper centrifuge-type of apparatus has 
only recently become available.
(a) G-astric Analysis.
The gastric contents of the fasting subject were removed
through a Ryle's tube, 100 ml. of 7% alcohol were given to drink,
and 5-10 ml. samples of gastric fluid were removed at intervals
of 15 minutes. If achlorhydria was detected in the fasting and
first post-alcohol samples, a deep subcutaneous or intra-muscular
*
injection of 0*5 mg. of histamine was administered.
A blood sample was taken at the very beginning of the test 
before the subject was disturbed by the passing of the Ryle's 
tube, and another was taken 2 hours after the alcohol solution 
had been drunk.
Results: These are given in Table W of the Appendix. The
three subjects (out of a total of 9) who received histamine are 
marked in Fig. 61 by interrupted lines.
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Fig. 61 The effect on the Plasma Viscosity of the ingestion 
of 100 ml. of 7/i alcohol, after emptying the stomach.
The interrupted lines represent the three subjects who also 
received an injection of 0.5 nig. of histamine.
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Discussion: Of the six subjects who did not receive
histamine, five showed a slight increase in the plasma viscosity 
while the sixth had a fall which was within the experimental 
error of the initial value. The haematocrit values also changed 
but little, 4 showing an increase and 2 a decrease. In contrast, 
the total protein had decreased in 3, remained unchanged in 2, 
and increased in 1 only.
These results may be explained as follows. The stimulus of 
the alcohol has caused a flow of gastric juice at a rate faster 
than the reabsorption in the small intestine, and a slight 
dehydration has occurred; this is reflected in the fall in the 
fluid portion of the blood (ie. increased haematocrit) and in the 
plasma viscosity. As the total protein has not shown a parallel 
change,an alteration in the plasma protein pattern must have 
taken place in which the proportion of the large molecules of 
globulin and/or fibrinogen has increased.
The three subjects who received histamine all showed a 
haemo-dilution (fall in haematocrit, plasma viscosity and plasma 
total protein). Further, this change occurred in the subject who 
later produced free acid in excess of the average amount. Because 
of its recognised action on the blood capillaries and their 
permeability for fluid, it is readily believed that the injection 
of such a large amount of histamine has been followed by the
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passage of fluid into the vascular system in sufficient volume 
to produce this significant haemo-dilution.
The increase in the plasma viscosity after this small 
amount of alcohol has "been caused hy the increased flow of gastric 
juice: we have already noted a similar change after alcohol
(§7) hut in that instance the acting physiological mechanism 
was a diuresis (Strauss (237)).
00 Renal Function Tests.
A combination of the Urea Clearance and Urea Concentration 
tests was used. The urine was collected at hourly intervals for 
5 hours in a fasting subject. A blood sample was collected at the 
end of the first and third hours; 15 g. of urea, dissolved in
about 250 ml. of water, were administered at the end of the second 
hour.
Results: These are presented in Table Vi of the appendix and in
the accompanying figure(Pig. 62).
Discussion: In the twelve tests, the plasma viscosity increased
in four, decreased in three, and showed no significant change in 
five. Some of these changes were large, the greatest being a fall 
of 0*015 cs.
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Pig. 62 The effect on the Plasma Viscosity of the ingestion of 
15 g. of urea in about 250 ml. of water, on a 
fasting subject.
The tests were made•one hour before and after the 
ingestion.
A clue to the cause of the different responses is available 
in the differences in the volumes of urine and their urea 
content which have been excreted between the blood samplings - 
the second and third urine samples in the table. The correlation 
is not absolute, but where a dehydration may have been caused by 
the excretion of a large urine volume the plasma viscosity has 
increased* similarly, a small urine volume tended to be associated 
with a decreased plasma viscosity. In all instances there is a 
variable factor acting whose effect is opposed to that of urine 
excretion, ie. the fluid absorption after the urea dose.
(c) Glucose Tolerance Test.
The fasting subject received 50 g. of glucose dissolved 
in 150 - 250 ml. of water. Blood samples were removed in the 
fasting state and at half-hourly intervals after the glucose 
ingestion for two and a half hours. The subjects spent the time 
seated; they were allowed to read or knit, but smoking was 
prohibited. They were allowed to take an additional 250 ml. of 
water at their own discretion^ few availed themselves of the- 
opportunity.
Results: These are given in Table W of the Appendix, and in
the accompanying figure(Fig. 63').
Discussion: In nine of the twelve tests the results have a
common pattern - there is a fall in the plasma viscosity for one 
or one and a half hours, a rise to approximately the original 
level, and sometimes a final slight fall. The figure resembles 
an inverted blood sugar curve.
No difference in the pattern could be distinguished between 
diabetic and non-diabetic subjects. No correlation was noted 
between the degree of the viscosity change and the degree of 
blood sugar change.
Three possible mechanisms are in action to cause the 
variations in the plasma viscosity level. The state of body 
hydration will depend upon the balance in water absorption from 
the administered glucose solution and in urinary water excretion. 
It is regretted that more careful note of these volumes was not 
made at the time, yet the two reported tests show that a haemo- 
dilution can occur in the face of large urine excretions and a 
haemo-concentration can occur in face of small excretions.
The discrepancy between the changes in the plasma viscosity and 
the plasma total protein might be due to changes in the plasma 
protein fraction pattern. The molecules of combined protein 
formed from the protein and such non-protein substances as
Hours after the ingestion of the 50 g. glucose in 
250 ~ 300 ml. water.
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carbohydrate or cholesterol may vary according to the 
concentration of the non-protein moiety, and the larger size of 
the combined molecule would have a greater effect on the plasma 
viscosity than the protein acting alone. The changes in the 
blood sugar levels would introduce a change in the viscosity 
which could not be distinguished by a technique of even our high 
accuracy.
There was no explanation for the three departures from 
the plasma viscosity behaviour of the other nine.
This subject will be re-investigated later with stricter 
attention to the water balance, examination of the protein 
fractions by chemical and electro-phoretic separation, and 
preparation of ultra-filtrates.
The three subsections here described have indicated that 
while the non-protein constituents of the plasma exert a 
negligible effect on the plasma visfcosity as compared to the 
proteins, the non-proteins may affect the whole metabolism of the 
body in such a manner as to cause a change in the plasma proteins 
and hence in the plasma viscosity itself.
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§ 12 The effect of the exhibition of sulphonamides on the plasma 
viscosity, serum viscosity, serum protein, haematocrit and ESR.
Material and Methods. The subjects in these experiments were 
all men, between the ages of 23 and 65 years. They were not 
physically examined at the time of testing except to exclude such 
conditions as pyogenic infection which were known to respond to 
these drugs. Two subjects later developed phthisis; one suffered 
from post-encephalitis. The response of the abnormal group of 
subjects was however identical with that of the normal group.
An attempt was made to restrict their lives to a routine of 
work, leisure, sleep, diet, etc. so as to reduce other physiolog­
ical stimuli to a minimum and to allow the serial blood sample to 
be removed under almost identical conditions. The effect of a 
possible psychological stimulus was reduced by not allowing the 
subjects to know beforehand when a blood sample would be taken.
The blood sample was removed by myself at 7.30 am. from the 
fasting subjects.
6 men were given 2 g. of sulphanilamide by mouth, followed 
in 4 hours by another 2 g. , and thereafter by 1 g, 4-hourly until 
a total of 20 g. had been administered. With another 6 men the 
same procedure was carried out with sulphapyridine.
Sodium citrate solution (3*8%) was used as the anticoagulant; 
the serum protein was calculated from the specific gravity 
determined by the falling-drop technique of Barbour and Hamilton.
Results. The details are given in Table Y of the appendix.
The effects of sulphanilamide and sulphapyridine were 
identical and therefore only the sulphanilamide results are 
presented in graphical form. These figures have been taken from 
my paper in the ’‘Lancet'1 on this topic. (Fig. 64) (98).
The plasma viscosity, serum viscosity, serum protein, and 
ESR. had all increased within 48 hours of the administration of 
the sulphanilamide. (The sulphapyridine tests were done at 
different time intervals, and the increases were evident within 
24 hours of giving that drug.) That these increases are not due 
to haemoconcentration can be ascertained from the haematocrit (PCV) 
values, in which the variation is smaller and inconstant, and by 
making allowance for the PCV. variation in calculating the 
changes in these other values (such as has been done for the 
serum protein only in the diagram).
The increase in the plasma viscosity exceeds the variation 
found in serial tests when ordinary physiological stimuli alone 
are acting. More significant however is the fact that the 
increase is sufficiently great, in every instance, to raise the 
initially normal plasma viscosity values into the abnormal range 
(over 1*600 cs. for corrected citrate plasma viscosity).
Discussion. This series of 12 tests is small, but I have had no
110
108
106
104
102
100
110
108
106
104
102
100
98
106
104
102
100
98
96
110
108
106
104
102
100
98
96
SULPHANILAM IDE
2 0 g .
I I I j B_
_l I 1 L.
O ESTIMATED 
•CALCULATED
J  i i i
2 3 4 5 6 7 
D A Y S
8 9 10
Fig. I—Variations in plasma viscosity, serum vis* 
cosity, packed cell volume, and serum-protein 
on exhibition of sulphanilamide. Results are 
expressed as percentages of values before 
administration of sulphanilamide. The linesjoin 
the means of the experimental results.
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Fig. 2—Variation in erythrocyte-sedimentation 
rate on exhibition of sulphanilamide. Results 
are expressed as percentages of value before 
administration of sulphanilamide. The line 
joins the means of the experimental results.
Fig. 64 Taken from my paper in Lancet (98 ).
The increase in the ESR. . serum total protein, 
serum viscosity, and plasma viscosity on the exhibition of 
sulphanilamide in ordinary therapeutic doses to normal 
subjects.
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further opportunity for experiments -with these drugs on suitable 
volunteers under suitable basal conditions.
I published the results in order to draw attention to an 
effect of the sulphonamides which had not been previously reported 
but which seemed worthy of further investigation. The findings 
can be discussed from two aspects.
(i) Effects of Sulphonamides on Plasma and Serum. The
interaction of the sulphonamides with the blood-protein has been 
described by Davis (57) but there has never been mention of any 
action by the drugs on the amount of the proteins. The increase 
in the serura-protein can be detected within 24 hours of giving 
sulphonamides and disappears within 3 days of stopping them. Prom 
the diagram it seems that the effect (ie. increase) on the second 
day was greater than on the third day and that the protein was 
already beginning to fall although the sulphanilamide was still 
being given. This opinion is supported by my earliest work where 
I found that the ESR was first slightly increased but had returned 
to its basic level before the completion of a 10-day course with 
sulphanilamide; control experiments had showed that this increase 
did not occur as a result of serial blood sampling alone but 
required the exhibition of the drug.
The effect on the protein must be regarded as the primary
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change in the blood constituents, of which the plasma viscosity, 
serum viscosity, and ESR. are but reflections.
Further metabolic studies should show whether the protein 
increase is due to an increased protein formation or to a 
decreased utilisation.
(ii) Significance of Clinical Pathology Tests. The
results of this section indicate that caution must be taken in the 
interpretation of the values derived in the tests of clinical 
pathology. Thus, in a case of pyrexia of unknown origin which vfas 
treated empirically with sulphonamides (admittedly bad therapeutics) 
following admission on an afternoon, the tests performed on the 
next morning would almost certainly be abnormal. If the clinician 
was unaware of the drug action, a diagnosis of an organic cause 
of the pyrexia might then be made with some confidence and a 
prolonged search made to discover its nature; furthermore, the 
fall in these values after the second or third day, whether the 
sulphonamides were stopped or continued, could be interpreted as 
an improvement in this non-existent disease.
Similarly, the action of salicylates in rheumatic diseases 
is still argued - whether the drug has a direct action on the 
disease process itself or acts by producing changes in the 
distribution of fluid in the body which relieves the symptoms.
(Reid - 205,206).
Bendien, Neuberg and Snapper ( 14 ) and Homburger (115) have shorn 
that the addition of salicylate to blood, in vitro, can produce 
a slowing of the BSR. Honiburger ( 116) also produced a lowering of 
the plasma fibrinogen and the ESR. in three cases of carcinoma 
by the administration of this drug; similarly Rapoport and Guest 
(203) found a decreased ESR. in subjects receiving salicylic acid 
or its acetyl derivative. The only reference to the effect on the 
proteins of normal persons is a paper by Dryer et al. ( 64) who 
could detect no change whatsoever in the electrophoretic pattern 
after 4 g. per day of acetyl-salicylic acid for seven days: 
unfortunately, they did not measure the ESR. In their book on the 
salicylates, Gross and Greenberg did not include among their 4093 
quoted references any which dealt with the effect on proteins( 90 ). 
This further emphasizes the trend of concentrating the studies on 
the response to drugs in the disease conditions without an 
adequate preliminary investigation of the response by normal 
persons.
Later, in the section on tuberculosis, I will refer to the 
change in the gold flocculation test which I noted after the 
administration of streptomycin and of streptomycin plus para- 
aminosalicylic acid. I could not determine whether this was due 
to a hepatotoxic action or to just an altered liver response.
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Fearnley and Bunim (78 ) have recently reported on the fall 
in the plasma ffbfinogen level and in the ESR. following the 
administration of A. C. T.H. to normal persons. They concluded - 
"But until more information is available it seems prudent to 
regard a normal E.S.R. as an unreliable indicator of absence of 
rheumatic activity in patients under the influence of A. C.T.H. 
and cortisone. ”
Doubtless, further investigations of other drugs will reveal 
that part of the response shown by the tests of clinical pathology 
is due to the action of the drug on the subject independent of 
its action on the disease process.
Discussion to part 7.
Innumerable quantitative and qualitative examinations 
have been made on the protein content of human blood plasma and 
yet our understanding of these proteins is still far from complete. 
These studies have given an indication of the amounts and the 
characters of the protein fractions normally present in the plasma 
without designating the functions fulfilled by the various 
fractions. Albumin is claimed to be important in the control of 
the fluid balance between the tissues and the blood stream, by 
virtue of its high effective osmotic pressure. Part of the 
globulin plays a part in the defence of the body as the immunity 
factors are included in the globulins; the function of the 
remaining (majority) globulins remains uncertain. The function 
of the fibrinogen in the normal body economy is also uncertain 
Schoenheimer1s work (223) with radio-active isotopes has 
emphasized the dynamic equilibrium which exists between the 
proteins of the plasma and the tissues, and among the plasma 
protein fractions themselves. He also stressed how great were the 
changes in the plasma proteins; he included them in the group of 
proteins showing the highest speed of change. Nevertheless, 
there is an accurate control on the plasma proteins wrhereby a 
careful balance is drawn between the anabolic and catabolic
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activities. This control affects the individual fractions 
independently4 there is no regular relationship between the 
changes in the total protein and the plasma viscosity. Similarly, 
the protein changes are more than a mere variation in concentration 
as a result of the passage of fluid to and from the blood, as 
the changes of the packed-cell-volume and the total protein do 
not correspond. However, the acknowledgement of an accurate 
control of the level of the plasma proteins has not helped to 
explain their functions.
The total protein of the plasma of women is slightly lower 
than that of men and this is enough to explain the difference in 
the mean plasma viscosities without having to include a difference 
also in the protein pattern of the two sexes. The lower plasma 
proteins of childhood would lead one to expect a lower plasma 
viscosity level also, but my experience has been such as to 
suggest that the diminution can be disregarded for practical 
purposes. These results of mine are not in agreement with Sato's 
( 220) who found a diminution in the serum viscosity from youth 
to old age and in the females of the same age groups as compared 
with males (his results are presented on the top of the next page). 
Benson, in contrast, measured the plasma viscosity in 361 normal 
individuals yet makes no mention of any differences on account 
of sex.
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The serum viscosity of different age groups in the two sexes, 
according to SatS -
No. of tests Age range
Males
25
45
23
Female
16
20
17 - 23 
24-40 
41 - 58
17 - 23 
24-40
1*890 ± 0*018 
1*797 ± 0*010 
1*744 ±,0*011
1*775 i 0*016 
1*732 ± 0*011
The absence of a diurnal, daily, or seasonal variation 
is also the finding of Benson, in periods up to six months.
More indirect, hut confirmatory, evidence is to he found in the 
reports on the plasma proteins hy Renboum (207), Kagan (l29), 
Widdowson and McCance (254), Perara and Berliner (l9l), and 
Dyson and Platt (66) where the variations within the day 
amounted to 0*2 g. °/o approximately and where Kagan and Dyson 
could detect no variation due to meals.
This latter finding is most reassuring in view of the 
significant changes which I have shown as following the ingestion 
of large amounts of glucose and urea in small volumes of water.
Of the two stimuli peculiar to women, menstruation can 
he ignored and the pregnancy must have advanced to an obvious stage 
before it has an appreciable effect, for which due allowance may 
be made.
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The reports in the literature also suggest that the effects 
of exercise are negligible.
Three physiological stimuli thus remain whose effect on 
the plasma viscosity test must always he taken into consideration 
when interpreting an increased plasma viscosity in clinical 
pathology.
Alcohol produces an immediate and prolonged increase of the 
plasma viscosity. Its effect need not he considered in children 
or hospital patients: in domiciliary and out-patient tests a 
morning examination will reduce the chance of the immediate effect, 
a search should he made for the odour of alcohol in the subject's 
breath, and recourse to direct questioning must he made on the 
slightest suggestion of its action. I believe that alcohol was 
responsible for major effects in one patient only (and even there 
I had no proof) - the case of acute rheumatoid arthritis who 
showed such large variations within a matter of days without 
corresponding changes in the clinical state.
The precautions to be observed in avoiding the potential 
pitfalls arising from changes in the plasma viscosity due to 
postural variations have been discussed already.
Drugs remain a big problem. Their use has become almost 
universal and forms such a common part of modem living that they 
may never be mentioned to the clinician. Aspirin, the drug most
frequently self-administered, is particularly important because 
it has the general salicylate action in causing a redistribution 
of the water within the body (Reid, Watson and Sproull (206)) 
and it may also produce a marked diuresis in susceptible subjects 
(my unpublished observations suggest that the latter group includes 
a high proportion of adults who have suffered from rheumatic fever 
in their youth). Aspirin is also the drug taken most frequently 
in the rheumatic diseases where the plasma viscosity test has 
been frequently employed. The action of the sulphonamide group 
of drugs has been described. Feamley and Bunim ( 78 ) have 
administered A.C.T.H. to normal persons and observed large changes 
in the fibrinogen, serum protein, and the ESR. Thus all three 
types of drug have shown an action which will affect the plasma 
viscosity values, and further search will probably reveal other 
drugs with a similar action. A direct question is therefore 
essential concerning the tested subject's recent history of 
drug exhibition.
To summarise - if one can exclude the effects of drugs, 
late pregnancy, and the ingestion of alcohol or concentrated salt 
solutions, the changes in the plasma viscosity in response to the 
ordinary physiological stimuli will be small indeed and these 
normal values will be confined to a narrow range which is the 
same for all ages and sexes. In serial testing, one must make
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certain that the postural position has been constant throughout 
or allowance made for alterations in it. Because of the meagre 
effect of physiological stimuli the significance of minor 
changes in the plasma viscosity values are thereby enhanced.
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Part 8.
The Estimation of the Plasma Viscosity as a test in Clinical
Pathology.
§ 1. Introduction.
In the previous seven parts the estimation of the plasma 
viscosity has been considered from the technical aspect and the 
values noted in normal subjects and following physiological 
stimuli. We will now proceed to a consideration of the plasma 
viscosity in disease. It will "be shown that a knowledge of his 
patient’s plasma viscosity will assist the clinician in his 
diagnosis, prognosis and treatment. The extent of this assistance 
is sufficiently great for the estimation of the plasma viscosity 
to be included in the routine tests of the clinical pathology 
laboratories.
The behaviour of the plasma viscosity will be studied in 
the different kinds of disease and where there are enough results 
various aspects of the plasma viscosity test will be stressed. 
However, in the next paragraphs, the relevant conclusions of 
parts 1 - 7  are summarised and a general indication is given 
concerning the information to be obtained from the later 
clinical sections.
(1) In normal health the plasma viscosity values of both sexes and 
all ages fall within a well-defined narrow range (1*665-1*915 cs.)
(2) The physiological stimuli of ordinary life* ie. diet, sleep, 
moderate exercise and physical labour, may cause small changes in 
the plasma viscosity but not sufficient to move the value outwith 
the "normal” range. The ordinary physiological stimuli include 
menstruation, and the first thirty weeks of pregnancy.
(3) Physiological stimuli of a severer nature, such as caused by 
ingestion of glucose or urea with small volumes of water, etc. 
can cause changes in the plasma viscosity sufficient to move a 
normal value outwith its normal range. Such stimuli are unlikely 
in patients attending a laboratory for a routine test.
(4) Disease conditions may be divided into two groups:-
(a) "Local" disease is a condition which affects a small or 
large part of the body but which does not cause a general upset 
such as could be evidenced by a loss of weight, elevation of 
temperature, sweating, etc. Examples of a local disease are an 
osteo-arthritis of a joint and a fibrositis of large areas of the 
body.
(b) "General" or "Systemic" diseases may or may not have 
local lesions but they are characterised as having the signs and 
symptoms of weight loss, etc. which results from a reaction in 
the body as a whole. Examples are malaria
(without a special local lesion) and rheumatoid arthritis.
The plasma viscosity usually remains within the normal 
range or shows a small increase in "local" diseases; it is 
usually increased in "general" diseases.
(5) The plasma viscosity increase is non-specific; the increase 
is found with all kinds of general disease.
(6) The increase in the plasma viscosity in response to general 
disease may he eighteen times the extent of the normal range.
(7) However, for the common diseases of tuberculosis, rheumatism, 
etc. the increase is restricted to seven times the range.
(8) The amount by which the plasma viscosity increases is 
roughly proportional to the amount of the general reaction.
(9) Many diseases have a general reaction whose severity bears a 
close relation to the severity of the local lesion. Hence, it 
follows, that in many instances the increase in the plasma 
viscosity is also proportional to the severity of the local lesion.
(10) Just as both sexes have the same normal range of values, so 
also the same severity of clinical condition is associated with 
the same increase in viscosity in both sexes.
(11) With the cessation of the general reaction following an 
improvement in the primary local lesion the plasma viscosity value 
falls once more to reach the normal range.
(12) It will be shown that the plasma viscosity estimation is a 
sensitive test. The viscosity becomes abnormal in some hours in 
acute diseases and abnormal values change also in response to 
changes in the clinical condition.
(13) The test will also be shown to be reliable. Apparently 
false positive tests may occur but further intensive or prolonged 
studies have proved a pathological cause for the viscosity 
increase; especially instructive cases will be described in the 
section on tuberculosis and rheumatism. False negative results, 
ie. plasma viscosity values within the normal range, do occur in 
an incidence of from 0 to 25fi of the tests of different types of 
disease studied^ a normal plasma viscosityvvaluetis, thus no 
guarantee of the absence of organic disease, but in the sections 
on the various diseases it will be shown how low the incidence of 
false negatives can be.
(14) The plasma viscosity estimation is presented as a test in 
clinical pathology as being a guide to the general reaction of the 
patient to disease. This is the same use to which the established 
ESR test is put. Throughout the following sections there will be 
a constant comparison of the value of these two tests to the 
clinician as it would be wrong to attempt to introduce another 
test unless this produced more reliable results than the original.
By a statistical comparison of the results it will he shown that 
the plasma viscosity has the necessary superiority to merit, its 
inclusion in addition to the ESR. Furthermore, analysis of my 
ESR results might lead to the interpretation that the ESR test 
yields such unreliable results that it might well be discarded, as 
has happened in one sanatorium and rheumatism clinic at least.
(15) It was shown in part 6 how the plasma viscosity reflects 
the change in the globulin and/or fibrinogen; the albumin and 
non-protein constituents may be neglected.
The results of the various sections will indicate the 
nature of the protein changes. There is a general pattern in the 
protein change in acute disease as follows - the fibrinogen 
fraction first increases, and if the condition rapidly resolves, 
it returns to normal: if the disease lasts more than a few days
and is severe, the globulin also increases, this increase being 
at a slower rate than that of the fibrinogen; if continued 
further, the globulin increase continues, the albumin falls 
slightly, and the fibrinogen falls from its initial high level 
to a value still above the upper limit of normal - this response 
has reached almost to the 'chronic* disease picture; with 
recovery, the steps are retraced and the normal protein pattern 
is resumed. A chronic disease, of several weeks or months
duration, is usually associated with an increased globulin, a 
slightly decreased albumin, and a normal or slightly increased 
fibrinogen.
A high plasma viscosity value can be expected in those 
conditions in which the globulin and/or fibrinogen are increased.
(16) It will be shown also why the plasma viscosity is measured 
rather than the protein fractions themselves. These reasons can 
be summarised as - (a) the measurement of the viscosity as
compared to the protein fractions is more simple, rapid and 
accurate; (b) the viscosity range of normal subjects is narrow 
and defined while the possible normal variation in the protein 
fractions is large: there are several instances in which the
plasma viscosity has moved from its defined limits when the 
protein fractions could all be regarded as normal; (c) the 
daily variations and other changes in response to physiological 
stimuli are greater with the proteins than with the viscosity so 
than changes are of less significance as indications of an 
alteration in the clinical condition.; (d) it is relatively 
simpler for the clinician to interpret the changes in the single 
viscosity value than the relative and absolute changes in the 
three protein fractions.
(17) Whittington and I have applied the name - "terminal decay1' -
257
to an interesting phenomenon which occurs in the final stages o f  
most diseases which are progressing towards death. A falling 
plasma viscosity is usually interpreted as an indication of a 
return of the protein pattern towards normal and an improvement 
in the clinical condition. However, where the outcome is to he 
death, at an interval of months to days before this event, the 
proteins begin to decrease in an irregular manner which affects 
all the fractions but chiefly the albumin. The plasma, viscositj'- 
shows a corresponding decrease and may have reached normal limits 
at the time of death. Since this terminal decay can begin some 
mopths before death without any apparent alteration in the 
patient’s condition otherwise and since we have never recorded 
a reversal of this decay with any treatment, the importance of 
its detection for assessing the prognosis is obvious.
(18) The majority of the plasma viscosity results from chronic 
general diseases of all types falls within a restricted part of 
the total possible abnormal range; this small range we have 
named - "The zone of chronicity".
(19) Similarly, the "zone of effusion" is a restricted range of 
the viscosity scale which contains the majority of plasma 
viscosity results from patients who were actually forming the 
fluid at the time of testing.
§ 2. The plasma viscosity test in rheumatic diseases.
The group of rheumatic diseases contains a variety of 
conditions whose relationship may he no closer than that they 
affect the same structures.
There is no classification of these diseases which is 
acceptable to all clinicians and pathologists who make a specia.1 
study of them. The aetiology of many being vague and a cause of 
much dispute, the classification is reduced to one which is 
dependent on the clinical appearances of the conditions. I have 
included a brief definition for my groups of diseases, together 
with their synonyms, in order that the reader may adjust my 
results into his own scheme of classification.
The large majority of the patients attended the Rheumatic 
Glinic of Sunderland Royal Infirmary. The organisation of this 
clinic has been described (182) as we regarded it as a model of 
its kind. The organisers believed that the problem of the full 
investigatibnn and the decision on the best treatment could be 
tackled only by a team of specialists who assessed the condition 
and planned the treatment in consultation together. With this 
basic principle in mind, the arthritis clinic began work with a 
team of four - a physician (Dr. A. A.McI. Nicol), a surgeon 
(Mr. W.Grant Waugh), a medical officer in charge of physical 
medicine (Dr. I. C.Cowan), and a clinical biochemist (myself).
According to the needs of the patient, specialists in other 
branches of medicine were added to the original team. This 
arrangement was most valuable to me in that I was investigating
a patient rather than a blood specimen attached to a form, and it\
allowed me to take my share in the assessment of each patient.
The clinical assessment was made most carefully as it was 
realised from the beginning that our results might be worthy of 
later publication. The final assessment was made by Dr. Cowan 
who also controlled the therapy (he obtained the degree of Doctor 
of Medicine at Aberdeen University in 1950 for his share of this 
combined investigation). This assessment was made independently 
and without knowledge of my laboratory results, except in those 
cases where the discrepancy between the laboratory and clinical 
opinions was so great that the patient had to be investigated 
fully again.
It would be impossible to give the detailed case reports of 
the 1,200 tests in rheumatic diseases. The numbers lend 
themselves to a statistical analysis; the rheumatoid arthritis 
cases have been selected for this treatment. The detailed results 
are given in the tables of the appendix, together with some 
illustrative case histories. The graphical presentation of 
these results is-iincluded in this text.
(A) Rheumatoid Arthritis.
Synonym:- Atrophic polyarthritis
Definition:- In the classical form, this disease is found in 
asthenic women in the child-hearing age groups; it is a 
polyarthritis generally commencing in the small joints of the 
fingers and toes and spreading centripetally. The aetiology is 
unknown,,hut the pathology is of an inflammatory nature. 
Ankylosis is common. Prom this group has been excluded, those 
cases where a focus of infection was believed to be connected in 
some way with the disease, but there are included those cases 
occurring on or about the menopause in which an endocrine factor 
was considered to be significant.
We divided our cases into four degrees of severity.
(i) Residual deformity; "burned-out". Into this group fall those 
cases which had an attack of rheumatoid arthritis several years 
previously, who had had no recurrence and showed no signs of 
present local or systemic activity, but who had varying degrees 
of joint deformity.
(ii) Chronic.* This group includes the cases where the disease 
is best described as 'smouldering*. There is usually a long 
history of the disease; the affected joints are in various stages 
of inflammation, with pain on movement, synovial thickenings and
"cold'’ effusions; there is marked muscular wasting. In this 
group is observed the greatest degree of joint damage and 
consequent deformity; the pathological changes in the joints are 
irreversible.
(iii) Subacute. Here there are marked signs of toxaemia - eg. 
loss of weight, lassitude, anorexia, tachycardia, hot moist skin; 
the involved joints are painful on movement and at rest, this 
rest pain being a feature of this group; the affected joints are 
hot, swollen and tender; and there is active muscle wasting.
(iv) Acute. These cases have the symptoms and signs of the 
subacute group but in a greater degree; pyrexia is frequently 
present.
It must be stressed that this classification takes into 
consideration the whole patient and not just the lesions in his 
joints and muscles. Rheumatoid arthritis is a general disease 
with local manifestations in the locomotor system. There can be 
a variation in the relation of the severity of the local lesions 
to the severity of the general upset; it is possible for the 
local conditions to become symptomless while the general 
disease remains active.
The changes in the plasma viscosity in rheumatoid arthritis 
will be described first; thereafter a comparison will be made 
between the results of the plasma viscosity and of the BSR.
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R e s u l t s For details, see Table II of the appendix. 
The results are summarised in the following table -
Clinical
Severity.
No. of 
tests
Sex
PLASMA VISCOSITY\4
s
Mean
PCV.
Mean
ESR
Mean
tot.
prot.Usual range Mean
Normal 158 B 1-663-1 -910 1-810 7 * 15
9 $S M 1-663-1-910 1-815 45 -7 0*0 CJ Lj 7*23 ;
63 F 1-665-1-910 1-802 41 *6 7 -8 7 -06
Residual 8* B 1-740-1-990 1-909 41-8 19 -8 7 *40
deformity 23' B 1-740-1-990 1-909 41*9 '15-0 • 7*24
Chronic 154# B 1*950-2-300 2-121 42*6 25*2 7*30
387' B 1-950-2-300 2-119 42-2 24*7 7-77
517 B 1-880-2-380 2-123 42 -0 25 *5 7*75
93 M it it 2-147 - 17-4 . .
424 F it it 2 -118 ~ 25 -6 -
Subacute 22# B 2-330-2-550 2-513 40*8 36-1 8 *50
79* B 2-300-2-550 2*506 41*1 34*6 8 * 56
96 B 2-300-2-720 2-523 40 *9 33-4 8 *58
14 M ti tt 2 *494 32-3 -
82 F it tt 2*528 - 33 *6 -
Acute 16# B 2-500-3-400 2-897 38-8 38*8 9 * 54
291 B 2-500-3-600 3-002 39 *9 35-9 S * 50
32 B 2*500-3*660 3*019 39-6 32 *5 S * 58
13 M tt tt 3*199 ~ 17-7
19 F tt it 2 *897 - 34-7 -
* = the figures of the original B.M.J. paper ( 54)
» = the figures of the J. Clin. Invest. paper (120)
It has been possible to apply statistical analysis to these 
figures. For example, the chronic group could be subdivided into
five subgroups - males, females, both sexes in B.M .J. paper, 
both sexes in interval until J. Clin. Invest, paper, and both sexes 
subsequent to that paper. There was no significant difference to 
be detected between any of the subgroups of between a subgroup 
and the total. Similarly, there is no difference between the 
sexes of the acute and subacute groups. However, there is a 
significant difference between the mean results of. the chronic, 
subacute and acute groups.
Clinical
group.
Plasma viscosity
No. oi 
tests.
Mean Standard deviation.
Chronic 2*123 0*1592 515
Subacute 2 *525 0*185 96
Acute 3*019 0*346 32
The difference between the means of the chronic and subacute 
groups (= 0*400) and of the acute and subacute (= 0*496) is 
19*6 and 7*7 times the respective standard errors of the difference 
of the means; it is accepted that values exceeding 2*5 are 
very unlikely to occur owing to chance sampling errors.
Further comparison of the plasma viscosity is made in 
Figs. 65 to 80 . The frequency distributions are shown according 
to sex and clinical severity; in Fig. 65 I had to make an 
arbitrary assumption, when I made the distances between the lines 
of the clinical groups equal, that the subacute disease was of a
five subgroups - males, females, both sexes in B.M. J. paper, 
both sexes in interval until J.Clin. Invest, paper, and both sexes 
subsequent to that paper. There was no significant difference to 
be detected between any of the subgroups of between a subgroup 
and the total. Similarly, there is no difference between the 
sexes of the acute and subacute groups. However, there is a 
significant difference between the mean results of the chronic, 
subacute and acute groups.
Clinical
group.
Plasma viscosity
Ho. oi 
tests.
Mean Standard deviation.
Chronic 2*123 0*1592 515
Subacute 2 *525 0*185 96
Acute 3*019 0*346 32
The difference between the means of the chronic and subacute 
groups (= 0*400) and of the acute and subacute (= 0*496) is 
19 *6 and 7 *7 times the respective standard errors of the difference 
of the means; it is accepted that values exceeding 2*5 are 
very unlikely to occur owing to chance sampling errors.
Further comparison of the plasma viscosity is made in 
Figs. 65 to 80 . The frequency distributions are shown according 
to sex and clinical severity; in Fig. 65 I had to make an 
arbitrary assumption, when I made the distances between the lines 
of the clinical groups equal, that the subacute disease was of a
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Normals
= 127 tests 
= 36^ 0
CHRONIC RHEUMATOID 
ARTHRITIS
FEMALE
ESR .
0
Normals 
= 29 tests
= 8*2 l/b
2C 35 50 mn/lst hour
Plasma Viscosity
2 *5 cs.
Pig. 66 The Plasma Viscosity and ESR. results in Female 
Chronic Rheumatoid Arthritis.
Number of 
tests
Normals
= 19 tests 
= 24/,o
Chronic Rheumatoid Arthritis 
Males
36 mm. /lst hour
Normals
- 5 tests 
= 6*3 %
Plasma Viscosity
1*8 2*9 cs.
Pig. 67 The Plasma Viscosity and. the Corrected. Wintrohe 
ESR. tests in Chronic Rheumatoid Arthritis of 
Male patients.
15"' Number of 
Cases.
10- -
5--
I d
267
SUBACUTE RHEUMATOID ARTHRITIS.
n - 1 case
ESR. in Females.
55 50
mm./lst hour
10- -
Normal-
limit
5 --
Plasma Viscosity in Females
n r
3*0cs.
4--
3 --
2 - -
1- -
[1
ESR in Males.
36
3--
2- -
1- -
Plasma Viscosity in 
Males.
1*915 2*5
Fig. 68 The Plasma Viscosity and ESR. results in Rheumatoid 
Arthritis of both sexes. - SUBACTJTE.
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Female
ESR
1- -
20 mnv/lst hour
Plasma Viscosity
5 —
3 —  
2 - -  
1 - -
1*7
ESR,
1 - -
Plasma viscosity
1*8
Fig. 70 The Plasma Viscosity and Corrected Wintrobe ESR. 
tests in Rheumatoid Arthritis, with Residual 
Deformity only.
(-L IM IT OF NORMAL VALUES
ACUTE
□ m n
SUBACUTE
r~i—i—I1—tt-
CHRONIC
= 29 TES TS
i i
N O R M A L
PLASMA V ISC O S ITY [cs) and E.S.R. [mm J 1st hour)
F ig . 2
T he  d is tr ib u t io n  of the  p lasm a v is c o s ity  and E S R  va lues o f in d iv id u a l p a tie n ts  w ith in  
the  g roups o f fem ale p a tie n ts , c lin ic a lly  c la ss ified  as described in  the  te x t.
T h e  so lid  d ia g ra m s represen t the  P lasm a V is c o s ity  resu lts .
The  open d ia g ra m s  represen t the  E S R  resu lts .
N o te  th e  h ig h  incidence o f n o rm a l E S R  va lues in  the  presence o f a c t iv i ty  detectab le  
b y  the  c lin ic ia n . N o te  also how  the  E S R  range is  the  same in  each group.
(The  n o rm a l E S R  d ia g ra m  is  th a t  o r ig in a lly  produced b y  W in tro b e  and Lan dsberg , 
It. Amer. Med. Sci., 189, 1935, 102.)
Fig. 71 Taken from Harkness and Cowan (103)
It shows the distribution of the Plasma Viscosity and E 
results in different grades of clinical severity in Rheumatoid 
Arthritis of female patients.
Note (a) the higher incidence of normal ESR. values.
(b) the same range of ESR. values is covered in all 
grades of severity of this disease.
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severity greater than the chronic as the acute was greater than 
the subacute.
Excluding the •Residual’ group for the present, my results for 
the plasma viscosity test in rheumatoid arthritis might he stated 
as follows.
Clinically active rheumatoid arthritis was usually associated 
with an increase in the plasma viscosity which raised the value to 
heyond the 'normal’ ranges indeed, with the acute and suhacute 
patients there was no instance of a normal value.
The amount hy which the plasma viscosity was increased was 
proportional to the severity hy the clinical assessment. The 
plasma viscosity measured the general reaction to the disease: 
inasmuch as the severity of the locomotor lesions frequently were 
parallel to the severity of the clinical assessment of the whole 
patient,..the plasma viscosity usually increased in proportion to 
the severity of the local lesions also. Discrepancies were more 
common between the viscosity value Mid the local condition than 
with the general condition.
In the individual case, as the severity of the general 
reaction increased so did the plasma viscosity rise: as the
general condition improved, either spontaneously or in response 
to treatment, so also was there a corresponding fall in the 
viscosity.
The changes in the plasma viscosity "bore a close time 
relationship to the changes in the clinical condition.
The extent of the viscosity change was the same in both 
sexes for the same degree of clinical change.
The mean viscosities of the clinical groups were well 
separated from each other; the scatter about the mean, within 
each group, was restricted but there was a slight overlapping of 
the groups which prevented the viscosity being used as an 
absolute guide to the clinical assessment of any individual 
patient.
The apparent errors of the plasma viscosity test in showing 
normal results in chronic rheumatoid arthritis were in excess of 
their true proportion as several cases were here included which 
had responded well and had made an apparent'recovery’ - the word 
'recovery' is so designated as there is a widely- and stronglv- 
held opinion among clinicians that a complete recovery in 
rheumatoid arthritis is so exceptional as to be ignored. Their 
motto might be - "once a rheumatoid, always a rheumatoid"; the 
spaces between the acuter episodes are regarded only as quiescent 
periods; patients in these quiescent periods following shortly 
after definite evidence of clinical activity were still classed 
with the chronic active cases.
Discussion. The plasma viscosity will "be discussed again in 
comparison with the ESR, hut it is discussed here on its own 
merits. The results can he described conveniently under the 
headings of diagnosis, -prognosis, and treatment.
Diagnosis - The plasma viscosity is a useful guide to the 
presence of active rheumatoid arthritis. If other causes of an 
increased plasma viscosity (such as an infective focus) can be 
eliminated, the finding of an increased viscosity in a patient in 
whom the vague symptoms of lassitude, loss in weight, vague joint 
symptoms and very few joint signs makes the clinician suspect 
arthritis, allows a diagnosis to be made with some confidence and 
the appropriate treatment begun without delay. The plasma 
viscosity test is a sensitive and reliable index of the presence 
of a general reaction in rheumatoid arthritis and of the degree 
of this reaction.
The test is also a sensitive and reliable guide to changes 
in the condition of the individual patient. A decrease indicates 
an amelioration; an increase reflects a worsening.
Prognosis - The plasma viscosity test has several special 
values to the clinician in deciding the prognosis of the cases.
A high plasma viscosity result carries a worse prognosis 
than a lower value, since recovery from a condition producing a 
severe general reaction would be expected to take longer than
from one producing a lesser reaction. Nevertheless, it has been 
possible to produce such improvement that the higher viscosity 
values have fallen until the normal range is reached and such 
patients can be regarded as much "cured" as a rheumatoid 
arthritis case can be.
"Zone of Chronicity" There is a restricted range of values 
(1*95 - 2*25 cs.) within the total range of plasma viscosity 
values into which falls the majority of the results from the 
patients with a wide variety of diseases with a chronic general 
reaction - eg. rheumatoid arthritis, rheumatic fever, tuberculosis 
syphilis, pyogenic infection, etc. Reference will be made to 
this zone again when these other diseases are discussed.
Cowan and I gave a great deal of attention to this subject because 
before Cortisone and A.C. T.H. altered the treatment so funda­
mentally, we believed that we were making some progress in guiding 
treatment into something besides the exhibition of gold or 
bismuth.
(a) A patient who first presented herself with a result in 
this zone usually proved very irresponsive to therapy. The 
effect of gold v/as not so dramatic as in patients with higher 
viscosity values; this finding corresponds to the belief that 
patients with high ESR values respond better to gold than those 
with low ESRs. It is possible, however, that a satisfactory
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This figure shows the relative distribution of the 
means of various types of disease and of the 
different clinical severities of single diseases.
outcome m a y  be achieved even in these chronic cases.
(b) With gold therapy, local heat and massage, etc. 
considerable improvement might be effected in the local 
conditions of the patients with values in this zone; some even 
became symptom-free. The plasma viscosity made a sharp division 
into two groups. Where repeated estimations of the plasma 
viscosity had revealed a failure to return to the normal range 
the condition was to be regarded only as quiescent or dormant, 
with a relapse in the future as the inevitable outcome; this 
relapse might be associated with a recognisable trigger stimulus 
such as exposure to cold, sore throat, influenza, etc. but there 
other cases in which a definite stimulus to set off the relapse 
could not be recognised. In contrast, v/here the plasma viscosity 
had attained the normal range a definite stimulus was always to 
be detected (cf. case 2, 5) and necessary.
(c) The zone of chronicity lay as a hazard between the high 
plasma viscosities of the more severe cases and the low normal 
values. A subacute or acute case of rheumatoid arthritis might 
respond initially to treatment, with a corresponding reduction 
in the viscosity towards normal and its corresponding hopeful 
prognosis: however, the decline may halt in this zone of chronicit 
as an indication that the nature of the disease has altered and 
the prognosis is correspondingly much worse, with the dismal
prospect of the long-drawn-out struggle of the chronic case. N o  
other test in clinical pathology is able to indicate this 
alteration in character of the disease process. (A similar zone 
will be described for pleural effusions in tuberculosis, which 
also acts as a possible bar to a straightforward reeoveiy. )
(d) The foregoing results caused Cowan and myself to try an 
empirical type of treatment. If a patient would not show a 
reduction of her plasma viscosity in response to therapy then we 
attempted a preliminary increase in the plasma viscosity by 
producing an increased general reaction with vaccines, etc., and 
then a further course of treatment with gold was instituted -- 
the hope was that the patient would now respond so well that she 
would traverse the chronic zone to the normal range without halt. 
Unfortunately I left Sunderland before any results of this scheme 
became available. I learned later from Coke ( 47) that he had 
employed the same gambit when his special |^ SR test also failed to 
show a decrease, and he believed that it was a successful mode of 
treatment in some of these difficult patients.
The subjects who had residual deformities only showed an 
abnormally high plasma viscosity in many instances. I interpret 
this as indicating that in the latter the disease is not completely 
cured and a relapse is possible at any moment. It strongly 
supports the claim that rheumatoid arthritis Is never cured and
justifies the clinics which never remove the name of a patient 
from their list of sufferers.
Treatment - The treatment of resistant patients within the 
zone of chronicity has been described above.
The test also assists the clinician in deciding the response 
of the individual patient to a particular type of treatment; a 
falling viscosity reflects a favourable response.
A raised viscosity after a course of treatment indicates that 
a cure has not been produced and that further treatment will be 
necessary.
Cowan has informed me that the decrease in the plasma 
viscosity with cortisone treatment has always been most dramatic.
I have seen one case only and while the initial decrease was 
obtained the viscosity soon returned to its original level in 
spite of the continued use of the drug.
(Further discussion appears later, in respect to the 
proteins, liver functions, etc. )
The ESR test in rheumatoid arthritis.
Mt experiences with the Wintrobe ESR test have been most 
unsatisfactory and disappointing.
Results. These have been included in detail in Table II of the 
appendix. They have been shown in graphical form in Fig. 65 to 80 .
Clinical No. of Corrected Wintrobe ESR.
Assessment Sex tests Mean Standard deviation
P. 554 25*6 11*46
Chronic M 78 17*4 11*60
B 452 24*1 9*85
P 64 • 55*5 12*60
Subacute M 10 26*2 16*86
B , 74- 52*5 15 *4-
P 10 54*6 16*25
Acute M 7 17*8 16*08
B 17 27*6 17*79
The number of tests differs from the viscosity table as the ESR 
was not measured in every instance.
(a) The range of ESR values was the same for all the grades of 
clinical severity; the highest value in the chronic group was 
above the highest of the subacute group.
(b) A statistical comparison was made of the six groups formed 
by the two sexes in three clinical assessments. Taking as the 
criterion that two groups were significantly different (ie. not 
drawn by chance from a single varied family of results) if the 
difference of their means was more than 2*5 times the standard 
error of this difference, it can be shown that female chronic 
and subacute groups differ, as does the chronic male and chronic 
female. There is no difference in the three male groups,or in 
the subacute-acute female groups^ or the chronic-acute female 
groups.
Clinical Wo. of Corrected Wintrobe ESR.
Assessment Sex tests Mean Standard deviation
F 354 25*6 11*46
Chronic M 78 17*4 11*60
B 432 24-1 9*85
F 64 33*5 12*60
Subacute M 10 26-2 16*86
B , 74- 32*3 13*4
F 10 34*6 16*23
Acute M 7 17*8 16*08
B 17 27*6 17*79
The number of tests differs from the viscosity table as the ESR 
was not measured in every instance.
(a) The range of ESR values was the same for all the grades of 
clinical severity; the highest value in the chronic group was 
above the highest of the subacute group.
(b) A statistical comparison was made of the six groups formed, 
by the two sexes in three clinical assessments. Taking as the 
criterion that two groups were significantly different (ie. not 
drawn by chance from a single varied family of results) if the 
difference of their means was more than 2*5 times the standard 
error of this difference, it can be shown that female chronic 
and subacute groups differ, as does the chronic male and chronic 
female. There is no difference in the three male groups,or in 
the sub acute—acute female groups^ or in the chronic—acu L,e female 
groups.
(c) In Fig. 65 , where the length of the base-line equivalent 
to the plasma viscosity normal range was made equal to that for 
the female BSR normal range, the relationships of the means of the 
ESR groups to themselves and to the corresponding means for the 
plasma viscosity results have been again presented. It stresses 
again how little difference there may be between the groups and 
makes obvious the anomalous decrease in the male acute mean from 
the subacute mean.
(d) The frequency of distribution graphs indicate how the ESR 
results cover the same range in all groups; they also indicate 
the frequency with which apparently normal ESR values may be 
found, from 0% in subacute males to 36% in chronic females.
(e) Study of the serial tests in individual patients has 
shown that wide fluctuations are possible in the ESR results which 
frequently could not be correlated with any change in the clinical 
condition, as assessed by the clinician.
A comparison of the Plasma Viscosity and ESR tests in Rheumatoid 
Arthritis.
In part 6, in that section where I described the periodic 
relationship between the plasma viscosity and the maximum ESR. it 
was indicated that it was impossible for both measurements to be 
accurate guides to the same thing, ie. the systemic reaction to 
disease.
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As a corollary, the better is one measurement as a guide to 
this systemic reaction by so much is the other less accurate.
Furthermore, I believe that the uncritical opinion is unduly 
biassed in favour of the ESR by those instances in which each 
change in the clinical state has been mirrored by an equivalent 
change in the ESR; when such a case is seen it is remembered 
while the others with smaller or larger discrepancies between the 
ESR interpretation and the clinician's findings are rapidly 
forgotten. The ESR has much latent criticism facing it among 
clinicians and pathologists.
The ESR has a much higher incidence of false negative tests ~ 
amounting to no less than 36% in chronic females. In contrast, 
the false negatives in the plasma viscosity amounted to 8* 2% only.
In the 433 tests which I analysed (103) , 28 were normal in both 
the ESR and plasma viscosity, 118 had normal ESRs associated with 
abnormal viscosities, but in one instance only was an abnormal 
ESR associated with a normal plasma viscosity. Thus, the extra 
effort in measuring these 433 ESRs has produced an improvement by 
less than 0*25% on the information yielded by the viscosity 
estimation alone. I believe that this is a satisfactory refutation 
to the proposal that both measurements should be made.
The abnormal range for the female ESR values is 1*75 
times the length of the normal range; for males it is about 5 
times. The abnormal range for the plasma viscosity for both
sexes for ordinary illnesses is about 7 times the normal range 
but on rare occasions the abnormal range can extend to 18 times. 
The effect of the small possible increase in an ESR value is well 
demonstrated in the insignificant increase in the mean ESR figures 
for the female subacute to acute groups; the ESR had reached its 
maximum in the subacute group and no further increase was possible 
with the increase in clinical severity. The plasma viscosity does 
not suffer from these restrictions. This difference betv/een the 
two tests can be noted in Fig. 65 where the plasma viscosity line 
stretches far to the right, and in Fig.71 where the ESR values 
appear above each other while the viscosity groups tend to move 
towards the upper levels with increasing clinical severity.
The scatter diagrams of Fig. 72 to 80 are important from 
two aspects. They show that the highest plasma viscosity can be 
associated with the lowest ESR value, but not vice versa. The^ r 
also show that different groups of results would yield different 
lines and equations of correlation between the ESR and the plasma 
viscosity.
My experience with the two tests in individual patients 
emphasized the superiority of the plasma viscosity test. In the 
end the only significant result in the ESR test was an increased 
value: a normal value does not rule out the possibility of an
active disease as the ESR error in that asx^ ect can be 36/-0 ; 
the degree of activity is not indicated closely by the degree of 
abnormality in the ESR value (from statistics above); we were 
never discomfited by discarding the ESR result when there was a 
discrepancy betwreen the clinical assessment and this value, but 
we learned that such a discrepancy with the plasma viscosity test 
could not be ignored with impunity.
There is nothing in the ESR test to correspond to the 
zone of chronicity whose importance we have discussed.
There is one type of case in which the ESR might be 
superior on occasion, and that is the early case - this aspect is 
covered however by the statement above that an abnormal result 
alone has significance.
I am of the opinion that the ESR is so unreliable and 
its results of such doubtful value that it could well be discarded 
in favour of the plasma viscosity test where this is available.
I would go further and suggest that a critical consideration of 
the evidence here presented would lead to the conclusion that the 
ESR as measured by the Wintrobe technique yields so little real 
information that it is not worthy of retention even if the 
alternative plasma viscosity test were not available. Cowan, at 
Sunderland, on the basis of these results has discarded the ESR 
completely; 1 am attempting to do this also at Portsmouth.
While not so emphatic irl his condemnation of the ESR test. Stone 
(236) writes concerning it - "Throughout the course of the disease 
widely different figures may he found, rises and falls occurring 
over the months, having no clear relation to the clinical 
condition.
Under the influence of gold therapy the general tendency is 
to a lower level and an ultimate fall to normal. But the rate 
does not necessarily decrease with clinical improvement: quite
often much the same figure is found although unmistakable amelior­
ation in symptoms and signs has occurred. All that can be said 
bfran increased sedimentation rate, whatever be the actual figure, 
is that it shows the infective agent to be at least latent, if not 
still active.
When the earliest manifestations of rheumatoid arthritis are 
appearing, and especially in the "pre-rheumatoid" stage, a normal 
figure may be found, and may be most misleading. It should not 
be allowed to disturb one's clinical judgment".
In contrast, the literature contains many papers which 
stress the value of the ESR test in rheumatic disease.
Gibson ( 87), in his paper comparing the plasma viscosity 
and ESR tests writes - "I have refrained from quoting individual 
cases. Any such selection may easily be misleading. The 
apparent unreliability of either test could have been shown by a
suitable selection of cases". Therefore, I must ask the reader 
to accept that the individual cases reported fully in the appendix 
were not specially selected to favour the plasma viscosity test 
and are representative of the general results.
The original publications on the plasma viscosity of 
Whittington and Miller had aroused ray interest alone among 
clinicians and laboratory workers; however, the later publications 
of Houston, Whittington and myself showed that the plasma viscosity 
test was of value in the investigation of many diseases among 
which rheumatic fever was specially named and the test was 
adopted by several laboratories. Their results have now been 
published and these have to be discussed.
The reports have not been uniformly in favour of either the 
ESR. or the plasma viscosity tests. Where a good ESR technique 
was used, especially one which measured a maximum sedimentation 
velocity, the value of the ESR to the clinician was correspond­
ingly higher; where an inferior viscosity technique was used, 
so was this test correspondingly decreased, in significance. The 
problem can be summarised approximately to the ratios obtainable 
of the abnormal range to the normal range of values; eg. Race ( 202; 
reduced my 7:1 ratio for plasma viscosity to 1:1, and thus found
that test less informative.
It is also more than a coincidence that those workers who 
had had previous wide experience of the ESR test (and some had 
even carried out the fundamental experiments required to develop 
their own special technique) reported more favourably on their 
ESR results than those who approached, the problem initially 
unbiassed in favour of either test: the gross discrepancies in
the percentage of ESR values in the abnormal range should be 
noted from report to report.
A suitable order for the discussion of these publications 
is according to spas and rheumatic centres.
(i) Buscton. Race employed the "Spa” ESR method which measures 
the fall in a wide tube in one hour, making a correction by 
formula for variation in the haematocrit result. "Previous 
experience with the Wintrobe technique has shown that it may be 
grossly inaccurate when the cell volume approximates to the normal 
level and that normal results may be obtained when the wide-tube 
method indicates a definite abnormality (Oollins and others,1839)”. 
He had the benefit of one of my Whittington-type viscometers, 
correlated to the Y5 scale by Whittington, but he introduced a 
modification of our technique which invalidated his use of my 
values for the normal range (especially when the older high 
1*950 cs. upper level was used). Race had as his anticoagulant
an indefinite volume of potassium oxalate solution: this would
cause a reduction in the plasma viscosity by dilution and hy the 
cell-constricting-action already described in §14 of part 6. It 
is most important to realise also that he was dealing with 
chronic rheumatic diseases only which could explain why in his 
series of 71 tests his highest figure was 2*23. Because his 
upper limit of normal viscosity was unduly high, the ESR was 
favoured and this may "be part of the reason why he concluded that 
"Contrary to the results of Harkness and others, who found the 
plasma viscosity test to he a more reliable index of activity in 
chronic rheumatic diseases than the erythrocyte sedimentation 
rate as performed by the Wlntrobe method, the results obtained with 
the wide-bore method recommended by Collins and others showed a 
greater sensitivity and in several ca.ses gave an abnormal value 
when the viscosity was within normal limits". However, he did 
find that the plasma viscosity was a better guide to the extent of 
the disease because it was not restricted, as was the ESR, by an 
upper limiting value - "-but it is quite obvious that the viscosity 
shows the extent of the abnormality better than is indicated by 
the C.S.S. figures." "It is clear, however, that the viscosity, 
being quite independent of the cell-packing factor, will give a 
somewhat better indication of the degree of abnormality. "
As Race complains of the upper limit to the possible ESR values 
interfering with a proper reflection of the extent of the disease 
in these chronic conditions, it would have been interesting to 
hear how much greater was the complaint when dealing Y/ith 
diseases of still greater severity such as in the acute and 
subacute groupings.
(ii) Harrogate. Woodmansev and Wilson introduced a viscometer of 
their own design (similar to that designed by Sato (123)) which 
has a simple construction and which is more simple and rapid, to 
use than the Whittington model. Their "viscosity’' value, however 
includes a variable fraction which is dependent on non-viscosity 
factors such as surface tension and this fraction is neither 
constant nor negligible as they have assumed. They also depart 
from standard viscosity units and. report their results as a ratio 
( = 100 x time of flow of plasma/time of flow of distilled water). 
The experimental errors are large: the specific gravity effect on 
the ratio is disregarded; the timing errors are equivalent to 
1*5% of the final value; the water-bath controls the temperature 
of the fluid but not of the glass of the viscometer and a variation 
of 1°C. causes an error of 2*5%.
They approached the problem in a critical mood (259) - 
"It is generally agreed, however, that the erythrocyte sedimentation
rate is not always a reliable index even if a correction is made 
for anaemia. " From their study of 200 consecutive cases >. they 
concluded - "Y/e believe that the plasma viscosity gives a more 
accurate figure than the erythrocyte sedimentation rate for 
estimating the activity of rheumatoid arthritis".
Their technician, Steel, has written two short articles on 
the relation of the plasma viscosity results to the ESR results, 
treated from the aspect of physical measurements rather than 
from the clinical aspect (2325233).
(iii) Worcester and Droitwich. Arnold and Salt repeated the 
mathematical analysis of Steel, and in a series of 182 tests 
( 7 ) obtained a correlation coefficient of 0*750. They also 
derived a series of equations by which one value might be calcul­
ated if the other was known. They found that the plasma viscosity 
did not suffer from the handicap of an upper limit and thus 
concluded - "Plasma viscosity determinations are valuable for 
further defining colloidal abnormalities in blood samples in 
which the corrected sedimentation rate is maximal. "
Dawson and Salt ( 59 ) investigated, a series of patients 
with the ESR and plasma viscosity tests at weekly intervals while 
they were undergoing a three-week course of treatment. They 
found - "In general, it appears that either the G. S. R. or the
P. V. value is dependable as an initial index of activity in 
chronic rheumatic disease, the C.S.R. being rather more sensitive 
for the detection of slight degrees of activity and the P. V. 
value being more reliable for demonstration of extreme severity 
of the disease process." "These findings suggest that, in rheumatic 
disease of short duration, C.S.R. values may occasionally yield 
more marked evidence of abnormality than do P. V. values. In 
contrast, when the disease is severe and of long duration, P.V. 
determinations may sometimes yield more pronounced evidence of the 
gravity of the condition than do C.S. R. determinations." "It is 
concluded from the foregoing observations that the 0. S. R. test is 
reliable for diagnostic purposes and is sufficiently sensitive to 
reveal slight changes'in a patient's condition, sometimes but not 
always associated with small degrees of clinical change. The P. V. 
test is likewise reliable for diagnostic purposes but is less 
sensitive as an indicator of slight changes in a patient’s 
condition, seldom varying within short periods of time even when 
there is clinical improvement. For diagnostic purposes the 
greatest amount of information is elicited by performing both the 
C. S. R. and P.V. tests. In most cases the results will be in 
agreement, but occasionally the values will show a. lack of 
correlation. When this occurs, the C. S.R. results are likely to 
be more reliable in inild early cases of rheumatic disease: the
P.V. results are likely to be more dependable in severe cases of 
long duration. "
These workers divided their ranges into five - a normal range 
and 4 abnormal subdivisions - for both the ESR and plasma viscosity. 
As a larger percentage of the ESR values were in the higher groups 
as compared with the viscosity tests, they interpreted this as 
showing that the ESR values are more markedly differentiated from 
normal than are the abnormal plasma viscosity results. I will have 
to deal with this point again with Gibson's paper and will leave 
it until then.
Salt assisted in the preparation of the "Spa" technique 
for the ESR measurement and it is not surprising therefore that in 
his introductory remarks his attitude to the test is shown - "The 
well-established, erythrocyte sedimentation test (E. S. R. ) is 
generally accepted as satisfactory in these respects, occasional 
anomalies serving to maintain the interest of rheumatologists 
rather than to discredit the test".
(iv) Bath. Gibson ( 87 ) has presented the best exposition of the 
correlation of the ESR and plasma viscosity by other workers. He 
used a Harrogate viscometer and a variety of ESR techniques. I 
mil quote his findings rather fully and include some of his 
diagrams and results.
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(The C.S.S. is a one-hour ESR "by the Spa tube, corrected by 
formula for PCV. variation; the C. S. I. is a m»yimum velocity 
technique, corrected later by a chart for FCV. variation. )
The results of 365 tests on 286 consecutive cases of 
rheumatoid arthritis are presented in Pig. 81 , copied from his 
paper. G-ibson stressed how the higher incidence of abnormal ESR 
results came at the upper values in contrast to the plasma 
viscosity where the greatest came just above the upper limit of 
normality (Dawson and Salt found this similarly and drew the same 
conclusion) ”It will be seen that the peaks of the curve are in 
groups far removed from the normal, in this respect contrasting 
with the viscosity distribution in the same series. In empirical 
tests of this kind in which an estimate is made of some ill-defined 
abnormality, their value both in diagnosis and in assessment of 
improvement or deterioration depends mainly on thet extent of 
abnormality indicated and the differentiation which this estimate 
affords between diseased and normal persons. On this criterion 
the B. S. R. appears to be more informative than viscosity.
This conclusion is not invalidated by the occurrence of early 
packing when the B. S. R. is estimated by the short tube of the Spa 
Hospitals Method. The writer agrees with Race (1948) that 
differentiation within the most rapid B.S.R. groups (0.S.S.
55-65>oj is not clearly made by the tube in question. This is seen
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Fig. 81 Traced figure from G-ibson's paper ( 87 ).
in the graph by the accumulation of large numbers of cases in 
these groups. This is not, however, a very serious disadvantage 
and it is far out-weighed by the sensitiveness of the method to 
small deviations from normal and by the consistency of its 
results which other methods lack." I consider that these results 
may be interpreted in a manner more favourable to the viscosity 
test^ the viscosity pattern is similar to my own findings.
From their derivation from consecutive cases it is probable 
that the majority of the tests were made on female patients with 
chronic disease. As chronic disease of all types occupy a 
restricted zone just above normal, G-ibson’s values conform to this 
pattern; the fact that a result falls in this zone is more 
important than the distance by which it departs from the normal 
range. Furthermore, if the numbers of acute and subacute cases 
had been increased to equal the chronic, the plasma viscosity 
results would have shown a corresponding increase in the 
intermediate abnormal values and in the high abnormal values, while 
the ESR values would merely have piled high in the ranges where the 
highest incidence appears at present. It is not valuable to claim 
a relatively greater tendency to high values in mild disease if 
in severe disease the same relative positions cannot be maintained.
In these 565 tests, the ESR was normal in 34- (9'3/o), the 
viscosity was normal in 41 (11'2y): 13 of the 34 normal ESR.
tests had associated abnormal viscosities, while 20 of the normal 
viscosity tests had abnormal ESRs. Using both tests no less than 
344 (=94*2^ b) would have had abnormal tests.
"The disagreement in some cases was very great and both 
tests in certain; cases disagreed with the short-term assessments 
of the patients1 clinical condition. Casts could be quoted in 
which the B.S.R. agreed better with the clinical state and. an 
equally good case could be made out for the viscosity as showing 
better agreement. "
"The conclusion seems to be warranted that B. S. R. and viscosi 
are measuring two different aspects of plasma abnormality. The 
B.S.R. is mainly influenced by fibrinogen, the viscosity by the 
total protein picture with globulins predominant. I cannot agree 
with the statement that because the tests do not agree then one of 
them must be inaccurate. Both may be perfectly accurate indices 
of different facets of abnormality in the same plasma". I am in 
full agreement with this last sentence of G-ibson but I must 
insist that if it is true then the indices cannot be equally 
applied to measure the same thing (in this instance the general 
reaction to the disease): one or other must be superior unless
the' errors of both are equally large.
G-ibson concluded - "Viscosity estimation has an important
place as an aid to the clinical assessment of activity in 
rheumatic disease. It supplements, but does not replace,the 
B.S.R.. In any case or series ih which a close watch is required 
on progress, both tests taken together give results which are 
more complete than either separately. The combination of tests 
should be of especial value in therapeutic trials in which for 
statistical purposes two independent indices would be available.”
Ratio of abnormal to normal ranges for ESR and plasma viscosity.
(a) ESR. The C. S. S. technique as used by the previous authors 
has a normal range of lOO-85/o, an intermediate or borderline 
range from 85-80^ > which was included with the definitely abnormal 
range for statistics, and an abnormal range of 80-50%. Thus 
the ratio is 7:3.
With Gibson’s G.S.I. technique the ratio was 8:1 which 
is closer to the viscosity ratio by my methods.
(b) Plasma Viscosity. Race studied only chronic cases and had 
a ratio of 1:1 (it would have been higher if he had produced his 
own normal range).
Woodmansey and Wilson had a ratio of 7:2,
Dawson and Salt had a ratio of 7:2, and 
Gibson had a ratio of 9:3.
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series (0*2, 0*3, 0*3 respectively as compared to 0*25) yet 
their absolute values differed; Woodmansey and Wilson =
1*60 -1*80 although Steel gives 1*60-1*82 -with a border zone up 
to 1*86; Dawson and Salt = 1*50-1*79: G-ibson = 1*50-1*80 cs.
Their highest value was only 2*9 as compared with iiy values 
frequently over 3 and up to a maximum of 3 .
(v) Walkden Clinic 5 Manchester. Lawrence has elaborated on the
single plasma viscosity measurement by which he measures the 
viscosities in the fluids remaining after the fibrinogen has been 
removed as a clot ,and the globulins by salting-out methods.
There is no doubt that this new method yields more information 
than obtainable by our original measurement. However, this method 
will not be widely adopted as 4 viscosity measurements are needed 
for each plasma plus manipulations of centrifuging, filtration, 
etc. The filter-paper electrophoresis technique is easier and 
yields the same information as Lawrence1s method but in terms 
which have a standard interpretation. (138,139,140)
I quote his results for 245 cases of clinically active 
disease - not all rheumatic. "HSR abnormal in 43 per cent; 
plasma viscosity abnormal in 59 per cent; fractional viscosity 
abnormal in 86 per cent; ESR or fractional viscosity abnormal 
in 94 per cent.u
"Comparison of the differential plasma viscosity -yvith the E. S. 
and the simple plasma viscosity indicates that the first is a 
more sensitive indicator of pathological plasma protein changes 
than either of the other two and that the E. S.R. is the least : 
reliable. "
(vi) Charterhouse Rheumatism Clinic, London. Coke uses a 
Whittington viscometer to the V5 scale. He has not published 
the details of his tests and the summary is taken from his part 
in the discussion on Gibson’s paper to the Royal Society of 
Medicine (49) - "My experience can be summarized by saying that 
the serum viscosity appears to be a useful addition to the 
assessment of the rheumatic patient, but there is little 
evidence that it should or indeed will ever replace the 
erythrocyte sedimentation rate. "
Coke studies serum rather than plasma as his scheme for the 
laboratory investigation of patients had been founded on serum 
and he was not prepared to upset these plans until he had found 
that serum viscosity would not yield as much information as the 
plasma viscosity. Salt ( 217) has also suggested more recently 
that serum viscosity might repay further investigation. As I 
informed Coke earlier in a private communication (47) 1 do not 
consider it important which fluid is studied in chronic states 
where the fibrinogen is either norma-i or but slightly increaseo..
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However, if the test is to he used more widely and include such 
acute conditions as rheumatic fever the plasma is the more 
suitable fluid; the earliest changes are in the fibrinogen and 
its detection requires the use of plasma. It would be possible 
for the laboratories whose work is confined to tuberculosis or 
rheumatism to obtain satisfaction with the serum viscosity 
estimation but I know from my own experience in a general hospital 
laboratory where I had the tests in duplicate that the plasma 
viscosity results are more valuable than the serum viscosity.
I am against the introduction of variations of the viscosity 
test except for techniques, such as Lawrence’s, which produce 
significantly better information. Consider the chaos which has 
arisen in the ESR test because of the multiplicity of methods.
Also, as plasma is the fluid present in the circulating 
blood, I think we should attempt to study this whenever possible 
rather than only a fraction of it.
The relation of the plasma proteins to the plasma viscosity and 
to the clinical condition in rheumatoid arthritis.
On many occasions when I have described my plasma viscosity 
test and explained how it was ultimately dependent on protein 
changes I have been asked if the same information was not
obtainable by the simpler specific-gravity technique of protein 
estimation.' The duplicate results in the rheumatoid arthritis 
can serve to answer this question.
The total plasma proteins were measured by the copper 
sulphate method of Phillips et al. (194). The upper limit for 
the plasma total protein is given in many books and papers as 
8 *0 g. per 100 ml.
The individual results in Table II show that a large 
majority of the chronic cases have total proteins still within 
the normal range. The majority of the subacute and acute cases 
have total proteins outwith the range, but each exception to this 
general statement weakens the possible value of the protein 
estimation relative to the viscosity estimation (100% abnormality 
in these two groups). There is relatively less difference between 
the means of the three groups for the total protein than for the 
viscosity results.
It has been shown that the protein fractions have equal 
effects on the specific gravity (186). Therefore, as the albumin 
decreases in disease it will cancel out the same amount of increase 
in globulin or fibrinogen and the resultant increase in the total 
protein may be small. The difference in the effect of the protein 
fractions on the viscosity has been described in detail earlier,
in §16 of part 6. A small increase in the fibrinogen or 
globulin would be able to compensate for even a large decrease in 
albumin and abnormal fibrinogen or globulin will almost always be 
associated with abnormal viscosity.
Nevertheless, I have found it worth while to estimate both 
the viscosity and the specific gravity when attempting to make an 
estimate of the acuteness or otherwise of a disease process. A 
very high viscosity result associated with a normal or low 
abnormal total protein must be due to fibrinogen increase chiefly 
and therefore with an acute clinical condition; aimoderate rise 
in the viscosity and a moderate rise in total protein probably 
results from an increase in the globulin fraction which is more 
characteristic of a chronic lesion.
The explanation of the viscosity increases in rheumatoid 
arthritis is found in the changes in the plasma protein fractions. 
G-utman (91) has reviewed the work of many investigators and shows 
that the changes in the serum proteins in rheumatoid arthritis 
characteristically lead to a decrease in albumin and an increase 
in globulin; there is also an increase in the plasma fibrinogen. 
The increase in globulin is due chiefly to increments in the 
alpha- and gamma-fractions, of an extent and proportion referable 
to the stage of the disease, although the bulk of the increase
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cannot "be accounted for try the development of specific antibodies. 
Wallis (268) has concluded that the hyperglobulinaemia is the 
result of the combined effects of inflammation, tissue destruction, 
and immunization, the last being the principal contributor in all 
but the early stages of the disease.
Salt (217) found that the "differences in plasma globulin 
(including fibrinogen) concentrations determined chemically, are 
seen to be closely paralleled by the values for plasma viscosity 
and for corrected sedimentation rate. A significant diminution 
in the albumin content of the plasma also accompanies the augmented 
globulin and fibrinogen levels, whereas the fibrinogen content 
differs only slightly in the two sub-groups." " - the hyperglob­
ulinaemia demonstrable in patients with chronic rheumatic disease 
is due chiefly to increments in the euglobulin and pseudoglobulin I  
fractions, - " "Serum total protein concentrations may also be 
increased because of the hyperglobulinaemia, but the increment 
may be partially off-set by a depletion in the albumin component. "
I did not have many tests in which I fractionated the 
proteins by Howe's salting-out technique, but these results have 
been in full accord with Salt's later findings.
ffhe relation of the gold and thymol flocculation tests to the 
plasma viscosity and the clinical condition in rheumatoid arthritis.
The serum colloidal gold reaction and the thymol turbidity 
tests were introduced hy Maclagan in 1944 (174 ,175 ) and the thymol 
turbidity was later improved by its extension to a flocculation 
technique (176 ). While Maclagan intended that these tests should 
be used for the investigation of liver disease and liver function, 
he realised that they could yield abnormal results in diseases 
which did not primarily affect the liver. It was shown (163 ,177 ) 
that abnormal results were due chiefly to qualitative and quanti­
tative changes in the gamma globulin but that the other globulins 
and the albumin played an active role in modifying the gamma 
globulin action.
It is generally accepted that the fibrinogen is formed in 
the liver only: the site of formation of the albumin and globulin
is not known definitely but the liver again plays a large part in 
their formation. The plasma viscosity is a measure of the 
abnormal fibrinogen and globulin and is thereby an indirect 
measure of an alteration in the protein-forming function of the 
liver. (An abnormally low catabolism of the proteins must also be 
considered. )
I thought that some useful information might be derived if a
comparison was made between the plasma viscosity and these other 
empirical tests for liver function. Therefore nearly a thousand 
tests were made in parallel between the gold flocculation and 
the plasma viscosity; the thymol turbidity and flocculation tests 
were discontinued early when the degree of correlation was 
absolutely low and relatively low as compared with the gold 
flocculation results.
Results. - These are given for the individual cases in table II, 
and these are shown graphically in Fig. 82.
They can be summarised as follows:- In a total of 401 tests 
in rheumatoid arthritis 317 abnormal gold flocculation results 
were obtained (=79 m05°/o), There was a relation between the 
severity of the disease and the incidence of abnormal results - 
100fo in 13 female and 4 male acute tests, and in 7 male sub-acute 
tests; 87*5% in 40 female subacute tests; 78*3% in 267 chronic 
female tests and 70c/o in 70 chronic male.
From Fig. 82 also it is noted that the degree of abnormality 
tended to be higher with the more severe clinical states, yet a 
normal result could be associated with moderately high viscosity 
values.
An abnormal result could be found in those patients in 
whom the disease was apparently burned-out and quiescent.
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Discussion. The high correlation "between the gold flocculation 
test and the plasma viscosity and clinical severity is found only 
in rheumatoid arthritis and the related diseases of rheumatic 
fever and Still’s disease. In the later similar series of 
duplicate tests with tuberculosis abnormally high viscosity values 
are almost constantly associated with normal gold tests.
§ B of this part is concerned with Infective Arthritis 
which is similar to rheumatoid arthritis except that a focus of 
infection is believed to have a large part in the production of 
the locomotor lesions. The results for the chronic cases of this 
disease in the plasma viscosity test are not distinguishable 
statistically from those of chronic rheumatoid arthritis, but the 
incidence of abnormal gold tests was much lower. Cowan and I 
applied this finding empirically to our investigation of cases 
which might be rheumatoid or infective arthritis - a patient with 
a normal gold flocculation test had a specially thorough search 
for a possible focus of infection.
The discovery of an abnormal gold flocculation test in a 
patient with vague signs and symptoms was an additional guide to 
a confident diagnosis of rheumatoid arthritis.
I had made a preliminary draft of a paper on the uses of 
the gold flocculation test in arthritis when Fraser (83)
published his results from a smaller similar series of tests. He 
also studied the cephalin-cholesterol flocculation test but found 
19% only abnormal in rheumatoid arthritis and 15% in rheumatic 
fever. "A relationship was observed between the results of the 
serum colloidal gold test and the erythrocyte sedimentation rate. 
It is concluded that the former is a useful test in rheumatoid 
arthritis, although a little less sensitive than the latter.,f 
"There was a moderate degree of relationship between the results 
of the serum colloidal gold reaction and the plasma albumin and 
globulin fractions, inverse in the former and direct in the 
latter. There was no apparent relation to the total protein or 
fibrinogen fraction." He found 61% abnormal gold results in his 
153 tests in rheumatoid arthritis and 40% in 20 tests in rheumatic 
fever. Incidently, he had 30 normal ESR results in his 133 
tests.
Carter and Maclagan (38 ) had 76% incidence of abnormal gold 
flocculation tests in a series of 34 patients with rheumatoid 
arthritis; > "there was a rough though definite correlation between 
the gold test and the sedimentation rate": all tests of 3+ and 
over had ESR results over 25 mm. in 1 hr. (Westergren) and the 
negative reactions had ESRs below 20 mm. The thymol turbidity 
test was abnormal in 38% only of these cases.
The plasma alkaline phosphatase in rheumatoid arthritis.
My technician at Sunderland, Mr. L. Haugh, A.I.M.L.T. , 
was specially interested in the phosphatase enzymes. He estimated 
the alkaline phosphatase content on the plasmata after I had 
completed the viscosity test. His results will be presented as 
a thesis for his Fellowship in the I.M.L. T..
In rheumatoid arthritis the alkaline phosphatase results 
tended towards two groups - a low group of about 4 - 6 K.A. units, 
and a high group of 12 - 17 K. A. units per 100 ml.. No correlation 
was obtained between these groupings and the clinical severity of 
the individual cases, the plasma viscosity or the gold flocculation 
tests. The only consistent finding was that in response to a 
satisfactory treatment the phosphatase of both groups tended to 
an intermediate value about 10 K.A. units.
In spite of the abnormal protein fractions, alkaline 
phosphatase, and flocculation tests which are so frequently 
associated with abnormal liver function that they are used in the 
diagnosis of liver disease, it is noteworthy that the incidence 
of liver disease at the post mortem examinations of patients 
with Rheumatoid arthritis has been remarkably low ( 0 ).
The packed-ce 11-volume (haematocrit) in rheumatoid arthritis.
When I was a student my textbook of medicine (Price, 4th 
edition, 1933) taught that in rheumatoid arthritis - "anaemia is 
usual". I refer to this matter here for the sake of completeness 
as my results indicate the beneficial effects of the exhibition 
of iron in large doses. All patients attending the Rheumatism 
Clinic at Sunderland received Pil. Persolate prophylact ic alIv 
and this procedure had been copied by the medical colleagues in 
general practice.
Consideration of my results in Table II and in the table 
on page 262, will show how seldom a severe anaemia was ever seen 
by us.
A scheme for the laboratory investigation of arthritic patients.
My routine investigation of an arthritic patient included 
the tests described above - plasma viscosity, total plasma protein, 
gold flocculation, haematocrit, and ESR - together with a total 
qnH differential leucocyte count and a simple urine examination.
To this I frequently added the serum uric acid, protein fract­
ionation originally by a chemical salting-out method but now by 
filter-paper microelectrophoresis, and urinary 17-ketosteroid 
excretion. The clinicians associated with my laboratories have
found this scheme most informative and satisfactory: it can he
recommended for the use by other laboratories (? minus the ESR).
It is interesting to compare my scheme with the tests 
proposed by Wuhrmann and Wunderly (260) in their book devoted to 
the protein changes in disease - their choice for routine testing 
is - ESR, solubility curve of the plasma, Takata-Ara reaction, 
Cadmium opacity reaction, nephelogram (= modified Weltmann 
reaction), and electrophoretic analysis of the proteins. The 
Takata-Ara, cadmium opacity, and nephelogram are reactions which 
depend on abnormal proteins, qualitative or quantitative, and are 
thus akin to the gold flocculation test.
The plasma viscosity test in other rheumatic diseases will now 
be described, but in less detail than in the case of rheumatoid 
arthritis. Only the outstanding points will be stressed.
(B) Infective Arthritis.
This disease presents a clinical picture identical with that 
of rheumatoid arthritis except that there is a focus of infection 
which is held to he one of the causes of the locomotor lesions. 
Many clinicians, especially American, do not differentiate between 
this type and the classical rheumatoid arthritis, treating them 
as a single entity.
Results. See table III of the appendix for details.
In 44 tests on chronic female patients, the mean plasma 
viscosity was 2*053, with 81*8% abnormal results; 50% only of 
the ESR tests were abnormal and 41% of the gold flocculation tests.
In 21 tests on chronic male patients, the mean plasma 
viscosity was 2*065, with 85*7% abnormals; 70*6% of the ESR tests 
and 33% of the gold flocculation tests were abnormal.
In 10 tests on sub-acute female patients, the mean plasma 
viscosity was 2*479, with 100% abnormal; 87% of the ESR tests 
and 43% of the gold flocculation tests were abnormal.
Discussion. The similarity of the means of the plasma viscosities 
of the two sex groups of chronic infective arthritis should be 
noted: this is further support to the claim that the behaviour
of the plasma viscosity test can be regarded as from a single 
family of subjects composed of all ages and sexes.
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These results for the chronic cases of this disease are not 
significantly different on statistical analysis from the results 
of the chronic cases of rheumatoid arthritis: the majority falls 
within the limits (1*95-2*25) of the ’Zone of Chronicity*, as one 
would expect if the existence of such a zone was to he credited. 
The suhacute results are similar to the subacute results of 
rheumatoid arthritis, (see Fig. 80 h. )
The use of the gold flocculation test in the differential 
diagnosis of this disease and as an indication for a thorough 
search for a focus of infection have heen discussed in the 
previous section.
The superiority of the plasma viscosity test as compared to 
the ESR can he discovered in the percentage figures for the 
incidence of abnormal results.
(0.) Still’s Disease.
Synonym - juvenile rheumatoid arthritis.
The spleen and lymphatic glands should be enlarged to fit the 
classical description; the joint lesions are similar to those of 
an atrophic arthritis of the adult.
Results. These are given in Table IV of the appendix.
Discussion. In this series of tests on eleven patients it is 
noteworthy that no plasma viscosity value came within the normal 
range; the ESR. results include a few high-normal figures.
The severity of the general reaction in this disease is 
indicated by the degree by which the plasma viscosity had 
increased. The increase was greater than one would have expected 
from a consideration of the lesions in the locomotor system alone. 
An example of this discrepancy was the case of a young man who 
was crippled by long-standing deformity of his joints but who 
complained little of present pain in the joints; he had suffered 
from the disease for 9 years; his plasma viscosity value was 
no less than 3*100 cs. (An adult with a similar history would 
almost certainly have had a plasma viscosity value within the 
zone of chronicity, about 2*1 cs. )
The details of the case-history of L:B. are included in 
the appendix because they illustrate several points. Local 
treatment to the affected joints was able to produce an improvement
in them but it did not make a significant change in the plasma 
viscosity. There appears to be a considerable variation in the 
plasma viscosity values yet almost every one of these changes can 
be correlated with a change in the total clinical state. On two 
occasions, major joints were affected for the first time when she 
was under observation and the plasma viscosity increased at the 
time of the fresh involvement.
The dramatic response to Cortisone therapy is shown in the 
diagram which accompanies her case notes. A fall of 1*25 cs. 
occurred within 6 days. The relapse on stopping the treatment 
was just as dramatic in her laboratory tests but the improvement 
in her locomotor system persisted with but little diminution until 
treatment with a further supply was resumed after a few weeks.
I have ventured to criticise this particular dosage in that it 
was never sufficient to cause a return of the plasma viscosity to 
within the normal zone; I argued on the analogy of gold treatment 
to adult rheumatoid arthritis where a persisting abnormal plasma 
viscosity, even in the absence of symptoms, is synonymous with an 
ultimate relapse.
The return of the plasma protein fractions to a pattern 
approximately normal was also worthy of notice.
The high incidence of positive gold flocculation tests is 
similar to the findings in the adult type of this disease.
(D) Rheumatic Fever. (including Chorea and Erythema Nodosum) 
Rheumatic fever can he defined as an acute, specific disease, 
characterised by fever, arthritis and a special tendency to 
endocarditis or carditis. (Acute rheumatic fever will be 
considered first; chorea and erythema nodosum come later in 
subsections. J
Results. See table V in the appendix, and the case histories 
given there in some detail.
Discussion. The majority of these tests were carried out on 
hospital in-patients. The rheumatic condition might have been so 
severe that hospital nursing was necessary or it might have been 
of such long duration that intensive treatment in hospital was 
being tried as a means of cutting short its course. Thus these 
results are not representative of all types of the disease. 
Therein also lies the explanation why I have so few early cases 
so that the complete cycle of the disease is incomplete.
These results can also be discussed conveniently from the aspect 
of diagnosis, prognosis and treatment.
Diagnosis. The plasma viscosity occasionally fails to become 
abnormal in the early stages of the disease until a few days or 
a week or so after the obvious clinical onset; therefore the 
clinician must rely on his clinical acumen and he must not be put 
off his diagnosis of an active disease by a normal viscosity.
This is one of the few occasions in which I admit that the ESR 
test can yield more information; the ESR may become abnormal before 
the plasma viscosity (although the opposite most certainly occurs 
also) and an abnormal ESR supports the diagnosis of an acute 
disease.
If the disease runs its usual course of a few weeks, the 
plasma viscosity serial results can be plotted as a smooth curve, 
with an eventual return to normal values. The ESR appears to be 
more labile: although the mean of the serial results produces a
curve similar to that of the plasma viscosity yet the variation 
of the individual tests from this mean curve can be relatively 
large without any corresponding change detectable by the clinician. 
A departure from the plasma viscosity curve is significant either 
as an increase indicates a relapse or complication or a decrease 
indicates an effective response to therapy.
The refusal to admit of the occurrence of false positive 
results in the plasma viscosity test has two important 
applications in rheumatic fever.
Firstly, in the children who are off-colour, underweight, 
and complaining of "growing-pains”, an abnormal viscosity value 
leads to the diagnosis of an active lesion which must be treated 
accordingly with rest in bed, salicylates, etc. y even if the 
ESR is normal; similarly, an abnormal ESR must take precedence
over a normal viscosity. An abnormal gold flocculation test is 
further support to the diagnosis of an active process.
Secondly, the plasma viscosity is the best guide to the 
time at which the disease is sufficiently convalescent to permit 
the passage from complete rest towards active movements. The ESR 
test has long been used for this purpose. Some clinicians, such
as Reid et al. (206), regard this aspect of the ESR test so highly
that they are prepared to use it as the criterion of cure in their 
consideration of the mode of action of salicylates. One of the 
fluctuations in the ESR curve might take it into the normal range 
and then return to the abnormal again without there ever arising 
the question of a relapse from cure; such would be the general 
interpretation of such a sequence in the plasma viscosity test. As 
long as the patient has a raised plasma viscosity, then so long
mist the patient be kept at rest in bed.
Prognosis. The case which is progressing in a satisfactory manner 
has serial plasma viscosity results which show a corresponding 
decrease. A relapse or complication will be indicated by an 
increased viscosity. The individual case, B.R., is an excellent 
example of this correlation between clinical change and laboratory 
test result.
The 'Zone of Chronicity' is also found in rheumatic fever.
The mean value of the 13 tests in the table is 2*052 , which is 
very close to the means of infective and rheumatoid arthritis. 
These cases were more than an acute attack lasting several weeks: 
they were cases in which the arthritic signs and symptoms were 
often negligible and the general malaise being important. Some 
of these patients could even work in spite of the evening rise of 
temperature, tachycardia, etc. The finding of the characteristic 
viscosity level was the most significant single piece of inform­
ation in the examination of such patients. (see Fig. 80 b) 
Treatment. The plasma viscosity serves as a useful guide to the 
effectiveness of treatment. A satisfactory regime is associated 
with a decreasing viscosity which should reach the normal range of 
values; an unsuitable mode of treatment or an inadequate dosage 
of a suitable drug will be accompanied by a slower fall in the 
viscosity or even by an increase. Such an example is the case,
B.R., already cited.
The plasma viscosity results were not increased beyond the 
level the clinician might expect from the severity of the 
general upset in the patient. This point is important in that 
it is rather against the theory that the rheumatic fever is due 
to an allergic state with a hyper-sensitivity to a streptococcal 
infection; in an allergic reaction, one would have expected an
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unusually high viscosity value, such as we find occasionally in 
cases of erythema nodosum. Wilson and Lubschez (255) have found 
that the protein pattern changes by electrophoresis are the same 
as in other acute infections: they wrote -'‘No evidence was obtained 
in these studies that the immune responses of rheumatic subjects 
to infections presumably streptococcal in origin differed from 
that of non-rheumatic individuals".
The high incidence of positive gold flocculation tests is 
to be noted. The percentage of positive reactions, however, does 
not compare well with those of the Weltmann Serocoagulation 
Reaction test which, in the hands of Nelson and Seal (180), had 
a correlation with the clinical assessment of from 93 to 99 %
They showed that this correlation was better than that for the 
Cutler ESR. It will be of interest to compare the Weltmann test 
with the plasma viscosity test. Even if the Weltmann proves to be 
the superior in rheumatic fever it is very unlikely that it will 
be applicable with the same accuracy to all diseases producing a 
systemic reaction in the same way as the plasma viscosity test 
can be applied.
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CHOREA.
The plasma viscosity test was applied to a small series of cases 
of chorea; there were few opportunities for investigating this 
condition as these patients seldom required other biochemical 
tests.
Results. These are given in Table VI of the appendix.
The results can be divided into two groups - (i) where no 
other evidence of rheumatic activity was found, the plasma viscosity 
was within the normal range even when the involuntary movements 
were so severe that it required the assistance of two nurses to 
keep the patient1 s arm sufficiently steady for the blood sample to 
be taken, and (ii) where there was evidence of rheumatic activity 
by joint pains or carditis, the plasma viscosity was usually 
increased.
Discussion. A recent annotation in the British Medical Journal 
(Jan. ,6, 1951) on chorea quotes the study by Lewis-Jonsson on 704 
choreic patients in Scandinavia. 467 of these showed other 
evidence of rheumatic activity (polyarthritis, carditis, erythema 
annulare or nodules); 22 followed non-rheumatic disease such as 
encephalitis, hemiplegia, etc.; there remained 215 cases of 
cryptogene tic chorea which because of the similarity in age, sex,
and seasonal incidence to that of frank rheumatic chorea he has
( * = all these references have now been checked by author;
concluded to be monosymptomatic rheumatism. This is further
supported by the quoted work of Sutton and Dodge (239) who found
that in 91 cases of initially uncomplicated chorea while only
10% had heart disease after 3 years, no less than 40% had it
after 10 years. Kagan is also quoted as claiming (265) that from
the ESR he could detect which cases would eventually develop
rheumatism, because in their 165 patients a normal ESR during the 
*
first attack indicated that rheumatism was not the cause: this
conclusion is at variance with that of Lewis-Jonsson ( 145) who 
found a normal ESR in nearly half of 150 cases of rheumatic chorea. 
The experience of most clinicians is that if the ESR is raised in 
chorea then some other rheumatic sign, such as carditis, is 
usually present, but that in uncomplicated chorea, even if the 
patient later develops rheumatism, the ESR is usually normal. 
Evidently the factor in rheumatic infection which causes a raised 
ESR is not the same as that which gives rise to choreic symptoms.
My results would indicate that the last two sentences of 
the previous paragraph could be written with Mplasma viscosity0 
in place of °ESR". The uncomplicated cases, in which no other 
sign of rheumatic activity was detected, had normal plasma 
viscosity values. Not all the cases with carditis or other signs 
of activity showed a raised value but several of them did so.
The normal values associated with carditis, etc. cannot he taken 
as evidence of failure "by the plasma viscosity test; these choreic 
patients were all hospital in-patients where they had been sent 
because of the severity of their involuntary movements or because 
they had not responded to treatment at home. If the patient had 
been admitted after salicylate therapy, the ’activity1 in the 
joints might have been controlled although the symptoms of chorea 
persisted. Such a case was D.V. in whom the first plasma viscosity 
test was made early in the disease condition and in whom salicylate 
therapy had been begun prior to the testing.
The case of M. P. is particularly interesting. The persistent 
high plasma viscosity and ESR tests caused repeated searches for 
other signs of rheumatic activity but without success— Her 
symptoms cleared, she felt very well, and her physician allowed 
her to resume her normal mode of life. As she was menstruating 
twice per month there may be a gynaecological cause for these high 
values, but I am most interested in her future history as her 
present values are definitely abnormal and almost within the zone 
of chronicity.
The normal gold flocculation results in all but one patient 
are also remarkable. This incidence of abnormal values is much 
lower than is found in rheumatic fever itself or in erythema 
nodosum of rheumatic origin. This is additional support to the
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hypothesis that in chorea the rheumatic mechanism is not acting 
exactly as it does in rheumatic fever.
If a normal plasma viscosity value is found early in chorea, 
if there is no other sign of rheumatism in the heart, joints or 
skin, and if salicylates have not been administered, the clinician 
may treat his patient as a case of uncomplicated chorea; we do 
not yet know how this normal value is related to later evidence of 
carditis. If an abnormal plasma viscosity is found, the patient 
should be treated as a case of rheumatic fever until there is very 
strong evidence that this activity has ceased.
Further researches on the lines of the long-term studies of 
Lewis-Jonsson and of Sutton and Dodge may yield valuable 
information regarding the significance of the plasma viscosity 
results from a prognostic aspect. Similarly, further researches 
are required into the response of the gold flocculation test and 
other tests which depend upon abnormal protein fractions.
t
Erythema Nodosum.
This is a suitable point at which to discuss Erythema Nodosum 
as this syndrome of skin lesions and other symptoms hgp been 
claimed to be related to rheumatic fever. More recently a 
tuberculous primary cause has been favoured more.
Results. These are presented in Table VII of the appendix.
The plasma viscosity was increased when the disease began, 
and the return to normal values took weeks or months.
The gold flocculation test was abnormal where the primary 
stimulus was a sore throat.
Discussion. In an authoritative paper based on a study of 155 
patients, Favour and Sosman (77) concluded that erythema nodosum 
is a hypersensitivity disease; there is an individual predis­
position but a variety of infections and chemical agents and local 
trauma contribute to its occurrence. They found an associated 
respiratory infection in 80% of attacks, in half of which a beta 
haemolytic streptococcus was isolated from the throat. They were 
against the commonly-held idea of a tuberculous or rheumatic 
causation as, in their experience, tuberculosis was a rare 
antecedent infection and rheumatic heart disease was a rare sequela.
The increase in the plasma viscosity would be in agreement 
with the hypothesis of a hypersensitivity reaction in some
instances. The values for M. W* , A.E. , and M. C. were surprisingly 
high because there was no other sign of a severe general reaction 
and the patients did not feel severely ill. Moreover, the 
severity of the upset in the protein metabolism was shown by the 
plasma viscosity values persisting at abnormal levels long after 
the primary condition had cured and the patient had resumed the 
normal mode of living.
My series contains an unduly large proportion of cases of 
tuberculous origin but this arose from an inadvertent selection of 
cases; for a period I collected all the blood samples from the 
tuberculosis wards and if this condition was mentioned I added 
enough blood to allow me to estimate the plasma viscosity also.
The results of the gold flocculation test were particularly 
interesting. Their number is too few to permit of confident 
assertions but I consider that they suggest a possible correlation 
between the abnormal positive values and sore throat (probably 
streptococcal) and between normal negative values and other types 
of primary stimulus. An intensive study of the gold flocculation 
test in relation to the nature of the primary stimulus in erythema 
nodosum was planned in collaboration with Dr. Inman, specialist in 
skin diseases at Sunderland, but was one of the researches which I 
had to abandon when I left that town; there has been no later 
opportunity of resuming this investigation.
(E) Qsteo- arthritis.
Synonyms:— Osteoarthrosis; hypertrophic, or degenerative, or 
non-ankylosing arthritis.
Results. These are given in the TableVIII of the appendix.
They are also presented graphically in Fig. 84 , which includes 
a tracing of Gibson's results ( 87) for the same condition.
Of the 36 tests on 32 patients exactly half were still within 
the normal plasma viscosity range, and the abnormal values fell 
into the lowest part of the abnormal range.
Discussion. I will quote from Gibson's paper ( 87 ) - "My 
experience has always been that in true osteo-arthritis, as found 
for example in the hip or knee, the B. S.R. is typically in a zone 
just outside the normal range. This is illustrated in fig. 8, in 
which the distribution of results in 42 cases is compared with 40 
controls. The shift to the right is apparent.
The viscosity in the same series shows the same shift to the 
more abnormal groups. The highest number in the controls is in 
the 170-179 range while in osteo-arthritis it is from 180-189.
As in the case of R.A. the graphs again show the spread of B.S.R. 
results is further from the normal line than that of viscosity, 
indicating a rather greater sensitivity in the former. "
My ESR. results were not nearly as abnormal as Gibson's, 
as I found 5 abnormal tests in a total of 23; they do confirm that
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84 The Plasma Viscosity and Corrected Wintrobe ESR. 
tests in Osteo-arthritis.
The inset figure is a tracing of Gibson’s diagram 
of his results in this condition.
the abnormal ESR. values are in the zone just outside the normal 
range.
As the disease is of a degenerative rather than inflammatory 
nature I was rather surprised to find so many abnormal plasma 
viscosity valuesj a degeneration should not produce a systemic 
reaction. Cowan and I discussed this point on several occasions. 
He eventually correlated the viscosity values with the general 
condition rather than the local lesions and was thereby enabled to 
divide his osteo-arthritic patients intp two groups - (l) an 
elderly group, of spare build, with normal plasma viscosities, 
and (2) a middle-aged group, with obesity and/or high blood 
pressure, with abnormal plasma viscosities.
I followed up this lead. I estimated the plasma viscosity 
of obese patients who were otherwise apparently normal, eg. 
ante-natal patients, persons passed as satisfactory for emigration, 
etc. and of hypertensive patients, eg. ante-natal or essential 
hypertension patients who were referred to me for the estination 
of their renal function: included within these groups were several
of Lawrence’s (141) younger type of diabetes mellitus. The 
large majority of these results were also found to lie just above 
the normal zone, between approximately 1*935 and 2*065 cs. This 
is exactly the same range as contains the highest incidence of the 
osteo-arthritis results.
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X therefore have ascribed the increased plasma viscosity 
results not to a systemic reaction to the local joint lesion hut 
to a systemic reaction to general obesity or hypertension.
A clinician who encounters an osteo-arthritic patient with an 
increased plasma viscosity must realise that the general condition 
also requires treatment in addition to the damaged joint. The 
plasma viscosity test might be used to distinguish between the 
obese, who are in need of reducing, and those who, by heredity, 
tend to be robustly built.
G-ibson' s plasma viscosity results are similar to nty own.
In contrast to rheumatoid arthritis, the gold flocculation 
test in this disease is usually negative.
Kellgren and Moore (133) have recently distinguished a 
clinical entity within the osteo-arthritis group of patients, for 
which they have suggested the name of "primary generalized 
osteo-arthritis". It was found most frequently in middle-aged 
women. These authors stressed that it was a constitutional 
disorder. The ESE. was frequently slightly increased. It would 
appear, therefore, that the plasma viscosity was probably 
making the same separation but that we had lacked the clinical 
acumen to follow it to the full potential possible.
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(F) Fibrositis.
Fibrositis is a disease of doubtful aetiology, doubtful 
pathology, and even doubtful existence - some writers have denied 
that there is such a disease as fibrositis and have suggested that 
this diagnosis covers a failure to recognise its true nature. I 
have applied this diagnosis to the cases of painful and tender 
induration of the subcutaneous connective tissue (panniculitis,) 
and of the fibrous tissue of the muscles (myositis).
Results. The details of the 32 tests are given in Table IX of 
the appendix. They are also presented graphically in Fig. 85. 
which includes a tracing of Gibson's results.
Discussion. Although the local pain may be very severe and 
although large areas may be involved, there is no indication of 
a general upset in the body - there is no elevation of temperature, 
anaemia, loss of weight, etc. The absence of a systemic reaction 
explains why the majority of the plasma viscosity values have 
remained within the normal range. Until we have learned more 
about the pathology of the disease we cannot be certain why it 
does not cause a systemic reaction.
The gold flocculation tests were normal except for two 
instances.
Gibson confirms our findings in all respects.
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(G) Ankylosing Spondylitis.
Synonyms - spondylose rhizom^flique, spondylitis arikylopoetica.
This disease affects young adults, mainly males; it usually 
begins in the sacro-iliac joints, spreading soon to the joints 
of the spinal column and later centrifugally to the joints of 
the limbs. The pathology is that of infective or atrophic 
arthritis.
Results. The results of 26 patients are given in Table X of 
the appendix.
Discussion. In all but 5 of these 26 patients the plasma viscosity 
was increased; in 9 out of 22 ESR. tests, the result was still 
normal; in only 1 of the 5 plasma viscosity failures was the ESR 
raised, 4 normal ESR. tests were associated with abnormal plasma 
viscosities, and in 4 tests both were normal.
These results are in contrast with Gibson's (87) where in 
34 patients he had 3 normal plasma viscosity tests (all with high 
ESR. values) and only 1 normal ESR. However, all his cases were 
"clinically active", while I had to include some vei*y early tests 
on patients in whom the diagnosis became definite some time later. 
Gibson has written - "As in the R. A. group the conclusion seems to 
be warranted that the tests are estimates of different abnormalities 
which often but not invariably occur together. The B.S. R. is 
rather more sensitive but in order to secure the maximum of
information both should be applied. " My ESR. results do not 
support his contention regarding the greater sensitivity of that 
test, but this may be due partially to his better ESR. technique. 
Even allowing for that, I cannot see how his method could increase 
my results of 2 or 4 mm. /lst hour to abnormal levels.
The proof of the plasma viscosity superiority is being 
shown by the Portsmouth clinicians who apply the plasma viscosity 
test to all the patients with vague pains of the sacro-iliac 
region because they now believe that an abnormal viscosity is a 
strong indication of an active disease which may be later 
definitely diagnosed as ankylosing spondylitis; the ESR. has been 
discarded. (These results have not been included as in many of the 
recent tests the clinician is unable to state a diagnosis.)
The results also indicate how the disease activity has 
persisted for 7 or 8 years, with the typical "chronic" viscosity 
values.
One patient was treated with great benefit with A.C.T.H. 
and his case notes have been included.
The low incidence of abnormal gold flocculation tests 
(confirmed by Gibson) is in support of the hypothesis that the 
general character of this disease is different from that of 
rheumatoid arthritis, in spite of the similarity of the pathology 
of the local disease in the joints. (See also Mowbray (270))
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(H) G-out.
The series of cases includes an unusually large proportion of 
female patients; gout was found to "be much commoner in the 
female population around Sunderland than one would have expected 
from reading about the disease in medical text-books.
Results. The results from 16 patients appear in Table XI of the 
appendix.
Discussion. In the acute attack, the plasma viscosity is 
increased just as in any other type of acute inflammation of an 
important structure.
The diagnosis in many patients was made with difficulty from 
rheumatoid arthritis; the gold flocculation test was positive 
sufficiently often in the cases of gout as to be of little 
assistance.
One case in which the chronic activity persisted for 18 
months had several plasma viscosity tests during this period; the 
values came within and just above the usual zone of chronicity.
The ESR. test has produced a series of results here which 
coincides completely in the interpretation with that of the 
associated plasma viscosity tests.
§ 3. The plasma viscosity in tuberculosis.
As the plasma viscosity estimation is recommended^ for use 
in those clinical conditions in which the ESR has hitherto been 
the accredited test, it was natural that I studied the viscosity 
test in the different types of tuberculous disease.
(A) Pulmonary Tuberculosis.
Statistical analysis of my results for pulmonary tuberculosis 
has not been possible, as for the rheumatoid arthritis. My early 
Montrose results were derived from the patients of an asylum. No 
X-ray facilities were available. The patients usually swallowed 
their sputum and gastric lavage was not considered a possible 
procedure as it would have involved the use of restraint. Thus 
the clinical assessment, and even the diagnosis, would have been 
based on evidence too weak to warrant inclusion in a thesis which 
attempts to assess the correlation between the clinical condition 
and the plasma viscosity results. My later Portsmouth results 
came chiefly from a selected series of patients chosen specially 
because this correlation was expected to be low. The intermediate 
Sunderland results were satisfactory but too few in number. 
Methods. The plasma viscosity has been studied with sodium 
citrate solution and mixed oxalates as anticoagulants; the ESR 
was correspondingly measured as a maximum sedimentation velocity 
and as the Wintrobe 1-hour value, corrected by graph for variation
in haematocrit values. The plasma proteins were fractionated by 
the salting-out technique of Howe.
Material. No special choice of subject was made at Montrose or 
Sunderland. At Portsmouth a special study was made of the cases 
picked-up by the Mass X-ray unit, the cases on streptomycin 
therapy, and a series of 59 consecutive cases in whom there was 
a positive sputum accompanied by a low ESR value (ie. Westergren 
less than 10 mm./lst hour).
Results. These are given in detail in Table XII of the appendix.
These have been summarised into tables within the text and 
in the figures.
The cases were classified according to the Ministry of 
Health scheme (166) which can be briefly summarised as follows:- 
A - category: in whom tubercle bacilli have never been discovered,
B - category: in whom tubercle bacilli have been found at some time. 
Each category is subdivided as follows:-
Group 1. Slight or no constitutional disturbance; physical signs 
and radiological findings of very limited extent; no 
complications (tuberculous or other) of prognostic 
gravity.
Group 3. Profound systemic disturbance of constitutional
deterioration, and marked impairment of function, either 
local or general; all cases with grave tuberculous or 
non-tuberculous complications are placed in this group.
Group 2. All cases which cannot be placed in Group 1 or Group 3.
A patient once classified in category-B can never enter category-A;
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6 cases of
B3
terminal decay
B2
B1
Normal
1*71-6
Corrected Citrate Plasma Viscosity (cs.)
Fig. 85 (Taken from our paper - Houston et al. (120))
The distribution of the mean plasma viscosities in 
the groups of patients classified according to the 
Ministry of Health (166) scheme.
330 tests were made on 289 individuals.
37 normals, with mean. of 1*544 cs.
44 in group A, " tt it 1*644
43 ii it Bl, " it i 1*098
152 n it B2, " tt tt 1*746
46 n tt B3, " tt tt 1*817
6 n tt B3, " it tt 1*650 cs. , who were in
the state of terminal decay.
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a category-A may have to be changed to category-B should the 
sputum become positive at a later stage of the disease.
Dr. A. B. White, chest-physician to Portsmouth, was 
responsible for the clinical assessment of his cases. He was 
interested in the correlation of the physical signs, the X-ray 
appearances, the laboratory investigations, and the symptoms in 
order to determine which were the most reliable indications of 
“activity'* in this disease. He made his clinical assessment 
without the knowledge of my laboratory results, except in those 
cases where the discrepancy was so great that the patient had to 
be reinvestigated (eg. patient J.F. ) (178).
Discussion. The discussion can be made under four main headings.
(i) the correlation of the plasma viscosity with the clinical 
condition, (ii) the comparison of the plasma viscosity and the 
ESR tests, (iii) pleural effusion, and (iv) “terminal decay”.
(i) The correlation of the Plasma Viscosity and the Clinical 
Condition in Pulmonary Tuberculosis.
From the tables of results, graphs, and individual case reports 
the; following claims may be made.
(a) The presence of active tuberculosis was accompanied by an 
abnormal viscosity in 91/6 of the tests, although there were included 
convalescent patients in whom it might be argued that the disease
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was becoming quiescent.
(b) Where the clinical condition is assessed on a quantitative 
basis, there is a good correlation between the degree of clinical 
severity and the amount by which the mean viscosity is increased 
above normal levels.
I include the results from the Frodsham sanatorium which 
were included in our combined paper (120); the decision to place 
the lines at equal distances apart was purely arbitrary as there
is no criterion by which one can judge exactly how much B. 3 exceeds
B. 2 as compared to how B. 2 exceeds B. 1 . (Fig. 86)
(c) The scatter of the results about the mean in each group is so
great that there is an overlapping of adjacent groups. The plasma 
viscosity test cannot therefore be used as an absolute guide to 
the clinical assessment.
(d) The plasma viscosity reflects the general reaction to the 
disease. As the reaction called forth is increased on account of 
greater clinical severity because of the involvement of more 
tissue, by the spread to other lobes, or by complications the 
plasma viscosity increases j as there is clinical improvement as a 
response to therapy the plasma viscosity decreases until, in a 
satisfactory case, the value may again fall within the normal 
range.
(e) In serial tests on individual patients, the plotted results
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lie on fairly smooth curves* These curves are parallel to the 
general trend of the clinical condition.
A worsening or complication is reflected in the laboratory 
results as a definite peak occurring in the course of the curve; 
the time interval between the stimulus, such as the induction of 
a pneumoperitoneum, and the appearance of the peak is short; this 
indicates that the plasma viscosity estimation is a sensitive 
index of the concurrent clinical state.
Examples of these curves are given with the case histories, 
in the appendix.
As in other diseases, the plasma viscosity changes in 
pulmonary tuberculosis reflect the changes in the plasma protein 
fractions. My salting-out technique shows that the initial change 
is an increase in fibrinogen, followed by an increase in globulin; 
the albumin decreases and in very severe cases may reach 3g./100ral. 
or less. With improvement, these changes are reversed, the albumin 
being the last to regain the normal range. These results have 
been confirmed by the papers of other workers ( 67, 73,126, 164). 
Seibert et al. (225 ,226 ,227), with electrophoretic studies, show, 
that in the early stage of human pulmonary tuberculosis the first 
serum globulin to change is the gamma fraction - ”it is reasonable 
to suspect that the rise in this component in the early stage of
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the disease process may represent an antibody reaction of the 
organism'1. As the disease progresses, the next change is in the 
a2 globulin. Finally there is an increase in all the globulins, 
especially the a,2 fraction: the increase in globulin is
balanced by a fall in albumin so that the total protein does not 
rise. This last claim regarding the normal levels of the total 
protein has been confirmed in my tests where the measurement was 
made by a specific gravity technique.
The estimation of the protein fractions is used as a test of 
liver function. There is additional evidence of altered function 
in tuberculosis in the bromsulphalein results of Hurst et al. (124j 
and Kruger and G-erber (136), and in the prothrombin index results 
of Savacol and Chodoff (221) who write -"in fact, the plasma 
prothrombin level appears to be a fairly sensitive index of the 
activity of pulmonary tuberculosis*'. Hurst could find no 
significant histological alterations in the liver to account for 
the modified function, except in those cases complicated by 
amyloid disease.
It should be noted how infrequently a positive gold floccul­
ation test is encountered among my results, even in the presence 
of a high plasma viscosity - this may be explained by the smaller 
changes in the gamma—globulin as compared to rheumatoid arthritis 
and similar diseases.
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(ii) A comparison of the Plasma Viscosity and ESR tests in 
Pulmonary Tuberculosis.
There is still no agreement on the relationship of the plasma 
viscosity to the ESR in pulmonary tuberculosis except that the 
plasma viscosity is the more informative test.
When I had found a normal ESR associated with a very high 
plasma viscosity in E. B. , one of my earliest Portsmouth tuberculous 
patients, Dr White and I decided that a suitable comparison of 
the tests could me made in just those cases where the ESR was so 
obviously at fault. We collected a consecutive series of 59 
patients in whom the clinical " activity'1 was guaranteed by the 
detection of tubercle bacilli in the sputum within a month of the 
laboratory tests and in whom the preliminary Westergren ESR was 
10 mm. or less. The state of the patients varied widely from 
sanatorium patients on full bed rest to convalescent patients who 
were doing a complete day's work and attending the out-patient 
department or chest clinic. Dr. White used this series also to 
determine the relative value of the different criteria of 
"activity" available to himself - eg. X-ray, physical examination, 
weight loss, temperature fluctuation, etc. - and it is hoped that 
we will publish our combined results.
Method. I collected the blood from all of these patients. From
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a single sample a Wintrobe ESR was measured and the viscosity of 
the plasma. The usual correction in the ESR.for haematocrit 
variation was made because in several instances the ESR was low 
as a result of excess of erythrocytes.
Results. These are given in detail in Table XII of the appendix. 
They can be summarised in the following table
WINTROBE
ESR.
Normal Abnormal
PLASMA Normal 9 4 13 22 *0%
VISCOSITY Abnormal 35 11 46 78*0%
44 15 total
74 *6% 25 *4%
In addition to this special series, the reader should consider 
the total tuberculosis results as presented in Pig. 87 , 88 , 89 ,
and some of the case histories.
Discussion. By statistical analysis (110) the results in the 
table of this page are significantly different. The duplicate 
tests have yielded information in 4 instances only (all males)more 
than obtainable by the plasma viscosity alone. These results 
support my contention that the plasma viscosity is the more
354
reliable test. They also emphasise, however, that the plasma 
viscosity test itself is not infallible, as some of the cases 
with normal values had advanced to definite cavitation.
The three figures were constructed from every test made in 
Portsmouth on tuberculous subjects; they therefore contain the 
tests made several years after the acute episode when the possibil­
ity of a relapse was under consideration and they include the tests 
performed well into the convalescent stages of the disease: thus, 
a value within the "normal'* range is not always equivalent to a 
failure to diagnose an active lesion. The plasma viscosity may 
show "normal" values occasionally in the presence of disease but 
it never shows abnormal values in the absence of disease; hence 
every result in the lower right segment of the figures is 
equivalent to a failure of the ESR test: comp are these large
numbers with the fev/ instances indeed where the opposite has 
occurred, in the upper left segment. These diagrams also show 
how the ESR test suffers by having an upper maximum limit as 
compared to the virtual limitless scale of the viscosity.
The reliability of the ESR test in pulmonary tuberculosis 
has varied tremendously from worker to worker. I cannot refer to 
every paper on this subject and will confine myself to a few 
representative examples. Wintrobe (256) reviewed the ESR test
reliable test. They also emphasise, however, that the plasma 
viscosity test itself is not infallible, as some of the cases 
with normal values had advanced to definite cavitation.
The three figures were constructed from every test made in 
Portsmouth on tuberculous subjects; they therefore contain the 
tests made several years after the acute episode when the possibil­
ity of a relapse was under consideration and they include the tests 
performed well into the convalescent stages of the disease: thus, 
a value within the "normal'* range is not always equivalent to a 
failure to diagnose an active lesion. The plasma viscosity may 
show "normal" values occasionally in the presence of disease but 
it never shows abnormal values in the absence of disease; hence 
every result in the lower right segment of the figures is 
equivalent to a failure of the ESR test: compare these large
numbers with the few instances indeed where the opposite has 
occurred, in the upper left segment. These diagrams also show 
how the ESR test suffers by having an upper maximum limit as 
compared to the virtual limitless scale of the viscosity.
The reliability of the ESR test in pulmonary tuberculosis 
has varied tremendously from worker to worker. X cannot refer to 
every paper on this subject and will confine myself to a few 
representative examples. Wintrobe (256) reviewed the ESR test
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and quotes Banyai ana Anderson as finding only 7-55^ normal 
ESR values in tuberculosis (2,000 patients), Cutler as having 5 
normal tests in 5,000 patients, and Friedman and ZaisioslgF as 
finding not a single discrepancy (11,56,131,8:p,} These reports are 
difficult to correlate with the report of Noefcrea (IS3) who fauna 
that slightly more than one third of his patients (U.S. -naval 
personnel) never had an abnormal ESE throughout the whole course 
of the disease. Sinton found the agreement between the ESE value 
and the clinical assessment held good in 54t% of his tests oslyl 2~I>, 
McIntosh and Keay (132,173) are particularly critical, of the ESE, 
concluding with the sentences - "Since in. the female subject the 
test carries an error of anything from 12 to 50^ its employment 
is, for practical purposes, valueless. No other test having, as 
error of this magnitude would be tolerated in practice. Those 
seeking guidance on the E. S. E. should follow the advice of Milliard 
(1942), who "abandoned the use of blood sedimentation tests long 
ago.” **. They also include an informative table concerning the 
number of abnormal ESE tests which were obtained by other iroraers 
in the cases picked up in Mass X-ray units and classified as 
"active" tuberculosis — this table is given at the top of ’<jo&  
next page.
( *= these references have now been checked by the writer.
No. of subjects No. of
examined with abnormal
active tuberculosis E. S. R. s
Stiehm (1933) (238) 69 33
Braeuning (1938) (32) 75 33
Clive (1943) (43) 102 84
Kahan and Close (1944) (130) 138 27
Robinson (1944) (209) 45 35
Abeles and Pinner (1944) ( 1) 91 54
The literature concerning the plasma viscosity in tuberculosis 
is short, only two independent papers having to be considered.
T'ang and Wang (24-0) have the credit of first suggesting the use 
of the estimation of the plasma viscosity as a test in clinical 
pathology, although there had been previous reports of changes in 
the plasma viscosity in disease. Their paper appeared in 1940 
but it did not come to the attention of British readers until 1946 
by which time Whittington and myself had got our independent work 
published. They studied blood preserved with a 1 in 10 dilution 
with 3*8% sodium citrate solution, so that their results are not 
directly comparable with any of mine.: this difference is shown in
their 'normal' range of 1*500-1*714, with a mean of 1*627. They 
also used a tenperature of 25°C. Their results for 176 cases of 
pulmonary tuberculosis are given in the table on the next page. 
Discussing the relative sensitivity of the plasma viscosity and 
the ESR as indications of the activity of tuberculosis they wrote -
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Clinical
Assessment
Average
Viscosity
Average 
E. S. R.
50 normal subjects 1*627 4*9
52 arrested tuberculosis 1*623 4*7
69 moderately active 1*744 13*5
55 active 1*920 20*6
"Although our data are not sufficient to allow us to draw a 
definite conclusion with regard to the relative sensitivity of 
viscosity and sedimentation test in tuberculosis, from Table 3 it 
can be seen that there are more cases of active tuberculosis 
(pulmonary and otherwise) with increased viscosity than with 
increased sedimentation rate, and this is particularly true in 
cases of pulmonary tuberculosis of mild activity and tuberculous 
meningitis. The authors are, therefore, inclined to think that 
plasma viscosity determination is perhaps a more sensitive test 
for activity of tuberculosis than the sedimentation rate". "In 
general, the viscosity of the plasma is parallel with the activity 
of the disease". They also found that generally there was a 
parallelism between the plasma viscosity and the ESR.
Benson (16) has studied the two tests in 294 adults who 
suffered from pulmonary tuberculosis: there were 92fi abnormal
viscosity results as compared to the 73/o abnormal ESR results. 
"Patients ill with pulmonary tuberculosis generally showed plasma 
viscosity values which were proportional to the degree of clinical
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evidence of activity. As the tuberculous process regressed or 
attained stability the plasma viscosity values approached normal 
limits (Table VI). On the other hand, as the disease progressed 
and became worse the viscosity values remained within abnormal 
limits (Table VII).1 "But whereas the plasma viscosity values 
appear almost constantly high in a disease such as tuberculosis, 
the total plasma proteins are very frequently found within the 
normal range of 6 to 8 g. per cent." "It is concluded that plasma 
viscosity offers valuable evidence in clinical medicine as a 
screening method for the determination of organic disease which 
may cause physiochemical plasma alterations."
( Lawrence (13S) has studied the fractional plasma viscosity 
changes in tuberculosis. Bircher (24) measured the serum viscosity 
and concluded - "In tuberculosis the refractoviscosimetric 
quotient of the serum has a definite relation to the stage of the 
disease". )
My colleague Houston, as a result of his comparison of the 
tests performed in parallel, has concluded that the ESR test was 
not worth estimating when the plasma viscosity was available; he 
has now gone further and discarded the ESR test completely even 
when the plasma viscosity is not available, as he believes, like 
McIntosh and Keay, that the test should be abandoned as unreliable. 
However he is in the position of having to deal only with
359
patients of* a sanatorium in whom the tuberculosis has been 
diagnosed. In December 1951, Benson informed me that he also had 
discarded the ESR test completely following his experience with 
the plasma viscosity test. ( 17).
Prom my own results and from a consideration of the work 
published by others I take up a position almost, but not quite so 
extreme, like Houston. I retain the ESR for one purpose only - 
to assist in the diagnosis of doubtful activity. There have been 
instances when the ESR could yield information not available by 
the plasma viscosity alone on that problem: the only significant 
finding is an abnormally high ESR. I consider that the clinician 
can obtain the information supposedly supplied by the ESR in the 
course of the disease by other more reliable methods.
(iii) Pleural Effusion : the "Zone of Effusion".
The “Zone of Chronicity" was described in the section on 
rheumatic disease as a restricted range into which falls the 
majority of the results from all types of chronic disease. 
Similarly we have found that in those cases in which there is 
evidence (X-ray, physical examination, etc.) that the pleural 
effusion is being formed at the very time of testing, the plasma 
citrate viscosity comes within Eos. 6 to 8 of the citrate~plasma 
subdivisions, and to this range we have applied the term - "Zone
of Effusion".
The combined results of Frodsham, Montrose, and Sunderland 
are presented in Fig. 90 , which is reproduced from our 
combined paper (120).
The Zone of Effusion applies only when effusions are 
actually forming, as a static effusion can be associated with 
almost any plasma viscosity value. We also noted that on tapping 
an effusion while the patient's plasma viscosity was in this zone, 
the fluid rapidly reformed. As a corollary, we found that the 
reabsorption of pleural effusions occurred when the viscosity was 
above or below this zone.
Three individual cases deserve special mention.
Dr. Houston induced an artificial pneumothorax on a patient 
while his viscosity was within this zone, and a large effusion 
rapidly formed.
As the zone of effusion is fairly low in the total viscosity 
range, it follows that nearly all cases with pulmonary tuberculosis 
will have a value within this critical range at some time or other 
yet only a minority have pleural effusions. Dr. Houston had a 
patient who produced an effusion as she rose into this zone and 
reabsorbed it when her plasma viscosity was higher: on the later
downward passage as her condition inproved she had a recurrence 
of the effusion, which was reabsorbed when her viscosity again
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Fig. 90 Taken from our paper (120).
When there was definite evidence that the pleural 
effusion was actually forming at the time of the 
test, most of the plasm viscosity values came 
within zones 6-8. (="Zone of effusion”)
rose: on her next downward movement of her viscosity the effusion 
was again formed and it was again reabsorbed with increase in her 
viscosity: on her next attempt the plasma viscosity returned to
the normal range without complications.
At Sunderland, I was lucky enough to see a child while 
forming a pericardial effusion (tuberculous) and the plasma 
viscosity fell within the zone of effusion.
I often discussed this phenomenon with Whittington but we 
could reach no conclusions which we could subject to experimental 
study, at that time. One hypothesis is that the formation of a 
pleural (or pericardial) effusion requires the simultaneous 
presence of two factors - (1) a pleural endothelial lining in a 
critical state ready to excrete or secrete the fluid,and (2) a 
condition in the hydrodynamics of the plasma. If the second 
factor is a critical osmotic pressure, as it well might be, it is 
ultimately a question of the condition of the plasma proteins 
which would explain why the plasma viscosity also becomes 
involved. The osmotic pressure of plasma and pleural fluids have 
been studied already without the detection of any characteristic 
values, but this I ascribe to a failure to make a clear distinction 
between static and forming effusionsj also, the osmometers used 
in earlier works have all been of the classical static type 
pyhj <?h take days to come to an equilibrium, as contrasted to more
recent “dynamic’' types where equilibrium is reached in 20-50 
minutes. In a reference which I cannot now trace, I read that by 
the dynamic instruments it was possible to detect differences in 
the osmotic pressure in diseases of liver and kidney which were 
not detectible by static instruments. Therefore, I have now 
obtained a Simms Osmometer (229 ) to study this problem but have 
had no suitable cases to date. In this connection, I have been 
informed very indirectly that Dr. A. McFadzean found that,in 
Egypt during the recent war, the formation of a pleural effusion 
was associated with a specific gravity (and hence with a plasma 
total protein) of a characteristic narrow range of values. It 
should be noted that he also was measuring the physical value of 
the plasma at the time of fluid formation. I understand that he 
has not published this finding.
Reference to this zone is made later in the discussion on 
the use of the plasma viscosity in prognosis and treatment.
(iv) "Terminal Decay”
I have referred to the condition for which we have made this 
title on earlier occasions but this appears to be the most 
appropriate part of the thesis in which to discuss it fully. We 
apply the title - “terminal decay" - to the interval between the
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■time when the disease gains the upper-hand over its host and the 
time of death. The human body marshalls its defence mechanisms 
to combat an infection by the tubercle bacilli or other organisms 
and the protein changes in the plasma are an indication of the 
extent of the body’s reaction. Somewhere between the initial 
infection and the fatal termination there must be a point at which 
the resistance is overcome and the invading power gains mastery. 
This point of transition will vary from patient to patient, 
depending partly on the virulence of the organism (=the seed) but 
more on the individual's constitutional capacity of resistance 
(=the soil). The previous sections have shown that the plasma 
viscosity is a fair measure of the general reaction of the body; 
terminal decay can set in when the plasma viscosity is moderately 
or very high, thus indicating numerically how the powers of 
resistance can vary. However, as high viscosities are associated 
with severe disease conditions which naturally have a poorer 
prognosis, the terminal decay was found most frequently subsequent
to such high values.
The behaviour of the plasma protein fractions, plasma 
viscosity, and ESR. during terminal decay is quite characteristic. 
The plasma proteins decrease in amount: the decrease affects the
albumin firstly and later the globulin and fibrinogen and these 
changes are detectible in the total and fraction values, in the
albumin/globulin ratio, and in the plasma protein equilibrium 
factor. The plasma viscosity also falls, the values plotted 
against time intervals forming a smooth curve which eventually 
reaches the normal range of values about the time of death. Thus 
the apparently 'normal' plasma viscosity results occasionally 
seen in very ill patients are associated with markedly abnormal 
protein patterns. The relationship of the plasma proteins to the 
ESR is different from that to the plasma viscosity, and while the 
ESR may also decrease, the return to normal ranges is seen more 
rarely; at the onset of terminal decay the ESR may even continue 
to increase for a short period. Because of the changes in the 
ESR and the plasma viscosity, the point for the duplicate estimation 
will no longer fall on the periodic curve described in §21 of 
part 6, or will do so only by chance.
Some graphs are included here from representative cases 
(not all tuberculous) which show how the plasma viscosity falls as 
death approaches. The phenomenon is found in acute as well as 
chronic diseases. (Pig. 91, 92, and 95)
In a disease of such long duration as pulmonary tuberculosis, 
it may happen that the decrease in the plasma protein, as indicated 
by the decrease in the plasma viscosity, occurs without any other 
change in the clinical picture. It may even be difficult to tell 
whether this decrease reflects the first sign of decay or an
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Fig. 91 ’•Terminal Decay" in a case of pulmonary tuberculosis.
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Pig. 93 These graphs show how the Plasma Viscosity falls 
as death approaches.
It is therefore possible to find a normal or 
low abnormal viscosity value in association with 
severe diseases in their terminal phase.
X ------- ------- X  = pulmonary tuberculosis.
D--- ------- 0  = pulmonary tuberculosis, plus pyaemic abscesses.
©----------o  = intestinal obstruction
+ ------- — + = cancer of ovary, plus septic knee.
improvement, and to settle this point recourse may be made to the 
plasma protein fractionation or to the correlation of the plasma 
viscosity with a maximum sedimentation velocity and its relation 
to the periodic curve.
The duration of terminal decay may be as long as 6 months. 
Once terminal decay was established I was never able to interrupt 
its course by any therapy available in 1943-1948. Similarly, even 
with the better facilities of his sanatorium, Dr. Houston failed 
to halt even one case. I have had no opportunity to study the 
response of patients in terminal decay to the latest treatment of 
tuberculosis with streptomycin and para-aminosalicylie acid.
The low viscosity and protein results as a terminal 
phenomenon has been noted by other workers. Bircher (24) reports 
normal serum viscosity values in his severest disease group;
Benson (17) writes -HThe patients ill with pulmonary tuberculosis 
who died during the period of observation had high plasma viscosity 
values which occasionally approached normal levels a few days to 
three months before death”- but he already knew of this special 
finding from reading our publications; Herwig found that a low 
albumin had a very bad prognosis (108); and Ham and Curtis ( 92 ) 
noted a low fibrinogen in the terminal stages of tuberculosis.
Discussion (cont inued)
It is my confident belief and claim that the plasma viscosity 
test can yield very valuable assistance to the clinician in his 
study of the individual patients. It helps him in reaching the 
correct diagnosis, prognosis and treatment.
Diagnosis - The detection of an abnormal plasma viscosity can 
be interpreted as an indication of a systemic reaction in the 
patient, but it cannot indicate the exact nature of the primary 
stimulus. However, if other causes of increased viscosity values 
can be excluded, the detection of a raised plasma viscosity in a 
patient in whom tuberculosis is suspected is very strong evidence 
of the presence of a lesion which is ''active11. Two examples can 
be given of the sensitivity of the test from this aspect. A 
female technician in our laboratory had been under the supervision 
of the chest clinic for many years as her father had been in a 
sanatorium. She volunteered to act as a normal control for my 
plasma viscosity series on 31st May when her result was 2*012, and 
it was.only then that I obtained her family history. In view of 
this finding 1 asked that the chest clinic should re-examine her, 
which was done with nothing abnormal detected. She continued at 
work, was examined at 3 month intervals, but following her test 
in January when a satisfactory report was again issued she asked 
that her viscosity be examined again. Her viscosity was now 2*103.
I now insisted on a further specialist opinion and an active 
lesion was verified by more intensive investigations and by her 
sputum becoming positive. The clinician then agreed that this 
lesion was probably present and active at the first testing, some 
eight months previously. The author detected his own plasma 
viscosity had become abnormal in April yet the clinicians and 
radiologists had great difficulty in detecting the small focus of 
infection by August, but in this instance the treatment begun so 
early led to a speedy and satisfactory outcome.
Dr. White found the test very reliable in diagnosing the 
activity of patients after courses of treatment, of patients in 
whom a possible relapse was suspected, and of pick-ups by the 
Mass X-ray unit.
A plasma viscosity within the normal range is no guarantee 
that active tuberculosis is not present, but the error is likely 
to be small as the incidence of normal values in my total series 
was only 9%. This compares well with Benson's 8% .
Prognosis - I have found that the higher is the plasma viscosity 
so is the prognosis worse. This is to be expected from the 
correlation between the clinical assessment by the Ministry of 
Health scheme and the mean plasma viscosity results: a high 
viscosity usually corresponds to more extensive disease.
I reproduce a table from our first publications (119) in ■which 
the incidence of a fatal outcome was shown for the higher citrate 
plasma viscosity zones: these results were derived by me from a
wide variety of diseases, and not from tuberculosis alone.
Viscosity
Zone
No. of 
cases.
Deaths ,
No. $
6 25 5 20
7 19 7 37
8 9 4 44
9 17 11 65
10 5 3 60
11 4 4 j 100
At that time I had a plasma viscosity level above which every 
result was associated with early death; further experience has 
shown, however, that recovery is possible with even extremely high 
viscosity values.
A low plasma viscosity is no guarantee of a satisfactory 
clinical course; we can only presume that the chance of this 
occurring is greater.
A very grave prognosis must follow the detection of 
terminal decay, with its consistently fatal ending.
There may arise occasionally a social problem in which the 
guidance to the time of death by the falling plasma viscosity/time 
chart may prove useful.
Serial tests will indicate the general trend of the disease, 
the viscosity falling with improvement and rising with worsening.
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An unexpected peak in the curve of serial tests may "be the first 
indication of a complication.
A satisfactory response to therapy is shown "by a return of 
the plasma viscosity to the normal range and its maintenance there.
Treatment - The treatment of pleural effusions can "be assisted 
"by the knowledge of the patient’s plasma viscosity relative to 
the ’zone of effusion". We have found that the removal of fluid 
while in this zone leads to it reforming; whenever possible, 
tapping should be delayed until the plasma viscosity has moved 
upwards or downwards.
After his mishap, Dr. Houston now hesitates to induce an 
artificial pneumothorax when the plasma viscosity is in this zone.
A programme of treatment which leads to a decrease in the 
plasma viscosity can be accepted as satisfactory; if the viscosity 
is increasing, the therapy needs to be reconsidered.
If the plasma viscosity remains high after such collapsing 
procedures as artificial pneumothorax, pneumoperitoneum, or 
phrenic crush, it may be interpreted as a sign of continued toxin 
absorption and of the need for more drastic treatment to produce 
complete rest in the affected part of the lungs.
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A (ii) Bpituberculosis : primary tuberculous complex.
Vfhen a primary tuberculous complex is being formed 
there is a general upset in the body -which is shown by the 
elevation of temperature and tachycardia, and in the malaise.
The severity of this reaction is indicated by the elevation of 
the plasma viscosity.
Nine out of the fourteen patients examined and whose 
results are presented in Table XII, page; al85, showed such an 
increase in the plasma viscosity: the serial tests had a decrease 
in the viscosity in response to treatment. The five normal 
viscosity values must not be regarded as failures of the test as 
some of these patients were not examined until just before 
discharge from hospital when the clinician wished the test to be 
carried out as a confirmation that the general reaction had 
ceased.
■(B) Non-pulmonary Tuberculosis.
This section is concerned with tuberculosis of the bones 
and joints, meninges, and skin and soft tissues, and with miliary 
tuberculosis. The results might have been divided into pre- and 
post-streptomycin groups as this drug has changed the outlook so 
greatly.
Generally, as with the tuberculosis of the lungs, this 
infection of the other tissues produces a systemic reaction, 
with its complementary increase in the plasma viscosity.
(i) Bones and Joints.
The incidence of abnormal values is shown in Table XIII of 
the appendix.
My orthopaedic-surgeon colleagues now acknowledge two 
problems in which they are glad to acknowledge the assistance 
which they are obtaining from the plasma viscosity test.
In an early stage of an infection of a bone (eg. spine) 
or a joint (eg. ankle) a marked increase in the plasma viscosity 
could be observed when the signs and symptoms were otherwise 
meagre and the diagnosis uncertain. Nevertheless, it is accepted 
that there were occasions when the surgeon detected a disease 
which was active by other criteria and yet associated with a 
normal plasma viscosity; but such events were rare and certainly
less frequent than with the ESR test.
They also find the viscosity test a valuable guide to 
prognosis and treatment. Rest to the affected part could be 
acheived by a plaster cast, etc. with the result that the local 
symptoms and the signs of general toxaemia disappeared. The 
surgeons now accept that a persisting abnormal plasma viscosity 
is a guarantee of a general reaction to a persisting local 
activity which requires appropriate treatment. In view of the 
known false-negatives, a normal viscosity cannot guarantee the 
absence of activity but only makes the probability of a quiescent 
state so much more likely. A fall to the normal range of an 
originally increased plasma viscosity is an indication that the 
treatment is causing a lessened toxin absorption.
T ’ang and Wang had five cases in their series with 
tuberculous meningitis. Each case had a normal ESR but an 
abnormal plasma viscosity; it was partly because of these results 
that they concluded that the plasma viscosity test might be a more 
sensitive index than the ESR. Since their paper in 194-0, the 
introduction of streptomycin has altered the outlook for these 
patients completely. Refinements have been made in the methods
of diagnosis so that it is reached at an earlier stage and active 
treatment begun without delay. Hence there are fewer chances of 
studying the untreated advanced cases such as those available to 
the Chinese workers. ,
My results are presented in Table Xlllof the appendix, and 
in the individual case notes. Several normal plasma viscosity 
values are included. In contrast to T'ang, I did find some high 
ESR values but their incidence was less than that of abnormal 
plasma viscosity values.
The diagnosis of a tuberculous meningitis will depend upon 
the examination of the cerebro-spinal fluid; the plasma viscosity 
increase is an interesting phenomenon which has no practical use 
to the clinician.
The viscosity test becomes of real significance after the 
streptomycin treatment has been given. The C. S.F., in a case 
which will eventually clear completely, does not return to a 
composition which is within the normal range for protein, cells, 
chloride, and sugar, for a period measured in weeks or months.
The criterion of improvement is that the progress towards the 
normal range is not interrupted, which requires frequent serial 
lumbar punctures. Now, if in such a convalescent patient a high 
plasma viscosity result is found, two explanations are possible - 
(a) there is an active tuberculous lesion somewhere else in the
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body (probably the site from which the infection spread to the 
meninges originally), or (3) the tuberculous infection of the 
meninges is causing a systemic reaction although it is producing 
no localising signs or symptoms; a relapse is therefore inevitable. 
(This reasoning has assumed that the plasma viscosity increase has 
not been the result of some non-tuberculous stimulus). If the 
plasma viscosity has ever attained the normal range and later 
becomes raised, the certainty of a relapse is still greater. The 
notes of a relapsing meningitis have been included.; the viscosity 
was increasing and a relapse had been forecast to the clinician 
before her C.S.F. culture again showed tubercle bacilli. (Her 
results are not in the table as they became available after its 
completion.)
The clinicians are going to follow up their other cases now 
and it may be possible to devise a scheme of examination where the 
use of the plasma viscosity test will obviate the need for so 
frequent lumbar punctures.
(iii) Skin, soft tissues, organs, etc.
The plasma viscosity was found to be abnormally high 
in the majority of patients with active tuberculosis affecting 
the skin, lymph glands, kidneys, etc. (see table XIII)
The weakness of the plasma viscosity test, on account of its 
non-specific character, was particularly noticeable in this group 
of diseases. While the raised viscosity value was an indication 
of a systemic reaction to an organic change, it remained for the 
clinician to decide the nature of the primary stimulus. For 
example, I have included two case-notes concerning two girls 
with identical plasma viscosity results: one had enlarged 
cervical lymph glands because of a tuberculous infection there, 
and the other had cervical lymph glands enlarged because of a 
chronic inflammation of the tonsils.
The value of the test to the clinician lies in its detection 
of an organic cause of the signs and symptoms, and in the return 
to normal with satisfactory treatment.
(iv) Miliary Tuberculosis.
The plasma viscosity was elevated in most of these 
cases until the disease was brought under control by streptomycin. 
The viscosity was raised because of the systemic reaction both to 
the miliary foci and to the primary focus from which the spread 
had taken place, (see Table XIIl)
This is a point at which it is appropriate to report on
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the change in the gold flocculation test following streptomycin 
therapy. A positive gold flocculation response is not a 
frequent finding in any type of tuberculosis, but it was seen on 
many occasions when streptomycin was administered to patients 
with different types of tuberculosis. As para-aminosalyeilic 
acid was exhibited in association with the streptomycin as a 
standard procedure and as this P. A. S. had caused liver dysfunction 
in a few instances, it was thought at first that the PAS. was 
responsible for the gold flocculation response. However, in the 
rare occasions in which the streptomycin was given alone, the 
positive gold flocculation results were encountered. I have had 
no opportunity of studying the effect of PAS. alone. There is 
no means of telling whether the altered plasma protein which is 
ultimately responsible for the gold, flocculation test has been 
produced as a result of liver dysfunction or as a direct action 
by the liver now capable of more efficient protein formation.
This is a further example of the need to distinguish between a 
change in a laboratory test due to a variation in the disease 
process and a change due to the treatment of that disease (cf. 
the section in part 7 concerning the effect of sulphonamides).
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§ 4  VENEREAL DISEASE.
Although the number of tests made in this group of diseases 
is small the significance of the findings is high. The paucity 
of tests arose from two causes. Very soon after our paper had 
"been published in the British Medical Journal I had some 
correspondence with Dr. IC.E. Hughes of the Venereal Diseases 
Department of St. Mary’s Hospital, London concerning the possible 
use of the plasma viscosity test in the investigation of these
diseases; it was my impression that he intended to employ the
test thoroughly and I left this field of research to him. In 1950, 
however, I learned that he had made no tests whatsoever. Also, • 
my Sunderland colleague who specialised in these diseases planned 
a study on certain aspects of tertiary syphilis but accepted 
another post soon after; Portsmouth did not have a civilian
specialist in V.D. until autumn 1951 .
(A) Syphilis.
I have no results available for the primary and secondary 
stages.
A little over thirty patients were studied in the tertiary 
stage.
General Paralysis of the Insane (G-. P. I. )
The results are given in Table XIV of the appendix and presented
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graphically in Pig. 94.
The tests were made on all the known cases of G-. P. I. in 
Montrose Asylum in 1943-44 and in St. James1 Hospital, Portsmouth 
in 1951. Each group of patients was tested within a few weeks so 
that the environmental factors would he constant.
The ordinary population of Montrose Asylum is drawn from the 
rural areas of The Meams, Caithness, and Shetland where the 
incidence of syphilis is low: during the war patients from
Larbert Asylum (urban) were evacuated to Montrose and several 
Gr. P. I. cases were included. Unfortunately no record'' of previous 
treatment accompanied them. Thus my 15 Montrose patients included 
only 3 in whom I was certain that malarial therapy had been given; 
8 had received no malaria; and 4 patients may or may not have been 
treated with malaria. I gave malarial therapy to some of these 8 
with the intention of including results of before and after 
treatment but these patients were all removed back to Larbert 
before the second tests could be made.
The Portsmouth group of 16 patients included 1 definitely 
without treatment, 2 with no recorded treatment, 4 with penicillin 
therapy, and 9 with malarial therapy.
Discussion. It is generally accepted that hyperpyrexia 
(induced either by a hypertherm apparatus or therapeutic malaria) 
can cause a halt in the mental deterioration of general paralysis
(* a request to Larbert for this information has been 
ignored. )
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of the insane. Further anti-syphilitic treatment with arsenic 
and "bismuth may produce a negative Wassermann reaction in the 
"blood.
The plasma viscosity results are important as they indicate 
that in spite of the quiescence of the syphilitic infection in 
the central nervous system, there is still an active systemic 
reaction of a "chronic" nature. It would he too much of a 
coincidence if all these (Montrose) patients suffered from 
another chronic infection in addition to the syphilis (chronic 
malaria would have some manifest clinical signs and symptoms) and 
one must assume that the syphilitic process is still active in 
other parts of the "body. Hitherto sufficient stress has not been 
laid on the difference between the local reaction in the brain 
and the reaction by the other parts of the body; in fact I have 
seen malarial therapy given by itself in the belief that the 
disease of all parts of the body is affected equally and becomes 
equally quiescent. Yet there is no significant difference between 
those cases in Montrose and Portsmouth who did and did not receive 
malarial therapy and I assume further that this treatment has 
produced neither an increased or decreased systemic reaction to 
the syphilitic infection. Moreover, an abnormal plasma viscosity 
may be caused by an alteration in the protein pattern of a blood 
in which the Wassermann reaction has become negative.
Malarial therapy must be followed by thorough anti-syphilitic 
treatment.
Four Portsmouth cases were treated with Penicillin and in no 
less than three (=75^ o) did the plasma viscosity return to within 
the normal range. These figures are too few to permit definite 
assertions but it does appear as if penicillin therapy has acted 
against the total syphilitic infection to cause such an amelioration 
(if not complete cure) that the systemic reaction cannot be 
detected by the plasma viscosity test. This is a fundamental 
improvement over the hyperpyrexial forms of treatment. Even vdth 
penicillin, however, the blood Wassermann reaction remained 
positive (++) in one of the three patients in whom the plasma 
viscosity had become normal; the persisting abnormal plasma 
viscosity was associated with a negative Wassermann reaction.
Penicillin therapy is now the standard method of treating
cases of G-. P. I. With the passage of time there will arise more 
results from this treatment and enough will be obtained for a 
statistical analysis. I intend to study the cases at other local
mental institutions in the near future.
Tabes Dorsalis.
A patient may present himself at a V.D. department suffering 
from tabes dorsalis yet with a record of what was considered as
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adequate treatment, both in duration and intensity, in the 
primary and secondary stages. If further treatment with arsenic 
and bismuth is given, the Y/assermann of the cerebro-spinal fluid 
can remain positive for years. The venereologist is constantly 
faced with the problem of deciding when the disease may be 
considered sufficiently inactive that treatment can be discontinued. 
Dr. Henry Bell in the Sunderland V. D. department had seen ray 
Montrose G-. P. I. figures and knew of the rheumatic disease tests, 
and he decided to co-operate in a study of this problem with the 
application of the plasma viscosity test.
The initial tests revealed that the plasma viscosity of 
cases of active tabes dorsalis was indeed increased into the 
f,zone of chronicity”. The results are similar to those from cases 
of G-. P. I.
Both Dr. Bell and myself left Sunderland soon after these 
tests were made and I have had no further opportunity to resume 
this study.
This disease is also being treated with penicillin and it 
is possible that, as with the G-.P. I. cases, the plasma 
viscosity will return to normal values.
Pachymeningitis (Syphilitic) or Cerebral Syphilis.
Of this third type of tertiary syphilis two cases only were 
seen. The results were again abnormally high and within the 
’’zone of chronicityH. These values had persisted in spite of 
anti-syphilitic treatment at the early stages of the infection 
and again, prior to the tests, during the teriary stage when the 
symptoms of the disease were again becoming manifest.
Discussion.
These preliminary results of the plasma viscosity test in the 
tertiary stage of syphilis, although few in number, are still 
sufficient to indicate that the application of the test to this 
disease is potentially valuable.
The exact relationship between the plasma viscosity test on 
the one hand and the Wassermann, Kahn, and similar tests on the 
other should be investigated further. However valuable the latter 
tests may be, it is acknowledged that they are not infallible so 
that an additional test would be welcomed. It is acknowledged 
also that a positive Wassermann in the later stages is no 
guarantee of activity of the disease process; the problem of the 
persisting positive Wassermann reaction in tabes under treatment 
has been mentioned above.
A problem somewhat akin to the ESR./plasma viscosity 
relationship is now presenting itself - which of the two tests, 
plasma viscosity or Wassermann reaction, is to be believed when 
the duplicate results on an individual patient are to be inter­
preted in direct opposition ? I have sufficient experience with 
the plasma viscosity test now to accept its abnormal values as a 
certain indication of activity, even if the Wassermann reaction is 
negative; on the other hand, false negatives do occur and 
therefore a normal plasma viscosity should be interpreted with 
great caution when associated with a positive Wassermann reaction. 
The collection of more individual values and preferably serial 
individual studies, together with a most careful assessment by 
the clinician, are essential to settle the latter point; such 
was the object of the research proposed by Dr. Bell and myself.
We also require some long-term investigations on individuals 
from the primary to the secondary and even to the tertiary stage; 
the response to penicillin treatment has been excellent but the 
failures form a percentage sufficiently high to yield enough 
cases to make their study worth while.
It has been claimed that, just as with invasion by other 
organisms, the infection by the spirochaete produces an increase 
in the plasma globulin and fibrinogen. An increase in the plasma 
viscosity could therefore be expected in the primary and secondary
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stages also. It is a definite possibility that the plasma 
viscosity test may act as a guide to a satisfactory response to 
treatment on a shorter time “basis than the Wassermann reaction.
A course of treatment which is to have an ultimate cure may “be 
reflected in an early return of the plasma viscosity to normal 
“before the Wassermann has changed^ failure to produce a normal 
viscosity, even if the Wassermann may change temporarily, might 
“be an indication of future trouble. This is reasoning in 
analogy with the position in rheumatoid arthritis where we have 
noted repeatedly that a normal plasma viscosity is the highest 
criterion for quiescence; even if a patient becomes symptom-free 
with gold therapy, unless the plasma viscosity has become normal, 
an ultimate relapse is assured. I am certain that the renewed or 
long-continued activity of syphilis which appears clinically as 
the tertiary stage could be detected as an increase in the plasma 
viscosity before the signs and symptoms become manifest.
I do not think that it is too fantastic to foresee a time 
when the estimation of the patient’s plasma or serum viscosity 
will be as routine a procedure in syphilis as the measurement of 
his Wassermann reaction; the viscosity of the serum could be 
estimated prior to the preparation of the serum for the Wassermann 
test; an automatic viscometer would reduce the time required for 
each test sufficiently to make this a practical procedure for a
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laboratory handling hundreds of sera per week. Although the 
fibrinogen is increased in the tertiary stages, the globulin 
increase would be reflected in the serum viscosity.
Bircher and McFarland ( 25), using Naegeli's combination 
of refractimetry and viscometry, noted that the changes were 
indistinguishable for primary, secondary, tertiary, and central 
nervous system syphilis. The total serum protein remained 
unchanged, as measured by the refractometer. The protein 
fractions, however, had an altered ratio in favour of an increased 
globulin^ this change was detected as an increased viscosity.
They also noted that arsphenamine treatment caused a fall in the 
viscosity, but in 31 only out of 4-0 cases; the fall was greatest 
in those cases where the serum viscosity was originally highest.
Similarly, Holker (114) found that the serum of untreated 
syphilitics tended to be more viscous than that of normal persons. 
The increase wras more marked in secondary than in primary , and 
more in tertiary than in secondary; the increase was less marked 
in parasyphilitics. His numbers were rather low for cases tested.
Subject
No. of 
tests.
Serum viscosity.
Mean Range
Normal 8 1*75 cs. 1*69 - 1*85 cs.
Primary 7 1*83 1*71 - 1*98
Secondary 6 1*8S 1*72 - 2*26
Tertiary 9 1*94 1*74 - 2*12
Parasyphilis 4 1*75 1*71 - 1*87
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Chopra and Choudhury ( 42 ) noted that the serum viscosity 
range in syphilitics (25 casesj stages not specified) was 
1*60 - 1*95 cs. as compared to their normal range of 1*40 - 1*64.
Kopp (135) has reported that the plasma proteins regained 
their pre-treatment level within 14 - 24 days of stopping malaria 
therapy, no matter the number or severity of the rigors.
These Earlier papers all support my claim that further 
studies with the plasma viscosity test in syphilis may yield very 
valuable information to the clinician.
(B) G-onorrhoea.
No ordinary cases were examined.
Two cases of gonococcal arthritis had increased plasma 
viscosity values, just as would be found with any other type of 
infection (acute) of such a vital structure as a joint.
(C) Lympho-granuloma Inguinale.
A single patient with this infection was studied.
His plasma viscosity was abnormally high.
§ 5 SEPSIS.
This group includes a variety of clinical conditions produced 
"by the invasion of tissues by pyogenic organisms.
Results. These appear in Table XV of the appendix.
By the time that a septic condition has advanced sufficiently 
for the doctor's advice to be saught, the plasma viscosity has 
become increased to abnormal levels; the increase is approximately 
proportional to the severity of the toxaemia caused by the sepsis; 
and the viscosity returns to the normal range when the original 
sepsis has cleared.
Discussion. The invasion of the tissues by the pyogenic organisms 
is followed by the absorption of the toxins and products of tissue 
destruction, which calls forth a reaction of the body as a whole. 
Antibodies against the organisms and their products are formed and 
circulate in the blood as part of the plasma gamma globulin. In 
addition, there is an initial increase in fibrinogen and a later 
increase in the other globulin fractions - how these increases 
benefit the body has not yet been determined. These protein 
increases are reflected in the increase in the plasma viscosity. 
Acute Sepsis. As the fibrinogen can increase by 100% in 24 hours 
and as the plasma viscosity is almost invariably abnormally high 
when the fibrinogen exceeds 0*4, g.%, the test becomes abnormal 
by the time the patient first presents himself for examination.
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The sensitivity of the test was shown "by the abnormal result 
in an apparently normal subject being traced to an axillary 
abscess which he considered so trivial as not worthy of mention.
The highest values in this group occurred in those patients 
in whom the septic condition (eg. bed sores, gangrene) would be 
the cause of their death.
Chronic Sepsis. This group includes the conditions of indolent 
sepsis - the child with enlarged cervical lymph glands and tonsils 
from which beads of pus might be expressed, the unfortunate youth 
with boils on his neck at all stages of development and healing, 
and the patient with a brown-blue indurated skin of the axilla, 
with subcutaneous abscesses which do not "point", etc. These 
patients had their plasma viscosity within the "Zone of Chronicity" 
which has been described already.
The plasma viscosity test does not assist the clinician 
greatly in the management of his patients; it usually merely 
expresses in numerals what is clinically obvious.
I have had no opportunity to study the use of the test in 
gynaecology but I think that it might, on occasions, indicate a 
deep-seated septic focus such as salpingitis. It might help in 
the differentiation between the acute appendicitis and the more 
chronic salpingitis.
SARCOIDOSIS.
It has been difficult to decide where, in the thesis, this
disease should be inserted because its exact nature has not yet
been elucidated. Robinson and Pound (211), on the basis of a
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thorough survey of- 30 cases, conclude that the disease could be 
interpreted as a chronic infective process of unknown aetiology. 
Hence I have included ny series as a special section after 
pyogenic infection.
Dr. Lendrum, medical director of the Mass Radiography Unit 
in Portsmouth, has a special interest in this condition and has 
a series of patients on whom he makes 6- or 12-monthly checks - 
he hopes to show that without treatment his end results will not 
be significantly inferior to those with Vitamin D, etc. Therefore, 
although some of these patients have been under observation for 
many years and have been showing a regression in the enlargement 
of the hilar glands and other sarcoid lesions, no positive steps 
have been taken to stop the activity of the disease.
Results: These are presented in Table XVI of the appendix, and
representative case notes are included.
Discussion: Only one patient had the plasma viscosity within
the normal range of values; the test was made about a fortnight 
after the diagnosis of sarcoidosis had been reached by the 
histological examination of an excised parotid tumour; a thorough
investigation has failed completely to detect any other evidence 
of this disease. Tests to be performed at a later date will 
prove most interesting. No explanation could be obtained for 
the fall in the plasma viscosity of patient, D.A. , within a 
month; his future tests are also awaited with interest.
The results of A. C , indicate that pregnancy has not affected 
the patient's reaction to the disease; the fall in the ESR. might 
be attributed to the passing from the gravid to non-gravid state 
and this case is an example of the limitations placed upon the 
ESR. test by its changes during pregnancy.
The majority of the remaining plasma viscosity values falls 
within the zone of chronicity and thereby support is given to the 
hypothesis that the disease is of a chronic inflammatory nature. 
The plasma viscosity can be just as high in the cases of several 
years duration as in those more recently diagnosed. Now, although 
these patients feel quite well and their lesions are regressing,
I must interpret the raised viscosity as a definite indication 
that the activity persists with no abatement in its reaction by 
the patient. Instead of waiting many more years until the 
clinicians can make their decision on the merits of different 
types of treatment we can make a statistical analysis of two 
series of plasma viscosity values. The Portsmouth tests have been 
made within the last few months only and Dr. Lendrum’s complete
series has not yet been examined. It is nry intention to approach 
the Brompton chest hospital which employs calciferol with 
enthusiasm in this disease for its co-operation in repeating the 
test on a series of cases where they believe this treatment has 
caused a clinical improvement. A significantly larger number of 
normal plasma viscosity results would indeed support the claims 
in favour of vitamin D therapy. (This investigation is similar 
to that proposed for penicillin in tertiary syphilis) The 
benefits arising from obtaining a definite decision regarding 
the proper treatment need no further stressing.
A problem in diagnosis frequently presents itself in 
differentiating between the hilar gland enlargement of sarcoidosis 
and tuberculosis. The plasma viscosity test, by itself, has been 
of no assistance. However, our present battery of tests has given 
two leads in this connection. The gold flocculation test has 
been found to be positive in a large number of cases of sarcoidosis, 
( 4 out of the last 5 tested), which is a less-common finding in 
tuberculosis. Also, in these same five tests, the (3^ globulin 
was increased in all. The chemical protein fractionation methods 
can show only a tendency for the globulin to be increased in 
both of these diseases.
In addition to its possible assistance in the differential 
diagnosis, the abnormal gold flocculation test gives a hint about
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the aetiology of the disease. It suggests that the infecting 
organism is more akin to the cause of rheumatic fever or rheumatoid 
arthritis than to the tubercle bacillus.
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§ 5 SPECIFIC FEVERS.
Very few cases of the specific fevers were studied, because I had 
no colleague in charge of these diseases who would take an interest 
in the plasma viscosity test.
By their very name, in which the general reaction is 
indicated by an elevation of body temperature, it might be 
forecast that the plasma viscosity would be increased.
My 14 patients of Table XV (d ) in the appendix had 13 raised 
plasma viscosities and one value of l*913cs.
The extremely high result in the case of amoebic hepatitis 
was in agreement with the profound systemic reaction; the very 
high result in the case of paratyphoid was unexpected as he was 
neither dehydrated or severely ill.
As with septic conditions, the value of the plasma viscosity 
test in specific fevers is not great: the number of occasions on 
which the clinician need call on its assistance is low. Perhaps 
it may found a use the diagnosis of delayed response to the new 
antibiotics and sulphonamides where a continued high viscosity 
will indicate that the speedy resolution has not been forth-coming 
as usual. Case W.B. was an example where the resolution with 
sulphonamides was delayed and the viscosity test showed this.
* $ # if. * * sfc ❖
§ 6 TUMOURS.
(a) Simple Tumours.
Results. These are given in Table XVTl(a), of the appendix. 
Discussion. A simple tumour which produces no hormonal secretion 
and which exerts no pressure on vital structures is usually- 
associated with a plasma viscosity value which lies within the 
normal range. In the event of a degeneration in a tumour (eg. in 
a fibroid) the absorption of material from the tumour can cause a 
general reaction which will include an alteration in the plasma 
proteins and an increase in the plasma viscosity. Similarly, it 
might be possible for a reaction and plasma viscosity increase to 
follow on the absorption of tissue in face of tumour pressure, but 
such a case has not occurred in my experience.
Simple tumours which produce hormonal secretions ( eg. 
thyroid, parathyroid, pancreas and pituitary) can cause such 
an upset in the working of the body that the plasma proteins and 
viscosity become abnormal. Case M.M. was a parathyroid adenoma 
and her viscosity was slightly raised. Her case history is 
given in some detail as the diagnosis of non-malignancy which I 
maintained on the basis of these non-specific tests was against 
the consensus of the opinion of several clinicians, yet at 
operation I was proved to be correct.
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(b) Malignant Tumours.
Results. These are given in Table XVII(b) of the Appendix.
In the majority of the tests the plasma viscosity was high. 
Nevertheless, viscosity values within the normal range could be 
found early in the disease (yet inoperable) and again later, as 
a result of Hterminal decay”.
Discussion. The plasma viscosity values in malignant tumours 
depend upon the stage to which the tumour has progressed, as in 
almost every instance the plasma viscosity will be abnormal at 
some time between the growth beginning and death.
(1) In the early stages of the clinical history the plasma 
viscosity may be normal. This stage may include cases in which 
there is a palpable mass (eg. in breast or stomach) detectable 
by the clinician. It may include cases with early local spread 
and involvement of the nearest lymph glands. The protein pattern 
remains normal also so that we know that we are not yet dealing 
with “terminal decay”.
(2) Later, the presence of a malignant tumour in the patient is 
almost always associated with an increased plasma viscosity. The 
increase is usually moderate - under 2*4 cs., but when the 
secondary deposits become widespread (especially if the bone- 
marrow, is involved) much higher values may be noted.
The plasma viscosity increases when -
(i) the tumour (or its metastases) is increasing and producing 
the absorption of other tissues by pressure or by invasion;
(ii) the tumour produces toxins which are absorbed to produce a 
systemic reaction as shown by an elevation of temperature, loss 
of weight, loss of appetite, lassitude, etc.; in contrast to the 
stage (l) above, while the laboratory tests are now abnormal the 
clinician may be unable to determine the exact location of the 
primary growth; at this stage the plasma viscosity/^SR point may 
still lie on the periodic curve of correlation;
(iii) the tumour undergoes definite degeneration with a consequent 
absorption of these products; and
(iv) the tumour becomes infected with pyogenic organisms.
(3) Later still, the plasma viscosity falls as part of the 
phenomenon of terminal decay. A normal plasma viscosity value is 
thus consistent with an advanced malignant tumour.
The clinical group of 'tumours* has yielded me some of my 
greatest successes in diagnosis by the plasma viscosity and some 
of my most dismal errors. However, I still think that a lot of 
useful information can be obtained from the test if it is used 
with caution; more information can be obtained if it is used as 
part of a battery of tests.
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When a clinician is searching for a tumour, simple or malignant, 
as an explanation of his patient’s signs and symptoms, a plasma 
/ viscosity value within the normal range is of little help. From
my experience it is known that a malignant tumour may still he 
present in spite of this normal result, although such an event is 
rare. However, a normal value might help in the differential 
diagnosis, as a normal value would he most unusual if a palpable 
mass was an inflammatory lesion.
The detection of an abnormal viscosity assists the clinician 
in confirming that there is a general reaction to some kind of 
primary stimulus which might well he neoplastic in nature. 
Furthermore, if the changes which can occur in a simple tumour to 
cause a reaction can he excluded, an increased viscosity plus a 
tumour strongly indicates its malignant nature.
Much more information can he obtained by the study of serial 
tests with the plasma viscosity; other non-specific tests can he 
added to produce a battery of investigations. My particular 
choice consists of the corrected citrate plasma viscosity, the 
corrected citrate maximum sedimentation velocity, haematocrit, 
plasma protein fractionation with a consideration of these results 
both as absolute values and in terms of my plasma protein equil­
ibrium factor, and the serum viscosity. A diagnosis of a
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malignant tumour could be supported if in serial tests at a few 
weeks interval there were noted any of the following; the 
certainty of the diagnosis increases with the total number of 
tests showing abnormal results.
(i) A decreased haematoerit which continues to fall.
(ii) An increased plasma viscosity.
(iii) A changing plasma viscosity: ie. an increase in the early 
clinical stage or a decrease in a late stage .
(iv) An increased ESR.
(v) A plasma viscosity/ESR correlation point which falls outwith 
the periodic curve. As a' decayed' value might fall on a lower 
curve (ie. to the left of the diagram) by chance only, serial tests 
reduces the possibility of finding false negative results.
(vi) A low plasma albumin, which continues to fall.
(vii) A protein equilibrium factor which is numerically low, 
which lies towards the lower left corner of the diagram, and 
which gets progressively smaller.
(viii) A serum viscosity/serum protein fraction correlation, which 
does not conform to the pattern shown in § 17 of part 6.
The plasma proteins change at first as in any other type 
of general reaction and later they change as in any other type of 
terminal decay. These changes have been described in detail in 
other sections.
#  s£ sjs &  #  JJC 7,'.
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(c) Multiple Myelomatosis.
This disease has a characteristic excessive growth of the
plasma cells of the bone marrow. Because Willis (253) believes
that the spread can be by metastasis or by multifocal origin he
classifies the condition among the malignant tumours.
Results. These are given in detail in Table XVIl(c) in the
appendix. Individual case histories are also included there.
Discussion. The plasma viscosity results for this disease had a
very high average value and included the highest (=6*660 cs. ) in
my series of tests: as far as I am aware, the only value which
surpasses this was found by Mann (private communication) in a
(■z^= Z0 cs)
. case of congenital hyperfibrinogenaemia. Hill et al. ( 111) 
describe a case in which the cryoglobulin present in the plasma 
produced a viscosity approaching infinity at 32°C., although its 
relative viscosity at 43°0 was approximately 2*6 .
Such high viscosity values may be diagnostic as in no other 
disease of iny own experience could I find these results in 
association with such mild signs and symptoms. For instance, 
case R.W. was referred to the laboratory for a plasma viscosity 
test as ordinary physical examination revealed no explanation for 
her pains in the back. The laboratory report included the 
diagnosis.
It is possible to have a lower and perhaps a normal plasma 
viscosity in a case of multiple myeloma as the extreme changes in 
the plasma protein fractions are not constant features of this 
disease, being present in about 70% of cases only. Bundles et al. 
(214) have recently detected abnormal proteins present in 25 of a 
series of 30 cases (=83*3%) but the amount varied from a few mg» 
up to 7-9 g. per 100 ml. : they examined their sera by an 
electrophoretic fractionation technique. The increase in the 
amount of protein is due to abnormal proteins rather than to 
the normally-present fractions; the abnormal fractions vary in 
their molecular size from case to case. Qualitative differences 
can be distinguished between normal fractions and the myeloma 
fractions of apparently identical molecular size, such as the low 
incidence of positive flocculation tests reported by Martin (177) 
in spite of high serum* gamma'globulin values. My own series does 
not agree with Martin's as I have a high incidence of these 
abnormal flocculation tests. Maher and Mann report only 1 
positive thymol turbidity test in a series of 4 test^l56 ) *
Case H.D. is of especial interest as it shows how a small 
change in the total protein, at these extremely high levels, can 
cause very large variations in the plasma viscosity; a decrease 
of 0*77 g.% produced a fall of 0*978 cs. overnight. However, the
first 'blood specimen was collected by another member of our 
staff who would have taken few precautions to avoid stasis: I
retrieved the plasma sample after I had detected the abnormal 
protein fractions by chemical fractionation: therefore such a
large variation from day to day may have included a large part 
due to technical errors. I went specially to the patient myself 
on the second occasion.
A search was made in the plasma of a patient (M.G-. ) for a 
cryoglobulin but no "kink" was detected in the temperature/ 
viscosity curve. As this curve was derived by warming a plasma 
from room temperature to body temperature it is possible that a 
cryoglobulin precipitated during the time the blood was allowed 
to stand on the bench and that this precipitate was removed with 
the erythrocytes during the centrifuging. I intend to study the 
next plasma from an ambulant patient at the laboratory from 
37°C. downwards.
§ 7 LIVER DISEASE.
The plasma viscosity test was applied to 73 patients who 
were suffering from a variety of diseases of the liver and the 
gall-bladder.
Results. These are given in Table XVIIIof the appendix. 
Discussion. The plasma viscosity was found to be increased in 
the majority of the diseases affecting the liver parenchyma, yet 
this finding has added very little to the clinician’s knowledge 
of his patient. As has been shown by publications too numerous to 
quote, the diseases of the liver comprise the group in which a 
great deal of information can be obtained by a consideration of 
the absolute values of the plasma protein fractions, whether these 
fractions have been determined by salting-out, electrophoresis, or 
ultra-centrifuge techniques. Furthermore, the study of the 
qualitative as well as the quantitative changes in the protein 
fractions by the flocculation tests of Maclagan ( 174,175), 
together with the measurement of the excretory powers of the liver 
as indicated by the serum bilirubin and alkaline phosphatase 
levels, will often supply sufficient information for a diagnosis 
to be made.
The plasma protein changes are reflected in the plasma 
viscosity. In disease of the liver parenchyma, even in the early
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acute phase, the protein fraction which is most affected is the 
globulin. Where the globulin is increased at any stage of the 
disease, the viscosity is usually also increased; where the 
globulin participates in the general protein decrease, such as 
occurs in the final stages of cirrhosis, the plasma viscosity will 
be normal or even abnormally low.
In acute cholecystitis the plasma viscosity is increased 
just as in inf lammatoiy conditions of any organ or tissue of the 
body.
Except for two instances which might have been cases with 
"terminal decay", the plasma viscosity was increased in jaundice 
due to obstruction in the bile-ducts. This may be the response 
to the lesion producing the obstruction (eg. cancer of pancreas) 
rather than to liver changes arising from the obstruction; even 
a stone in the duct produces an inflammation around it which in 
turn will call forth a general reaction.
§ 8 RENAL DISEASE.
In this section we are concerned with nephritis or Bright1 s 
disease, rather than with pyelitis or abscess of the kidney which 
may be expected to produce the same plasma viscosity changes as 
caused by sepsis in any other , tissue or organ.
My classification was into three stages of nephritis and 
nephrosis, according to Price (201) and to Muir (170).
A. Nephritis.
(i) Acute glomerulo-nephritis.
(ii) Subacute nephritis (= large white kidney)
(iii) Chronic nephritis (= small white kidney)
B. Nephrosis.
Results. These are presented in Table XIX of the appendix, and
I*
in the individual case histories.
Discussion. The results are composed of a series of single tests 
performed at a time when the diagnosis was fairly certain, but it 
must be recognised that there are intermediate stages between the 
nephritis groups. My tests do not attempt to indicate the total 
possible responses of the plasma viscosity in these conditions 
but are intended merely as a pilot investigation in order to 
discover whether there is another fruitful field for a more 
thorough research programme.
In acute gloraerulo-nephritis, the plasma proteins show
the changes common to all types of inflammation - viz. an increase 
in the fibrinogen fraction - which in turn causes the plasma 
viscosity to rise into the abnormal range. The plasma viscosity 
did not become markedly abnormal except in two instances.
Subacute nephritis was associated with a protein pattern in 
which the globulin and the albumin were low while the fibrinogen 
was slightly increased or normal; the corresponding plasma 
viscosity values were mostly within the normal range.
Chronic hephritis cases had normal or slightly raised plasma 
viscosity results because of the low albumin partly compensating 
for the increased fibrinogen, as the globulin was again within its 
usual range.
The characteristic change in nephrosis was a marked rise
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in the fibrinogen, yet, such was the decrease in the albumin and 
globulin, the plasma viscosity was only moderately abnormal.
(it was shown in part 6 that the non-protein constituents did 
not affect the plasma viscosity even when grossly deranged. )
At present I can see no stage or condition of nephritis in 
which the plasma viscosity test can assist the clinician by 
supplying information concerning the patient not otherwise 
available, except perhaps in determining when the inflammatory 
phase of the acute stage has passed by a return of the raised 
viscosity into its normal range. Even there, however, the test
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cannot differentiate between a low viscosity due to a "cure" and 
one where the condition is going to progress into the subacute 
stage.
There is a close relationship in this series between the 
viscosity and the ESR results.
The clinician would gain a satisfactory picture of his 
patient’s condition, from the laboratory aspect, by estimating 
the haematocrit, protein fractions considered as absolute values 
and relative to each other, blood urea, and cholesterol.
§ 9 Disorders of Carbohydrate Metabolism.
These tests were made on the fasting blood specimens taken 
at the beginning of Glucose Tolerance Tests in order to teach my 
technicians how to use the viscometer. In many instances the 
patient had been referred by a general practitioner who was later 
unable to supply the clinical details of blood pressure, etc. We 
must therefore not attempt to read too much significance into the 
results.
Results: These are given in Table XX of the appendix.
Discussion* The nine tests made in cases of low renal threshold 
and lag curve types of disorder fell within the normal plasma 
viscosity range.
The incidence of high normal and low abnormal values is 
unusually large in cases of diabetes mellitus; the viscosity 
value bore little relation to the shape or maximum height of the 
glucose tolerance curve.
It is not possible from these few results to ascribe the 
raised plasma viscosity to the dehydration which occurs in 
diabetes (the haematocrits were not abnormally high), to the 
increase in the plasma proteins which follows the administration 
of insulin ( 37), or to a true systemic reaction to a general 
degeneration. The high incidence of hypertension and obesity (10 ) 
within the diabetic group would lead one to expect a high
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incidence of abnormal plasma viscosities.
Emphasis has been recently laid on the two chief types of 
diabetes mellitus by Lawrence (14-1) and by Lister et al. (272) .
It is possible that a significant correlation could be obtained 
between the plasma viscosity values and the clinical group, but 
to arrive at a definite opinion on this the whole problem must be 
re-investigated with a more adequate clinical control.
Case No 18 should be noted where an obese diabetic, with 
a moderately increased blood pressure, still had a normal plasma 
viscosity, thus indicating that the association of these changes 
with an abnormal viscosity is not absolutely consistent.
Harris and McLoughlin ( °IG ) found that the viscosity of 
the whole blood was increased in 35 out of 40 cases with increased 
blood pressure.
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§ 10 Miscellaneous Diseases.
During the collection of the blood specimens from patients 
for the biochemical investigations requested by the clinician-in­
charge I have taken this opportunity of removing an additional 
sample for the plasma viscosity estimation in the rarer diseases. 
The numbers now available in the different diseases are still not 
sufficiently large to allow of any definite opinion and I do not 
intend to include them in this thesis.
Instead of making a full-scale and intensive research into 
a large group of diseases as we have done previously with tuber­
culosis and rheumatoid arthritis, I now make a few tests in 
selected diseases. In this manner I hope to detect a tendency to 
abnormal plasma viscosity results in some diseases and I can 
consider if such a finding would be of significant value to the 
clinician before I study that disease more intensively. For 
example, I am making plasma viscosity tests in the skin disease 
patients who are occasionally referred to me, in order to discover 
if there are certain types of skin disease (excluding septic 
lesions) in which the abnormal plasma viscosity results have a 
high incidence: the high viscosity would be an indication of an 
upset of the general metabolism as contrasted to an upset 
confined to the skin.
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Discussion to Part 8.
Each different disease has had its own discussion but it is 
necessary to have a general discussion concerning the plasma 
viscosity test in disease.
Each infective disease is the inter-action of the infecting 
organism (the seed) and the host (the ground). To obtain a 
complete picture of the disease process it is essential that the 
clinician receives information on both facets. The character of 
the organism can be investigated by the detection of the actual 
bacillus (eg. tubercle bacillus in sputum), the reaction of a 
bacillus to drugs in vitro, its toxicity to animals, and the 
host’s formation of specific anti-bodies (Widal reaction). The 
assessment of the part played by the host does not lend itself 
to its expression in numerical or other form which allows the 
comparison of two individual patients or the comparison of the 
serial stages in any one patient. There is no scale in which so 
many marks are allocated to each sign and symptom and in which the 
sum would be a guide to total reaction. Therefore, the clinician 
and the clinical pathologist have become accustomed to employ a 
variety of tests which measure the extent of the change' in 
function of one organ of the body and to use this aberration of 
a part as an index of the derangement of the whole.
Many of these tests are non-specific in as, much as the same 
reaction can he produced by a variety of diseases.
Some of the non-specific tests are important because the 
incidence of the reacting diseases is uneven and the significance 
of the detection of an abnormal result is high from the aspect 
of diagnosis - eg. Paul-Bunnell test in infective mononucleosis, 
blood cold agglutinins in atypical pneumonia.
There are other tests in which their value to the clinician 
lies in the large number of diseases in which they are liable to 
show changes. Into this group come the plasma viscosity and the 
ESR. tests.
These non-specific tests usually have their origin in the 
discovery (chance or purposeful) of a high positive correlation 
between the findings in some laboratory procedure and a certain 
type of disease. My introductory part included a brief sketch of 
the development of the ESR. test and how from the. : study of this 
ESR. , Whittington chanced on the plasma viscosity changes which 
Whittington and Miller rendered into the plasma viscosity test.
The earlier literature contains many references to the measurement 
of the plasma viscosity in disease (160,195 ,24-2) and even to a 
conparison of the plasma viscosity and ESR. values (148,161,200) 
yet it remained for Whittington and Miller (and T'ang and Wang) 
to have just that extra power of observation and ingenuity to
carry the correlation between the plasma viscosity and the 
clinical condition the step further and to advocate its estimation 
as a test in clinical pathology. The later developments of the 
test, in which I played the major part, have been more of the 
nature of persistent hal’d work.
Furthermore, in the original investigations , one worker 
notes in a particular disease (type or group) a particular 
reaction which differs from his normal controls; his picture is 
an abnormal black in contrast with a normal white. His publication 
leads to the use of the test by other workers for (a) the same 
disease as was studied and (b) other diseases. These workers may 
discover exceptions in (a) in which the test fails to respond, 
and other diseases in (b) which yield the same reaction; and in 
both (a) and (b), with the larger number of tests, it frequently 
happens that a few abnormal values are encountered among the 
controls. With the extension of the canvas the original results 
form but a small portion and the original crude black-on-white 
has been modified either to a smudge of greys or the delineations 
of an etching, (cf. the ESR was originally noted to be abnormal 
in pregnancy, and later work directed its use to general diseases) 
If a test can survive this stage of independent investigation and 
still yield a positive impression, it will be retained in use and 
attain an accepted place in clinical pathology until it is
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superceded "by a later test in which the etching is of a higher 
standard. This is the present state regarding the ESR. test 
which I now claim as due to "be replaced "by the superior plasma 
viscosity test.
Before a reaction should he introduced as a test in 
clinical pathology it is essential that the sponsor should have 
made certain that it fulfils the following requirements
(A) it yields information that the clinician will find valuable 
in the management of his patients;
(B) the information supplied has a value related to the cost in 
equipment, reagents, and man-power required to produce it;
(C) the same information is not already available by an 
established test, if the latter is as simple to perform;
(d ) the same information could not be obtained by the direct 
measurement of the constituent on which the reaction 
ultimately depends; and 
(E) the scope, sensitivity, and reliability of the new test should 
have been investigated thoroughly so that it can hope to 
withstand the independent investigation by others.
I believe that in the evidence reported in this 
thesis I have shown that the plasma viscosity test has satisfied 
all these criteria.
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(a ) The valxie of the plasma viscosity test- to the clinician.
*
It is claimed that the plasma viscosity is increased by the 
reaction by the body as a whole against a disease and that the 
amount of this increase in viscosity is in proportion to the 
severity of this reaction. • It is further claimed that the degree 
of this reaction is thereby summarised into a single numerical 
value which can be compared with other similarly-produced figures.
I have made repeated references to the importance of the 
plasma viscosity estimation as a guide to diagnosis, prognosis, 
and treatment but I will recapitulate briefly.
Diagnosis - The plasma viscosity can be abnormal in the early
I
stages of disease when the signs, symptoms, and results of other 
laboratory tests are inadequate to allow a definite diagnosis 
(eg. pulmonary tuberculosis, ankylosing spondylitis); it can be 
the determining factor for a decision on "activity” in the 
presence of vague symptoms (eg. rheumatic fever); and it can 
assist in the differential diagnosis in which the conditions are 
known to have significantly different responses (simple and 
malignant tumours, for example).
Prognosis - The prognosis of a disease is related to the severity 
of the host’s reaction which the test indicates; the changes in 
the reaction in response (or lack of response) to treatment are 
also shown; the termination of an active reaction to disease
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can be determined with a reliability greater than in any other 
tests, on occasion. The phenomenon of terminal decay requires 
special mention.
Treatment - The changes in the plasma viscosity test indicate 
the satisfactory nature (or otherwise) of treatment. The 
potential uses of the test as a guide to the duration and type 
of treatment especially in syphilis and sarcoidosis have been 
discussed earlier.
(b ) The cost of producing the plasma viscosity result relative
to its value*to the clinician.
This is a problem which vexes all laboratories which use the 
plasma viscosity test. It has not been possible to combine 
accuracy with numerous testing.
There has been no worker with the plasma viscosity test who 
has not reported on it favourably. The initial tests are regarded 
as in the nature of a research problem where the economics 
involved receive scanty consideration; however, having introduced 
the test to the clinicians, the laboratory is frequently faced 
with their request that the new test should be used in addition to, 
if not in place of, the ESR. test in their routine investigations. 
Mann, at the Mayo clinic, has managed to measure scores of plasma 
viscosities per day by employing his oim type of viscometer
which has a potential error of 5% due to blockage, in addition 
to being subjected .to the criticisms of all single-tube 
viscometers such as used by Gibson, Woodmansey and Wilson, Sato, 
Arnold, etc.
I have been designing automatic viscometers which Whittington 
condemned until January 1952. With the model now planned, in 
which the only error is a fraction of the error in the calibration 
of a 1 ml. pipette, at least 20 tests per hour will be possible 
with any intelligent technician.
At the present stage where four tests per hour is a fair 
output per technician, I cannot recommend the plasma viscosity 
test for use at the clinician’s every whim but retain it for 
definite problems of the individual patients - eg. ? activity in 
a mass-radiography pick-up, ? quiescence in rheumatic fever.
(0) Is the same information supplied by any other test ?
The ESR. test is the only one with which the plasma viscosity 
needs comparison, as it is the only one which claims to indicate 
the same thing.
If in the comparison, the plasma viscosity test cannot show 
a superiority (equality is insufficient reason for the diiscarding 
of an established test) then it must be forgotten and its
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recommendation with-held.
In the course of this thesis I have shown-"by statistical 
analysis of groups of cases in rheumatoid arthritis and pulmonary 
tuberculosis, and by a more general consideration of other types 
of disease and of individual case histories that the plasma 
viscosity test is definitely superior to the ESR. test. The same 
evidence also supports the contention (which is the corollary to 
the question posed above) that the ESR. test is so frequently in 
error, unreliable and insensitive that it might well be discarded. 
As a result of their own experiences, the ESR. test has already 
been discarded by Benson, Cowan, and Houston. I favour its 
retention for a single use - the detection of activity in the 
early stages of a disease - as I believe that there are rare 
occasions in which the ESR. becomes abnormal before the plasma 
viscosity test. To ask that such a long-established test as the 
ESR. should be abandoned now is not a matter to be suggested 
lightly but I am convinced that it is the proper procedure. I 
would have been happier in this suggestion if my automatic 
viscometer was in commercial production yet I can quote Houston 
as being quite content without his ESR. and having only an 
occasional plasma viscosity test available with convalescent 
patients as his technicians.
(d ) Could the same information be obtained from an investigation 
of the plasma constituents (ie. proteins) on which the 
viscosity depends ?
The estimation of the plasma protein fractions has always 
been a technical headache because it has been impossible to 
combine speed with accuracy - the accurate Kjeldahl method is not 
convenient for the routine laboratory.
This thesis has shown that significant changes in the total 
protein occur only in association with marked clinical changes. 
Although it can be measured rapidly but inaccurately with a 
specific gravity technique, the total protein estimation has few 
uses as a clinical test as compared with the plasma viscosity.
Even employing the simplest colorimetric techniques, 
combined with a chemical fractionation, it would be impossible 
to meet the demands of the clinicians if this method was to 
replace the plasma viscosity and ESR. The recently-introduced 
filter-paper electro-phoresis technique has many potential uses 
but it is still too time-consuming for universal adoption. If 
later modifications render it an ecceptable technique, the 
protein fractionation may not necessarily displace the plasma 
viscosity test completely as two major difficulties will restrict 
its use.
(a) The limits of the normal range for each protein fraction are
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so wide apart - eg. 1*3 - 3*0 g./lOO ml. of globulin - that 
relatively large changes may be necessary in initially-low normal 
values before they become recognized as abnormal. The fractions 
which are primarily affected have the greatest effect on the 
viscosity and it is therefore possible (as I found on several 
occasions) for the plasma viscosity to be definitely abnormal 
before the protein pattern is accepted as abnormal.
(@) The interpretation and comparison of 4 or more fractions 
(according to the technique in use) is much more difficult than 
the single numeral of the plasma viscosity. It is harder to 
reach a final assessment of the relative and absolute variations 
in the multiple fractions in the serial tests of the individual 
patients unless a complicated system such as Whittington and I 
developed for the combined-protein molecule reduces the fractions 
to a single numeral also. It would be equally awkward to compare 
the results of two patients.
It must be stressed that nothing written above is intended 
to discredit the measurement of the plasma protein fractions in 
disease of the liver, kidney, tumours, and other diseases where 
experience is proving it valuable. The criticism is directed 
only against the routine use of protein fractionation as the 
index of the severity of the general reaction.
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(E) OgjL-the test hope to 'withstand independent criticism.,
comparison with similar tests and their developments, and 
comparison with suggested modifications in itself ?
The original work hy Whittington and Miller (and T’ang and 
Wang) dealt solely with the plasma viscosity test in tuberculosis. 
My later work at Montrose, Sunderland and Portsmouth showed that 
the test could be applied to a wide range of diseases indeed; 
this extension of our knowledge of the test did not give us cause 
to modify our claims concerning its use which is now based, on 
over 4,000 tests.
Furthermore, the independent work by Arnold, Benson,
Dawson, Gibson, Lawrence, Race, Salt, Steel, Wilson, and Woodman- 
sey has introduced no major controversial opinions concerning the 
plasma viscosity test itself, while the variety of opinions 
expressed by them on the relative merits of the plasma viscosity 
and ESR tests arises really from the differences of the ESR test 
only. Their reports have been discussed earlier and need not be 
mentioned again except to point out the dangers of studying 
restricted disease groups such as done by Race, by Steel, and by 
Arnold and Salt.
We may therefore conclude that the plasma viscosity test 
has passed the preliminary independent investigations in a 
satisfactory manner.
The plasma viscosity test has a fairly low percentage of 
”failures” where an abnormal viscosity is not detected in the 
presence of activity by clinical assessment in a typd of disease 
which usually produces a systemic reaction. It is quite possible 
that further experience will explain why this minority of 
individuals behaves differently and this very variation from the 
majority reaction may add further significance to the test. 
However, until this knowledge has been gained, it is possible that 
other tests or modifications of the plasma viscosity test may be 
proposed as its superior because of a lower percentage of 
failures. It is therefore proper for us to consider the position 
of our sponsored test relative to these other tests and their 
future developments.
In a way these other tests (Takata-Ara (177),Cadmium 
sulphate of Wuhrmann and Wunderly ( 260), Thymol test of Maclagan 
(174), Gold flocculation of Maclagan (l75), Weltmann's test ( 53 ), 
etc.) support the validity of our own plasma viscosity test in 
that most of them are based on a measurement of the general upset 
of the body as indicated by a change of the liver function as 
indicated by an alteration in the plasma protein. Tests of this 
nature have usually been introduced to measure the primary liver 
dysfunction of infective hepatitis, cirrhosis, etc. and then
applied to the liver dysfunction secondary to disease of other 
parts of the "body. There is justification in this procedure in 
the high incidence of abnormal results with a variety of liver 
function tests in such diseases as pneumonia (262),malaria (157-), 
tuberculosis (136), rheumatic fever (180), rheumatoid arthritis 
( 83), amoebiasis (228), and others, and by the lesions of the 
liver at post-mortem in such diseases (eg. 9 ). Some writers
have shown that a better correlation can be obtained between the 
clinical assessment of a disease and some of these tests than 
obtained with the ESR. (eg. Weiger’s paper (247) reports a better 
correlation with Hayem’s solution reaction as compared with the 
ESR. in tuberculosis) and it is only a matter of time before a 
similar comparison is made with the plasma viscosity test.
My own comparison between the plasma viscosity and gold 
flocculation tests has had instances in rheumatoid arthritis 
(see Fig. 83 ) where the gold test was abnormal in the presence 
of a normal plasma viscosity, yet the reverse was much more 
frequent. Similarly, the very difference of the behaviour of 
the two tests in Infective and Rheumatoid Arthritis was made a 
significant diagnostic point. The gold flocculation test was 
usually normal in tuberculosis.
I believe that there are four aspects of the plasma viscosity
4-26
test which will maintain its superiority over the other tests 
and any likely development in the near future.
(i) Provided we can reach an agreement on a standard 
viscosity scale (eg. to the Sucrose line) the plasma viscosity 
test will have an internationally acceptable standard which will 
be independent of modifications of only parochial importance.
The results are in the form of simple numerals of which the 
clinician need only remember the upper limit of the normal range.
A variation of clinical significance need be only 1-2 °/o of 
the total possible range of change.
Contrast this with the tests (cephalin-cholesterol 
flocculation, for example) where the total responses are restricted 
to six ( 0 to +++++ ), where the result is subject to the idio- 
syncracies of personal interpretation, and where the crude 
division does not lend itself to close correlation with the 
clinical condition.
(ii) While it is possible that a flocculation test might 
give a closer correlation with the clinical state than the plasma 
viscosity test in some particular disease, it is most probable 
that this same test will be normal in the presence of other 
diseases causing a systemic reaction. It follows,therefore, that 
where such a test is more specific in character it may be used
only in the appropriate disease which requires that the clinician 
be certain of his diagnosis. The plasma viscosity test reacts 
more or less equally for the saipe clinical severity of a wide 
variety of diseases; what it may lose by lack of sensitivity, it 
gains by the capacity for a more general application.
(iii) The flocculation and similar tests seem to depend 
upon one fraction only of the plasma proteins, which is usually 
a globulin. (The principal globulin may be modified in its 
action by the albumin and other globulin fractions. ) Thus, a 
test of this type will have little application in the more acute 
diseases where the main protein change is in the fibrinogen and 
where the total course may be so brief that the globulins never 
have time to change at all.
(iv) To have equal application in acute and chronic 
diseases, a test reflecting protein change must be based on a 
reaction in which the small absolute fibrinogen change of the 
acute disease has an effect equal to the larger absolute globulin 
changes of the chronic disease, somewhat in the proportion of
their molecular dimensions. \
The reactions likely to comply with this requirement are 
those measuring the physical rather than the chemical properties 
of the protein fractions. The specific gravity effect has been
shown to "be the same for Albumin and Globulin, and probably 
for Fibrinogen. The surface tension of serum was shown by du 
Nouy to have a range of variation which amounted to only 3/b of 
the values. The osmotic pressure of serum and plasma is not 
readily measured and the physical characters are the opposite of 
those demanded - the fibrinogen effect is negligible, and the 
globulin less than albumin. The viscosity fulfils the specific­
ations excellently, as shown both by the experiments with solutions 
of the purified proteins and by the correlation of the serum and 
plasma viscosity with the protein components.
The only other test at present in use in clinical pathology 
which attempts this differential reaction to fibrinogen and 
globulin is the ESR in which the sedimentation velocity has been 
shown to be affected by the molecular size ( 88 t 89 ) (cf dextran 
experiments (107)), but I have already demonstrated the 
inferiority of the ESR.
We can conclude, therefore, that although there may be 
superior, tests with an application restricted to certain diseases, 
provided the diagnosis is certain, there is no prospect of a 
test which can be so widely applied as the plasma viscosity and 
which will retain as good a correlation to the clinically 
assessed severity.
Two modifications of the plasma viscosity test require 
consideration.
Coke has used a Serum Viscosity Test to his own satisfaction. 
Salt has recently suggested that the serum viscosity should he 
studied further. Because of its absence of change in acute 
disease and because the abnormal range of values relative to the 
total range appears to be relatively smaller than the corresponding 
figures for the plasma viscosity (see Pig. 18 ), I cannot see any 
immediate benefit arising from the use of this modification. Prom 
my own experience with duplicate estimations in several hundreds 
of tests in a variety of disease conditions I am certain that 
the Plasma Viscosity is definitely superior.
Lawrence has introduced the Fractional Plasma Viscosity 
test in an attempt to combine plasma protein fractionation with 
the plasma viscosity estimation. He has supplied statistics 
which are convincing evidence that more information is made 
available by his technique than the simple plasma viscosity test 
in his hands. (However, his abnormal results in only 59% of his 
plasma viscosity tests are very much lower than the figures of 
Benson, G-ibson, or myself, who obtained results more of the 
order of the 86% of his fractional technique). However, his 
figures are not convincing proof that the extra information
is worth the extra cost in technician's time required by the
various manipulations and the three additional viscosity
*
estimations. There exists already a plethora of protein fraction­
ation techniques with their corresponding normal ranges of 
figures (salting-out with various salts; electrophoresis by 
various buffers; ultracentrifuge; etc.) and to add yet another 
which, because it involves the measurement of the viscosity of 
non-Newtonian fluids, is not reproducible exactly by independent 
workers would be permissible only if the value of the results 
really introduced something fundamentally better. I cannot 
concede that Lawrence has done so. The reader will remember that 
I could not justify the expenditure for replacing the routine 
ESR. tests with the plasma viscosity estimation until the 
automatic viscometer became available commercially, and the 
additional information produced by Lawrence's method does not 
merit the quadrupling of the cost. Doubtless there will be 
individuals who will be able to adopt Lawrence’s technique and 
who will obtain much information from it, but I do not imagine 
that it will be used generally in pathology departments.
We may conclude, therefore, that the modifications so far 
suggested in the plasma viscosity test itself are either inferior 
or too complicated to become generally accepted by clinical 
piathologists.
The plasma viscosity test remains one of the very best 
among the non-specific laboratory indications of the systemic 
reaction by the patient to his disease process.
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Part 9 
SUMMARY
(1) The history of the development of the Plasma Viscosity Test 
from the Erythrocyte Sedimentation Rate Test hy Whittington 
and Miller, in tuberculosis, has "been described.
(2) The events leading up to my own interest in this test have 
also been related and how I have become the principal worker, 
in the later developments of the: test.
(3) The physical property of ordinary liquids named "Viscosity" 
has been defined.
(4) Fluids have been divided into "Newtonian" and "non-Newtonian" ; 
the non-Newtonian liquids have only "apparent viscosities" as 
the corresponding physical property varies according to the 
conditions under which it is measured.
(5) Plasma and serum are non-Newtonian liquids.
(6) A technique for the accurate estimation of the viscosity of 
small volumes of plasmata has been given in detail.
(A) Preclinical Part.
(7) The potential errors of the technique have been discussed 
and have been shown to be less than 1 % theoretically and 
still less practically.
(8) Venous stasis must be avoided during the venipuncture.
(?) Significant errors can be introduced into the plasma 
viscosity estimation by centrifuging with un-capped tubes. 
Evidence is given for a marked degree of concentration of 
the plasma by such treatment; most measurements of the 
constituents of the plasma must be similarly affected.
(10) A significant change can be caused in the plasma viscositjr 
by a delay in the separation of the plasma from the erythrocyte 
either before or after centrifuging.
(11) The viscosity of a plasma is not affected by mechanical 
violence.
(12) Neither is it affected by standing on a bench for five 
days with precautions taken only against loss by evaporation.
(13) The viscosity of plasma decreases by approximately 2*35 % 
for each rise in temperature by one degree centigrade.
(14) The viscosity of a plasma estimated at 20°C is representa­
tive of the viscosity at body-temperature (37°C).
(15) In some ill subjects, however, the viscosity/temperature 
curve contained a kink between 52 and 36°C. approximately, 
whose cause was tentatively suggested as being due to a
■ cryoglobulin.
(16) Of the anti-coagulants in common use in the laboratories of 
clinical pathology, the mixture of potassium and ammonium
oxalates of Heller and Paul has been shown to be the most 
convenient for general use.
(17) The viscosity of a plasma is representative of the whole 
plasma sample from which the 1 ml. was taken, of the total 
blood specimen from which the plasma was prepared, and of the 
venous blood of both arms.
(18) The viscosity of the ultra-filtrate of serum (and therefore 
probably of plasma also) can be regarded as constant in spite 
of large changes in the non-protein constituents.
(19) The viscosity of plasma is ultimately a measure of the 
viscosity of the plasma proteins.
(20) The viscosity of solutions of the separated protein 
fractions, in equal concentration, is greatest with fibrinogen 
and least with albumin; in l/o concentrations the effect of 
fibrinogen, globulin, and albumin is in the proportion of 
6:2:1 approximately.
(21) An original hypothesis by which a solution is treated as if 
it were a single homogeneous compound has been derived from a 
study of these results, whereby the molecular weight of the 
solute may be calculated by viscosity measurements.
(22) The viscosity of serum and its component protein fractions 
were studied in a large series of cases. The viscosity of the
the serum was found to he greater than the value calculated 
from the viscosities of its proteins.
The globulin:albumin action now seemed to be nearer a 
ratio of 3:2 .
(23) A combined-protein molecule, formed by the union of 
albumin and globulin molecules, was suggested as a possible 
explanation for the unexpected viscosity results.
(24) A similar combined-protein was suggested for the proteins 
of plasma.
(25) Brief mention has been made to the plasma protein 
equilibrium factor which Y/hittington derived by a mathematical 
analysis of my results, on the hypothesis that there exists
in the plasma a dynamic equilibrium between the free protein 
fractions and a combined-protein molecule.
A brief mention is also made to the possible use of this 
plasma protein equilibrium factor in clinical med.icine,; I 
have suggested that it is more valuable than the simple 
albumin/globulin ratio.
(Reprints of the two papers are included in the appendix. )
(26) A periodic wave relationship is demonstrated between the 
serum viscosity and the protein fractions; confirmation of 
the wave-pattern was obtained in the published results of 
Petschacher.
It is possible that a somewhat similar wave-pattem may be 
obtained between the osmotic pressure and the proteins.
(27) Large discrepancies (up to 1*5 g./lOO ml.) were found 
between the duplicate estimations of the serum and plasma 
total proteins by a micro-Kjeldahl and a specific gravity 
technique.
(28) The plotting of the points of the duplicate estimation of 
the corrected citrate plasma viscosity and the maximum 
corrected citrate sedimentation velocity produced another 
periodic curve relationship.
This curve can be reproduced by independent workers.
(29) The point may fall off this curve in patients suffering 
from primary liver disease, protein loss via the kidneys, and 
the clinical state called "terminal decay".
(30) Gibson obtained a somewhat similar pattern with blood 
containing the oxalate mixture as anti-coagulant.
(31) The pattern is seen only where the ESR. technique measures 
a maximum sedimentation velocity as contrasted to the more 
common - distance fallen in 1 hour - techniques.
(32) The Wintrobe ESR. /plasma viscosity relationship has a very 
wide scatter which cannot be correlated to a straight line 
nor to a periodic curve.
The linear correlations which appear in other papers are 
based on studies of restricted types of disease.
(33) The correlation between the ESR. and the plasma proteins 
have not been sufficiently strict to ascribe a "cause and 
effect" relationship. In general, a high ESR. was associated 
with an increased fibrinogen and/or globulin.
It is suggested that a closer correlation might be found 
between the change in the ESR. and the change in the plasma 
proteins from the normal basic levels.
(34) The need for an international standard to which all 
viscometers may be correlated is emphasized.
(35) Three techniques have been described by which viscometers 
can be correlated:-
(i) by the correlation of the viscosities of the characteristic 
points of the ESR/viscosity periodic wave;
(ii) by a correlation of the viscosities of the characteristic 
points of the serum viscosity/protein periodic wave;
(iii) or by deriving the equation by which the viscosity 
values of a protein solution are made to coincide with 
the sucrose line.
(B) Physiology
(36) The plasma viscosity results in health have a restricted 
range of values which is the same for both sexes and all ages.
(37) The variation within the day, from day to day, and from 
season to season is small.
(38) Moderate exercise and ordinary food and fluid intake cause 
no significant changes in the plasma viscosity.
(39) The viscosity, however, can be varied significantly by the 
post-alcoholic dehydration and by the ingestion of concentrated 
solutions of urea and glucose in the fasting state.
(40) The reported changes in the plasma proteins with variation 
in posture for any length of time are such as to produce a 
lowered plasma viscosity in the recumbent position and an 
increase on again becoming vertical. It is most important 
that the effects of posture and exercise be separated in 
such experiments.
(41) Menstruation does not cause a consistent change in the 
plasma viscosity.
(42) During pregnancy there is no significant change until the 
last two months during which the viscosity rises slightly.
(43) The effects of the sulphonamides upon the subject himself, 
as contrasted with the effect upon the disease process, has
been studied in subjects free from any disease known to be 
influenced by these drugs. There was an increase in the serum 
proteins, serum and plasma viscosity, and ESR.
The significance to be attached to changes in the tests 
of clinical pathology during therapy has been discussed.
(c) Disease
(44) Diseases have been classified into two groups
(a) Localised and degenerative, in which there is little or
no upset of the body as a whole, and
(b) Diseases, with or without a main focus, in which the 
working of the whole body is upset.
(45) In diseases of type (b), with a systemic or general reaction, 
the plasma viscosity is usually increased above the normal 
range of values.
(46) The amount of the increase is proportional to the severity
of this systemic reaction.
(47) In those diseases where the degree of general upset is 
proportional to the severity of the local lesion, there is 
some relation between the increase in viscosity and the 
severity of the local lesion also.
(48) The change in the viscosity is quite non-specific. It is 
much the same for the same degree of systemic reaction no 
matter the nature of the primary stimulus.
(49) The plasma viscosity alters during the course of a disease 
and these alterations bear a close time relationship -with the 
changes in the clinical state which are their ultimate cause.
(50) A further rise in the viscosity is an indication of a 
worsening of the original condition or of a coup lie at ion; a 
decrease usually indicated, an improvement.
(51) Such changes in the plasma viscosity allows it to be used 
as a test in clinical pathology.
(52) The value of the test to the clinician has been discussed 
in detail under the headings of:-
(i) Diagnosis.
(a) An abnormal viscosity guarantees the presence of a 
disease, but a normal viscosity, although suggestive, 
cannot guarantee its absence.
(b) The severity and (c) nature of the disease can be 
indicated.
(ii) Prognosis.
(a) The higher values carried a worse prognosis.
(b) The test may indicate a disease of chronic character
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with its corresponding prognosis.
(o) The test denotes the response to treatment.
(d) It is frequently a very good criterion of cure.
(iii) Tre atment.
(a) The treatment may he guided hy the response of the 
viscosity.
(h) A treatment based on an attempt to increase the
viscosity prior to lowering it was considered possible 
in chronic disease.
(c) The potential uses of the test as the criterion of 
cure in cerebro-spinal syphilis and sarcoidosis, and 
the design for further researches in this aspect, have 
been discussed specially.
(53) The high incidence of plasma viscosities from all types of 
active chronic disease within a restricted part of the total 
viscosity range led to it being named the “Zone of Chronicity”. 
This zone has a special significance to the clinician.
(54) A similar high incidence of viscosities in patients 
actually forming a pleural effusion at the time of testing to 
a restricted range of values led to the range being named the
“zone of effusion”.
(55) We have also produced the name - “Terminal Decay"- for the
phenomenon of the fall in the plasma viscosity as death 
approaches. This “terminal decay” is very important to 
diagnosis, prognosis, and treatment.
(56) The results of the plasma viscosity and Wintrobe ESR. tests 
have been compared by statistics in rheumatoid arthritis and 
tuberculosis, and the plasma viscosity has been shown to be 
definitely superior; this conclusion was supported by a 
general consideration of other groups of results and of 
inclividual case records.
(57), It is even suggested that the ESR. test should now be 
discarded as unreliable.
(58) The plasma viscosity has been applied to sufficient cases 
of the following diseases to permit of a special discussion of 
each.
Rheumatic Disease: Rheumatic fever; rheumatoid arthritis;
Still's disease; infective arthritis; osteo-arthritis; 
ankylosing spondylitis; fibrositis; gout.
Tuberculosis: pulmonary and non-pulmonary.
Venereal disease.
Pyogenic infection, plus sarcoidosis.
Tumours: simple and malignant.
Renal and Hepatic disease.
(59) The behaviour of the Gold Flocculation Test has also been 
studied in these diseases and valuable information thereby 
gained.
(60) In a discussion on the relative merits of other non-specific 
tests, reasons were given why I cannot foresee any of them 
replacing the plasma viscosity test in the near future.
(61) Similarly, the two proposed modifications in the plasma 
viscosity test itself are unlikely to receive a general 
acceptance.
(62) The evidence supports the claim that the plasma viscosity 
test is one of the very best guides to the general upset in 
the body as a result of disease.
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Part 1
M E T H O D S
APPENDIX - Part 1.
METHODS.
The full details of the methods will he given only for those 
procedures which are not included in the system of tests 
of a large clinical pathology laboratory.
The technique for estimating the plasma viscosity has been 
given in part 4. of the general thesis.
(A) Collection of Blood Specimens.
Prom a critical study of the methods of blood removal in 
many laboratories and out-patient departments I am certain that 
these ordinary techniques would introduce appreciable errors in 
the plasma viscosity values. A scrupulous attention to our 
technique has been maintained throughout and I will not examine 
a plasma removed by any person who has not had the following 
details emphasized to him.
Apparatus:- "Vim" syringes, 10 or 20 ml. capacity, sterile and
lightly lubricated with paraffin. These have glass 
pistons and metal nozzles.
"Vim" hypodermic needles - 22, 20, 19 gauge.
Collecting Bottles - Bijou, 1 oz. screw-capped, or centrifuge tube. 
"Plain’1 - containing no anticoagulant.
"Potassium Oxalate" - dried salt, allowing 2 mg- per ml. blood. 
"Mixed Oxalate" - containing crystals derived by drying off from 
the solution at 37°C. , allowing 6 mg. ammonium oxalate and 
4 mg. potassium oxalate per 5 ml. of blood.
"Heparin” - containing 10 units per ml. blood.
"Citrate" - these containers were 10 ml. graduated flasks or 
centrifuge tubes, or a 10 ml. tube which I had made to a
design of my own, with the intention /■---- -— y /-----
that the passage of the blood through iOni. ~ ^ _____ Jg~J
the constriction during shaking
would ensure a thorough mixing of the blood and citrate solution. 
All these tubes contained 2 ml. of 3*8% sod. citrate solution.
Preparation of the apparatus:- Our experiments showed that the 
plasma viscosity could be affected by psychological stimuli and 
it is obviously essential that the psychological trauma of serial 
venipuncture should be reduced to the minimum. Hence, each 
needle was sharpened by myself after each use. Also, the 
smallest needle was used which would allow a rapid removal of an 
adequate blood volume - 22 gauge for 5 and 10 ml. 20 gauge for 
20 ml, and 19 g&uge for larger volumes.
Preparation of the patient:- The patient was arranged sitting 
comfortably in bed or at a table. Both antecubital fossae were 
examined by inspection and palpation in search of a large medial 
or lateral vein (the central veins were preserved wherever possible 
in case of later requirements for blood transfusion or intravenous 
therapy). The selected arm was rested on a pillow. The needle 
and syringe were selected and patency of the needle tested.
Removal of the blood:- A rubber tourniquet must not be used. For 
crippled patients I have an assistant but in all other instances 
I make the patient act as his own tourniquet as his attention is 
thereby detracted from the venipuncture. He grasped .his upper 
arm firmly while the skinves being swabbed, the position of the 
vein was confirmed by palpation, and the needle introduced 
rapidly and smoothly. The constricting hand was removed, the 
dammed blood was milked towards heart by the swab, and gentle
steady traction applied to the plunger of the syringe. When 
enough blood was in the syringe, the needle was withdrawn. A 
swab was applied firmly over the puncture and the patient was 
made to continue this pressure with his arm held straight, 
not flexed as is the usual method. These few seconds will 
reduce the incidence of haematomata formation to the minimum 
and thus please the patient (while preserving a vein for 
immediate future use). The needle was removed from the syringe 
and the appropriate amount of blood injected smoothly into each 
container. Solution of the anticoagulants was obtained by gentle 
rocking; shaking was avoided as it was liable to produce frothing 
which, in turn, might produce haemolysis. These samples were 
transferred to the laboratory without delay.
On a few occasions, because of small veins or defective 
circulation, the antecubital veins only became detectable after 
the arm was warmed in hot water: rarely, the blood was removed
from the veins of the wrist.
(b ) Preparation of Plasma and Serum.
The contents of the blood containers were transferred to 
15 ml. centrifuge tubes. These were centrifuged for 15 minutes, 
by a timing device, at 5,000 r.p.m.. (As the diameters of the 
centrifuge heads varied from laboratory to laboratory, the 
r. c. f. values were not constant. ) It is essential that the 
centrifuge tubes are stoppered during the centrifuging.
a5
(O) Estimation of the Plasma and Serum Protein Fractions. 
Principle: - The protein was digested with sulphuric acid to 
form ammonium sulphate from which strong alkali liberated the 
ammonia which was distilled into a known volume of standard 
acid. Fibrinogen was estimated from the fibrin clot of 
recalcified plasma; the fractions in serum were separated by 
the salting-out technique of Howe (121, ) using solutions of 
sodium sulphate.
Apparatus:- Digestion tubes and heating racks for rnicro-KjeIdahl 
tubes.
2 Markham stills (161).
Various burettes, pipettes, flasks, etc.
Reagents:- Pumice powder; normal saline, 5>o calcium chloride 
solution, digestion mixture composed of 3 vols. of 
MAR sulphuric acid and 1 vol. of phosphoric acid AR, 
potassium persulphate AR, N/lOO HC1, N/lOO baryta,
0*l^ b methyl red and 0*03^ b p-nitrophenol in 50> alcohol 
as indicator, 1*6M, 1*33M, 1*Q6M sod. sulphate solns. 
10> sodium tungstate soln, 2/3N sulphuric acid.
Method:- The quantities chosen of protein-containing material
yielded about sufficient ammonia to neutralise 10 ml. of W/100
acid. Duplicate results agreed to better than 1%,
a) Total serum protein. With a re-calibrated pipette, 1*0 ml. of
serum was added to normal saline in a 10 ml. volumetric flask and
saline added to graduation: 1*0 ml of diluted serum was
transferred, in duplicate, to Pyrex digestion tubes.
"b) Fibrinogen. 1 ml. of Wint robe-blood plasma was added to 30 ml.
normal saline, 2 ml. of Ca0l2 soln. added, and incubation
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carried out at 37°G for about an hour. The white fibrin clot 
was removed by whipping it onto a glass rod from which it was 
pulled by filter-paper and squeezed dry. The tiny clot was 
then washed for an hour in two changes of distilled water, 
again squeezed dry, and added to 1 ml. of water in a digestion 
tube. Duplicate tests were run when there was sufficient plasma.
c) Serum protein fractions. 1*0 ml. of serum was added to
15 ml. of each concentration of sodium sulphate soln. (to give 
1*5M, 1*25M, and 1*0M finally) in stoppered flasks kept in the 
incubator overnight. Still in the incubator, filtration through 
No50 Whatman filter-papers was made with the full precautions of 
Robinson (208) whereby preliminary saturation of the paper with 
protein prevents a loss of albumin by adsorption. 2 ml. of the 
fluid was filtered, refiltered, and discarded; this was repeated 
with another 2 ml. sample. The remainder of the fluid was then 
filtered. 3 ml. of filtrate, in duplicate, were pipetted into 
digestion tubes.
d) Non-protein-nitrogen (NEN). 1 or 2 ml. of serum was added to 
15 ml. of distilled water, and the protein was precipitated by
2 ml. of tungstate soln. followed by 2 ml. of 2/3N acid. A 
No42 Whatman paper was used for the filtration. 5 ml. of the 
filtrate, in duplicate, were transferred to digestion tubes.
e) To each tube was added 1 ml. of digestion mixture and a
a7
pinoh of pumice (to minimise bunping).
f) Digestion was continued on a gas micro-burner until the 
contents were well-charred and heavy white fumes were rising, 
heating was continued for another 5 minutes, and the tube 
allowed to cool.
g) 1 g. of pot. persulphate and 1 ml. of water were added and 
the digestion resumed until the contents were clear and the dense 
white fumes were again rising, and heating was continued for
a further 3-5 minutes.
h) The contents of the tubes were transferred in tuin to a 
Markham still, the ammonia was liberated by 40/t. NaOH soln. and 
received into 10 ml. N/100 acid, and the excess acid was 
titrated with standard baryta.
The 2 Markham stills allowed eight distillations per hour 
and revolutionised the number of Kjeldahl ^ estimations possible 
by a single worker.
i) The classical protein/nitrogen factor of 6 ‘25 was used 
throughout. There is not yet any agreed factor for the fractions 
although it has been realised that the factor probably differs 
slightly from 6*25 and from each other for the individual 
fractions.
j) To obtain the plasma values corresponding to the serum
results a correction was introduced to allow for the space in
the plasma occupied by the fibrinogen (specific volume = 0*75).
k) Calculations: -
Fibrinogen = 6*25 x nitrogen of Fibrin clot
Total serum protein = 6*25 x (Total serum nitrogen - KEN)
Total plasma protein = Serum protein x (100 - 0*75 x fibrinogen)
+ fibrinogen.
Serum Albumin = protein in filtrate from 1*5M sod.* sulph. soln.
Serum Globulin = total serum protein - albumin.
Pseudoglobulin II = filtrate protein from 1*25M sod.* sulph -
albumin.
Pseudoglobulin I = filtrate protein from 1*GM sod. sulph. -
(albumin + pseudoglobulin II).
Euglobulin = total .globulin - pseudoglobulins II and I.
( D )  Preparation of Pure Albumin and Globulin Fractions.
Principle: - I devised a method from the papers of Hopkins (H7j, 
Young (261), and Adair and Robinson ( 3 ).
Globulin was salted-out and filtered off; the albumin was 
precipitated from the filtrate by adjustment of the pH. Both 
proteins were purified further.
All the technique required full aseptic precautions of sterile 
apparatus and solutions.
Method: - 1. A pint of blood was collected from each of 10
normal subjects. - The clots were separated from the bottle wall 
by a wire and the bottles placed in the refrigerator overnight. 
2. The serum was pipetted into centrifuge tubes, spun, and the 
clear serum was bulked and preserved in the refrigerator till 
next day.
A. Albumin.
a) To 1 volume of serum was added an equal volume of saturated 
ammonium sulphate solution, and this mixture was stored at 0°C 
for 1 day.
b) The precipitated globulin was removed by centrifugation.
c) To the supernatant, 10% acetic acid was added, with constant 
stirring, to the point of definite faint turbidity which 
corresponded to a pH of 6*0. The red colour of the fluid 
changed to yellow just before this end-point.
d) This mixture was allowed to stand for 2 hours at room 
temperature.
e) The same volume of acetic acid as was added in stage (c) was 
now added to bring the pH to between 4*9 and 5*1. The yield 
could be increased by a further slow addition of saturated 
ammonium sulphate solution to a total of 1 ml. per 100 ml. of 
fluid.
f) Crystallisation of the albumin took place overnight at room 
temperature.
g) These crystals of albumin were separated by centrifugation.
h) Washing; the crystals were mixed with an equal volume of a 
solution composed of 60 ml. of molar sodium acetate, 40 ml. of 
molar acetic acid, 100 ml. of saturated ammonium sulphate soln. 
and then recentrifuged.
The crystals were again washed and recentrifuged.
i) Purification: 2 g. of crystals were dissolved in 50 ml. of
distilled water, and the solution filtered to remove insoluble 
residue such as lipoids. To the filtrate were added 8 ml. of 
molar sodium or ammonium acetate and then saturated ammonium 
sulphate equal in volume to (filtrate + acetate solution).
Over a period of 15 minutes, with stirring, was added a mixture 
of equal volumes of molar acetic acid and saturated ammonium 
sulphate solution; 1*33 ml of this mixture for each ml. of 
sodium acetate solution added in stage three above, - usually 
about 10*6 ml.. Crystallisation took place in the next 2 hours 
during which the fluid was stirred frequently: the yield was 
increased on standing overnight at room temperature. The 
crystals were removed by centrifugation.
j) The crystals were purified again as above.
The yield of albumin was 1 g. per 100 ml. of serum 
in 3-4 days.
k) Dialysis: the crystals were redissolved in distilled water
and dialyzed at 0°C against 0*8/15 molar NagHPO^ and 0*2/15 
molar KHgPO^ per litre (pH = 7*41 at 0°C). Cellophane sausage 
skins were used. Dialysis continued until the levels remained 
constant.
l) These cellophane skins were hung in a current of warm air 
and after many days a dried protein product (sodium albuminate) 
was obtained.
B. Globulin.
a) The globulin prepared at stage (b) above was redissolved, in 
water.
b*) It was reprecipitated by an equal volume of saturated 
ammonium sulphate solution, and again separated by centrifugation.
c) This solution and reprecipitation was repeated for a further 
four times.'
d) The globulin was dissolved in water and’dialyzed at 0°C 
against the same buffer as used for albumin.
e) The protein was dried in a stream of air.
(E) Preparation of Ultrafiltrates from Serum.
The ultrafiltrates were prepared from sera by filtration, under 
pressure, through cellophane sausage skins. Figure I indicates 
the arrangement of the apparatus.
One end of the casing was eased onto a firm rubber bung and
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Fig. al. Apparatus for the preparation 
of Ultra-filtrates.
Filtration-pressure was obtained by a
bicycle pump, with a Winchester bottle as
the reservoir.
The ultra-filtrate passed through a
■cellophane sausage skin; the skin was
. fixed tightly to the glass tube above and
the stiff rubber bung below. The outer
tube was kept as narrow as possible and
closed with a plug of cotton-wool to
reduce evaporation.
Scale = actual size.
sealed with cellophane tape. The other end was eased onto the 
end of a 4” length of glass tubing of about. 3/4” diameter Y/hich 
had been selected because of the tight fit between tube and 
casing; seal was again made with cellophane tape. About 3” of 
casing lay between the bung and tube, to give a capacity of 
about 30 - 40 ml. when allowance was made for the expansion of 
the casing under pressure and loss of fluid in the filtrate.
This filtrate was collected in a large test-tube, closed lightly 
with cotton-wool. A pressure of 3" of mercury v/as obtained by 
a bicycle pump and winchester-bottle-reservoir. The overnight 
yield was only about 2 ml.
All the ultrafiltrates (10) were tested for protein and no 
sample had to be discarded,
(Elek and Hilson (69 ) have recently described an apparatus 
by which a large yield is obtained from a smaller volume of 
serum than I required. The pressure head is obtained by 
centrifugation. This apparatus will be obtained for ny 
further experiments. )
(F) Measurement of the Specific Gravity.
Three techniques were employed.
(i) Density Bottle Method.
In my first experiments I used a density bottle of 2 ml. 
capacity. As the number of estimations per day increased, this
a M
technique became so inconvenient that it was discarded in 
favour of the following method.
(ii) Falling-Drop Method of Barbour and Hamilton (18).
Their original technique was followed in detail. A new 
nomogram was constructed to allow of rapid calculation of the
r
results.
This method has the advantage over the third technique • 
in that it can "be used with non-protein-containing liquids as 
well as for plasma and serum.
Principle: - A drop of defined volume of the fluid fell through a
less dense liquid with which it was immiscible and the time taken
by this drop to travel a defined distance was noted; similar
measurements were made with identical drops from liquids of
known specific gravity; the specific gravity of the test
fluid can be calculated by a comparison of the times of fall.
Apparatus; - see Figure II and III.
Water-bath; NPL thermometer, stop-watch; pipette-holder; 
tubes of 50cm. length and 7 mm. bore, with graduations 
30 cm. apart and 10cm. from the ends.; pipettes to 
deliver 0*01 ml. ,between two graduations.
Reagents: Aqueous solutions of potassium sulphate of known
specific gravity; various mixtures of zylol and bromobenzene.
Method:- a) The temperature of the water-bath was adjusted to
within a degree of 20°0 and the temperature noted to the nearest
0*1° on the thermometer.*
al5
Fig. all. Barbour and Hamilton’s 
Falling-drop Specific Gravity Apparatus.
A tall glass tube of 60 cm. length acts 
as a water-bath: a small electric bulb 
compensates for heat loss to the air: 
the water is mixed by air bubbles intro­
duced below the perforated plate.
The upper surface of the plate is 
covered with perforated plasticine which 
anchors the lower end of the graduated 
tubes but permits easy removal.
The tubes are 7 mm. in diameter and 
50 cm. in length; the graduations are 
50 cm. apart and 10 cm. from the ends.
The tubes are filled to within a 
millimetre or so of the end. In 
practice the water would be higher in the 
outer jacket and the inner tubes would 
not project so far.
The graduated tubes must be 
maintained vertical.
al6
Fig. alii. The pipette and 
pipette-ho'lder of the specific 
gravity apparatus.
The pipette is held tightly "by the spring 
attachment.
The contents of the pipette are controlled by 
the knurled disc.
One hand only is required to hold and 
manipulate the assembled apparatus.
b) The tubes containing the bromobenzene-zylol mixtures were 
arranged vertically by comparison with a plumb line, in two 
planes.
c) The special pipette, with teat attached, was inserted into 
the holder (designed by myself; made by an asylum inmate).
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d) The pipette was filled to the upper graduation, the tip was 
wiped dry, and the tip was inserted just below the surface of 
the bromobenzene-zylol. Compression on the teat until the fluid 
fell to the lower graduation, a sharp upward movement to detach 
the protruding drop, and exactly 0*01 ml. of fluid was falling.
e) By stop-watch, the time taken for the drop to pass between 
the graduations 30 cm. apart on the tubes was noted.
f. A duplicate test usually agreed to within 0*2 seconds.
g. The technique yras repeated with solutions of known specific 
gravity.
h) By means of a nomogram, the specific gravity was calculated 
from the times of fall, a correction for temperature variation 
being included.
This method is accurate to about 0*0001.
Three standard solutions of potassium siilphate, and five 
bromobenzene-zylol mixtures were sufficient to cover the range 
of the specific gravities from the ultrafiltrate to the heaviest 
plasma.
(iii) Copper Sulphate Method of Phillips et al. (194)
Principle: Solutions of copper sulphate were prepared of known
specific gravity, at 0*0005 intervals. If a drop of a 
protein-containing fluid was: introduced the protein was 
precipitated to form a coating to the remainder of the fluid;
al8
the drop then adjusted its level according to the relation of 
its specific gravity to that of the copper sulphate solution, 
rising if lighter, falling if denser, remaining at constant 
level if identical.
Further fluid was abstracted from the drop in 30 seconds or 
so, and the drop fell to the bottom, leaving the bottle ready 
for the next test.
Apparatus:- Pasteur pipettes and teats.
Copper sulphate solutions, in 150 ml. bottles, in a
series from sp. gr. 1.0100 to 1*0380.
Method: - A drop of plasma or serum was dropped from a pipette
from 1 cm. above the copper sulphate solution surface. The
behaviour of the drop was noted. By interpolation, the
specific gravity was read to the nearest 0*0001.
(Gr) Erythrocyte Sedimentation Rate or ESR.
Three techniques were used in the course of ny work.
(i) Wintrobe ESR.
a) 5 ml. of venous blood was added to the appropriate amount of 
Heller and Paul’s oxalate mixture (this is often wrongly called 
’Wintrobe!s mixture”, but he acknowledges the previous work by 
the other two authors). The salts were dissolved by gentle 
rocking.
b) Immediately before the further stages of the test, the blood
«
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was mixed thoroughly hy shaking hy hand or in a machine - this 
wascessential in order to break down the aggregates of cells 
which had already formed during the period of standing.
c) With a long dry Pasteur pipette the blood was introduced into
t
a Wintrobe tube to the zero level (this tube is 3 mm. in diameter 
and 120 mm in length, of which the graduations are from 0 to 100 
in mm, the closed end being the 100 mark).
d) The tube was arranged vertically in a special stand.
e) The depth of the plasma was read after 1 hour exactly.
f) The tube was then spun in a centrifuge as a liaematocrit,
g) and by the correction chart of Wintrobe and Landsberg (258 ) 
the ’Corrected ESR' was estimated. This chart correction gave 
the value of the ESR which would have been obtained with the 
average packed-cell-volumes (= 42/o for females; =47/6 for males),
(ii) Westergren ESR.
a) 4 volumes of blood were added to 1 volume of an aqueous 
solution of tribasic sodium citrate, 3*8 g. per 100 ml..
b) Thorough mixing before further testing was made as in Wintrobe 
method.
c) A Westergren tube was filled to the upper graduation and 
the tube arranged vertically in the special stand. (The 
Westergren tube is 300 ram. long, bore is 2*5 mm, the lower 
200 mm. length is graduated in millimetres, and both ends are
Fig. alV The chart prepared by Wintrobe and Landsberg (258 ) 
for the correction of an experimental Wintrobe 
ESR. value for variation in the haematocrit from 
from the normal 42% in females and 47% in males.
F ro . 42. C h a rt fo r  co rre c tio n  o f s e d im e n ta tio n  ra te  a c c o rd in g  to  v o lu m e  o f  |>nck<-<l red 
cells. T h e  lo g a r ith m ic  c u rv e  on w h ic h  th is  c h a rt  is based is h e a v ily  o u t lin e d .  T h e  m ean 
n o rm a l v o lu m e  o f  packe t! red cells fo r  m en (47 ee.) a n d  fo r  w om en (42 cc.) a re  a lso  h e a v ily  
o u t lin e d  a n d  th e  range o f n o rm a l s e d im e n ta tio n  is rep resen ted  b y  so lid  and  o|M>n co lu m n s  fo r 
each sex, re s p e c tiv e ly .
T o  " c o r re c t ”  se d im e n ta tio n  ra te , f in d  on  th e  c h a rt the  h o r iz o n ta l lin e  co rre sp o n d in g  to  th *  
s e d im e n ta tio n  ra te  fo r  th e  p a t ie n t;  f in d  also th e  v e r t ic a l lin e  co rre sp o n d in g  to  th e  v o lu m e  o f 
th e  packe d  red  ce lls  in  th e  p a t ie n t ’s b lo o d . S e lect th e  c u rv e  ly in g  nea rest to  th e  |>o in t o f 
ju n c t io n  o f th e  h o r iz o n ta l an d  th e  v e r t ic a l lin e  and  fo llo w  th is  to  th e  n o rm a l lin e  fo r  th e  sex 
o f th e  p a t ie n t.  T h e  h o r iz o n ta l lin e  co rre sp o n d in g  to  th is  last p o in t o f  ju n c tu re  g ives  th e  
co rre c te d  s e d im e n ta tio n  ra te . S ince the  d iffe rence  be tw een the  n o rm a l s e d im e n ta tio n  ra te ,  
in  m en  an d  w om en is la rg e ly  due  to  the  d iffe re n ce  in  v o lu m e  o f packed red cells, a l l s e d im e n ta ­
t io n  ra te s  m a y  be co rre c ted  to  a v o lu m e  o f 47 cc. and  a s in g le  s ta n d a rd  o f n o rm a l (0  to  ti m m
VO LU M E OF PACKED RED CELLS, CC. PER 100 CC. BLOOD
a21
open.
d) The depth of the clear plasma was measured after 1 hour,
2 hours and 24 hours.
No correction was made for variation in the haematocrit 
values.
(iii) Corrected Maximum Sedimentation Velocity.
The corrected maximum sedimentation velocity was measured 
with "blood containing citrate solution, mixed oxalates, or 
heparin as anticoagulant. The normal average haematocrit value 
was assumed to "be 45>o in "both sexes. The technique for the 
citrate "blood is given here; the other two methods are closely 
analogous.
a) An accurate 4:1 "blood; citrate solution was made in a 
graduated centrifuge tube, volumetric flask, or special tube as 
already described.
b) The blood was mixed by shaking. Two haematocrit samples were 
removed and the remainder of the blood was divided equally between 
two graduated centrifuge tubes.
c) The haematocrits were spun for 30 minutes; the centrifuge 
tubes for 15 minutes.
d) The erythrocytes in one tube were adjusted to 36/6 by removing 
plasma or adding plasma from the other tube - 56/6 = 45/b in the 
original blood when allowance was made for the dilution with
citrate solution.
The equation is given in Figure ! V, but the nomogram removed 
the need for detailed calculations on each test values.
e) The adjusted blood was thoroughly remixed by a long stirring 
rod or by a syringe and lumbar-puncture needle - repeated 
filling and emptying never produced haemolysis.
f) A Westergren tube was filled, the lowero end was closed by 
plasticine contained in a one-holed bung, and the tube was 
arranged vertically on the shelf at the end of the 20°C water- 
bath, as illustrated in Fig. 4 of the general text.
g) The depth of clear plasma was noted at frequent time intervals. 
These values were plotted on graph paper until the line joining 
the points had become straight and steepest. The test was then 
discontinued. Thus a test might require from a half to seven 
hours.
From the slope of the straight line, the maximum velocity 
was calculated in terms of ram./hour or cm./second.
(H) Estimation of Facked-Oe 11-Volume (P.C.V. )
Two techniques were used.
(i) Wintrobe Haematocrit Tube.
The dimensions of the tube have been given in the section on 
the estimation of the Wintrobe ESR. Their capacity is slightly
/vnimCiCMM for jnzi/sTjm ceil-v o l v m
TO T UB 36Z.STM/0AJBD
yofis/73C of P/osmo /o be removed (or ot/JeJ)
• Y(t-±)ml.
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V The nomogram for the adjustment of a citrate blood 
so that the cells "will be 36% of the total volume.
An accurate haematocrit value ($) is measured; a 
blood sample is centrifuged in a graduated tube; 
a line joining the total blood volume and the 
haematocrit will cross the central vertical line at 
a point which will indicate how much of the plasma 
has to be removed or added. A second small volume 
of blood is centrifuged to supply this extra plasma 
if required.
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less than 1 ml.
The tubes were centrifuged for 30 minutes at the maximum 
speed of which the MSE Minor centrifuge was capable (3,000 rpm. ).
The percentage of the erythrocytes was estimated to l/lOth 
division, and a correction was made for any inaccuracy in the 
original filling-volume.
(ii) Papillary Haematocrit Tube.
These tubes are of 6 cm. length and under 1 ram. bore.
They are graduated into 100 divisions. To stand the stress of 
centrifugation, they are held within a metal sheath.
The tubes were filled with blood as in filling a counting 
pipette and closed within the sheath by screwing up the rubber 
washers of the ends. The centrifugation was carried out as 
for the Wintrobe technique.
 ^Sfc a* &  ^ n* *1® SjC 3$C
This concludes the methods for which the details are required.
The results from these techniques have been discussed in the 
general text and the accuracy and value of some of the methods 
have also been criticised.
The estimations included in the following list are in 
general use by all physicians and clinical pathologists. The 
reference for the detailed technique is given after each test.
Gold flocculation test. (175~)
Thymol turbidity test. (174)
Thymol flocculation test. (176)
Alkaline phosphatase of plasma and serum. (134) 
Acid phosphatase of serum. (134)
Urea of blood and urine. (104)
Blood sugar. (134)
Cholesterol of whole blood, serum and plasma. (134) 
Uric acid of whole blood, serum and plasma. (33) 
Serum calcium. (104)
Serum inorganic phosphate. (80)
Sodium of serum. (63 and 104)
Potassium of serum. (63 and 134)
Chloride of serum and plasma. (222)
Alkali reserve of serum and plasma. (104)
a}*, sje >•< >jc jje si< aj< $
(X) Plasma Proteins were measured colorimetrically 
by a method based on a combination of 
G-omall et al. J. Biol. Chem. ,1949,177, 751 
and
Woolf son et al. -Amer. J. clin. Path. ,1948,18,723.
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Part 2
TABLES of- RESULTS 
for 1
PRE-CLINICAL SECTION
Table - A
a26
• The estimation of the viscosity of duplicate samples taken 
from single specimens of mixed oxalate plasraata.
Test 1. Test 2. Difference
1*653 1*652 0*001
1*660 1*662 0*002
1*661 1*661 0
1*661 1*666 0*005
1*661 1*666 0*005
1*747 1*751 0*004
1*785 1*786 0*001
1*785 1*782 0*003
1*797 1*795 0*002
1*805 1*804 0*001
1*835 1*833 0*002
1*860 1*866 0*006
1*903 1*898 0*005
1*915 1*914 0*001
1*983 1*982 0*001
1*987 1*984 0*003
2*005 2*001 0*002
2*031 2*036 0*005
2*166 2*167 0*001
2*263 2*262 0*001
2*398 2*392 o*ooe|
2*459 2*460 0*001
2*499 2*499 0
2*524 2*529 0*005
Maxi, rarem 0*006
Minimum 0
Mean 0*0027
Standard deviation 0*0020
Table- B
Duplicate estimations made on two separate Blood samples 
drawn from single Blood specimens.
No precautions were taken to mix the Blood in the syringe 
Before filling the collecting Bottles.
PLASMA VISCOSITY PCV
~ \
WintroBe 
E. S. R.
Plasma
Protein
No. A B Diff. A J B J A_J B A ___! B
cs. % iI
mn/ 1 hr* g/io0ml*
1 1*895 1*886 0*009 46 5 46*3 ! 11 11 6*95 6*98 j
2 2*178 2*176 0*002 39 3 40*0 I 40 39 7*63 7*85 I
3 2*381 2*388 0*007 39 6 39*7 \ 47 36 7*67 7*78 :
4 2*114 2*111 0*003 41 1 41*6 | 18 18 7*85 7*88
5 2*056 2*051 0*005 41 3 41*3 : 35 37 7*31 7*34 !
6 2*052 2*047 0*005 40 2 40*4 j 27 21 7*45 7*49 |
7 2*059 2*062 0*003 46 3 45*9 i 20 19 7*31 7*31 I
8 1*883 1*900 0*017 39 8 40*0 i 12 - 10 7*31 7*20 1
9 2*066 2*051 0*015 37 7 37*7 ; 31 29 7*99 7*96 !
10 1*838 1*843 0*005 42 5 42*4 1 13 13 6*98 • 7*02 :
11 2*441 2*435 0*006 47 1 47*6 | 13 5 8*39 8*35
12 2*356 2*351 0*005 42 6 43*4 | 20 29 8*06 8*06
13 2*178 2*183 0*005 44 4 44*6 | 24 39 7*56 7*52
14 2*170 2*175 0*005 42 7 42*5 ! 36 36 7*67 7*70
15 2*141 2*134 0*007 40 3 40*3 ! 39 38 7*74 7*74 i
16 2*258 2*244 0*014 45 3 45*3 | 19 20 8*03 8*03
17 1*863 1*864 0*001 43 8 43*4 j 10 10 6*98 7*09 !
18 1*901 1*905 0*004 45 2 44*4 ! 20 19 7*13 7*06 1
19 1*799 1*808 0*009 40 8 40*4 ! 7 6 7*09 7*09 j
20 2*013 2*008 0*005 40 0 40*3 25 27 7*52 7*63
21 1*972 1*974 0*002 40 0 39*9 | 40 38 7*31 7*45 ?
22 2*010 2*032 0*022 47 4 47*4 | 9 12 7*70 7*96 |
23 1*903 1*911 0*008 40 3 40*2 | 14 15 7*34 7*31 !
24 1*863 1*856 0*007 41 8 42.1 ! 5 4 : 7*31 7*45 !
25 1*762 1*769 0*007 40 5 40*1 | 5 5 6*44 6*52 |
26 1*876 1*884 0*008 41 8 42 *4 | 12 12 7*56 7*56 |
27 1*798 1*797 0*001 37 6 37*6 j 11 11 6*88 6*80
28 1*927 1*926 0*001 49 9 49*0 I 2 2 7*34 7*38
29 2*313 2*314 0*001 45 0 45*3 | 28 30 7*63 7*81
30 2*078 2*081 0*003 45 5 45*8 | 11 11 7*63 7*66 !
31 2*100 2*095 0*005 47 4 46*4 | 28 28 7*52 7*52
32 1*997 1*983 0*014 ! 39 6 39*1 | - - 7*49 7*45 |
33 1*952 1*944 0*008 1 44 1 | 44*4 | 14 14 7*16 7*24 |
34 2*114 2*118 0*004 ! 47 6 47*6 | 15 14 8*03 8*06
35 2*098 2*089 0*009 j 44 7 45 *6 1 12 14 7*49 7*70 I
36 1*989 1*996 0*007 | 48 3 i 47*9 | 6 7 ! 7*63 7*67
37 1*890 1*885 0*005 j 49 3 49 *! 1 2 | 7*13 7 *09
38 2*331 2*342 0*011 I 45 0 44*7 j 7 11 * 7*52 7*56
39 2*206 2*204 0*002 | 49 5 49*2 ! 4 5 ; 7*74 7*70
40 2*026 2*043 0*017 1 52 8 1 53*0 ! 3 3 \ 7*31 7*31
41 1*938 1*928 0*010 48 0 48*8 j 11 10 ! 6*59 6*62
42 2*201 2*203 0*002 46 6 46*3 j 10 8 | 8*10 8*17
43 2 *lo8 2*lo7 0*001 43 1 42*7 30 27 7*38 7*45
44 1*898 1*901 0*003 43 9 43*1 6 7 6*91 6*95
45 1*871 1*865 0*006 48 5 49*0 j 2 2 7*1.6 7*27
Table - C a28
Duplicate tests by taking blood samples from both arms 
with as short a time-interval between the venipunctures as possible.
The arm mentioned first in the table is the arm from which 
the first blood sample was taken.
Arm PCV. PLASMA
vise.
Wintrobe
ESR.
Plasma
Total
Protein
Plasma
Spec.
G-ravity
% cs. mm/l hr g./o
Left 49*6 1*660 0*5 6*44 1*0259
Right 49*3 1*661 1* 6*41 1*0258
Right 48*1 1*759 1 6*88
i
1*0269 ;
Left 48*0 1*761 1 6*88 1*0269 !
Right 34 *9 2*171 55 7*42
i
1*0286 \
Left 34-2 2*163 55 7*42 1*0286 j
Left 38*2 2*262 39 7*31 1*0283
Right 38*4 2*255 52 7*27 1*0282 j
Left 40- 1*845 32 6*41 1*0258 !
Right 40; 1*840 32 6*48 1*0260 j
I
Left 40*7 2*088 46 6*98 1*0274 |
Right 39*7' 2*077 49 6*88 1*0271 :
S
Right 35 *8 1*830 11 6*84
j
1*0268
Left 36 *3 1*826 10 6*95 1*0270
Mean difference = 0•0054 cs.
Standard deviation = 0 *0035
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Table - E a30
Comparison of the Plasmata derived from three samples of 
a single blood specimen
‘A1 = supernatant plasma from 5 ml. of blood which was
centrifuged as soon as possible.
'B’ = supernatant plasma from 5 ml. of blood which was
put into a centrifuge tube, stoppered, allowed to 
remain undisturbed on the bench, and centrifuged 
after 24-hours at tame time as * 01;
'O' = supernatant plasma from 5 ml. of blood which was
kept in a Bijou bottle, with several gentle mixings, 
for 24-hours and then centrifuged.
'B! represents plasma v/ith minimal but continual contact with 
erythrocytes.
*C’ represents plasma with considerable contact with*erythrocyte
Centrifugation was standardized for all samples - 15 minutes, at 
2,300 r. p.m., in a MSE Ma j or centrifuge.
PLASM VISCOSITY TOTAL PROTEIN.
1a B n Differences. A B nA 1 A-B A-C 1
1*637 1*667 1*678 +0*030 +0*041 6*12 6*23
|
6*23 1
1*688 1*693 1*695 +0*005 +0*007 6*26 | 6*34 6-41 |
1*710 1*732 1*723 +0*022 +0*013 6*59 6 *66 6*62 j
1*731 1*742 11*743 +0*011 +0*012 6 *48 6*30 6 *30 1
1*806 1*820 1*808 +0*016 +0*002 6*91 7*06 6*98 j
1*813 1*818 1*845 +0*005 +0*04-2 7*27 6*95 7* 02 j
1*817 1*821 1*842 +0*004 +0*025 6*95 6*88 6*95 |
1*860 1*865 1*889 +0 *005 +0*029 7*24 7*09 7 *09 ;
1*863 1*868 1*882 +0*005 +0*019 7*27 7*13 7*63 j
1*919 1*928 1*948 +0*009 +0*029 7*56 7*13 7*45 !
1*972 2*011 2*024 +0-039 +0*052 6*80 6*95 6*98 |
1*978 2*029 2*029 +0*051 +0*051 7*49 7*56 7 *67 j
1*981 2*005 2*002 +0*024 +0*021 6*98 7*09 7*09 |
1*995 1*999 2*012 +0*004 +0*017 7*45 7 *45 7*49 |
2*022 2*038 2.*040 +0*016 +0*018 6*62 6*98 6*91 !
2*027 2*028 2*046 +0*001 +0*019 6*84 6*77 6*95 j
2*042 2*038 2*068 -0-004 +0*026 7*31 7*31 7*31 j
2*103 2*137 2*143 +0*034 +0*040 7*45 7*49 7 *49 |
2*207 2*215 2*217 +0*008 +0*010 7*34 7*31 7*45
2*480 2*480 2*491 0 +0*011 8*03 8*17 8*03 [
Range -0*004
+0*051
+0*002
+0*052
Mean +0*0143 +0*0237
Standard deviation 0*0146 0*0136
Table - P and G- a31
The loss which may be produced by using centrifuge tubes without 
closures.
(P) Pyrex centrifuge tubes, calibrated in 0*1 ml marks, were 
filled to the 10 ml. mark with distilled water; they were spun, 
without caps, for 4 successive periods of 15 minutes, with the 
smallest possible interval between. The temperature recorded is 
that of an accompanying tube of water so that the thermometer did 
not remove any of the contents of a graduated tube.
Original after 15. after 30. after 45. 
Vol. 7 Temp
f
after 60 |t > 
jL o s s  I
Vol. (Temp.; |Vol. Temp. Vol. Temp. ! Vol. Temp.
ml. °c. ml. "H °C. ml. °C. ml. °C. ml. °0 ; >o ;
10*00 - 9*95 - — - - _ 9*20 - 18 *0 ;
10*00 - 10*05 _ - - - 9-25 -  17*5 ;
10*00 _ 9*90 ~ - - - 9-17 - |s *3 |
10*00 9*90 - - - 9*15 - ;8 -5 !
10*00 18 9-90 25 9*79 25 9*61 30 9*47 33 i5-3 i
10-00 »» 9*92 ti 9*83 ti 9-69 9 -53 " ;4 -7 1
10*00 9*90 i i 9-82 it 9*67 it 9-53 " (4-7 ;
10*00 i i 9*92 i i 9-80 i i 9-68 " ] 9*50 " 15*0 1
___ ___i_________1
10 ml. of blood were introduced into a graduated pyrex 
centrifuge tube and spun without a cap for 4 periods of 15 minutes; 
about 1 ml. was removed at each interval for the plasma viscosity 
estimation. Another specimen of the blood was centrifuged for 
the complete hour in a stoppered tube.
Note the small amount of concentration which has occurred within 
the first 15 minutes, and the later larger changes.
Specimen
PLASM
vise. Sp. G-rav.
Plasma
Total
Prot.
PCV
/
Tot.
Vol. after 
removing 
plasma
Loss /o of 
total
/0 Of 
plasma
cs. g*
\
ml. ml.
15 min. 1*937 1-0241 5-80 391:989 ] 8*60 0*11 1*1 1*6
30 min. 1*963 1-0255 6-30 385:357 7-43 0*03 0-35 0*63
45 min. 1*982 1-0262 6-55 379:789 5-70 0*04 0*55 1*1
60 min. 2*057 1-0272 6*91 377:567 - 0*03 0-53 1-6
Capped 1*919 1-0242 5*83 j
15 min. 2*233 1*0217 4*94 402:978 8*67 0*22 2*2 3-8 J
30 min 2*282 1*0224 5*18 403:860 7*39 0*07 0*81 1*6
4-5 min. 2*325 1-0231 5-44 402:731 5-91 0-08 1-1 2*4
60 min. 2*443 1-0238 5-69 400:587 ~ 0-04 0*7 2-1
Capped 2-216 1-0219 5-00
Table - (G) continued. ad2
Note the increase in the plasma viscosity and the total protein 
as a result of centrifuging without closures to the tubes.
The figures are also included for the plasina prepared by 
allowing the cells to sediment.
The haematocrits of four of these bloods have their 
results presented in Table (Bj.
Specimen PLASMA.vise.
Increase Sp. G-rav.
Plas.
Total
Prot.
Increase Test
No.
(B)
Temp.Vise. % Prot. /°
15 min. 
30 min. 
45 min. 
.(30 min.
Sediment
cs.
1*881
1*897
1*928
2*009
1*880
cs.
0*016
0*047
0*128
0*9 
2 *5 
6 *8
1*0286
1*0292
1*0297
1*0305
1*0284
g-L>
7*42
7*63
7*81
8*10
7*34
g. >
0*19
0*39
0*68
\
2*6 
5 *3 
9*2
14
°C.
52
15 min. 
30 min. 
45 min. 
60 min.
Sediment
1*743
1*759
1*796
1*914
1*760
0*016
0*053
0*171
0*017
0*9
3*0
9*8
1*0271
1*0273
1*0287
1*0309
1*0271
6*88
6*95
7*45
8*24
6*88
0*07
0*57
1*36
0
1*0
8*3
19*8
15
32
15 min. 
30 min. 
45 min. 
60 min.
Sediment
2*102
2*142
2*222
2*382
2*087
0*040
0*120
0*280
W
1*9
5*7 
13 *3
1*0290
1*0296
1*0304
1*0328
1*0285
7 *56 
7*78 
8*03 
8*93
7*38
0*22
0*47
1*37
2*9
6*2
18*1
13
32
15 min. 
30 min. 
45 min. 
60 min.
Sediment
1*813
1*837
1*883
2*020
1*809
0*024
0*070
0*207
1*5
3*9
11*4
1*0283
1*0288
1*0295
1*0322
1*0277
7*31
7*49
7*74-
8*71
7 *09
0*18
0*41
1*40
2*5
5*6
19*2
16
32
15 min. 
30 min. 
45 min. 
60 min.
1*919
1*940
1*994
2*081
0*021
0*075
0*162
1*1
3*9
8*4
1*0289
1*0294
1*0300
1*0318
7*52
7*70
7*92
8*57
0*18
0*40
1*05
2*4
5*3
15*7
-
15 min. 
30 min.
Sediment
.1*924 
1*972
1*948
0*048
0*024
2*5
1*2
1*0283
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1*0279
7*31
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7*16
0*11 1*5
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Table - I a37
The effect of centrifuging upon the plasma viscosity values - 
the difference caused by failure to stopper the centrifuge tubes.
The first twenty tests were centrifuged for 15 minutes; 
the capped tubes only in the last two tests were centrifuged for 
60 minutes.
Test
Plasma Viscosity Specific G-ravity Total Protein
No. Open
tube
Closed Differ. Open \Closed
__ _ J
I ' 
Open s Closed
-......... .................... —
1 1*643 1*627 -0*016 1*0237 1*0234 1 5*65 5*54
2 1*718 1*703 -0*015 1*0263 1*0258 ' 6*59 6 *41 !
3 1*722 1*706 -0*016 1*0248 1*024-7 1 6*05 6*01 |
4 1*770. 1*748 -0*022 1*0272 1*0268 | 6*91 6*77 :
5 1*770 1*753 -0*017 1*0268 1*0265 6*77 6 *66
6 1*771 1*761 -0*010 1*0237 1*0233 5*65 5*51 j
7 1*788 1*767 -0*021 1*0263 1*0259 6 *59 6 *44 •
8 1*804 1*780 -0*024 1*0266 1*0265 6*70 6 *65 ;
9 1*820 1*807 -0*014 1*0265 1*0263 6 *66 6*59 !
10 1*825 1*811 -0*014 1*0265 1*0263 6*66 6 *59 :
11 1*842 1*826 -0*016 1*0288 1*0282 7*49 7*2 7 ;
12 1*872 1*845 -0*027 1*0287 1*0282 7*45 7*27 |
13 1*872 1*849 -0*023 1*0286 1*0284 7*42 7*34 |
14 1*892 1*882 -0*010 1*0248 1*0242 6*05 5*83 i
15 1*889 1*883 -0*016 1*0289 1*0283 7*52 7*31 ^
16 1*903 1*888 -0*015 1*0279 1*0276 7*16 7*06
17 1*906 1*892 -0*014 1*0289 1*0287 7*52 7*45
18 1*919 1*905 -0*014 1*0278 1*0274 7*13 6 *98
19 1*965 1*948 -0*017 1*0264 1*0262 6*62 6*55 I
20 2*180 2*159 -0*021 1*0287 1*0287 7*45 7 *45 |J
Range
-o~*cT(T
-0*027
j
Mean -0*0171 |
Standard deviation 0*0043
21 1*937 1*919 -0*018 1*0241 1*0242 5*80 5*83
22 2*233 2*216 -0*017 1*0217 1*0219 4*94 5*00
Table - j(i)
Comparison of the Plasmata derived from two samples of one 
blood specimen:-
’A1 supernatant plasma from a 4- or 5 ml. blood sample which
stood in a stoppered centrifuge tube on the bench at 
room temperature until the cells had sedimented enough
to yield at least 1 ml. of plasma.
'B* = supernatant plasma derived by centrifuging 4 or 5 ml. of
blood in a Major MSE centrifuge at 2,300 rpm. for 
15 minutes.
These results should be compared with those of the following 
table.
................................. .
PLASMA VISCOSITY. SPEC. GRAV. TOTAL PROTEIN.
A B difference r  a B A B difference
1*657 1*681 +0*044 (1*0250 1*0248 6*12 6*05 -0*07
1*710 1*742 +0*032 11*0263s 1*0263 6*59 6*59 _
1*731 1*757 +0*026 j1*0260 1*0258 6*48 6*41 -0*07
1*760 1*743 -0*017 | 1*0271 !1*0271 6*88 6*88 -
1*760 1*711 “0*049 j1*0274 1*0268 6*98 6*77 -0*22
1*809 1*813 +0*004 1*0277 1*0283 7*09 7*31! +0*22
1*813 1*841 +0*028 | 1*0282 1*0272 7*27 6*91 -0*36
1*869 1*863 “0*006 j 1*0278 1*0282 7*13 7*27 +0*14
1*880 1*881 +0*001 1*0284 1*0286 7*34 7*42 +0*08
1*916 1*920 +0*004 | 1*0257 1*0257 6*37 6*37 -  -
1*930 1*919 -0*011 j 1*0279 1*0280 7*16 7*20 +0*04
1*944 1*937 “0 *007 1 1*0279 1*0286 7*16 7*42 +0*26
1*945 1*936 -0*009 1*0280 1*0284 7*20 7*34- +0*14
1*948 1*924 -0*024 1*0279 1*0283 7*16 7*31 +0*15
1*972 2*005 +0*029 1*0269 1*0269 6*80 6*80 -
1*978 1*996 +0*018 1*0288 1*0288 7*49 7*49 -
1*981 1*955 -0*026 1*0274 1*0273 6*98 6*95 -0*03
2*042 2*041 -0*001 1*0283 1*0283 7*31 7*31 -  -
2*087 2*102 +0*015 1*0288 1*0290 7*49 7*56 +0*07
2*207 2*200 -0*007 1*0284 1*0282 7*34 7*27 -0*07
Range of +0*044 +0*0007 +0*26
differences -0 *049 -0 *0010 -0*36
Mean of +0*002 +0*000035 +0*014
differences
Table - j(ii;
Comparison of the Plasmata derived from a single "blood sample:-
'A* = supernatant plasma taken from the upper layer of plasma 
formed by the sedimentation of the cells of 8-10 ml. of 
blood, standing in a stoppered centrifuge tube on the 
bench at room temperature ; about 1 ml. of plasma formed 
this sample.
*Bf = the remaining plasma and cells were centrifuged at 2,300 
rpm. in a Major MSE centrifuge for 15 minutes; 1 ml. of 
this plasma was removed to form this sample.
These results should be compared with those of the preceding 
table.
y...~ —
PLASMA VISCOSITY. SPEC. GRAV. | TOTAL PROTEIN.
A B difference f A B
— — ----------
A B difference
1*681 1*675 -0*006 F1*0248 1*0257 6*05 ! 6*37 +0*52~~— ""
1*742 1*733 -o*009 1 1*0263 1*0263 6*59 i 6*59 -
1*757 1*743 -0*014 1 1*0258 1*0258 6*41 6*41 _
1*760 1*708 -0*052 ] 1*0274 1*0271 6*98 6*88 -0*10
1*777 1*767 -0*010 j 1*0258 1*0260 6*41 6*48 +0*07
1*841 1*818 -0*023 ! 1*0272 1*0275 6*91 7*02 +0*11
1*869 1*863 -0 *006 1*0278 1*0280 7*13 7*20 +0*07
1*916 1*917 +0*001 ! 1*0257 1*0254 6*37 6*26 -0*11
1*930 1*914 -0*016 1*0279 1*0278 7*16 7*13 ; -0*03
1*944 1*954 +0*010 1*0279 1*0283 7*16 7*31 +0*15
1*955 1*989 +0*034 1*0273 1*0282 6*95 7*27 +0*32
1*996 2*041 +0*045 1*0288 1*0291 7*49 7*60 +0*11
2*005 2*010 +0*005 1*0269 1*0273 6*80 6*95 +0*15
2*017 1*998 -0*019 1*0284 1*0282 7*34 7*27 -0*07
2*041 2*065 +0*024 1*0283 1*0283 7*31 7*31 | _  -
2*070 2*045 -0*025 1*0285 1*0281 7*38 7*24 i -0*14
2*185 2*160 -0*025 1*0303 1*0302 8*03 7*99 -0*04
2*096 2*066 -0*030 1*0297 1*0295 7*81 7* 74 -0*07
2*200 2*204 +0*004 1*0282 1*0288 7*27 7*49 +0*22
2*603 2*640 +0*037 1*0298 1*0298 7*85 7*85 -
Range of +0*045 +0*0009 +0*32
differences -0*052 -0*0004 -0*14
Mean of -0*0038 +0*00013 +0*057diilerences
Table- K &An
The effect of Delay in the Estimation on the viscosity values of 
citrate plasma, oxalate plasma, and serum.
These fluids were separated from the cells and kept in a 
stoppered tube on the bench at room temperature, without an 
attempt to obtain sterility.
The first test was made as soon as possible.
Initial
Viscosity
Delayed
Viscosity
Time
Interval
cs. cs. hours
Citrate Plasma
1*707 1*698 4
1*707 1*707 28
1*540 1*553 5
1*895 1*885 5
1*895 1*876 26
1*667 1. 644 24
1. 657 1*653 25
2*017 2*041 25
Oxalate Plasma
1*763 1*760 2
1*888 1*887 3
1*763 1*764 4
1*797 1*795 4
2*012 2*012 4
1*885 1*895 19
2*066 2*085 19
1*923 1*915 22
2*355 2*369 23
1*763 1*766
Serum
24
1*893 1*898 1/2
2*046 2*050 3
2*084 2*063 4
2*044 2*041 4
1*878 1*888 4
1*694 1*693 18
2*083 2*082 24
1*566 1*574 23
2*426 2*422 24
1*878 1*888 27
2*044 2*021 27
Table- L ail
The effect of Delay in the Estimation on the viscosity values of 
oxalate plasma, citrate plasma, and serum.
These fluids were separated from the cells and kept on the 
"bench, at room temperature and without precautions for sterility, 
as 1 ml. samples in small stoppered tubes. Each day a tube was 
chosen at random.
Days.
0 1 2 | 5 4 I _ 5_ 6 I 7 1 8 Mean
Oxalate plasma.
r
2*466 2*490 2*472 2*468 12 *470 - 2*484 2*483 2*481 2*477
1*880 1*882 1*881 1*879 1*877 - 1*888 1*882 - 1*881
1*743 1*742 1*748 1.742 1 - 1*754 1*746 1*745 - 1*746 1
1*982 1*987 1*984 1*977 - 2*002 2 *003 2*005 2*020 1*995 ?
2*012 2*013 2*003 2*008 - 2*020| 2. 021 - 2*013 !
1*936 1*934 1*941 1*927 1*950 - 1*948 1*952 11*957 1*943 !
1*874 1*875 - 1*875 11*846 1*861 1*858 1*861 1*863 1*864 !
1*929 1*914 1*917 1*920 1*924 1-319 — 1*921 j
2*220 2*226 2*245 - 2*237 - - 2*232 |
2*059 2*052 2*072 2*072 - - - - - 2*064 [
1*777 - - 1*785 1
1*802 - - 1*802 j
2*338 - - 2*334
2*017 - — 2*013 s
2*421 - - 2*425
2*055 - - 2*054
1*907 - - 1*905
1*955 - 1*950
2*800 - - 2*765
2*902 - - 2*907
3*228 - 3*240 - 3*225
Citrate plasma.
1*495 1*508 “ |1*519 1*495 1*524 1 1
Serum*
1*792 - - 1*798
1*624 - - - 1*616
Maximum differences from mean 0 = + C 1 * 0 2 5 and - 3*013
Minimum differences from mean = + 0*007 and - 0*004
Table - M a42
The effect of violent shaking for four hours in a Griffin and 
Tatlock Microid Flask Shaker on the viscosity of mixed oxalate 
and of heparin plasmata. In addition to the effect of 
ill-treatment, the effect of the four-hour delay must he 
considered.
Test
Plasma Viscosity Specific Gravity Total Protein
No. Before
Shaking After Differ. Before After Before After
(a ; Mixed C)xalate Plasma.
i 1*730 1*739 +0*009 1*0258 1*0262 6*41 6*55
2 1*779 1*779 0 1*0278 1*0278 7*13 7*15
3 1*722 1*726 +0*004 1*0272 1*0273 6*91 6 *95
4 1*692 1*689 -0*003 1*0268 1*0268 6*77 6*77
5 2*031 2*025 -0*006 1*0273 1*0273 6*95 6*95
6 1*796 1*790 -0*006 1*0267 1*0268 6*73 6*77
7 2*415 2*411 -0*004 1*0262 1*0266 6*55 6*70
8 2*076 2*075 -0 *001 1*0297 1*0300 7*81 7*92
Range +0 *009 
-0*006
(B) Heparin Plasma.
Range +0*011-0*009
1 1*735 1*748 +0*011 1*0241 1*0238 6*16 6*05
2 1*777 1*768 -0 *009 1*0237 1*0237 6 *ol 6*01
3 1*732 1*739 +0*007 1*0245 1*0245 6*30 6*30
4 1*610 1*608 -0 *002 1*0218 1*0218 5*33 5*33
Table - N a43
Experiments carried out to measure the effect of rough treatment 
and delay of postal specimen transport on the plasma viscosity.
The specimens were sent 1.000 miles (Portsmouth-G-lasgow-Portsmouth). 
The first eight specimens were received "back in 3 days, the last 
four specimens took 7 days. The non-transported blood was 
centrifuged and its plasma viscosity measured after 5 days in 
every instance.
20 ml. of blood were collected into mixed oxalate. 10 ml. 
were centrifuged: the plasma viscosity, etc. was measured at once 
on the plasma; another sample of the plasma was sent off by post 
and the same measurements made on its return. 5 ml. of blood was 
similarly sent by post, centrifuged on its return, and the usual 
measurements made.
’P1 = plasma sj>ecimen; ’B 1 = blood specimen.
Non-transported Tra
Plasma
Vise.
nsported
No. PCV. Spec.
G-rav.
Tot.
Prot
Plasma
Vise.
Tot.
Prot
Spec.
G-rav.
PCV.
% 0/ &• /° cs. cs.
i
ii % \
1 P 41*1 1*0307 8*17 2*421 2*425 8*42 ! 1*0304
B 44 * 5 1*0310 8*28 2*547 2*501 8*14 1*0306 42*5
2 P 45-1 1*0305 8*10 2*055 2*054 8*03 1*0303 -  I
B 48*0 1*0305 8*10 2*086 2*092 8*03 1*0303 45 *5 ;
3 P 45*1 1*0289 7*52 1*905 1*907 7*45 1*0257 —
B 47*5 1*0289 7*49 1*908 1*910 7*38 1*0255 45 *9
4 P- 41*3 1*0269 6*80 1*955 1*950 6*73 1*0267 -
B 45*2 1*0270 6*84 1*999 1*992 6*84- 1*0270 43*0
5 P 46*3 1*0284 7*34 2*017 2*013 7*45 1*0287 | i
B - - - - 2*068 7*63 1*0292 |I
6 P 45*3 1*0302 7*99 2*338 2*334 7*99 1*0302 —
B - - - - 2*363 7*99 1*0302 1f
7 P 49*7 1*0275 7*02 1*802 1*802 7*02 1*0275 j —
B - - - - 1*861 7*13 1*0278 | -
8 P 49*0 1*0270 6*84 1*777 1*785 6*84 1*0270 1 _
B - - - - 1*887 7*38 1*0285 j -
continued over -
Table - N (continued) a44
In addition to the plasma prepared by centrifuging blood, for 
these last four tests a supernatant plasma after sedimentation 
of the cells was prepared. The blood was allowed to stand on 
the bench undisturbed for 3 - 4  hours, about 1 or 1*5 ml. of 
clear plasma was pipetted off and sent off with the other postal 
specimens, and this plasma was centrifuged on its return.
^  = plasma specimen, as prepared by centrifuging,
’S’ = supernatant plasma specimen,
’B ’ = blood samples.
. Non-transported Transported
No. PCV. Spec.
G-rav.
Tot.
Prot
Plasma
Vise.
Plasma
Vise.
Tot.
Prot
[Spec. 
| G-rav.
[bcv.
0/
7° g*% cs. cs. g •¥<>
i
9 P 35*6 1*0264 6*62 1*944 1*957
\
6.59 j 1*0263 _
S - - - - 1*942 6*55 1*0262 -
B 37*1 1*0263 6*59 1*975 2*265 7*4-5 1*0287 36 *5
10 P 33*9 1*0269 6*80 1*864 1*878 6*80 1*0269 —
S - - - - 1*882 6*59 ! 1*0263 -
B 35*8 1*0271 6*88 1*904 2*018 7*24 1*0281 35*6
11 P 43*7 1*0285 7*38 2*129 2*155 7*52 1*0289
S - - - - 2*129 7*31 1*0283 —
B 46*9 1*0272 6*91 2*185 2*503 8*28 1*0310 49*2
12 P 37*6 1*0282 7*27 2*034 2*070 7*16 1*0279
S - - - - 2*041 7*16 1*0279 -
B 40*1 1*0279 7*16 2*066 2*187 7*81 1*0297 45 *0
v
Table - 0 a45
The effect of temperature upon the viscosity of water, plasma,
and serum.
The recorded figures are the ’'Times of Fall", corrected for 
variation in the rest levels from the ideal.
There are seyeh tests where the test was repeated with the 
specimen after 24 hours on the laboratory bench; there has been no 
alteration in the response to temperature changes.
Fluid. H3
to o o
T
37*5°
Difference 
as a fo of 
T
20°
T
20°
T‘
37*5°
Difference j
as a /o ox i
T ^20- j
sec. sec. sec. sec.
j
|
Water 49*0 33*6 31*5 j
P+A 95*6 65*5 31*4 89*4 58*8 34*2 I
Plasma 97*2 65*0 33*1 89*3 59*8 33*1 \
85*1 57*9 31*9 104*3 68*9 33*8 ;
109 *4 73*8 32*6 84*7 56*7 33-1 I
92*2 62*6 32*1 121*9 81*6 33*1 i
86*1 58*2 32*4 87*4 59*6 31*9 I
109*8 72 *7 31*7 90*7 60*6 33*2 1
1. A 88*8 60*9 31*4 86*9 59 *2 31*8 |
B 90*1 61*8 31*4 84*2 57*7 31*5 j
2.A 96*2 65*3 32*1 90*5 61*1 32 *5 ' j
B 96*8 67*4 30*3 ' 89*4 60 *1 32 *7 i
3. A 88*0 60*9 30*8 95 *4 65*1 31*5 j
,B 88*7 60*9 31*3 90*3 61*4 3i *4 j
Serum 4. A 81*3 56*7 30*3 81*3 56*4 31*6
B 81*5 56*9 30*2 76*8 51*9 32*4
5. A 86*9 58*5 32*7 78*5 53*8 31*5
B 87*8 59*5 32*2 75*2 53*1 29*4
6. A 86 4 57*6 33*3 80*2 56*2 30*0
B 86*6 57*6 33*4 79 *8 53*8 32*6
82*0 55*5 32*4
Citrate A. 73*9 50*5 31*7
Plasma B. 73*8 50*7 31*3
Table - 0 continued a46
The effect of temperature change on the viscosity of plasma.
In this experiment it was intended to discover if the plasma 
had undergone any fundamental change by being cooled to room 
temperature.
The subject was a healthy woman and her temperature/viscosity 
curve did not contain the "kink" noted in some patients. It is 
essential that this test be repeated in a plasma from a patient 
with such a kink.
A specimen of blood was collected into a syringe heated to 57*5°C 
in an incubator, transferred to a warm tube and centrifuged in 
the incubator; the plasma was transferred to a viscometer already 
at 37*5°C. and the "time of fall" noted as the temperature was 
lowered to 15°C. Another portion of the blood specimen was 
treated at room temperature as usual; the plasma was introduced 
into a viscometer at 15°C and the "time of fall" measured as the 
temperature was gradually increased.
Specimen with temperature 1 Specimen with temperature
being reduced. j being increased
°0 Time j Timei !....°c ~.
15*0 176*7 | 177*1
\
15*0
20*0 153*7
i
153*9 20*0 !
24*1 139*3 139*7 24*0
28*1 127*1 127*0 28 *0 j'
31*1 118*4 118*8
j
31*0 1
33*0 113*7
115*2 32*5
34*5 110*4 110*7 34*5
36*0 107*1 107*3 36*0
37*5 103*8 104*0 37*5
These results are presented in graphical form as 
Fig. 7, page 86 of Volume 1.
Table - 0 continued. a47
The Effect of Temperature Changes on the Plasma Viscosity.
In this table the "Time of Fall" (T), to ■which the viscosity is 
closely related, is given instead of the viscosity values. It is 
not certain that the calibration formula can be applied at any 
other temperature than 20°C. Tests were made with Citrate, 
Heparin and Wintrobe Plasmata, and with Serum.
Test
201 a
Test Test A. P.
G> P. I. M. F.
M.G-.
Citrate ; Citrate ; Serum | P+A.
r
Ox. P. P+A.
----
Plas. P+A.i ■ - - Plasma!
°C T ! O Q T ! °C. T | °C.
t
S
j T °C. T « °c.
;
i
m  1 
JL
15 88*0 i
t
!15 j 120*2 15 ■109*4 15
j
128 *4 |
16 86*8 | | j
17 84-4 \ !i \
18 82*4 . 18 ! 110*7 18 100*7 |
19 80*6 Ii} | ]j \
20 -o 
'
CO 20 93*8 20 86*1 > 20 1105 *2 20 95*4 20
3
111*9
21 76*5 21 91*8 21 85 *4 !
22 74*8 22 89*5 22 83*0 ! 22 91*0 22 107*1
23 73 *4 23 86*8 23 81*6 i
24 71*6 24 84*5 24 80*3 ]
25 69*5 25 83*2 25 78*8 25 1 92*6 25 84*0 25 99*5
26 68*5 26 82*1 26 76*5 i\ ; •
27 67*2 27 79*8 27 75*2 \ ;
28 66*2 28 77*7 28 72*8 28 | 85*8 28 79*3 28 92*4 !
29 63*6 29 76*6 29 71*3 . | |
30 62*3 30 73*4 30 70*4
31 60*6 31 72*2 31 68*8 31 80*6 31 i 74*2 31 86*6
32 59*2 32 71*0 32 66 *9 32 78*4 32 72*8 32 84*3
33 59*2 33 68*9 33 66*1 33 76*6 i33 70*7 33 82*4
34 57*8 34 68*2 34 64 *5 34 75*5 j34 69*3 34 80*8
35 66 *6 35 66*6 35 61*7 35 74*5 ! 35 | 68*0 35 79*1
36 55*4 36 65*1 36*6 59*9 36 72*3 |36 ;66*7 36 77 *3
37 64*1 37*1 59*4 37 70*8 i 37 64*8 37 75*5
38 62*5 38*5 58*2 ■
39 62*4 38*5 68*5 38 *5 63*1 38 *5! 72*8
40 61*3 40*4 56*2
|
Table - 0 continued a.48
The effect of temperature changes on the viscosities of 
different types of plasma and of the serum of a single subject;, 
who was suffering from chronic sepsis and possibly phthisis.
Citrate
Plasma
Citrate
Plasma
Heparin
Plasma
vVintrobe
Plasma
Serum
24: 3:44 25: 3:44 20: 3:44 18 3:44 23: 3:44
°C. T °C. T °C. j T °C. T °C. | T
i| 17*9 109*8
j
j j
18*7 108*4
20*0 88*7 20*0 85 *1 20*0 j101*5 20*0 104*3 20*0 89*8
21*4 86*7 21*7 82*3 21*5 99*3 21*3 103*2 21*7 86*0
22*6 83*5 22*6 80*1 22*2 . 97*6 22*2 100*8 22*4 85*5 j
23*6 82*1 23*5 79*0 23*1 ! 95*3 23*4 98*1 23*5 83 *5
24-8 79*3 24*5 77*4 24*2 | 93*0 24*4 96*4 24*3 81*4
25*6 78*2 25 *6 74*2 25*1 90*5 25*2 93*9 25 *3 79*7
26 *0 77*8 26*6 73*4 26*3 ; 87*7 26*0 92*2 26 *4 78*6
27*2 75*1 27*3 71*2 27*4 : 86*3 26*9 89*3 27*5 77 *1 j
28*0 74*6 28*4 70*0 28*5 84*3 27*9 87*8 28*3 75*6
29*1 72*6 29*7 68*3 29*5 81*9 29*1 86*0 29*5 74*0 |
30*3 70*8 30*4- 81*0 30*5 83*7 30*9 71*1 |
31*1 69 *4 31*1 66*7 51*3 79*4 51*0 82*9 32*1 69*9
32*5 67*7 32*0 63*9 32*1 77*1 32*1 80*7 32*9 68 *9
33*7 66 *6 32*8 63*5 33*2 74*9 33*1 78*3 33*9 66*8
54*8 :65*5 34*2 62*8 34*3 73*2 34*0 77 *6 34*5 ;65*9
35*5 64*6 34*9 61*3 35*2 72*6 35*1 75*3 35*5 ■65 *6
36 *4 62*7 36*2 60*3 36 *4 71*4 36*3 73*6 36*3 65 *1
36*9 61*6 37*3 57*9 37*4 70*5 36*8 72*9 37*3 63*7
38*0 60*5 38 *4 57*3 38*3 68 *6 - ■ 38*2 62*7
38*8 60*1 39*7 56*4 39*8 67*0 38*9 60 *8
40*1 58*2 - - - ~ 40*0 57*9
Table - 0 continued a49
The effect of temperature change on the viscosity of plasma.
All three bloods contained the potassium and ammonium oxalate 
mixture as anticoagulant.
Lipoma Gr.P. I. Still’s
disease.
°0. T °C. T °C. T
20 88 *2 20 *0 87*6 20*0 146*8
23 82*2 23*0 81*6
26 76*6 26 *0 75-7 26*0 128*1
29 72*3 29‘0 70‘6
28*0 118*4
32 67 *8 32*0
33-5
35*0 
36*0 
37 *0 
38-0 
39 *5
66 *2 
64*0
62*0
60*9
59*6
58*2
56*8
31*0
32*0
33*0
34*0
35*0
36*0
37*0
38*5
109*7
107*3
104*7
102*4
100*4
98*1
95*7
93*2
Table - 0 continued. a50
The effect of temperature change on the v i s c o s i t y  of plasma.
0
The anticoagulant in all the following tests was the mixture of 
potassium and ammonium oxalates.
The "time of fall" (t ) has been studied rather than the viscosity 
itself.
Time of Fall Effect of 1°C. change4-. n .. . „ - , . —
Wo.
Tempei
18
-ature
s 20
- °C.
22 . 25
T20-T18
as jo
of T18
T -T±22 20 
as jo
of T20
T 20~T 25 
as jo
o f  T 20
x 5 j
1 96*8 91*85 87*3 82*2 2*55 2*48 H  *3 j
2 86-3 82*3 78*35 73*1 2*31 2*39 11*2
3 91 *1 86*65 82*6 77*0 2*98 2*33 11*17
4 118*1 110*6 105*2 97*4 3*17 2*4-4 11*93
5 100*7 95*4 91*0 84*0 2*56 2*31 11*94
6 110*65 105*2 - 92*6 2*46 - 11*96
7 - 87*9 - 77*6 - - 11*5
8 - 89 *44 - 79*2 - - 11*4
9 - 146*8 - 128*1 - - 12*7
10 - 112*4 107*2 99*5 - 2*31 11*77
11 - 90*2 - 80*2 - - 11*7
Means 2*67 2*38 11*69 
= 2*34 per °C.
Table - p
The effect of a variety of anticoagulants on fractions of 
the same blood sample.
Cit. = 1 vol. of 3.Q% Sod. Citrate solution to 4 vol. blood.
P+A. = Heller and Paul's mixture of oxalates (1*2 mg. of Ammonium
oxalate and 0*8 mg. of Potassium oxalate per ml. of blood) 
Hep. = Heparin, 10 units per ml. of blood.
Oxa. = Potassium oxalate alone, 2ipg. per ml. of blood.
PCV. PLASMA VISCOSITY MAX. ESR. SPEC. GRAV.
Cit. P+A. Hep. Citr. ] P+A. f Hep. | Oxal.Ii Cit. jp+A. |Hejp. | P+A. J Oxalate
(%)
f (c^l 1 " ./ A-c-c-. i ■ i
32*4 40*9 1*64-2 i2 062 12 087 il 944- 6 8 I 8 7 I 8 3 1 - 11*0286
29 *7 - 36*8 1*610 n 94411 926 !1 873 3 2 S 2 6 { 4 211*0284j1*0281
34*8 - 44*6 1*678 12 140 |2 280 ii 996 4 8 i 13 5 ill 411*0281j1*0270
29*3 - 39*0 1*692 \2 568 12 401 12 141 15 0143 0141 3 j1*0262 11*0268
29*9 - 38*0 1*592 \2 084j 2 081 il 955 12 6 i 17 2 ; 47 2 j1*0269j1*0263
35 *7 - 45*8 1*642 (2 073 j 2 097 \2 000 4 3 1 6 6 1 8 1(1*028411*0283
34 *3 42*6 - 1*621 |2 035 (2 044 il 897 3 2 10 2 ! 6 5 j1*030111*0283
31*0 - 40*0 1*542 ll 99711 948 il 885 4 3 ! 3 8 j 6 0 j1*0270j1*0274
29 *0 37*9 - ! 1*587 I2 015 j 2 032 il 939 3 3 1 6 4 ! 8 0|1*0273|1*0274
35 *0 46 *3 - 1*578 12 026(2 037 ll 896 4 6 ill 0 j 13 3 j1*0269j1*0275
36*8 47*3 - 1*426 jl 69411 688 ll 600 0 6 I ° 5 I 0 4!1*0242j1*0240
33*0 44*4 - 1*656 ;2 170! 2 208 ;2 012 45 6 35 0 135 6 j1*0282|1*0281
31*7 41*0 - 1*578 ll 956 1 980 jl 868 9 2 18 5 il 8 6 j1*0256i1*0264
31*4 40*4 - 1*596 12 014 i 2 041 l 925 10 0 138 3 118 8 |1*0269j1*0261
28*1 37*4 - 1*677 12 211 j 2 208 I2 061 10 8 131 4 S 31 5;1*0281|1*0273
28*7 38*2 - 1*74012 383(2 420 12 267 21 1 50 9 (49 Oj1*0266j1*0273
32.4 42.0 - 1*649 2 186 2 168 2 043 10 1 24 3 (19 7!1*0296|1*0301
25*2 33*6 1*547 I1 968 12 016 1 908 5 3 '18 6 117 1 j1*0255 11*0257
38-5 49 *7 1*896 12 532 2 640 i2 043 16 7 161 8 >43 lj1*0296|1*029234*4 46*3 1*428 ll 695 11 659 1 614 0 4! 0 7 11 4 |1*0236j1*0238
29*7 38*8 - 1*568 ll 990 il 956 |1 897 4 1 8 8 ! 8 4 j1*028511*0280
29 *7 40*0 - 1*574 12 000 |l 996 |1 954 4 2 9 6 jio 6 j1*0285!1*0274
29*9 39 *4 1*585 ?1 99112 012 1 943 5 3 10 4 jio 9 |1*0271j1*0269
29*3 39*2 _ 1*552 jl 988 12 018 il 927 4 9 10 5 | i o 8 j1*0275j1*0276
34*0 44*7 - 1*570 il 954 jl 927 ll 869 4 4 10 1 12 31 - j1*0273
31*5 41*0 - 1*894 2 878 >2 751 2 740 25 0 81 3 >85 8 j1*0307 j1*0309
30-0 39 *4 - 1*566 ;1 954 |l 972 i1 867 6 5 11 4 22 311*0255!1*025536*0 47*0 - 1*540 1 957 jl 970 jl 878 1 0 1 9 1 2 3!1*0288j1*0281
31*0 - 39*8 1*676 2 11812 126 - 17 5 11 5 |36 1 1■H ~ 1
30.3 - 39*1 1*904 2 758 j 2 763 - 15 7 26 9! - j
39*0 - 48*5 1*862 2 312(2 317 ' 7 5 11 9 110 2! -
34.8 - 45*0 1*577 1 922 11 930 | - 2 5 3 0 4 31 - !
31*2 - 41*5 1*730 2 267 j 2 304 14 6 34- 8 20 o s  - j ~
38 *9 50-0 - 1*894 2 648 j 2 656 66 7 66 71 - I -8 ti
36*0 45*4 - 1*569 2 042 j 2 062 4 1 7 9|11 6j - -
24.3 32*9 - 1*954 3 10713 206 - 62 5 51 0 37 8 ! -  i
38*5 50*5 - 1*624 2 005 j 2 005 - 3 4 - 13 3! - -
36-8 47*0 - 2*026 2 905 2 919 _ 11 4 34 7 33 7 - -
33 *0 44*0 - 1*651 2 17212 159 - 11 0 29 9 23 0 -  1
30*4 40*3 - 1*497 1 782 1 782 - 2 3 3 3 4 8| - | -
Table - p continued
PCV. PLASM VISCOSITY ] MAX. ESB. SPEC. GRAV.
Cit. P+A. Hep. Citr. I P+A.( ■ Hep. jU-...-
Cit. P+A. jHep«* Citr, ! P+A. faep.*ti s
33*1 46*1
i
1*764 |2 389 ) 2 425 | 7 9 24 6 19 4 1 0249
\ i
|l*0274 1*0265
34.2 48*0 1*53112 070 :2 063 j 2 0 13 2 8 9 1 0254 i1*0283 [1*0279
29*0 — 39*5 1*82112 450 12 484 I 23 6 62 5 63 8 1 0268 1*0300 11*0297
30*0 _ 41*0 1*516 jl 800 il 803 2 2 2 3 *11 9 1 0240 Sl*0265 jl*0249
31*2 — 43*8 1*590 [2 040 '2 046 j 3 1 6 8 7 5 1 0257 11*0291 1*0281
36*0 51*6 1*639 |2 024 '12 089 | 3 2 9 5 ,11 1 1 0251 11*0288 11*0272
24*0 31*1 1*950)2 807 2 806 j 37 0 16 9 42 2 jl 0298 1*0331 11*0321
22*6 — 29*5 2*010 \2 760 2 811 ; 33 3 35 8 ‘45 0 1 0294 11*0322 1*0305
27*3 36*3 _ 1*518 1 847 :1 847 ; 4 4 7 1 7 0 1 0232 jl*0247 .1*0236
25.2 33*6 — 1*843 2 502 2 556 i 37 5 75 0 *70 0 1 0263 i1*0288 ;l*0278
35 *1 47*8 1*811)2 455 2 457 95 8 35 8 !34 4 1 0270 ‘1*0302 1*0289
25*6 34*2 - 2*030 \2 885 2 925 j 33 3 47 5 j 66 7 1 0293 1*0328 1*0316
24*3 31*6 - 1*995 2 737 2 785 I 30 6 24 2 26 0 1 0285 |1*0320 1*0302
26*3 35*0 - 1*766 ;2 325 \2 329 i 16 8 54 2 55 8 1 0260 1*0284 1*0273
31*6 42*2 - 1*639 \2 062 2 091: 28 6 48 9 74 4 1 0252 ‘1*0278 il*0268
14*4 19*6 1*5211 705 1 723 ‘ 0 5 1 0 0 8 1 0211 1*0220 1*0208
31*8 42*5 1*802 [2 422 2 463 ; 15 8 37 9 38 9 1 0280 1*0318‘1*0304
36*8150*2 1*565 !l 948 1 960 | 2 8 5 2 22 2 1 0248 1*0268 1*0267
32*7 44*5 - 1*660 2 122 2 173 j 6 7 9 6 9 8 1 0268 j1*0300;1*0289
29*5 39*7 1*738 12 297 2 295 I 6 9 29 3 31 7 1 0260 11*0288'1*0278
37*3150*3 1*583jl 973 :2 026 | 3 2 8 2 6 7 1 0256 [1*0282i1*0276
32*3 43*6 1*523 il 855 ;i 870 j 0 4 1 2 1 4 1 0254 i1*0278 1*0266
30*0140*2 1*822 |2 459 2 500 j 11 7 38 9;4C 0 1 0261 [1*0287 1*0275
30*0 39*8 1*597)2 018 |2 033 1 7 8 13 8 16 6 1 0251 1*0274 1*0266
20*2127*3 2*092 13 078 ‘2 995 1 30 5 55 3 42 0 1 0297 1*0327 1*0322
34*3 46*6 - 1*558il 931 X 928 j 1 0 2 3 2 4 1 0253 1*0283 1*0273
35*1|45*0 - 1*560:1 883 ;l 928 ! 1 0 1 3 1 0 1 0248 1*0275 1*0268
32*0]43*4 1*756 j2 293 i2 337 1 j 18 3 22 0 1 0264 1*0302 1*0291
34*6 - 47*1 1*843 2 530 2 543 ! 5 4 26 8 28 6 1 0277 1*0325[1*0311
26*0 - 36*0 1*776 2 375 2 373 ; 25 2 53 9 61 3 1 0244 1*0267!1*0256
26*5 - 36*0 1*819:2 4-79 2 488 ! 27 8 58 3 58 6 1 0251 1*0275 j1*0265
28*4 38*5 1*910 2 765 2 717 |44 2 59 2 |56 1 1 0257 1*0281)1*0273
32*2 - 43*3 1*859 12 624 2 655 1 12 2104 • 38 3 1 0268 1*0319 j1*0309
21*4 - 28*11 1*818)2 483 2 514! 22 5 127 1 21 7 1 0266 1*028711*0282
30*0 - 40*0 1*806 12 508 ;2 557 I 14 l|50 0l44 4 1 0248 1*0284jl*0272
25*3 - 34*7 1*599)2 033 2 030! 6 4 9 5 9 5 1 0257 1*0280U*0275
27*0 - 35*7 1*778 2 400 2 412 I 15 6 ] 39 3 35 0 1 0256 1*0281j1*0269
26*4 - 36*1 1*663\2 193 2 197 1 3 7 j 12 7 24 3 1 0235 1*0252j1*0238
24*1 - 32*5 1*677 2 190 2 234| 3 8 14 5 14 3 1 0260 1*0283|1*0273
24*7 - 34*0 1*510 1 856 '1 837 j 0 2 2 8 1 4 1 0216 1*0226!1*0215
28*2 - >37*7 1*814 2 693 2 677) 27 5 40 7 47 1 1 0259 1*0276!1*0267
31*3 - 41*2 ! 1*563\1 891 1 947* 1 9 3 6 3 1'1 0256 1*027411*0266
27*0 - 37*2 1*808 2 468 2 474| 19 1 72 4 50 0 1 0256 1*027111*0264
26*5 i “ 36*0 2 *083 3 138 13 047 | 32 2 53 3 29 4 11 0273 1*030811*0295
29*7 ‘40*7 1*583:1 958 2 036 j 6 7 13 5 13 1 1 0248(1*0270j1*0262
26*0 |35*0 1*837|2 472 2 438 j 27 2 58 1 58 6 1 0264j1*028811*0279
34*5 45*5 - 1*500:1 817 jl 836 0 7 0 5 0 8 1 0248 1*0273 1*0258
26*5 36*3 1*781 2 303 |2 336 13 9 43 3 43 3 1 0244 1*0266j1*0253
25*2 34*5 - 1*749 2 296
1
288 12 1 49 3 40
__
6 1 0236 1*026411*0249
Table - P continued 3.5 o
PCV. [ plasma vise.
18*0 
23*0 
32*0 
48*0 
25
32*4 
30*0 
27*5 
24*8 
28*6 
29*4 
31*9 
30*4 
33 *0
Viscometer V4 results above
PCV. PLASMA VISC. 
Citr. P+A.fmCit. P+A.Citr.
1*728
1*679
1*549
1*645
1*836
1*700
1*668
1*628
1*468
1*715
1*675
1*878
1*597
24*0
31*0
43*0
2*218
0*41
*2*220
Viscometer V5 results below.
28*8 36 *3 [ 1*664 2 174 | 28 6 1*639 2 186
33*9 - 1 1*576 2 035 | 26 7138*5 1*682 2 228
27*9 39*0! 1*651 2 183 | 30 0 41*4 1*618 2 107
33*1 46*0 1*568 2 013 ! 20 3 29*7 1*759 2 500
30*0 41*31 1*575|1 997 ! 35 3 i49*0 1*727 2 382
20*0 29 *3 | 1*547 1 855 i 27 6 39*2 1*576!2 047
31*2 42*3 1*540 1 962 ‘ 33 2 45 *8 1*497 1 914
28*1 40*3 1 1*59012 021 27 7 38*1 1*777 2 547
27*2 38*7! 1*725 2 464 32 7 45*7 1*750 2 549
33*7 - | 1*490 1 833 31 4 43*1 1*671 2 284
27*8 39*0 1 1*689 2 318 |30 4 41*5 1*536 1 987
33*6 46*4! 1*521 1 913 36 1 47*2 1*530 1 895
30*6 43*5l •1*900 2 920 32 1 44*6 1*547 1 979
33*2 46*8; 1*470 1 886 34 0 1*512 1 888
33*8 ! 1*533 1 894 28 4 38*0 1*555 1 902
29*5 39 *o! 1*484 1 792 33 i;44*6 1*501 1 859
31*2 43*9| 1*777 2 609 34 7 46*3 1*509: 1 878
27*5 37*7 \ 1*641 2 139 33 1 ‘44*2 1*568 2 o35
33*6 45 *11 1*501 1 349 33 4 >44 *4 1*500[ 1 852
31*4 41*2 | 1*491 1 765 32 8 45*2 1*505 i1 848
33*2 44*8 | 1*475 1 802 35 9|46*9 1*4931 1 794
33*0 43 *4 j 1*642 2 184 33 2 44*1 1*500 1 844
33*7 43*5 1*492 1 800 26 0 35*0 1*470! 1 734
33*9 44*51 1*502 1 835 33 4|46*0 1*500 1 826
- 46*0 1*489 1 810 34 0 ] 45 *6 l*49l| 1 823
32*0 I 1*496 1 851 32 2 45*3 1*484 1 800
32.4 44*5! 1*663 2 206 31 6 44*0 1*487 1 796
30*2 1 1*542 1 899 29 2 - 1*525; 1 916
24*8 34*0 | 2*057 3 171 26 9 42 *4 2*058 3 245
26*0 38*5 2*113 5*677
t
Table - Q a54
The viscosity of serum ULTRA-FILTRATES.
There is no correlation between the viscosity of the 
ultra-filtr&te and its nitrogen content.
No.
ULTRA-PILTRAT'E Ser.
NEN.
Serum protein Serum
Vise.vise. Nitrogen. Total| Alb. |Grlob
cs. Ipg.^o mg •% g./100 ml. cs.
1 1*026 140* 125* 7*14 4*59 2*55 1*782
2 1*021 28-0 28*7 6*47 4*29 2*18 1*637
3 1*024 26*9 27*7 6 *66 4*37 2*29 1*644
4 1*023 22*1 24*5 6*74 4*43 2*31 1*726
5 1*034 19*3 20*7 5*97 4*31 1*66 1*602
6 1*030 26 *6 26*1 6*73 4*15 2*58 1*722
7 1*035 26*3 29*5 6*58 4*41 2*17 1*720
8 1*034 22*3 21*0 6*06 4*13 1*93 11654
9 1*034 27*6 25*5 6*16 4*20 1*96 1*627
10 1*024 31*7 26.1 6*35 4*55 1*80 1*654
Table - R
a55
The experimental kinematic viscosity and specific gravxoy 
of an aqueous solution of albumin and of a saline solution 
of globulin; the absolute viscosity has been calculated 
from these two experimental values.
Abs. Vise. = Kin. Vise, x Spec. Gravity
HUMAN SERUM  ALBUM IN D ISSOLVED IN  D IST ILLE D  W ATER
Experimental Interpolated
A
g/100 ml CO>
A
g/100 ml CO
> ^
1
*
Q ^V6 iog^ve
A'
g/100 g
15.21 2-795 15 2.745 1.0553 2.897 0.4620 14.22
10.54 1-934 12.5 2.250 1.0438 2-349 0.3709 11.98
8.79 1.691 10 1-857 1.0362 I.924 0.2842 9-654
7-33 1-523 7 1.488 1.0247 1-525 0.1832 6.829
6.28 1.409 5-5 1-342 1.0190 I -367 0.1358 5.400
5-33 1.310 4 1.232 1.0133 I.246 0-0955 3-950
4.10 1-235 3 1.174 1.0095 I.185 0.0738 2.970
3-18 1.177 2 1.119 1.0056 1.125 0.0511 1.988
2.29 ' I - I 33 1 1.065 1.0018 I.067 0.0282 0.9982
0.71
0.36
0
1.056
1.030
I .O IO
0 I .O IO 0.9980 I.008 0.0033 0
*  QA =  O.9980 +  O.OO382  A 
All determinations at 20.o° C
HUMAN SERUM  GLOBULIN DISSO LV ED  IN  NORM AL SA LIN E
Experimental Interpolated
G
g/100 ml Vve
G
g/100 ml vV6
*
Q ^V6 lo^ V 6
G'
g/ioog
8.41
6.28
4.06
2.02
I.OI
0
(saline)
3.041
2.152
1.621
1.274
1-130
1.016
8
7
6
5
4
3
2
1
0
(saline)
2.845 
25404 
2.072 
1.825 
1.605 
1.430 
1.270 
1-130 
1.016
1.0461 
1.0410 
1-0359 
1.0308 
1.0257 
1.0206 
i-o i55 
1.0104 
1-0053
2-955
2.503
2.146 
1.881 
1.646 
1-459 
1.290 
1.142 
1.021
0.4705
0.3984
0.3316
0.2744
0.2164
0.1641
0.1106
0.0577
0.0090
7.649
6.725
5-793
4.852
3-899
2-939
i -97i
0.9902
0
* QG =  1-0053 +  0.00510 G 
All determinations at 20.0° C
a 56
Table - R (b)
The values calculated from the hypothesis that a solution can 
be treated as if it was a uniform single substance with a 
molecular weight derived from the solute and solvent.
s
g/100 g fho log^o
1800 M'( 1800 \ ,
- L o J  (i +  aS)
ioo-S
SUCROSE (B ingham  &  Jackson) a =  —  0.00143
20 1.960 0.2923 22.50 21.86
40 6.200 0.7924 30.00 28.71
60 56.5 1.7520 45.00 4I -I 4
ALBU M IN  (Interpolated from Table I) a =  +  0.008
1 0.028 18.32
2 0.051 18.67
2-73 0.068 18.91
4 0.097 19.34
5-5 0.139 19.89
7 0.189 20.40
8 0.225 20.84
9 0.261 21.21
10 0.297 21.60
M'
G LOBULIN (Interpolated from Table I I) ( 1810 \ , ,
~  L o - s )  ( i  +  a S)
a =  -f- 0.025
0.5 0.034 18.46
1.0 0.058 18.74
x.25 0.072 18.91
i -5 0.085 19-05
2.0 0.112 19-4°
2-5 0.140 19-73
3 0.168 20.08
4 0.223 20.77
5 0.284 21.43
6 0.346 22.18
7 0.420 22.90
Sucrose viscosity is expressed in terms of B ingham  &  Ja ckso n ’s viscometer; 
Albumin and Globulin in terms of V6
\  M is calculated on a 30 cm slide-rule for Albumin and Globulin
a57
Table - T.
The total range of the Corrected Citrate Plasma Viscosity 
can he subdivided into Zones according to the periodic curve of 
the. Maxiumum corrected sedimentation velocity/plasma viscosity 
correlation.
Number
of
Zone
Limit value of 
Citrate Plasma 
Viscosity.
cs.
1 - 1*515
2 - 1*558
3 - 1*585
4 - 1*671
5 - 1*698
6 - 1*762
7 - 1*832
8 - 1*865
9 - 1*963
10 - 2*050
11 2*050 -
a58
Part 3
#
TABLES of RESULTS 
for
PHYSIOLOGY SECTION
Results from Normal Adult Males.
This table also shows the daily variations in 
viscosity, E. S. R. , P. 0. V. , and plasma protein.
Name Sex Date PCV.
PLASMA
VISCOSITY
Wintrobe 
E. S. R.
Total
Plasma
ProteinOrd. Cor.
cs. ran/ 1 hr. g/lOQml
P. S. M 4: 3:49 1-763 1 - -
2: 9:49 43*6 1-803 2 o 7-09
20: 2:50 44*8 1-753 1 0 6-77
21: 2:50 43*2 1-754 1 0 6-77
22: 2:50 44*2 1-749 1 0 6-70
23: 2:50 43*0 1-751 1 0 6-95
24: 2:50 44*4 1-755 1 0 6-73
25: 2:50 45*9 1-857 1 0 7-38
27: 2:50 44-*5 1-754 1 0 6-77
28: 4:50 44-6 1-830 2 0 7-06
E.D. M 25: 4:49 45*8 1*904 - _ 7-60
1: 5:50 45*0 1-870 8 •6 7-16
2: 5:50 45-0 1-902 7 5 7-20
3: 5:50 45*7 1-893 9 8 7-06
4: 5:50 44*3 1-874 3 0 7-27
K.H. M 15: 5:50 43*0 1-840 9 5 7-27
16: 5:50 41-7 1-758 - 6-77
17: 5:50 43*3 1-804 6 3 6-95
18: 5:50 43*6 1-806 6 3 6-95
19: 5:50 42*6 1-772 6 2 6-80
R.C. M 1: 5:50 46*9 1-779 2 2 6-88
2: 5:50 47*9 1-797 2 3 6-84
3: 5:50 47*8 1-802 2 3 6-91
4: 5:50 47*5 1-787 2 2 6-84
E.J. M 15: 5:50 46*1 1-781 1 0 7-16
16: 5:50 46*1 1-778 - 6-98
17: 5:50 45*6 1-697 1 0 6-73
19: 5:50 47*2 1-762 1 1 7-20
L.H. M 2: 1:48 46*9 1-852 — _ 7-45
13: 4:48 46*0 1-825 - - 7-45
13: 9:48 45*6 1-798 - - 7-56
J.D. M 26: 9:50 49.2 1-880 1 3 7-74
24: 2:51 - 1-860 - - 7-67
H.D. M 1: 3:51 43. 1-778 2 0 7-31
M.T. M 28: 2:51 42*5 1-866 5 1 6-98
the plasma
Remarks.
Post-alcohol
Post-alcohol
Table- U (continued) Normal Adult Males
Name N°
. 1
pcv ] PLASMA 
* iVISCOSITY
1 WintroLe 
! E.S.R.
10rd.~]0or.
Total
Plasma
Protein
% cs. ,mo/  1 hr. g/lOOml
G.R. 10 48*9 1*899 | - 7*34
M.G. 11 44*8 1*858 - - 7*31
A.G. 12 41*6 1*851 7*09
J.B. 13 47.4 1*844 - - 7*02
G-.D. 14 1*798 - - 6*84
S.M. 15 48*1 1*776 - 6*95
A.C. 16 42*8 1*739 - - 6*84
J.W. 17 47*5 1*846 - 7*42
M.B. 18 46.9 1*839 - 7*70
A. S. 19 46*6 1*840 - - 7*16
J.H. 20 51*3 1*903 - - 7*88
M.O. 21 47 *8 1*900 - 7*96
J.S. 22 43*8 1*877 - - 7*67
A.M. 23 51*8 1*812 - 7*45
R.H. 24 40*9 1*849 - 7*45
M. B. 25 - 1*729 - - 6*41
P. A. 26 45*3 1*849 — 7*70
R.A. 27 52*9 1*892 - 7*20
J.L. 28 47*8 1*850 — 7*16
S.C. 29 49*0 1*770 1 3 7*27
J. S. 30 51.3 l*91o ' 7*67
A.W. 31 41*9 1*734 - - -
| J.P. 32 43*8 1*728 - - 7*09
] D.N. 33 45*8 1*847 3 2 7*20
1m . 0. 34 46*7 1*853 - 7*09
W. A. 35 1*807 - - -
P.P. 36 47*5 1*820 3 3 —
M.G. 37 46*4 1*848 8 7 7*16
B.W. 38 51*0 1*743 1 4 7*06
M.T. 39 49*0 1*777 1 3 6*84
M.D. 40 49*7 1*802 2 4 7*02
M^* 41 49*6 1*663 1 3 6*44
G.D. 42 52. 1*801 2 7 6*95
A.R. 43 40. 1*805 3 0 7*60
S.E. 44 47*3 1*860 3 3 7*31
J.H. 45 47*2 1*829 3 3 7*02
B« E. 46 46*3 1*869 - - 7*63
Remarks
Table-U continued a61
Normal Adult Males
Name No Date
PCV. PLASMA VISC. E.S. R. Total
Plasma
Protein
Cit. P+A. Cor.
Citr.
P+A
Oxal.
Max.
Cit.
Wintrobe
Ord. Cor.
7° cs. C.mm/ 1 hr g/lOOmlX/0"*
J.H. 47 7: 8:44 32 0 - 1 549 1•900 2-3 - - 7*30
13:11:45 32 0 - 1 503 - 1-1 - - -
8: 1:46 34 7 - 1 504 - 0-5 - - -
10: 1:46 34 3 - 1 500 - - - - -
11: 1:46 35 0 - 1 496 - 1*5 - -
8: 2:46 34 2 - 1 502 - 1-6 - _ -
4: 3:46 34 4 - 1 510 - 1-9 - - -
1: 4:46 34- 6 - 1 497 - 1-4 - - -
6: 6:46 31 S - 1 475 - 1*0 - -
11: 7:46 34 0 — 1 4-67 - 1-3 - -
2: 8:46 34 7 - 1 472 - 1*5 - -
21:10:46 33 3 - 1 510 - 1*3 - - _
27:11:46 34 7 — 1 532 - 2-1 - - ~
3: 3:47 35 4 - 1 547 - 2*7 - -
24: 3:47 33 2 1 504 - 0*5 - - -
19: 5:47 33 7 1 504 - 1-2 - - _
29:10:47 33 2 45 •8 1 497 1*914 1*3 - - 7*70
2: 1:48 33 6 46 •4 1 521 1•913 2*1 - - 7*39
17: 1:48 34 8 _ 1 555 - 2*6 - - -
3: 2:48 33 2 - 1 505 - 1*5 - — 6 -76s
6: 5:48 33 1 A if44 6 1 501 1 859 1*8 - - 7*34
21: 6:48 34 7 46 3 1 509 1 878 1*6 _ — 7*45
17: 7:48 33 6 (45 1 1 501 1 849 1*4 - _ 7*31
12: 8:48 33 4 44 4 1 500 1 852 1*3 - 7*38
12:11:48 31 3 41 2 1 491 - - - -
3: 2:49 32 9 145 2 1 505 1 848 - 3 1*5 _
28: 3:49 33 2 44 8 1 475 1 802 - 3 1
26: 5:49 33 0 43 3 1 493 1 794 _ 2 0 6*95
11:10:49 33 2 44- 1 1 500 1 844 _ — - 7*24
3: 3:50 33 7 43 5 1.4-92 1 800 - 4 1 6 *95
13: 6:50 33 9 44 5 1 502 1 835 _ 2 0 7*20
4: 7:50 33 4 46 1 500 1 826 _ 3 2 7*02
10:10:50 33 4 4-6 1 4-89 1 810 4 3 6*88
24:11:50 34 0 45 4 1 491 1 823 - 3 1*5 7*24
21:12:50 32 0 45 3 1 496 1 851 - 4 2*5 7*13
2: 2:51 32 2 45 3 1 484 1 800 - 4 2*5 7*06
13: 3:51 32 2 44 1 487 1 796 - 3 1 6*98
10: 5:51 45 4 - 1 831 - 5 3*5 7* 20
12: 7:51 34 8 45 0 1 494 1 819 - 3 1-5 7*27
21: 1:52 35 0 46 6 1 503 1 820 ~ 3 3 7*31
Table- IT continued a62
Normal Adult Males.
Name No
PCV. I PLASMA VISC. r.MAX. ESR..
P+A
Total
Plasma
Protein
Cit. P+A. c3rT[~P+A 
Citr. 1 Oxal.
Cit.
% j cs. xlO g/lOOml
cn/sec.
G-.S. 48 36*8 47*3 1*426 1*694 0*57 0*49 5*65
H.D. 49 35*0 46*3 1*430 1*695 0*35 0*68 5*39
J.M. 50 3o*4 40*3 1*508 1*782 2*31 3*27 5*60
C.P. 51 32*3 43*6 1*523 1*855 0*44 1*43 6*47
R.M. 52 34*5 45*5 1*500 1*817 0*68 0*50 6*34
J. U. 53 33*7 - 1*490 1*833 - - 7*09
R.L. 54 32*8 - 1*564 - 1*67 - 6 *81s
A. C..55 38*0 - 1*538 - 0*41 - 6* 71s
J. B. 56 34*2 - 1*552 - 1*63 - 6 *67s
A. C. 57 32*2 - 1*525 - 0*65 - 6 *41s
C.B. 58 34*2 - 1*442 - 0*34 - -
W.D. 59 35*1 - 1*437 - 1*12 - -
Table- U (continued; a65
Results from Normal Adult Females.
This table also includes two subjects in whom the daily 
variations in the plasma viscosity, E.S. R. , P. C. V. , and 
plasma proteins were studied.
Name No. Date PCV.
PLASMA
VISCOSITY
Wintrobe 
E. S.E.
Total
Plasma
Ord.J Q0r< | Protein
55 os. ram/ 1 hr. g/lOOml
L.C. 1 12:12:49 38.7 1*782 10 6 6*84
13:12:49 37*2 1*758 16 10 6 *66
14:12:49 37*2 1*758 15 9 6*66
15:12:49 39*0 1*779 14 10 6*84
16:12:49 37*4 1*788 14 8 6*88
9:10:50 — 1*783 - 6*44
F.K. 2 12:12:49 45*6 1*885 3 6 7*74
13:12:49 42*0 1*748 10 10 6*88
14:12:49 43*7 1*781 9 11 7*13
15:12:49 42*7 1*754 9 10 7*13
16:12:49 42*2 1*769 9 9 6*91
17:12:49 43*0 1*771 8 9 7*02
E. S. 3 — — 1*892 - -
A.B. 4 42*2 1*795 - 7*52
M.G. 5 47*11 1*897 - - 6*95
M.T. 6 41*2 1*805 7*02
M.S. 7 35*2 1*828 - — 7*13
V.W. 8 46*0 1*665 - - 6*23
D.B. 9 - 42*7 1*750 - - 7*02
L.M. 10 _ 42*5 1*821 7* 70
C.P. 11 — 39*9 1*807 -
M.W. 12 42*2 1*850 - - 7*67
E.E. 13 18: 7:47 j 42*8 j 1*808 . 5 6 6*91
4: 9:47 : 45*0 1*799 - - 6*80
M.D. 14 - ! 44*4 1*864 - 7*13
E.M. 15 | 40*0 1*773 6 4 -
Gr. S. 16 ! 45*2 1*749 3 6 7*34
J.C. 17 2: 2:48 41*5 1*798 2 2 7*34
23: 2:48 i 41*7 1*788 3 3 7*45
H .  0 . 18 - 140*4 1*901 27 24 7*42
A. Q. 19 - 31*0 1*869 16 3 6*95
M.P. 20 ! 39*2 1*801 11 8 6*88
D. S. 21 - 1 1*860 3 - -
A.B. 22 _ 42*8 1*806 - - 7*20
S. S. 23 - 44*7 1*893 - 7*63
R.F. 24 - 41*7 1*886 - 6*98
J.P. 25 - 41*9 1*803 4 4 7*52
N.C. 26 - 39*0 1*713 10 6 6*16
M.D. 27 - 42*2 1*791 - - -
Remarks
P o s t - a lc o h o l
Table- U continued a64
Normal Adult Females.
Name No. Date PCV.
PLASMA
VISCOSITY
Wintrobe
E.S.R.
Total
Plasma
Protein
Remarks
Ord. Cor.
% cs. mra/ 1 hr. g/lOOml
M.B. 28 - 42.7 1*876 12 13 7*56
P. V. 29 - 37*1 1*798 11 5 6*88
M.D. 30 41*4 1*896 9 8 7*85
M.R. 31 _ 44*4 1*865 13 16 6*59
M.M. 32 - 38*5 1*732 3 0 7*06
M.S. 33 - 41*6 1*722 5 5 6*84
M. R. 34 - 46 * 1*768 1 5 7*31
C.B. 35 - 40*9 1*888 9 8 7*45
J. A. 36 - 42-8 1*874 7 8 7*38
A. R. 37 - 45* 1*810 6 9 7*02
M.D. 38 - 43* 1*885 8 9 7*34
M.B. 39 - 38*6 1*677 9 5 6*44
M.T. 40 " 46* 1*794 10 14 6*98
M.B. 41 _ 35*3 1*789 22 13 7*27
P.L. 42 30: 1:51 46* 1*724 10 15 6*66
16: 5:51 - 1*761 - - 6*91
A.B. 43 - 41*9 1*728 5 5 6*55
S. J. 44 - 43*8 1*787 5 7 6*80
M. J. 45 - 43*3 1*690 5 6 7*02
M.G. 46 - 39*5 1*769 13 9 6*80
M.P. 47 - 40* 1*765 25 21 6*77
M.M. 48 - 43*5 1*880 13 15 7*13
B. J. 49 - 43*7 1*692 2 4 6*48
M. H. 50 - - 1*910 - - 7*01
M.H. 51 - 41*0 1*800 - - 6*66
CITRATE
PLASMA
M. H. 50 38 *4 1*565
M. H, 51 - 30* 1*516
B.R. 52 21* 1*560
B.M, 53 - 32*4 1*559
M.M. 54 - 30*3 1*531
S.H. 55 - 30 *4 1*532
Table - V a65
PREGNANCY.
These tests were made on a consecutive series of patients who 
attended the Central Laboratory at Portsmouth for their routine 
ante-natal Wassermann examination.
There is no guarantee that the pregnancy was normal nor that 
the patient was free from all other disease. She appeared to he 
in good health, she claimed to he in good general health, she was 
free of the symptoms of the usual complications of pregnancy as 
far as I could determine hy direct questioning, and her doctor 
had given her no hint of any such complications being present.
Another larger series is being investigated now with the 
co-operation of an obstetrician.
No. PCV. PLASMAvise.
Wintrobe] Plasms 
ESR. |Total 
OrdJCort1*0'6-
Plasma
Proteins Serum
No. j 
of
Preg. jAlb. Glob Fib. Urea Choi.
% cs. mm/ 1 hr1 g./ &./loo ml. mg./ mg*/ I
4 - 7th Week period. J
1 42*3 1*807 5 5 6*77 4*4 1*9 0*34 28 333
!
1 |
2 36*6 1*980 20 13 7*63 5 *9 2*6 0*4 24 430 2 !
3 41* 1*770 9 8 6*91 4*5 2*5 0*39 27 258 1 i
4 41*1 1*821 10 9 7*31 4*9 1*52 0*28 - - i !j
mean 40S5 1*84-4 11 9 7*17 4*93 2*13 0*35 26 340 l
i
8 - 11th Week period i
1 40* 1*988 15 13 6*95 4*2 2*6 0*36 22 288
j
2
2 39*1 1*867 16 13 6*62 4*6 2*01 0*39 29 205 i I 1 1
3 42* 1*881 8 8 6*66 4*5 1*8 0*32 28 252 2 I
4 40*5 1*972 23 21 6*98 4*9 2*3 0*43 28 247 1 I
5 39*5 1*900 20 17 6*91 5*2 1*8 0*45 13 243 i j
6 40*5 1*873 17 15 6*77 4*9 2*1 0*42 17 252 2 1
7 37* 1*810 14 8 6*93 4*8 2*1 0*35 27 - 2 i
8 38*4 1*843 17 13 6*91 3*8 3*04 0 *36 23 ~ 4
9 33* 1*825 34 20 6*66 3*8 2*6 0*30 36 204 7
10 37*7 1*781 _ _ 6*16 4*2 1*8 0*31 250 1
11 36*8 1*812 11 5 6*84 4*7 2*23 0*37 16 400 3
12 I 37*5 1*774 20 14 6*84 4*7 2*69 0*31 28 240 1
13 |42*3 1*762 6 6 6*73 4*9 2*7 0*40 28 318 3
14 39*5 1*807 19 15 6*55 4*3 2*43 0*27 26 228 3
15 41*7 1*722 6 6 6*26 4*5 2*1 0*30 20 |303 2
16 42 *4. 1*827 14 14 6*52 4*0 2*46 0*34 22 246 2
mean 39*2 1*840 16 13 6*71 4*50 2*30 0*36 24 263 j
Table - V (continued) Pregnancy. a66
No. PCV. PLASMAvise.
Wintrobe 
_ E. S. R. 
OrdTlCor.
Total
Plas.
Prot.
Alb. Glob Pibr Urea Choi.
No. ” 1 
of
Pregn.
% cs. mm/ 1 hr mg. /lOOml. |
12 - 15th Week period.
Ijl
j
1 38*3 1*980 17 | 12 7*02 4*6 2*2 0*4 43 278 10 |
2 34* 1*752 4 o 5*87 4*52 1*9 0*31 20 251 1 1
3 36*7 1*799 17 11 6*44 4*9 1*7 0*32 32 249 1 |
4 40-3 1*818 21 19 6*55 4*5 2*1 0*32 16 244 2 3
5 37 ‘ 1*836 22 17 6*26 4*2 2*2 0*41 15 297 2 !
6 41* 1*699 9 8 6*59 4*6 1*8 0*3 29 199 1 i
7 40* 1*671 3 1 6*37 4*6 1*8 0*31 26 - 5 1
8 38* 1*896 23 17 6*70 4*5 2*3 0*4 20 308 1 j
9 37* 1*729 13 7 6*61 4*7 a  *46 0*44 17 216 1 i
10 36* 1*868 25 17 6*98 4*9 2*58 0*32 - 359 i !
11 42* 1*882 11 11 6 *55 5*0 2*58; 0*42 - « i i
12 36 *6 1*720 12 6 6*08 4*5 1*8 0*35 20 404 2 !
13 31 *5 1*842 49 28 6*48 3*8 2*6 0*39 27 i !
14 45* 1*891 6 9 6 *95 4*6 1*96; 0*44 16 242 1 I
15 39* 1*804 25 20 6*70 4*3 2*2 0*35 22 263 j 1 1
16 37* 1*812 20 13 6*73 4*7 2*3 0*37 33 517 1 1
17 37*1 1*706 17 10 6*05 4*1 1*8 0*45 294 2 !
,18 38 *7 1*790 22 17 6*34 4*0 2 *75!0*35 20 330 | 1 1
39*0 1*841 18 14 6 *37 - i ~ - 1 2 1
20 - 1*735 - - 6*37 - - | - - - j 2 i
21 - 1*732 - - 6*30 - - - | l i
22 41*1 1*884 - - 6*77 - - - -
2 1
Mean 38*3 1*804 18 13 6*95 4*75 2*11 0*37 24 297 i
1
16 - 19th Week period.
!
%ii
1 39 • 1*721 10 7 6*08 |4*2 1*9210*3 j 41 279 i j
2 36* 1*717 21 13 6*19 |4*8 2*1 10*38 17 345 2 1
3 40* 1*742 20 171 6*30 4*5 2*0 0*4 25 235 j 2 i
4 35*2 1*717 18 11 6*12 4*2 1*89 0*41 - - 4 !
5 43* 1*943 12 13 7*02 4*53 1*98 0*41 34 349 1 1
6 38* 1*902 28 22 6*05 13*5 2*3 !0*3 1 21 365 ! i !
7 35 *0 2*030 15 6 7*31 |4*2 2*7 |0*36 | 35 j 357 ■ 1 1
8 38* 1*929 20 15 6*73 j4*68 2 *09 j0*42 | 25 I 345 ] l i
9 34*8 1*855 24 13 6*70 j4*3 2*3 10*34 | 29 1 i i 1
10 33 * 1*643 23 11 5*65 !3*8 2*1 j0*33 |
j
267 | 5
11 38*4 1*705 14 9 5*94 14*4 2 *05!0*37 ! 20 | 280 | 1
12 40*3 1*676 10 7 6*05 j4*2 2 *09 j0*31 I 21 ! 260 1 2 1
13 40*6 1*814 13 12 6*19 j4*0 2*45 j0*35 ! 29 | 341 | i !
14 39*2 1*759 28 24 5*90 |3*9 2*1 I0*46 : 19 ; 376 | 4 !
15 39*2 1*854 24 20 !6*37 j 4*3 2*0 j0*46 | 22 i 348 j 2 j
16 40* 1*862 | 20 18 j6 *95 j 4*6 2 *09 j0*41 j 18 i 300 | 1 |
17 37* 1*777 21 15 ;6*95 |4*9 1*84 0*36 ] 19 | 290 | 2 !
18 33*8 1*826 31 17 6*33 j3*93 2*51 0*38 | 17 I -  I 319 36*9- 1*805 23 15 6*41 |3*76 2*76 0*38 ! 20 I - j 2 1
2
Mean 37*8 1*804 20 14 6*38 4*25 2*17 0*38 24 316
!
Table - V (continued) Pregnancy. a 67
No. PCV. PLASMAvise.
Wintrobe
ESR.
OrdTJCor.
Total
Plas.
Prot.
Alb.
% cs. mm/ 1 hr &•%
Glob I T T  I ” ?Fibr | Urea i Choi. [ of
Preg.
m g . /lOO ml
20 -23rd Week period.
1
2
3
4
5
6
7
8 
9
10
11
12
13
29*
37*8
32 *0 
40*2
33 *4 
36*6 
43*6 
40*6 
41*0 
34*8 
39*3 
37*2
*876
•832
*868
•890
*777
*807
*990
*840
•741
•888
•840
•006
*791
43
32
29 I 
25 
43 25 I
18 I 16 I
27 I 14 ;
44j 34 ! 
20 j 22 ! 
13 13 I
29 | 28 |
36 { 24 I
41 j 36
28 I 20 I
’26
•55
•23
•66
•02
•05
•98
59
•94
48
41
24
30
3*9 I 2-2 
4*2 j 2*44 
3*6 2*41
|4-0
4-2
4 
3 
2 4 
4
2 ' 
3* 
2 2 - 
9 [I-
941 2" 
0 2 ' 
5 2'
1
2
5
76
36
54-
5
0*48
0*46
0*39
0*36
0*38
0*38
0*34
0*45
0*42
0*44
24
21
25
28
20
18
18
4*4 I 2 *06|0*34 I 18
331
390
280
440
440
280
300
300
1
1
3
1
1
5
3
1
3
1
2
1
1
Mean 38*8 1*857 31 23 6*44
COo• 2*37 0*40 22 345
24 - 27th Week period.
1 37- 1*850 22 15 6*30 4*1 2*1 0*4 22 ! 337 | 3
2 38- 1*926 27 21 6*59 4*1 2*3 0*41 20 j 411 1
3 38* 1*878 24 20 6*95 4*2 2*08 0*32 ! 302 1 1
4 37* 1*777 27 20 1 6*08 4*4 1*46 0*54 | 262 ) 1
3 34* 1*814 32 20 6*37 4*1 1*87 0*43 403 1 1
6 33*5 1*843 34 20 6 *05 4*9 2*7 0*4 28 318 | 4
7 39*7 2*027 33 29 6*66 4*9 2*67 0*43 20 430 | 3
8 32*2 2*024 56 35 6*55 4*1 2*5 0*41 29 _ i 2
9 37*0 1*841 29 21 6*55 4*5 2*0 0*34 27 - ! 1
10 34*2 1*722 24 13 6*05 3*6 2*2 0*35 18
i
- 1 1
11 30* 1*965 59 31 6*62 4*4 2*35 0*55 - 2
12 40*2 1*839 17 15 5*90 4*2 2*52 0*38 26 391 2
13 37*2 1*816 26 19 6*01 4*0 2*72 0*38 ( 25 290 j 1
Mean 38 *4 1*871 32 22 6*36 4*27 2*27 0*41 24 349
Table - V (continued) Pregnancy. a68
No. PCV. PLASMAvise.
Wintrobe
ESR.
Total 
Plas * 
Prot.
Alb.
n ..i
Glob Fibr
1
j Urea
r _
Choi.
No.
of
Preg.Ord. j(
% cs. xm/ 1 hr ' mg./lOO ml
28 - 31st Week period.
1 37* 1*806 47 |37 5*94 |4*1 2*0 0*45 I 16 273 2
2 38 * 1*917 35 j28 5*90 3*8 1*7 0*43 28 494 1
3 29* 1*939 47 S23 6*30 3*8 2*7 0*48 1 23 234 2
4 33* 1*840 39 |23 5*76 3*9 2*1 0*44 25 447 1
5 31*8 1*808 48 28 5*94 3*9 2*55 0*45 - 3
6 34-3 1*753 32 !20 5*76 3*82 2*03 0*45 - _ 2
7 36 *0 1*746 27 ;18 5*76 3*8 2*01 0*39 400 2
8 30*2 1*867 44 ;23 6*26 3*8 3*18 0*42 400 3
9 36* 1*871 35 I25 6 *11 3*8 2*95 0*43 17 301 3
10 33*6 1*848 23 i12 6*05 - - - - - 5 :
11 34*1 1*906 35 !22 6*26 4*8 2*55 0*35 j 25 410 2
12 39* 1*817 35 |30 5*76 4*45 2*26 0*54 ! 24 380 1
13 32*5 1*707 27 13 5*47 3*8 2*12 0*38 ! 29 290 2
14 40‘0 1*769 20 |17 5 *69 4*3 2*57 0*33 19 370 415 36*6 1*841 32 123 6*12 - - - - 2 j
Mean 34*7 1*829 35 23 5*94 4*01 2*36
60•P 23 363
!
32 - 35th Week period. i
1 34*3 1*810 45 | 30 5*72 3*9 2*0 |0*42 24 372 2 12 34*8 1*894 i 26 j15 6*26 4*3 2*1 0*36 26 296 9A j
3 33* 1*803 I 25 ‘13 ! 5*40 3*97 1*60 0*41 21 382 1 I
4 34*3 1*948 33 I21 6*44 4*2 1*9 0*41 20 438 3 I
5 34*9 1*977 32 |21 6*73 4*1' 2*2 0*49 26 375 3 j
6 36*8 1*932 31 |22 6*55 4*3 2*08 10*42 21 285 4 !
7 29 *6 1*972 58 I■'32 6*41 4*0 1*92 0*48 23 322 2 i
8 34* 1*942 53 j37 6*44 3*9 2*5 0*45 16 301 2 I
9 35*0 1*794 43 (30 6*34 3*9 2*0 0*39 21 343 2 j
10 32* 1*961 59 ■37 6*84 3*9 2*3 0*49 33 378 2
11 36*7 1*983 50 j39 6*59 i4*2 2*42 jO *48 - - 2
12 33*8 1*871 46 j30 5*98 |4*0 2*47 jO *43 - 1
13 35*5 1*827 29 !19 6*23 3*89 1*89 j0*52 - — 4
14 36*2 1*837 34 j24 6*26 j4*55 1*9 0*45 _ — 2
15 29*6 1*811 47 |24 5*72 4*5 2*18 0*42 - 242 3
16 37*0 1*868 23 |17 6*16 |4*7 2*47 0*43 20 280 7
17 27*5 1*975 36 |12 6*48 |4*8 2*48 0*42 21 520 6
18 36* 1*771 36 26 5*65 3*7 2*1 0*47 22 348 1
19 34*2 1*907 48 34 6 *ol 3*9 2*62 0*38 19 365 3
20 41*1 1*937 35 j34 6*59 4*0 2*48 0*42 18 300 1
Mean 34*3 1*891 40 26 6*24 4*14 2*18 0*44. 22 347
Table - V (continued) Pregnancy.
No. PCV. PLASMAvise.
Wintrobe 
ESP. 
Ord. |Cor.
Total
Plas.
Prot.
Alb. £p 
I
! 
H
 
| 
& Fibr
i
Urea Choi, j
L
No.
of | 
preg, j
% cs. mm/ 1 hr
I
m g . / 100 ml]
j
sa|
36 -
&-po Week period.
j
j
1 35* 2*067 56 40 6*84 4*2 1 *8410*56 ! 27 582 | 2 i
2 39'8 1*966 45 40 6*59 4*54 1*8 0*56 28 430 i i !
3 35* 1*957 40 28 5*72 3*8 2*0 0*42! 19 395 1 l
4 37*8 2*170 42 34 6*95 4*8 2*5 0*4 27 493 j 2 i
5 35* 2*069 48 34 6*55 4*2 2*4 0*5 31 407 | 2 1
6 35*8 1*973 53 40 6*77 4*2 2*53 0*47 - -  | 1 f •*•* {
7 35* 1*892 35 23 6*19 4*0 2 *5410*36 19 377 | i !
8 39* 1*920 35 30 6*59 4*2 2*06 0*54 431 f i  !
9 34* 1*913 39 25 6*19 3*9 1*81 0*59 - 468 | 1 i10 38*5 1*992 49 41 6*30 4*0 2*3 0*56 26 ■425 | 311 37*5 1*918 47 38 6*48 3*7 2*4 0*47 - 336 | 2 j
12 35*2 1*838 38 26 6*12 4*9 2*38 0*42 18 280 1
13 40*8 1*734 7 5 5*34 4*2 1*73 0*37 17 260 j i
Mean 36*8 1*955 41 31 6*40 4*20 2*17 0*48 22 407
Table - V continued.
a70
PREGNANCY
The Means of the Plasma Viscosity, ESR, Haematocrit, and Plasma 
Proteins, for 4-weekly periods.
The top row of figures presents the absolute values; the lower 
row presents these values as a percentage of either the accepted 
mean normal or of the first results in this series. The chosen 
standard is obvious in the table.
Weeks
in
Period
No.
of
Tests
PCV.
PLASMA
v i s e .
Wintrobe
E.S.R.
Plasma protein
Total Glob Fibr.Ord. Cor.
% cs. mm/ 1 hr g./l0(j) ml.
i
'
Normal _ 42*0 1*802 9 9
!
|
f
100* 100 100 100 j I
4 - 7 4 40-3 1*844 11 9 7*17 4*93 j  2*15 0*35 j
96 *0 102*3 118 100 100* 100* 100-
f
100* !
8 -11 16 39*2 1*840 16 13 6*71 4*50
i
! 2*30 0*36 j
93*4 102*1 179 139 93 *4 91*2 108*0:102*9 j
i !  !
12 -15 22 38*3 1*804 18 13 6*95 4*75 ! 2.11 0*37 |
91*2 100*1 193 140 96*8 i 96*2
i
j 99*1
I
105*8 |
16 -19 19 37 *8 1*804 20 14 6*38 4*25
\
2*17 0*38 !
90 *0 100*1 218)154: 88*9 86*1 101*9 107*7 j
20 -23 13 38 ‘8 1*857 31 23 6*44 4*08
t
2*37 0*40 |
92*4 103*1j 346|256
i i
89*8 81*7 111 * 2 114*4 1
i
24 -27 13 38 *4 1*871 32 22 6 *36 4*27 2*27 0*41 \
91*4 103*8 350 239 88*6 86*5 106*5 117*2 I
]
28 -31 15 34*7 1*829 35 23 5*94
!
4*011 2*36! 0*43 |
82-5 101*5 378 253 82*7 81*1 110*7 123*0 j
32 -35 20 34‘3 1*891 40 26 6*24 4*14 2*18 i 0*44
81*6 104*9 439 288 86*8 84*0 102*2 125*8
36 - 13 36 *8 1*955 41 31 6*40 4*20 2*17 0*48
85 *3 108*5 457 345 89*3 85*1 101*9 137*2
Total = 135 tests
Table - W (a) a71
The changes in the plasma viscosity during an alcohol test meal 
for Gastric function.
The first "blood sample was removed from the fasting subject 
just before the administration of 100 ml. of 7% alcohol; the 
second sample was removed 2 hours later. 5-10 ml. of gastric 
huice were removed at 15-minute intervals.
Subjects with initial achlorhydria were given, in addition, 
a subcutaneous injection of histamine (0*5 mg. ).
No. S PCV. PLASMAv ise .
Wintrobe
E SR.
Plasma
Total
Prot.
Remarks
0rd.}Cor.
°/° cs. ram/l hr.
1 M 48*8 1*691 _ - 6*91 Slightly high curve
49*5 1*723 - _ 6*91
2 F 37*9 1*736 8 3 6*91 Achlorhydria, persisting
35*0 1*709 9 1 6*84 after histamine.
3 F 36*0 1*875 24 15 6*62 Low acid curve
38*0 1*895 26 20 6*73 I
4 M 51 *7 1*783 1 6 7*02 Normal acid curve
51 *3 1*776 1 5 6*95
5 M 30*8 1*932 35 11 7*27 Normal acid curve
30-9 1*943 37 13 7*27
6 M 40*7 1*882 16 9 7*42 Free acid appeared in normal
40*1 1*866 15 7 7*24 amount after histamine.
7 M 32*1 1*777 27 7 7*09 Achlorhydria after histamine;
29*1 1*712 30 4 6*77 pernicious anaemia .
8 M 46*3 1*777 7 6 7*02 Normal acid curve.
46*8 1*806 8 8 6*98
9 M 47*0 1*906 13 13 7*38 Normal acid curve.
46*9 1*921 14 14 7*34
Table - V/ (b)
The changes in the plasma viscosity during a Urea Concentration 
and Clearance Test of Penal function.
Urine specimens are collected from the fasting subject and 
then at hourly intervals for 5 hours. A blood specimen is 
taken after 1 hour; 15 g. of urea in about 200 ml. of water is 
given after another hour; and another blood specimen is taken 
after yet another hour. The clearance values presented are the 
average of the first two hourly urine samples calculated relative 
to the first blood urea level and of the third and fourth urine 
specimens relative to the second blood urea level.
Thus the second blood indicates the effect of one further hour 
of fasting and one hour after 15 g. urea.
s PCV.
PLASMA
vise.
Plasma
Total
Prot.
Blood
Urea
| Urine Clearance| Volume Urea Alb.
°/o cs. g.% ng. % ml. % of average normal
F 41*3 2*016 7*31 20 38 1*73 o
40*3 1*993 7*27 53 31 2*05 0 132
68 3.47 0
66 4*14 o 141
50 4*5 0
F 36*6 1*841 6*12 18 88 1*38 ++++
36*8 1*877 6*41 45 62 1*22 •+•+++ 142
142 1*15 ++
60 3*84 ++++ 120
44 4 *.70 ++++
F 51*2 1*730 6*41 24 24 2*2 0
51*4 1*777 6*88 44 33 2*44 o 123
142 1*46 o
72 2*46 o 109
72 2*78 0
M 50*6 1*841 7*13 35 134 0*53 0
50*3 1*813 6*70 50 90 0*76 o 61
90 0*77 o
126 1*04 o 39
108 1*11 o
M 46*5 1*996 7*27 37 32 1*56 0
46*7 2*028 7*38 64 49 1*7 0 67
120 2*18 °
45 1*97 o 70
46 2*5 o
Table -
jS PCV.
•j
r  >
F 47*0 
45*1
F 41*3 
41*3
P 41*5 
41-5
P
i
m |
i
P 37*7 
36*7
F 43*2 
42 *4
W (b) continued, a 73
PLASMA
v ise .
Plasma
Total
Prot.
Blood
Urea
Urine Clearance
Volume Urea Prot.
cs. g-> m g . y o ml. °/o of average
1*910 7*63 19 25 1*45 s. tr.
1*905 7*52 42 30 2*06 s. tr. 116
84 2 *66 s. tr.
76 2*20 s. tr. 124
52 2*90 s. tr.
2*070 7*56 26 52 0*94 s. tr.
1*955 6*80 48 53 1*27 s. tr. 74
76 1*91 s* tr.
88 2*38 s. tr. 79
70 2*35 s. tr.
2*432 8*53 55 38 0*84 tr.
2*465 8*64 68 48 0*96 tr. 26
54 1*00 tr.
70 1*32 tr. 32
98 1*26 tr.
1*906 7*52 40 170 0*72 o
1*899 7*52 71 47 1*81 o 70
210 1*04 o
74 2*84 0 75
45 3*83 o
1*842 7*49 19 56 1*40 tr.
1*820 7*34 34 44 1*58 tr. 132
54 2*08 o
54 2*98 tr * 130
26 4*30 +
1*781 6*16 22 42 1*38 o
1*788 6*59 55 50 1*50 o 106
140 2*24 o
64 3*55 0 134
44 4*15 o
1*859 7*27 22 79 0*55 0
1*872 7*42 55 115 0*62 o 62
288 0*61 0
150 1*48 o 80
49 3*10 o
Table - W (c) a74
The changes in the plasma viscosity during a Glucose Tolerance 
Test for carbohydrate metabolism control.
The first blood sample was removed from the fasting subject 
just before the administration of 50 g. of glucose in 150-250 ml. 
of water. The later blood samples were removed at 30-minute 
intervals.
No. S PCV.
PLASMA
vise.
I'/introbe
ESR.
Plasma
Total
Prot.
Blood
Sugar
Urine
Sugar AcetoneOrd. Cor.
% cs. mm/ 1 hr g •% mg. %
F F 44*8 1*874 8 9 6*55 180 +•+++ ++++
1 43*7 1*829 6 8 6*95 257 ++++ ++++
2 42 *0 1*812 7 7 7*06 286 ++++ ++++
3 42*3 1*792 7 7 6*59 312 ++++ ++++
4 43*5 1*885 7 . 8 7*02 272 ++++ ++++
5 43 *6 1*852 9 10 7*02 242 ++++ ++++
F M 49*0 1*854 1 3 7*13 59 o o
1 50*0 1*839 1 3 6*95 102 o o
2 49*2 1*837 2 4 6*95 80 o o
3 47*2 1*797 2 2 6*95 76 o 0
4 47*1 1*791 1 1 6*41 66 0 o
5 47*2 1*764 1 1 6*70 49 0 o
F M 45*9 1*812 2 1 7*02 62 o o
1 46*3 1*779 2 1 6*98 110 o o
2 45*0 1*762 2 0 6*95 110 o o
3 45*8 1*776 1 0 7*13 97 o o
4 46*4 1*827 2 1 7*16 55 o o
5 45*9 1*802 3 2 7*09 33 o o
F M 47*7 2*123 13 14 7*24 55 + ±
1 47*2 1*999 13 13 7*06 124 ++ +
2 46*9 1*995 15 15 6*88 132 +++ o
3 47*1 2*043 13 13 6*98 113 + ++ 0
4 47*2 2*069 15 15 6*98 89 ++ o
5 46*7 2*048 16 16 7*13 57 + o
F M 48*8 1*885 5 7 6*73 75 + o Post­
1 48*7 1*872 6 8 6*91 171 ++ 0 gastrectomy
2 47*9 1*816 4 5 6*77 176 + + + o syndrome
3 47*9 1*823 5 6 6*66 135 ++ o
4 47*4 1*866 6 6 6*70 94 + o
5 47*8 1*857 5 6 6*91 66 + o
Table - continued ~ W (c)
No. S PCV.
PLASMA
vise.
Wintrobe
ESP.
Ord.ICor.
Plasma
Total
Prot.
Blood
Sugar
Ur:
Sugar
ine
Acetone !-------- . - , - . t
% cs. ram/ 1 hr g- % mg. % i
F F 44*9 1*852 6 9 6*98 118 o o
1
1
1 44*4 1*827 5 7 6*98 188 / /
1
2 42 *7 1*746 5 6 6*62 232 / / !
3 41*9 1*737 6 6 6*70 204 ++++ + !
4 41*3 1*760 7 6 6*59 174 ++++ + 1
5 43-4 1*800 6 8 6*84 174 ++++ +
F F 43*5 1*822 — - 7*09 128 tr o 1
1 41*8 1*784 4 4- 7*02 198 tr o 131 ml. j
2 41-7 1*750 6 6 6*91 236 + o 142 ml. [
3 41*6 1*722 4 4- 6*70 240 ++++ o 163 ml. |
4 41*7 1*764 5 3 6*70 214 ++++ o 74 ml.
5 41*6 1*775 5 5 6*91 190 + o 36 ml.
F M 47*1 1*807 5 5 7*02 76 o o
1 47*1 1*776 4 4 6*84 126 o o
2 45*9 1*765 5 4 6*77 94 + o
3 47*4 1*808 6 6 6*84 40 tr 0
4 48*7 1*835 5 6 6*95 35 o o
5 47*5 1*838 6 6 6*98 42 o o
F F 41*2 1*884 9 8 7*42 84 o o 321 ml.
1 40*9 1*882 8 7 7*52 108 o o 36 ml.
2 41*8 1*892 8 8 7*45 91 + o 28 ml.
3 41*6 1*914 9 9 7*38 78 o o 36 ml.
4 42*2 1*926 9 9 7*74 78 o o 35 ml.
5 42*1 1*913 10 10 7*49 85 o o 24 ml.
F F 37*5 1*918 47 38 6*48 34 tr 0
1 37*8 1*912 48 39 6*55 66 tr o
2 - - - "" - 104 tr 0
3 36*9 1*897 50 40 6*30 113 / /
4 36*1 1*877 50 39 6*30 107 ++ 0
5 35*9 1*892 48 37 6*05 116 ++ o
F M 43*6 1*705 3 0 6*62 79 o o
1 44*0 1*699 1 0 6*80 32 o o
2 45*1 - 2 0 6*91 64 o 0
3 42*2 1*683 3 0 6*55 55 o o
4 43*6 1*725 3 0 6*95 66 o 0
5 42*6 1*727 4 0 6*77 58 0 o
6 43*6 1*722 5 1 6*95 83 o o
7 43*4 1*756 4 0 6*77 82 o o
8 43*2 1*737 5 1 7*24 90 o o
Table - Y/ (c) continued a76
No. S PCV.
PLASMA.
vise.
Wintrobe
ESR.
Plasma
Total
Prot.
Blood
Sugar
Urine
Sugar Acetone
Ord.Cor.
% cs. rarn/l hr mg.%
F F 46*5 1*985 4 8 7*52 231 ++++ _
1 44*4 1*874 6 8 7*16 280 ++++ —
2 43*7 1*885 8 10 7*13 303 ++++ -
3 44*3 l-*883 8 10 7*09 300 ++++ -
4 46*1 1*941 7 11 7*27 278 ++++ -
5 45*1 1*936 8 11 7*24 262 ++++ -
Table - I a77
The effect of Sulphanilami&e and Sulphapyridine on the Serum 
Protein, Plasma Viscosit}?-, and Erythrocyte Sedimentation Rate.
(A) Sulphanilamide:-
In all subjects the sulphanilamide was given in the dosage of 
2g., then 2g. after 4 hours, and then lg. 4-hourly to a total 
of 20g. in three days.
The subjects were normal or suffering from conditions 
such as phthisis, post-encephalitis, etc., which do not 
respond to this treatment.
The figures in red. express the result above as a 
percentage of the initial value; the third row of figures 
under serum protein expresses the value as a percentage of 
the initial protein, after correction for variation in the 
plasma proportions as shown by the packed-cell-volume.
Citrate 
PI. Vise.
Ser. Vise.
P. C.V.
Max. ESR.
Ser. Prot.
1*564
1-770
52-8
1*67
6*81
1*637 
104*3 
1-875 
106*0 
32*5 
199 -1 
2-01 
120*4 
7-38 
108*3 
108*9
1-575
100-8 
1*757 
99*3 
30*6 
94 *4 
1*17 
70*3 
7*01 
102*9 
106*3
'
Days of Test 0 1 2 3 4 5 6
PI-Vise. 1*538 1*667 1-547
108*3 100-8
Ser. Vise. 1-687 1*855 1*663
110*0 98*7
P. C.V. 38*0 39*2 35*0
103*1 92*0
Max. ESR. 0*41 * 2*81 1-01
686* 246-
Ser. Prot. 6*71 7-13 6-47
106*4 96 *4
104*4 100*8
PI. Vise. 1-705 1*768 1-705
103*6 100*0
Ser. Vise. 1*872 1*976 1-888
105-6 100-4
P. C.V. 28*6 31*3 31-0
109 *4 108 *4
Max. ESR. 2-78 5 *96 7*67
214*0 276*0
Ser. Prot. 6-95 7-64 7*04
110*0 101-3
105*8 98-0
Table - Y continued. a78
(A) Sulphanilamide (contd. )
Days. 0 1 2 3 9
Citrate
PI. Vise. 1*605 1*653
103*0
1*616
100*7
Ser. Vise. 1*785 1*866
104*4
1*821
102*1
P. C.V. 36*7 34*6
94*2
32*7
89*0
Max. ESR. 2*19 3*79
173*
2*80
128*
Ser. Prot. 6*84 7*25
106*0
109*6
7*03
103*0
109*2
Citrate
PI. Vise. 1*657 1*722
104*0
1*674
101*1
Ser. Vise. 1*806 1*840
101*9
1*900
105*1
1*829
101*2
P. C.V. 34*8 33*9
97*4
34*0
97*7
Max. ESR. 6*51 10*93
168*0
8*22
126*3
Ser. Prot. 6*69 6*97
104*2
105*7
6*72
100*5
101*7
Citrate
PI. Vise. 1*645 1*664
101*2
1*615
98*2
Ser. Vise. 1*893 1*945
102*7
1*857
98*0
P. C. V. 32*5 33*7
103*7
32*8
100*9
Max. ESR. 5*44 6*19 
113 *8
4*22
77*6
Ser. Prot. 7*15 7*53 
105 *4 
103*7
7*03
98*3
98*1
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(b ) Su lphapyridine.
Dosage was exactly the same as for sulphanilamide - 2Gg. in 
three days. The subjects were taken from similar clinical 
material.
Days. 0 1 2 3 4 5 6 7 8
Citrate
PI. Vise. 1*562 1*613 
103 *4
1*627
104*1
1*555
99*5
Ser. Vise. 1*777
■ $
1*836
103*3
1*845
103*9
1*748 
98 *4
P. C. V. 35.4 35*4
100*0
35*6
100*6
35*0
98*8
Max. ESR. 1*04 1*50
144*4
1*54
148*0
0*86
82*5
Ser. Prot. 7*14 7*21
100*9
100*9
7*23
101*3
101*1
6*54
91*6
92*1
Citrate
PI. Vise. 1*614 1*598
99*0
1*660
102*8
1*602
99*3
Ser. Vise. 1*822 1*832
100*6 j 02 *9
1*878
102*9
1*848
101*4
P. C. V. 33*8 32*4
95*7
33*6
99*5
33*4
98*8
Max. ESR. 2*41 1*50
62*3
■ 2*76
114*4
2*64
109*5
Ser. Prot. 7*02 6*89
98*1
100*0
7*17
102*2
102*5
6*89
98*1
98*9
Citrate
.
PI. Vise. 1*568 1*604
102*3
1*573
100*3
1*586
101*2
Ser. Vise. 1*757 1*845
105*0
1*760
101*1
1*766
100*4
P. C. V. 33 *o 34*2
103*6
33*0
100*0
32*3
98*1
Max. ESR. 1*97 2*83
143*6
2*89
146*8
2*47 
125 *4
Ser. Prot. 6*7 7 7*24
106*9
105*0
6*85
101*1
101*1
7*09
104*77
105*2
Table - Y continued
(B) Sulphapyridine (contd. )
a80
Days. 0 1 2 3 4 5 6 7 8
Citrate
PI. Vise. 1*810 1*812
100*1
1*853
102*3
1*808
99*9
1*814
100*2
Ser. Vise. 1*903 2*033
106*8
2*011
105*6
1*983
104*2
1*950
102*5
P. C.V. 35*5 34*0
95*8
36 *4 
102*6
36*8
103*7
36*2
101*9
Max. ESR. 9*26 8*24
90*0
11*27
121*8
10*56
114*0
10*26
110*8
Ser. Prot. 6*95 7*62
109*7
112*1
7*63
109*8
108*2
7*00
100*8
98*6
7*44
107*1
106*0
Citrate
PI. Vise. 1*552 1*611
103*9
1*651
106*4
1*710
110*1
Ser. Vise. 1*772 1*773
100*1
1*924
108*5 *
1*985
111*4
P. C.V. 34*2 34*4
100*4
36*5
106*8
38*2
112*7
Max. ESR. 1*63 1*96
120*2
2*47
151*6
2*00
122*5
Ser. Prot. 6*67 6*75
101*2
101*0
7*27
109*1
105*2
7*89
118*3
111*2
Citrate
PI. Vise. 1*663 1*726
103*6
1*719
103*3
1*687
101*4
1*719
103*3
Ser. Vise. 1*923 1*946
101*1
2*010
104*4
1*963
102*1
1*956
101*6
P. C.V. 34*0 37*6
110*7
34*5
101*5
34*0
100*0
34*8
102*3
Max. ESR. 5*43 6*75
124*2
6*67
122*8
5*00
92*2
5*98
110*0
Ser. Prot. 6*95 7*56
108*8
102*8
7*38
106*3
105*7
7*09
102*0
102*0
7*4-7
107*5
105*3
a81
Part 4
TABLES of RESULTS 
and
CASE HISTORIES 
of
DISEASE SECTION
Table- II a82
(A) Chronic Rheumatoid Arthritis - Female.
mame No. Date PLASMAvise.
Wintrobe
E.S.R,
OrdjTCor.-
Total] 
Plas. 1 
Prot, |
Cold | pp-rr .
Floe ]
..___i
j  Remarks
cs. im/ 1 hr. % ii ! %I 1"
H.C. 1 12: 5 2-200 20 | 24 7-88 145-2 1
13:10 2-051 32 I 38 7-16 j + 145-6 I Gold-21/10/47 to
13: 9 2-105 27 j 31 7-74 | + 44-6 | 13/1/48
M.C. 2 7:7 2-096 23 | 31 7-52 | - 45 -3 Gold - 7/8/47 to
18: 9 1-981 2o ! 7-13 j - i "* ! 25/10/47
ij7:11 2-025 10 ! 13 7-45 ] 0 |44-2
R.D. 3 27:10 2-263 - - 8-21 | + |42 -6 jGold 9/9 to 25/11/47
29:12 2-088 44 j 43 7-31 ] + |41-5 | Much improved*
H.F. 4 13: 1 1-949 - 8-44 ! _ ) 47 *5 i
25: 9 2-227 29 | 38 7-96 | - 147-9 ‘Gold 27/9 to 29/11/47
7:11 2-252 - - 8-46 j + j48-0 j
E.H. 5 24: 1 2-094 ;
t - (40-2
j
[Gold begun 27/1/47Ij 2: 5 1-935 40 1 43 7-74 I - 143-8
!17:11 2-255 20 i 12 7-99 !} 3+ 136-1\
L.B. e | 24: 3 2-095 30 ! 36 7-83 j _ ji46-2
\!i
j30: 6 2-003 21 21 7-52 i - ]42 -2 |
7:5 2-129 14 : 19 7*74 | - 45-8
1
i 23: 4 2-101 26 28 7-63 ] + 143 *3 Gold begun 27/2/48i10: 9 2-085 10 14 7-52 | + 145 -3
A.C.
i
7 j14: 4 2-045 2 1 7-81 ! - 145-7j Gold 3/4 to 26/8/47
I28: 8 2-068 - - 7-70 | - 40-8 Locally improved
i14:11 2-127 9 12 8-10 | + |44-5 Much improved
1.0. 8 ! 9: 4 2-334 24 ' 29 8-28 |
- |45-4 Gold 15/4 to 15/7/47
j
i 30: 5 2-341 46 46 8-i4 ; - 141-9
i 17: 7 2-207 - - 8-21 j - 41-8f
j 31 : 12 2-190 11 : 12 7-99 j - f 42 -6
j20: 2 2-061 27 ; 28 7-60 1 + !42*4
i21: 4 2-064 38 : 36 7-60 | + 40-3
1| 6: 9 2-054 33 ! 32 7-74 | +
141 *4;
D.B. 9l16: 1 2-211 25 j 20 8-24 | - 138-3 Gold 17/1 to 28/2/48
s1j 27: 2 | 2-088 33 ! 24 7-81 j 2+ 1 36 -31
j 128: 4 j 2*037 28 | 19 !7-67 | 2+ 36-2
M.A. 10 j 3: 3 2-118 ;25 ! 1 9 !7-92 | + 36-0 Gold begun 23/4/48?
| 7: 5! 2-11A |29 i! 183 f 7-63 | 2+
35-Oj after 7 injections
E. A, 11 10: 1 1-920 ! 7 7 -  !
1
42- Gold begun 18/12/46
j 24: 2 j 1-887 ! -
-  !
_ !
j - 39'4 j Improving
A.M. 12 1 13:10 2-236 1 29 1 32 ii  a 8-03 { 0 43 *91 Gold 28/10 to 17/1/48
J
10:12 2-180 1 16 .15 j 7 / 8 1 l + 4 1 : ! J
Much improved
Table- II continued a8-3
Name No. Date PCV.
plasma]
vise.
ffintrobe 
E. S.R. 
Drd. j Cor.
!Total 
Plas.
! Prot.
Gold
Floe
% cs. ;mm/r L hr.p r r ~;
A.B. 13 27 8 40*3 1*977 |34 32 | 7*27
j
31 10 41*8 2*080 I26 26 [ 7*81 0
14 4 41*2 2 *024 |26 25 | 7*49
15 9 41*2 2*072 || 29 28 \ 7*31 +
M.B. 14 7 8 4o*2 2*071 | - ~ I 7*63 -
25 9 41*3 2*146 35 33 i 7*74 ! -
28 11 38*7 2*153 131 26 | 7*85 1 +
16 1 38*5 2*193 ! 9 5 1 7*78 I —
20 2 40*7 2*274 36 34 | 7*92 i +1
8.6. 15 24 11 43. 2*109 | 21 23 i
t
21 3 47*1 2*114; 15 21 _
12 11 43*3 2*308 I 39 40 8*35 j 3+
19 3 39*0 1*930 29 24 1 7*16 1 0
13 9 43*8 2*257 29 32 | 7*99 : 2+
A. B 16 29 9 45*8 2*242 30 : 36 1 7*92 \
5 11 43*9 2*218 33 i 36 i 7*99 I 0
24 4 46*6 2*214j 27 ; 34 : 7*78 1 +
A.B, 17 21 4 •
0
0
to 2*158 - : : 7*74
5
j
28 5 40*3 2*216 48 ! 46 ; 7*92 ! -
7 11 38*4 2*279 32 ; 26 ; 8*21 ! 0
12 12 40*9 2*251 39 ! 37 ; 7*70 1 2+
9 2 42*4 2*061 21 ! 22 7*88 ; +
8 9 41*01 2*187 22 i 21 I 7*99 ] +
A.H. 18 27 10 38*6 2*093 41 i 35 1 7*74 1 2+
19 12 37*9 2*036 28 i 21 : 7*42 j 2+
3 2 39*71 2*115 j 22 ! 18 ; 7*81 \l
E. H. 19 2 2 39*4 2*090 39 ! 34 7*92 1 +
2 4 39*8 2*054 ;38 j 34 7*92 j +
V.F. 20 12 5 39*1 1*830 j 7 1 4 : 6*98
1
25 7 41*8 1*892 15 ! 15 ! 7*42 1 ~
6 10 43*3 2 *024 16 j 17 ; 7*60 1 -
E. C. 21 21 7 35*5 2*126 123 } 14 7*74 ! *
4 9 43*1 2*206 - ! ! 8*03 -
3 11 43*8 2*112 19 j 22 8*24 +
G.M. 22 28 5 40*9 2*165 31 j 29 7*81 : “*
17 7 41*3 2*085 - | - j 7*56 S —
C. J. 23 6 12 44* 1*993 20 ! 22 1 ! -
10 10 40*4 2*049 42 j 40 j 7*38 ! 2+c
5 12 38*9 2*076 35 30 1 7‘65 3+
28 1 40*9 2*114 42 l il j 7*81
j 3+
j Remarks.
| Gold begun 23/9/47
! Gold 13/1 to 6/4/48
)
|
Gold 1/7 to 10/9/47 
I Gold 12/12 to 17/2/48
jf
i
| Gold ended 20/1/47
I
| Gold begun 12/12/47
I
j Gold begun 13/10/47
j
| Gold 15/11 to 28/2/48 
improving
j Gold 4/11 to 27/1/48
j
I Gold 10/2 to 27/4/48
j Gold 23/3 to 28/6/47
j
j Gold 29/7 to 25/11/47
| much improved 
| Gold begun 6/6/47
j
j Gold 14/10 to 20/1/48 
S much improved
Table- II continued. a84
Name | No.
! ►
Date PCV.
jpLASMA
| vise.
Fwint 
1 E.
robe
S.R.
Total
Plas.
Prot.
Gol
Flo
!0rd. Cor.
[ % cs. jmn/ 1 hr.
i. p. 24 6 2 - j 1*959 i - ! . -
22 9 40‘7 ! 2*052 1 25 1 23 7*56
13 11 37*0 ! 2*050 ! 5 i ° 7*78 2+28 1 41*4 ! 2*004 i 24 23 7*56
15 3 39*0 1 2*106 i 22 I 18 7*34 +
15 9 41*7 j 2*120 | 37 1 37 7*85 2+
E. P. 25 29 7 35*8 j 2*114 ! 53 ! 39 7*49 -
20 10 40*3 1 2*136 • 4o ■ 37 7*85 2+
10 11 42*7 ; 2*258 1 24 I 25 8*78 3+
17 12 41*3 1 2*082 j 26 I 25 8*24 3+
21 4 38-3  ^ 2*129 : 45 1 38 7*67 +
15 9 40*3 1 2*190 j 46 i 43 7*92 +
D. S. 26 24 7 39-1 ; 2*109 - - 7*38 .
11 9 38*7 i 1*959 1 25 ! 21 7*02
27 10 40*9 1*972 7 1 6 7*78 +
12 5 36*9 1*888 : 20 i 13 6*80 -
M.S. 27 30 7 44*3 2*056 J - - 7*42 -
17 9 43*3 1*955 13 : 15 7*38 -
10 12 44*3 1*969 18 21 7*70 +
10 3 41*8 1*913 : is : 18 7*16 0
7 5 42*3 1*911 : 14 j 14 7*06 0
M.T. 28 10 7 41*4 2*172 - - 7*20 -
(10 9 41*2 2*364 ! 44 • 43 7*92 -
15 10 40*1 2*316 ; 43 ; 40 8*03 5+
1 7 1 41-5 2*242 39 38 7*67 4+
118 2 41*7 2*320 ■ 42 42 8*03 5+
; ( 5 5 40*0 2*306 ; 45 : 41 7*70 5+
M.T. 291 15 9 42*0 2*306 i 40 40 8*06 -
j 5 11 45*7 2*231 15 20 8*60 +
| |20 12 41*1 1*922 16 15 7*27 2+
M. S. 30 10 1 4-0* 1*802 10 8 - -
10 3 39*4 1*831 8 5 -
28 5!38*0 1*936 20 15 7*34 -
j31 io!36*8 2*086 30 22 7*99 +
i
I19 12 1!34*3' 1*918 19 9 7*24 3+
E.S. 3l| 9 12 142* 2*167 39 39 - -
|22 i!40*8 2*210 40 38 - ! -
30 4|41 *4 2*254 49 48 7*99 j -
11 8]43*1, 2*230 39 41 8*17 1 -
25 9 40*7 2*104 32 30 8*06 1 -
30 4 41*6 2*041 26 25 7*92 +
M. J. 32 28
i
5 44*2 2*046 10 13 8*06
1 28 8 j44*5 1*958 l_5_ 12
7*56
1
Remarks 
Gold 12/2 tc 2/4/47
Gold 9/9 to 20/11/47
Gold 29/7 to 21/10/47 
Clinically improved
Gold 12/8 to 28/10/47 
Clinically ISQ.
Gold begun 6/3/48
Gold 16/7 to 1/10/47 
) clinically worse 
Vaccine begun
’’Subacute1 
Gold 23/9 to 16/12/47
Improved.
Gold course ending
Gold begun 31/3/47 
but discontinued.
Gold 4/11 to 9/12/4-7
Gold 17/1 to 25/4/4-7
Gold 15/8 to 28/10/47 
Gold 26/5 to27/8/47
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Name
1
r ~ | ..."
No. j Date
J
PCV.
PLASMA
vise.
Wintrobe 
E. S. R. 
prd.f Cor.
!Total 
j Plas. 
iProt.
1
Gold
Ploc
j I 6/P cs. m / 1 hr ; ^
S.K. 33 30 5 37 ‘6 2*219 37 1 29 j 8*53 i _
17 7 41*4 2*194 ; | - S 8*57 ! -
28 8 42*9 2*147 i 21 I 22 | 8*24
(16 1 41*5 2*321 ; 20 j 20 \ 8*96
i'
1 3 39*7 2*164 40 ! 36 1 7*92 ; +
28 4 39*3 2*196 38■ i 33\ | 8*32 ! 2+
A.H. 34 6 12 43* 1*886 10 i 11 i — —
7 5 41*4 1*877 23 [ 22 ! 7*38 —
19 11 42*5 2*194 32 ; 33 7*85 : 3+
15 1 39*9 2*176 43 ; 39 7*63 2+
10 3 38*5 1*961 38 ! 32 ; 7*02 +
L.H. 35 27 3 45*9 2*126 26 i 32 7*92 _
21 5 43*8: 2*330 13 ; 15 7*88 -
A. P. 36 27 3 44*9 1*960 - ; 7*71 _
21 5 41*5 1*909 10 9 1 7*52 -
M. 0. 37 20 10 39*8! 2*393 - - ! 8*46 +
22 12 41*2 2*251 42 ; 41 1 8*14 +:
1 3 3 39*2 1 2*125 39 34 i 7*81 0
5 5 40*2 1 2*339 44 40 ; 8*42 +
M.M. j 38 3 3 38*7 2*278 46 39 i 8*39 3+
i 30 4 41*4 2*300 39 38 ; 8*10 3+
E.S. | 40 13 8 43*0 2*339 43 44 ! 8*68 ~
i 3 12 42.2 2*176 23 23 : 8*25 +
6 2 40*2 2*072 22 20 : 7*74 +
[ 23 3|42 *3 2*115 24 25 ! 8*03 +i! 16 4|139*5: 2*000 27 23  ^ 7*52 0
J. R .  - j 41 10 3!37*8 1 1*970 23 16 7*60 +
i 12 3 i36*7: 1*993 25 17 7*60 01 24 si38*4! 1*964 20 15 7*85 0
M.T. 42! 6 8 43*1 2*041 — - 7*34' -!24 11 j45*6 1*908 10 14 6 *70 +I
I 9 llJ44*8 1*928 16 19 7*20; +
M.H. | 43 25
\
7|33*1 2*259 ;52 34 7*89 -
1 23 3!33*1 2*272 41 25 7*70 3+i j14 6 Sj30*4 2*080 56 32 6*47 3+
I.B. j 44118 2 i38*1 2*397 |50 41 8*75 4+j30 4 i36*2 2*368 j48 36 9*11 4+
112 5 i537*7 ij 2*360 j45 37 8*17 4+
K.H. j 45!14 4I42 *6 I 2*462 |46 47 8 *17 0I
26 5 38 *3 j 2*324 j44- 36 7*63 0
A.T. 46 26 11 42*1 j 2*011 j 12 12 7*78 0
1 12 3 39*0| 1*804 jI 10 I 6*84 0
r ...  . .........
j Remarks
j Gold 1/6 to 26/8/47
|
' Much improved 
) Now nSubacute" 
j Gold 20/1 to 13/4/48
j Gold begun 11/12/46 
I Gold begun 2/12/17
j Gold begun 12/4/47 
| Gold begun 24/3/47
j Gold 28/10 to 2/12/47
1 Gold begun 9/3/48
|
[ Gold begun 9/3/48 
j Gold 13/1 to 16/3/48
Gold begun 5/4/48
Gold begun 24/11/47 
after 6 injections
1947
1948
Gold begun 24/4/48 
Gold begun 5/3/48
Gold begun 23/4/48
Gold begun 6/12/47 
Gold resumed 28/2/4-8
Table-il continued. a86
“ T “
Name [No. Date PCV. i PLASMA! vise.
Wintrobe
E.S.R.
T lor.
Total. . 
JPlas. gold | 
SProt. Floci
 ^ |5 ! %.r cs. jinm/ 1 hr f° [ J*|
S.B. S 47 i 5:11 41*1 1*936 S 11 10 7*70!
fi!
+ ii
j *22:12 41*6I 1*862 1 5 5 7*24!
?
0 !
1 9: 2 41*1! 1*830 | 7 6 6*84| 0 !
| 7: 4 42*5 1*797 6 6 6*52 j 0 !
A.B.
CO 19: 3 41*51 2*245 | 47 46 7 *90 j — !
( 7: 5 39*7| 2*331 ! —) —! 8*28 | - f?j 124: 7 41*2: 2*478 J 8*60 [ - i
i 18: 9 42*8' 2*429 j 46 47 8*39 ! - j
E. S. | 49 29:10 41*75 2*075 i 17 17 7*92 j o i
1i 17:12 43*4 2*031 : 14 16 7*88 | + ;
M. S. j 50 28: 4 41*5: 2*246
to 36 8. 03 1 — 1| 2: 7140*35 2*355 I - - 7*92 ;
!sj 14: 8 138*5 j 2*152 ; 42 36 7*88 j
1
E . S . 1 51 3: 9 52?4i 2*261 - - 7*63 : - 1
j (28:11!30*7; 2*384 22 7 8*64 ;5+ )
1 20:12| - 2*257 i 23 - 7*88 ; - !
E. R, i 52 7: l\44*6; 2*169 : 47 52 8*34 !
1
1 11: 2 143*6 2*088 i 16 19 7*99 ; 0 I
jt 17: 3 j44*6! 2*034 : 18 22 7*92 + 1
E.H. 1 53 18: 4143.4 2*024 - ~ 7*49 : - ;i 13:10=46*1 2*091 13 17 7*81 ! + ■
I 17:12!43*6 1*991 - - 7*49 : - \
F2: 4142*9 1*898 13 14 7*02 ;
i
+ 1
9: 2!s43*4 1*971 3.3 14 7*60 ;2+!*
M.H. 54 30: 5|36 *5 2*102 ! 49 38 7*85 -!
24: 9|38*0: 2*112 ■ 46 38 7*56 ;
I;
14:11! 34*3 2*052 34 21 7*88 + !
L.H. 55 21: 2I40*0 1*916 : 6 5 - - !
23: 5 42*7 1*965 - - 7*42 ; - i
2:10 43*9 2*008 ; 34 16 7*31 - ■
19:11 43*1 1*993 ! 14 10 7*49 52+ 5
31:12 43*3; 1*970 18 20 7*31 ■ - :
10: 9!42*6 2*020 : 33 34 7*13 ; + ;
E.W. 56 23:12)37* i 1*963 1 33 23 -  ^ 'i
28: 1!39*8: 2*029 \ 30 26 7*70 1 + !
19: 3j45*3 2*222 | 29 24 7*92 I
+ !
D.W. 57 17: 9!38*7: 2*116 1 44 38 7*34 I - 1
(29:12j39 *7 J 2*266 1 29 j 25 8*46 j 3+ )
J. J. 58(23: 5j45 *0 ■ 2*402 ' 7
!
10 8*86 *■ - )
28: 8j43*1 2*042 j 22 24 7*67 ; " 1
1
11:11J46*3) 2*066 16 : 21 I
7*81 j 0 !
Remarks
Gold 7/11 to 5/1/48 
improving
Now subacute
Gold 9/8 to 25/10/47
Gold 20/9 to 6/12/47
Gold 25/4 to 19/8/47 
improving
Gold 16/9 to 25/11/47 
now subacute 
improved
Gold begun
Improving 
Gold begun 12/12/47 
Improved
Gold 7/10 to 51/12/47
Gold 3/3 to 20/5/47 
improving 
Gold 4/10 to 20/12/47
1946
Gold begun 3/2/48
Gold 28/10 to 6/1/48 
now subacute
subacute 
Gold 3/6 to 20/8/47
Table- II continued a87
PLASMA IWintrobe Total
i ~i
z o • ilate PCV. vise. E.S>. R. Plas.
I.- Qrd. j Cor. Prot.
' cs. jirnn/ 1 hr
W.C. 59 9 12 40. 2*082 19 17 -
21 7 39*2 2*073 - - 7*92
2 10 37*5 2*330 47 38 8*24
21 11 35*5 2*247 50 37 8*10
7 4 36*0 2*191 45 34 7*96
8 9 36*0 2*383 51 40 8*64
M.F. 60 IS 12 42*5 2*011 24 24 -
M.D. 61 23 12 - 2*044 - - -
S.G. 62 23 12 44* 2*151 5 7 -
9 5 43*7 2*341 17 19 8*32
I. S. 63 17 1 A A •XI 1*882 2 4 8*06
J.I. 64 8 1 43* 1*995 29 31 -
M.L. 65 17 1|48* 1*996 - -
E.N. 66 22 1 44*2 1*899 12 14 -
M.C. 67 23 1 44*5 1*862 10 13 -
5 2 41*6 2*021 - - 7*85
E.B, 68 24 1 40*9 1*864 14 12 -
31 3 45*1 1*930 20 24 7*31
2 4 - 1*916 - - 7*31
29 12147*6 2*091 4 10 7*81
28 5 42*9 2*066 29 30 7*67
H.B. 69 28 1 45*5 2*016 - - -
[11 8 44*7 2*425 33 36 8*39
18 9 - 2*287 16 - 8*17
10 10142*5 2*284 23 24 8*03
24 12 40*4 2*068 28 26 7*34
15 3 43*6 2*136 19 21 7*70
7 5 40*5 2*148 20 18 7*81
10 9 42*0 2*460 7 7 8*71
15 9 38*8 2*231 - - 7*81
E. J. 70 31 1 45*1 1*907 - - -
S.H. 71 8 2 46*9 2*290 - - -
F.D. 72 14 2 47*1 2*170 - -
H. L. 73 24 2 45*0 2*043 - - -
23 4 44*7 2*017 16 19 7*60
15 10 42*9 2*009 14 15 7*74
3 12 41*6 1*924 7 7 7*34
E.C 74 24 2 42*5 2*054 - - -
E.P. 75 3 3 41*2 1*993 29 28 7*46
Gold
Floe
3+
2+
3+
3+
+
3+)
5+
2+
3+
4+
4+
+
2+
Remarks
1947
1948
now subacute
(i
Table- II continued
Name No. Date PCV.
PLASMA
vise.
Wintrobe 
E. S.R.
Total
Plas.
Prot.
Cold
FloeOrd. 1 Cor.
I T cs. mm/ I hr. %
I. H. 76 17 3 47‘9 1*954 3 8 7*3 7 -
11 8 44‘9 1*987 14 17 7*60 -
__ _ 
E. L. 77 31 3 43*6! 2*021i 30 32 7*20 -
M.W. 78 31 3 44*1 2*011 12 15 7*13 -
2 4 - 1*899 - - 7*02 -
25 7 39*6 1*997 29 35 6*99 -
20 10 38*9 1*976 15 11 7*06 +
2 2 43*6 2*238 10 12 8*21 0
E.W. 79 2 4 44*9 2*361 34 39 8*96 -
27 11 43 *5 2*505 14 17 9*14 3+
E. J. 80 9 4 40-0 2*220 19 17 7*84 -
21 5 39*7 2*175 30 26 7*88 -
K.P. 81 14 4 43*2 2*100 13 14 7*81 -
M. A 82 16 4 45*4 2*121 6 10 8*06 -
9 10 47*1 2*036 15 21 7*67 -
10 3 41*2 1*943 - 6*88 3+
S. A. 83 3 ll 35*1 1*932 14 6 7*60 +
M.R. 84 17 4 41.3 2*010 14 13 7*49 -
M. S. 85 18 * 44*3 2*210 5 7 8*06 -
E.K. 86 21 4 46*3 2*034 6 11 7*85 -
17 9 46*7 2*087 12 18 7*60 -
D. S. 87 21 4 41*8 2*206 _ 7*70 -
30 5 39*6 2*273 49 45 7*99 -
5 9 39*1 2*255 - - 7*99 -
21 10 38*7 2*154 - 7*67 +
y. j . 88 28 4 39*9 2*381 38 34 8*35 -
E.C. 89 28 4 142 *0| 2*197 - 7*45 -
E.S. 90 2 5137*0i 2*038 38 29 7*52
-
M .& . 91 5 * i 46*7 1*874 5 10 7*38 -
E.D. 92 7 5!43*6 2*lo6 27 29 7*60 -
E.H. 93 9 5 j  40•7 2*084 29 27 7*45 -
18 7|4-3*8 2*282 43 46 8*14
o.s. 94, 12 5 42*2 2*050 20 20 7*88 -
D. B. 95 9 547*7 2*005 8 15 | 7*38
E.R, 96 12 5|41*0 2*118 25 24 8*14
_
28
H
5 j 43*5 2*007 34 36 7*74 ~
31 7 41*5 1*918 19 18 1 7*20 - j
29 9 4-5*2
2*247 26 31 8*17 ....j l J
Remarks
early case 
early case
Table- II continued
Name
E. R. 
E.S. 
A. P. 
E.H. 
M.W. 
M.S. 
J.S. 
M.P. 
J.T. 
E.T. 
H. G.
G. W.
O.G.
M.M.
K.B.
M.W.
M.S.
M.K.
M.O. 
J. P.
A.B.
No. Date PCV,
PLASMA
vise.
Wintrobe 
E. S.R.
Total
Plas. GoldFloej Ord. |Cor. Prot.
j cs. mm/ 1 hr z
97 14 5 37*7 j 2*147 45 37 7*34 -
98 14 5 43 *81 2*137 - - 7*34 -
99 16 5 42 *1 j& 1*835 6 6 7*42 -
100 21 5 42-9!\ 2*350 39 41 8*96 -
101 28 5 41*8! 1*889 11 11 7*45 -
102 28 5 41*8 | 2*299 42 42 8*32 -
103 30 5 41*2! 2*071 28 27 7*67 -
104 30 5 40‘6 2*087 25 23 7*96 -
105 5 6 35 ‘8; 2*049 - 7*52 -
106 5 6 36*3j 2*441 • - 7*92 -
107 6 6 43 *8 ; 2*103 - 7*45 -
4 7 45*2; 2*140 24 28 7*67 -
108 2 7 44*3 | 2*162 22 25 7*92 -
109 2 7 41*2 j 2*117 - - 7*67 -
9 9 39 *6 ' 2*038 - 7*45 -
30 9 40 *4; 1*974 - - 7*16 -
22 12 43 *4; 2*326 28 30 8*46 +
9 3 39*3 2*103 40 36 7*70 +
1 7 42*9 2*213 32 33 8*35 2+
15 9 42*4 2*101 34 35 7*70 +
110 2 7 39*61 2*121 39 34 7*54 -
18 9 43 *8 i 2*071 18 20 7*42 -
5 11 40*8 2*120 27 25 7*96 0
8 3 38*3 2*200 37 30 7*70 +
7 5 37*6 2*125 40 32 7*42 0
111 10 7 43 *0 2*018 - - 7*38 -
112 18 7 42*8' 2*283 - - 8*42 -
6 8 40*0 2*099 31 28 7*52 -
30 12 42*1: 2*262 - 8*71 -
16 2 41*9; 2*331 - 8*82 -
18 5 43*1; 2*275 - 8*17 0
113 7 7 42*6] 1*791 1 1 7*24 -
114 24 7 38* I 2*122 - 7*92 -
18 9 36*1 j 2*110 30 21 7*49
-
115 24 7 32 *9 | 2*230 - 7*74 -
116 24 7 42 *1 j 2*175 - 7*88 -
117 25 7 45*9 2*161
___________ _
26
—
32 8*57 -
Remarks
early
Table- II continued a90
T
Name No. Date PCV. | yjqq
j.
M. B.
S.O. 
B. L.
I1*P*
E.B. 
G. R.
118 25
119
120
121
28
8 ;
6: 8
7
24
lo
122 111;
i
123113;
I
124119;
: 8 
:10 
: 12
8
42*9 2*305
41*8
42*6
2*014
1*938
40*8 2*153
38*7
40*0
38*7
M.C. 1125 128:
I !
A*S. 1126 | 2:
‘ ! 5:
37*6
i
8 j 39 *1
8143 *8
!
8|42*9
9|35*3 
9|37*4
2*227
2*117
2*240
2*187
2*173
1*834
2*353
2*373
M.B. |127 
P.
2:9 |23*1' 1*883
128! 3: 
! 14:
D. J, j 129 | 3;
M.S. j 113 | 8:
I
M. S. 1130 112: 
! 23:
9[40*3 
4 141*7
9 <44*7
i
9 j 41*5
9!39*2 
4:37*0
2*273
2*212
2*263
1*844
2*322
2*478
E.S. 1131112: 9:41*0 2*053
LH. 1132 115:
! !*>«
' ; 20:
17:
I.M. j 133 j 17: 
P.M. j134|17: 
P. A. j 135 j 17: 
.S. ; 27 25: 
J. B. ; 136 ; 6:
L.C. 1371 6:
I I 9:
9|40•9 
11|38*9 
12;39*5 
3|40•0
9 j 43 *8
9;37*0
9|45*9
9:43*6
10)44*3
10)43*5 
9i 40*3
2*236
2*138
2*224
2*113
1*988
1*995
2*055
2*023
1*902
1*913
1*877
M.P. 138; 6:10;38*8 1*973
I.D. 139 10: 
20: 
27:
10143*3 i 
ll| 38 *9 \ 
2 39*7j
12: 5 38*3
2*014
2*035
1*963
1*951
Wintrobe
E.S.R.
Ord. [Cor.
rair/ 1 hr
Total
Plas.
Prot.
%
Gold
Floe
46 48 8*18 j
16 16 7*31
16 17 7*13 -
38 36 7*56 -
- 8*03 ~
46 42 7*88 2+
37 31 8*06 3+
45 37 8*17 -
40 35 7*63 -
47 50 8*10 -
11 12 6*77 -
51 37 8*34 _
51 42 8*35 -
27 0 6*66 -
47 44 7*96 -
39 39 8*10 -
44 50 8*28 j -
1 1 7*49 -
53 47 7*74 -
51 40 7*92 13+
42 40 7*38 -
38 36 7*56 -
58 51 7*78 2+
24 ; 20 7*99 | +
31 ! 28 7*45 12+
3 * 7*85 -
19 i 13 7*24 -
13 1 17 7*45
-
20 S
j
22 7*67 -
13 i
i
15 7*38 -
20 | 22 7*49 *" i
10 j 8 6*95 + !
34 | 28 7*27 j
i
o |
15 | 16 7*49 | o [
21 1 17 7*78 j +
16 13 7*13 o
17 1 3 ! 7*34 j +
Remarks
Table- II continued a91
Name
A.W.
[M.G.
I.N.
[M.P.
M.O.
M.P.
E.S. |
E.W. |
I
I.R. | 
E.E. |
M.W. '
No.
140
141
142
143
144
145 
14-6
147
148
149
Date Pcv.
PLASMA
vise.
Wintrobe
E.S.R.
Total
Plas.
Prot.
Gold
Floe
0//°
150
I
S.cJ 151*
L. J„ I 152
!
M. C. | 153
M.G.1
M.S.I
M.H.S 
J. A. I
M.C.
G. B.'
154
16
16
16
fl3
27
31
17
13
20
22
24
29
9
3
5
5
29
13
24
24
17
26
16
27
1551 1 
(29 
22
156 5
157 8
[29
I 3
|10 
158(29 
112 
j 28
159(31
|19
| 3
S 5
* ci 6
10 140
I
10 143
10 143
2 42 
10 44
3 |45
10 144
2143i
10 S 39f
10 [44
10! 38
10 i 38 
2 139
11139 
12 145
ll! 44 
12 145
11
11
42
44
11 42 
3 142
11143
2 139
11141
12 140 
1143
3 i 41
12 143
8 '45
9 43 
ll! 43 
12.43
10 42 
12 41
1 42
10 40 
12 39
2 41
4 42
cs. 1 hr
81
3i
0! 
81 
6|
0^]I
8
o;
8
7!
6:
2
3;
2 
2
1 
2 
1 
2
2 
2
2
1
2
2 
2
2 
2
2 
2
2
2
2 
2
3 1 
9 1
2 1
4 2
0
5 
3
9
1
8 ;
2
6 
7
oi-
2:
7\
198
484
799
004
915
049
162
187
393
847
223
264
492
095
202
369
319
008
106
073
082
960
896
935
977
405
086
| 2 5  
j 4 7
i
I 2 
I 16
i13
| 13
i
I 20 
' 14
; 3 
i 48
! 45
: 51
i 16j
; 35 
: 6
I 37 
■ 7
23 
50
3
17
16
17
24 
16
6
41
38 
46
21
39 
12
38
10
24 25
24
10
22
43
23
21
9
20
45
22
908
019
015
975
569
323
336
344
199
145
119
068
14
15 
10
39
39
45
50
44
20
30
30
16
17 
12
39
39
45
47
39
18
30
31
%
8 *06 
7*49
7*49
7*67
6*91
7*88
7‘78 
7*78
8*46
7*88
8 *17
7*63
8*96
6*95
7*45
8 *86 
7*88
7‘60
7*38
7*34
7*96
7*06
7*42
7*85
7*52
8*32
7*75
+
o
o
+
+
+
+
2+
+
o
3+
2+
4+
5+
5+
+
2+
+
+
+
+
+
+
+ ! 
o )i
358 21 ' 23 8*89
7*45
7*85
7*99
7*96
8*93
7*81
8*57
8*06 
7‘63 
7*52 
7*42 
7*20
o
3+
| + ;
+
12+)
! + !
■ + i
i © )
I 0
1 + !j !
| + |
+
Remarks
early case 
early case
early case
now subacute 
again chronic
early case
subacute here 
now chronic
subacute
Table- II continued a92
Name No. ! Date PCV. 'PLASMAi vise.
Wintrobe 
E. S. R.
Total 
I nlas. 
Prot.
Cold
Floe
1- ■ • !! "'[ % \ cs- irniy^ 1 hr
— —
E.B. ! 160 19 12 39*6 2-120 - | - 8-14 +
I 3 2|38-0 1-928 13 1 8 7-45 +
| 16 4|41-4: 1-966 16 j 15 7-52 +
j 3 9 [40*41 2-027 - j 7-96 +
N. R. 161 22 12 40-3!
I ;
2-038 17 | 15 7-92 2+
E.M. [162 29 12! 43 *8j 1 2-053 8 j 10 7-34 2+
H.P. 1163 (12 11 j46 *6 3-027 21 ! 28 9*79 5+1
i1 31 12)46*9: 2-450 13 1 21 8-53 -\
\ 9 4:43*5 2-267 32 I 34: 7-70 4+
K.P. |81 14 4 i 43 * 2 2-100 13 ! 14 7-81
1 31 12;44-l 2-162 42 1 46 8-24
i
I 28 4 139 -0 1-978 19 I 15 7-63 +
H.T. | 164 5 l|41-l 2-333 11 ! 10 8-64 2+
I I30 3137-0 2-171 16 | 10 7-70 +
E. J. j 165 7 1 j43 *4 2-135 26
I
! 28 7-92 0
!t? 14 4 |43•1 2-152 33 1 35* 7-78 -
M.T. !166 7 1141-6i 1-935 12 I 12 7-49 0
M.M. i 167 15 1140-1. 2-185 21 ! 18 8-21 2+
24 3;41-8 2-218 29 f 29 8-06 2+
S.C. 151 15 143-1 2-051 11 ! 12 7- 74 +
N. B. 168 16 1:31-9 2-265 23 9i 8-06 2+
M.L. 169 16 1:45-0 2-239 28 : 32 8-10 +
C. H. 170 16 1:39-7 2-131 40 36 7-88 +
26 5 ;39 -4 2-261 39 ' 34 ; 7-92 e
D.T. 171 19 1147-6 2-235 - ~ i 8-32 +
7 2.44-3 2 -001 -
;
I 7-31 0
M.R. 172 19 l|40-7 1-879 6 5 7-20 2+
L, L. 173 28 1:39*8 2-193 41 37 ! 8-21 0
12 3:41-8; 2-217 28 28 ! 8-39 0
E.W. 174 3 2 39-4: 2-029 37 32 j 6-84 +
W.C. 175 6 2:37 -0 1-893 11
1
5 I 7-45 +
22 3:38-5 1-946 I10 6 ! 7-52 0
M. P. 176 6 2.43*5 1-916 : 7 9 i
1
7-16 | +
B. S.. 177 6 2:44-0
j j 2-085 j 11 13 j 8-06 0
H. H.
1
178 .6 2.39-7- 2-052 j 16 13 7-67 4+
L.W.j 179 7 1:43-2: 1-980 j 15 16 7-87 j 0
M. W. |180 25 2 1 45 -8 ! 2-081 | 46 53 7*16 [ 4+
21 4 42-5 2-133 | 38 39 J 7-56J 3+
Remarks
Subacute here
Burned out
i
Table-II continued 8.95
Name No. Date PCV. 'PLASMA! vise..
tWintrobe 
j E. S. R,
fOrd. ]Cor.
Total
Plas.
Prot.
Gold
Floe
\j 5 1 * ; cs. mm/ 1 hr %
!l.b . 6 j 25 2 44*21 1*950 i 3° | 34 6*95
i
+
E.B. 181
i
j 27 2 36*5 2*052 ; 33
i
| 24 6*98 3+
M.A. 182 i 1s 3 42 *91 1*812 ■: 7 i 8 7*02 0
j 23 4 41*4: 1*904 18 17 6*95 0
! L. H. 183 I 3i 3 39*0| 2*070 39 | 34 7*49 +
|E.O. 184 I 8 3 42*2! 2*080 41 j 41 7*52 ! 2+
it 12 5 44*7 221132 32 ! 37 7*52 2+
•K.W. 185 10 3 41*0 1*947 18 1 17 7*34 +
ic.c.!
i 1^86 .18 3 43 *3 2*082 - - 7*99 0
1 A.T. |i187 118 3 j - 2*049 - ; - 7*63
M.T. j188 120 3 31*5 2*543 58 36 8*39 5+
F. H. ;189 S22 3 43*2 2*005 5 j 6 7*49 +
E.W. |190 j 23 3 36*9 2*356 42 1 33 8*06 +
28 5 42*0 2*435 50 j 50 8*03 2+
E.G. j191 ! 6 2 41*8 2*013 10 1 10 7*52 +
1 ;‘24 3 40*0 2*066 19 ' 17I 7*63 +
V.M. j192 31 3 42*3: 1*921 15
1
j 15 7*09 2+
H.W. j193 2 4 48*8; 2*261 17 ; 26\ s 8*39 0
C.H. j194 7 4 40-7 2*093 33 ; 31 7*78 +
E.M. |195 7 4 42*5 2*043 24 1 25 ! 7*63 0
26 5 40*5 1*922 21 | 19 7*13 +
A.B. |196 7 4 45*0 2 *004 ’22 | 26 7*24 | +
M.S. |197 9 4|42*3 2*189 36 i 36< i 7*52 2+
e .b. j198 9 4 j32*7 1*880 ; 7
° 1
7*27 2+
G.T. j 199 14 54j H 00 1*859 3 1 3 I 7*49 !j 0
E.B. !j200 14 4 44*0 2*197 8 i 1 1 1 7*88 j +
M.B. |201 14 4 44*0; 2*165 27 1 30 J 7*811 -
E.W. |202;16 4|37‘7 2*435 j51
• \ 
42 j 8*35 3+
E.S, |203;19 4 j 38 *3 | 2*392 i - 1 _ i 1 1 8*24 2+
S. P. j 204; 5 12 j40*5 2*100 |24 1 22 7 *60 j 2+
I •11 2 47*1; 2*372 j 16 1 22 8*89 ) 0
j 123 4 38*2 j 1*938 j 20 1 1 5 ! 7*16 1 +
M.F. | 205 j30 4 43 *4 j 1*795 | 4
1 5 1
7*27 J 0
H.K. j 206 j 3 5;46*2 I
if
2*179 I30 37 7 *34 [ 0
G.H. j 5 5 41*01 1*987 12 j 11 6 *98 J 0
Remarks
See earlier note
Gold begun 6/4/48
4
Table-II continued aSi
Name No. 1 n + Date
!
jpcv. PLASMA
Wintrobe 
E. S.R.
] Total 
j Plas. Goldvise. lOrd.rcor:j Prot. Floe
j \5 j % cs. 'hue/ 1 hr ( olj /°
J. C. 208 | 6: 5 ; 35 *8| 2*043 i 34
i
24 I 7*34 +
M.M. 209 I 7: 5 43 *2 2*362
'
: 34 36 1 8*64 4+
(6: 9 42*0 » 2*440: 34 34 8*86 4+ )
S.B. 210 21: 5 Ol • o 2*112 35 | 40 7*63 0
H.E. 211 22: 5 i 35 *9 : 2*078 19 ! 12 j 7*85
M.W. 212 22: 5 |34 ‘8 i 2*153 50 36 j 7*56 2+
E.W. 213 ! 24: 5
o•o 2*697 21 ! 18 I 9*29i 4+
M.C. 214 26: 5 44 *7 2*151 21 1 24 | 7*88 o
A. M. 215 7: 4 43*2 2*021 15 17 I 7*70 +
26: 5 |41‘3 2*036 27 26 7*52 2+
R. W. 216 26: 5 4-5*0i 2*188 - - 8*24 0
M. W. 217 26: 5 40*0 1*855 9 7 ! 7*16 0
M.T. 218 26: 5 142.2 2*400 16 16 j 8*75 2+
£.B. 219 28: 5 45*4 2*250 31 37 7*99 2+
E.T. 220 28: 5 43*2 2*068 30 32 7*52 o
M.M. 221 2: 6 CO • o 2*305 44 A AIT 8*14 2+
F.N. |222 18: 6 43*9 2*128 26 29 8*14 +
B.G. ;223 29: 7 - 2*085 - - 7*13 -
M.T. !]224 4: 8 44*2 1*954 12 14 7*38 +
0.0. ii225 19: 8 40*7 2*145 39 37 7*34 0
W. P. 1226 26: 8 36*3 1*958 29 19 7*70 +
S.G. 227 2: 9 45*7 2*140 16 21 8*14 +
J. C. 228 3: 9 35*0 2*379 - - 8*46 2+
D.F. 2291 8: 9 37*6 2*187 31 24 8*46 +
Remarks
subacute
Table- II a.95
(B) Chronic Rheumatoid Arthritis - Male
Name
r
! No.
!
Date
r .".'
;pcv. PLASMA
Iwint
LJ-*
;robe 
S. R. _s[ vise. Ord.l.Coi\
f"' ~ !( ! j.
cs * ma/ 1 hr
i
j J. B.
!
1 1 23 9 146*0 2*170 1 29 ! 28
t 1 4 11 41*2I 2*041 i 44 ! 34
!t.b .! 2 11 11 41*2 1*885 ! 9 [ 3
1 30 12 ■41*8 2*039 ; 8 1 3
j 12 2 |41*8 1*838 ! 5 f °
A.R. 5 4 2 4^4*8 2*119 ; i8 1 16!
16 9 41*7 2*096 ' 44 1 35
28 10 47 *2 2*373 20 1 20
:18 11 47*0 2*353 11 i ii
] 15 1 48*1 2*180 • 11 ! 12 !
1
■ 13 2 47 *4; 2*156 15 i 15 1!j ;29 4 46 *91 2*198 17 1 17 1j
i 7 9 44*9 2*314 30 | 27 I
jD.R. 4 !27 2 46*3 2*154
— - i
\ 25 9 46 *2 2*140 18 : 15 :
| \i 4 12 44*51 2*lo2 12 • 9 !
j i18 12 46*2; 2*242 17 i 16 !
I !i r [j29 1 48*4; 2*175 16 18 |
jw.W.j 5 ! 4 12 37*0; 2*105 18 7:
i\ \29 1 43*3! 2*193 28 23<ii " i
11 5 39*7 2*o21 25 15 ;
|F. H. i 6 | 4 2 49*5 2*005 - - '
1 8 5 47*7 2*072 - - :
i
I
4 11 49*5! 2*159 - - ;
22 12 44*7 1*933 8 5 :
If ] 5 2 46*7’ 1*976 9 9 !i
1 ■14 9
00• 1*983 14 ! 13
S.L J 7 !18 8 44*9 2*345 27 24 1ij 11 9 45*3 2*054 25 23 ;f
j 28 10 48*8 j 2*241 14 16 ;
J.P.j 8 ! 8 7 48*6 2*353 22 ; 24 [
128 8;45*2 2*243 35 32 i
11: 1 2 10144*7 2*203 25 ; 22 1
F.D. 9 !26 7 43*8; 2*131 30 : 25 1S
I i11
!
9f45 *8 2 *003 15 t 14 !
| 111 lit46*9. 2*075 10 ! 10 j
| ii 28 2 j44*0: 1*875 9 i 6 i
A . C . j 10 | 29
m
4j46*0: 2*031 8 ; 7!
I 9 3 43. *7 j 1*955 | 22 i 15 j|
_ I 12 .„5 .J4! *9 j 2*077 8 1 3 !
Total
Plas.
Prot.
Gold
Floe Remarks
%
7*74 - Gold begun 27/9/47
7*38 2+
7*36 + Gold 13/11 to 3/2/48
8*10 -
7*20 +
- Gold 6/2 to 29/4/47
7*56 -
8*60 4+
8*32 4+ Gold begun 4/11/47
7*68 3+
7*70 3+
7*85! 3+
7*85 3+
7*62
7*60 Gold 14/10 to 13/1/48
7*38 5+
7*88 3+
7*96; 3+
7*88 + Gold 24/10 to 13/1/48
8*10 i +
7*56 + Gold dermatitis
7*63;
8*39 o Gold begun
7*16 +
7*45 + I
7*31; , 0 I
8*42; - Gold 16/9 to 9/12/47
7*42 -
8 *60 j + 1Clinically improved
8*28
i
Gold begun 15/7/47
8*21; 1
8*03 —  !! Much improved
7*92
|
7*63 i - [ Gold 16/8 to 8/11/47
8*28 1 + !
7*45 j
1o |
7*78 _  j 1947
7*16 j 2+ Gold begun 12/3/48
7*4-5 3+
Table- II continued a96
Name
.. I
Ho.
... I l
Date I PCV.
PLASMA
vise.
fwint 
| E. 
!0rd.
robe ] 
S.R.J 
j Cor.!
Total
Plas.
Prot.
Cole
Flo<
.'%.j cs. jmm/ 1 hr j..* .r ~
T.P. 11 24 2 35*7; 2*214 \ ” 1 “ i -
1 3 38*7 2*065 r1 - It 7*10 -
C.G. 12 18 3 45*6; 2*184 i i - i 8*0
-
[20 5 43*9 2*309 | 40 l 34 i 8*28 -
116 9 44*3 2*218 j 45 i 40 ! 7*92 -
(30 10 44 *4; 2*502 1 44 I 39 ! 8*86 -
11 12 45*0 2*225 j 30 j 27 ! 8*10 3+
21 9 45 *0 2*059 | 33 j 30 7*56 0
J. M. 13 10 4 47*4 2*263 I 13 ! 13 ! 8*28 -
22 5 46*1 2*121 : 9 i s i 8*32 -
. 24 7 46*7 1*975 -
[ 5 7*56 -
. 30 12 45*5 2*252 [ 11 1 10 |‘ j
7*88 -
J.A.I 14129 4 45 *4; 2*036 ! 21 19 ! 7*38 -
j 9 9 47*2 1*896 ; 5 1 5 i 7*20 -
16 10 43 *1 2*225 29 ! 23 1 8*28 2+
9 3 44*3 1*817 4 ! 2 ! 6*84 2+
i| 7 9 46 *9 1*874 6 1 6 | 7*31 2+
!j. h.
!
15 1 1 5 45*3 2*191 i 30 I 28 1I ‘ 8*03 -
J.B, 16 I 1 5 47*0 2*001 34 | 34 | 7*45 -
J.K. 17 j 15 5 45*4 2*088 : 22 ! 21 ! 7*72 -
M.C. 18
! 2 1
5 49*4 1*918 17 i 20 j
1 .
7*38 -
M.H. 19 1 21 5 45 *4 1*963 1 20 j 18 1
i |
7*99 -
J. Gr. 20 22 5 50*3 1*971 - 7*78 -
M.C. 21 1 5 6 i41*2 2*461 - ! - i 7*45 -
G.C.
i
22 ! 4 7 44*1 2*115 -
1 j
8*06 -
A. S. 23 lie 7 48*6 2*453 17 ! 24 ■ 7*38 -
R. H. j 24 1 s 8 :45*2 1*999 11 ! 9 i 7*38 -
22 12 ,44*4 2*153 ; 1 1 0 1 7*92 +
jl4 9 46 *1 2*055 ; 19 1 1 8 ! 7*27 0
T. W. ! 25 113 8 36*8 2*131 -
j  ;
i ■ 7*81
-
R.K. : 26 ! 23 7 41*1 2 *o39 j 45 1 35 i 6*30 -
H.D. 27 18 8 46*2 1*965 ! 14 1 13 1; r 7*09 -
G. L. | 28 25 9 ,47*5 1*779 : 2 1 2 | !
6*98 -
R.F. 1 29
j
( 2 10 45 *4 1*976 j 24 1 22 1I '•
7*06 0
W.C. ! 301 i 2 10 47*71 1*919 I 12 ! 13 i 6*26 0
R.G. 31
1
10 10 '47-1 2*168 ! 22 ! 2 2 ' 7.74 0
R.H. 1 32 |l6 10 ;48*1 2*028 I 7 1 8 j 7*70 0
1 8
12 146 *3 2*091 | 16 i 15 i
7*70 +
1 1 4 46 *3 1*900 ! 3 2j 7*13 2+— 1_„.... ....—
Remarks
subacute here 
again chronic 
again subacute 
again chronic
no clinical activity
Table- ll continued a97
r..
jName No.
1
[ Date
I f 
;PCV |PLASMAvise.
JWintrobe | Total
U 9 4 - J U  Plas.
!0rd. ] Cor. j Prot.
Gold
Floe
!-- J .! cs. ;mn/ 1 hr j %
is*B* 33(17:10i 146-0; 1*997 j 7 I 6 1 8*o6 o
J. H. 34 j 4:11 36*61 | 2*397 t **I ! -1 8*10 0
R.W 35 ! 4:11 47*6 2*070
i  5 ! 5 i 7* 70 3+
J.M, 36112:11 42*7 2*902 24 i 1 9 ! 9*00 3+
Ir.k.1 37 j20:11{47*11 1*928 11 : ii Ii 7*56 0
jW.G. 1 38 | 2:12 36*01 2*902 22 ' 8 | < j 9*79 +
;k.b. 39 115:12 42.61 2*148 - 7*92 o
j 7: 2 146 *5 j 1*918 2 ! 2 ! 7*70 o
IjLM. i 40;15: 1 j 58*3j 2*090 1 ; 11 1p 7*78 2+
jp. S. 41 16: 2 42*5; 2*105 38 1 3 1 1 7*42 o
Gr. C. i 42 128:11 46*1 1*831 5 5 j 7*02 0
jw.M.; 43 ; 24:12 47*7 1*803 j 2 ; 3 i 6*95 o
,M. A. 44 ‘25: 2 44*7 2*505 46 j 44 j 8*68 4+
H.M. 45 126: 2 49 *41 2*618 22 ! 25 i 8*46 +
\
22: 4 48*91 2*198 7 1 9 ; 7*31 +
:B.W. 46 26: 2 49*3 1*930 1° ! 13 ! 7*16 0
;B-T. 47 28: 2 38*3 2*716 22 ! 11 i 9*32 3+
H. J. 48 39: 3 46*8 2*189 20 • 20 I 7*85 +
A.T. 49 : 1: 4 46*2; 1*961 8 ; 7 1 7*13 5+
G.F.: 50 6: 5 40*41 2*056 32 ! 22 | 7*52 +
J. R.: 51 22: 5 46*41 2*064 24 ; 23 1 7*56 2+
i ; 31: 8 45 *4 1*788 7 5 j 7*16 0
T.S.j 52 27: 5 43*0: 2*113 30 24 j 7*63 +
W.E.: 53 | 3: 6 - 1*983 11 - j 7*63 +
t.b .; 54 \ 3: 7 - 2*092 - - 1 7*16 -
P. H.j 55 16: 8 46*1; 2*145 21 20 1< 7*60 . +
C.T. 56 116: 8 f 2*325 - - 1 7*78
R.H.' 57 ; 6: 9 41*3 1*918 20 13 | 7*27 o
W.G7 58 j 14: 9 49 *0 \ 2*367 30 33 i 8*17 2+
L. H. 59 114: 9141*71 2*261 36 28 j 7*45 5+
W. R.j 60 31: 8 34*7 2*105 49 28 ] 7*16 3+
15: 9 37*9; 2*031 34 17 j 6*84 4+
?1 28: 9j39*2 I 2*055 36 | 24 I 7*92 2+
f 6:10]40*0 \ 2*056 j28 | 18 1 7*06 +
14:101 39-1 [ 2*050 | 34 | 2 2  j 7*13 +
| 9: 11137 *5 1 1*974 I 25 12 7*20 +
_ _ i . 12: 1 40*7[ 1*696 A _ i L 5*58 °  1
Remarks
early case
Table- II a98
(c) Subacute Rheumatoid Arthritis Female
Name No. i Date PCV. PLASMA jwintrcbe j Total Plas. 
Prot.! VISC.
E. S. R.
Ord.rCorT
sGold 
IFloe !
Remarks
i | j % "I
cs * ran/ 1 hr . %
A.B. | 1 | 7: 5 39-7 2-331 : -
I 8-28 : - i
| 24: 7 »41-2| 2-478 - : 8-60 - | Gold 9/8 to 1Z/11/A7
1 1 18: 9i I |42-8j 2-429 46 47 : 8-39 - !
jM. H. \ 2 | 11: 7 45-9! 2-448 9 9-04 ■ _
\
| ! i 16: 9• i 141-4! 2-734 - - 9-25 - ; Gold 7/10 to 3/1/48
! i i (5:12:45-4!1 I 2-358 : 21 22 8-89 3+ ) reduced to chronic
!j.c. | 3 i 1: 8 36-9 2-341 54 43 8*28 - Gold 1/8 to 16/9/47
i i ! 24: 9 38-8 2-433 47 40 8-78 -
I 1 15:12? t 40-9 2-558 42 40 9-40 4+ Gold begun 16/12/47
j I ! 27: 2 37-5 2-370 50 40 8*53 3+
i\ | 1(23: 3 38-1 2-070 37 30 7*78 0 ) improved to chronic
|m .t .! 4 ! 10: 3 37*7 2-486 16 11 - - Gold begun 17/3/47
! j 5: 5 36-9 2. 538 45 33 8*60 - clinically worse
1 I ! 16: 9 37-7 2-367 - - 7*99 - improving
j ! 23:' 9 39-7 2-442 50 45 8-50 -
M.3L : 5 ! 8: 9 41-4 2-434 - - 8-60 - Gold 23/9 to S/12/47
] I 31:10 39-5; 2-724 4 2 9*07 ! 0
| | 24:12 42-7 2-600 40 41 9-14 2+ Slightly improved
S. S. ' 6 | 22: 9 41-7 2-645 - - 8-82 - Gold 21/10 to 2/3/48
i | 30:12 41-31 2-510 1 1 8-46 -
1 | 12: 3 39-7 2-550 45 40 8-48 +
K.S. 7 10:11 42-0 2-500 27 27 9-00 ; 3+ Gold 23/9 to 9/12/47
24:12 39-7 2-449 39 35 8-35 4*
M.C. 8 | 18: 9 — 2*465 38 - 8-68 -
10: 3 0 00 2-463 35 33 8-42 + Gold 9/8 to 25/10/47
A. S. 9 E (Is 5 40-0 2-727 42 38 8*71 : -) I Acute stage
I 20: 5 37-7 2-325 - - 7-78 - ; Gold begun
17: 7 39-6 2-759 - - 9*00 -
28: 8 38*7 2-514 48 41 8-42 , ! Gold ended 26/8/47
j 9: 4:41*9; 2-651 39 39 8-75 4+ !
28: 5 40-2! 2-480 50 46 8-03 3+
14: 7| .39*2 2-446 30 26 8-32 3+ j
A. S. 10 j 4: 7 36-3 2-675 50 38 9*14 - j
1 17:11 42-7 2-665 33 34 9-14 5+ jGold begun 12/11/47
16: 4j34-8 2*503 53 38 8*96 4+ i!
M.H. :11 1 21: 4 41-71 : : 2-498 40 34 8-32
,
*!* i1
M.S. 12 j 30: 4: 01 CD • CO 2*546 52 45 7*88 -
ij
j
M.S. 13 | 5: 5:42*8; 2*410 26 27 8-14 -
s
| 11: 9|42-0 j 2-405 43 43 8*21 -
M.T. 14 J '19:. 5j41-lj 2-351 17 16 8-39 - 1 ____ - -
Table- II continued a99
jNaine!No.l
j t |
jP.M. 11 5  |
J j J
jj.J. 116 |
M . S .  17 I
;H.B. 17
 .j.____[__  iQrd.l Cor.
!Total 
j Plas. 
s Prot.
cs. Finin,i/ 1 hr.
23
5;40*8 2*339
939*8; 2*418
5!45 *01 2*402
7:37*8i 
9;37*l|
10: - I
5:36*9 I 
8 44*7
9 ; - 1
10:42*51
3*102 53
2 *793 | -■ 
2*686 | 56 
2 *637 | 49
2*425 | 33 
2*287 | 16 
2*284 j 23
jGr. B. 25
4 38*2 2*978 | -
5 41*0 2*800 j 48
6140*6j 2*735 1 48
4 135 *5 I 2*531 [ 55 j 39 8*50
Remarks
Table- II continued alOO
f !
Name! No.
f
f.
Date PCV. PLASMAvxsc. ol| ,
sum1
Total
Plas.
Prot.
Gold
Ploc Remarks
/ CS. mm/ 1 hr. %
D.F. 42 22: 4 31*8 2*712 42 24 8*71 3+
M.T. 21 5: 5 40*0 2*306 45 41 7*70 5+
G.B. 43 3: 6 - 2*732 - - 9*07 3+
L. S. 44 2: 9 39*2 2*499 19 16 9*00 3+
M.M. 45 6: 9 42 *0 2*440 34 34 8*86 4+
Table- II continued alOl
(D) Subacute Rheumatoid Arthritis - Male
-)
jName No. Date
r
PCV, ! PLASMAvise.
Wint]
E.S
Ord;
robe
3.R.
Cor.
[ M t f
Prot.
-
Gold
Ploc
\ % . . . csT"" mm/ L hr
L. H. 1 14: 1 ; 44- ! 2*485 26 22
j _
8: 5 40*1 2*500 47 35 ! 8*24 -
(24: 9 45.1 2*750 i 8*75
24:10 42*1 , 2*513 47 38 : 7*92 5+
9:12 45*0 2*543 26 23 8*68 5+
8: 1 45*1 2*324 13 11 7*85 3+
(14: 9 41*7 2*261 36 28 7*45 5+
C.G. 2 20: 5 43*9 2*309 40 35 8*28 _
30:10 44*4 2*502 44 38 8*86 -
J.S. 3 24: 4 45*6 2*576 21 17 8*46 -
6:11 43*0 2*738 - - - -
J.M. 4 12: 2 - 2*703 8 - 9*14 5+
W.G. 5 19: 2 48*5 2*426 24 26 8*10 2+
29: 4 46 *6 2*363 24 24 7*99 2+
YiT.G. 6 9: 3 35*3 2*903 40 21 9*50 5+
J.D. 7 9: 8 - 2*870 - - 9*76 -
Remarks
Gold 2/1 to 5/5/47
here acute 
again subacute
now only chronic
Table- II al02
(E) Acute Rheumatoid Arthritis - Female
Namej No.! Date jPCV. j yjgQ
pt.asma 'Wintrobe Total
E.S.R. Plas. Gold
Floe
I ' P . 1
cs. jmm/ 1 hr r *  ~
|m .m . 1 20: 1 42 *51 2*734 [ 31 ! 32
1 —
1 (6:9:4842*0! 2*440 j 34 1 34j | 8*86 4+
jM.S. 2 24: 2 41*5! 2*523 - j _ _
j (30: 4 39*8, 2*546 52 j 46 ! 7*88 -
E.T. 3 3: 3 40*9! 2*691 - - 8*5 1 -j 14: 7 39*8? 2*983 9*14i
1 15: 9 41*3 3*027 - - 8*86 -
51 17:10 37*9 2*565 50 : 41 8*03 5+
1 21:10|41*9; 3*o49 - - 9*25 5+
! 8:11 36*5 2*306 - - 7*67 5+
j 17:12 40*8 3*032 1 40 37 9*11 5+
10: 1:41*6 2*878 - - 9*18 5+
!( 7: 4 38 *2 ; 2*978 - - 9*07 5+
28: 5 41*0 2*800 : 48 46 8*57 5+
25: 6 40*6 2*735 ■ 48 I 46 8*60 5+
A. S. 4 11: 4 38*3! 2*531 52 45 8*78 -
E.M. 5 12: 4 40*3 2*698 , 42 39 8*82 -
A. S. 6 1: 5
0•0 2*727 42 39 8*71 -
E.H. 7 9: 5 ca • 00 2*638 10 12 9*32 -
A. S. 6 21: 5 35 *5 2*798 - - 9*22 -
M.C. 8 30: 5 41*4! 2*536 48 47 8*96 -
I. B 9 21: 7 4-3*7 3*364 52 56 10*40 -
24: 7,36*7 3*442 - - 10*98 -
9: 9:35 *6 * 3*147 - - 10*04 -i
; 2:10! | 3*245 - - - 5+
: 4:10 j36*3| 3*269 — - 9*61 -
21:10136 *31 2*948 - 9*43 5+
| 13: 9137*0] 3*197 3 0 10*51 5+
M.B. 101 1:12 143- ! 2*989 14 15 j8*78 5+
5:12|43-5 2*890 7 8 8*64 -
11:12 44* 2*929 4 6 8*96 5+
18:12 43- 2*668 23 24 8*60 5+
24: 1 43* 2*608 22 23 8*03 4+
4: 4 42 *6 j 2*822 8*68 4+
Remarks
1947 
) now subacute
) now subacute
agranulocytosis
now subacute
it tt
On Cortisone
tt
tt
»t
t
Table- U alOo
(F) Acute Rheumatoid Arthritis - Male
! 1 IpiASMA j^trc^e j Total! T
NoJ DatejPCV. | yiSC. i E- S.R.j pias. |Gold
0rd.]Cor1 Prot. I Floe
Remarks
cs. |mn/ 1 hr %
A. S. 1 22: 5 |49*8 | 2*797 i 7 : 10 9*00 -
W.D. 1 2 27: 5j |41*9 I 2*565| j 51 ! 41 8*60 -
W.G. ! 3 ! 30: 5 |35*9 I 3*346 i 57 ; 34 1 10*51 _
26: 7 137*7i 3*619 j 3 0 11*05 -1i1 30: 7 37*0 ! 3*341 - - 10*66 -:
6: 9 |37*9 ; 3*611 ; 22 10 11*38 -
15: 9 34*0 3*171 - - 9*90 -:
13:11 138*5 3*677 - 11*09 -
22:11 35 *7 3*228 - - 9*43 4+
( 2:12[36*0 2*902 22 8 9*79 + subacute
9: 3 35*3 2*903 40 21 9*50 5+ ) t
21:  8 38*5 3*315 12 3 10*55 5 + acute again
14: 9 36*3 3*059 - - 9*90 5 +
K.W. 4 1: 9 45*5 3*100 31 29 8*10 -
L.H. 5 24: 9 45*1 2*750 - -
.
8*75
J.F. 6 17: 1 38*5 2*581 - - 8*10 +
al04
Case No. 1 Chronic Rheumatoid Arthritis.
This male patient was aged 63 years when he first attended the 
rheumatism clinic on 15: 3:47. His relevant history was that in 
1943 there was a gradual onset of fusiform swelling of the 
proximal inter-phalangeal joints of both hands, and of pain and 
swelling of "both wrists. His only treatment had been a course 
of gold therapy in 1944 from which he derived no benefit.
He was a tall, well-built man in fairly good condition. Both 
hands showed fusiform tender swelling at the proximal inter- 
phalangeal joints, but with full range of movement at these joints. 
There was wasting of the interossei muscles, without ulnar 
deviation. The right wrist had a marked thickening of the joint 
with carpal cysts present; there was an increased local heat; all 
movements were painful; and dorsiflexion was limited by 5°*. In 
the left wrist there was thickening around the joint and free but 
painful movements. All other joints appeared to be normal.
X-ray examination showed a generalised osteoporosis of the carpal 
bones and phalanges, and diminished joint spaces at the inter- 
phalangeal joints. The changes were typical of rheumatoid arthritis.
There was also evidence of emphysema. A maxillary sinus was 
opaque to X-rays: the ear,nose and throat specialist washed it out 
and reported the sinuses clear after 2-3 weeks treatment. After 
the eradication of this possible focus of infection, a course of
al05
r
j Date
r — “i 
PCV.
PLASMAfWintrobe’
vise. -----
Ord. Oor
Total
Plasma
Prot.
% cs. mm/1 hr. &•%
18: 3:47 45 *6 2*184 30f 28 8*0
20: 5:47 43*9 2*309 40 34 8*28
16: 9:47 44*3 2*218 45; 40 7*92
30:10:47 44*4 2*502 44 1 39 8*86
11:12:47 45*0 2*225 30 1 27 8*10
21: 9:48 45 *0 2*059 331 30i... 7*56
myocrisin was begun: the dose was 0*01 g.* weekly for 12 doses.
On reviewing his condition after 6 weeks of treatment, on 
20:5:47, there was no increase in the number of joints involved, 
but those originally affected were still swollen and tender. In 
view of the rise in the plasma viscosity to 2 *309 cs., together 
with the increase in total protein and ESE. , and the decrease in 
the haematocrit, the patient was admitted to hospital for rest in 
bed and further gold treatment.
By the end of treatment on 28:6:47, there was an improvement in 
the general condition as shown by an increase in weight and a 
slight local improvement as the wrists were not so swollen or 
painful. He was discharged to a convalescent home.
16:9:47 - he reported for review. There had been no involvement 
of other joints. The wrists were much improved - the periarticular 
thickening and the synovitis had subsided; the movements were 
almost free and nearly painless; the fingers were still painful.
The general condition was also improved. The clinical impression 
of an improvement was not fully supported by the laboratory tests
al06
where the plasma viscosity and ESR were in agreement that a 
considerable degree of general reaction persisted. Hence a 
further course of 12 x 0*01 g. of Myocrisin was begun.
After* 6 injections there was again an increase in the plasma 
viscosity; after 12 injections the plasma viscosity had reached a 
level which was not significantly different from that at the 
beginning of treatment. By 11:12:4-7 the wrists had become almost 
normal while the interphalangeal joints were still swollen and 
painful. The right knee had developed pain, all movements were 
painful, and there was increased local heat and synovitis. An 
X-ray had the appearance of an atrophic arthritis. The fact that 
a further joint had become involved in spite of treatment showed 
that the disease was still very active and this was truly 
reflected in the increased plasma viscosity. We cannot tell what 
would have happened if the second course of gold had not been 
given, but one might venture the suggestion that the original 
high viscosity value was a better guide to the activity than the 
clinician's own impressions.
He received another course of spa treatment at Harrogate.
The final viscosity at 9 months later showed a diminution in the 
level but it still remained within the zone of chronicity, in 
accord with the chronic clinical state.
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Case No. 2 Rheumatoid Arthritis.
After 3 years of service in the WRAP in medical category A.1, 
this patient married in 1945 and in July 1946 gave birth to a 
normal healthy baby. Three months later she began to complain of 
pain and stiffness of the small joints of the fingers, and then of 
a tendency towards ulnar deviation of the fingers at the metacarpo-
r
phalangeal joints. Gradually pain and swelling developed in both 
knees, and there was swelling of the right ankle.
On examination, she was underweight and had a moist skin.
There was fusiform swelling of the proximal inter-phalangeal 
joints of both hands, ulnar deviation at the metacarpo-phalangeal 
joints, was ting of the interossei, periarticular thickening of 
both wrists with limitation of dorsiflexion of the right wrist; 
both knees were hot and swollen, and there was a limitation of 
flexion of the right knee by 20°; the right ankle was '’puffy" and 
painful, although there was a full range of movement; the right 
tarsal joints were painful and limited in movement. The X-ray 
appearances of the affected joints were typical of atrophic 
arthritis. No other pathology of other parts of the body was 
detected.
She had been confined to bed at home for 8 months prior to 
her admission to hospital on 2:7:47. She was then treated by iron 
and vitamins, plaster splints to knees and wrists, active
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non-weight-'bearing movements, and general rest in "bed.*
By the 20th August she had improved to be standing alone and 
walking with assistance. By the 9th September she was sleeping 
well, the temperature and pulse rate were normal, and the joints 
were more free from pain. The right knee was regaining movement 
but the ankle joints were still painful on all movements. The 
treatment was continued, plus the Guthrie Smith apparatus for 
assisted movements.
On 30:9:47 it was noted that the ankle joints were settling down 
and that a full flexion in the right knee could be obtained. Her 
weight was increasing. She was beginning to walk without 
assistance. The plasma viscosity results had shown a corresponding 
improvement but had not quite reached the normal range when she 
was discharged to continue her convalescence in her own home, on 
14:10:47.
She reported on 15:11:47, when she was able to show further 
improvement. She was able to walk and do a little housework.
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At the beginning of December she had an attack of influenza. 
This was followed by a flare-up of all the joints previously 
affected. She looked pale, lethargic and ill. Both knee joints 
were swollen and had increased local heat. The shoulders were 
painful and the right arm could not be abducted above 80°. This 
flare-up in the condition was reflected in the increase in the 
plasma viscosity. The patient was rested in bed, physical 
therapy was resumed, and a course of 12 x 0*01g. Myocrisin was 
begun. The fluid was aspirated from the knees.
By 9:3:48 there was clinical improvement. Her weight had 
increased. The knees had settled; the movement of the shoulders 
was painless and increasing in range. The plasma viscosity had 
decreased but the ESR had increased.
The gold treatment was discontinued on 13:4:48 while the local 
therapy continued. The improvement continued steadily.
Unfortunately, on 28th June she reported pain in the right 
hip which had not been affected previously; a skiagram showed the 
osteoporosis of the head of the femur and diminution of the joint 
space which is' typical of an atrophic arthritis. There was a 
further increase in the plasma viscosity as a true reflection of 
the increase in the activity of the disease which caused the 
involvement of a new major joint, yet the ESR had decreased.
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With more treatment, the plasma viscosity had fallen by 
15:9:48 to a level almost identical to that in the initial test.
It should he noted how all values hut one have fallen within the 
zone of chronicity and yet the variation has heen sufficiently 
large to indicate changes in the activity of this chronic disease.
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Case No. 3 Rheumatoid Arthritis -(satisfactory response to gold
therapy by an early case.)
Eleven weeks prior to his admission to hospital on 19: 8:49 this
man had attended his own doctor,conplaining of bronchitis. Three
weeks later he had pains in hands, arms and shoulders and in the
ankles and knees. These pains had persisted since; they were dull
aching and got less on exercising; they kept him awake at night.
On examination, there was spindle deformity of the joints of 
the digits. The wrists, elbows, ankles and knees had pain on 
movement; these joints showed periarticular thickening, especially 
the knees which also contained a little fluid. The lymph glands 
of the groin and axilla were enlarged. No pathology was detected 
in other structures of the body. An X-ray of the chest was normal 
in appearance.
The diagnosis was - an early severe multiple arthritis of 
Rheumatoid type.
At first the treatment was of a general sustaining nature, 
including splinting of the wrists at night, quadriceps drill and 
other remedial exercises,. 1 pint of blood was given on 23: 9;47 
to assist his definite anaemia. By the 26th Sept. he was so 
improved as to be considered as a possible remission - there was 
remarkably little pain in the joints and they were no longer 
painful on movement.
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vise.
Wintrobe 1 Total
Date PCV. ESR. 
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1 Plasma 
I Prot.
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Floe
cs. mm/ 1 hr
30: 8:49 34*9 2*105 48 26 7*16 +++
13: 9:49 36*5 2*031 34 17 | 6*84 ++++
28: 9:49 39*2 2*055 36 25 7*06 ++
6:10:49 40*0 2*056 28 18 7*06 +
14:10:49 39*1 2*050 34 24 ! 7*13 +++
9:11:49 37*5 1*974 25 12 i 7*20 +
12: 1:501^40*7 1*696 9 3 i5/58.. o
Serum uric acid 
=6*4 mg./lOO ml
G. C. F. T. = neg.
However, because of the persistently abnormal laboratory results, 
and especially because of the plasma viscosity stationary within 
the zone of chronicity, the clinician decided on more intensive 
treatment which would include gold. Beginning on 6:10:49, 0*01 g.
of Myocrisin was given and the weekly dose was gradually raised to 
0*08 g. and a total of 0*51 g. had been administered by 14:12:49 
when the gold was stopped.
There was a temporary recurrence of the effusion into the 
right knee noted on 9:11:49, but the fluid was rapidly reabsorbed. 
By the end of December, all the joints had shown continued 
improvement and by the middle of January he was so well that he was 
allowed to resume work as a boiler-maker.
He had had no recurrence of his arthritis at the end of 1951.
The plasma viscosity decreased in this patient in response to 
the general improvement following rest in bed, etc. Nevertheless, 
the viscosity then remained at a constant level as an indication
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that in spite of the amelioration in the locomotor system there 
was continued activity in other parts of the body. When this 
was acknowledged and a further attack was made on the disease 
with gold a satisfactory response in the total organism was 
obtained and the plasma viscosity became almost subnormal (the 
total protein is certainly below the lowest normal value). The 
gold flocculation test also reflects the cessation of the 
rheumatoid activity; so also does the ESR.
This is one of the cases in which a recurrence of the 
rheumatoid arthritis is unlikely unless there is a frank primary 
trigger-stimulus such as bronchitis or influenza.
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Case No. 4 Rheumatoid Arthritis.
This miner, aged 29 years, started to have pains in all his 
joints, particularly the small joints of the fingers, about a year 
before his attendance at the rheumatism clinic. These small joints 
had become swollen in the past few weeks;;he had felt weak and 
stiff on waking; and he had been unable to work at the coal face 
for the last fortnight. He had suffered from rheumatic fever 
when 4 years old, and again when he was twenty.
On examination, he was a tall, round-shouldered, asthenic man. 
The skiii was moist; there was acne of the face. A slight 
presystolic murmur was present at the apex, without a cardiac 
enlargement. No abnormality was discovered in any other system 
except the locomotor.
The hands had bilaterally symmetrical fusiform swelling of 
the proximal inter-phalangeal joints of the fingers and slight 
swelling of the first metacarpo-phalangeal joint; there was 
wasting of the interossei muscles; there was no ulnar deviation of 
the fingers. The spine showed a dorsal kyphosis, flexion of the 
lumbar spine limited by 20%, and spasm of the sacrospinalis 
muscles. All the other joints had full function and were free 
from pain.
Skiagrams showed osteoporosis of the phalanges of both hands 
and diminution of the joint space between the first and second
alio
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phalanges, and some generalised osteoporosis of the lumbar spine 
with dorsal kyphosis. The appearances of the lungs and head 
sinuses were normal. Urine was normal. The Wassermann and the 
gonococcal complement fixation tests were negative.
The treatment consisted of ferrous sulphate (9 grains per day;, 
wax baths and heat to the hands, occupational therapy, and 
myocrysin in weekly doses of 0*01 g. for 12 weeks, beginning on 
16:8:47.
The initial plasma viscosity was in accord with the clinical 
assessment of a disease of rather short duration and of moderate 
severity. By the time of the second test there was an improvement 
in the joints and a considerable improvement in his general 
condition. The third test was made a few days after he had a 
slight clinical relapse - he did not feel so well, his pain in the 
fingers and the back had increased, the knees were painful but 
examination could detect no abnormality there apart from a painful 
movement. The plasma viscosity had risen in accord with this 
worsening, but the decrease in the ESR. had continued.
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A course of brine and aerated baths rendered the patient free 
from these pains in three weeks. He was discharged from the 
clinic on 1:12:47.
He left the mines to obtain sedentary work.
Three months later he reported back to the clinic for a review. 
He had kept free from pain completely, his general condition had 
been satisfactory, and he had been able to carry out his work in 
an efficient manner. There was a residual painless fusiform 
swelling of the proximal inter-phalangeal joints but a full range 
of movement was possible in them. The quiescent state of the 
disease was supported by the normal laboratory tests at this date.
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Case No. 5 Rheumatoid Arthritis.
This woman of 33 years gave a history of 15 years duration - 
pain had started in the small joints of the fingers, it spread later 
to the elbows and knees, and the patient became bedfast. She 
remained so for the following 2 years during which the treatment 
administered by her own doctor had no effect; during this period 
she had a low-grade temperature increase. Treatment at a Spa by 
"the waters", general physiotherapy, and myocrysin did cause an 
improvement sufficient to let her walk again. Four years later 
both hips became painful and stiff; she was confined to bed for 
18 months. Since that time her hips have been so stiff that she 
had great difficulty in walking; she complained little of the 
other involved joints. She had suffered from rheumatic fever
when 16 years old but had otherwise been free from illness.
When she attended the rheumatism clinic in December 1947, 
she was a pale under-weight woman who could walk only with the 
assistance of two sticks. No abnormality could be detected except 
in the locomotor system.
The hands had fusiform swelling at the proximal interphalangeal 
joints with a tendency towards subluxation at these joints.
Flexion was limited at all these joints. All joints were painful.
The tendency to ulnar deviation at the metacarpo-phalangeal joints 
was greater in the left hand. The right wrist was ankylosed in good
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position and painless: the left wrist had restricted painful 
movement and increased local heat. The right shoulder and elbow 
were ankylosed; the movements in the left were painful and 
markedly limited. The maximum movement in any direction of the 
right hip was 10°; the left hip could flex to 30°, but no other 
movement would reach 2o° - movements in both joints were painful. 
The right knee flexion was limited to 95°, there was gross 
quadriceps wasting, - there was synovial thickening without an 
effusion; the left knee moved through a full range of movements, 
the quadriceps was wasted, there was synovial thickening plus an 
effusion, and there was increased local heat. The feet and spine 
were apparently free from the disease. The tone of the muscles was 
generally low and the wasting was most marked in the muscles 
controlling the severely damaged joints.; the interossei of both 
hands were very wasted.
The skiagrams of the joints had appearances typical of an 
atrophic polyarthritis; the ankylosis of the right wrist, elbow 
and shoulder were confirmed; there was marked diminution of the 
joint space of both hips.
The clinical impression was that this was a patient in whom 
the distress was caused by advanced joint changes in which the 
activity of the disease was no longer high: the general reaction
was of correspondingly low severity. The plasma viscosity of this
all9
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date was in accord with the clinical impression.
Treatment consisted of cod liver oil and malt extract, 
ferrous sulphate (6 grains per day), myocrysin in 12 weekly doses 
of 0*01 g., remedial exercises on the G-uthrie Smith apparatus, 
re-education in walking, and splints to correct the ulnar deviation 
of the fingers.
By February 1948, at the end of the gold course, she had 
put on weight, she walked in a modified manner with an increased 
range of hip movements, the joints were less painful generally 
and some were considered to he quiescent. Treatment was stopped 
for a period of two months.
By April, her hands had improved markedly, the pain had 
decreased further, and she could still get about with the aid of 
her sticks although the hip movement range had not increased 
further. The disease condition was assessed clinically as being 
quiescent: the laboratory results remained abnormal although much 
decreased from the original test. Further local treatment was 
given in an attempt to improve the function of the joints.
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Her condition remained satisfactory until August when she had 
an attack of influenza. A relapse in the rheumatoid arthritis 
followed, with a flare-up in hoth knee-joints and in the small 
joints of the hands. The plasma viscosity at the beginning of 
September had increased as a result, yet the ESR value remained 
low.
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Case No. 6 Rheumatoid Arthritis.
This grocer, aged 60 years, had suffered for many years 
from pain and swelling in the wrists, elbows, and inter-phalangeal 
joints of the fingers and from pain in the feet but had received 
no treatment. He had been unable to work for 4 months. He had 
always been a healthy man apart from pneumonia in 1929 and 1942 
and chronic bronchitis from 1940 onwards.
On examination at the rheumatism clinic he showed signs of a 
chronic bronchitis and the rheumatoid arthritis lesions only. The 
hands had gross fusiform swelling of the inter-phalangeal joints 
of the fingers, swelling of the 1st and 2nd metacarpo-phalangeal 
joints, ulnar deviation, wasting of the interossei. Both wrists 
had marked periarticular thickening and carpal cysts, with limit­
ation of movements. Both elbows were painful on movement; the 
right had synovitis, local heat and an ulnar bursitis. The feet 
showed bilateral pes planus and marked limitation of movement of 
the toes..
Skiagrams of the chest had the appearance of chronic bronchitis. 
The inter-phalangeal joints showed diminished joint space and 
marginal erosion, plus osteoporosis of the phalanges. The carpal 
bones were very osteoporotic, and the right bones showed signs of 
ankylosis. The joint space in the wrists appeared diminished. The 
elbow joints also appeared to be normal.
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The plasma viscosity and ESR results of that date were rather low 
for the activity by clinical assessment.
Treatment with myocrysin was begun at once in weekly doses 
of 0*01 g. The pain in the fingers increased markedly and the 
wrists became more painful and swollen. Wax baths and heat to the 
small joints of the fingers. The plasma viscosity had risen 
appreciably.
The patient was admitted to the Royal Baths Hospital at 
Harrogate where the intensive physiotherapy and the completion of 
the gold course produced a marked general and local improvement.
Hee was an in-patient for 3 months.
' He remained well for a little more than 2 months - all the 
small joints and the right ankle became swollen and painful some 
3 weeks before the blood test was made on 16:9:47, in which the 
raised plasma viscosity indicated a continued activity. G-old 
therapy was resumed only to be followed by a worsening generally with
a right ankle so swollen and painful that walking was impossible 
and sleep was disturbed. The plasma viscosity increased in 
parallel.
He was admitted to hospital for complete rest in bed, 
splints to hands and ankle, and iron tonic. The gold was stopped. 
In December an intensive non-weight-bearing physiotherapy course 
began. By 15:1:48 he^ was just getting up again. He felt better 
generally. The feet were less painful and the toes were beginning 
to move; the elbows were settling down; but the wrists and 
fingers remained painful.
Procaine and lactic acid injections to the wrists at fort­
nightly intervals caused some improvement in the joints.
A flare-up of the chronic bronchitis in April 1948 failed to 
cause an activation of the joint symptoms and the laboratory tests 
also showed no significant change.
He stopped attending the clinic at this time and did not attend 
again until 8:9:48. He reported that he had returned to his work 
but recently the joints had become more painful. Both knees were 
painful and swollen, with increased local heat: the wrists, hands
and feet which had given so little trouble were again painful.
The clinical assessment was that of a relapse; the plasma viscosity 
result was in agreement with this diagnosis. It was arranged 
that he should be re-admitted for further treatment.
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Case No. 7 Rheumatoid Arthritis (Residual deformity only)
This housewife, aged 25 years, had an attack of pain and 
swelling of the wrists, knees and small joints of the fingers 
three years prior to her attendance at the rheumatism clinic.
She had been treated as an in-patient of St. Thomas’ Hospital, 
London with gold. The improvement was marked.
. She attended the clinic complaining of deformity of her hands, 
vague pains in the hands, and limitation of the movement of her 
right knee. (The only relevant illness in her past history was 
chorea in 1939)
She was a thin, pale woman who walked apparently normally in 
spite of her complaint regarding the knee. The knee had some 
thickening of the synovial membrane, a full range of movements, 
no synovitis, and associated quadriceps wasting. The wrists 
showed periarticular thickening with slight synovitis, and a full 
range of movements. The second metacarpo-phalangeal joint of both 
hands was swollen and thickened; the inter-phalangeal joints had 
symmetrical fusiform swelling; and the interossei were wasted.
No abnormality in the other systems could be detected.
Skiagrams of the chest showed normal lungs and heart. There 
was osteoporosis of the carpus, metacarpals and phalanges, with 
diminished inter-phalangeal joint spaces. The right knee showed
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osteoporosis plus a reduced joint space. The antral sinuses of 
the head appeared opaque (this examination was made as a routine 
in every patient and there was nothing clinically in this patient 
to make the clinician suspect a septic focus).
The specialist on diseases of the nose reported that there was 
a bilateral antrum suppuration; this was treated within days by a 
bilateral Caldwell-Luc operation. The operation was followed 
by three weeks complete rest in bed, but no other active therapy.
The case presented a diagnostic problem. The clinician’s 
assessment was that the rheumatoid arthritis was no longer active 
and could not be held responsible for the raised plasma viscosity. 
The blame for this was placed on the latent septic focus. The 
laboratory test after the operation showed a markedly reduced 
plasma viscosity: as there had been no change in the joints, the 
correctness of the original diagnosis was supported.
A course of myocrysin was begun at the end of December to 
stimulate metabolism and improve the general condition. Iron 
was administered empirically as the patient was not anaemic.
By February an improvement in the general condition was
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noted and this improvement was even more obvious by April. The 
weight had increased; the complaints concerning the vague pains 
had ceased. On 8:5:48 she reported that she felt very well and 
that she was two-months pregnant.
The laboratory results of this case assisted the clinician 
by attributing the reaction to a latent infection when this had 
been eradicated. The results are also interesting in that they 
show that treatment can so relieve a rheumatoid arthritis case 
that the laboratory results all fall within their normal ranges.
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Case No. 8 Subacute Rheumatoid Arthritis.
This housewife gave a history of arthritis of 7 months duration 
only. She complained of pain in the shoulders, knees and small 
joints of the fingers. Both knees became swollen when she stood 
for any length of time. During the weeks immediately prior to 
her attendance at the clinic she had had very severe pain in her 
fingers so that her sleep was disturbed. She noticed that she had 
lost weight and that her hands and feet perspired readily.
On examination, no pathology was detected except in the loco­
motor system. In both hands there was enlargement of the first 
metacarpo-phalangeal joint, painful fusiform swelling of all the 
proximal inter-phalangeal joints which still foads a full range of 
movement, and wasting of the interossei muscles without ulnar 
deviation of the fingers. Both knees had increased local heat, 
synovial thickening, effusion, painful movement without restriction 
of range. The other joints appeared to be unaffected. The 
osteoporosis and diminution of the joint spaces as revealed by 
the skiagrams were typical of an early rheumatoid arthritis.
Because of the pain in the joints, the hot swollen knees, and 
the painful tender fusiform swelling of the inter-phalangeal 
joints, the disease process was considered to be very active. This 
was supported by the high plasma viscosity value (2*425 cs.)
Myocrisin in weekly doses of 0*01 g. doses and bed rest were
al28
r Late PCV. PLASMAvise.
Wintrobe
ESR.
Ord.jCorT'
Total
Plasma
Pfot.
~ ~ I
Gold 1 
Floe, j
% cs. mm/ 1 hr g.$
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■begun at the patient’ own home.
By 19:9:47, after 5 weeks of this treatment, there was an 
improvement in her general condition. The knees had also settled 
down but she still complained of considerable pain in the small 
joints of the fingers.
There was no appreciable difference on 10:10:47. Local 
treatment to the fingers was then begun, while the gold was still 
exhibited.
Slow improvement was detected on 24:12:47. The hands were 
much less painful, the knees still had some synovial thickening 
but the effusion had gone, and there was some pain in the shoulders. 
Treatment was discontinued for three months.
On 15:3:48, she still complained of considerable pain in 
the small joints of the fingers and in the shoulders, although the 
knees were still satisfactory. She had suffered from bronchitis 
during the three weeks previously and as there was no definite
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deterioration in the arthritic state the increase in the plasma 
viscosity was ascribed to this infection. Nevertheless, when the 
tests were repeated 8 weeks later when the bronchitis had cleared 
completely, almost identical values were found. As it was 
believed that the systemic part of the disease had entered the 
chronic smouldering stage (as supported by a viscosity within the 
zone of chronicity) it was proposed that another attack should be 
made on it with 1/iyocrisin.
This case is an example of an incomplete response by 
a subacute disease which eventually assumes the characters of 
the chronic type. The plasma viscosity has been a reliable 
guide to these changes in the disease process.
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Case No. 9 Acute Rheumatoid Arthritis.
This male patient, aged 57 years, had a sudden onset of pain 
and swelling in both knees, followed by a rapid development of 
fusiform swelling of the inter-phalangeal joints of the fingers 
and painful swelling of the wrists.
He first attended the rheumatism clinic on 4:1:47. No 
abnormality could be detected except in the locomotor system.
There was gross effusion of both knees, plus thickening of a 
"doughy” consistency and marked limitation of movement. There 
was a symmetrical and very marked swelling of #the inter-phalangeal 
joints of both hands; there was no ulnar deviation of the fingers. 
The right tempero-mandibular joint was painful on movement and 
marked crepitus was detected in it. The clinical assessment was 
that the knee lesions were acutely active.
Skiagrams of the lungs revealed healed and calcified apical 
lesions on both sides. The joint appearances were typical of an 
atrophic arthritis.
The Wassermann and gonococcal complement fixation tests were 
negative. The serum uric acid amounted to 3 mg. per 100 ml.
130 ml. of straw-coloured fluid was aspirated from the right 
knee and 90 ml. from the left. Plaster gaiters were applied to 
both knees. A full course (12 weekly injections of 0*01 g. )of 
Myocrysin caused little amelioration except for slightly reduced
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30: 5:47 35*9 3*346 57 34 10*51 _ Fri.
26: 7:47 37*7 3*619 3 0 11*05 — Sat.
30: 7:47 37*0 3*341 - - 10*66 - Wed.
6: 9:47 37*9 3*611 22 10 11*38 — Sat.
15: 9;47 34*0 3*171 - -9*90 - Mon.
13:11:47 38*5 3*677 - - 11*09 ++++ Thur.
22:11:47 35*7 3*228 - - 9*43 ++++ Sat.
2:12:47 36*0 2*902 22 8 9*79 + Tues.
9: 3:48 35*3 2*903 40 21 9*50 +++++ Tues.
21: 8:48 38*5 3*315 12 3 10*55 +•++++ Sat.
14: 9:48 36*3 3*059 - - 9*90 +++++ J Tues.
activity in the knees* He was admitted to hospital.
An intensive course of physiotherapy followed. He was at 
complete rest in bed; iodine ionisation was applied to the knees; 
re-education of the quadriceps muscle was practiced; and the 
joint movements were entirely passive. By the end of May, 1947, 
at the time of the first plasma viscosity measurement, very 
little improvement could be recorded.
A second course of Myocrysin was begun. On account of a 
general and local deterioration the treatment had to be stopped 
after six injections. The knees again required aspiration. This 
change was reflected in the increased plasma viscosity value.
The test after a week free from treatment showed a dramatic fall 
in the plasma viscosity, without any obvious change in the 
clinical assessment.
Treatment was resumed. He was rested in bed; the knees were
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aspirated frequently; and the myocrisin was resumed, combined 
with mixed vaccine. Sodium salicylate was given to relieve the 
pain, and iron to combat the persistent anaemia. After 6 weeks 
the plasma viscosity had increased to its originally high value 
and an even greater fall ensued when treatment was discontinued 
for a week. The joint condition had not improved in these 6 
latest weeks of treatment.
Physiotherapy was continued through the autumn in a less 
intense programme. Quite suddenly, for no obvious reason, an 
improvement in the local and general condition began about the 
middle of November, just after another viscosity peak. Myocrysin 
was again given. Active exercises were resumed. He was sent home, 
to continue his treatment as an out-patient, in March 1948.
He failed to attend and it was learned that he was doing 
light work. However, in August he had a relapse which forced him 
to seek further treatment. The plasma viscosity had again risen 
to a value almost identical with that in the initial test.
This case was of particular interest because of the rapid 
changes in the plasma viscosity values. These changes resembled 
the fluctuations possible in acute pyogenic infections, rather 
than those of a very severe chronic condition. No similar changes 
were noted until the cortisone and A. C. T. H. drugs were introduced 
for the treatment of rheumatoid arthritis - the decrease at the
al35
beginning of treatment could be just as great as in the 9 days 
here between the 6th and 9th September (cf. Case No. 10 ); 
unfortunately, the increase on cessation of drug treatment can be 
just as rapid as the decrease.
Table - III a!54
INFECTIVE POLYARTHRITIS
Name N o !  Date PCV.
PLASM
vise.
Wintrobe 
E. S.R.
Total
Plas.
Prot.
Cold
Floe RemarksOrd. Cor.
°/o cs. mm/ 1 hr %
A. Chronic - Female
E.H. 1 3: lUl* 1-989 20 19 - -
F.T. 2 13: 1 146 * 1-911 - - - -
M.S. 3 27: 1 50* 1*985 8 17 - -
JLVL 4 4: 3 44-1 2*188 - - 8*0 -
M.W. 5 24: 3 48-8 1*948 7 14 7*47 -
F. R. 6 2: 5 44-0 1*869 11 14 6*70 -
J.P. 7 19: 5 42-9 1*894 - - 7*52 - early case
D.W. 8 11: 4 j43*6 2*214 45 48 7*85 -
E.W. 9 8: 8 36-8 2*245 59 47 7*38 -
29: 9]39*6 2*315 47 42 7*45 -
19:12140-1
i
2*140 39 36 7*34 4+
G. C. 10 11: 8 39-3 2*076 39 34 7*92 -
D. A. 11 20:10 38*3 2*175 42 35 7*56 +
13:11 39*2 2*165 27 22 7*63 +
16:: 4 39-1 2*288 45 39 8*04 +
M.A. 12 28:11 36-1 1*898 | 19 11 7*85 +
I.H. 13 5:11 40-3 1*854 9 7 7*24 +
V.T. 14 5: 1 41-5. 1*978 12 12 7*85 0
24: 3 40-1* 1*989 i 31 28 7*45 o
P. B. 15 5: 1 49-4 2*251. 8 16 8*14 o
A.H. 16 7: 1 39-3 2-040 24 20 7*45 0
M.D. 17 28:11 42*7 2*248 i 16 17 8-46 3+
M.W. 18 i12: 1J45 *6 2*005 20 25 7*27 0
M.C. 19 15: 1 42-1! 2*325 | 27 27 7*99 o
M.S. 20 11: 2 36 -lj 2 *068 ! - - 7*49 0
M.C. 21 16: 2 47-8 1*995 | 11 18 7*38 3+
W.M. 22 26: 2 41-7 2*050] 22 22 7*63 o
2: 4 41-71 1*900 ] 9 ! 9 7*13 +
O.W. 23 10: 3 42*01 1*916|j 10 10 7*34 0
J.B. 24- 3: 3
j
44*0j 2*013 13 !15 7*60 0
30: 4 48 *41 2*096 ] 3 9 8*60 o
j12: 5 47*5] 1*948 ] 5 110 7* 52 0
A.W. 25 17: 3 45-lj 2*142j 29 I34 7*67 0
Table - III continued al-35
Date POV.Name No.
[plasma
VISG.
cs. rany 1 hr 
Chronic infective polyarthritis
Wintrobef Total! _ _ T 
E.S.R. Plas 1 &old 
OrcL| Cor. Prot. Plocl
%
(contd. )
E.M. | 26 19: 3 145 *51 2*092 28 34 7*70 1 0
! 5: 5 45*5 1 2*114 29 35 7*67 0
H.T. 27 24: 3 45*8 1*973 18 22 7*20 o
C.B. ! 28 24: 3 39‘7 1*984 27 24 7*09 2+
H.H. 29 31: 3 42 *7| 1*895 6 7 7*38 o
E.T. 30 31: 3 41*2 ! 2*216i 35 34 8*06 2+
M.C. 31 7: 4 37*2 i 1*920 15 11 7*06 o
A.L. 32 7: 4 35*3 | 1*812 8 1 6*98 o
F.H. 33 14: 4 39*1 1*942 15 12 7*56 -
M.C. 34 10: 5 42 *8 2*084 29 30 7*63 2+
M.K. 35 9: 9 40-7 2*168 45 42 7*88 +
Subacute infective polyarthritis - female
E. H. 36 23:12 40* 2*571 24 27 _ -
M.S. 37 17: 2 43*5 2*441 - - -
H. J. 38 18: 4 31*7 2*584 - - 8*28 -
L. Gr. 39 7:11 44*5 2*468 37 41 8*46 0
M*Gr. 40 5: 1 43 *0 2*474 30 31 9*40 0
E.M. 41 17:11 45*4 2*518 32 38 8*86 3+
P.M. 42 16: 1 31*1 2*663 6 0 8*32 o
12: 3 29‘0 2*475 60 32 7*96 0
I.B. 43 24: 3 39 *6 2*334 37 33 8*21 4+
M.H. 44 14: 4 41*0 2*210 A A ■arr 42 7*34 —
Remarks
Table - III continued. al36
Name
IYWr PLASM 
DateJPCV. j yjsQ^
cs.
Wintrobe 
E. S.R.
Ord. Con
mm/ 1 hr
Total. 
Plas. £?ld 
Prot.' ^ 1°°
Remarks
%
Chronic infective polyarthritis - male.
W.C. 1 j 9 1 49 * 1*940 1 1 2 14
T.R. 2
9
1 49* 2*074 I " - - -
J.A. 3 18 3 48-1 2*043 | 10 11 7*30 —
j 23 10 47*6 1*949 5i 5 7*74 3+
W.P. 4 8 4 45*0 | 2*026 j 20 18 7*38 -
W.M. 5 i 15 4 55-7 ! 2*128 ! 2\ 11 7*85 -
T. J. 6 I 18| 4 42-2 ! 1*978 Si5 - 7*16 -
W.M. 7 j 24 4 43*7 2*227 j 27 22 7*42 -
H. S. 8 i11 12 45*9 1.996 ! ii! 10 7*02 0
J. H. 9 I n 12 44*2 2*115 1 19 16 8*06 +
30 3 46*3 2*120 1 10 9 8*17 0 1
J.T. 10 j 18 12 43*0 2*178 j 30 25 8*28 0
R.W. 11 ! 5 2 45*7 1*991 20 18 6*95 3+
P.T. 12 J 15 3 45*1 1*809 i - 6*80 0
W.T. 13 ! 1 * 46*8 1*816 1 1 7*09 0
M.M. 14 ; 13 4 44*8 1*695 1 0 6*44 +
A. B. 15 15
4
44*3 2*213 38 34 7*49 o
R.G. 16 22 4 47*3 2*212 30 30 7*56 +
F.K. 17 5 44*2 2*377 4 1 8*24 +
T.W. 18 6 5 40*9 2*329 44 38 8*23 o
R. H. 19 16 9 48*3 2*161 - - 8*35 0
Subacute infective polyarthritis - male
T. R. 20 11: 9 39*0 2*646 „ «■» 7*99 _
M.L. 21 9; 4 39*7 2*346 46 33 7*52 o
A. H. 22 20: 5 43*8 2*408 44 38 7*92 4+
Table- IV a!37
STILL’S DISEASE
Name
r
Isil
[»o.
1
Date jPCV..
...
1
•PLASMA
| v i s e .
IWintrobe 
1 E.S.R. 
lOrd. I Cor.
Total 
! Plas.
! Prot.
Gold
Floe
|
| f o 1 cs.
1
]m&/ 1 hr
*
L.D. |F 1
23: 4 28*8
I
1 2*081 j 35 14 7*60 -
| A. D. !f
1  2
28: 5 39*2 2*285 ! ~ - 8*24 -
jL. S. |f j 3 28: 5 38*4 i  2*473 | - 8*78 -  1
;J.T. 4 24: 7 41*2 I  2*424 i i 7*85
!  ! 
f  -i1
|
ii 9:10 | 38*0 j 2*311 i 50 42 I  7*85 !0  j
Ij.b.
I
■ F
6
30: 7 16 *8 ;  2*052 - - i  6*80 ' -  I
|a.h. 1 m ! 6 19: 2 37 *4 |  2*836 ;  50 40 | 8*96
i -  > 
! + |
s. a. M ' 7 15: 6 39 *21 2*477 I 50 45 | 8*60 i + i
| i 2: 9 40*8 2*085 - - ! 7*45
3  J
1 o j
L.B. )F 8 12: 4 32 * • 2*961 : 57 36 | 8*71 ! + i? 21: 4 34* 3*144  ^19 8 ! 9*11 + i
30: 4 47*  ^ 3*266 3 7 1 9*72 o I
16: 5 41* 3*021 : 12 11 ! 9*09 ++ i
28: 5 36* • 3*052 35 25 i 8*94 + |
5: 6 - 2*935 - - 1 8*93 - :
6: 7 29*5 2*687 63 35 ! 8*57 + j
23: 8 34* • 3*337 42 28 j 9*20 + 11
13: 9 30* i 3*005 : 63 36 | 8*75 i1I
17: 9 33* : 3*353 ' 41 25 ! 9*29 -  |
i 9:10 33*3; 3*i4i 57 30 8*93 ij24:10 32* : 3*266 59 36 9*72
s
i
| 13:11 36 * 3*218 36 26 9*50 + + +  I
20:11 36* 3 *516 49 37 9*86 -  1
II 26:11 37*0 2*273 44 34 7*70 •
I 29:11 38*9 i 2*165 38 32 7*80 +  i
3:12 41*3 2*003 16 is 6*80 j-  ]
110:12 44*6 2*000 13 16 7*60 - !
i
i 15:12 44*5 1*992 14 17 7 * 7 8 _ ji
! 19:12 47*2 2*177 19 26 8*42 — 1
24:12 45* 2*155 27 31 7*57 _  ii
1 3: 1 37* 2*560 53 42 - - J
G. H. F 9 1: 9 39*1 2*415 47 42 8*86 + i
J. H. F 10 1: 9 41*6 2*660 44 44 9*32 +
K . W . M 11 1: 9 45*5 3*100 31 29 8*10 +
Remarks
\ after transfusion
I Cortisone "begins
Cortisone ends
yr. history 
2 *5 yr. history. 
9 yr. history
Case No. 10 Still's Disease (treated with Cortisone)
This girl was aged eight and a half when she was admitted to 
hospital on 11:4:51.
Four years previously she had suffered from rheumatic fever 
for which she was nursed in hed for 6 months; she had apparently 
escaped without cardiac damage. She had remained well since then 
until 4 months prior to admission.
A history of a sore-throat was obtainable. A typical 
polyarthritis began in December for which she received salicylate 
and penicillin treatment; she was allowed to sit up but more 
active movements were prohibited. The swellings around the 
joints varied in size, but never disappeared; the swellings were 
painless.
On admission, she was a pale thin child. Both tonsils were 
enlarged, but not inflamed. All systems were normal, apart from 
the locomotor. The liver and spleen were not palpable.
The spine, elbows, shoulders, hips, toes, and fingers were 
not involved. The wrists had marked peri-articular swelling and 
limited movement. There was also peri-articular swelling of the 
knees, with effusion into the right knee. The ankles also showed 
swelling. None of the affected joints were painful.
The laboratory tests corresponded to a severe general reaction.
Her treatment consisted of rest in bed and rest to the arms
al-39
Date PCV.
PLASMA
vise.
Wintrohe
ESR. Plasma protein G-old 
Floe. 1
iO
Cor. Total) Alb.lG-loh jFih.
% cs. mu/ 1 hr g./100 ml. |
12: 4:51 32* 2*961 57 36 8*50 3*80 3*97 0*73 + ;
21: 4:51 34* 3*144 19 8 8*74 4*55 3*50 0*69 + 1
30: 4:51 47* 3*266 3 7 9*72 - - - o j
16: 5:51 41* 3*021 12 11 9*09 4*33 4*00 0*76
1
++ }
]28: 5:51 36* 3*052 35 25 8*94 4*35 3*85 0*74
!
+ \
5: 6:51 - 2*935 - - 8*93 - - IJ 6: 7:51 29‘5 2*687 63 35 8*57 4*2 3*7 0*67 | I+ |
23: 8:51 34* 3*337 42 28 9*20 4*0 4*41 0*79 | + !
13: 9:51 30* 3*005 63 36 8*75 _ - - j ]
17: 9:51 33* 3*353 41 25 9*29 ~ -
? 1j
9:10:51 33*3 3*141 57 30 8*93 ~ - - | j
24:10:51 32* 3*266 59 36 9*72 - - - I j
13:11:51 36* 3*218 36 26 9*50 4*0 4*76 0*74 i +++ |
20:11:51 36* 3*516 49 37 9*86 * — - _ i1 j
26:11:51 37-0 2*273 44 34 j 7*70 4*2 3*06 0*44 j |
29:11:51 38-9 2*165 |58 132 1 7*80 4*5 2*98 0*32 |
i
+ i
3:12:51 41*3 2*003 16 I15 i 6*80 4*1 |2*36 !0*34 |
]ij
10:12:51 44*6 2*000 13 j16 | | 1
15:12:51 44*5 1*992 14 i17 I | j
19:12:51 47*2 2*177 !19 j26 i j
24:12:51 45* 2*155 27 !31 7*57 4*8 j2*3 0*47 j
3: 1:52 37* 2*560 53j[42 I
1
!
and legs “by splints. Her pulse rate fluctuated markedly throughout 
her illness and she had a swinging low-grade pyrexia also.
On 23:4:51 she received 800 ml. of hlood intravenously- There 
was an immediate rise in the haematocrit, plus a slight increase 
in the plasma viscosity while the ESR fell to 3 mm./hour. By the 
end of April an improvement in the movements of the right wrist 
and ankle could he detected and the effusion in the right knee 
had lessened. She was feeding herself early in May.
al40
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The slight rise in the plasma viscosity in the middle of May 
was associated with a “brief period of more definite rises in the 
temperature - no cause was detected. The joints had shown no 
relapse.
Sulphamezathine was given on 29:5:51 to cover the removal of 
two teeth. The temperature thereafter resumsd its low-grade 
pyrexial pattern, and the plasma viscosity fell.
Her tonsils and adenoids were removed on 13:6:51. The 
operation caused no flare-up in the joints but she suffered from 
repeated haemorrhages from the tonsil bed on 19th and 21st*-This 
explains the anaemia present in July although 2 pints of blood 
had been given on 23:6:51, especially as there were further small 
blood losses on 24th and 25th.
The low plasma viscosity level in July corresponded to an 
apyrexial interval when the joint swellings were minimal and 
movement was free.
The August test followed another pyrexial bout; the original 
joints still maintained there improvement but a definite stiffening 
of the cervical and dorsal spines was becoming obvious. The rise 
in the haematocrit resulted from another transfusion on 11:7:51.
Her illness continued its chronic course, with a fare-up in 
the original joints in the middle of September to coincide with 
the viscosity peak there.
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Another pint of blood was given at the beginning of November 
to prepare her for her Cortisone; the haematocrit increased. On 
the 19th November, she complained of pain in her hips for the 
first time; the involvement of these major joints was indicated 
by the rapid rise in the plasma viscosity to the highest value in 
her serial tests.
Cortisone: - She received, by mouth, 100 mg. daily from 19th Nov. 
to 6th Dec., and from 11th to 16th Dec; 50 rqg. daily from 7th to 
10th Dec. , and 17th to 20th Dec. ; and 25 mg. daily from 21st to 
23rd. December.
Clinical improvement was obvious in three days when she was 
sitting easily straight up in bed; in six days she was scrambling 
about the bed and could move her arms and hands sufficiently 
freely to play ball with the patient in her next bed. She showed 
an increased feeling of well-being. Her weight increased steadily. 
The improvement was maintained until the supply was finished.
The relapse which followed was not nearly so marked as was feared 
and it was considered that the treatment had been justified.
The laboratory results showed some noteworthy changes.
The increase in the haematocrit values must have been due to 
a haemo-concentration by a passage of fluid from the blood stream 
as the cell increase was beyond any recorded rate of cell 
formation.
al4-3
In spite of the fluid loss from the blood, the plasma proteins 
decreased in amount and rapidly approached to a normal fraction 
pattern. This protein alteration had additive actions leading to 
a plasma viscosity decrease.
The changes in the plasma viscosity and ESR were roughly 
parallel but the time-phase of the changes were different.
In as much as this treatment never caused the plasma viscosity 
to attain a normal value and thus indicate a possible cessation in 
the “activity" of the disease process, it is open to criticism.
I have ventured to suggest that a higher dosage would have had a 
greater chance of an ultimate quiescence if thereby a normal 
viscosity had been attained.
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Case No. 11 Still’s Disease.
This case has been included to show how extremely high 
plasma viscosity results can be found in this disease even after 
many years duration. The high values are characteristic of this 
disease in that the results are frequently much higher than one 
would forecast from the clinical assessment of the disease 
activity.
This man was 22 years old when his plasma viscosity was 
first estimated. He had suffered from rheumatoid arthritis since 
the age of 13. On examination, he could walk only with difficulty. 
Both feet were fixed at the mid-tarsal joints; the ankle movements 
were free. The right knee had a flexion deformity of 35°; the left 
was of 30°^ flexion of both knees was limited to 90°; effusions 
form in the knees when he attempted to walk. The right hip had a 
restricted external rotation but otherwise it and the left hip 
had free movements. The muscles of the thigh and calf showed gross 
wasting on both sides. The elbows had deflexion deformities of 30°, 
and the movements of pronation and supination were accompanied by 
considerable crepitus. The shoulders and the spine were free.
He had received six courses of gold injections without a 
halt in the disease progress. More recently the treatment had 
been restricted to injections of procaine and lactic acid into
al45
the affected major joints but very little relief was being 
obtained.
The laboratory results of 1:9:47 were:-
Plasma viscosity = 3*100 cs.
Blood haematocrit = 45*5 °/o
Wintrobe ESR. = 31 mm. in 1st hour
Corrected Wintrobe ESR. = 29 mm. in 1st hour
Plasma total protein = 8*10 g./lOO ml.
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Case No. 12 Still's Disease.
This girl of 14 years had suffered from arthritis of hands, 
feet and knees for two and a half years. Cold injections and 
physiotherapy produced hut little impression on the progress of 
the disease.
At the time of the plasma viscosity estimation her chief 
complaint was of the pain and deformity of the hands and wrists. 
The wrists were almost fixed; the fingers were locked at the 
proximal interphalangeal joints. The left elbow movement was 
limited. The right knee was swollen and hot; flexion deformity 
affected both knees. The feet and ankles were free.
Skiagrams of the wrists were suggestive of bony ankylosis 
and decalcification of all the bones of the wrists; the elbows 
were similarly affected.
Date PCV. PLASMA
vise.
Wintrobe
ESR.
Plasma
Total Cold
Ord.Cor. Protein Floe.
% cs. rain/ 1 hr g.%
1: 9:47 41*6 2*660 44 A AmCT 9*32 rt*+
The plasma viscosity value is typical of the higher result 
than one would have expected from the clinical assessment of the 
disease activity.
Table - V al47
Name
S.L. | 
1N.K.|
H.K.j
r.f /
J.W.
| I.M.;
R.N. :
I :
\L,Lt)
•M.D.
|l.c.;
|m .H. I 
|h.M.| 
P. S.
|g.v.I
A. S.
M.S.; 
A. S.
W.H :
j.c.; 
A. P.!
R.B,
W.R.5
RHEUMATIC FEVER.
Remarks
Cases which were clinically active, in that the tests were 
carried out early in the disease and usually before 
salicylate therapy had been started.
M ! 11 9 12 '38 *9| 2*359 - 1 - 8*02 +
F j 2 |18 12 44*2 ; 1*952 5 i 7\ 8*06 0
M 1 3 :28 1 39 *9 2*493 48 35 7*88 2+
M i 4: 4 3 37 '9 2*123 46 30 7*78 0
M 1 5 i 4 3 44*0 2*271 - i “ 7*85 0
F i 6 23 3 35 *0 2*411 55 1 40 7*85 +
30 3 30 «6 2*476 60 | 35 7*49 +1 5 4 31*9 2*455 58 | M 7*99 +
F i 7 :24 3 35*0 2*548 55 ! 4-0 7*34 2+
30 3 36*2 2*202 48 ! 36 6*59 +
i 5 4 38 *8 1*970 37 | 32 6*95 +
F i 8 1 4 39 *8 2*544 32 ! 28 7*92 2+
j 5 4 33*3 2*632 57 ! 38 7*38 +
F : 9 1 4 44*0 2*249 11 | 13 8*21 2+
M 10 8 4 39'0 2*228 - i - 7*16 0
F 11 16 4 33*9 2*143 21 1 11 8*03 +
F 12 16 4 40*2 2*323 47 44 8*03 2+
F 13 8 5 27 *7 2*151 65
j
| 33 7*02 +
M ;i4 13 5 41*4 2*042 20 13 7*74 0
M 15 20 5 40*9 2*470 45 ! 34 7*45 o
27 5 41*9 2*139 59 j 31
!
7 *09 | o
F 16 24 5 41*3 2*334 38 37 7*74 +
F 3.7 27 5 36*9 2*269 45 36 8*14 0
M 18 22 6 41*2 2*341 40 31 8*42 | +
. 3 8 43 *e 1*957 10 ! 6 7*67 ij 0
F 19 28 6 31*4 1*957 47 27 6 *37 f 0
F 2° 28 6 36 *6 2*279 46 36 8*32 j 0
: 6 7 40*6 2*064 21 19 7*96 [ 2+
13 8 41*9 1*986 10 10 8*10 j +
M 21 i24 8 23*8 2*385
_ - 1 7*99 j 0
9 8 25*9 2*562 65 22 ! 8*14 1 +
15 9 28*2 2*333 60 23 I 8*60 1s +
M 22 1 4 10 38*0 2*861 -
!
- i 7*95 | -
125 10 43*7; 2*026 - -  i
6*97 1 -
Sk0.\ Date ;PCV.
%
1 PLASMA fWintrobe Total]
v i s e . E. S. R.
[OrdTj Cor 
cs. imm/ 1 hr
£laa- Prot. \
%
Table- V continued al43
“  * I ' !
Name! S NO.
6
 L— [— —
Date PCV.
! P L A S M  ^W i n t r o t e
i 7ISC.  ^ E.S.R.
cs.
Ord. j Cor, 
mm/ 1 hr
Total
Plas.
Prot.
%
Remarks
A. Clinically active Rheumatic Fever (contd. )
S. C. j F j 23 ! 15: 6 36 *81 2-468 !j 3 I o 8*14 3+
B. R. j M j 24 12: 8 41*2 2*186 j -
!
j 1 7*34
I 1 18: 8 38*5; 2*228 ! - ; 7*13 -s ? : 25: 8 39 *0' 2*183 ’ - : 1 7*42 -
! 4: 9 41*3 2*107 i -
:
i ” 7*241 5
1 1 11: 9 41*3 1*997 ; - - 6*91?
E.F. |F|25 26: 6 36 *6 2*044 ,40 30
;
7*52 o
S.P. ;Fl26 19: 6 44*0 2*039 !23 26 7*49 0
1 | 
I i 29:11 44* ; 1*957 ;17 19 7*45 o
B. D. | M127 4: 7 39* 2*203 19 9 8*68 O
G. F.; M 28 ;23: 2 35* 2*078 44 25 6*98 o
A. P. | M ! 29 |14: 3 36* i 1*931 28 13 7*30 o
S.H.|f |30 115: 3 39- 2*121 1
1
47 41 7*78 0
see also conval­
escent section*
B. Clinically active rheumatic fever, in which activity 
has continued for months in spite of treatment.
K.C. Iff | s i 30:10!40 *3 * 2*021 31 ! 29 ! 7*81 !
11:12 39 *4 2*032 16 | 13 j 7*96 |2+
S.P. ;F |26 29:11 A A •; TX 1*957 17 | 19 j 7*45 ! °
J.H. F 32 17: 4 42* 1*914 20 | 20 1 7*31 0
F.G. M 33 23: 1 45*7 2*027 25 ; 23 ; 7* 17 0
E.S. F 34 6: 8 28 *4 2 *o27 40 17 : 7*70 2+
F.M. F 35 3: 5 •40*6 1*942 10 : 8 7*45 0
M.R. F ;36 13: 5 35*3 2*070 45 : 34 7*45 +
M.R. ; F |37 18: 2 - 2*117 - : - ; 7*27 +
D.W. F 38 27: 2 42*0 '2*286 15 15 j 8*68 +
20: 5 42*2 j2*001 11 11 7*70 : +
6: 8 45*4 |2*024 4 5 7 8*17 +
7: 9 45*2 j2*264 17 ; 21 8*28 2+
R. V. U :ss 14: 2 4-5 * !2*000 4 I 2 7*52 o
S. (y» F 40 1: 1 89 • 1*957 21 j 17 ' -
15: 1 40*4 !2*244 38 35 8*06 ; ~
24: 1 40*4 |1*998 29 25 7*42 ! -
15: 2 57* !2*145 50 40 7*67 ; -
after 7 months.
after 5 months.*
after 8 months.
1 month after acute 
phase "cured"
after 14 months
At work, several 
months after acute 
phase.
ambulant; 8 months 
of vague symptoms.
after 4 months.
Table- V continued. al4-9
Name? S No.. Date j PCV. > "yXSC
PLASMA [W^trobe
m . % cs.
_  E* S*R‘ 
OrdTj Cor,
mm/ 1 hr
Total _ n. 
Plas. g°lc 
Prot. >Floc
Remarks
0. Convalescent rheumatic fever - cases ■which were once 
definitely clinically active.
D.N. If [39 14 2l - 1*846 | 18 - -
G. H. If 40 19 3 38*6 1*917 [14
10
7*70 0
P.M. |f 4! 9 4 141*4
j
1*848 j 3 2 j 7*52 0
In . w. If 42 29 4 38 '4 1*851 I 8 4 7*34 01 £ ! 2 7 38*3 1*865 I 8 4  I 7* 38 0
| L. C. [ M 10 27 5 43*3 1*942 |14 10 | 7*52 0
U r .,M 24 9 1 47*2 1*895 ; 3 3 1 7*05 +
!r.f . 4 15 6 44*2 1*844 i 9 a i 6 | 7*24 0
|g.f.|m 28 19 3 36*5 1*795 16 5 | 6*98 0
3 4 36 • 1*710 8 0 | 6*80 0
16 4 38* 1*698 j 7 0 1 6*73 0
30 4 39* 1*795 8 0 ! 6*80 0
J. H.iF 32 30 4 41* 1*857 ;14 1 3 1 7*20 0
G.D. M 43 11 11 41*8 1*846 i10 5 ! 7*09 "
30 11 39* 1*708 i 8 0 [ 6*48 0
M.E. * 44 7 12 35* 1*701 11 3 1 6*30 0
3 2 40* 1*772 14 12 ! 6*80 0
12 2 42*1 1*740 ; 6 6 !
1
6*73 -
P. D. F 45 j 29 1 38*2 1*819 25 20 ! 7*13 0
1 12 2 40*0 1*774 10 8 ! 6*98 0i 16 4 40* 1*738 ; 7 5 ! 6*80 . 0j
1 30 4 44* 1*868 i| 6 8 7*45 0
R.W. M 46 12 2 39*3 1*749 7 ° 6*95 +
cf.
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D. Cases which clinically might have been rheumatic fever - 
children with vague joint pains, pyrexia of unknown origin, 
or valvular disease of the heart.
These cases were sent to the laboratory for tests to 
help in the decision concerning the "activity".
P.T. F 47 27: 2 37*9 1*869 14 8 7*02 0
R.N. F 48 3: 4 38*9 1*873 19 15 7*13 0
26: 4 37*4 1*815 20 14 7*16 0
A.B. M 49 16:11 41* 1*892 13 7 6*98 +
11:12 40*5 1*787 5 0 7*27 +
A.H. M 50 7: 2 42* 1*798 7 3 6*95 O
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Case No. 13 Acute Rheumatic Fever.
Three weeks prior to his admission to hospital on 22:7:47, 
this man, aged 42 years, had a sore throat which was treated by 
sulphonamides. He improved for 4 days but bilateral quinzy next 
developed and burst after a further 4 days. At the same time 
(ie. 8 days from start of illness) he had a pain in his right 
ankle; later he had pains in the ankles, knees, elbows and 
shoulders - the joints were painful to move, but without any 
marked swelling or redness. Five days prior to admission he was 
treated with sodium salicylate in doses sufficient to produce 
buzzing in the ears yet the pain in the joints was not reduced.
There was a history of previous sore throats; there was no 
history of previous attacks of rheumatic fever.
On admission, the throat appeared to be normal again. The 
joints chiefly affected were the knees, left wrist and left 
shoulder - the wrist was tender but not swollen, the shoulder was 
swollen and held rigid. The patient would not move these joints 
over their full range. There were no rheumatic nodules. The 
heart sounds were pure and its size, to percussion, was within 
normal limits. The spleen was enlarged to percussion but it was 
not palpable.
He was treated by sodium salicylate internally, methyl
Silo 1
Date  ^PCV.
----------
PLASMA
v i s e .
r~.
;Max.
jCitr.
|ESR.
_ Plasma proteii 
TotaljAlb. !Glob
i ______
Pibr K
Serum
NPN.
% cs. jmV'hr . g./100 ml. mg. Jo
12:8:47 41*2 2*186 [55*71 7*08 3 *62!2 *90 0*56 0*393 28*2
18:8:47 38*5 2*228 [41*2 6*91 3*3912*80 0*72 0*3887 26*7
25:8:47 39*0 2*183 4-3*5 6*68 3*65!2*37 0*66 0*3905 33*8 [
4:9:47 4’1*4 2*107 ‘35*1 7*03 3*94!2*54 0*55 0*3938 38*0 1
11:9:47 41*3 1*997 128*8 6*76 3*81j2*48 0*47 0*3943 48*5 |
9:1:48 47 *2 1*895 7*4 7*09 4*72 j1*96 j0*37 0*382
i
28 *7 1 
i
salicylate locally to the joints, and with potassium "bromide + 
chloral for the pain.
A few days after admission, the apex of the heart began to 
move out to the left and a systolic murmur appeared. Improvement 
in the joints was very slow.
The plasma viscosity was first estimated on 12:8:47 when the 
value corresponded to that of a moderate reaction. At this time 
the patient was rather drowsy and his speech was indistinct - these 
were attributed to the salicylates, and these were replaced on 
13:8:47 by calcium aspirin.
This alteration in treatment was followed immediately by an 
acute recurrence of the joint pains, elevation of temperature, 
sweating, etc. and on 15:8:47 there was a pericardial rub in the 
third interspace which disappeared within the day. The pyrexia 
continued to increase until the 17:8:47 when the sodium and methyl 
salicylates were resumed^ there was an immediate response in a 
reduction of joint pains, lowered temperature and decreased
sweating.
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The relapse was reflected in the increased plasma viscosity 
(and in the fibrinogen) of the 18:8:47, yet the ESR. showed an 
appreciable reduction.
On 23:8:47, while he was receiving large prophylactic doses 
of penicillin, some decayed teeth were removed. This operation 
caused no apparent upset to the patient but it might be the 
explanation for the slight rise in the ESR. although there was no 
interference with the steady decrease in the plasma viscosity 
results.
When his temperature had remained normal for a week and he had 
had only occasional joint pains, he was discharged on 11:9:47 to 
continue his convalescence at home.
When the patient reported to the out-patient department 
three months later his laboratory results had returned to within 
the normal ranges: there was now no clinical indication of
activity and there was no evidence of cardiac involvement.
The plasma viscosity test appears to have been a useful 
index to the pathological processes occurring in this patient.
(The behaviour of the plasma protein equilibrium factor 
(K) in this patient has been discussed in my paper.)
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Case No. 14 Acute Rheumatic Fever.
This case is of importance as it shows how high the 
plasma viscosity may he at the first occurrence of pain. This 
finding supports the hypothesis that the disease is a hyper-reaction 
and that it has been active for several days at least before the 
symptoms appear.
This young man of 24 years had been apparently normal to 
physical examination when admitted to the asylum a few months 
prior to the present illness. He complained of pain and swelling 
of both knees and ankles,which pain had appeared since he went to 
bed on the previous night. The plasma viscosity was: measured on 
the same day. The high plasma viscosity, increased globulin and 
fibrinogen, and high ESR. were changed to an extent greater than 
would have been possible in any disease condition of only 24-hours 
duration.
He responded well to salicylate therapy; he was convalescent 
within a month; and his heart escaped obvious damage._____ _____
Date PCV.
!
PLASMA VISC.
Max.
Citr. Plasma Protein i Serum j
Cit. P+A. Citr. P+A. ESR. Total Alb. Glob Pibr. NPN. 1
% cs. ma/hr g./lOO ml. rag ]
3:10:43
23:10:43
29*1
34*0
38*0 1*983
1*607
2*861 64*4
9*7
7*95 (4*21 
- |4*73
2*9810*76 
2 *65 J -
32-3 j
30*1 |
Case No. 15 Acute Rheumatic Fever.
This patient gave the classical history of a sore throat 
which was followed in two weeks by a polyarthritis.
On 4;5:48 he developed a tonsillitis which kept him from 
work for 4 days. On 14:5:48 he had pain and swelling in both feet 
and ankles which were relieved by rest in bed sufficiently to let 
him work again on the 15th. By the 16th, however, his feet were 
painful again and the knees had become swollen; the wrists were 
affected on 17th.
On examination on admission to hospital on 18:5:48, he was 
complaining chiefly of pain in the wrists, left shoulder and right 
knee; these joints were slightly swollen and tender. His pulse rate 
was 100 per minute and his temperature was elevated. The apex 
beat was in the 5th interspace, outside the midclavicular line.
There was a systolic murmur at the apex. The liver was just 
palpable. The throat and tonsils were apparently normal. No 
abnormality was detected in any other system.
Date PCV.
PLASMA
vise.
Wintrobe
ESR.
Plasma
Total
Prot.
Cold
Ploc.Ord.jCor.
% cs. mm/ 1 hr g-C/o
20; 5:48 40*9 2-470 45 36 7*45 +
28: 5:48 41-9 2-139 39 31 7-09 0
His temperature fell with salicylate treatment. He was sent 
home on 31:5:48 to convalesce there. His heart size later 
diminished but the systolic murmur persisted.
Case No. 16 Acute Rheumatism, becoming chronic.
This girl of 11 years had had a previous attack of 
rheumatic fever; the course had been of insidious onset and mild 
symptoms so that her treatment but been scanty, which might have 
been the reason that she developed a carditis.
About the seventh of October, 1951, she began to complain of 
mild pains in the back, foot, shoulders, and fingers; her temper­
ature was not elevated. There was no history of a sore throat.
As these symptoms had not cleared in a fortnight her mother called 
in the doctor. He put the girl to bed for a week, without drug 
treatment, but the pain persisted. There was still no elevation 
of temperature but a tachycardia of 108 beats per minute was 
noted. There was no appreciable alteration in the heart sounds 
and in the presystolic murmur which was left after the original 
attack.
The plasma viscosity was requested in order to ascertain if
any active disease was present, and the value of 2*707 cs. was a
surprise to myself and the patient's own doctor.
She was treated with salicylates from 28:10:51 until 
1:1:52. The pains had gone in four days and the pulse rate had
fallen to 84 per minute in the same period. The pulse rate
remained steady thereafter apart from an increase from 10th to 
13th January, 1952.
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n .i "--- f ! Wintrobe" Plasma
j Date [
s
PCV. |
PLASMA
vise.
| E£ 
1 Ord.
>R.
Oor.
Total
Protein
i
j
11I 
n
P
i 
o^s. cs. | mm/
j
1 hr Z-%
26:10:51j 36* ; 2*707 1 54 41 8*75
12:11:51: 37* 1 2*140 | 51 40 8*03
28:11:51 37- I 1*980 I 37 28 7*60
17:12:511 38-0 j 2*160 | 45 37 8*14
1: 1:52 |39- I 1*937 1 21 17 -
15: 1:52 j40*4 j 2*244 j 38 35 8*06
24: 1:52 [40*4 1*998 i .29. 25 7*42
This case is a good example of the manner in which the plasma 
viscosity test can assist the physician.
The only evidence of an active disease were some slight pains 
and a ' tachycardia, in an apyrexial patient. The rapid clinical 
improvement with salicylate therapy was reflected in the rapid 
fall in the plasma viscosity (The ESR remained unaltered).
The rate of fall suggested a return to normal levels by the 
middle of December, hut an actual increase was detected - this 
change I interpret as the alteration from the acute phase of the 
rheumatic disease to a more subacute or chronic phase. There was 
absolutely no clinical evidence of this change in the clinical 
picture.
By the beginning of January, 1952, the ESR had reached a 
normal value, but the plasma viscosity persisted high. After the 
salicylate was stopped the pulse rate was again increased for a 
few days and the plasma viscosity had increased significantly.
The pulse rate increase amounted only to a rise to about 90-94 
per minute from its usual 80-84.
Nine days later, the pulse had remained steady except for 
the evening previous to the test when it again reached 90, but 
the plasma viscosity and ESR. remained abnormally high.
Her physician intends to keep her at rest in bed until these 
two tests attain and maintain normal levels.
A test' on 15:2:52 showed that another increase had 
occurred in the plasma viscosity to 2*145 cs.
Case No. 17 Chronic Rheumatic Fever.
This girl, aged 16 years, had been confined to bed at 
home for 7 months because of rheumatic fever, with severe cardiac 
involvement. She was free from joint pains. Her Wintrobe ESR. 
remained between 23 and 26 mm. /lst. hour.
Her own doctor was of the opinion that her disease was not 
quiescent and saught the assistance of the laboratory to obtain 
additional abnormal tests to strengthen his position in keeping 
his patient in bed in face of parental criticism.
The plasma viscosity values were typical of a chronic 
disease process. The gold flocculation was also abnormal in the 
second test.
Date PCV. PlasmaVise.
Wintrobe
ESR.
Total
Plasma
Prot.
Gold
Floe.Ord.jCor.
fo cs. mm/ 1 hr
30:10:47 40*3 2*021 31 28 7*81 0
11:12:47 39*4 2*032 14 11 7*96 ++
Case No. 18 Chronic Rheumatic Fever.
This case illustrates how the plasma viscosity remains 
persistently elevated into the "zone of chronicity" in the presence 
of continued clinical activity^ the ESR, in contrast, had 
returned to normal limits.
In April 1945, when 22 years old, this girl had an attack of 
rheumatic fever for which she was treated in hospital for 6 weeks. 
Thereafter she remained well and free from pain.
In November 1947 she had a recurrence of the rheumatic fever. 
She was treated at home, with 6 weeks confinement to bed followed 
by a slow return to full activity.
On 28:2:48.she attended the medical out-patient department 
for a specialist's opinion regarding her fitness to resume work.
She felt well apart from occasional pain in her left shoulder and 
elbow. She had no dyspnoea. On examination, the apex beat was 
in the 5th interspace in the mid-clavicular line, there were 
systolic and diastolic bruits at the apex, there was a marked 
ttachycardia, and no other abnormality. In view of these findings, 
together with the abnormal laboratory results, the clinician 
considered that the rheumatic fever was still active: she was
sent home to have further complete rest.
She reported on 20:5:48. She felt very well and was keen to
1 Date
*:
PCV. PLASMAv i s e .
' Wintrobe T  Total | 
ESR. J  Plasma j 
Ord.iCor. | Prot. I
Gold j 
Floe, j
r % cs. g,fo 1 — H
28:2:48 42*0 2*286 1 15 j 15 |
[
8*68 ! + 1
|20:5:48 42*2 2*001 11 i i  | 7* 70 | +  1j 6:8:48 45 *4 2*024 '■ 4 7* 8*17 j +  I
7:9:48 45*2 2*264 | 17| 21 j 8*28 | + +  J
resume work. There was no alteration in the heart to physical 
examination: the - tachycardia was 120 per minute. Although there 
was some improvement in her laboratory results, the plasma 
viscosity and gold flocculation remained abnormal. The clinician 
again assessed that the disease was not quiescent and a further 
period of rest was ordered.
On 6:8:48 she again claimed to be very well and to be 
managing a little light work. Her tachycardia persisted at 120 
and she had now developed an aortic diastolic murmur. The ESR. 
was only 7 mm. per hour. The clinician preferred the plasma 
viscosity abnormal value and considered that her rheumatic carditis 
was still active. Further rest was prescribed.
A month later, even when she still made no complaint, all 
the laboratory tests had become more abnormal. The clinician 
again assessed her rheumatic condition as active.
Table- VI al61
CHOREA
.."i..... !.;
1.....
- PLASMA ’Wintrobe ! TotalH oName S INo.‘ Date iPCV. s vise. E.S. R. Plas.
' u r O
i t :0rd. j Cor ' Prot. : J? X
j i i cs. jmn/ 1 hr 1|
A.G. !m ; 1 I 20: 5 40*9 1*744 ; 5 I 0 6 *62
i!
I 0
P.W. |F | 2 j 24: 6i 39*61 1*850 ; 14 ;11 7*42 : 0
E.O. |m
f
! 3 j 22:12 C
O • 00 ! 1*849 ; 9 ! 5 ) 7*13
i
! 0
D. V. |f ! 4 | 23: 2 43* ; 1*888  ^13 14 6 *88 ; 0
j ; 12: 4 42* 1*754 ' 6 6 6*62 : -] i 5: 5 ; 42 *2; 1*815 6 : 6 ; 6*91 i 0
I ! 17: 5 '41*9 1*779 7 7 ! 6*77 1! 0
t : 28: 5141*4 1*754 4 3 !■ 6 *41 I 0
I : 4: 6 i40*5 1*745 7 5 | 6*84 0
\ I 12: 6 40*2 1*789 5 4 I 6 *44 0
; 5: 7 1 - 1*767 - - ! 6*70
i
-
R.D. |m 5 1 4: 4i41* 1*934 17 10 1 7*67 0
| 21: 4 40* 1*934 17 9 7*24 0
j 5: 5 40*7 1*905 i 12 5 : 7*16 0
! 17: 5 *38 *4 1*757 13 4 ! 6*48 0
! 28: 5 138 * 1*796 : 9 0 ! 6*62 0
j ! 23: 6 i38 * 1*829 7 0 ; 6*98 0
M.F. F 6 -■ 21: 4 !42* 1*941 J 17 17 ; 7*34 0
, ! 30: 4 :43- : 2*003 15 16 ; 7*49 0
 ^28: 5 42*  ^ 1*960 ! 14 14 ; 7*49 0
• 1 13: 6 41* ; 1*948 ; 1 6 15 | 7*16 0
J.P. ]F 7 ! 16: 5 38* | 1*857 ; 15 11 I 7*49 0
A.B. ;F 8 30: 6 45* 1*943 : 9 13 ! 7*20 2+
j 28: 8j38* 1*837 I 16 11 j 6*84 -
R.D. 1M 9 19:10 j 40 * 1*764 | 8 ! 2 I 7*20 -
R.N. jM 10 16:11j 43 * 1 2: j 0 j 6*48 -
M. A. F
\
11 19: 1|41*9 1*729 : 1 1 I 6*66i ! 0
R. 0. j M 12 19: 3!37 *8I 1*793 11 3 J 6 *80 0
D.J. F|15 17:12 144 *6 1*827 12 15 7*27 ] 0
! 31:12 39* 1*758 15 12 i > -
i i| , 
S
7: 1 42*0 1*833 13 13 7*02 j
i
Remarks
with carditis.
hemi-chorea
cardiac murmur 
also joint pains
a!62
Case No. 19 Chorea.
This child was aged 13 years when she was admitted to 
hospital on 17:1:48. She gave a history of involuntary movements 
and of dropping articles for about three weeks.
In 1941 she had had sin attack of chorea for which she 
recieved treatment in the Childrens' Hospital for seven weeks.
She had not suffered from rheumatic fever or sore throats.
On examination, she was a bright intelligent child. Her 
hands kept moving over each other or plucking at the bed-clothes; 
her face kept frowning, grimacing and making other involuntary 
expressionsi her legs made persistent gentle movements below the 
bed clothes. She was apyrexial. No abnormality could be detected 
in any other system.
Her treatment consisted of luminal and calcium aspirin.
Two days later her laboratory tests were apparently normal.
PCV.
PLASMA
Wintrobe
ESR.
Plasma [ 
Total Gold
Ploc.
Date
v i s e . Ord.Cor. Protein, j
% cs. W B i/ 1 hr. &•% T
41*9 1*729 1 1 6*66 0 19:1:48
Case No. 20 Chorea and Carditis.
The illness began in this girl of 14 years as a tv/itching 
of the arms and repeated purposeless movements. These had 
increased in intensity when grimacing, frowning and jerking of 
the head began. A week later she was unsteady on her feet and 
unable to walk straight; her speech was slurred. No improvement 
resulted from 2 weeks rest in bed at home and she was admitted to 
hospital at the end of the fourth week of her illness.
She had had no previous illness; there was no family history 
of rheumatic fever.
On admission, she was extremely restless and jumpy. All her 
limbs and shoulders moved in continual purposeless actions; 
she grimaced and frowned continually. Abnormalities were detected 
only in the cardiovascular and nervous systems.
There was tachycardia; the heart size appeared within normal 
limits; there was a systolic murmur at the apex and along the left 
side of the sternum.
The outstretched hands attained a slight choreiform posture. 
She had an "ant-eater" tongue movement. The tone of the arm muscle 
was low, with a general diminution of power in the arms and legs,; 
the grip could not be sustained. The speech vra.s slightly slurred.
Her treatment consisted of sedation with phenobarbitone.
Improvement in her choreiform movements resulted and the pulse
Date PCV.
PLASMA
v i s e .
Wintrobe
ESR.
Plasma
Total Gold
— — ... Ord.Cor-. Protein. Floe.
% cs. mm/ 1 hr
50: 6:51 45* 1*943 9 13 7*20' ++
28: 8:51 38 * 1*837 16 11 6*84 0
was settling. The plasma viscosity of this date was increased 
and this was attributed to the stage of the disease which led to 
the carditis; note also the positive gold flocculation test which 
also favours an active rheumatic fever.
An inflammation of the tonsils and fauces on 12:7:51 was 
treated successfully with sulphonamides and penicillin. No flare- 
followed either in heart or chorea.
Later in July she could feed herself. At the middle of 
August she was allowed up slowly. Another sore throat interrupted 
the illness so that the tonsils were removed in September.
The laboratory tests at the end of August supported the 
clinicians in their assessment that the disease processes had 
become quiescent.
She was discharged at the end of September, free from any 
chorea but with an unchanged systolic mitral murmur and an 
accentuated second pulmonic heart sound.
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Case No. 21 Chorea, with carditis.
This girl of 13 years was admitted to hospital on 22:2:51. 
Three weeks earlier she had a laryngitis and head cold; one week 
prior to admission she began to fidget and to have involuntary 
movements, which rapidly became more energetic. When she was seen 
in hospital these involuntary movements frequently threatened to 
throw her out of bed and I had to have the assistance of three 
nurses to restrain her movements so that her arm remained suffic­
iently steady to obtain a blood sample.
In February 194-6 she had an attack of fidgets and grimacing 
which cleared only after six months treatment by sedation; a 
similar attack began in February 1947, lasting four months, and 
another in July 1950, lasting three months. During these attacks 
she did not feel ill and she was never confined to bed; between 
the attacks she also felt very well. She had never suffered from 
rheumatic fever. Her family history was free from rheumatic fever 
and nervous diseases.
On admission, she was very restless, with continuous purposeless 
movements of the face, arms and legs. She was very noisy and 
extremely dysarthric. The tone of the muscles on both sides was 
reduced, the right being the more flaccid. The power was reduced 
in all limbs; she could not sustain her arms outstretched; there 
was hyperextension of the fingers, and flexion of the wrists; her 
grip waxed and waned. The tongue movements were typically of the
PLASMA
v i s e .
2:51143
5:51
6:51
7:51
Wintrobe 
ESR.
Ord.[Cor. 
ram/ 1
Plasma 
j Total 
Protein
Gold
Ploc.
6*88 o
6*62 -
6*91 O
! 6*77 o !
i 6*41 ° 1
; 6 *84 o
| 6 *44 o j
| 6*70 i
i 6 -77 -
"ant-eater'* type. The throat was slightly inflamed. Some scattered 
rhonchi were detected in both lungs. She was afebrile.
The heart apex beat was in the 5th interspace, just outside 
the nipple line. The rhythm was regular. The first sound was soft, 
but no murmurs were noted. The blood pressure equalled 116/70 ram. 
mercury.
Her treatment consisted in phenobarbitone in doses of 1*5 
grains 6-hour ly, 20 grains of "disprin" 6-hourly, and rest in bed.
She made rapid progress so that there were no further choreic 
movements after the beginning of March.
On 2:4:51 she complained of pain in the shoulder and calf; on 
re-examination a blowing systolic murmur was then present at the 
apex. Sodium salicylate therapy was therefore begun, but the amount 
actually administered was doubtful as on 12:4:51 I could detect no 
salicylate in the blood and her medicine was proved to be lacking
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any salicylate; however, her pains had disappeared by date but 
a few choreic movements had returned.
A further attack of sore throat and tonsillitis, with pyrexia, 
began on 23:4:51 and this may have been responsible for the rise 
in the third plasma viscosity value although the viscosity had 
shown no increase in response to the joint pain: treatment
consisted of sulphamezathine. By 25:4:51 she was again afebrile. 
The phenobarbitone dosage was reduced and she again became more 
jumpy and her out-stretched hands attained a choreiform posture.
On 5:5:51 she was still afebrile, her choreiform movements 
had almost ceased, and no changes could be detected in the heart 
signs. The barbiturate was stopped on 21:5:51.
She began to get up on 24:5:51. There was now a coarse, 
diffuse systolic murmur at the heart apex.
She had another bout of pyrexia and joint pain on 2:6:51 
but this passed in two days without causing any change in the 
laboratory tests. Thereafter her progress was uneventful and 
she was discharged on 16:7:51.
Her last test was made when she reported to the out-patient 
department after six months during which she had remained well.
ERYTHEMA. NODOSUM.
In addition to the results of the Plasma Viscosity and E.S.R. tests, 
the difference in the G-old Flocculation results should he noted; a 
positive result is found in a'Rheumatic' primary stimulus, and a 
negative result in a 'Tuberculous* primary stimulus.
Name s No. Date PCV.
PLASMA
v i s e .
jWintrobe 
! E. S. R.
'Total 
1 Plas. G-oldFloe
"
Remarks.
|0rd. ! Cor.j Prot.
cs. jmm/ 1 hr %
M.H. F 1 11: 2 30*3 2*226 ; - ! —I ! 7*53 o + phthisis
J.S. F 2 8: 4 38*4 1*916 14> 1 10 7*34 o + phthisis
W.L. F 3 13: 7 43*7 1*952 ' 4 6 7*63 o Mantoux positive
A. P. F 4 31: 3 40*9 2*104 23 21 ; 7* 70 0 ? primary stimulus
L.S. F 5 19: 3 43*2 1*891 : 8 9 7*34 O test done after
E. Gv F 6 18: 4 39*1 1*858 : 14 11 7*02 skin cleared.
M.B. F 7 13: 2 42* 2*165 32 32 8*06 0 ? primary stimulus
M.W. F 8 11: 1 141 * 2*524 1 5 4 8*64 4+ follows tonsillitis
30: 1 43*7 2*310 : 4 6 8*82 3+
30: 3 41*5 1*856 4 4 7* 38 2+
R.P. M 9 17: 4 30* 2*233 : 60 27 7*38 o tuberculous stim.
17: 5 35 *4 1*748 : 10 3 6*44 0
A.E. F 10 2: 5:40* 2*577 ; 27 24 8*57 + follows sore throat
23: 5 39* 1*928 26 22 7*02 o
6: 6 40* 2*001 17 15 7*78 0
27: 6 39* 2*053 | 34 29 7*49 o
18: 7 42* 1*962 j 30 30 7*27 o
19: 9 44* 1*812 8 10 6*77 o
V.J. F 11 15: 6 42* 2*183 36 36 7*45 0 ? primary stimulus
M.C. F 12 21:11 39*8 2*758 40 36 8*35 - after sore throat
A.D. M 15 10:12 36*3 2*099 48 28 7*60 o ? primary stimulus
Case No. 22 Erythema nodosum.
This patient, M..W. , developed erythema nodosum following 
tonsillitis and quinsy - probably streptococcal,but this was not 
proved by bacteriological investigation. The points to be noted 
in the laboratory findings are (l) the positive gold flocculation 
tests, (2) the high plasma viscosity values which had not returned 
to normal by the time the patient felt quite well, and (3) the 
low ESR values.
This lady was aged 31 years. There was no evidence of 
pulmonary tuberculosis. On 22:12:50 she had a moderate attack of 
tonsillitis which had apparently cleared by the 24th with oral 
penicillin; she went on a short holiday over Christmas as she 
felt perfectly well; on the 27th, however, she complained again 
of her throat and a quinsy was found. Intramuscular penicillin was 
administered over the next five days during which the quinsy 
resolved.
A typical erythema nodosum rash appeared on both legs on 
3:1:51 and it lasted about 5 days. As she was apparently anaemic 
her doctor kept her in bed for a further fortnight when she got 
up to look after her home. The patient herself felt quite well 
while the rash was present and afterwards; she was carrying out 
her normal domestic duties at the end of January with a plasma 
viscosity still raised to 2*310 cs.
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8 *64 | ++++ 
8*82 | +++
7 *38 ++
t ’wintrobe] Total j
"ISO ; SSR. Plasma |
tord.jCor. | Prot. j
cs. \ma/ 1 hr g. % j
This initial high plasma viscosity value of 2*524 cs. was much 
higher than would have been expected from the patient's own 
expressed opinion concerning the degree of her general upset and 
from the severity of the local lesions in the throat. It lends 
support to the hypothesis that the erythema nodosum is part of a 
excessively great reaction to a primary stimulus. This hypothesis 
would also explain why the viscosity remained high long after the 
primary stimulus had ceased. The degree of the reaction is also 
shown by an abnormal gold flocculation test persisting for three 
months after the skin lesion had cleared.
Table - VIII ai'/i 
OSTEO-ARTHRITIS.
Name No. PCV.
PLASM
vise.
Winti
E.S
robe Total
Plas.
Prot.
Gold
FloeOrd. Cor.
% cs. mm/ 1 hr.
(A) Females.
G.W. 1 47.7 1*867 - - —
R.T. 2 42 *0 2*071 - - -
44*4 1*979 - - 6*66 -
M. M. 3 46*8 2*003 - - - -
E.K. 4 47*4 1*890 - - 7*20 -
E.L. 5 42-2 1*984 - - 7*41 -
I. S. 6 47.7 1*965 5 11 7*52 -
1/i. S. 7 41-4 2*056 24 23 7*78 -
P. S. 8 42-2 1*980 17 17 7*81 -
A. P. 9 43*6 1*922 - - 7*02 -
K.M . 10 37*9 1*871 10 5 7*45 -
C.S. 11 43*8 1*753 3 5 6*66 -
48*0 1*755 1 7 - -
I.M. 12 43-1 1*779 5 6 6*88 -
E.T. 13 41*1 1*928 13 12 6*88 -
M. A. 14 42*9 1*867 5 6 7*60 0
V. M. 15 45-6 2*011 2 5 7*67 +
M. J. 16 39*3 2*049 42 37 7*06 0
40-6 2*041 - - 7*13 0
D.B. 17 - 1*688 13 6*37 0
E.H. 18 33*7 2*012 55 37 7*52 2+
M.T. 19 43*8 1*862 8 9 7*06 0
A. G. 20 41*4 1*767 9 9 7*16 0
D.W. 21 39*2 1*704 20 16 - -
I. P. 22 37-6 2*224 45 37 8*17 -
E.S. 23 39*2 1*853 5 3 7*31 0
E.B. 24 43*1 1*844 8 10 7*27 0
G. L.!25 40*0 1*866 10 8 7*49 0
(B) Males.
A. S. 1 48*0 1*781 - - - -
T.R. 2 - 1*931 3 - - -
H.P. 3 46.6 1*889 8 8 7*45 -
J.M. 4 43-4 1*938 20 16 7*02 0
39*3 2*001 _ - 6*95 0
W.C. 5 48*6 1*908 9 11 7*31 0
E.D. 6 50* 1*923 - - -
T.D. 7 39*3 1*672 6 0 6*30 0
Remarks
3/2/47
28/2/47
4/7/47
6/1/47
13/2/48
20/5/48
10/2/48
14/4/48
Case No. 23 Chronic hypertrophic osteo-arthritis.
This patient had injured his elbow at work several years 
before he attended the rheumatism clinic, complaining of pain in 
his right elbow and limitation of all its movements.
There was marked periarticular thickening of the joint, and 
some crepitus. All movements were limited, especially pronation 
and supination. Skiagrams of the joint showed the changes of 
an advanced stage of chronic hypertrophic osteo-arthritis. No 
other abnormality was detected by a general examination.
His laboratory results were:-
Plasma viscosity = 1*889 cs.
I
Blood haematocrit = 46*6 jo
Corrected Wintrobe ESR. = 8 mm. in 1st. hour
Total Plasma Protein = 7*45 g./lOO ml.
Case No. 24 Chronic Hpypertrophic Osteo-arthritis.
This female patient, aged 50 years, had had no illnesses 
in her life and would not admit to any injury. She complained 
of pain and stiffness in both knees, of 6 weeks duration.
On examination, there was marked periarticular thickening of 
both knees, with considerable quadriceps wasting. There was no 
increased local heat and no synovitis. Her fingers showed 
Heberden's nodes. Skiagrams of the knees showed the appearances 
typical of chronic hypertrophic osteo-arthritis.
No other abnormality could be detected.
Her laboratory results were:-
Plasma viscosity = 1*871 cs.
Blood haematocrit = 37*9 %
Wintrobe ESR. = 10 mm. in 1st hour
Corrected Wintrobe ESR. = 5 n *’ 1 "
Total plasma protein = 7*45 g./lQO ml.
Case No. 25 Osteo-arthritis (with high blood pressure)
This man, aged 64 years, had complained of pains in his back 
for 3 years and this pain had been slowly increasing; for 1 year 
he had pains in his legs , present only after walking. His right 
shoulder and wrist were stiff.
On examination, apart from the locomotor system, the only 
abnormality detected was a blood pressure of 160/100. The left 
hip appeared to be stiff; the right shoulder and wrist were stiff 
and swollen; there was marked kyphosis of the spine; the hands 
were normal.
Skiagrams:- Osteo-arthritic changes were present in both wrists. 
There was gross abnormality of the head of the left femur either 
due to old injury or Perthes* disease. There were gross arthritic
changes in the lumbar and dorsal spine.
r
PCV.
%
45-8
PLASMA. Plasma protein  ' Gold
ViSC. 0^r^ -;r-  Total’Alb. 'Glob Fibr Floe.
Serum
Alkaline
Phosphatase
cs. |mn/ 1 hr g./lOO ml. \ un. /l00 ml
I ' • ’
2*052 7*5 S 6 i 6*1 3*5 2*21 0*39. o 7*5! i » ( ;
This case is an example of the association of an increased 
plasma viscosity value with osteo-arthritis plus hypertension.
The hypertension appears to be the factor determining this rise as 
similar plasma viscosity results were seen in other subjects in 
whom the hypertension was the only pathology.
Table - IX a!75
FIBROSITIS and MYOSITIS.
Name T„:j PCV.
PLASMA
vise.
Wintrobe 
E.S. R.
Total
Plas.
Prot.
Gold
FloeOrd.ICor.
% cs. im/ ] hr. °/°
(A) Females.
S. P. 1 37*8 1*701 6 1 6*44 0
G. J. 2 38*7 1*717 6 3 6*59 0
M.P. 3 44 *3 1*723 3 5 - -
J.M. 4 42*8 1*730 2 3 6*91 -
c.s. 5 47-8 1*755 - - - -
M.H. 6 46 *5 1*772 1 5 6*55 0
L.C. 7 44*4 1*825 5 7 6*98 0
P.M. 8 38 *5 1*840 14 10 6*77 0
S. S. 9 45’2 1*843 4 7 7*10 -
S.M. 10 41*9 1*875 9 9 7*24 0
S. P. 11 37 *8 1*895 18 13 6*77 +
P. H. 12 - 1*897 - - 7*24 0
L*S. 13 42 *2 1*904 12 12 7*52 0
V.T. 14 39 *9 1*925 11 9 7*45 -
M.R. 15 45‘6 1*965 12 16 - -
M.W. 16 48-8 1*974 1 7 7*50 -
C.S. 17 40*9 2*139 24 22 8*28 +
(B) Males.
R.M. 1 47-4 1*796 ; 3 3 6*44 0
A.W. ’ 2 47*6 1*827 1 1 6*95
0
W.D. 3 43-1 1*828 18 14 7*06 -
J.D. 4 47*8 1*839 1 2 7*49 0
J. H. 5 45 *2 1*849 - 7*31 0
W.H. 6 52-7 1*853 1 7 7*34 -
G-. P. 7 44-4 1*864 8 5 7*20 -
R.M. 1 8 43’3 1*871 13 9 7*31 -
R.B. 9 43*3 1*898 10 6 7*56
0
R.C. ! 10 49*5 1*899 2 5 7*67 0
W.B. 11 48-3 1*953 - - 7*07 -
P. W. 12 48*3 1*965 9 11 7*70 -
G. A. | 13 46*2 1*996 8 7 7*49 0
J. T. 1 14 42*6 2*000 35 28 7*24 0
R. C. 15 45*4 2*163 21 19 7*88 0
a!76
Case No. 26 Non-articular Rheumatism - Acute Fibrositis.
At the age of 17 years this male patient had had a mild 
attack of acute rheumatic fever and four years later he had a 
severe recurrence which incapacitated him for two years. Since 
then he had suffered from fibrositis of the neck and shoulders 
of varying intensity. The subcutaneous tissue over these areas 
was indurated. Deeper, in the muscles, there were exquisitely 
tender nodules, especially along the insertion of the neck muscles 
into the skull.
Three days before the blood test he had an acute exacerbation 
of the fibrositis which caused the head to be held rigidly on the 
spine and any rotatory movement had to be confined to levels 
below the shoulders. Fortunately there were earlier and later 
blood tests for comparison, and it is obvious that the acute 
fibrositis has not caused a significant alteration in his plasma 
viscosity result.
-- »■
Date j PCV. PLASMAv i s e .
Total
Plasma
Prot.
% cs.
(j/g-/°
21: 6:48 46 *3 1*878 7*45
17: 7:48' 45*1 1*849 7*31 3 days after acute fibrositis 
begun.
12: 8:48 j 44*4 1*852 7138
Case No. 27 Acute Fibrositis.
One of my male laboratory technicians had suffered from 
severe fibrositis of the right neck and shoulder for 3 days when 
his plasma viscosity was estimated on 22:5:51. He had never 
suffered from this condition before.
Not only was the plasma viscosity value within the normal 
range but it was actually less than the results of two previous 
tests when he was in apparently good health and acted as a 
control subject for my series of normals.
Date PCV. PLASMvise.
Wintrobe
ESR.
Total
Plasma
Protein
Gold
Ploc.0rd.|Cor.
fo cs.
1
mm/ 1 hr g.%
26: 9:50 49 *2 1*880 1 3 7*74 0
24: 2:51 - 1*860 - - 7*67 -
22: 5:51 47‘8 1*839 1 1 7*49 o
Table - X &178
ANKYLOSING- SPONDYLITIS.
Name f No. iPCY.
I % 
(a) Male
PLASMA
v i s e .
cs.
Wintrobe I 
E.S. R.
Ord.|Cor.
mm/ 1 hr| g. %
Total 
Plasma! 
Prot.
F. B. 1 51*8 2*246 1 3 7 8*0 o
R.H. 2 33-9 2*164 ! 10 0 7*34 +++
W.G. 3 45*7 2*225 28 26 8*21 +
J. A. ’ 4 43-6 2*106 7*92 +
W.W. 5 40-3 1*990
:
- 6*84 -
P.T. 6 43-0 1*811 10 6 6*62 0
g.p. : 7 4-5*1 1*896 10 8 7*20 0
C.P. | 8 39* 2*204 45 31 7*60 -
c.h. ; 9 45*7 1*953 17 16 7*13 -
A.W. ! 10 45*3 2*610 3 2 8*64 0
J.B. : 11 39*5 2*115 36 23 7*81 0
g.s. j 12 44* 1*983 12 9 j 7*67 o
j.h. ; 13 “ j 2*175 3
1— , 8*28 0
I.T. I 14 46 *3j 1*942 5 4 7*38 0
T.C. 15 45*1 2*034 23 j20 j 7*49 -
F.D. ! 16 - 2*543 8*70 -
W.B. 17 34* 2*512 54 30 8*86 -
G.W. j 18 34*3 2*163 55 31 7*42 -
s 34* 1*910 54 ! 30 6*29 -
36* | 1*857 42 23 7*3 -
(b) Female
G-old
Floe
M.C. 19 42* 2*345 36 36 7*85 0
M.B. 20 30* 2*357 59 33 7*52 o
K.E. 21 42* 1*851 4 4 7*13 0
T.H. 22 37*9 1*857 6 2 7*16 0
M. H. 23 - 2*052 20 7*99 0
M.B. 24- 36* 2*092 31 21 7*52 -
E.L 25 17*5 1*754 77 21 5*83 0
O.W. 26 - 1*922 27 - 7*67 0
--  i _ __ ___ __ _ -- —
Remarks
Early case 
Early case
7 yr. history 
4 yr. history
7 yr. ; no treatment
8 yr. ; X-ray 3 yr. ago 
1 yr.; bamboo spine.
10: 9
19:9 On A.C.T.H. 
17:10 " "
?? very early case 
very early case
Case No. 28 Ankylosing Spondylitis ( with A.C.T.H. .therapy-)
This male patient was aged 21 years. He had had no previous 
illness and his family history was free from rheumatic disease.
He had an attack of ankylosing spondylitis of very rapid onset. 
It began three years before he came under the present observation. 
An ache and swelling in the lumbar region rapidly increased to an 
intensity which made work inpossible; within 6 months his hips 
were stiffened and he was unable to walk. Deep X-ray treatment 
to the back and hips caused the pain to disappear and the joint 
stiffness to lessen. In March 1951, he began to conplain of pain 
in the hips; this pain was only occasionally present at first 
but by June it was invariably produced by any movement; pains 
shooting down the thighs were frequently troublesome when he was 
dropping off to sleep. Finally he was unable to move his legs 
and thus became confined to bed.
He was admitted to hospital on 21:6:51 to receive another 
course of deep X-ray therapy. On examination, he was a pale 
young man who lay rigidly in bed. His lumbar and dorsal spines 
were fixed, rigidly, but the cervical spine moved freely. Both hips 
were almost fixed, no movement being greater than 10°; the left 
knee could flex through 22° and the right through 15°. Skiagrams 
showed an obliteration of the sacro-iliac joints; the hips had 
rarefaction of the bones, with diminution of the joint spa.ce,
Date PCV.
PLASMA
vise.
%
10: 9:5lj 34*3 
19: '9:51 34* 
17:10:51 36*
Wintrobe
SSR. | Plasma protein 
0rdT|Cor. T ot aljArbt] Glob I Fibr~
cs. mm/ 1 hr g«/100' ml.
2*163 55 31 7*42 —
1*910 54 31 7*29 3*5 2*40
1*857 42 23 7*3 4*4 2*5
0*39
0*4
Serum
Urea
rag. /o
24
18
the lumbar and dorsal spines showed changes in the hones, the 
intervertebral joints and the costo-vertebral joints, hut no 
bambooing. The muscles of the legs and hips showed gross wasting.
The deep X-ray treatment was given from 25:6:51 to 15:8:51.
There was no significant change and the patient remained confined 
to bed.
A.C.T.H. treatment was begun on 12:9:51. The drug was given 
in doses of 20 mg. per day in the form of a slow drip which took 
about 12-17 hours to introduce the pint of liquid intravenously.
In this manner a total of 640 mg. only had been given by 29:10:51.
( 7 x 20 ng. to 18:9:51, when dose was halved; 10 x 10 mg. to 
30:9:51 ; 15 x 20 ng. to 17:10:51 ; 10 x 10 mg. to 29:10:51 )
The course was completed by 27 intramuscular injections of 10 ng. 
to 27:11:51 .
The response to this treatment was slow but this might have 
been expected from the severity of the joint fixation and the 
poor muscular condition. Within a week it was noted that he was 
moving about in his bed, markedly freed from pain. The plasma 
viscosity had fallen significantly in nine days, to within the
a!81
normal range, while the ESR persisted unchanged. Increased flexion 
of the dorsal spine was present by 2:10:51. He took his first 
assisted steps on 5:10:51 and walked unaided on 10:10:51.
Further improvement followed when the ground gained was consolidated 
by physiotherapy. When he went home on 12:12:51, he was walking 
with the aid of sticks; he was completely independent for the toilet, 
shaving, etc. He was far from cured,however. The adjective "slow"
applied to this progress was used only when comparison was made 
with the dramatic response of the cases of rheumatoid arthritis.
Case Wo. 29 Ankylosing Spondylitis.
This young man had a rotation strain of his right knee, 
with considerable effusion in 1939; a right external meniscectomy 
was performed six months later. He then required treatment for an 
effusion of the left knee. The hips, shoulders, and later the 
spine*became stiff; the spine had been stiff for 3 to 4 years at 
the time when the plasma viscosity was measured.
On examination, on 3:4:47 the locomotor system alone was 
found to be abnormal. The knees showed a flexion deformity of 
20°, which he could straighten on standing; there was gross 
wasting of the thigh muscles and gross effusion of both knees.
The ankle movements were normal. Both hips had a 50% loss of 
flexion, no external rotation, and 20° internal rotation. The 
left elbow and shoulder movements were considerably restricted; 
the right joints were less affected. The spine had some loss of 
the lumbar curve and a slight prominence of the thoracic curve; 
it was rigid up to the second dorsal vertebra.
Skiagrams showed an ankylosing spondylitis of the sacro-iliac 
joints plus a general decalcification of the spine; there was 
decreased joint space in the hips and knees.
Treatment had consisted recently of injections of lactic acid 
to the hips and knees, but with no obvious benefit.
^^DatTTpCV.
PLASM
vise.
Wintrobe
ESR.
Plasma
Total
Protein
g.%
10*12
Gold
Floe.Ord. Cor.
1: 9:47
rl 1
o
1 
^
!
cs.
3*021
mm/l hr 
47 | 35 ++
This viscosity value was unusually high for this disease, 
yhe differential diagnosis from rheumatoid arthritis was assisted 
by the relative low gold flocculation result] in rheumatoid 
arthritis a plasma viscosity of this extreme height would almost 
certainly he associated with a 4+ or 5+ result.
Name] S
■ja
No. Date PCV. [PLASMAj vise.
Wintrohe 
E. S. R.
Total
Plas. Remarks
Ord.1 Cor. Prot. JJ'JLOC
j
i
Si % 1 CS* mm/ 1 hr %
M.W. |F 1 I 7 7 41*0 2*392 49 47 8*22 _i
| 11 7 ! 42 *4 2*469 - - 8*39 _1 28 7|41*8 2*302 31 31 7*60 -
| 1 9 ; 40 *4 2*186 49 46 7*56 _
1 l 6 10 i 38 *8 2*443 48 41 8*38 oj fi 10 11 40-0 2*356 43 39 8*10 +
1 i 7 4 >40 *8! 2*485 47 45 8*10 o Uric acid=3*6 mgfoI | 28 1141*1 2*286! 47 45 8*14 0
A. L. j F 1 2 | 12 3 47*5 2*096 9 15 7*8 -
J.P. \ M
!
3 i 27 3 |43*4 2*058 - - 7*64 -
A.F. j F A.* j 2 7 43*8 1*903 5 7 7*88 -
E. J. jF 5 ! 9 7142 *2 1*898 - - 6*98 -
J.K. ; M 6 | 17 ■Nl 00 • 00 1*775 - 7*13 - Uric acid =3*6 mg.
P.O. F 7 1 8 !43 *7I 1*965 - 7*49 -
M.C. F 8 ! 15 10|40*3 2*137 - - 7*67 0 Uric acid =4*4 mg.
R.O. M 9 11 12 j 45 *1■! 2*122 36 33 7*45 0
B.S. F 10 15 12j43*3 2*164 21 23 8*06 0 Uric acid =3*8 mg.
E.R. F 11 20 12 45*1 2*159 25 29 7*88 +
J.W. F 12 115 4 40 *4 2*325 - - 8*06 0 Uric acid = 7*3 mg.
22 4 36*9 2*092 - - 7*34 0
E.R. M 13 16 4 - 1*929 10 - 7*34 - Uric acid =5*6 mg.
A.D. M 14 1 7 45*2 1*936 15 13 6*62 5+ Uric acid =6*4 mg.
A. P. F 15 14 3 42*0 2*147 - - - - Uric acid =2*8 mg.
M.A. F 16 2*245 7*60 2+ Uric acid = 7*8 mg.
Table - XII i.185
EPITUBERCULOSIS ; PRIMARY TUBERCULOUS COMPLEX.
Name No S Date PCV.
PLASM
vise.
Wintrobe
ESR.
Plasma
Total
Protein
Go!
Fl<Ord,Cor,
% cs. mm/ 1 hr g-%
R.L. 1 M 19: 3 38-5 2*150 30 18 7* 96 +
17: 5 38*6 2*066 25 14 7*74 o
13: 6 38' 2*094 21 10 7'69 o
30: 6 41' 2*122 20 13 7*96 +
13: 7 38 *7 1-955 24 13 7'56 o
27: 8 37-0 1*897 34 •m mA - -
26: 9 37 *0 1*796 14 3 6*73 -
28:11 40* 1*791 11 5 6'70 -
R. Gr, 2 M 25: 4 35' 2*073 48 26 6 *62 o
5: 5 34*4 2*133 49 26 7*27 o
21: 5 40* 2*214 25 16 8*21 +
4: 6 38* 2'737 21 10 7*67 +
18: 6 SO­ 2*035 31 18 7* 67 +
9: 7 SO' 1*966 16 7 7*27 +
J.W. 3 F 14: 6 39- 2*432 23 19 7*85 -
28: 6 39' 1'972 15 12 7*63 0
26: 7 42' 1'963 13 13 7*78 0
D.D. 4 M 12: 7 42*0 1*912 7 3 7*49 -
B. H. 5 M 21: 8 - 2*119 - - 7*74 -
26: 9 42*2 2*081 15 10 7*49 -
P.O. 6 M 6: 9 40*0 1*919 41 29 7*13 -
11:10 35*0 1*689 6 0 6*41 —
L.S. 7 F 26: 9 39*2 2'011 15 11 7*52 -
16:10 39 • 1*884 15 11 6*95 -
31:10 40' 2*025 9 7 7*67 -
28:11 40' 1*915 15 13 7 *27 —
B. P. 8 M 13:10 38' 1*887 8 G 6*98 -
4:12 40'0 1*867 8 2 7*31
N.D. 9 M 5:11 38' 1*678 5 0 6*08 -
T.F. 10 M 7:11 39' 1*963 15 6 7*52 -
T.D. 11 Mi 29:10 38'0 1*888 23 12 7'13 -3
1 22:11 37'0 1*828 19 7 6*80 —
C.T. 12 f | 4:12 36*1 1 * 94-0 22 14 7*49 ~
R, B. 13
1
Fj 4:12 41*0 2'016 21 20 7'38 -
E.L. 14 F 7: 1 44'
2'120 30 34 7*81 -
J. G. 15 F 6:11 37*6 2'097 35 27 7-31 -
4:12 37 *4 1-893 20 15 7'38
Table - XII a 186
PULMONARY TUBERCULOSIS
Name No
H.A 1 |M
i
j
I
| I
J.B. 2 |m
f ;
A C.; 3 M
R.C. j 4 M
W . E .  | 5  M
\
A E . I  6  Ip
AC. j 7 P 
J. C. j 8 P 
F.H.I 9 M 
J. L.! 10 M
P. C.V.
DatejCit.
-L
P
P+A.
|18;11 
| 6: 5 
[25: 7 
j 4 1 8 
|17: 8
I 9:11  
| 4: 8
! 3: 7 
111: 7 
18: 7 
21:12
130*0 
29*5
13: 9 
23: 9 
12:10 
4:11 
5: 1 
1: 2 
27: 3 
27: 3 
17: 4 
19: 5 
4: 7 
14: 8
31 
i 29 
128 
28 
29 
29 
129 
126
125 
25
126 
124
*0 |39 
•2 139 
'7 138 
‘0 |35 
*2 I 
*0 ! ■ 
*0 \ ■ 
‘9 I ■ 
•2 
*7 
>3 
>8
33*7 
135 *0 
135*6
L. J. lllMj 23:12;32*4 \ - j
<12: 134*2 | - j
124: 7 ^ 31*3 141*2 !
M.R.! 12
39*0 
39*7 
129*9 |40*5 
|28*2! -
*30*41 -
,35*3 45*5 
34*6 - j
29*0 40*0! 
;30*0140*0! 
33*0; - \
20*0 - I
I 2:12 37*0; - \
| 4: 7 40*0 152*0|
;29:12 29*0! - |
j31:12;28*6! -  j
5: 8 32*01 - I
I 9: 8 130*0j - j
! 5: 8;31*s| - I
: 5: 8 129*6 j - |
; 8: 8 132*4 | - I
F
J
4:12126*0 
31: 1]25*7 
22: 2 23*8 
11: 8 27*5
34*3
PLASMA VISC. Max.
Total
Prot.
--- --?
Cor.
Citr.
P+A
Oxal.
Cit.
ESR.
Remarks
cs. *€*77set 
* to1*
%
1*663 2*063 2*9 7*21 p
1*738 2*297 6*9 6*71 s
1*866 2*476 7*8 7*18 s
1*681 - 14*3 6 *34 s
1*744 2*236 9*7 7*59 p| died 19/5/45
1*707 2*279! 6*4 8*54 p
;
1*788 - 12*2 7* 03 s
1*743 2*324 9*2 5*58 s pleurisy
1*806 2*508 14*1 7*19 p
1*733 2*287! 5*717*24 pi
1*553 1*868 0*9 5*30 p (^Sfgd 23/12)
1*692 - 3*8 8*22 p Chronic case, who
1*642 2*159 1*5 7*84 s\ worked on farm.
1*748 2*340 9*6 8*23 p
1*742 - 9*817*32 s
1*836 2*500 6 *9 |8 *10 p
1*770 2*362’16 *7 18 * 16 p
1*708 - 7*4 7*46 s Chronic disease 
Sin two sisters,
1*714 — 10*0 7*44 s S ambulant.
1*767 2*371 10*4 7*18 p
1*702 2*118 Il7*5 - pleural effusion
1*783 2*568 15*0 6*44 p 2 pts* aspir.
1*784 2*383 21*1 7*03 p 1 pt. aspirated.
1*759 2*390 22*3 6*82 p 1 pt. aspirated
1*870 - 33*3 7*64 p
1*886 2*631 33*7 7*54 p
1*943 2*723 141*4 7*94 p •
1*920 2*669 33*3 -
1*843 2*502 j37*5 6*62 s
1*837 2*472 27*2 6*83 s
1*908 2*715 ;28*9 7*36 s fluid still
1*816 2*416 |23*8 7*04 p present in pleura
1*875 2*639 119*0 8*22 p
1*690 2*193 5*3 7*92 p
1*563 j1*893 1*9 6*99 p
1*663 | 2*085 25*0 6*44 p
1*720 2*260 13*0 6*90 p
1*738 2*269 9*2 7*11 p
1*715 2*292 9*3 7*44 p
— . - ..------ *-*— - ----- -- -.. -
Table - XII continued al37
rName
J. H.
No
13 M
D.W. 14
l“STTP. C.V.Date jCit
7 
25 
31 
3 
7 
13
M 27 
29 
3° 
31 
1 1
! 2 
1jio
ii8
! 2
112
Il8
M.S. 115 F 121
! 8 
| 125
J.P. j 16 jM 115
j ! f 28
! M  3 
I ! I 
N.R. j 17 jM! 30
110
129
! 20
W.L. 118 |M 130 
120
i 2 
112 
118
G.J. 119 jM j 13
j ! ! 16
! i I 3
I ! ! 5
22
E. S. j 20 If
A. S. j 21 M
R. K. 22 M
8
21
23
19
5
4 35
5 34 
5 33
7 33
8 32 
111 32
5 j 26 
5 \ 28 
5 1 27
5 j 27 
6 1 25
6 j 25 
7 1 25
7)25
7 26 
8126 
8 1 25
8 1 26I
2 128 
1| 24
2 j 15
9 139 
9 35
11136
!
10 j 24 
111 24 
12 j 23
1 j 22
5-23 
7 1 24
8123
8 124
8)24
3 132 
3130 
5 j 31 
7 130 
7 j 27
3 26
24
19
31
32
P+A.
PLASMA VISC.
46*7 
46 *0
44*7
36-0
38*5
Cor.
Citr.
P+A
Oxal.
>
7
9 
5
4 
0 
0
5
4 
3
6
3
5
5 j 34*0
7 j 35 *4 
4!36 • 1
5 ! - 4j -
5 i ~ I
6 ! - |
3 ! -
8 j -  !
I
0 ‘48 *5 j 
7 145 *8 j
9 j - iI [
1|33*4 I 
3|32*9 :
5! _ I
7j “ j
0 j 31*0 I
7 134*0 I} ;
8! -  j 
2! - I
4  -  i
5! - I
21 - !
8 !42 *5 j 
4141*2 j 
5 1 - !
31 - j
81 - !
eg
614
666
647
603
549
503
44*5
1*819
1*910
1*884
1*891
1*869
1*893
1*720
1*679
1*663
1*660
1*580
1*599
1*650
1*745
1*488
1*838
1*644
1*558
2*044
2*050
2*078
1*755
1*593
1*519
1*564
1*627
1*597
1*835
1*747
l*8o2
1*858
1*877
1*783
1*881
1*572
1*660
1*660
2*032
2*070
2*037
1*900
479
'765
Max.
Cit.
ESR,
3 
9 
3 
3 
3 
1
27 
44 
57 
- ,61 
“ 188
- 174 
239 j 12 
193] 8 
193 j 3
- ! 3
- I 4
- I 1
2 *105 j
2*312 |7*. 
2*0731 4 
-  j 2
3*050 142 
3*107 162 
3*144143 
2*325; 6
►930
•856
5
0
- j 0
- I 1
- 1 1  
•533 116 
*300\ 9 
*422 j 15 
*605 119
~  I21
*383! 8 
*682 120 
- ! 6
•110
•122
Total
Prot.
%
*79 s 
*11 s 
*29 s 
*87 s 
*30 p
6*14 s 
6*66 s 
5 j 6 *45 s 
116*64 s
Remarks
9 [ 6 *62 
4 ]6 *55 
515 
6 
6 
5
4
5
•93
•33
•30
•68
•90
•16
6*95 p
8 -
6 *89 s 
7*10 p 
6*97 s
8*91 p 
9*03 p 
8*67 p 
6*50 p
8]4 *99 s j 
215*51 p 1 
6 j5 *25 s | 
9 5 *62 s ‘ 
3
7*61 p 
7*42 p 
7*76 s 
7*08 s 
6*35 s
7*48 p 
6*47 p
7*28 p 
7*30 s
X-ray negative.
still working. 
X-ray abnormal. 
15 months later.
Test done 5 hrs. 
after spontan. 
pneumothorax.
decay begun
died 8/9/44
1944 
1946 Decay 
died 25/2/46
rapid decay
Rapid course in 
mongol, with 
decay, 
died 29/1/44
died 13/1/45
One lobe only 
affected
recovered later, 
died 24/3
died after 2 yrs.
Table - XII continued. al8S
Name No S Date
PCV. PLASMA VISC. Max.
Cit.
ESR.
Tota
Prot ooarks.
Cit. P+A. Cor.
Citr.
P+A
Oxal.
1 Re]
i% cs. %KfO'1*
A.N. 23 F 6 7 31*6 41*8 1*559 1*892 0*6 6*62 s not active
J.S. 24 M 15 1 35*0 - 1*810 2*469 11*8 8*41 P
17 1 32 *2 - 1*875 2*589 19*4 8*32 P
20 1 30*0 - 1*810 2*467 21*7 7*83 P
17 2 31*1 - 1*587 1*984 8*6 6*94 P
14 4 31*2 j43*9 1*590 2*040 3*1 6*80 s
25 7 32*0 - 1*608 4*4 - still active
J.S. 25 M 29 12 31*5 - 1*812 - 10*4 8*08 P
31 12 31*1 - 1*793 - 13*5 7*74 s
7 2 32 *2 |43 *3 1*859 2*624 12*2 7*77 s
1 4i 8 31*5 | - 1*827 - 25*9 7*49 s died 2 yrs. later!
E.T. 26 F 24 4 25*6 154*2 2*030 2*885 33*3 7*97 s
25 4 24*3 131*6 1*995 2*737 30*6 7*84 s
27 4 24*0 31*1 1*950 2*807 37*0 8*32 s
4 D 21*6 29*5 2*010 2*760 33*3 7*38 p
12 5 20*2 27*3 2*092 3*078 30*5 8*07 s decay Begins.
24 5 18*0 24*0 1*847 2*501 12*8 7*31 s died 5/7/44
M.U. 27 F 3 2 |27*4 1*790 2*511 18*3 7*15 p
14 2 22*4 - 1*707 2*188 32*7 6*20 p
25 2 24*7 1*787 2*357 20*0 7*18 p
( 7 8 25*7 - 1*776 2*342 8*3 6*77 p
21 8 30*6 1*720 - 5*2 6*45 s
D. W. 28 M 9 8 23*0 1*700 2*135 11*3 6*28 p
6/9/4415 8 21*0 1*715 2*220 13*0 6*35 p died
E.M. 29 |M 1 6 34*8 - 1*796 _ 11*9 7*08 s died 18 mnths.
J. H. 30 M 6
|
111327*7 38*1 1*777 2*547 14*9 8*12 p
later.
K. J. 31 F 23 i° |31*2 42*3 1*540 1*962 1*4 7*78 p Pleural effusion
R.P. 32 jM ]27 101j24*7 — 1*708 - 15*3 7.01 p
l it
C. H. 33 M 113 11!27*2 38*7 1*725 2*414 13*1
7*52 p (i i
Gr. A. 1134|Mjl7 n  j 32*7 45*7 1*750 2*549 15*2 7*48 p
it ti
D. S. 35 m | 9 12 |27*8 39*0 i 1*689 2*318 11*1 7*64 p
n it
K.S. 36 M 27 12 27*9
.
1*675 - 9*5 - ti ti
E. I. 37 F 30 1 30*7
- 1*685 - 18*6 - it it
J. S. 38 F 3 7 1 27*5 57*7 1*643 2*139 6*4 7*06 p it ii
12 7 - 38*3 - 2*163 - 8*03 p
L.R. 39 M 10 8 - 43*0 - 1*889 - 7*99 p 3 math effusion
D.B. 40 F 13 8 - 39*7 - 1*824 - 7*34 p /effusion present '•in May, now gone.
Table - XII continued al89
I PCV. PLASMA VISC. Max.
iName No Is 1 Date [Cit. |P+A. Cor. P+A Cit.* Remarks.
|
j $
Citr. Oxal. ESR.
■
cs.
X.ICT4'
%
Id. W. 41 M 6: 6 134*0 - 1*445 - 4*o - inactive.
IGr. G. 42 M 4: 6• 32 *7 - 1*440 - 2*2 - doubtful activity
A.B. 43 M 4:10 32*3 - 1*632 — 6*7 - artif* A. P.
M.A. 44 P 10: 2 25*7 1*553 - 0*6 - inactive *
D. B. 45 M 14: 4 - 29*2 1*789 17*7 -
M.B. 46 P 8: 7;21*4-1 28*1> ! 1*818 2*483 22*5 6*92 s
N. 0. 47 P 12: 7 33*1144*2 • Cn o > 00 2*035 2*7 7*99 p
Gr. A. 48 F 3: 3 34*3 1*550 10*2 - ? asthma ? tb.
9: 3 33*8 1*533 1*894 6*2 6*91 p
J.D. 49 F 5: 4 29*5 39*0 1*484 1*792 1*6 7*02 p ? activity
L.B. 50 M 13: 5 31*2 43*9 1*777 2*609 18*8 8*03 p
D.M. 51 jM 131? 10i i 31*4 43*1 1*671 2*284 11*0 7*85 p
J.I. 52 M 4: 8 22*0 1*637 - 9*4 4*80 s
16: 8 23*8 • 1*675 2*160 13*5 6*29 p
G. 0. 53 M 6:12 31*3 - 1*596 - 7*1 6*61 p
E.G. 54 P 2: 9 - 39*8 - 2*048 - 7*78 p
29: 9 - 39*1 - 2*097 - 7*86 p
16:10 27*6. 39*2 1*576 2*047 4*2 7*88 p
5:12 41*4 *"' 2*132 *" 8*60 p
Table - XII continued. al90
Name s
_ T _ _  
No. Dfi+.o PCV. [plasma
[Wintrobe
E.S.R.
Total
Plas. Gold
Ploc Remarks.j vise. Drd. (Cor. Prot.
| % | cs.f
[mm/ 1 hr %
L.V. P 55 21 8 44*7! 1*925| I 1° 12 7*56 0 early case
M.M. F 56 17 6 41*71 1*969 ! 17j 17 7*70 0 recent effusion
W.M. M 57 15 7 - | 2*333 | 35 8*57 o
A.M. P 58 3 9 34*6| 2*001 ! 8\ 0 7*88 0
M.H. M 59 15 9 42*2 ! 1*946 1 19i 15 7*49 - early case
W.M. M 60 ! 24 4 43*7| 2*227 ! 27i 23 7*42 -
J. A. jMI 61
\
I 3 9 48*4! 1*959 j 10 11 7*49 o
J.M. Ml 62 j 12 2 49*1! 2*703
I 8
10 9*14 5+ koni-phthisis +
J.M. M | 63 10 4 47*4
1
j 2*263 I 15 13 8*28 _
rheumatoid arthritis
22 5 46*1| 2*121! 9 8 8*32 -
24 7 46*7 ! 1*975 [ •* - 7*5 6 !
30 12 45*5 j 2*252 S ii 10 7*88 - ji
C. C. P 63 13 4 38*3! 2*320 48 40 7*92 0 B2, on P. P. in
10 5 38*1| 2*398 j 43 36 8*35 0 sanatorium.
22 6 38*9 | 2*222 ! 43 37 7*88 + +streptomycin
29 7 42*3 j 2*173 | 36 36 7*68 + + PAS.
26 8 43.2 1 2*090 ( 24 26 7*74 0
29 9 41*1 | 1*977 ! 25 24 7*34 +
2 11 38*2I 2*139 1 32 26 7*78 0
1 12 42*2 | 2*177 I 24 24 7*99 2+
4 1 40*8 ! 2*040 | 36 34 7*74 2+
15 2 42*4! 2*119 j 40 40 7*52 2+
21 3 40*7 1 1*965 j 20 19 7*38 + discharged.
M.B. P 64 30 11 40*9 1 2*143 28 26 7*99 0 A2, in sanatorium
30 12 42.1 I 1*961 | 1 6  I16 7*60 0
23 1 40*7 ! 1*868 20 |18 7*16 0 quiescent now.
M.B. P 65 6 9 40*0] 1*973 i36 7*31 + B2, in sanatorium
4 10 40*3 I 2*047 ! ~  ! i 7*34 -
2 11 40*5 i 2*092 32 s28 7*67 o
30 11139*2 1*883 1 24 |20 7*06 2+
5 1 40*6 1*793; 20 |18 6 *66 + discharged•
W. J. M 66 18 3 |43 • 2*075 14 j10 ! 0 in snatorium
12 4 44*5| 2*059 29 j25 7*70 0
16 5 43*2 1*999 7 ■ ' ! s 7*49 o
21 6 43*2 1*913 16 |ii ! 7*13 0
25 7 47*5 2*024 29 !29 | 7*78 0
26 8 46*4 2*146 20 |19 j 8*03 +
29 9 44*7 2*012 17 |14 7*56 +
2 11 44*6 2*000 9 1 6 7*67 o
2 12 46*2 2*009 15 14 7*81 0
5 1 45*6 1*915 - - 7*02 +
12 2.46*2 1*997 7 6 7*81 o discharged.
Table - XII continued. a!91
Name S No. Date PCV.
PLASMA
vise.
Wintrobe 
E. S.R.
Total
Plas.
Prot.
Gold
Floe
Remarks.
3rd.! Cor.
£ cs. 1 hr fo
S. F. F 67 19:11 31*5 2*529 60 37 - 0 B2, in sanatorium
22:12 35.0 2*312 50 36 - 0
H: 1 36*5 2*246 50 39 - o
31: 1 41*0 2*341 38 36 - 0
15: 2 41*0 2*093 31 29 - o
18: 3 41*5 2*045 16 13 - o
12: 4 43*0 2*087 34 36 7*70 o
9: 5 38*1 2*354 44 36 8*14 0
8: 6 38*7 2*266 33 27 8*28 o
13: 7 37*7 2*059 30 23 7*98 o
26: 8 41*0 1*910 14 13 7*63 o
21: 9 41*3 1*968 16 15 7*85 0
20:10 40*3 1*907 15 13 7*33 o discharged.
P. F. F 68 8:12 36*3 2*725 36 26 - - B2, in sanatorium
11: 1 39*5 2*437 43 38 - +
31: 1|41*5 2*554 28 27 - 0
15; 2 39*8 2*247 43 39 - 0
18: 3 37 * 2*259 16 10 - o
13: 4 40*4 23274 36 34 8*14 0 discharged
W.H. M 69 26: 8 44* 2*072 31 26 7. 70 + B2, in sanatorium
29: 9 43*8 2*033 21 17 7*81 • 0
2:11144*3 2*087 16 13 8*39 0
2:12(45*2 1*950 14 12 7*52 0
5: 1 47*3 1*927 6 6 7*02 + discharged
J. H. F 70 7: 9 44*6 1*894 - ~ 7*67 0 ? activity, in a
29: 9 40*6 1*783 4 2 6*98 0 suspect.
1:12 42*5 1*911 8 9 7*78 +
7:12 41*9 1*835 10 10 6*84 “ admitted to san.
M.M. F 71 18: 3 37*0 1*762 14 8 - o B2, in sanatorium
4: 4 38*6 .2*151 35 29 7*16 +
12: 4 35*5 2*249 46 34 7*09 +
9: 5 35*7 2*295 50 27 7*38 +
7: 6 39*1 2*280 17 14 7*88 0
5: 7 40*3 2*050 24 21 7*47 +
24: 8 42*3 1*864 10 10 7*04 o
22: 9 43*5 1*826 12 14 6*77 o
21:10 40*3 1*766 5 4 6*48 +
30:11 41*0 1*782 6 5 6*77 + discharged
D.M. F 72 19:11 37*9 2*569 22 16 - 0 in sanatorium.
22:12 38*5 2*417 16 12 - 0
28: 3 44*3 2*176 14 17 7*81 +
16: 5 43*5 2*058 3 5 7*81 +
21: 6 43*3 2*019 17 19 7*45 , o discharged.
Table - XII continued. a!92
r ~ — |Wintrobe " Total
Name s No. Date PCV. PLASMAvise. E. S.R.
Plas.
Prot.
Gold
Floe
Remarks
Ord. Cor.
% cs. 5 7 " 1 hr %
D. 0. M 73 12 5 36*5 2*413 38 21 7*81 o B2, in sanatorium
: 8 6 40*4 2*264 20 12 8*10 0
1 5 7 41*4 2*113 18 12 7*86 0
24 8 45*3 2*258 19 17 8*03 o
22 9 45*1 1*989 12 10 7*45 o discharged.
Iff. P. F 74- 18 3 43* 2*224 18 19 + B2, in sanatorium
12 4 45* 2*130 37 42 7*67 0
10 5 42*1 2*355 34 34 7*88 +
7 6 43*1 2*201 34 36 7*81 o
5 7 41*3 2*053 36 35 7*33 0
25 8 42*1 1*922 27 27 7*02 +
21 9 41*6 1*983 29 29 7*20 3+ discharged.
J. S. F 75 13 4 40*0 2*155 35 32 7*60 o B2, in sanatorium
10 5 41*2 2*035 21 20 8*06 0
8 6 43*1 1*827 8 9 7*16 o
13 7 42*5 1*841 13 13 7*00 o
26 8 43*2 1*861 10 11 7*27 o
21 9 42*9 1*821 7 8 7*20 0 discharged.
P. Y. F 76 27 6 39 *7 2*385 45 4-0 7*73 o A2, in sanatorium
22 7 41*1 2*196 44 42 7. 07 0
26 8 42*3 2*152 19 19 7*63 o
29 9 41*5 1*968 15 ! 14 7*74 0
3 11 40*4 1*879 10 \ 8 7*52 +
1 12 42 *4 1*965 15 115 7*63 +
4 1 43 *4 1*977 9 i 10 7*74 +
15 2 43*2 2*000 4 I 5 7*92 +
23 3 39*0 1*955 15 12 7*38 0
5 5 40*2 1*977 9 7
- o discharged.
M.B. F 77 6 9 40*0 1*973 40 36 7*31 + B2, in sanatorium
4 10 40*3 2*047 - - 7*34 -
2 1 1 40*5 2*092 32 28 7*67 0
30 1 1 39*2 1*883 24 1 20 7*06 2+
5 1 40 *4 1*793 20 18 6*66 + discharged
J. C. M 78 25 8 44*8 1*903 19 116 7*10 0 B2, in sanatorium
21 9j46*3 2*017 19 118 7*70 0
20 10 47*3 2*021 1 1 1 1 7*83 0
W. J. M 79 16 5 !38*2 2*095 30 18 7*85 + B2, in sanatorium
21 6 40*6 2*006 34 25 | 7*42
_
25 7 41*7| 2*141 25 18 | 8*03 o
W.K. M 80 28 5 44*3: 1*880 8 6 7*02 o Bl, in sanatorium
22 6 43*7 1*866 14 10 6*73 0
22 7 46*4 2*090 36 35 7*60 0
, , ..... ..... ... .. -
Table - xil continued al93
Name
N. L. F
No.
81
r i
Date | PCV.
J
P. M. F
D.R. F
J.B. F
A.T. M
A.H. IM
B. 0.
T.O.
M.H.
L.M.
P.W.
D.S.
D.E.
J.T.
J.F.
N. A.
F. S. 
N.M.
B. F. 
S.D.
F
M
F
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97 
160
161
162
163
163
164
10
122 
129 
125 
12
7 
6
18
20
2
4
8 
21
2
27 
6
13
22
4
21
15
22
-31
30
28
31
17
3 
11 
28
4
5 
29
5140*4 
6 142•2 j 
7 |40*3j 
8 |40*2j
5 <46 *5 J
6 j39 *3 j 
39*7
41*8 j
45*5
4!*3j
4 j45 *4 j
6 |46 *9 !
6 |46 *4 | 
i 1
7 44*6 | 
I |
6 *40 *0 j 
! j
7 |37*li
7 |44*5 j
7 k-8* |
1134*6 I
i
4 145 *9 j 
7 |44*01 
7 143*1!
42*0
46*
33*5!
34* !
j
4-4*6
40*
41*
38*
38*
41*
38*
PLASMA
v i s e .
cs.
2*328
2*192
2*138
2*011
2*149
2*529
2*468
2*063
1*946
2*617
2*050
2*184
1*786
1*907
2*178
1*902
2*056
2*090
2*081
1*944
2*351
2*108
2*012
2*103
1*956
1*902
1*967
1*833
1*904
1*865
1*853
1*976
2 *638
jWintrobe 
E. S. R.
Ord. Cor. 
nin/i hr"
22 
, 12 
| 38 
26
j 41 
34 
48
23
5
| 27
i 12
!
9
! 15!
j 39
i 6
20
12
35
23
38
29
43
23
8
20
10
16
8
13
28
0
40 38I
14 115
50 j 35
10 j 9
20 j 17
30 | 24
26 
25
25 
24
9
13
16
11
17
23
24
26
32
12
13
7
11
15 
6
12
16 
18
Total! ~~~1 
Plas. Cold 
Prot. Floe
T
8*42
8*28
7*74
7*58
7*02
8*32
8*10
| 7*56 
| 7*56
I 8*21
I 6*84
I
j 7*13 
j 7*63 
| 7*20 
| 7*45 
! 7*85
i -I
| 7*60 
1 8*06 
7*38
7*85
7*85
7*52
7*34
7*20
7*34
7*42
6*95
7*38
7*45
7*88
o
o
o
o
o
+
2+
o
o
o
+
o
o
o
o
o
o
0
2+
0
0
0
o
o
o
o
o
o
Remarks.
B2, in sanatorium 
discharged.
died
pleural effusion A1 
pleural effusion A2 
on PAS therapy. B3 
Ambulant, B2 
forming effusion B2 
on PAS therapy B2 
pleural effusion A1 
B2
B1
B2, prior to strept­
omycin.
admitted to san. B2
Al, in sanatorium
very early case
Table - XI1 continued. a!94
1 | jwintrobe [ Total]
— .——- 1
Name S No. Date Ipcv.
j . . . . . . .
PLASlviA
j vise.
E.S.R.
fOrd. I Cor.
Plas. 
| Prot.
! Gold 
Floe Remarks.
t
I 0/0 ! cs.
taro/ 1 hr %
A. S. M 98 26: 8 42 *71 2*323 j 35 28 j 7*74 0 Rl, in sanatorium
29: 9 43*2 ] 2*219 28 23 7*85 o on streptomycin
3 2: 11 42-6 | 2*306 42 37 7*78 0
2: 12 46*2 I 2 *465 | 18 17 8*57 2+
5: 1 47*2 I 2*270 24 24 7* 74 o
13: 2 47-0 2*402 1 14 14 8*24 0
15: 3 44*8 2*244 j 14 12 7*99 o
4 : 5 45*3 2*126 i 12 11 7*60 + PAS for 6 weeks
6: 6 47 *4 2*097 ! 28 29 7*52 o
5: 7 49 *4 2*205 ! 4 7 7*72 0
18: 8 48*9 2*208 10 11 7*85 +
12 10 47* 2*050 23 23 7*49 -
20:li:46*3 2 *ol7 | 16 15 7*34 o
21:12 47*0 1*983 | 16 16 i 7*16 +
31 1 50*3 2*166 i is 117 ! 8*10 +
12 3 47*2 2*064 \ 11 in( 7*85 o discharged to a
! J! convalescent home.
E.B. F 99 26 1 45*2 ! 2*502 I 8 1 0 B2, in sanatorium,
10
18
2
3
44*8
48*
! 2*187 
: 2*194
1 n
! 10¥
1 13 
! 17
_
_
+
+ on streptomycin, until 30:4
12 4 45*6 2*174 1 12 I16 7*34 0
9 5 46 *4 2*232 i24 ! 30 7*92 o
8 6 45*51 2*047 I 18 1 22 7*56 0
5 7 46*1 2*061 ) 20 j 25 7*31 O
24 8 44*5 2*181 ] 36 40 7*54 0
22 9 41*9 2*333 ) 42 42 7*63 0
21 10 42*3 2*381 1 7 7 8*06 2+
30 11 46*0 2*292 | 33 40 8*03 o
30 12 4-5*3 2*295 1 22 27 7*96 2+
31 1 42 *8 2*249 36 37 7*67 +
1 3 44*1 2*313 16 17 7*67 +
1 5 45*8 2*353 4 8 8*10 o
1 6 44*5 2*313 30 34 7*63 0
5 7 45*0 2*331 7 10 ,7*54 0
18 8 45 *4 2*260 20 25 7*81 +
11 10 47* 2*326 17 23 7*92 o
20 11 45*3 2*338 19 23 7*99 +
21 12 48*7 2*398 4 11 7*99 +
31 1 47*6 2*460 15 21 8*03 +
12 3 43*8 2*510 6 8 7*81 0
5 4 42* 2*558 4 4 7*67 0
10 5 40*8 2*640 28 26 7*85 0
19 6 35* 2*420 54 39 7*55 0
20 8 29*1 2*328 60 32 7*56 — died on 5:9
Table - XII (l-; al95
FIJIMONARY_^  TUBERCULOSIS; a selected series of patients in whom 
the Westergren E.S.R. was low (under 10 mm/ 1st hour) yet with a 
clinical activity shorn by tubercle bacilli being detected in the 
sputum within a fortnight of these tests.
The Wintrobe E.S.R. technique, with a correction for 
alteration in the packed-cell-volume from normal, allows for those 
instances where the E. S. R. was low because of a large PCV.
Name S No. Date PCV.
Plasma
Vise.
Wint]
E.!
robe 
p. R
Cor.
Total
Plas.
Prot.
Gold
Ploc Remarks.Ord.
p cs. mm/ 1 hr %
J.M, M 100 20 11 43*3 1*888 17 12 - 0
(3 3 45*0 1*928 13 11 - 0 ) not included in
K.D. M 101 24 3 48*5 2*218 5 7 - + statistics
B. B. M 102
i
25 3 43*7 1*833 8 5 - 0
V.F. M 103 25 3 48*1 2*030 5 6 - o
J. H. M 104 4 4 45*4 2*050 12 10 7*56 +
P. S. M 105 8 4 40*9 2*534 16 9 8*57 0
A.B. M ! 106 11 4 51*0 1*991 5 9 7*52 o
I.C. M 107 21 4 4-0*7 1*939 15 8 7*02 o
C. P. |M 108 29 4 46*4 1*830 11 10 6*77 o
N.C. M 109 29 4 46*7
3
2*005 8 8 7*99 o
R. 3L M 110 25 5 48*6 1*968 3 5 7*24 0
(27 6 47*2 1*895 11 11 6*95 o not included in
25 7 |48 *7 1*915 8 10 7*52 O ) statistics.
W.K. M 111 28 5 •44*3 1*880 8 5 7*02 0
(22 6 43*7 1*866 14 11 6*73 O v not included in
22 48* 2*090 36 38 7*60 O ) statistics.
J.T. M 112 9 6 47*4 1*834 5 5 7*45 o
D. H. M 113 21 6,43*3 1*933 14 10 7*31 0
J.W. M 114 22 7 47*6 2*111 28 29 7*81 o
J.C. M 115 25 8 44*8 1*905 19 19 7*06 0
(21 9!47* 2*017 19 19 7*70 0 not included in
|
(
20 10!47* 2*032 12 12 7*96 O ) statistics.
P.M. m |116 2 Ili47*l 1*990 3 3 7*81 0
A.L. M1117a 11
J
1114-5*
5
1*970 14 11 7*78 0
A.M. 118 30 12142 *8 1*800 3 0 7*20 +
J. P. M!119 31 1 j 47 *4 1*951 3 4 7*31 o
R. P. M jl20 51 . 1|47*5 1*919 6 ! 7 6*80 +
G. B. Ml121 11 21
i
46*2 1*830 6 5 7*02 o
A.B. m I123 10 3 47*1 1*848 3 3 6*66 o
C, A. m 124 28 4 48* 2*090 15 16 7*78 o
Table ~ XII continued. al96
Name No. Date
E.P. Ml 125 16
R.A. M |126 130
!
D.T. M 1127 I 2
D.E. M 1128 | 2
H.H. M [129 j 30
S.H. jM |130 i30 
i i ! 
V^ C. IM 11311 8
1 f !
J.B. \ Yi ] 132 I 8f 8 [
H. L. i M i 133 I 8i i \
R.H. |M[l34|20 
P.G r . :m!135 I 6 
P.W. | M 1136 | 6
E.D. ! M ! 137 ! 7! I i
S.M. ! M 1138 jl4 
V.B. j M |l39 114
W.W. |m  140 ! 19i I *
J.H. |m  Il41125
C.G. jM 142 !28
!
D.R. | M *143 128 
P. S. |m  144(15
A.N. jM 
D. G. j M
P. S. )M
I
A.B. jM
A. B. | M 
G. C.
B. S.
J.D. 
E.B. 
J.R. 
B. 0.
Q.M. 
A. J.
G. S. 
A.M.
145 116
146 j 16 
147j17 
148 116
149
150
151
152
153
154
155
156
157
158
159
17
18 
2
PCV.
49 *4
56*3
44*9 
I I 
6 [46 *3 j
5149 *oj
5 (45 *5 j 
6.j 44*11
6 {47*6 | 
6 ;47 *91
6 ' 49 * 1 =' I
7.48*3
7 150 *1!‘ |
7 j -  j
7 52 *8 j 
7|48*0I 
7 46*3;
7 48 *5 
7:45*1 
7150*8 j 
8(50*0 
8|45*5 j 
8142 *8 j
8 (44*6 j 
8:48*8 
8j54*0 I 
8145 *4 ! 
5 ;50* |
15: 7j4-8*3
26:
18:
8: 6 
6: 7
22:
28:
22: 8
45*2
36*0
44*7
43*1
4-3*1
41*4
42*7
PLASMA
vise.
cs.
2*083
1*957
1*931
1*947
1*927
2*078
1*952
2*114
1*996
1*890
2*077
2*062
2*868
2*026
1*938
2*203
1*871
2*029
2*133
1*984
1*930
2*088
1*967
2*134
2*015
2*260
2*007
2*441
2*502
2*080
2*098
2*154
1*898
1*780
2*120
Wintrobe 
E. S. R.
Ord. | Cor. 
mm/ 1 hr
9
ifo
8
4 
2
10
14
14
6
1
2
5
4
3 
10
8
2
17
5
4
6 
12
9
5
1A
20
5
5 
8
16
12
9
6 
5
16
10
9
6
3
5
9
11
15
7
3
3 
8
8
11
7
4 
13
8 
7
5 
7 
7 
7 
7
19
12
12
8
15
11
8
4
17
Total
Plas.
Prot.
%
7*56
7*13
7*34
7*67
7*34
7*63
7*16
8*03
7*63
7*13
7*92
7*63
8*60
7*31
6*59
8*10
7*16
7*13
7*42
7*45
6*98
7*45
7*20
7*42
8*03
7*81
7*24
8*39
7*49
7*49
8*03
6*91
6*44
7*92
Gold
Ploc
+
+
o
o
o
o
o
o
o
o
o
o
o
o
o
o
+
o
o
o
o
o
o
o
o
+
o
o
o
+
o
3+
o
o
+
Remarks.
Case No. 30 Pulmonary Tuberculosis.
This female patient, aged 61 years, had complained of a pleural 
effusion in 1923, from which she made a good recovery with only 
scanty treatment. She remained well until 1944 when her cough 
returned; a skiagram of the chest at that time was considered to 
be of normal appearance. The cough persisted, she lost much 
weight during 1945-46, but managed a trip to America in 1947.
At the end of 1948 she became definitely ill. A skiagram in 
January 1949 revealed tuberculosis of both lungs, involving the 
right upper lobe and the left midzone; cavities were present in 
both affected parts. There were signs of toxaemia in the raised 
temperature, pulse rate, and loss of weight. The sputum contained 
tubercle bacilli in large numbers. At this time the plasma 
viscosity was markedly elevated, yet the ESR was within normal 
limits. (it was this particular finding which led to the special 
investigation of the plasma viscosity test in those patients who 
had a normal ESR in association with activity guaranteed by a 
positive sputum. )
Streptomycin was given in doses of 2 g. per day from 25:1:49 
until 17:3:49, and then 1 g. per day until 30:4:49, to reach a 
total of 140 g. The clinical improvement was most dramatic - the 
temperature fell rapidly to normal, she felt much better, her 
appetite returned, and she put on a little weight. The cavity of
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Date PCV.
PLASMA
vise.
Wintrobe
ESR.
Ord.jCor.
Total
Plasma
Prot.
Gold
Floe
7° cs. im/ 1 hr
26: 1:49 45*2 2*502 8 12 _ 0
10: 2:4-9 44*8 2*187 11 13 - +
18: 3;49 48* 2*194 10 17 - +
12: 4:49 45*6 2*174 12 16 7*34 0
9: 5:49 46 *4 2*232 24 30 7*92 o
8: 6:49 45 *5 2*047 18 22 7*56 0
5: 7:49 46*1 2*061 20 25 7*31 0
24: 8:49 44*5 2*181 36 40 7*54 o
22: 9:49 41*9 2*333 42 42 7*63 0
21:10:49 42*3 2*381 7 7 8*06 ++
30:11:49 46*0 2*292 33 40 8*03 0
30:12:49 45*3 2*295 22 27 7*96
31: 1:50 42*8 2*249 36 37 7*67 +
1: 3:50 44*1 2*313 16 17 7*67 +
1: 5:50 45*8 2*353 4 8 8*10 0
1: 6:50 44*5 2*313 30 34 7*63 0
5: 7:50 45*0 2*331 7 10 7*54 o
18: 8:50 45 *4 2*260 20 25 7*81 +
11:10:50 47* 2*326 17 23 7*92 o
20:11:50 45*3 2*338 19 23 ! 7*99 +
21:12:50 48*7 2*398 4 ii! 7*99 +
31: 1:51 47*6 2*460 15 21 j 8*03 +
12: 3:51 43*8 2*510 6 8 ! 7*81 o
5: 4:51 42* 2*558 4 I 4 1 7*67 o
10: 5:51 40*8 2*640 28 26 j 7*85 o
19: 6:51 35* 2*420 54 39 | 7*55 o
20: 8:51 
— —— _—
29*1 2*328
!
60 j
• *
32 7*56 -
of the left midzone was almost closed and that of the right apex 
had reduced to half its original size. This improvement in the 
lung and general conditions was accompanied by a decrease in the 
plasma viscosity; the ESR, in contrast, increased just as 
steadily. In «June she was allowed up for an hour daily and this 
was increased to 2 hours in July 1949.
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On the 6th September 1949 she suddenly produced a temperature of 
102 *6°F; the evening, temperatures persisted in this region until 
the end of the month and then gradually declined to the 99°F 
level. On the 4:8:49 the skiagram had shown the cavity at the 
right apex to have become blown up. It should be noted from the 
accompanying chart how the plasma viscosity (and ESR) had risen 
before the clinical worsening had become obvious by the increased 
temperature, etc.
There was little clinical or radiographic change noted 
throughout the next 12 months. The plasma viscosity maintained 
a plateau in which a central hump was associated with another 
temporary temperature rise. In this same period the ESR had 
large inexplicable fluctuations; to exclude* the possibility of 
experimental error I made these ESR measurements in duplicate or 
triplicate on duplicate blood samples.
In the winter of 1950 she began to lose ground and the 
lung lesions began to spread. The skiagram of 21:3:51 noted gross 
cavitation of the upper and mid zones on the right side, with a 
fibrotic infiltration of the lower zone; there was infiltration 
of all zones on the left side. The plasma viscosity continued to 
rise as a result of the increasing reaction to this increasing 
toxin formation and absorption until the peak in May 1951; the 
inevitable fall of "terminal decay" set in and two more tests were
a201
possible only before death ensued on 5th September 1951
The plasma viscosity test has been a reliable index of the 
pathological changes in this patient - the initial toxaemia, the 
improvement in response to streptomycin, the early reduction to 
a lower level which was maintained until there occurred the 
final spread which led to death. The ESR, on the other hand, 
had a most erratic course in which the changes were frequently 
directly opposed to that expected if the ESR was reflecting the 
alterations in the disease condition.
The positive gold flocculation tests following the 
administration of streptomycin should be noted. This association 
was not infrequent but in this case no P. A. S. was being given and 
the effect can be attributed solely to the streptomycin.
The results of this case also demonstrate the difference 
between the viscosity and total protein results. The protein 
changed approximately in parallel with the viscosity changes yet 
the protein changes were so small that seldom could any 
significance be attached to them.
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Case No. -31 Palmonary Tuberculosis.
This young woman was a Mass Radiography Unit pickup in 
Nov. 1948; an acute bronchopneumonic tuberculosis involved the 
whole of the left upper lobe and part of the left lower lobe. Her 
evening temperature was 102 °F.
She was transferred to a Portsmouth hospital on 16:1:49, 
when the degree of toxicity attracted attention on admission. The 
evening temperature and pulse rate were 100°F and 110 per minute. 
Her sputum contained tubercle bacilli. Skiagrams showed continued 
active disease in the left lung where there had now appeared an 
upper left lobe cavity.
A pneumoperitoneum had been induced in her first hospital 
and this was continued with at Portsmouth. A left phrenic crush 
was made on 16:1:49.
Because there was no radiological or other improvement by 
April, streptomycin was given in 2 g. doses per day from 8:4:49 
until 2:6:49 ; para-aminosalycilic acid was given in 18 g. doses 
per day from 14:6:49 until 25:10:49. By the end of 1949 the 
sputum was free from tubercle bacilli and there was some 
radiological evidence of clearing in the lungs. Thereafter her 
progress was slow and steady. She was discharged in April 195Q,
Her latest skiagram showed a slow absorption and hardening of the
a205
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Date 1PCV, J PLASM
vise.
Wintrobe
ESR.
Ord.jCor.
|- . . . ™ 
I Plasma
i Total
i Prot.
Gold
Floe.
% 1 cs. mm/ 1 hr g '%
13: 4:49. 38•3 j 2*320 48 40 7*92 o
10: 5:49; 38 •1 * 2*398 43 36 8*35 o
22: 6 :49; 38 •9 j 2*222 43 I 37 7*88 +
29: 7:491 42 •3 I 2*173 36 I 36 7*68 +
26: 8:49; 43 •2 j 2*090 24 26 7*74 o
29: 9:49! 41 •1 j 1*977 25 24 7*34 +
2:11:491 38 *2 j 2*139 32 26 7*78 0
1:12:49; 42 •2 | 2*177 24 24 7*99 ++
4: 1:50 40 •8 ; 2*040 36 j 34 7*74 ++
15: 2:50 42 •4 I 2*119 40 40 7*52 ++
21: 3:50j 40 *7 I 1*965 20 19 7* 38 +
of the lung infiltration, and an absence of the lung cavity. Her 
v/eight had increased by 20 lb.
The rise in the plasma viscosity value in November 1949 
followed closely on the stopping the PAS. and this rise may be 
related to a flare-up in a lesion which was being held in check by 
this drug. The later decrease was again in parallel with the 
clinical improvement. At the time of her discharge, the lung 
lesion had shown a remarkable improvement but it was still 
regarded as active; this clinical assessment had the support of 
the persisting high plasma viscosity and ESR values.
The positive gold flocculation tests should be noted.
Such findings were frequent during and following streptomycin 
therapy. In this instance the effect may be due to the P. A. S. 
also.
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Case No. 32 Tuberculous bronchopneumonia.
This young woman was admitted to the tuberculosis v/ar&s 
of the hospital on 1:6:49. Her illness had had an acute onset 
only three weeks before. The general examination and the skiagrams 
of the chest revealed a tuberculous bronchopneumonia of the left 
lower lobe and of part of the left upper lobe. Her pulse rate 
at admission was 128 per minute, and her evening temperature was 
100 'S0]?. Her weight was 8 st. 2 lb.
She received 2 g. of streptomycin daily between 9th June and 
20th September. A left phrenic crush was made on 4'th August and 
a pneumoperitoneum was induced on 16th August; by the end of that 
month the diaphragm had risen by 5 cm.
The severity of her toxic state was most noticeable at the 
time of admission and this was truly reflected in the high plasma 
viscosity value. Her response to therapy was satisfactory. By the 
end of June the evening temperature was 99°F and by August it was 
only 98*6°F. The skiagrams of the chest showed some clearing in 
the lung lesions by August, and more clearing by December. Her 
weight increased steadily, beginning in September, until at the 
time of her discharge in July 1950 she was a plump 10 st. 12 lb.
Her last positive sputum was obtained on 24:1:50.
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Date 1 PCV. PLASMv i s e .
Wintrobe 
E S R .   ^
0rd.|Cor.
Total
Plasma
Prot.
Gold
Ploc
cs. mm/ 1 hr g. %
29: 6:4-9 39*7 2*385 45 40 7*75 o
22: 7:49 41*1 2*196 44 42 7*67 o
26: 8:49 42*3 2*152 19 19 7*63 o
29: 9:49 41*5 1*968 15 14 7*74 o
3:11:49 40*4 1*879 10 8 7*52 *
1:12:49 42*4 1*965 15 15 7*63 +
4: 1:50 43*4 1*977 9 10 7*74 +
15: 2:50 43*2 2*000 4 5 7*92 +
23: 3:50 39*0 1*955 15 12 7* 38 o
5: 5:50 40*2 1*977 9 7 - o
No explanation was ever reached definitely to explain the 
increase in the plasma viscosity again in Debember; the patient 
had had a head cold for a few days towards the end of November 
which might have been part of a small flare-up which was not 
otherwise detectable.
Plasma viscosity values raised to just above the upper limit 
of the normal zone has been a phenomenon encountered sufficiently 
frequently among the patients to make us hesitant to interpret the 
finding as certain proof of continued activity in the lung lesion; 
the air may act on the peritoneum as a minor irritant. On the 
other hand, it might be concluded that the pneumoperitoneum was 
unable to produce sufficient immobilization of the lungs to 
prevent toxin absorption.
Note how small were the variations in the plasma total 
protein as compared with those in the plasma viscosity.
Corrected Wintrobe ESR
Tor Trot.
Total Protein
Months
30 2.K
20 2.2
10 2 .0
a20S
Case No. 33 Pulmonary Tuberculosis,
This patient was picked up "by Mass Radiography in the
navy in February 1947, with an infiltration at the right apex. He
was thoroughly overhauled in a naval hospital in July 1947 when no
evidence of activity could be detected; he was boarded out as a 
case of quiescent pulmonary tuberculosis. He remained under 
medical observation; his light work occupied four days per week.
On 15:7:48 his sputum contained tubercle bacilli. He 
continued with his work and took care of himself but by 3:2:49 
there was radiographic evidence of a spread of the disease at the 
right apex. His Westergren ESR was only 2 mm. in 1st hour.
When he was admitted to the sanatorium 
on 8:6:49 there was right apical infiltration 
which included a doubtful cavity. Bed rest 
alone did not arrest the progress of the 
disease. A skiagram of 16:8:49 showed an
invasion of the left mid zone and a cavity at the right apex of 
3 cm. diameter.
At this time, when the first plasma viscosity was soon to 
be made, the degree of toxaemia was estimated as of moderate 
severity. Streptomycin therapy was begun ,on 20:8:49 in doses of 
1 g. daily for 42 days. The temperature returned to the normal
a209
Date PGV.
PLASMA
v is e .
Y/introbe
ESR.
Total
Plasma Cold
FloeOrd.'Cor. Prot.
7° cs. mm/ !1 hr g */°
26; 8:49 42 *7 2*323 35 28 7*74 o
2S 9:49 43*2 2*219 28 23 7*85 o
2:11:49 42*6 2*306 4-2 37 7* 78 o
2:12:49 46*2 2*465 18 17 8*57 ++
5: 1:50 47*2 2*270 24 24 7*74 0
13: 2:50 47*0 2*402 14 14 8*24 o
15: 3:50 44*8 2*244 14 12 7*99 0
4: 5:50 45*3 2*126 12 11 7*60 +
6: 6:50 47*4 2*097 28 29 7*52 o
5: 7:50 49*4 2*205 4 7 7*72 0
18: 8:50 48*9 2*208 10 11 7*85 , +
12:10:50 47* 2*050 23 23 7*49 -
20:11:50 46*3 | 2*017 16 15 7*34 o
21:12:50 47*0 1*983 16 16 7*16 +
31: 1:51 50*3 2*166 13 17 8*10 +
12: 3:51 47*2 I 2*064 11 11 7*85 o
range. This initial improvement was associated with a decrease in 
the plasma viscosity values.
The skiagram of 7:10; 49 showed that the spread into the 
left midzone was settling and while the 
infiltration at the right apex was less 
the cavity maintained its 3 cm. diameter.
The skiagram of 7:11:49 had little change 
to show except that the left lung lesion 
suggested an early possible break-down.
By 5:12:49 there had been a further spread at the right upper zone 
and at left middle and lower zone. The weight had actually 
increased in the past months and no change in the temperature or 
pulse had occurred to mark this deterioration; the ESR had
a210
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actually decreased; the plasma viscosity, however, had shown an 
increase by the November test.
The plasma viscosity fell again following the left phrenic 
crush on 15:12:49.- no obvious clinical improvement ensued, so 
that a pneumoperitoneum was induced on 16:1:50. In spite of this 
the skiagram in February indicated a 
further spread in the left mid zone.
The increased plasma viscosity at 
that time might have been due to the 
increased toxaemia following the spread 
or to the reaction to the pneumoperitoneum.
The clinical and radiographic picture remained unchanged 
until May 1950. Para-aminosalicylic acid was given in doses of 
12 g. daily for 6 weeks, beginning on 4:5:50.
The exhibition of this drug was followed by 
a fall in the plasma viscosity, and in its 
later return to the original level as soon 
as it was stopped.
Later radiographic examinations showed only a slight 
clearing and a slight reduction in the cavity size when he was 
sent to a convalescent home in April 1951 - still with a positive 
sputum for tubercle bacilli.
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Case No. 54 Pulmonary Tuberculosis.
After a normal pregnancy and labour, this young Y/oman was 
complaining of haemoptysis, night sweats, shortness of breath, and 
cough, about five weeks after the birth of her baby. Because of 
the acuteness of the onset of these symptoms she was admitted to 
hospital on 7:3:49 as a case of lobar pneumonia. However, when 
tubercle bacilli had been recovered from the sputum and the 
skiagram had shown a left lower lobe tuberculous pneumonia plus 
a small amount of scattered disease at the left apex she was 
transferred to a sanatorium on 15:3:49.
tests were in accord with the clinical
assessment. The plasma viscosity changes were closely parallel 
to the changes in the activity as assessed by the clinician.
Streptomycin was given in doses of 1 g. twice daily for three 
months from 18:3:49. By 1:4:49 the general condition was only 
slightly improved although the temperature had returned to normal 
levels.
By the end of May, the skiagram could not show any 
improvement and tubercle bacilli were still present in the sputum.
were normal in spite of the obviously
active disease. The second and subsequent
The first laboratory tests of 18:3:49
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Date
------ . . . . . .
PCV. PLASMv i s e .
Wintrobe
ESP.
OrdjCor.
Total
Plasma
Protein
% cs. mm/ 1 hr g.%
18: 3:4-9 37*0 1*762 i 14 8 -
4: 4:4-9 38*6 2*151 35 29 7*16
12: 4:4-9 : 35-5 2*249 46 34- 7*09
9: 5:49 i 35*7 2*295 50 37 7*38
7: 6:49! 39*1 2*280 17 14 7*88
5:7 :49 ! 40*3 2*050 24 21 7*47
24: 8:49 ! 42*3 1*864 10 10 7*04
22: 9:49 | 43*6 1*826 12 14 6*77
21:10:49 1 40*3 1*766 5 4 6*48
30:11:49 41*0 1*782 6 5 6*77
The plasma viscosity had remained at a constant increased level 
during April, May, and June.
A left artificial pneumothorax was induced on 24th June and 
the reduced absorption of toxins was reflected in the rapid fall 
in the plasma viscosity and ESK values.
The skiagram on 10:8:49 showed that the left lung had 
collapsed completely except for a part of the lower lobe kept 
expanded by a single adhesion. No attempt was made to cause a 
re-expansion of the lung because of the long delay in surgical 
treatment. She was discharged in December 1949.
When she was weighed in Jan. 1950 she had 
increased 3*5 stones since the beginning of 
her illness. The lung collapse was still 
present in April 1950.
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Case No. 35 Pulmonary Tuberculosis.
This is an important case in that the plasma viscosity 
(and ESR. ) was abnormally high no less than eight months before 
the clinician would admit to an active lesion being present, in 
spite of frequent examinations during the intervening period.
A female technician volunteered to act as a control subject 
for my series of normal plasma viscosity values. She claimed to 
be feeling well. She had been medically examined for superannuation 
requirements a few months previously. Yet, on 31:5:50, her plasma 
viscosity value was definitely abnormal at 2*012 cs.
She then admitted that her father had been in a sanatorium 
some years previously and that she was examined at 6-monthly 
intervals as a "contact”. She recalled a slight attack of a 
"head cold” three weeks earlier, from which she had apparently 
fully recovered.
In view of my findings, she was again specially overhauled 
by the chest physician, who was satisfied that tuberculosis could 
be excluded.
In January 1951, on her own initiative, she asked that a 
further plasma viscosity test be done as she was not feeling as 
well as usual. Two weeks prior to my testing she had had her 
routine check in the chest clinic and was given a satisfactory 
report.
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Date PCV. PLASMA
vise.
Y/introbe
ESR.
0rd.|Cor.
Total
Plasma
Prot.
G-old
Floe.
cs.
/ I
mm/ 1 hr
31: 5:50 42*0 2-012 26 26 7-85 —
30: 1:51 46- 2-103 25 32 7*85 o
The plasma viscosity had increased slightly over the first 
result. I took my results to the chest physician who agreed that 
something was being missed. Another thorough overhaul and 
intensive radiology revealed a lesion of the middles lobe of the 
right lung whose tuberculous character was indicated by the 
tubercle bacilli in the sputum.
The lung was eventually treated by lobectomy.
It is on examples such as this that I state uy claim on the 
reliability of the plasma viscosity test in which an increased 
result is tantamount to an abnormal condition somewhere within 
the body.
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Case No. 36 Pulmonary Tuberculosis.
This case should be considered in conjunction with Case 
No. 35 . In the present instance, the plasma viscosity failed 
to detect activity which was demonstrated by serial radiology.
At the routine examination for superannuation purposes, the 
skiagram of the chest revealed a calcified area at the left lung 
apex of one of our female student technicians. The problem of the 
activity of the lesion could not be settled at that time by a 
clinical examination or by a laboratory investigation. Later 
skiagrams, after two months interval, showed a spread of the 
apical lesion and yet the plasma viscosity had increased to 
1*911 cs. only and had fallen to 1*835 after another 6 days.
Thus, it must be emphasised that a normal plasma viscosity 
result cannot guarantee the absence of an active tuberculous 
lesion.
Date PCV.
PLASMA
vise.
Wintrobe
ESR.
Total
Plasma
Prot.Ord. Cor.
7: 9:49 44*6 1*896 7* 67 ESR = 8 mm in 1*5 hr
29: 9:49 40*6 1*783 4 2 6*98
1:12:49 42*5 1*911 8 9 7*78 Active by X-ray
7:12:49 41*9 1*835 10 10 6*84
She was admitted to a sanatorium and was able to resume work 
after 15 months. No surgical treatment was necessary.
Case No. 37 Pulmonary Tuberculosis.
This case is another example of the plasma viscosity 
becoming abnormal several months before an active lesion may be 
detected by radiology or by physical examination.
The author had been grossly overworking during 1943; there 
were war-time staff depletions, holiday periods had been halved, 
and a research programme had had to be terminated because of such 
difficulties. The research into the plasma viscosity changes 
began in August 1943. The acid digestion of the proteins was 
carried out in a defective fume-chamber so that a morning sputum 
which appeared in the Spring of 1944 was blamed on the irritation 
of the acid fumes. However, the weight had decreased by 7 lb. in 
as many months. (See Pig. 55, page 204)
In April, a skiagram of the lungs and a general examination 
by a chest physician were normal.
At this time the plasma viscosity results were abnormally 
high. - This observation was made early in the research programme 
and we could not then ascribe to it the significance which later 
experience has taught us.
Further testing produced viscosity values which slowly fell 
to normal, although the same high rate of work had continued and 
the same sputum (tubercle-free) was formed; there was no further 
loss in weight.
Date
PCV. 
Cit.1P+A.
! /0
7: 4:44! 35*746*7 
25: 5:44 34*9 46*0
31: 5:44 J  33*5 
3: 7:44| 33'4'44*7 
7: 8:44j 32*0
13:11:45 32*0
.1 .
PLASMA VISC. ^ Max. Total Protein”!
Cor. Citr. " -- 1
Citr. ESR.
—  ...
Serum Plasma j
cs. Tm/hr g*
1*614 2*063 8*1 7*79 ~ j
1*666 2*070 10*5 7*11 _  I
1*647 - 12*0 7*29 -
1*603 2*037 12*0 6*87 -
1*549 1*900 8*4 - 7*30
I 1*503 - 4*0 - - ]
In August, when the viscosity was at the upper limit of the 
normal range, a small opaque area was detected at the right apex. 
Three months rest in bed in a sanatorium caused the lesion to 
regress and full normal duties were resumed in May 1945.
Repeated discussions have never yet settled the problem of 
what would have happened if the search for a lung lesion had not 
been persisted in - would the disease have progressed to such a 
stage that more active treatment would have been necessary or 
would it have regressed to the quiescent scar which is present in 
the majority of an adult population ?
Case No. 38 Tuberculous Pleural Effusion.1 1 "”•«   —■— %
This male asylum inmate, aged 65 years, had been noted to 
be failing in his general condition prior to his complaint of a 
pain in his left chest on 2:9:43. The whole of the left side of 
the chest was dull to percussion because of the large pleural 
effusion. On the same day, two pints of clear straw-coloured 
fluid "were aspirated. It was hoped that a partial aspiration might 
lead to a further absorption by the patient.
However, the fluid reformed. The plasma viscosity was 
measured on four occasions at two or three weeks interval, with 
an aspiration of 1 or 2 pints between, and the fluid reappeared 
on each occasion. The plasma viscosity values were within the 
"zone of effusion". Prom the experience acquired by myself and 
Houston, I now realise that when the fluid reformed after the 
first aspiration the chances of further formation after repeated 
aspiration, as long as the plasma viscosity values persisted in 
this particular zone, were so great as to stop such interference; 
aspiration should have been delayed until the plasma viscosity had 
increased or decreased significantly.
The asylum had no facilities for radiography. The fluid 
persisted in that pleural cavity for the next three years during 
which the patient was confined to bed. Thus the nature of the 
tuberculous lesion of the lung, if any, was never identified.
a221
PGV. PLASM VISC.
1/lax.
Cit. Plas. Serum.
AspirationDate cit- P+A.""" :
| Citr. ! P+A. ESR. Total Prot.
13: 9:4-3
.
7°
31*0 39*8
cs
1*702 2*118
ram/
sec.
17*5
g*%
23: 9:43 29*2 39*0 1*783 2*568 15*0 6*44
2 pints.
12:10:43 28'7 58*2 1*784 2*383 21*1 7*03
1 pint.
4:11:43 28*0 35*9 1*759 2*390 22*3 6*82 “
1 pint.
5: 1:44 29*2 - 1*870 - 33*3 7*64 -
1: 2:44 29 *0 - 1*886 2*631 33*7 7*54 -
27: 3:44 29*0 - 1*943 2*723 41*4 7*94 -
27: 3:44 26*9 - 1*920 2*669 33*3 - -
17: 4:44 25*2 33*7 1*843 2*502 37*5 - 6*62
19: 5:44 25*7 35*0 1*837 2*472 27*2 - 6*83
4: 7:44 26*3 35*6 1*908 2*715 28*9 - 7*36
14: 8:44 24*8 - 1*816 2*416 ' 23*8 7*04 -
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Case No. 39 Terminal Decay in Pulmonary Tuberculosis.
The patient was an in-mate of the asylum in 1940-41 and was 
then suspected to be suffering from pulmonary tuberculosis without 
a definite diagnosis being made. (See Pig. 93, p367.)
She was re-admitted on 15:4:44 as a case of Recurrent Mania 
in the 14th day of the puerperium* The doctor who examined her 
at that time noted that her general condition was very weak and 
that adventitial sounds were heard all over the chest. A mastitis 
of the right breast began on 17:4:44 and discharged on the 19th. 
Her mental state got worse so that she interfered continually with 
the dressings to the wound, yet on sulphathiazole therapy the 
abscess had healed by 4i5i-44.
The plasma viscosity tests on 24, 25, and 26:4:44 showed 
the falling values expected from a healing abscess.
At the beginning of May, however, she began to bring up 
foul sputum and the diagnosis of pulmonary tuberculosis, was made 
definitely. The plasma viscosity showed another increase for 
two tests and then another decrease, without any corresponding 
improvement in her general condition. The plasma protein pattern 
of 4:5:44, especially its low albumin content, was an early guide 
to the poor prognosis. She later developed a mastitis on the 
other side, and further abscesses. She died on 5:7:44.
Permission for a post-mortem was refused.
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PCV. PLASlvA VISC.
Iviax.
Cit. Plasma protein Serum ?
Date Cit. ‘P+A. Citr. [ P+A ESR Total] Alb. ‘G-lob jPibr. NPN. j
C£ rarn/h g. /100 ‘ ml. m£* > i
24: 4 25*6 ‘54*2 2*030 2*885 120* ' „  _ :
25: 4 24*5,51*6 1*995 2*737 110* - - - - ;
27: 4 24*0;31*1 1*950 2*807 133*3 I ~ -
4: 5 22*6 129*5 2*010 j 2*760 120* 7*38 2 *90? 4 *03,0*4-5 72*4 j
12: 5 20*2 27*3 2*092 3*078 109*8 - _ i _ j
24: 5 18*0 24*0 1*847 2*501 46*1 - 1" i - .... J
a224
Case No. 40 Terminal Decay in Pulmonary Tuberculosis.
This female asylum patient had a history of cough and loss 
of v/eight of some six months duration before she was found to have 
advanced pulmonary tuberculosis on 5:1:46. Her treatment 
consisted in bed-rest only. The disease progressed very rapidly 
and death ensued on 4:5:46. Permission for a post-mortem 
examination was refused.
This case is included to show to what low values the plasma 
viscosity may fall towards the end of terminal decay.
Date
Citr.
PCV.
Citrate 
PLASM VISC.
Max.
Cit.
ESR.
% cs. mm/hr.
8: 1:46 24*3 1*745 35*4
25: 2:46 15*8 1*488 13*7
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Case No. 41 Terminal Decay in a Tuberculous Mongol.
When he was admitted to an asylum on 30:3:43 this mongol had 
attained the age of 34 years which is unusually old for subjects 
with this condition. I examined him particularly for any 
evidence of pulmonary tuberculosis at that time but failed to find 
any by ordinary physical examination.
At the beginning of September he was confined to bed for 
about a week with severe enteritis for which no pathological 
organism could be detected.
On 11:10:43 he had a bronchitis which was really the presenting 
symptom of pulmonary tuberculosis. The disease progressed rapidly 
to produce death on 27:1:44. The admission of such a patient to 
an asylum where tuberculosis was so rife that no possible 
isolation from the infection could be made,had been the equivalent 
of a death sentence. (See Pig. 92, p366.)
In view of the known susceptibility of mongols to this 
disease, the extent of the reaction produced by this patient is 
worthy of note. Although the reaction was of great height, its 
duration was short; perhaps the susceptibility lies in this 
failure to maintain the fight in chronic diseases while the 
reaction is sufficient to combat the ordinary short-duration 
pyogenic infections.
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r ~ Max.
. ..  1
PCV. PLASM VISCOS. Git. Plasma protein Serum
Date Oit. P+A. Citr.! P+A.
-........... » ESR. TotaljAIb. Glob Fib. NFN.
* cs. im/h. g./100 ml. mg« >
3o:10:43 24*1 33 *4 2 *044 ! 3‘050 153 8*98 3*56 5*01 0-41 25*3
10:11:43 24*3 32-9 2*050 3*107 225 9*03 3*67 5*03 0*33 26*0
29:12:43 23*5 - 2*078 | 3*144 158 8*68 3*55 4*76 0*37 30*6
20: 1:44 22*7 - 1*755 2*325 23 6*50 3*30 2*55 0*65 17 *8
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Case No. 42 Terminal Decay in Pulmonary Tuberculosis.
This male patient had been admitted to the asylum in 1929 
at the age of 28 years as suffering from secondary dementia. His 
general health was only moderate; he would do no work but lay on 
a couch all day, taking no interest in his general surroundings.
On 22:5:44 the attendant noted an extremely rapid respiration 
rate; the patient was too demented to complain. His pulse rate and 
temperature were also elevated. His physical signs were of a 
left spontaneous pneumothorax. On tapping the chest a mixture of 
air and fluid was obtained. The fluid contained cells of the 
monocyte and lymphocyte series, and tubercle bacilli were 
identified. There was also evidence of infection of the right 
lung.
The first plasma viscosity test was made within 5 hours of the 
onset of the pneumothorax. The viscosity increased for one, weeker 
and then fell; the initial fall was slow and irregular, but after 
a month it was more rapid and regular. (See Pig. 91, p366. )
The clinical picture showed a corresponding deterioration.
The pneumothorax persisted unchanged. The temperature increased 
each evening. There was a progressive loss of weight. Oedema 
appeared at the beginning of August. He died on 8:9:44.
Treatment had consisted only of rest in bed; no surgical 
intervention had been attenpted.
a,22o
r ' Max. Plasma or
PCV. Plasma Viscos. Cit. Serum
J Date Cit. - P+A. Citr. P+A. ESR. Protein
j cs. inm/h. g./'O
22: 5:44 26-5'36*3 1*781 i 2*303 50 5*89 s
123: 5:44- 25*2 34*5 1*749 2*296 43*7 5*58 s
!26: 5:44 26*0 36*0 1*776 2*375 90 *6 5*83 s
j27: 5:44 26*5 36*0 1*819 2*479 100* 6*14 s
J 29: 5:44 28*4 38*5 1*910 2*765 159* 6 *66 s
]30: 5:44 27*3 - 1*884 - 207* 6 *45 s
•31: 5:44 27-6 - 1*891 - 220“ 6 *64 s
j 1: 6:44 25 *3 j - 1*869 - 320* 6 *62 s
j 2: 6:44 25*5 - 1*893 - 268* 6*55 s
! 1: 7:44 25*5:34*0 1*720 2*239 45*0 5*93 s
10; 7:44 25*7 35*4 1*679 2*193 31*0 5*60 s
118: :7:4Ar 26*4 36*1 1*663 2*193 13*4 5*63 s A=2*77, (1=3*19
1 2: 8:44 26*5 - 1 *660 - 13*4 5 *68 s
12: 8:44 25*4; - 1*580 - 16*0 4*90 s oedema present
.18: 8:44 26 *5 j - 1*599 - 5*7 5*16 s
* 8: 9:44 
_____________
died.
This patient has important daily results which show the 
difference in the time phase of the plasma viscosity and the ESR. 
changes. The terminal decrease in the ESR. is also well 
demonstrated. The failure of the anaemia to increase in severity 
is an unusual finding.
At post mortem, 5 pints of clear yellow-green fluid were 
found in the left pleural cavity; the lung was compressed against 
the mediastinum; caseous masses to the size of a plum were found 
in hoth lohes. Large tuberculous areas were present also in 
the right lung. There was also a tuberculous peritonitis; 2 pints 
of free fluid were present and the lower ahdomen had a fine 
fibrin membrane all over the peritoneum.
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Case No. 43 Epituberculosis : primary tuberculous complex.
This patient was a hoy of 7 years. His parents were free 
from tuberculosis when they were examined as contacts: an elderly 
lodger of 67 years was found to be suffering from pulmonary 
tuberculosis and it was thought that he might be the probable 
source of infection.
The illness began as a cold-in-the-head in the first week of 
December 1950; he was off school for a fortnight. On 17th and 18th 
January 1951, he had a cough and fever which were diagnosed as 
influenza; this was repeated after a week. On 25:1:51 he had 
pain in the scrotum on coughing; on 26:1:51 the scrotum was 
swollen. He was admitted to hospital on 31:1:51.
On examination, he was a well-developed boy who had signs of 
recent loss of weight. The right apex of the lung was dull to 
percussion: there were no adventitial sounds and air entry 
appeared to be equal and good. The scrotum was normal but the 
right spermatic cord showed marked thickening. The other systems 
were normal. The mantoux test was strongly positive. Tubercle 
bacilli were identified in the stomach washings. Skiagrams 
revealed an opacity occupying most of the upper right zone, and 
some fine mottlings throughout the left lung.
Treatment consisted of rest in bed, plus an abundant diet.
The spermatic cord was settling by 10:2:51 and normal by 19:2 .
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PLASM Wintrobe Plasma
Date PCV. vise. hSR. Total Gold
Ord.’Cor. Protein Flo
ft cs. mm/ 1 hr’ ' rr *g* P
19: 3:51 38-5 2*150 30 18 7*96 +
17: 5:51; 38 *6 2*066 25 ! 14 7*74 o
13: 6:51 38* 2 *094- 21 j 10 7*69 o
30: 6:51i 41* 2*122 20 i 13 7*96 +
13: 7:51 38*7 1*955 24 ; 13 7*56 o
27: 8:51 37*0 1*897 - ; - - -
26: 9:51 37*0 1*796 14 3 6*73 -
28:11:51 40* 1*791 11 5 6*70 -
His response to this regime was satisfactory. In the summer he 
was nursed in the garden. He got up for brief periods in August 
and the time increased gradually until by October he was up most 
of the day. The skiagrams showed a definite improvement in the 
apical lesion and a gradual enlargement of the hilar glands. If 
it had not been for the continued presence of the lodger he 
could have completed his convalescence at home; on 28:11:51 he 
was discharged to a cottage hospital to await admission to a 
sanatorium.
The plasma viscosity results show a steady decrease to 
within the normal range; the small elevation on 30:6:51 was 
associated with a pyrexia due to pharyngitis and tonsillitis.
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NQN-FULMONARY TUBERCULOSIS.
Name S No.1 DatejPCV. I
____ I..._.J
PLASMA
vise.
Wintrohe 
E. S.R.
Total
Plas.
Prot.
Gold
Ploc
Remarks.
Ord.| Cor,
% 1 cs. mn/ 1 hr %
Meningitis. •
M.M. M 1 11 4|48'0 2-070 - - 6 -@7s _ *
15 4151-6! 2-024 - - 6-67s - died on 19/4
©.S. M 2 16 21 40. 0 1*755 13 6 - 0
J.A. M 3 22 7 45- 1-986 21 19 7-52 0
Q.H. P 4 1 5 43-4 2-081 13 14 7-16 - also pulmonary
5 6]38-6 2-031 30 18 7-38 0 on streptomycin
P. A. M 5 2 5|39-7 1-852 25 15 6*70 0
5 6 34-6 1-946 44 16 7-27 0
R.G. M 6 2 5 41-2 1-860 25 17 6-48 + also miliary
5 6|42-9 1-848 15 7 6-48 o
L.M. M 7 3 5 42-4 1-793 8 3 6-73 0
S.H. M 8 3 5 44-8 1-780 14 11 6-05 + also pulmonary
5 6 48 *0 1-842 14 15 6-48 0
M.M. P 9 5 6138 -6 1*938 32 26 7-24 0 also miliary
8 5 _ 1-795 10 7-30 -
B.H. M 10 27 6 36 *4 2-133 15 8 7-63 +
R. J. M 11 13 7 42-6 1-912 14 9 7-13 o also pulmonary
V.H . P 12 13 7 41-8 2-074 25 25 7-20 o
M.T. P 13 31 l|47-3 2-263 10 16 7-56 0 recurrence
R.S. M 14 7 2 41-5 1-874 14 8 6-70 0 + pleural effusion
B.W. P 15 5 4 40- 2-658 50 37 8-10 o
Peritoneal Cavity
M.R. P 16 20:11 43*7 2-017 - - 7-88 o ascites
9:12 41-5 1-987 - - 7-54 +
J. A. P 17 14: 7 38-5 2-603 36 30 9-11 3+
M.H. F 18 3: 4 41- 1-875 3 2 7*38 o after 6 mnth treat.
Pericardial Cavity
Citrate plasma
R. S. M I S 11: 9 22* 1-701 62 - — -
24: 9 25-6 1-706 - - 7-47 -
21:10 29-1 1-830 - - 8-39 -
13:11 .32-1 1-618 - - 7-61 5+ _____ _____________—
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Name S No. Date PCV.
PLASMA
vise.
Wintrobe
ESP.
Plasma
Total
Prot.
Gold
Floe RemarksOrd.jGor.
Bone arl& Joint
>
s.
cs. ram/ 1 hr g.%
H. J. F 20 6: 7 40*1 2*810 . . 7*5 7s Spine, + sinuses
| 13: 7 35*7 2 *4-00 - - 7* 29 -
r
17: 8 2*730 - - 8*74 -
W.M. M 21 10: 1 ----- 2*994 - - 8*87 - Ribs
K.R. M 22 6 : 4- 44*0 2*149 - - 8*24 - Hip
M.O. F 23 3: 6 ----- 2*163 26 - 8*28 + Knee
M. F. F 24 2: 6 ----- 2*227 - - 8*42 + Hip
W.N. M 25 11: 3 34*2 2*147 - - 7*99 0 Carpus
L.S. F 26 16:
4
2 35* 1*892 32 21 6*81 + Hip, at end of a
2: 4 39* 1*811 14 10 6*91 0 long period of
21: 4 41* 1*861 13 12 6*88 o treatment.
30:10 36-0 1*779 18 10 6*91 -
26:11 38* 1*898 29 24 7*16 -
7: 1 42*1 1*978 28 28 7*52 -
M.W. F 27 13:11 42*9 2*008 37 38 7*60 + Femur
J. G. M 28 14: 3 48*5 1*985 5 6 7*49 0 Foot
B.G. M 29 31: 1 43* 2*369 21 16 8*53 - Sacro-iliac joint
K.P. M 30 23: 2 40* 2*330 32 22 8*68 + Ankle
5: 3 39* 2*499 35 23 6*75 +
17: 4 40* 2*321 35 25 8*68 o
8: 5 40*0 2*160 26 16 7*99 o
D, H. M 31 5:12 41*1 2*431 22 15 8*17 0 Spine
M. M. M 32 1: 2 38* 1*784 18 8 6*55 o Spine
13: 3 38* 1*708 9 0 6*70 o
24: 4 40* 1*832 17 9 6*77 o
5: 5 38*4 1*747 8 0 6*48 o
17: 5 38*4 1*754 12 3 6*62 o
28: 5 36* 1*770 13 1 6*41 o
5: 6 - 1*909 - - 6*91 -
18: 6 36* 1*703 12 0 6*55 o
30: 6 38* 1*811 16 6 6*55 o
13: 7 39. *2 1*700 7 0 6 *66 o
J.D. F 33 21: 2 46* 2*015 12 17 7*34 + Spine
P. M. M 34 15: 5 38*2 2*276 35 21 7*74 - Spine, + sinuses
A.M. F 35 3: 9 34*6 2*001 8 0 7*88 o Knee + lung lesion
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Name S No. Date PCV.
PLASMA
vise.
Wint
ES
robe
R.
Plasma
Total
Prot.
Gold
Ploc. RemarksOrd. 3 or.
% cs. rani/ 1 hr g./°
Bone and Joints (continued)
G. H. M 36 13: 2 40*0 2*116 35 32 7*31 o Spine
9: 3 40*0 1*938 25 21 6*77 o
2: 4 41* 1*912 21 20 6*91 o
21: 4 40* 1*877 18 16 6*88 o
22: 5 44* 1*877 11 13 7*02 0
W.H. F 37 6: 2 46*9 2*106 13 18 8*06 0 Spine
31: 2 44* 2*026 17 20 7*52 o
18: 4 44* 1*935 15 17 7* 38 -
M.S. F 38 5: 6 45* 2*105 25 29 6*95 o Spine + hip
A. S. M 39 25: 7 - 2*293 7*09 - Spine
1:11 35* 2*330 - - 7*31 -
26:11 36*3 2*178 49 28 7*31 -
K. J. M 39 30: 7 47* 1*928 9 9 7*20 - Spine
F.C. F 40 hr
1 00 44* 2*278 18 20 - - Spine
E.P. F 41 22: 9 39*2 2*056 27 23 7*09 - Hip
11:10 39* 1*951 25 20 6*95 -
1:11 37* 1*926 - - 6*95 -
26:11 44* 2*119 11 13 7*31 -
D.F. P 42 26: 9 43*0 2*076 25 26 7*81 - Spine
11:10 40*0 2*041 18 15 7*56 -
1:11 38* 1*979 - - 7*49 -
26:11 40* 1*971 34 30 7*31 -
7: 1 39*7 1*987 22 19 7*85 —
M. A. P 43 16:10 39* 1*884 15 12 6*95 - Spine
1:11 40*0 1*941 - - 7*13 -
26:11 A A •ii 1*987 20 22 7*49 -
7: 1 46*0 1*893 8 12 7*27 —
J.E. M 44 28:12 - 2*155 - - 6*50 -
Ljnnph Glands.
E. L. P 4-5 18: 8 40*2 1*922 15 13 7*27 o Tabes inesenterica
M .  S. P 46 25: 4 38* 2*477 47 39 8*06 o Glands of neck
5: 5 43* 2*107 7 8 7*88 +
E.F. M 47 26: 1 41*8 2*046 18 11 - o Glands of groin, +
15: 2 41*9 1*823 12 7 - o sinuses, on
N. S. P 48 17: 7 44*4 1*978 12 15 7*74 c
streptomycin 
tlands of neck
J.G. P 49 6:11 37*6 2*097 35 27 7.31 " _i
t t» '»
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Name[sL>.1 Date
7
PLASMA
vise.
Wintrobe 
E. S.R.
Total
Plas. Gold
Floe
Remarks.uo01o 1 Prot.
y* cs. mm/ 1 hr *
Organs and soft tissues.
W. J. M|49 19: 7 32 *51 2*190 | _ 6*93 Testis, bladder,etc
18: 8 - 2*016 - 6*68 -
K.D. M 50 15: 3 42- 2*121 35 27 7*52 0 testis, etc.
4: 4 44* 2*255 17 14 7*45 0
E.D. M 51 7: 7 - 2*868 4 - 8*60 o * Addison’s + lung.
J. H. M 52 2: 4 50* 2*125 3 6 7*34 0 kidney.
A. J. M 53 16: 4 44* 2*061 44 38 7*45 o after nephrectomy
24: 4 37* 2*017 25 18 7*56 0 of one of two
5: 5 36*9 1*884 14 8 7*34 o affected kidneys.
F. C. M 54 7: 2 39-4 2*266 - 7*96 - sinus of arm, of
14: 8 - 2*008 _ 6*94 - several years
duration.
E.F. M 63 24: 1 41*8 2*046 18 11 - o sinuses of abdomen,
15: 2 41*9 1*823 12 7 - o on streptomycin
S.H. F 64 3: 9 35* 2*058 57 41 7*20 - abscess of soft
tissues of back
M. W. M 65 7: 8 45* 2*450 29 26 - - pyelitis
F. N. M 66 7: 9 35* 2 *072 46 26 7*31 o pyelonephritis
18: 5 28* 2*187 48 16 7* 27
Lupus.
J.W. F 67 12: 3 45 *5 1*834 - - 7*25 -
T.R. F 68 21: 3 - 1*960 - - 7*78 -
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Organs and soft tissues.
W. J. M|49 19: 7 32*5 2*190 I - _ 6*93 _
18: 8 - 2*016 - 6*68 -
K.D. M 50 15: 3 42* 2*121 35 27 7*52 o
4: 4 44* 2*255 17 14 7*45 o
E.D. M 51 7: 7 - 2*868 4 - 8*60 o
J. H. M 52 2: 4 50* 2*125 3 6 7*34 °
A. J. M 53 16: 4 44* 2*061 44 38 7*45 0
24: 4 37* 2*017 25 18 7*56 o
5: 5 36*9 1*884 14 8 7*34 o
P. C. M 54 7: 2 39*4 2*266 - - 7*96 -
14: 8 — 2*008 — 6*94 -
E.P. M 63 24: 1 41*8 2*046 18 11 o
15: 2 41*9 1*823 12 7 - o
E.H. P 64 3: 9 35* 2*058 57 41 7*20 -
M. W. M 65 7: 8 45* 2*450 29 26 - -
F.N. M 66 7: 9 35* 2 *072 46 26 7*31 o
18: 5 28* 2*187 48 16 7* 27
Lupus.
J.W. P 67 12: 3 45*5 1*834 - - 7*25
T.R. P 68 21: 3 - 1*960 - - 7*78
Remarks.
Testis, bladder,etc,
testis, etc.
Addison's + lung, 
kidney.
after nephrectomy 
of one of two 
affected kidneys.
sinus of arm, of 
several years 
duration.
sinuses of abdomen, 
on streptomycin
abscess of soft 
tissues of back
pyelitis 
pyelonephritis
Table - XIII continued a235
Name S
n
No. Date
~ 1PGV.
PLASMA.
/Vint robe 
2SR.
Plasma
Total
Prot.
Gold
Plocvise. Ord. lor.
>0 cs. mm/ 1 hr g./°
Miliary Tuberculosis.
I.D. F 56 10: 5 39 *1 2*342 ~ - 8*06 o
24: 5 35*6 2*235 - - 7*24 o
7: 6 39*4 2*176 38 34 7*74 o
28: 6 41-5 2*357 33 32 8*17 0
2: 7 39*3 2*185 - - 7*60 o
29: 7 38*7 2*204 48 41 7*62 o
12: 8 41*8 2*360 37 37 8*26 0
15: 9 40*0 2*076 25 22 7*12 -
R.D. P 57 18: 3 46* 2 *253 12 17 - ++
13: 4 42*2 2*067 18 18 7*78 +
9: 5 41*4 2*136 12 11 8*17 +
7: 6 39*5 2*000 17 14 8*03 +
6: 7 39*9 1*892 11 9 7*26 +
25: 8 40*6 1*804 6 5 7*09 o
21: 9 41*7 1*805 5 5 7*24 o
20:10 42*0 1*860 5 5 7*38 +++
1:12 49*0 1*755 7 5 6*80 +
4: 1 42*2 1*879 6 6 7*60 +
15: 2 42*6 1*895 6 7 8*03 +
J. S. P 58 13: 4 40*0 2*155 35 32 7*60 o
10: 5 41*2 2*035 21 20 8*06 o
8: 6 43.1 1*827 8 9 7*16 0
13: 7 42*5 1*841 13 13 7*00 o
26: 8 43*2 1*861 10 11 7*27 o
21: 9 42*9 1*821 7 8 7*20 o
IvL. IvL P 59 5: 6 38*6 1*938 32 26 7*24 o
8: 5 - 1*795 10 - 7*30 —
R. G. M 60 2: 5 41*2 1*860 25 17 6*48 +
5: 6 42*9 1*848 15 7 6*48 o
D. B. P 61 10: 5 41* 1 2*273 38 37 7*78 -
24: 5 42* 2*565 26 26 8*39 o
4: 6 39*8 2*662 27 24 8*46 -
25: 6 42* 2*503 31 31 7*97 —
30: 7 38* 2*353 47 39 - —
22: 8 40* 2*239 38 34 7*92 —
17: 9 42* 2*216 33 33
Intestine
P. H. M 62 13:10 36*9 1*863 40 22 6*41
Remarks
on streptomycin
on streptomycin
stopped on 9:7
discharged 
on streptomycin
discharged
on streptomycin
enteritis + 
lung lesion
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Oase No. 44 Acute Tuberculous Meningitis (Pre~ streptomycin)
This man of 32 years was admitted to an asylum because 
he had been showing evidence of mental derangement in the previous 
few days. When I came to examine him physically I found signs of 
meningeal irritation in nuchal rigidity and a positive Kemig test. 
There was an elevation of the temperature and the pulse and 
respiration rates. The optic fundi appeared to be normal. No 
abnormality could be detected in any other system.
A history of headaches in the two weeks prior to his admission 
on 10:4:44 was later elicited.
The laboratory tests on his cerebro-spinal fluid taken a few 
hours after admission strongly suggested the diagnosis of a 
tuberculous meningitis. However, in case a meningococcal or* other 
pyogenic organism cause was being overlooked, a full course of 
sulphonamides was given j this drug had no effect on the T.P. R. , 
which further supports the tuberculous nature of the disease.
The plasma viscosity was estimated on two occasions and the 
value was abnormally high on both; the ESR at the first testing 
was within its normal range.
Date
PCV. | PLASMA VISCOSITY
Max.
Citr.
Serum
Total
Oitr. !Hep. 1 Cor.CitrJ Heparin ESR. Protein
. *
—  {■
cs. mm/hr g;°/o
11: 4:44 
15: 4:44
34 *2 j 
36 *0 j
46 *0 j 
51*6]
1*591 ! 
1*639 |
2*063
2*089
7*2
11*4
6*67
6*67
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10:4:44 - The GSF. removed on this day was under slightly increased 
pressure; it was slightly turhid; it contained 800 cells per cmm. 
which were mostly small lymphocytes; Tandy’s test was strongly 
positive. No organisms could be found in direct films; there were 
no facilities for culture or animal inocculation. Protein content 
was 800 mg. per 100 ml.
13:4:44 - The CSF. was of similar' composition. The cells had risen 
to 900 per cmm. and the protein to 900 iqg. per 100 ml.
17:4:44 - The CSP. was under such high pressure that it spurted 
from the needle. It had become quite turbid and the proportion 
of polymorphs had risen.
Following his admission, he rapidly grew weaker. On the 
15th, he had become unconscious at times. He became mentally 
clearer after the lumbar puncture on the 17th. By the next day 
he was again unconscious; death took place on 19th April. The 
illness had lasted for about 23 days in all.
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Case No. 45 Relapsing Tuberculous Meningitis.
This girl of 19 years was picked up by the Mass Radiology 
Unit on 4:4:50 when all the employees were having a yearly check. 
She was not complaining but did admit to having been tired for 
the previous 2 months during which she had worked overtime; to 
having a reduced appetite recently; and to having a sharp stabbing 
pain at the right costal margin associated with coughing. She 
denied having excess sputum, dyspnoea, night sweats or headaches. 
The skiagram showed an apical lesion plus miliary invasion of both 
lungs.
She was admitted to admitted to hospital for observation. 
Physical examination could detect no abnormality in the chest. 
There was a low-grade pyrexia and her sputum contained tubercle 
bacilli. Her treatment consisted of 12g. of para-aminosalycilic 
acid and 1 g. of streptomycin daily.
In spite of this treatment, she showed signs of meningitis 
in the middle of May; with continued treatment this phase of the 
disease also yielded so that she was discharged on 23:9:50
A skiagram on 27:1:51 could show no evidence of tuberculous 
activity in either lung.
On 7:3:51, she was readmitted to hospital in a comatose 
condition, showing the signs of a recurrence of her meningitis. 
Tubercle bacilli were recovered from the CSP. Treatment *toith PAS.
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Date PCV.
; c/o
PLASMA
vise.
1 Wintrobej
j ESR. Plasma protein.
fOrdT|Corr
1
cs. fmm/ 1 hr
121:11:51; 46*3 1*961 14 20 7*80 5
112:12:51; 46* 1*932 14 19 7*14 4
[ 2: 1:52j 43* 2*011 20 21 7*24 4
Total Al~b. | Glob. | PibrT
g./lOO ml
and Streptomycin was resumed at once and continued until 8:10:51. 
Her meningitis appeared to respond once again as the last positive 
culture of the CSP. was obtained on 7:5:51: nevertheless, the
CSP. did not return to a normal chemical constitution as even by 
1:1:52 the cells numbered 8 per cmm. and the protein amounted to 
60 mg. per 100 ml. in a fluid which was under a pressure of 100 mm. 
Prom October 1951 she lived a normal quiet life in a convalescent 
annexe to the hospital and made no complaints. A skiagram of 
19:11:51 was completely satisfactory, with clear lung apices on 
both sides.
The persistently elevated plasma viscosity values, the 
increased ESR and fibrinogen results, and the progressing anaemia 
all point to the grave prognosis that some organic disease is 
still active. In view of the satisfactory reports on the lungs 
and the abnormal composition of the CSP. I believe that the 
meningitic condition is ohly quiescent and that another flare-up 
is inevitable (typed 11:1:52).
On 16:1:52 the C. S. P. again contained tubercle bacilli.
Case No. 46 Tuberculous Meningitis, with Epituberculosis.
This child was bom on 2:4:48 and had suffered no illness. 
There was no history of tuberculosis in the family and none was 
discovered when his parents and sister were examined as contacts.
The present illness began on 15:6:50 as a palsy of the right 
face, arm and leg; it lasted only 3-4 minutes and had left no 
trace after 20 minutes. On 18th he vomited his tea. By the 19th 
the child was obviously unwell; he began to ask to be put to bed. 
This progressed until the 23rd when he refused to get up, but 
objected to being handled. The doctor found dullness at the left 
lung base, on 24:6:50.
He was admitted to hospital on 26:6:50. He was a pale silent 
ill child. The lung base on the left side was very dull and the 
cause was revealed in a skiagram as epituberculosis with a good 
deal of collapse of the left lung; there was a mediastinal shift 
to the left. A tender mass palpable in the left epigastrium may 
have been the spleen.; the liver was enlarged to a finger-breadth 
below the costal margin. The right pupil was larger than the 
left and it reacted sluggishly to light; the eye fundi were normal. 
The other systems showed no marked abnormality.
A lumbar puncture on this date produced an opalescent CSP. 
under a pressure exceeding 300 mm. The protein amounted to 70 mg. 
per 100 ml; the cells numbered 670 per cmm, nearly all lymphocytes;
the chloride was 620 mg. per 100 ml. , and the sugar 25 mg. /100 ml. 
In spite of the severity of the general upset the temperature 
was 98*4°F. only, pulse was 86 per minute, and the respiration 
rate was 36 per minute.
The plasma viscosity was measured on the day following his 
admission. The value was elevated iin contrast to the low ESR. 
level.
The child was transferred to a sanatorium where he died 
on 19:10:50.
Date PCV. PLASMAvise.
Wintrobe
ESR.
”to*d^ Cor.
Plasma
Total
Protein
Gold
Floe.
% cs. ram/ 1 hr •
27: 6:50 36*4 2*133 14 3 7*63 +
Case No. 47 Tuberculous Pericardial Effusion.
This case is noteworthy in that the plasma viscosity 
value measured at the time when the effusion was forming was 
similar to the viscosity values characteristic of pleural effusion 
formation.
This boy , aged 6 years, had been healthy until 6 months 
before admission to hospital: he had been complaining of pain in
the region of the umbilicus and of vomiting after food, both 
symptoms becoming worse in the last 2 weeks.
On examination at admission on 1:9:47, he was a pale restless 
child, with a purpuric rash over the lower abdomen. His liver was 
enlarged by three finger-breadths; no other abnormality could be 
detected in the abdomen. Cardiovascular system was normal apart 
from a tachycardia (130 per minute). He had a cough; there were 
scattered ronchi in both lungs; the percussion note and breath 
sounds were reduced at the left lung base; respiration rate = 26. 
Temperature = 102*4°F.
He was diagnosed as a case of pneumonia. He was treated 
with 25,000 units of Penicillin 3-hourly and sulphamezathine in 
0*75 g. doses 4-hourly (total =26*25 g. ) until the 7:9:47.
A skiagram of the chest on 3:9:47 suggested a pericarditis 
and the clinical signs were obvious by 5:9:47. There was strong 
pericardial friction over the whole praecordium and the cardiac
Date
.....
Cit,
POV.
CITR.
PLASM
VISC.
T  "
Max.
. Citr. 
j ESR.
, Plasma protein, 
j Total|Alb. |Glob|Fibr
% cs. [ mm/hr j g./100 ml.
11: 9:47 22*0 1*701 ; 46*4
24: 9:47 25*6 1*706 ; 48*4 7*47 13*70;3*35 !o*42
1/21:10:47 28 *1 1*830 j 31*5 s 8*39 ;4*26 3*69:0*44
13:11:47 32 *1 1*618 11*7 S 7*61 3*58|3*74 |0*29 :
_L_ ... 1 1 1 1
dullness area had increased to the left. The diagnosis was made 
of a pericardial effusion, probably tuberculous in nature. The 
liver enlargement was attributed to cardiac failure.
On 6:9:47, 50 ml. of cloudy straw-coloured fluid was aspirated 
from the pericardium, and tubercle bacilli were identified in this 
fluid. The first plasma viscosity estimation was done on 11:9:47.
By 13:9:47 the fluid had reformed so that 115 ml. could be removed.
Calciferol treatment was begun on 21:9:47. The pericardial 
fluid did not reform (as might have been expected because of the 
plasma viscosity value persisting in the ’zone of effusion”). 
Tuberculosis of the lungs became obvious on radiological examination 
so that he was admitted to a sanatorium on 20:11:47.
The serial skiagrams were reported as follows:- 
3:9:47 "Possible pericarditis" (No mention was made of an 
abnormal lung or leural condition. )
18:9:47 Pneumonia of left lung.
25:9:47 Possible bilateral bronchopneumonia.
1:10:47 Bilateral bronchopneumonia, some collapse of left lower 
lobe, and probable effusion at left base.
8:10:47 Pericardial effusion; no present evidence of broncho­
pneumonia; resolution of previous pleural effusion, but with 
exudative pleurisy in left costophrenic angle; enlargement of 
left hilar glands, but no present evidence of tuberculous 
infection.
31:10:47 Resolution of pericardi-al effusion and heart image
reduced in size; some extension from left hilum - suggestive of 
pulmonary tuberculous infection; resolution of the resultant 
pleurisy in left costophrenic angle.
10:11:47 Some haematogenous and lymphatic invasion of the right 
and left lungs.
Case No. 48 Tuberculosis of Spine.
Since the birth of her baby five months prior to her 
attendance at the rheumatism clinic, this patient had complained 
of severe pain in the lower part of the back. The pain was 
constantly present and it was worse at night. Otherwise she felt 
very well. She fed her baby herself for three months. Menstruation 
had not been resumed.
On examination, full movements of the spine could be obtained; 
full flexion was accompanied by some increased pain. The hip and 
the sacro-iliac joints appeared to be normal: there was no muscle
tenderness.
Skiagrams taken on this day showed a collapse of the bodies 
of the 9th and 10th dorsal vertebrae, with a paravertebral abscess 
in the region of the 9th, 10th and 11th vertebrae. The pelvic 
and lumbar bones were normal. The lungs were normal.
The laboratory results on the same day were:-
Plasma viscosity = 2*314 cs.
Blood haematocrit = 38*0 %
Wintrobe ESR. = 43 mm. in 1st hour
Corrected Wintrobe ESR. = 36 mm. in 1st hour
Total plasma protein = 8*06 g./lOO ml.
Gold flocculation = 0
Plasma alkaline phosphatase = 6*8 K.A. units /100 ml.
Case Wo. 49 Tuberculosis of the Spine.
From 1936 until 1939 this female patient was treated in a 
sanatorium for tuberculosis of the 1st and 2nd lumbar vertebrae; 
she was discharged well. In December 1941 her back was again 
painful but she refused to be examined until July 1942 when she 
was again admitted for treatment. Because of mental symptoms. _ of 
paraphrenia she had to be transferred to the asylum in August 1943 
(aged 42 years); she then had an angulation of the spine at the 
region of the 1st and 2nd lumbar vertebrae, with a healed sinus 
in the left groin and a discharging sinus in the right groin and 
in the left lower flank. The discharge from the sinuses was 
intermittent. There was never any evidence of a tuberculous 
infection of the lungs.
It was found that her mental state was greatly inproved when 
she was not confined to bed. She was allowed to move around within 
the asylum grounds provided she rested at other parts of the day. 
This procedure kept the condition active as indicated by the 
evening temperature increase, low body weight, and undiminished 
discharge from the sinuses. She died about a year after these tests 
were made when her intestine became infected by the tuberculosis.
Date
PCV. PLASMA VISCOSITY
ESR.
Plasma protein Serum
WPW.Cit. | P+A. Cit. | P+A. Total Alb. jdobJPib.
13:7:44
"  %
27*0 J 35*7
cs.
1*778 ' 2*412
»
56*2
g./100 ml.
7*29 13 *52!5 *15 10 *62
L. .1... _L _J
mg, yo 
30*1
BSE = maximum corrected citrate
sedimentation velocity (mm/hr-)
Case No. 50 Tuberculous G-lands of Neck.
This case was selected to show how the results from 
different kinds of chronic disease may be almost identical. This 
enphasises the non-specific nature of the plasma viscosity test.
The laboratory results of a nurse who was suffering from 
tuberculous enlargement of her cervical lymphatic glands were:-
Plasma viscosity = 1*978 cs.
Plasma total protein = 7*74 g./lOO ml.
Blood haematocrit = 44*4 %
Wintrobe ESR. = 12 ram. in 1st. hour
Corrected Wintrobe ESR. = 15 mm.- in 1st. hour
These results should be compared with those of Case No. 66. 
where the girl was suffering from an enlargement of the glands 
secondary to a pyogenic infection of the tonsils.
Case No. 51 Multiple tuberculous lesions.
The patient was a man of 52 years. In 1924 he had 
suffered from tuberculosis of the upper dorsal vertebrae, for 
which he spent 2 years resting in a plaster cast; the recovery 
was so good that he could continue with the heavy labour involved 
in working a croft which included the carriage of heavy loads of 
peat. In 1935 his left kidney was removed on account of a 
tuberculous infection.
He was admitted to Montrose Asylum on 18:7:44 after a 
war-time journey from Shetland. His general condition was fair. 
His lungs were normal. His heart size and the blood pressure were 
within normal limits so that there was no indication that the loss 
of a kidney had led to a hypertension.
He complained of a frequency of micturition (every 20-30 
minutes) which had troubled him for 7 weeks. The urine contained 
erythrocytes, leukocytes, epithelial cells, and 0*16 g. per 100ml. 
of protein. Tubercle bacilli could not be identified in a direct 
film of the urine: there were no facilities for culture or animal 
inocculation. The maximum urea concentration after 15 g. of urea 
was 1*1 %
The right epididymis was enlarged to twice the normal size; 
from it a narrow sinus passed to the surface of the scrotum; 
tubercle bacilli were identified in the discharge. The left
testis and epididymis were swollen to a mass of 3” diameter, due
partly to a hydrocele and partly to a tuberculous epididymitis.
PCV. Plasma Viscos.
Date Cit. P+A.
'
Cit. P+A.
% cs.
19:7
18:8
24*1
24-4
32*5 1*677
1*597
2*190
2*016
g. /lOO ml
Serum
NPN.
mg. >o
3*91 2*56 0*46 63*8
3*83 2*43 0*42 46 *8 j
The first plasma viscosity test was made on the day following 
admission: the second test was made after a month during which
he was given a generous diet and adequate rest, while his sleep 
was relieved from disturbance by the wearing of a rubber urine 
receiver. He had shown an improvement by an increase in weight.
The reduction in the apparent toxaemia was reflected in the 
fall in the plasma viscosity. The ESR. increased; the plasma 
protein fractions showed no significant alteration.
The plasma viscosity results fell within that part of the 
total range which has become associated with chronic infections of 
many kinds.
Case No. 52 Tuberculous sinus of arm.
This patient was admitted to an asylum in 1926 at the age 
of 22 years. At that time it was noted that the left lung was 
dull to percussion; the diagnosis of tuberculosis v/as never 
applied, however, and he was never treated as suffering from 
pulmonary tuberculosis.
In May 1941 a large swelling appeared in the soft tissues on 
the lateral side of the left arm, just above the elbow joint; the 
bone was not involved. Pus was later discharged in which no 
ordinary pyogenic organisms could be detected by film or culture: 
tubercle bacilli were never identified either, but the appearance 
of the lesion and its later clinical course made the diagnosis of 
a tuberculous abscess fairly certain. The abscess never healed 
completely. A sinus persisted. Treatment consisted only in 
packing with B.I. P. P.
The plasma viscosity was first estimated in February 1944 
when there was a more acute inflammatory reaction around the sinus; 
the second test was made in August when this reaction had subsided 
and the value typical of a reaction to a chronic infection was
obtained. Max.
Cit.
ESR.Date
PCV. Plasma viscos. Plasma -protein Serum ! 
NFN. jCit. IP+A. Cit. | P+A. Total Alb. G-lob | Pib.
7:2:44 
*14:8:44
%
29-0
27*7
39*4
cs.
1*795 2*401 
1*628 2*008
um/h
42*3
13*2
g./100
7*93 4*05 
6 *94 3 *88
ml. 1
3*30 0*58 
2*69 0*37
mg, jo !
21*5 , 
27*7 I
Case No. 53 Miliary Tuberculosis.
In October 1950 this girl of 19 years had her chest examined 
by the Mass Radiography Unit and the lungs appeared to be normal; 
the examination was made when her staff was being surveyed and 
she felt quite well.
In February 1951 she had pneumonia which ran an uncomplicated 
course. At the beginning of April she was complaining of a 
slight cough; when this persisted in spite of treatment for 2 
weeks another radiographic examination was made and a typical 
miliary tubercuosis skiagram was found.
She was admitted to hospital on 23:4:51. Streptomycin in 
doses of 0*5 g. twice daily and para-aminosalycilie acid in 12 g. 
dosage daily was begun on this same day. She was not very toxic 
and this moderate reaction was reflected properly in the first 
plasma viscosity result of 10:5:51.
At the end of May she became much more ill. Her temperature 
had been normal since the second day of admission; it rose to 
99*5° on 25:5 and reached 101*6° by 5:6:51, and thereafter fell 
slowly again to the normal range which was attained by the end 
of July. The clinician’s could not explain the pyrexia but 
suspected the formation of a new focus. The plasma viscosity 
increased correspondingly and fell more slowly so that it was not 
until August::r that the level of May was regained.
Date ' F IA S M A  rCV. | yjg^
r _
; j/.i utroee
ESR.
Plasma
Total
Protein
Gold
Floe.Ord.jCor.
% cs. mm/ 1 hr g.$
10: 5:51 41* 2*273 38 37 7*78 _
24: 5:51 42* 2*565 26 26 8*39 o
4: 6:51 3S *8 2*662 27 24 8*46
25: 6:51 4-2* 2*503 51 31 7*99
30: 7:51 38* 2*353 47 39 - -
22: 8:51 40* 2*239 38 34 7*92 -
17: 9:51 42* 2*216 33 33 - -
The streptomycin dosage was doubled on 10:6:51 and stopped 
on 26:7:51 after 14 weeks of treatment. It was given again in 
doses of 0*5 g. tvri.ce daily, with PAS (12 g. daily), on 3:9:51 
and continued 25:11:51. She was allowed to get up gradually 
from the beginning of October and had attained 7 hours per day 
at the time of her discharge on 2:12:51. At the time of 
discharge her Corrected Wintrobe ESR. was still 30 mm. in 1st hour. 
Her latest skiagram had been satisfactory, she felt very well, 
there was no evidence of toxaemia, and her convalescence at home 
would be under the supervision of the Chest Clinic.
Case No. 54 Miliary Tuberculosis.
This girl of 16 years was picked up in the Mass Radiography 
Unit on 4:3:49 when small fluffy shadows were detected at hoth 
apices. When she returned for a large skiagram on 14:3:49 she 
had the ''snow-storm'1 appearance typical of early miliary tubercul­
osis. She was admitted to hospital immediately.
She had no signs or symptoms of an active disease process.
She was apyrexial throughout her illness. No abnormality could 
be detected by ordinary physical examination. Gastric lavage 
f failed to reveal any tubercle bacilli on three tests. Lumbar 
punctures of 5:4:49 and 20:4:49 produced normal cerebro-spinal 
fluids.
Streptomycin treatment was begun on 17:3:49 in doses of 0*5 g. 
twice daily; on 21:4:49 this dose was doubled as the skiagram now 
was unchanged and the blood streptomycin level was only 1 unit. 
There was no evidence of toxic effects a£ the high dose and it was 
continued until 9:7:49: total dose = 198 g. Radiologically she 
was then almost clear except for small opacities at both apices 
and in the 2nd. left interspace. Her weight had increased by 4 lb.
Tubercle bacilli were cultured from the sputum of 25:8:49 , the 
only occasion when a positive test was ever obtained.
By 20:11:49 her weight had increased a further 15 lb. and she 
was able to be up for 4 hours daily.
r ..
Date PCV. PLASMv ise .
Wintrobe
ESR.
Total
Plasma
Prot.
_ _ _ _ _ _
Gold
Floe.Ord.[Cor.
% cs. mm/ 1 hr g.%
18: 3:49 46* 2*253 12 17 ++
13: 4:49 42*2 2*067 18 18 7*78 +
9: 5:49 41*4 2*136 12 11 8*17 +
7: 6:49 59*5 2*000 17 14 8*03 +
.6: 7:49 39 *9 1*892 11 9 7*26 +
25: 8:49 40*6 1*804 6 5 7*09 o
21: 9:49 41*7 1*805 5 5 7*24 0
20:10:49 42*0 1*860 5 5 7*38 +++
1:12:49 39*0 1*755 7 5 6*80 + i
4: 1:50 42*2 1*879 6 6 7*60 + !
15: 2:50 42-6 1*895 6 7 8*03 + 1
She was discharged in February 1950. Her skiagram of the 
lungs was normal except for a small scar in the upper left zone. 
She remained well subsequent to her discharge.
The positive gold flocculation tests did not correspond 
to the usual results in tuberculosis and must be attributed to 
liver dysfunction because of miliary involvement.
The ESR. test never became abnormal although the disease 
was obviously active.
The plasma viscosity values showed a significant decrease 
even before there was radiological evidence of improvement. The 
second slight increase was not explicable by a change in the 
clinical assessment. On the whole, the plasma viscosity test 
gives a reliable indication of the pathological processes in this 
patient.
Table - XIV
SYPHILIS
Sex PCV.
/°
PLASMA
v i s e *
Y/introbel Serum |
ESR. Plasma protein \YR Kahrl T re atment
Ord.jCor. [ 
mm/l hr. 1
fotalj Alb. [Glob
g[/lOO ml.
Fib.
q ............................................................... -
(a) Portsmouth patients GENERAL PARALYSIS of the INSANE.
M 49' 1*754 - 6*63 4*16 | 2 *09 0*38 ++ / Penicillin
M 51* 1*813 - 7*27 4*90 j 1*60 0*42 - - » t
F 41*21 1*688 1 1 6*18 4*52 11*38 0*28 / it t>
F 37* i 2*042 17 11 6*20 3 *97 1*81!0*42 - i» it
M 147: ■ 1*981 “ - 6*98 4*30 ! 2 *10 0*551++ 4* Malaria
M j 43 * 2*207 ~ - 7*30
oto• • 2 *33 0*67 - - t
M 147 * 1*998 14 14 6*04 I 3*68| 1*82 0*54 - -
it
M 43' 2*045 20 15 7*24 | 3*68 2 *32 0*54 - 9 it
F 40* 2*082 39 36 7* 92 5-22 2*28 0*42 - - it
F 49*5 1*978 ; 9 17 7*23 4*52 2*26 0*45 ++ + t
F 40*3 1*995 21 19 7*64 4*8 2*45 0*39 ++ + it
F 45*5 2*103 27 30 7*40 4*53 2*37 0*50 / t
F 42* 1*731 5 5 6*48 3*98 1*67 0*43 it
F 48* 1*639 1 6 7*69 4*00 1*57 0*33 - unknown. ??
F 42*1 1*710 4 4 6*23 4*00 2*00 0*23 - unknown. ? ?
F 45*8 1*972 34 40 6*29 4*00 1*77|0*52 ++ 4* none
1
[b) Montrose patients
M 37*4 2*211 _ 6*53 3*59 2*94 0*57 1 Malaria
30* 2*106 “ - 5*69 3*01 2*58 0*66 after 2 *5 months
M 41*5 2*123 - 7*42 4*16 3*26 0*29 Malaria
M 45*3 2*023 - - 7*28 4*75 2*53 0*36 Malaria
M 45*0 2*138 6*85 4*39 2*46 0*32 None 15:2
39*0 2*019 - 6*76 4*07 2*69 0*35 29:2
M 38*8 2*232 - 6*57 3*91 2*66 0*49 None
M 45* 2*212 - 7*11 4*25 2*86 0*41 None
M 42-5 2*107 - - 7*23 4*42 2*81 0*32 None
M 46* 2*040 ~~ mm 6*67 4*18 2*49 0*36 None
Table - xrJ continued
Sex Date PCV. I PLASMA Plasma proteins
4 ;  ^ i 1
cs.
TotallAldlGlobiFibTl Treatment» et=-
7° CS. g./lOO ml.
Cb) Montrose patients . (contd. ) General paralysis.
M
7:10 
13:10 
29:11 
6:12 
7:10
I 8:10
I 9:10
I 26:10 
: 26: 1
M i19:10 
:20:10 
i 21:10 
?22:10 
I 25:10
41*5
42*0
31*4
•4
•7
*6
2*267
2*186
2*040
2*364
2*170
1*956
2*014
1*954
1*891
1*956
2*000
1*991
1*988
2*011
2*042
1*953
1*934
•77
•54
•84
•60
•42
•11
'38
15
37
86
90
98
89
i 6*38 
; 6 *09 
: 5*52
2:11 45 *4
23:11
6:11 39 *4 
35*0 
38*7 
37*5 
34*0 
43*6 
43*5
47*0
50*0
33*0
13 f 11
22:11
22:11
26:11
22:12
7*40
7*65
6*17
| 4*39! 
! 4*27!
•45
•58
•68
•48
•79
65
02
*39
*27
•39
•02
•74
•63
•59
0*411
0*35
0*41!
0*37 f
0*53 j
0*45!
0*44!
4*22
4*13
4*18
4*29
4*06
•60
12
4*08 2*30 
3 *55 2 *54 
2*73 2*79 10*27
Just infected with 
malaria.
Rigors begun
M rl
No records
2*50i0*30| 
2*35|0*32| 
2*64!0*29 I 
2*7710*33 I 
2*80. 0*36 I
No records
0*36 j
0*43 ! 
0 *41'
3*55 2*33|0*47S 
3 *52 1*93 j0 *38 | 
3*51 1*9810*45 | 
3*36 2*17|0*44j 
3*54 2 *00j0*50 |
4*84 2*96:0*39 | 
4*29|2 *91)0*42 j
4*71 2 *69|o*29 
5 *05|2 *60jO*27 
2 *69 13 *48 f0 *13
No treatment.
Malaria infection 6:11 
Rigors began 22:11 
died 4:12 
No records
Also cancer of colon, 
with liver deposits. 
Died 25: 4 
No records
No treatment
Malaria infection 30:11
Rigors began 5:12
N. B. - The Montrose proteins were measured by an accurate
micro-Kjeldahl technique, as contrasted with a Biuret 
method at Portsmouth. In the latter the globulin values 
are significantly lower and they should be viewed with 
suspicion. The increased globulin levels of the Montrose 
results are more in accord with other published values 
and they are accepted as accurate and used in the 
discussion.
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c ’ Tt urnr PLASMSex Date PCV.
V jLo O
70 1 cs.
TABES DORSALIS.
Plasma protein 
P T ot alj Alb.j Globj Fibr.
g./lOO ml. ' _
Remarks
' M 125: 1 
s 8: 2 
1 21: 3 
111: 5I
! 50* 
49 • 
49* 
44*0
2*030
1*930
1*958
2*037
-
-
? activity
29:12
1
I
23*7 2*494 7*38 - - - Charcot1 joint + 
fractured femur
_F !15:12
5: 5
44*6
43*0
1*801
2*384
6*84
8*68
_ Aged 40; congenital; 
assessed as "burned 
out" by clinician.
? activity
M 10: 6 2*182 6*98 - - ? activity
M 17: 7 45 *8 1*949 7*31 - - - Charcot' joint
M to H O 41*0 1*955 7*63 ? activity, after 
treatment with 
penicillin.
F 20:10
23:10
25:10
40*2
38 *6
39 *5
2*040
1*992
2*040
7*38 
7* 02 
7*20
-
_
-
Tests during 
treatment with 
penicillin.
CEREBRAL SYPHILIS.
M 29: 7 _ 2*080 6*80 — —
M 23: 2 47. 1*945 6*81 4*02 2*45 0*34
TERTIARY SYPHILIS, not affecting the O.N.S. specially.
F 10: 4 
•
36 ‘4 1*935 7*31 Lues, negative W.R. 
for 3 yr., which 
relapsed repeatedly 
in spite of courses 
of treatment.
Case No. 55 General Paralysis of the Insane.
This male patient was admitted to the asylum with the 
mental symptoms of grandeur etc. which are typical of G.P. I. He 
was then 42 years old, he had been mentally changed for about a 
year, but there was no information available regarding the date 
of the primary infection of any subsequent treatment.
No physical disease was detected apart from the syphilitic 
infection.
The plasma viscosity was measured before malarial therapy 
was begun.
Date PCV. PLASMA ESR. Plasma protein Serumvise. TotaljAlb. jGlob Fibr. NEN.
26:11:43
%
50*0
cs.
2*037
g./100 ml.
7*92 |5*05]2*6010*27
mg./*
26*9
These results are noteworthy in that the plasma viscosity 
value comes within the "zone of chronicity" and the abnormal 
viscosity is associated with plasma protein fractions which all 
come within the limits of normal values for these substances; yet 
the plasma viscosity is ultimately dependent on these protein 
fractions.
Case No. 56 G. P. I. plus von Recklinghausen* s Disease.
This man had suffered from von Recklinghausen’s disease 
(general neurofibromatosis) since birth. He was infected with 
syphilis at the age of 17 years and he then received some treatment 
which seems to have been half-heartedly applied. He again was 
treated with bismuth and arsenic when he was 46 years old but 
two years later he was admitted to an asylum with the symptoms 
typical of general paralysis of the insane. A general examination 
revealed no active organic disease apart from his cerebral 
condition, but he was not considered strong enough to undergo 
malarial tharapy.
His tests, made within a few weeks of admission, show the 
plasma viscosity values within the "zone of chronicity" and the 
the individual plasma protein fractions within their normal 
ranges. As these results are similar to the others found in cases 
of tertiary syphilis, it is probable that the widespread but 
simple tumour has not affected the proteins or the viscosity.
Date Tpcv. |PLASMA IeSR. 
1 I vise. |
Plasma protein Serum
Total Alb. Glob jFibr NPN.
j .„ ! : 
: % j CS. g./100 ml. I mg'°/o
I
15:2:44j36*oi 2*138 j - 
28:2:44j31*5j 2*019 j -
7*21
7*11
4*39
4*07
2*46
2*69
0*361 27*7
0*35 23*4i
Case No. 57 Tabes Dorsalis.
This female patient was referred to a V. D. clinic when her 
22 year-old daughter was found to he suffering from congenital 
interstitial keratitis. Her mother had not known of her infection 
and had received no treatment.
The patient .had no symptoms hut signs of tahes dorsalis 
were discovered. The pupils were small, not quite circular, and 
they reacted slowly to light (direct and consensual) and rather 
slowly to accommodation. The fundi were normal. The ankle and 
knee jerks were absent on hoth sides. No other abnormality to 
physical examination could he elicited, and a skiagram of the 
chest was normal in appearance.
Blood:- Wassermann = + ; Kahn = weak +ve .
C. S. P. Cells = lper cmm. ; protein = 25 mg./lOO ml. ; Pandy test 
= negative ; Wassermann = ++; Lange curve. = normal.
Total
Date { PCV. f 1 ESR1 * [ v i s e
•0! 2*384
A plasma viscosity result which came within the “zone of 
chronicity” would have been expected, and no explanation of this 
higher value was ever discovered, in any disease additional to 
the syphilitic infection.
Case No. 58 Tabes Dorsalis, plus Charcot’s .joint.
This male patient was infected with syphilis in 1959 but did 
not attend a clinic until November 1942. During the next five 
years he received regular courses of Bismuth and Tiyparsamide 
injections.
By chance, in January 1947, he received a general examination 
and a well-advanced Charcot’s joint of the left knee was found - 
he had never complained of any trouble with this knee. The 
quadriceps muscle was wasted; the tibia was displaced laterally; 
the knee was not "flail" but all the ligaments were stretched.
The knee was supported in a leather splint which allowed him to 
get around quite comfortably. Bismuth and arsenic treatment was 
resumed. A course had just finished on 10:7:48, with the Kahn = % 
and the Wassermann still positive (+).
PCV. PLASMAvise.
! Wintrobe j 
ESR. ! 
Ord.ICor. |
Plasma
Total
Protein
°/0 i
cs.
— —T— ..j"
mir/ 1 hr | „  o7g./°
17:7:48 45*8 1*949 20j 19 | 7*31
The clinician in charge of the patient agreed that this 
abnormal plasma viscosity value could be interpreted as indicating 
a continued activity of the syphilitic condition and the need for 
further anti-syphilitic therapy.
Case No. 59 Cerebral Syphilis (Pachymeningitis syphilitica)
This man, aged 59 years, had had no anti-syphilitic treatment 
prior to his attendance at a V.D. clinic in the spring of 1948.
He was treated for 4 months.
He was admitted to hospital on 24:7:48 on account of 
weakness of both legs, more marked in right, of 3 weeks' duration. 
The weakness was well-marked after 2 days from onset.
On examination, no abnormality was found in any system apart 
from the legs. Both legs were weak;. The deep reflexes were 
brisk except for the left ankle jerk which was diminished. There 
was impairment of the pain and touch sensations below the right 
knee.
Cerebro-spinal fluid:- Cells = 4 per cram, (lymphocytes); Lange - 
normal; Wassermann - negative; chlorides = 740 mg./100 ml. ; and 
protein = 20 mg. /100 ml.
29:7:48 Plasma viscosity = 2*080 cs.
Total plasma protein = 6*80 g./100 ml.
The date of the primary infection could not be obtained.
Case No. 60 Cerebral Syphilis.
This man was aged 63 years at the date of estimation of 
his plasma viscosity.
He was admitted to Montrose asylum on 29:7:42 because of 
his mental symptoms. No details could be obtained regarding any 
previous anti-syphilitic treatment.
On admission, he was a rather weak old man but he was able to 
be up in the ward and carry out a few minor tasks to assist the 
nurses. No definite disease condition was ever detected, apart 
from his cerebral syphilis.
On 26:8:42, treatment was begun with 3 g. of Tryparsamide, 
which was discontinued on 10:11:42, after eight injections, 
because of failing eyesight. By the beginning of 1943 he had 
gone completely blind, and thereafter, for his own safety, he had 
to be confined entirely to bed. There had been no further 
deterioration in his mental and general health when his plasma 
viscosity estimation was made on 23:2:44
PCV. Plasma Tp^ -p T  Plasma protein SerumNPN.Vise. Total Alb. | Glob Pibr
% cs. g./lOO ml"
1*945 J - j 6*81 |4*02 2*45j0*34
mg* 7°
27*1
Note how the plasma viscosity is abnormally high and 
just below the usual range of the "zone of chronicity".
Note also how the plasma viscosity is abnormally high while the 
plasma protein fractions, on which the viscosity ultimately 
depends, are all within the ranges of "normal" values.
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Case No. 61 Acute gonorrhoea, with arthritis.
This male patient was admitted to hospital on 14:12:47 
with acute gonorrhoea plus an acute swelling of the right ankle 
and foot - diagnosed as gonococcal arthritis.
Treatment consisted of magnesium sulphate and glycerine 
dressings to the foot and ankle and of 640,000 units of penicillin 
given over 4 days beginning on 16:12:47. He was discharged on 
31:12:47 to attend the Rheumatism Clinic where he received short­
wave diathermy because of restricted ankle movements, and later 
in February he had wax baths and exercises. All treatment was 
stopped on 15:2:48 and he remained free from complaints.
The plasma viscosity value was initially increased and its 
decrease corresponded with the amelioration of the affected joint.
Date PCV. PLASMAvise.
Maximum 
Sed. Velocity
fo cs. ram. / hour
17:12:47 45 *2 2*016 135*7
4: 1:48 47 *8 1*847 38*0
15: 2:48 48*5 1*765 10*5
Case No. 62 Lymphogranuloma inguinale.
Four weeks prior to admission to hospital, this sailor was 
infected in Spain. He had a history of typical swollen and 
matted inguinal lymphatic glands, of 10 days duration. He had no 
primary sore or urethral discharge; the Wassermann and Kahn tests 
were later proved to be negative.
On 26:2:48, on admission, he looked ill. His pulse, temperature, 
and respiration rate were elevated. The inguinal lymphatic glands 
were swollen, matted, tender, and painful. No other active 
organic disease was detected.
Treatment was begun at once with sulphathiazole (5g. and then 
3 g. daily to a total of 24 g. ) and with icthyol and glycerine 
applied locally.
On the second day the laboratory tests were:-
Date iPLASMA^ \ Plasma protein J Serum j G-old
■ v ise .
.
27:2:48
7o cs.
47*4 2*258
BSR1 T otaljATb.fG-lob fFibr. j NEN. Floe
ml. j mg. fo j
•41 15 *1212 *8110 *«8 1 21*3 j o
On 27th also, he received 15 million TAB. intravenously.
His recoveiy was rapid, so that he was discharged on 6:3:48.
These results correspond to the findings in a reaction to an 
infective process of moderate severity and show no feature 
characteristic to this disease.
SEPSIS and SPECIFIC FEVER
Name S No. Date
| E.S. R. Total
Plas.
Prot.PCV.
PLASMA
vise. Max.
Wintrobe 
Ord. Cor.
% cs. mm/ 1 hr fo •
(A) Skin. + Soft Tissues.
A.B. M 1 9: 9 37*5 2*330 24.1 - - - septic toe.
M.H. P 2 1:11 42*3 2*624 49*1 - - 7* 33 bed sore, moribund
W.B. M 3 9:11 39*5 2*603 !47*8 ~ - 7*79 bed sores.
D.E. M 4 1:12 44.0 2*172 29*8 - - 7*10 mltiple septic spotj
G.L. ; M 5 6:12 - 2*515
! - - 6*91 H tl tt
W. H. Mj 6 7: 1 - 2*174
_ - 7*92 Legs and hands,! rant!
D.L. 7 11: 1 - 2*634 ~ - 7*80 sptic knee- severe
J.M. :m 8 8: 2 - 2*313
_ - - 7*05 abscess of thigh
W.R. m 9 11: 2 - 2*535 _ - - 7*75 severe abscesses of
; i14: 2 - 2*480 “
_ - 7*71 ankle and groin.
i 19: 2 41*7 2*278 18-7 - - 7*39
24: 2 - 2*236 - - - 8*77
6: 3 - 2*268 - - - 8*21
C. P. M: loj 2: 2 - 2*487 - - 7*40 sepsis of face
E.S. F n; 22: 2 - 2*248 - - - hands and leg.
H.P. M 12! 7: 3 “ 2*177 - “ 7*42 nose and scalp
: 9: 3 2*137 — - 7*46
10: 4 21*3 it2*021 2*5 - - -
J. C. P 13!10: 4 - 2*167 - - 6*16 abscess of buttock
A.B. M 14:21: 3 !3 *034 - - 7*24 gangrene of foot
I.R. P 15 112: 4 39*5 12*450 i 62 *5 - - 7*13 gangrene of foot127: 4 35*0 2*325 54*2 - 6*64
F.D, M 16 j19: 4 47 *8 j2*455 35*8 i 7*25 am 7*16 sepsis of elbow
19: 4 44*4 j2*306 11*5 1*30 pm 6*87Si
20: 4 44*8 |2*280 |23*0 1*55 pm 6*69
[28: 4 42*2 2*062 48*9
6*59
S.C. P 17 |10: 5 *40*2 |2*459 38*9 | - - 6 *48s
K.W. P 18 -21: 7l37*7 2*693 40*7 I - - 7*56 sepsis of knee
29: 7 36*0 3*138 53*3 i - - 7*99
J.C. P 19 27: 7 37*2 2*468 72*4 - - 6*89 sepsis of leg
W.R. M 2° j16: 8 - 2*068 - - - 6*70 abscess of shoulder
I.R. P
21 1: 5
43*9 2*171 - - - 7*92 axillary abscesses
E. P. M 22 10: 4 47* 1*960 - 9 9 7*78 chronic sepsis of
! arms.
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E. S. R.
PLASM 
Vise. Max.Date PCV
ZTTotaT
Wintrobel Plas.
I I seP P ro t*
mm/ 1 hr
Remarks
(a) Skin and Soft Tissues, (contd.)
J.C. M 23 19: 2 - 1*978 - - 1 - 7*81 abscess of shoulder
S.M. M 24 13:12 43* 1*903 - H 9 7*27 skin sepsis.
M.T. F 25 24: 4 34*2 2 *885 47*5 - - 7*97s mastitis
25: 4 31*6 2*737 24*2 - - 7*84s
27: 4 31*1 2*807 16*9 - - 8 *32sj
4: 5 29*5 2*760 35*8 - - 7*38
12: 5 27*3 3*078 55*3 - - S*07s! died of toxaemia
24: 5 24*0 2*501 21*7 - - 7 *31s| on 5/7.
T.T. M 26 23: 5 43 *4 2*293 18*3 - - 7 *22s chronic sepsis of
24: 5 47*1 2*530 !26*8 - - 8 *04s skin + more acute
29: 5 39-8 2*270 |12*6 " 1 - 7 *lls 1 abscesses.
(b ) Lungs.
G-. L. M 27 6:12 - 2*515 - - - 6*91 | pulm. congestion
J.M. M 28 23:12 - 2*175 - - - 6*34 1 pulm. congestion
\ + fract. femur.
G.M. M 29 25:12 - 2*007 - - 6 *46s j acute bronchitis.
C.H. M 30 6: 1 41*7 2*244 37*5 - _ 7*64 ! pulm. congestion
J.M. F 31 22: 1 - 2*332 - - - 8*04 1 acute bronchitis.i
C. H. M 30 25: 1 - 2*773 - - 9*04 | pulm. congestion.
M.H. P 32 27: 1 - 2*533 - - - 7*69 J pulm. congestion.
3: 2 — 2*557 - - - 7*40 31
C.C. M 33 7: 2 45 *0 2*267 46*3 - - 7*08
5
1 pulm. congestion.
21: 2 - 2*269 - - - 7* 28
11: 8 - 2*218 - - - 7*06 1
I.R. P 34 27: 3 - 2*167 - - • 6*62 | bronchitis.
A.L. M 35 13: 5 42 *4 2*061 17*8 - j " 7*31 | bronchitis.
W.P. M 36 18:12 46*1 2*125 - 19 18 7*15 | bronchitis, chronic
M. S. P 37 25:11 41* 2*029 - 21 20 7*99 \ cold in head.
P.V. P 38 17:11 40 *5 1*915 - 18 16 7*20 j common cold.
M.B. _P 39 4: 1 _ 2*064 - - 6*10 ; dry pleurisy
18: 2 - 2*101 - 6*56 j
M.D. P 40 25:11 42*8 1*925 - 6 7 7*81 | pleural pain,
16:12 43 *7 1*863 - 6 8 7*27
[ ? cause
M.H. P 41 9: 5 4o* 1*965 _ 45 41 6*48 | recovering from
atypical pneumonia
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S No.
E.S.R.
PLASMA 1 | Wintrobe
VISC. I Max. R)rd. [ Cor.
Total! 
Plas. j 
Prot. i Remarks.• r cs. 1 !mny/ 1 hr 1 %
(c) Miscellaneous infection. . :
J.B.j M|42 9:11 45*5 2*279 ! - 1 - 1 - 8*54
j
I
| septic teeth
H.W. F 43 1:11 42*3 2*624 49*l] -! - 7*33 cholecystitis
M.W. F 44 16: 2 - 2*165 1 - 7*49 pyelonepritis.
; J.C. 45 10: 7 149*2 2*057 j - - 1 7*49 choroiditis, with
| 1 chronic sinusitis.
;M. K. F 46 17:11144*7 2*045
! i -
8*35! cystitis.
jP,D. M 47 22:11 “ 1*996
( sj i
1 - 7*31 cystitis.
jp.s. F 48 13:12 |42*0 1*998 - 14 1 14 j 8*06 tonsillitis, with
1 i | gland enlargementS. L. F 49 17: 3 “ 2*238 - 54s & - i 7*45 salpingitis.
Gr. H.j M 50 14: 4 140*1 2*063 6*42 appendix abscess
J.B. F 51 12: 4 32*7 2*197 - 7*75 bilateral otitisj media + purpura.
|
| (D) Specific Fevers.
i j. s. M 52 17: 9 141*5 ! 2.267 |34*8! - 1 - 1 7‘18 malariaI 13:10142*0 2*186 24*3; - J - 1 7*89
i 29:11j31 *4 2*040 ! 8*2 ! " i ~-I ! 6*25
6:12 ! 2*364
t _
! j 6*97
J.C. M 53 23:11143*3 1*953 j !i 1 ! _ i 6 *50 malaria
29:11(35*5 I 1*934 V. „ S w ; (
i 5*79
W.P. M 54 22:12 j - 2*042 1 - 6*30 malaria
T.S. M 55 14: 9 ;39*1 2*758 : - I - \ | 6-85 paratyphoid B
27: 9 41*3 2*808 35*0 ] - | - | 8*07
M.F. F 56 24: 9 38*0 to • o CO 17*2: - 1 - 1 6*91 dysentery
M.H. F 57 29: 1 - 2*104 • -  ^ -
i
\ i 6*93! dysentery
C.P. F 58 2: 2 - 1*913 -• “ s -
}i
j ~ ! 5*97 dysentery
K. A. M 59 15: 1 43*2 2*920 | - 24 19 8*53 amoebic hepatitis
21: 143*0 3*103 \ ~ i 39 32 9*43
R.T. M 60 25: 2 - 2*158
;
j i “ 7*26 erysipelas
S. S. F 61 29:10 41*0 2*878 81*3 - - 6*94 lobar pneumonia
M.B. F 62 13: 3 39* 2*142 j - j 44 38 7*31 t» i
E.C. F 63 2:12 - 2*043 ■ ! " 6*52
! H
G.H. F 64 25:12 - 2*438 - 1 - 6*88
It I
W.B. M 65 9:12 2*300 - 7*57
I I
3: 1 - 1*985 - — 7*75
___ ! __.....I...... — ..— -—— — — —---- - -----
Case No. 63 Acute Sepsis.
Acute cholecystitis + cholangitis.
This elderly man of 75 years had begun to complain of epigastric 
pain. Thereafter he had a fairly rapid onset of jaundice, a 
dark-coloured urine, and clay-coloured stools. He was not 
admitted to hospital until 8 weeks after the onset of his first 
symptoms.
The laboratory results were obtained on the day after 
admission. They supported a diagnosis of an M obstructiveM type 
of jaundice and an inflammatory primary cause (high fibrinogen 
and albumin) rather th^n malignant. At operation, six days later, 
pus was found in the peritoneum, sealed off by adhesions, 
surrounding an empyema of the gall-bladder. Death ensued and at 
the post-mortem it was found that the infection had passed up into 
the liver without the actual formation of abscesses.
PCV.
PLASM Plasma protein Ser. Serum Thymol
vise. Total Alb. GlobjPibr. Npn. Bilirubin Turbidity
% cs. g. / 100 ml mg.% mg.% unit
39*6 2*401 7-76 | 3*94 2*97|0-85 36-3 19-2 1
Serum alkaline phosphatase = 30*6 K.A. units/100 ml.
Case No. 64 Sepsis of Knee, + Terminal Decay.
This female asylum patient was comp 1 ainin^ continually of 
aches and pains for which no cause could he detected so that when 
she did eventually develop a sepsis of the knee joint the disease 
had progressed far before it received attention. She was 63 years 
old but did good work in the kitchen.
On 14:7:44 the knee was first seen and treated with heat 
applied to the part, eusol dressings, and rest. No improvement 
was obtained. On 19:7:44 the knee abscess was incised; sulpha- 
thiazole treatment was also begun. The knee continued to discharge 
until the first few days of August when a satisfactory healing 
ensued and the drug was stopped.
While she was in bed her doctor took the opportunity of 
over-hauling her thoroughly. He found that her rotundity was due 
in part to a large cyctic growth of the ovary which he considered 
to be malignant in character. She was allowed to remain in bed.
Hypostatic pneumonia was detected on 14:8:44. She died on 
17:8:44.
The first three plasma viscosity results show the normal 
rise with a severe pyogenic infection and fall as the infection 
healed. The fourth value is lower than the third at a time when 
a rise would have been expected because of the intercurrent 
additional infection by the hypostatic pneumonia and this further
a270
PCV. PLASMA VISC
Max.
Cit. Plasma protein
% cs.
.
mci/h g./100 ml
21:7 28*2 37*7 1*874 2*693 99 * 7*56 3*96 2*61 0*99
29:7 26*5 36*0 2*083 3*138 116 • 7*99 3*56 3*59 0*84
1:8 27 *6 - 1*978 - 106* - — —
15:8 21*1 - 1*806 - 60* - _ _ _
Serum 
NPN.
decrease had to be interpreted as a terminal decay.
There is no guarantee in dealing with serial tests at such 
long intervals that the plasma viscosity had not actually fallen 
to a low abnormal or even to a normal value by about the 10th of 
August and that the final value did not, in fact, present a time 
increase in response to the pneumonia. Further criticism to the 
assumption that the 4 plasma viscosity points were to be joined 
into a smooth decay curve can be found in the fact that this would 
indicate a plasm viscosity value (at 'death) of approximately 
1*77 cs. which is a high abnormal figure; the criticsm might be 
countered by the claim that the hypostatic pneumonia interfered 
so suddenly with the gradual terminal decay due to the sepsis and 
malignant tumour that the curve was never given its true length. 
Caution must be exercised against trying to derive more information 
from the laboratory tests than one is truly justified.
(See fig. 93, page 367. )
a270 (b)
Case No. 64 (b) Terminal Decay in Acute Intestinal Obstruction.
This case is included to illustrate the speed of the 
terminal decay and protein changes in an acute abdominal 
catastrophe.
In August 1943 this female patient of 56 years had a colostomy 
operation because of an intestinal obstruction due to a volvulus 
(part of bowel affected is not known). She took a long time to 
recover from her operation and the surgeon did not undertake to 
close the colostomy.
On 20:1:44 she complained of a cold in the head and of 
general malaise. On 27:1:44 her abdomen began to become tense 
with a recurrence of an intestinal obstruction; the surgeon 
thought she was too weak to stand Agaihaad surgical interference.
She died on 30:1:44. There was no post-mortem.
The laboratory tests were made on 27th and 29th. The high 
fibrinogen and low globulin were indications of an acute reaction 
as contrasted to the expected findings in a chronic infection or 
malignant tumour.
j J | Max. 
Git. [PLASMA VISC. j Git. 
Date | PCV. |Citr. ”|p+A. 1 ESR.
Plasma Protein Serum , 
NPN. ITotal Alb. jG-lob jPibr.
27:1:44
29:1:44
% cs. mio/h
57*0 1*954 2*840 109*0 
34*21 1*757 2*413 | 78*8
S-/
8*10
7*01
/100 ml.
4*05 2*9111*14 
3*40 2*64j0*97
mg. %
118*4
148*4
Case No. 65 Subacute bacterial Endocarditis.
This girl was 17 years old at the time of the present 
illness. Seven years previously, she had been in hospital for 
6 months because of acute rheumatic fever which involved the mitral 
valve; a recurrence, four years later, did not cause any more 
cardiac damage but she again required hospital care for 3 months.
This illness began as a sorethroat, about 10 weeks prior to 
admission; treatment consisted in penicillin tablets to suck. Two 
weeks later pain developed in the left shoulder; she was confined 
to bed for 2 weeks and received no specific treatment. When she 
resumed work she found that the fingers of both hands were painful, 
and that her ankles were swollen at night if she had been standing 
all day. Three weeks later she had a return of the pain to the 
left shoulder; one week later she was admitted.
On admission, she was in a dirty untidy condition; she was a 
poor witness. There were no clubbing, no cyanosis, no splinter 
haemorrhages, and no purpuric spots. The pulse rate was 160 per 
minute. Blood pressure equalled 90/60. The heart size was within 
normal limits; the apex beat was 5*5,f from the midline in the 5th 
interspace, with no palpable thrill; an apical blowing pre-systolic 
murmur was conducted into the axilla. The liver edge was tender 
where it just projected below the costal margin; the palpation of 
the spleen produced pain without detecting the organ with certainty.
Date PCV.
PliASPA
v i s e .
vVintrohe
iliolrt.
Ord.jCor.
Plasma
Total
Protein
7° cs. ram/ 1 hr g-%
17:12:51 38*2 2*131 40 33 7*78
31:12:51 41* 2*000 24 23 —
7: 1:52 41* 1*905 15 13 7*34
15: 1:52 40* 1*783 15 13 7*06
Nothing could he detected abnormal in the shoulder joint apart 
from the slight tenderness.
When she was admitted on 21:11:51 the diagnosis was that of a 
recurrence of the rheumatic fever and she received sodium salicylate 
in doses of 30 grains three times per day; vitamins and iron were 
also administered. The initial temperature of 102°F. fell only 
to 100*6.
The "blood culture examination detected a streptococcus 
viridans infection; the organism was sensitive to penicillin, 
streptomycin, aureomycin, and Chloromycetin to a normal degree.
The salicylate was stopped on 25:11:51. On the same day 
intramuscular injections of penicillin were "begun in doses of 
1 million units 6-hourly. The evening temperature still rose to 
100*6°F. until 4:12:51 and to 99°F. until 11:12:51. Increasing 
the dose to 1*5 million units 4-hourly, on that date, caused the 
temperature to remain "below 98*4°F.
The penicillin was stopped on 17:12:51 in favour of aureomycin 
in doses of 1 g. four times per day • The plasma viscosity on that 
day showed a low abnormal value.
The temperature rose to 100'4°F. on the 18th; penicillin was 
promptly resumed. After another peak to 100*6°F. on 19:12:51 
the temperature was never again abnormal. The combined treatment 
with penicillin and aureomycin produced a satisfactory clinical 
response as judged by the patient’s condition; the blood culture
t
became negative; and the laboratory tests were normal by 15:1:52.
a274
Case No. 66 Chronic Sepsis.
This girl of 11 years suffered from chronically infected 
and enlarged tonsils, with secondary enlargement of the lymphatic 
glands in the neck. There was no other abnormality.
Date j PCV. PLASMAv ise .
Wintrobe
ESR.
"OrdTCor.
Total
Plasma
Prot.
'  ^  
315:12:471 42*
cs.
1*998
im/ 1 hr 
14 14
t , —
&•%
8*06
These results show the slightly raised plasma viscosity 
associated with a relatively greater rise in the plasma total 
protein which is characteristic of a chronic disease process.
It should be noted also that these results for a pyogenic 
infection cannot be distinguished from those of a tuberculous 
infection, such as in Case No. 50 .
Case No. 67 Chronic Skin Sepsis.
This woman had suffered from skin sepsis for 10 years.
At first it affected the face, chest, shoulders, arms, and legs. 
Three years ago it had affected the* axillae and these regions 
were the chief cause for her complaints. During these ten years 
it was seldom that her skin was completely free from an abscess 
somewhere.
Her own doctor began a course of injections but discontinued 
this because of abscess formation at the sites of injection. 
Penicillin cream, applied locally, was at last producing some 
improvement. Her Wasserraann was negative.
On general examination, no abnormality could be found apart 
from the skin. Scars from healed abscesses were seen on all 
parts. The skin in both axillae was moist, darkened and indurated. 
In the left axilla there were several small indurated discharging 
abscesses. The axillary glands related to the axillary drainage 
were enlarged.
Plasma viscosity = 2*171 cs.
IBQasoda haematocrit = 43*9%
Plasma total protein = 7*92 g./lOO ml.
Table - TTL a276
SARCOIDOSIS.
• - - - .... -
Name S L
r...
PCV. PLASMA
vise.
Wintrobe
ESR.
0rd.bor.
Plasma protein 
Total! Alb. jG-lob |Fib.
G-old
( Ploc.
i
; °/o cs.
,
mm/l hr g./lOO ml. ;
I /
P. H. P | 1 : 40*4
.
1 1*998 - - 7*70 - - 1 -
i
■ O
A. C. P 2 ; 39*
|
2*468 44 38 8*17 4*0 4*0 lO *38 +++ 26:2 preg.
1 43 *8 2*354 18 20 7*00 4*6 2*08 jO*32 +++ 11:12
M. L. P 3 1 41*5c 1*877 10 10 6*91 4*5 2*6 j0*35 + parotid
M . W . P 4 I 4-2 ‘0 2*137 27 27 7* 35 4*50 2*45 jo *58 o only
L.L. F 5 40*5 1*987 15 15 7*67 4*90 2*54 |0 *36 0
M . C . P | 6 ; 46*3 2*518 16 20 8*96 4*9 2 *97 10*53 +
M. H. P 7 43*5 2*055 12 14 8*15 4*6 3*2 0*35 ++++
M . T . F 8 42*0 2*207 34 34 8*37 4*7 3*30 i0*37 +++
M.K. P 9 43*3 1*919 31 35 7*12 4*60 j 2 *10 |0*42 +
P. C. P 10 45* 1*923 13 19 7*20 - - - -
0. H. P 11 43* 1*995 35 37 o
D. A. M 1 1*922 6 7*60 5*0 2*36 0*34 o 24:10
50*5 1*893 1 6 - - - 0-*31 + 24:11
P.L. W 2 47* 2*180 15 15 8*90 5*0 3*53 0*37 0
M.G. M 3 49*8 2*001 7 10 7*70 4*9 2*45 0*35 o
P.B. M 4 4!*! 2*103 32 23 7*70 5*00 2*35 0*35
+
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Case No. 68 Sarcoidosis.
This man had had an irido-cyclitis of the left eye in 
1945; his right eye became affected three months later. He had 
lost some weight; his Mantoux test was negative. With prolonged 
treatment, his eyesight had returned to normal by 1948. The 
eye lesions were diagnosed as tuberculous.
A skiagram of his chest showed some enlargement of the 
superior mediastinum for which the radiologist thought the most 
probable diagnosis was lympho-sarcoma.
This diagnosis was discounted when he remained well and 
no change had occurred in -the skiagrams by 1948. In March, 1949, 
he had a flare-up in some lymphatic glands of the neck - probably 
due to a septic tooth; the skiagram of the chest had still not 
altered. A gland was removed from the neck for histological 
examination: the histological features were those of sarcoidosis. 
Since that date the size of the mediastinum has gradually reduced 
so that by the summer of 1951 the skiagram was virtually normal in 
appearance.
Nevertheless, the plasma viscosity in January 1952 persisted 
in the "zone of chronicity".
Date PCV.
PLASMA J Wintrobe
VISC. i— i t p k  j 
I Ord.jCor.
Plasma protein ! G-old
Totalj Alb. !G-lob fPibr j Floe.
g. /100 ml. |
7-70 | 4*9 j2-45jo-35j o14: 1:52
%
49-8 j
cs. |mm/ 1 hr
2*001 | 7j 10
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Case No. 69 Sarcoidosis.
The disease had been present in this female patient for at 
least eight years when the plasma viscosity was estimated; the 
viscosity gave a result typical of chronic infection.
In 1944 she complained of bronchitis and pain in the chest 
but the chest physician obtained no evidence of tuberculosis. She 
also suffered from irido-cyclitis of the right eye. The left eye 
was affected similarly in 1945; both eyes had yielded to treatment 
by August 1945. Also, in 1945, she was admitted to hospital for 
a fuller examination when her chest skiagram showed considerable 
hilar enlargement suggestive of lymphadenoma^ no definite evidence 
was obtained and she was discharged.
In 1948 she attended the Mass Radiography Unit where the 
skiagram indicated an old left basal pleurisy, a diffuse shadowing 
in both lung fields,suggestive of some interstitial fibrosis, and 
some enlargement of the hilum on each side. She remained under 
observation. Subsequent skiagrams have shown the parenchymatous 
shadowing to have almost wholly disappeared and some persisting 
hilar enlargement.
The medical director of the M.R.U. is quite confident that 
this is a true case of sarcoidosis although the diagnosis has not 
been verified by biopsy.
a2‘7S
Date PCY..
PLASMA
v i s e .
Wintrobe
ESR. Plasma Protein Ser.
Urea
Gold
Floe.Ord.Cor. Total Alb. Glob Fib.
14: 1:52
%
43*5
cs.
2*055
im/
1 2
1 hr 
14
g./lOO ml.
8*15 1 4 * 6  | 3*2 |o*35 28 ++++
Case No. 70 Sarcoidosis.
This female patient was picked up in the Mass Radiography 
Unit in 1949 when her film showed hilar and mediastinal enlargement 
due to enlargement of the lymphatic glands in these sites. At 
that time (November, 1949) she had no symptoms, her blood count 
was normal, and a tuberculin-jelly skin test was a doubtful 
positive. Subsequent skiagrams have shown a slight reduction in 
the hilar enlargement. To exclude lymphadenoma, a lymphatic 
gland biopsy was made in a groin; the histological appearance 
was typical of sarcoidosis.
The was still free from symptoms when the laboratory tests 
were made on 14:1:52.
PCV. PLASMA
v i s e .
Wintrobe !
ESR. 1 Plasma protein 
Ord.fCor. \ Total]  Alb. j GldbjFibr.
Blood 
Urea j
%
4 6 * 3
cs.
2 * 5 1 8
rm/ 1  hr 
1 5  * 5  |  2 0
g *
8 * 4 0
/ 1 0 0  ml.
4 * 9  |  2 * 9 7 J  0 * 5 3
m g . $  1 
2 0
Filter-paper electro-phoresis indicated that the globulin 
increase was mainly in the fraction.
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Case No. 71 Parathyroid Adenoma.
This case presents some problems in differential diagnosis.
She was admitted to hospital to have gold therapy for her 
arthritis on 12:12:46. Three years prior to admission her knees 
became stiff, but painless; a few months later her neck was 
painful on turning her head. Early in 1946 her condition became 
suddenly worse and the severe pain in her knee confined her to a 
chair. Two months later she was treated at Harrogate with sulphur 
baths, etc. During treatment she fell and tore the right patellar 
tendon which was sutured; later progress to walking was slow.
Since the accident in the summer of 1946 she became more helpless 
and could walk only with assistance
On admission, she was a small thin weak patient with no other 
definite pathology apart from a limited flexion of left ankle and 
a swollen right knee due to synovitis. In addition to the gold 
therapy, local treatment to the right knee consisted of radiant 
heat and quadriceps drill for a weakened muscle.
15: 1:47 While using the bed-pan she had a spontaneous fracture 
at junction of middle and lower third of the right femur. This 
fracture was treated in a Thomas splint and later in a plaster 
splint. An X-ray of the femur showed the fracture plus another 
rarified area higher in the shaft: her left femur showed areas of
sclerosis. At this time it was noted that the patient had become
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sufficiently hirsute as to need shaving. It -was also noted that 
she had "been having repeated bouts of sickness. An X-ray of her 
skull had yielded a picture which the radiologist then and later 
diagnosed as that of secondary malignant deposits.
20: 1:47 the laboratory results of this date were:-
Urine - No Bence-Jones protein; 17-ketosteroid excretion
within normal limits for her sex and age (= 56 years) 
Blood - Wassermann and Kahn, negative.
Serum calcium = 16*3 m g - A 0 0  ml.
Serum inorganic phosphate = 3*9 mg./lOO ml.
Plasma alkaline phosphatase = 19*5 K*A* units/100 ml.
Plasma acid phosphatase =2*4 K.A. units per 100 ml.
Plasma total protein = 7*25 g./lOO ml.
albumin = 3*99 " " .rcn.T ko.o &
globulin = 2 *66 ” " “ /0
fibrinogen = 0*60 1 "
Haematocrit: Citrate = 26*2/ , P + A Oxalate = 36*1%
Plasma Viscosity: Corrected citrate = 1*695
P + A Oxalate = 2*192 .
Maximum citrate sedimentation velocity = 13*4 cm./sec xlO
The clinicians in charge of the patient considered four main 
possible diagnoses - Cushing’s syndrome, Paget's disease, 
Parathyroid adenoma or carcinoma, Malignancy elsewhere. A mass 
was palpated in the stomach with the patient relaxed under a 
general anaesthetic, and this finding, together with the report by 
the radiologist and the history of vomiting, led! to the diagnosis 
of carcinoma of the stomach with secondary deposits in the bones.
It was admitted that the blood biochemistry was also in agreement 
with a diagnosis of parathyroid overactivity.
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I obtained permission for a further blood test, "which was made:on 
3: 2:47. Her general condition was too weak to permit a barium 
meal or a gastric test meal being applied.
Blood - Serum calcium = 18*5 mg./100 ml.
Serum inorganic phosphate =4*4 mg./lOO ml.
Plasma alkaline phosphatase = 22*8 K.A. units/100 ml.
Plasma acid phosphatase = 7*2 K.A. units per 100 ml.
Plasma total protein = 7*69 g./lOO ml.
albumin = 4*43 " '*
globulin = 2*70 •' ”
fibrinogen = 0*57 " *•
Non-protein-nitrogen = 67 mg./lOO ml.
Haeraatocrit: Citrate = 26/o ; P + A Oxalate = 36*3%
Plasma Viscosity: Corrected citrate = 1*664
P + A Oxalate = 2*174
. -4
Maximum citrate sedimentation velocity = 26*7 cm./sec. xlO 
On reviewing the information then available I decided that all 
the signs and symptoms could be explained on the basis of a 
Simple Parathyroid Adenoma, except for the palpable mass in the 
stomach. The biochemical tests on the calcium, phosphate and 
phosphatase would fit in with this diagnosis; the hypercalcaemia 
would explain the vomiting; the changes in the skull in parathyroid 
disease are acknowledged to resemble that of secondary deposits.
In addition, the non-specific tests supported a simple tumour as 
(l) the plasma proteins, and especially the albumin fraction had 
actually increased at a time when the fall of "terminal decay” 
would have been expected, and (2) the citrate plasma viscosity/ 
maximum sedimentation velocity had remained on the periodic curve
a2Sl
in spite of a decrease in the viscosity and a rise in the ESR.
I pleaded that an exploratory operation on her parathyroid glands 
would be Justified even in her weak state in view of her hopeless 
prognosis. This suggestion was refused^ further investigations 
were also forbidden.
She fractured her other femur spontaneously on 30: 3:47.
She was sent home on 15: 4:47, with a very short expectancy 
of life.
A surgeon in another hospital successfully removed a tumour 
of her parathyroids which was histologically verified as a simple 
adenoma.
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Case No. 72 Adenoma of Bronchus.
A physician colleague, aged 33 years, was sitting quietly 
at his fire-side when he brought up about a cup-ful of bright red 
blood via his larynx. Because of staff shortage he had been 
over-working in the wards; he was attempting some laboratory 
investigations for an M.D. thesis; he travelled nearly 40 miles 
daily; he had many domestic worries; and he had been slimming 
successfully during the previous six weeks with the aid of 
’dexedrine’ tablets. Naturally he was afraid that he might be 
suffering from pulmonary tuberculosis. His X-ray of the chest 
revealed no pathology.
The laboratory results of a blood test on the day following 
the haemoptysis were completely normal also.
Plasma viscosity = 1*879 cs.
Haeraatocrit = 47 *4/
Wintrobe ESR. = 1 mm. in first hour.
Total plasma protein = 7*92 g./1Q0 ml.
Further investigation by the bronchoscope showed an adenoma of a 
bronchus. The tumour was removed by an approach through the 
chest wall. The simple nature of the tumour was confirmed by 
histological examination.
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Case No. 73 Fibroids of Uterus.
This patient was a nurse aged about 35 years. She was 
admitted to her sick quarters because of her complaint of severe 
abdominal pain. Menstruation was regular and not excessive in 
amount or duration; there had been no change recently in-its 
character.
On rectal examination the cavity was found to be almost 
closed by a very firm mass in the anterior wall; the finger tip 
could Just feel the upper border of this mass. A carcinoma of the 
rectum was feared but the laboratory results were all in favour 
of a tumour of a simple nature.
Laparotomy revealed multiple fibromata of the uterus; 
hysterectomy was performed.
Laboratory results on a blood investigation:-
Plasma Viscosity: Corrected citrate = 1*468 cs.
P + A Oxalate = 1*716 cs.
Haematocrit: Citrate = 30*0/ ; P + A Oxalate = 41*0^
-4
Maximum citrate sedimentation velocity = 0*31 cm./sec. xlO
Plasma total protein = 6*17 g./100 ml.
albumin = 4*50 M "
globulin = 1*67 " "
fibrinogen =0*23 " M
Non-protein-nitrogen = 30*6 mg./lOO ml.
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Oase No. 74 Teratoma testis, with metastasis.
My cousin, aged 21 years, had received his inoculations 
and his medical examination in preparation for going overseas when 
he came to spend part of his embarkation leave with me, in August 
1946. He had had a severe bronchitis three weeks previously 
from which his recovery was not complete; he also complained of 
lassitude, lack of appetite, and vague pains in the shoulders and 
the praecordium.
Because of my recent attack of tuberculosis his mother was 
rather worried. I volunteered to estimate his plasma viscosity to 
reassure her.
Corrected citrate plasma viscosity = 1*557 cs.
4Max3bnum citrate sedimentation rate = 24*0 mm. /hour
= 6*67 mm./sec. x 10""
Citrate blood haematocrit = 56*0/b 
The plasma viscosity value was at the upper part of the normal 
range. This satisfactory result was offset by an abnormally high 
ESR. which removed the combined point from the viscosity/ESR 
curve of correlation. Thus I was dealing with a probable case 
of ” terminal decay'1.
In the asylum I lacked facilities for a thorough 
investigation. I made certain that he reported sick on his 
return to the army and thus miss his draft. A radiographic 
examination readily detected a secondary tumour invasion of the
lungs "but the discovery of the primary growth in a teratoma of 
a testis (verified histologically) proved more difficult.
The earlier diagnosis made possible by the plasma viscosity 
test allowed of his discharge from the aray and of his care in the 
comfort of his own home until his death only four months later.
Case No. 75 Amelioration of Cancer of Rectum by •
This man suffered from a carcinoma of the rectum which had 
ulcerated into the bladder when a colostomy was performed in the 
autumn of 1947. The abdominal wound broke down and granulation 
tissue grew out from the wound. For the later claims for the 
effect of this drug (H^) it should be noted that the diagnosis of 
malignancy was confirmed by histological examination of a piece of 
tissue removed at the operation.
In desperation, H ^  was given and I first came in contact with 
the patient when I carried out the biochemical investigations 
demanded by the SUSA laboratories in order to control its therapy. 
He had to be brought to the laboratory by taxi and he needed help 
to mount the stairs. There was a dreadful stench from his 
colostomy, from the foul dressings of his broken-down and granulat­
ing wound, and from the clothes soiled with septic urine. The 
first results show the increased plasma viscosity in accord with 
his horrid conditions; the albumin is notably high.
The therapy continued and the patient improved steadily. The 
sinus between the bladder and rectum healed; hexamine treatment 
ultimately produced a sterile urine. The abdominal wound slowly 
healed until only a few granulomatous spots remained. He learned 
to control his colostomy properly. His interest in life increased.
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Date PCV. PLASMA.vise.
Wintr.
ESR.
P
Total
lasma Protein 
Alb. | Glob jpibr
Gold
Floe
% " cs. mm/hr g*//100 il.
14:10:47 39*5 2*306 — 7*43 4*02 2*66 0*75 0
8:12:47 42-3 2*166 - 7* 03 3*94 2*77 0*32 0
3: 2:48 40*9 2*190 - 6*92 3*82 2*40 0*70 0
31: 3:48 38*0 1*902 33 6*25 ! 3*67 2*07 0*51 o
25: 5:48 39-1 1*876 ~ 6*24 |3*67 2*08 0*49 0
23: 7:48 43*2 1*941 17 6*72 ! 3*92 2*55 0*47 o
20: 9:48 43*5 1*905 6*66 j 4*08\ 2*19 0*38 0
He was able to resume his occupation as a dentist where the close 
contact with the patient demands a fastidious standard of personal 
hygiene.
Th§ fall in the plasma viscosity and the plasma proteins in 
the first five tests might he attributed to a terminal decay and 
no indication is given by them that the usual progress to death 
will not ensue. The maintenance of the high haematocrit values, 
however, is quite contrary to the usual experience in such a severe 
case. The later increase in albumin is also contrary to the usual 
behaviour of this protein fraction in malignancy in its later 
stages, and I believe that the H-p must be given some credit for 
this extraordinary progress of disease. The high plasma viscosity 
values which persist at the end of the series of results are an 
indication that there has been no complete ''cure”. (No further 
knowledge of the case is available since X left Sunderland.)
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Case No. 76 Hypernephroma.
The extremely high plasma viscosity, ESR., and protein values 
are noteworthy - they far exceed any values found in my series of 
malignant cases with other types of disease.
This patient was admitted to hospital at Sunderland in October 
1946. He was complaining of marked loss of weight and of a hard 
cough of several months duration. He was obviously anaemic. His 
age was 51.
A malignant cause for his symptoms was suspected and he had 
a thorough investigation, including pyelograms; no indication was 
obtained of the site of a possible lesion. The pile-bearing area 
of the rectum was removed because it might have been the cause of 
repeated blood loss leading to the anaemia.
In January, 1947 he was readmitted and another full examination 
was made, but again nothing definite could be detected. He had an 
irregular evening elevation of /temperature which lead to a further 
search for a septic focus - again without success. Blood culture, 
Widal, and Paul Bunnell tests were consistently negative.
Penicillin therapy had no effect on the elevation of temperature.
Date [ ELASMljWi”^ ol5e 
vise. - 3Sf-.-1: Ord. | Cor
Plasma I 
Total Alb.
r^ote:
Glob
Ln__
Fibr NFN.
Max.
ESR.
27: 1:47 
7: 2:47
% j cs. ma/ 1 hr
28*1 3*278 1 60 I 26 
32*4 3*689 ; - -
g./lOC
- 1 - 
9*00 |3 *80
) ml. 
3*69 1*51
tdq.%
48*4
mm/hr
184
204
He next went to Manchester for the investigation of his 
anaemia by the haematologists of that city. The diagnosis was 
Aleukaemic leukaemia, but it was applied reluctantly and with 
hesitation.
However, two weeks before his death in May 1947 he developed 
haematuria and a swelling in the loin, so that a confident 
diagnosis of Hypernephroma was finally reached.
The high plasma viscosity values were due to unusually high 
fibrinogen levels. There is no known reason why the fibrinogen 
should be so elevated but the explanation may be found ultimately 
in the same mechanism by which an elevation of temperature is a 
characteristic phenomenon of tumours related to the kidney.
This high fibrinogen produced a very low figure for the plasma 
protein equilibrium factor and it was well below the maximum 
of the group in which a 100% mortality rate had been noted j the 
ordinary albumin/globulin ratio was still above unity.
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Case No. 77 Carcinoma of Stomach
This lady, E.R. , had a year’s history of epigastric pain 
which lasted for 1 - 2 hours, was not related to food or exertion, 
"but was relieved by alkali. She vomited on several occasions. 
There had been no loss of weight. She was aged 58.
No abnormality of the abdominal contents was detected by 
physical examination.
A barium meal did not show evidence of a gastric ulcer or 
neoplasm. An alcohol test meal had an initial achlorhydria, with 
free hydrochloric acid after histamine injection; there was no 
lactic acid in the fasting juice. The tests for occult blood in 
the faeces were positive on 10 occasions.
Date PCV. ‘PLASMA| v ise .
Wintr. 
| ESP.
%
1j cs. j ram/hr
6:12:47
16:12:47
35 ‘1 
32*0
1 1*961 
1*902
39
1
Plasma Protein 
;alj Alb. ’Glob 'Pi
g'/lOO ml
7 *34
NPN. GoldPloc
- o
37*3 0
The plasma viscosity test did not assist much in the different­
ial diagnosis between an ulcer and a carcinoma. The most definite 
indication of malignancy was in the falling haematocrit values 
yet this might have followed the bleeding of a simple ulcer (cf. 
positive occult blood tests).
At operation on the 31:12:47, a large indurated malignant ulcer
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was present in the stomach wall, a short distance from the 
pylorus. There was Already secondary involvement of the associated 
lymph glands, but there were no obvious deposits in the liver or 
elsewhere.
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Case No. 78 Multiple Myeloma.
This man, aged 52 years, wa£ admitted to hospital on 6:6:50, 
with a history of loss of weight (24 lbs. in 1 year), anorexia 
plus nausea after coughing for 6 months, and a constant feeling of 
constriction around the lower chest, not related to food, for one 
month. Otherwise he had been a very healthy man except for a 
little sputum as a result of gas in the 1914 war.
On examination, he was a thin wasted and obviously anaemic man. 
There was a single enlarged lymphatic gland in left supraclavicular 
region. No other abnormality was detected.
His temperature was elevated: this did not respond to the
empirical exhibition of salicylate, penicillin, or aureomycin.
The diagnosis made at this stage was of a Neoplasm, probably 
of stomach or lung.
Further special investigations did not help much. Barium 
meals revealed no pathology in stomach or duodenum; tests for 
occult blood in faeces were always negative; and free HC1 was 
found in a test meal analysis. Skiagrams of chest showed no 
abnormality of lungs or ribs; no tubercle bacilli or malignant 
cells were ever detected in the sputum. Blood agglutination tests 
for B. abortus, typhoid and paratyphoid were negative. The 
enlarged lymphatic gland was removed and examined histologically 
but there was no evidence of neoplastic invasion or any other
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Date PCV.
PLASM
vise.
Wintrobe
ESR.
0rd.|Cor.
i
% CS. hue/ 1 hr
26: 7 28* 6*123 19 0 .
27: 7 26*5 5*155 36 6
116: 8 26*5 6 *660 16 0
[17:10 22* 5*585 ""
 ■'--■-I
Plasma protein j Gold j 
Fibr 1 Floe 1
Serum j 
Aik.
) Phos-ase
units %
i f otallAlb.[Glob
g./lOO ml
11*27 2 *0 
10*5 1*9 0*71
10*72 2*3
10*0 0*66
abnormality. Bone marrow biopsies on 31:7 and 4:8 showed an excess 
of cells of the plasmocyte and reticulum series - not sufficient 
to allow a definite diagnosis. Serum acid phosphatase was low
(= 1*0 K.A. units per 100 ml.). Bronchoscopy did not detect a 
tumour when performed later in September.
The diagnosis was given with some confidence when the plasma 
proteins were first investigated some 7 weeks after admission.
The first plasma sample was prepared by blood drawn in another 
laboratory and there was no check on the withdrawal being free 
from stasis and the history of the plasma sample until it reached 
me for viscosity estimation could not be guaranteed as shielded 
from evaporation losses, etc. Hence there may be a large part of 
the difference between the viscosities at 24-hours interval due to 
laboratory errors but it has also to be accepted that such a large 
difference may be due entirely to changes within the patient. He 
was most uncooperative so that I was unable to make further tests 
at short intervals on him to study this point.
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The results of this patient also demonstrate how small 
changes in the protein fractions, when their total amount is high, 
can he associated with large changes in the plasma viscosity 
values - this is to he expected from a consideration of the 
graphs of the relation between the concentration and the viscosity 
of solutions of the purified fractions.
The gold flocculation and thymol turbidity and flocculation 
tests were consistently normal in spite of the increased globulin.
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Case No. 79 Multiple Myeloma.
This case presents the diagnostic problems which this
disease can raise. The biochemical results from my laboratory
gave a lead towards the correct diagnosis.
This lady, aged 58 years, was treated in April 1948 with 
penicillin and sulphonamides for a septic thumb. She was in bed 
for two weeks, and on getting up she felt very weak, especially 
in the legs. She then recalled that she had had ’rheumatism* in 
her legs prior to the episode of the septic thumb and her rate of 
walking had been slowed. After a further 3 weeks of convalescence 
she still felt tired, she had a sharp pain in the right submamraary 
region, she had lost a little weight, and she felt generally 
shaky. Her own doctor detected exaggerated reflexes, tremors of 
hands, no tacchycardia but frequent extrasystoles, but no excess 
sweating. He referred her to hospital as a possible case of 
hyperthyroidism.
7:7:48 Her B.M.R. on this day was +8 . A skiagram of the 
chest was normal. She now reported a very severe pain across her 
back which had appeared 2 weeks previously; she was never free 
from pain and at its worst she had to retire to bed for relief.
She had become so weak that she could not do her housework. Yet 
on physical examination nothing abnormal could be detected. The 
diagnosis of rheumatoid arthritis was now raised and she was again 
referred to me for her plasma viscosity to be estimated.
r  ■ j  f } I . .  . -  —  .
I PT.AflMA Wintrobe •nl , .
Date PCV. I pop : P1^sma protein. _
J V1SC. — jTotal: Alb. | Glob iFibr
12:7 29 *3[ 2*793
Ord.[Cor.
cs. jmm/ 1 hr g./lOO ml.
59! 32 9 *90 - -
24:8 129 *0 s 3*656 
14:9 i24*6; 3*495 
20;9 123*21 3*346
Plas.
V
Aik. Thymol Gold
Phos. | Tur. FI. Floe
un. % ij un.
4*7 • 16 4+f 5+
4*0 ! 18 5+ 5+
4*5 | 15 4+ 5+
5*2 ! 12 3+ | 5+
4*3 ; 15 4+ 5+
4*2 1 18 5+ 1 5+
12:7:48 The laboratory tests of this date are given in the table 
above. In view of this indication of a severe disease condition 
she was admitted to the ward for a thorough investigation. She 
then had her severest pain in the spine and pelvic bones so that 
she had skiagrams taken to determine if any signs of ankylosing 
spondylitis. The radiologist reported that there was no evidence 
of ankylosing spondylitis but a generalised hypocalcification of 
the lumbar spine and pelvis required the exclusion of generalised 
osteitis fibrosa. The femora also showed a decreased calcification 
but the humeri appeared normal.
*
24:7:48 The laboratory findings of this date, especially the low 
phosphatase, made, a parathyroid disease unlikely -
Blood urea = 24 mg./100 ml.
Serum calcium = 10 mg«/l00 ml.
Serum inorganic phosphate =4*4 mg. /100 ml.
Serum alkaline phosphatase = 4*7 K.A. units per 100 ml.
28:7:48 The repeated biochemical tests of this date, plus the 
other tests and clinical information, now stongly suggested the 
diagnosis of multiple myeloma. Bence-*Jones protein could not be
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Case No. 79
cs.cs.
3-6 -■ Plasma — 
Viscosity
/'Serum Viscosity.
34
mnu/lst hr.
30
E. S. R.
P. C.V.- - x—
28
Fibrinogen
Albumin
0*3
SeptemberAugust
The plasma and serum viscosities, the corrected Wintrobe ESR. , 
the haematocrit, and the plasma protein fractions - studied in 
a case of Multiple Myeloma over a period of just less than 
two months.
detected in the urine on repeated testing. In view of our other 
very high results in the case of hypernephroma (see section of 
cases of malignant disease) an attempt to exclude this condition 
was made by an intravenous pyelogram for kidney positions.
7:8:48 The diagnosis was verified by the discovery of myeloma 
cells in a sternal marrow puncture.
Treatment with Urethane caused little change in her condition. 
She was weaker and entering her terminal decay when the last test 
of my series was measured: she then was so light that a single 
ambulance attendant was able to carry her like a large infant.
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Case No. 80 Multiple myeloma.
This man was admitted to hospital in a semi-comatose 
condition on 9:3:50 and died on 13:3:50. Because of slow 
cerebration a vague history only was obtained - he had had a fall 
at work 2 years ago; for 1 year he had pains in the back and chest 
and these pains had been getting so severe that he required 
sedatives to sleepy chief pain was in lower chest.
On examination, he was a wasted elderly man. Bony tenderness 
was found only over the right lower ribs. The liver was enlarged. 
No other definite abnormality was detected.
11:3:50 Laboratory results:-
Plasma viscosity = 3*182 cs.
Wintrobe ESR. = 52 mm. / 1st hour
Corrected " " = 26 H "
Haematocrit = 33*4- % Gold flocculation = +++++
Plasma total protein = 11*9 g./lOO ml.
albumin = 4*2 ” 1
globulin = 7*3 ” "
fibrinogen = 0*41 " "
Blood urea = 95 mg./lOO ml.
Serum calcium = 15*8 ” "
Plasma alkaline phosphatase = 9*0 K.A. units per lOOml.
Serum acid phosphatase =2*5 *' H H
Formalin-fast acid phosphatase =1*0 H M
The post-mortem on the 14:3:50 confirmed the diagnosis. The 
3rd and 5th lumbar vertebrae had collapsed. Myelomatous tissue 
was detected in the veretebra, ribs, calvarium, and sternum.
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Case No. 81 Acute Infective Hepatitis.
This youth had -what appeared to he a mild attack of 
infective hepatitis beginning on 3:4:50 - anorexia, malaise, 
headache, diarrhoea with pale stools, dark urine for 2 days, and 
yellow conjunctivae for 3 days. He became quite well again until 
he had a relapse in May to produce the illness now to be described.
On 28:5:50 the yellow colour returned to the conjunctivae; the 
stools became pale in colour, the urine became dark. He felt 
quite well. His liver was enlarged to 2 finger-breadths below the 
costal margin, and it soon reached 4 f inger-bre adths. No other 
abnormality was detected on examination. There was no recent 
injection. He was treated at home with rest in bed and a high 
protein diet. No apparent improvement followed so that he was 
admitted to hospital on 16:6:50.
On examination on that date his liver was still enlarged, but 
soft and not tender; the spleen was palpable. The same treatment 
was continued. By the time bfcthe firstobl°Odr.t^ st: (ie* plasma 
viscosity) the jaundice had decreased somewhat although the liver 
and spleen were still enlarged - 29:6:50. By 12:7:50 the liver 
was slightly smaller and the spleen was just palpable; similar 
findings were noted on 26:7:50. He was discharged on 7:8:50 to 
continue his convalescence at home. He went back to boarding-school
Date PCV.
PLASMA
vise.
Wintrobe
ESR. Plasma protein Gold
Floe
Aik.
Phos
Bili­
rubin0rd.|Cor. Total Alb. G-lob Fibr
% cs.
1
mm/ 1 hr g /100 ml. un. % mg«>°
12: 6:50 - - 26 - 8*5 4 *4 3*77 0*33 5+ 25 11*0
29: 6:50 38* 2*265 31 18 8*70 4*2 4*09 0*31 5+ 22 3*0
12: 7:50 34*3 2*355 48 26 7*62 4*2 3*2 0*22 5+ 22 0*8
26: 7:50 - - - - 8*05 4*4 3*3 0*35 4+ 30 0*6
16: 9:50 - - - - 8*2 4*9 3*0 0*30 4+ 44 0*2
14:12:50 41* 1*987 15 9 8*90 5*0 3*61 0*29 4+ 44 0*2
26: 3:51 43* 2*000 18 13 9*15 4*5 4*2 0*45 2+ 36 0*2
3: 9:51 41*6 1*796 5 0 7*50 5*6 1*58 0*32 0 38 0*2
but took no part in games.
The diagnosis at this stage was that an acute hepatitis was 
passing into the chronic phase, with a 50% chance only of recovery. 
He continued on a high protein diet and a general regime which 
protected him from stress. This diagnosis was further supported 
by the results of September, December and March. For some reason, 
not detectable by the clinical observers, he suddenly changed for 
the better. Apart from a rather high serum alkaline phosphatase 
and a low haematocrit, the laboratory tests had all returned to 
within their normal ranges by the following September; the whole 
illness had lasted about fifteen months.
It is noteworthy that the plasma viscosity falls within the 
“zone of chronicity'1 during that period of the illness when the 
clinicians regarded it as being in a chronic phase.
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Case No. 82 Acute Nephritis.
The plasma viscosity is usually increased in cases of 
acute nephritis just as in any other kind of acute inflammation; 
the increase reflects an increase in the plasma fibrinogen.
This man was aged 65 years when he had his first attack of 
acute nephritis. He had led a healthy life; the only relevant 
illness was scarlet fever at the age of 12 years, which was free 
from complications.
The present illness began a little over 2 weeks prior to 
admission to hospital, as a sore.throat, tonsillitis, headache, 
pains in legs, and increased temperature. These signs and 
symptoms cleared in a week but were followed in another few days 
by a swelling of the ankles, of the legs and later of the face.
He was breathless. His urine diminished in volume but darkened in 
colour.
On examination, on admission (27:2:50) he had much oedema of 
the legs and sacrum and his face was puffy. The heart size was 
within normal limits; the vessels of the optic fundus were markedly 
a±;erio.solferotiC;; the blood pressure was 280/140. The urine 
contained a heavy cloud of albumen, large numbers of erythrocytes, 
occasional leukocytes, occasional epithelial casts and a fair 
number of hyaline and granular casts.
Treatment consisted of rest in bed, sedation, iron, low-salt
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Date ; PCV„
il: 3:50
°/o
34*2
PLASMA
vise.
Wintrobe
ESP. Plasma protein Serum
Ord. Cor. Totalf Alb. f G-lob|Pibr NPN
cs. mm/ 1 hr g./lOO ml. mg.%
2*167 56 30 7*90 | 3*lo|3*19|o*61 34 1
diet and restricted fluid intake, and penicillin.
He showed an excellent response to this treatment so that 
he was discharged on 4:5:50.
The diagnosis was of an acute nephritis in an arterio­
sclerotic subject rather than a flare-up in a chronic nephritic.
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Case No. 83 Nephrotic Nephritis.
This elderly man (79 years) had led a healthy life until 
his legs had begun to swell slightly about 3-4 years before the 
present illness. For the past 2-3 months he had suffered from a 
severe swelling of the legs and a shortness of breath.
On admission, he appeared to be fairly healthy except for a 
suggestion of periorbital oedema^ however, there was gross oedema 
of legs and scrotum, and of left arm. There was a minimal venous 
congestion of the neck veins; the apex beat was in the 6th space, 
5H from midline; the heart sounds were pure; blood pressure = 
200/100; and there was no clubbing of the fingers. There was a 
pleural effusion on both sides, greater on the right. No other 
abnormality was noted.
3 pints of pleural fluid had been removed by three tappings 
by the time that the laboratory tests were made, 11 days after 
admission.
PCV. PlasmaVise.
Wintrobe
ESR. Plasma protein Ser.
Urea
Serum
Choles
-terolOrd.jCor.
Total Alb. | Glob Fib.
fo
38*5
cs.
2*107
mm/l hr 
52 38 5*45
y. /100 ml 
2*7 j1*8 |0*95
mg •% 
83
iflg •% 
368
Urea clearance = 55 and 547° of average normal.
Urea concentration = 2*3% as maximum after 15 g. urea. 
Urinary protein = 700 mg. per 100 ml.
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Case No. 84 Chronic Nephritis.
In 194-9, when 16 years old, this girl had a sore throat or 
tonsillitis which was followed "by an albuminuria; her general 
practioner sent her to hospital as a case of Nephritis but the 
diagnosis of the hospital was meningitis (it was a cottage 
hospital only and acute uraemia might have been missed). She had 
never suffered from rheumatic or scarlet fever.
Early in January 1951 she had an attack of influenza. Two 
weeks later she noted a swelling in her ankles and in her face 
and eyelids: the urine was redder than usual for a week. The
blood pressure was 160/100 mm. mercury; there was gross albuminuria. 
She went to bed at the beginning of March and the blood pressure 
had fallen to 142/90 when she was admitted to hospital on 7:4:51.
On examination, apart from this slightly increased blood pressure 
and pale mucous membranes no abnormality could be detected. The 
urine contained 320 mg» per 100 ml. of protein, large numbers of 
epithelial cells and leucocytes, and scanty staphylococci. The 
blood biochemistry was as is shown in the table.
She made very slow progress indeed and was not discharged 
until 16:11:51. A fortnight later she had another head cold which 
was followed by a recurrence of haematuria, oedema, increased 
blood pressure so that she is still a patient in January 1952.
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Date P07.
PLASM
vise.
Wintrohe
ESR. Plasma protein qSerum
Ord.Cor. Totalj Alh. | GlohjFih. Urea Cholesterol
% cs. mm/ 1 hr g./lOO ml. lag.fo
7: 4:51 31* “ 27 11 5*36 | 3*15|1*75|G*46 39 370
21: 4:51 - - - 4*87 2*87 1*62 0*38 40 346
5: 5:51 33* 1*617 27 14 4*85 2*8 1*7 0*35 56 321
4: 9:51 - - - - 4*9 2*7 1*8 0*4 47 330
14:11:51 32* 1*514 29 14 4*7 2*8 1*53 0*37 44 320
This case illustrates how the low plasma proteins which 
may he found in chronic nephritis can he associated with normal 
or sub-normal plasma viscosity values.
Table XX a32 7
Errors of Carbohydrate Metabolism.
Name No. PCV.
PLASMA [Plasma
VISC. Total.
Protein
Remarks
70 cs. 
Low Renal Threshold
g.°/o
S. P. M 1 48*1 1*776 6*95
T.U. M 2 42*1 1*833 7*09
P. A. M 3 52*9 1*892 7*20
R. A. M 4 45*3 1*849 7*70
B.B. M 5 49*1 1*761 7*09
R.P. F 6 41*7 1*886 6*98
M. C. F 7 46*7 1*853 7*09
M.G. M 8 - 1*729 6*41
"Lag Curve 
A. B. [ F | 1 | 42*2 | 1*795 
Diabetes Mellitus.
7*52
M . Gr. F 1 47*1 I 1*897 1 6*95 j Requires insulin
G . R . M 2 48*9 I 1*899 | 7*34 1 Mild; controlled by diet
Gr. B. M 3 47*4 1*997 I 7*85 ’ Arteriosclerosis; gangrene
Mu W. F 4 43 *4 2*020 ! 8*03 Arteriosclerotic; slightly obese
D. B. F 5 42*7 1*750 1 7*°2 Young girl; insulin given later
A.R. M 6 50*0 2*047 1 8*14
M . S . M 7 46*6 1*840 I 7*16 Controlled with insulin
H .  H . M 8 41*0 1*839 | 6*37 Oedema due to Vit. B deficiency
M . D. M 9 49 *4 1*991 i 7*02
I. W. F 10 30*0 2*132 ! 8*14 | Essential hypertension.
M . C . F 11 43*0 2*005 7*56 [ On insulin
M . B . F 12 45*5 1*973 ; 7*49
ji
J . T . M 13 44*2 1*974 - On insulin; neuritis
J.C. M 14 - 1*978 : 7*81 j Small abscess of shoulder; retinit
W.T. M 15 49*1 1*794 j 6*80 | Blood press. = 170/110 mnuHg.
R .  A. F 16 41*9 2*070 7*34
M . R . M 17 50*0 1*905 7*45
M.A. F 18 42*8 1*862 6*84 j Obese; B.P. = 160/100 mm.Hg.
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Case No. 85 Osteitis deformans (Paget's disease)
This man had been treated successfully with Pepsac for 
his pernicious anaemia from 1943 until 1946, but thereafter he 
lost his appetite, his tongue became sore, his ankles swelled, and 
the picture was that of pernicious anaemia in relapse. After a 
period of 8 months in this state liver therapy was tried for 4 
months without producing any improvement.
In July 1947 he was admitted to hospital and his anaemia 
responded to folic acid, large doses of liver extract, and large 
doses of iron by mouth.
No other abnormality was found on general examination. A 
routine skiagram of the chest, however, revealed osteitis 
deformans in the dorsal spine, and the disease was later shown to 
be affecting the lumbar spine, skull, femora and tibiae.
In September 1947, laboratory tests indicated that the
anaemia was under control.
22:9:47 Plasma viscosity = 2*221 cs.
Haematocrit = 40*2$
Haemoglobin = 82 %
Erythrocytes = 4,250,000 per cmm.
Colour index = 0*98
Film = cells appear normal.
Plasma alkaline phosphatase = 119 K.A. units/100 ml.
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Case No. 86 Osteitis deformans (Paget's disease).
This old man, aged 72 years, was admitted to hospital in 
December 1947 with a history that he had collapsed at Easter of 
that year and had been confined to bed since. He had lost 20 lb. 
in the 9 months; his knees had become fixed in flexure; he was 
incontinent of urine and faeces.
On general examination, he was a frail old man with no 
apparent definite abnormality apart from the flexed knees. A 
skiagram of the spine, however, showed gross patchy dense areas 
in all the bones of the spine and pelvis, with deformity at the 
2nd. lumbar intervertebral joint.
The diagnosis lay between Osteitis deformans and secondary 
carcinomatous deposits from a primary growth in the prostate; the 
latter possibility was discarded because of the low serum acid 
phosphatase level and the very high alkaline phosphatase value.
PCV. PLASMA
vise.
ESR.
Plasma 1 _ n,
total l ^ ld . i floe, prot.
Serum 
Acid Aik. 
phosphatase
(Si7°
33*3
cs.
2*139 —
g- %
6 *66 j o
unit/lOOml. 
1*5 88*2
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